DELETE FROM omim;
INSERT INTO omim VALUES
('100070','AAA','Aortic aneurysm, familial abdominal 1 (2)'),
('100070','AAA1','Aortic aneurysm, familial abdominal 1 (2)'),
('100650','ALDH2','Alcohol sensitivity, acute, 610251 (3); {Hangover, susceptibility'),
('100650','ALDH2','to}, 610251 (3); {Sublingual nitroglycerin, susceptibility to poor response to} (3); {Esophageal cancer, alcohol-related, susceptibility to} (3)'),
('100678','ACAT2','?ACAT2 deficiency, 614055 (1)'),
('100690','ACHRD','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100690','CHRNA1','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100690','CMS2A','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100690','FCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100690','SCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100690','ACHRD','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100690','CHRNA1','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100690','CMS2A','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100690','FCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100690','SCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100710','ACHRB','Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100710','CHRNB1','Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100710','CMS1D','Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100710','CMS2A','Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100710','SCCMS','Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100710','ACHRB','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100710','CHRNB1','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100710','CMS1D','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100710','CMS2A','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100710','SCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100720','ACHRD','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100720','CHRND','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100720','CMS2A','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100720','FCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100720','SCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100720','ACHRD','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100720','CHRND','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100720','CMS2A','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100720','FCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100720','SCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','CHRNE','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','CMS1D','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','CMS1E','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','CMS2A','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','FCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','SCCMS','Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)'),
('100725','CHRNE','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','CMS1D','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','CMS1E','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','CMS2A','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','FCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100725','SCCMS','Myasthenic syndrome, slow-channel congenital, 601462 (3);'),
('100730','ACHRG','(3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100730','CHRNG','(3); Multiple pterygium syndrome, lethal type, 253290 (3)'),
('100730','ACHRG','Myasthenia gravis, neonatal transient (2); Escobar syndrome, 265000'),
('100730','CHRNG','Myasthenia gravis, neonatal transient (2); Escobar syndrome, 265000'),
('100740','ACHE','[Blood group, Yt system], 112100 (3)'),
('100740','YT','[Blood group, Yt system], 112100 (3)'),
('100790','ASCL1','Central hypoventilation syndrome, congenital, 209880 (3); Haddad'),
('100790','ASH1','Central hypoventilation syndrome, congenital, 209880 (3); Haddad'),
('100790','ASCL1','syndrome, 209880 (3)'),
('100790','ASH1','syndrome, 209880 (3)'),
('100850','ACO2','Infantile cerebellar-retinal degeneration, 614559 (3)'),
('100850','ICRD','Infantile cerebellar-retinal degeneration, 614559 (3)'),
('101850','PPKP3','?Keratoderma, palmoplantar, punctate type 3 (2)'),
('102300','RLS1','{Restless legs syndrome 1} (2)'),
('102480','ACR','?Male infertility due to acrosin deficiency (2)'),
('102510','ACRPV','Acropectorovertebral dysplasia (2)'),
('102540','ACTC1','Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial'),
('102540','ASD5','Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial'),
('102540','CMD1R','Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial'),
('102540','CMH11','Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial'),
('102540','LVNC4','Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial'),
('102540','ACTC1','hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)'),
('102540','ASD5','hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)'),
('102540','CMD1R','hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)'),
('102540','CMH11','hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)'),
('102540','LVNC4','hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)'),
('102560','ACTG1','Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter'),
('102560','BRWS2','Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter'),
('102560','DFNA20','Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter'),
('102560','DFNA26','Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter'),
('102560','ACTG1','syndrome 2, 614583 (3)'),
('102560','BRWS2','syndrome 2, 614583 (3)'),
('102560','DFNA20','syndrome 2, 614583 (3)'),
('102560','DFNA26','syndrome 2, 614583 (3)'),
('102565','ABPA','(3)'),
('102565','ABPL','(3)'),
('102565','FLN2','(3)'),
('102565','FLNC','(3)'),
('102565','MFM5','(3)'),
('102565','MPD4','(3)'),
('102565','ABPA','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102565','ABPL','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102565','FLN2','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102565','FLNC','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102565','MFM5','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102565','MPD4','Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065'),
('102573','ACTN2','Cardiomyopathy, dilated, 1AA, 612158 (3)'),
('102573','CMD1AA','Cardiomyopathy, dilated, 1AA, 612158 (3)'),
('102574','ACTN3','[Alpha-actinin-3 deficiency] (3); [Sprinting performance] (3)'),
('102576','ACVR1','Fibrodysplasia ossificans progressiva, 135100 (3)'),
('102576','ACVRLK2','Fibrodysplasia ossificans progressiva, 135100 (3)'),
('102576','ALK2','Fibrodysplasia ossificans progressiva, 135100 (3)'),
('102576','FOP','Fibrodysplasia ossificans progressiva, 135100 (3)'),
('102578','MYL','Leukemia, acute promyelocytic, PML/RARA type (3)'),
('102578','PML','Leukemia, acute promyelocytic, PML/RARA type (3)'),
('102582','APRF','Hyper-IgE recurrent infection syndrome, 147060 (3)'),
('102582','HIES','Hyper-IgE recurrent infection syndrome, 147060 (3)'),
('102582','STAT3','Hyper-IgE recurrent infection syndrome, 147060 (3)'),
('102600','APRT','Urolithiasis, 2,8-dihydroxyadenine (3)'),
('102610','ACTA1','255310 (3)'),
('102610','ASMA','255310 (3)'),
('102610','CFTD1','255310 (3)'),
('102610','NEM1','255310 (3)'),
('102610','NEM3','255310 (3)'),
('102610','ACTA1','Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,'),
('102610','ASMA','Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,'),
('102610','CFTD1','Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,'),
('102610','NEM1','Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,'),
('102610','NEM3','Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,'),
('102610','ACTA1','with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1,'),
('102610','ASMA','with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1,'),
('102610','CFTD1','with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1,'),
('102610','NEM1','with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1,'),
('102610','NEM3','with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1,'),
('102620','AAT6','Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic'),
('102620','ACTA2','Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic'),
('102620','ACTSA','Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic'),
('102620','MYMY5','Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic'),
('102620','AAT6','smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)'),
('102620','ACTA2','smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)'),
('102620','ACTSA','smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)'),
('102620','MYMY5','smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)'),
('102630','ACTB','243310 (3)'),
('102630','BRWS1','243310 (3)'),
('102630','ACTB','Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 2,'),
('102630','BRWS1','Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 2,'),
('102680','ADD1','{Hypertension, essential, salt-sensitive}, 145500 (3)'),
('102750','ADK','Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)'),
('102770','AMPD1','Myoadenylate deaminase deficiency (3)'),
('102772','AMPD3','[AMP deaminase deficiency, erythrocytic], 612874 (3)'),
('103000','AK1','Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)'),
('103020','AK2','Reticular dysgenesis, 267500 (3)'),
('103220','ANT1','deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)'),
('103220','PEO2','deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)'),
('103220','PEO3','deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)'),
('103220','SLC25A4','deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)'),
('103220','T1','deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)'),
('103220','ANT1','Progressive external ophthalmoplegia with mitochondrial DNA'),
('103220','PEO2','Progressive external ophthalmoplegia with mitochondrial DNA'),
('103220','PEO3','Progressive external ophthalmoplegia with mitochondrial DNA'),
('103220','SLC25A4','Progressive external ophthalmoplegia with mitochondrial DNA'),
('103220','T1','Progressive external ophthalmoplegia with mitochondrial DNA'),
('103280','ASM1','180860 (3); Wilms tumor 2, 194071 (3)'),
('103280','BWS','180860 (3); Wilms tumor 2, 194071 (3)'),
('103280','D11S813E','180860 (3); Wilms tumor 2, 194071 (3)'),
('103280','H19','180860 (3); Wilms tumor 2, 194071 (3)'),
('103280','WT2','180860 (3); Wilms tumor 2, 194071 (3)'),
('103280','ASM1','Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,'),
('103280','BWS','Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,'),
('103280','D11S813E','Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,'),
('103280','H19','Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,'),
('103280','WT2','Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,'),
('103320','AGRN','Myasthenia, limb-girdle, familial, 254300 (3)'),
('103600','ALB','Analbuminemia (3); [Dysalbuminemic hyperthyroxinemia] (3);'),
('103600','ALB','[Dysalbuminemic hyperzincemia], 194470 (1)'),
('103720','ADH1B','{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)'),
('103720','ADH2','{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)'),
('103720','ADH1B','{Alcohol dependence, protection against}, 103780 (3);'),
('103720','ADH2','{Alcohol dependence, protection against}, 103780 (3);'),
('103730','ADH1C','disease, susceptibility to}, 168600 (3)'),
('103730','ADH3','disease, susceptibility to}, 168600 (3)'),
('103730','ADH1C','{Alcohol dependence, protection against}, 103780 (3); {Parkinson'),
('103730','ADH3','{Alcohol dependence, protection against}, 103780 (3); {Parkinson'),
('103850','ALDOA','Glycogen storage disease XII, 611881 (3)'),
('103850','GSD12','Glycogen storage disease XII, 611881 (3)'),
('103950','A2M','Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer'),
('103950','A2MD','Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer'),
('103950','A2M','disease, susceptibility to}, 104300 (3)'),
('103950','A2MD','disease, susceptibility to}, 104300 (3)'),
('104000','AA1','Alopecia areata 1 (2)'),
('104150','AFP','alpha-fetoprotein] (3)'),
('104150','HPAFP','alpha-fetoprotein] (3)'),
('104150','AFP','[AFP deficiency, congenital] (1); [Hereditary persistence of'),
('104150','HPAFP','[AFP deficiency, congenital] (1); [Hereditary persistence of'),
('104155','ATBF1','{Prostate cancer, susceptibility to}, 176807 (3)'),
('104155','ZFHX3','{Prostate cancer, susceptibility to}, 176807 (3)'),
('104170','NAGA','Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3);'),
('104170','NAGA','Schindler disease, type III, 609241 (3)'),
('104250','ADRA2C','{Congestive heart failure and beta-blocker response, modifier of} (3)'),
('104250','ADRA2L2','{Congestive heart failure and beta-blocker response, modifier of} (3)'),
('104311','AD3','Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3,'),
('104311','PSEN1','Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3,'),
('104311','AD3','frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); Acne inversa, familial, 3, 613737 (3)'),
('104311','PSEN1','frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); Acne inversa, familial, 3, 613737 (3)'),
('104311','AD3','with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia,'),
('104311','PSEN1','with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia,'),
('104614','ATR1','Cystinuria, 220100 (3)'),
('104614','D2H','Cystinuria, 220100 (3)'),
('104614','NBAT','Cystinuria, 220100 (3)'),
('104614','SLC3A1','Cystinuria, 220100 (3)'),
('104620','ACY1','Aminoacylase 1 deficiency, 609924 (3)'),
('104620','ACY1D','Aminoacylase 1 deficiency, 609924 (3)'),
('104760','AAA','Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic'),
('104760','AD1','Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic'),
('104760','APP','Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic'),
('104760','CVAP','Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic'),
('104760','AAA','variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)'),
('104760','AD1','variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)'),
('104760','APP','variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)'),
('104760','CVAP','variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)'),
('104770','APCS','{?Amyloidosis, secondary, susceptibility to} (1)'),
('104770','SAP','{?Amyloidosis, secondary, susceptibility to} (1)'),
('105550','ALSFTD1','Amyotrophic lateral sclerosis with frontotemporal dementia 1 (2)'),
('105580','ANC','?Anal canal carcinoma (2)'),
('105590','ALK','{Neuroblastoma, susceptibility to, 3}, 613014 (3)'),
('105590','NBLST3','{Neuroblastoma, susceptibility to, 3}, 613014 (3)'),
('105600','CDA3','Dyserythropoietic anemia, congenital, type III (2)'),
('105600','CDAN3','Dyserythropoietic anemia, congenital, type III (2)'),
('105800','ANIB1','Aneurysm, intracranial berry, 1 (2)'),
('105850','ALS9','Amyotrophic lateral sclerosis 9, 611895 (3)'),
('105850','ANG','Amyotrophic lateral sclerosis 9, 611895 (3)'),
('105850','RNASE5','Amyotrophic lateral sclerosis 9, 611895 (3)'),
('106150','AGT','{Hypertension, essential, susceptibility to}, 145500 (3);'),
('106150','SERPINA8','{Hypertension, essential, susceptibility to}, 145500 (3);'),
('106150','AGT','{Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3)'),
('106150','SERPINA8','{Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3)'),
('106165','AGTR1','267430 (3)'),
('106165','AGTR1A','267430 (3)'),
('106165','AT2R1','267430 (3)'),
('106165','AGTR1','Hypertension, essential, 145500 (3); Renal tubular dysgenesis,'),
('106165','AGTR1A','Hypertension, essential, 145500 (3); Renal tubular dysgenesis,'),
('106165','AT2R1','Hypertension, essential, 145500 (3); Renal tubular dysgenesis,'),
('106180','ACE','susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);'),
('106180','ACE1','susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);'),
('106180','DCP1','susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);'),
('106180','ICH','susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);'),
('106180','MVCD3','susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);'),
('106180','ACE','{Myocardial infarction, susceptibility to} (3); {Alzheimer disease,'),
('106180','ACE1','{Myocardial infarction, susceptibility to} (3); {Alzheimer disease,'),
('106180','DCP1','{Myocardial infarction, susceptibility to} (3); {Alzheimer disease,'),
('106180','ICH','{Myocardial infarction, susceptibility to} (3); {Alzheimer disease,'),
('106180','MVCD3','{Myocardial infarction, susceptibility to} (3); {Alzheimer disease,'),
('106180','ACE','{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('106180','ACE1','{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('106180','DCP1','{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('106180','ICH','{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('106180','MVCD3','{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('106410','ANK2','ankyrin-B-related, 600919 (3)'),
('106410','LQT4','ankyrin-B-related, 600919 (3)'),
('106410','ANK2','Long QT syndrome-4, 600919 (3); Cardiac arrhythmia,'),
('106410','LQT4','Long QT syndrome-4, 600919 (3); Cardiac arrhythmia,'),
('106700','TAPVR1','Total anomalous pulmonary venous return (2)'),
('107200','ANIC','Anosmia, isolated congenital (2)'),
('107265','CD19','Immunodeficiency, common variable, 3, 613493 (3)'),
('107265','CVID3','Immunodeficiency, common variable, 3, 613493 (3)'),
('107269','CD44','[Blood group, Indian system], 609027 (3)'),
('107269','IN','[Blood group, Indian system], 609027 (3)'),
('107269','MDU2','[Blood group, Indian system], 609027 (3)'),
('107269','MDU3','[Blood group, Indian system], 609027 (3)'),
('107269','MIC4','[Blood group, Indian system], 609027 (3)'),
('107271','CD59','CD59 deficiency, 612300 (3)'),
('107271','MIC11','CD59 deficiency, 612300 (3)'),
('107280','AACT','Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular'),
('107280','ACT','Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular'),
('107280','SERPINA3','Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular'),
('107280','AACT','disease, occlusive (3)'),
('107280','ACT','disease, occlusive (3)'),
('107280','SERPINA3','disease, occlusive (3)'),
('107300','AT3','Thrombophilia due to antithrombin III deficiency, 613118 (3)'),
('107300','AT3D','Thrombophilia due to antithrombin III deficiency, 613118 (3)'),
('107300','SERPINC1','Thrombophilia due to antithrombin III deficiency, 613118 (3)'),
('107300','THPH7','Thrombophilia due to antithrombin III deficiency, 613118 (3)'),
('107320','ATPLS','?Antiphospholipid syndrome, familial (2)'),
('107323','ALDH7A1','Epilepsy, pyridoxine-dependent, 266100 (3)'),
('107323','ATQ1','Epilepsy, pyridoxine-dependent, 266100 (3)'),
('107323','EPD','Epilepsy, pyridoxine-dependent, 266100 (3)'),
('107323','PDE','Epilepsy, pyridoxine-dependent, 266100 (3)'),
('107400','AAT','Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due'),
('107400','PI','Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due'),
('107400','SERPINA1','Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due'),
('107400','AAT','to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility'),
('107400','PI','to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility'),
('107400','SERPINA1','to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility'),
('107400','AAT','to}, 606963 (1)'),
('107400','PI','to}, 606963 (1)'),
('107400','SERPINA1','to}, 606963 (1)'),
('107470','IFNGR1','BCG infection, generalized familial, 209950 (3); {H. pylori infection, susceptibility to}, 600263 (3); {Tuberculosis, susceptibility to}, 607948 (3);'),
('107470','IFNGR1','Mycobacterial infection, atypical, familial disseminated, 209950 (3);'),
('107470','IFNGR1','{Mycobacterium tuberculosis infection, protection against}, 600263 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)'),
('107580','AP2TF','Branchiooculofacial syndrome, 113620 (3)'),
('107580','BOFS','Branchiooculofacial syndrome, 113620 (3)'),
('107580','TFAP2A','Branchiooculofacial syndrome, 113620 (3)'),
('107670','APOA2','Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial,'),
('107670','APOA2','modification of}, 143890 (3)'),
('107680','APOA1','ApoA-I and apoC-III deficiency, combined (3);'),
('107680','APOA1','Hypoalphalipoproteinemia, 604091 (3); Corneal clouding, autosomal recessive (3); Amyloidosis, 3 or more types, 105200 (3)'),
('107720','APOC3','Hyperalphalipoproteinemia 2, 614028 (3)'),
('107720','HALP2','Hyperalphalipoproteinemia 2, 614028 (3)'),
('107730','APOB','Hypobetalipoproteinemia (3); Hypobetalipoproteinemia,'),
('107730','FLDB','Hypobetalipoproteinemia (3); Hypobetalipoproteinemia,'),
('107730','LDLCQ4','Hypobetalipoproteinemia (3); Hypobetalipoproteinemia,'),
('107730','APOB','normotriglyceridemic (3); Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)'),
('107730','FLDB','normotriglyceridemic (3); Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)'),
('107730','LDLCQ4','normotriglyceridemic (3); Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)'),
('107741','AD2','Hyperlipoproteinemia, type III (3); {Myocardial infarction'),
('107741','APOE','Hyperlipoproteinemia, type III (3); {Myocardial infarction'),
('107741','LDLCQ5','Hyperlipoproteinemia, type III (3); {Myocardial infarction'),
('107741','LPG','Hyperlipoproteinemia, type III (3); {Myocardial infarction'),
('107741','AD2','Lipoprotein glomerulopathy, 611771 (3)'),
('107741','APOE','Lipoprotein glomerulopathy, 611771 (3)'),
('107741','LDLCQ5','Lipoprotein glomerulopathy, 611771 (3)'),
('107741','LPG','Lipoprotein glomerulopathy, 611771 (3)'),
('107741','AD2','susceptibility} (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {Macular degeneration, age-related}, 603075 (3);'),
('107741','APOE','susceptibility} (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {Macular degeneration, age-related}, 603075 (3);'),
('107741','LDLCQ5','susceptibility} (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {Macular degeneration, age-related}, 603075 (3);'),
('107741','LPG','susceptibility} (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {Macular degeneration, age-related}, 603075 (3);'),
('107776','AQP1','[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)'),
('107776','CHIP28','[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)'),
('107776','CO','[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)'),
('107777','AQP2','Diabetes insipidus, nephrogenic, 125800 (3)'),
('107910','ARO','(3)'),
('107910','CYP19','(3)'),
('107910','CYP19A1','(3)'),
('107910','ARO','Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300'),
('107910','CYP19','Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300'),
('107910','CYP19A1','Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300'),
('107930','DDC','Aromatic L-amino acid decarboxylase deficiency, 608643 (3)'),
('108420','ASG','Spermatogenic failure 2 (2)'),
('108420','SPGF2','Spermatogenic failure 2 (2)'),
('108600','SPAX1','Spastic ataxia 1, autosomal dominant (2)'),
('108725','ALP','{Atherosclerosis, susceptibility to} (2)'),
('108725','ATHS','{Atherosclerosis, susceptibility to} (2)'),
('108730','ATP2A1','Brody myopathy, 601003 (3)'),
('108730','SERCA1','Brody myopathy, 601003 (3)'),
('108733','ATP2B2','{Deafness, autosomal recessive 12, modifier of}, 601386 (3)'),
('108733','PMCA2','{Deafness, autosomal recessive 12, modifier of}, 601386 (3)'),
('108740','ATP2A2','Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)'),
('108740','ATP2B','Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)'),
('108740','DAR','Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)'),
('108780','ANP','Atrial fibrillation, familial, 6, 612201 (3)'),
('108780','ATFB6','Atrial fibrillation, familial, 6, 612201 (3)'),
('108780','NPPA','Atrial fibrillation, familial, 6, 612201 (3)'),
('108780','PND','Atrial fibrillation, familial, 6, 612201 (3)'),
('108800','ASD1','Atrial septal defect 1 (2)'),
('108961','AMDM','Acromesomelic dysplasia, Maroteaux type, 602875 (3)'),
('108961','ANPRB','Acromesomelic dysplasia, Maroteaux type, 602875 (3)'),
('108961','NPR2','Acromesomelic dysplasia, Maroteaux type, 602875 (3)'),
('108962','ANPRC','?Hypertension, salt-resistant (1)'),
('108962','NPR3','?Hypertension, salt-resistant (1)'),
('109200','AFA1','Alopecia, androgenetic, 1 (2)'),
('109200','MPB','Alopecia, androgenetic, 1 (2)'),
('109270','AE1','Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3)'),
('109270','EPB3','Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3)'),
('109270','SLC4A1','Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3)'),
('109270','AE1','Ovalocytosis (3); Spherocytosis, type 4, 612653 (3); [Malaria,'),
('109270','EPB3','Ovalocytosis (3); Spherocytosis, type 4, 612653 (3); [Malaria,'),
('109270','SLC4A1','Ovalocytosis (3); Spherocytosis, type 4, 612653 (3); [Malaria,'),
('109270','AE1','resistance to], 611162 (3); Renal tubular acidosis, distal, AD, 179800 (3); Renal tubular acidosis, distal, AR, 611590 (3); [Blood group,'),
('109270','EPB3','resistance to], 611162 (3); Renal tubular acidosis, distal, AD, 179800 (3); Renal tubular acidosis, distal, AR, 611590 (3); [Blood group,'),
('109270','SLC4A1','resistance to], 611162 (3); Renal tubular acidosis, distal, AD, 179800 (3); Renal tubular acidosis, distal, AR, 611590 (3); [Blood group,'),
('109350','GER','Gastroesophageal reflux (2)'),
('109480','BSG','[Blood group, OK], 111380 (3)'),
('109535','CD40','Immunodeficiency with hyper-IgM, type 3, 606843 (3)'),
('109535','TNFRSF5','Immunodeficiency with hyper-IgM, type 3, 606843 (3)'),
('109543','CLLS2','{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)'),
('109543','D13S25','{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)'),
('109543','DBM','{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)'),
('109560','BCL3','Leukemia/lymphoma, B-cell, 3 (2)'),
('109565','BCL6','Lymphoma, B-cell (2)'),
('109630','ADRB1','beta-blocker response, modifier of} (3)'),
('109630','ADRB1R','beta-blocker response, modifier of} (3)'),
('109630','RHR','beta-blocker response, modifier of} (3)'),
('109630','ADRB1','[Resting heart rate], 607276 (3); {Congestive heart failure and'),
('109630','ADRB1R','[Resting heart rate], 607276 (3); {Congestive heart failure and'),
('109630','RHR','[Resting heart rate], 607276 (3); {Congestive heart failure and'),
('109690','ADRB2','susceptibility to}, 601665 (3); Beta-2-adrenoreceptor agonist, reduced response to (3)'),
('109690','ADRB2','{Asthma, nocturnal, susceptibility to}, 600807 (3); {Obesity,'),
('109691','ADRB3','{Obesity, susceptibility to}, 601665 (3)'),
('109700','B2M','Hypoproteinemia, hypercatabolic, 241600 (3)'),
('109720','PBC1','Biliary cirrhosis, primary, 1 (2)'),
('109750','BLVRA','Hyperbiliverdinemia, 614156 (3)'),
('110300','ABO','[Blood group, ABO system] (3)'),
('110600','ART4','[Blood group, Dombrock] (3)'),
('110600','DO','[Blood group, Dombrock] (3)'),
('110600','DOK1','[Blood group, Dombrock] (3)'),
('110750','GE','{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich] (3)'),
('110750','GPC','{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich] (3)'),
('110750','GYPC','{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich] (3)'),
('111100','FUT3','[Blood group, Lewis] (3)'),
('111100','LE','[Blood group, Lewis] (3)'),
('111300','GPA','[Blood group, MN] (3); {Malaria, resistance to}, 611162 (3)'),
('111300','GYPA','[Blood group, MN] (3); {Malaria, resistance to}, 611162 (3)'),
('111300','MN','[Blood group, MN] (3); {Malaria, resistance to}, 611162 (3)'),
('111680','RHD','[Rh-negative blood type] (3)'),
('111700','RHCE','(3)'),
('111700','RHCE','[Blood group, Rhesus], 111690 (3); Rh-null disease, amorph type'),
('111740','GYPB','[Blood group, Ss] (3)'),
('111740','MNS','[Blood group, Ss] (3)'),
('111740','SS','[Blood group, Ss] (3)'),
('111800','SF','[Blood group, Stoltzfus system] (2)'),
('112205','CD79A','Agammaglobulinemia 3, 613501 (3)'),
('112205','IGA','Agammaglobulinemia 3, 613501 (3)'),
('112210','CD20','Immunodeficiency, common variable, 5, 613495 (3)'),
('112210','CVID5','Immunodeficiency, common variable, 5, 613495 (3)'),
('112210','MS4A1','Immunodeficiency, common variable, 5, 613495 (3)'),
('112250','BDMF','Diaphyseal medullary stenosis with malignant fibrous histiocytoma (2)'),
('112250','DMSMFH','Diaphyseal medullary stenosis with malignant fibrous histiocytoma (2)'),
('112261','BDA2','type A2, 112600 (3)'),
('112261','BMP2','type A2, 112600 (3)'),
('112261','BMP2A','type A2, 112600 (3)'),
('112261','BDA2','{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly,'),
('112261','BMP2','{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly,'),
('112261','BMP2A','{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly,'),
('112262','BMP2B','(3)'),
('112262','BMP2B1','(3)'),
('112262','BMP4','(3)'),
('112262','MCOPS6','(3)'),
('112262','OFC11','(3)'),
('112262','BMP2B','Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625'),
('112262','BMP2B1','Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625'),
('112262','BMP4','Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625'),
('112262','MCOPS6','Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625'),
('112262','OFC11','Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625'),
('112410','HTNB','Hypertension with brachydactyly (2)'),
('113505','ANON2','607499 (3); {Anorexia nervosa, susceptibility to}, 610269 (3)'),
('113505','BDNF','607499 (3); {Anorexia nervosa, susceptibility to}, 610269 (3)'),
('113505','BULN2','607499 (3); {Anorexia nervosa, susceptibility to}, 610269 (3)'),
('113505','ANON2','syndrome, congenital, 209880 (3); {Obsessive-compulsive disorder, protection against}, 164230 (3); {Bulimia nervosa, age of onset of weight loss in},'),
('113505','BDNF','syndrome, congenital, 209880 (3); {Obsessive-compulsive disorder, protection against}, 164230 (3); {Bulimia nervosa, age of onset of weight loss in},'),
('113505','BULN2','syndrome, congenital, 209880 (3); {Obsessive-compulsive disorder, protection against}, 164230 (3); {Bulimia nervosa, age of onset of weight loss in},'),
('113505','ANON2','{Memory impairment, susceptibility to} (3); Central hypoventilation'),
('113505','BDNF','{Memory impairment, susceptibility to} (3); Central hypoventilation'),
('113505','BULN2','{Memory impairment, susceptibility to} (3); Central hypoventilation'),
('113520','BCAT1','?Hyperleucinemia-isoleucinemia or hypervalinemia (1)'),
('113520','BCT1','?Hyperleucinemia-isoleucinemia or hypervalinemia (1)'),
('113530','BCAT2','?Hypervalinemia or hyperleucine-isoleucinemia (1)'),
('113530','BCT2','?Hypervalinemia or hyperleucine-isoleucinemia (1)'),
('113705','BRCA1','susceptibility to, 4}, 614320 (3)'),
('113705','BROVCA1','susceptibility to, 4}, 614320 (3)'),
('113705','PNCA4','susceptibility to, 4}, 614320 (3)'),
('113705','PSCP','susceptibility to, 4}, 614320 (3)'),
('113705','BRCA1','{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer,'),
('113705','BROVCA1','{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer,'),
('113705','PNCA4','{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer,'),
('113705','PSCP','{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer,'),
('113721','BCPR','Breast cancer (1)'),
('113730','UCP1','{Obesity, susceptibility to}, 601665 (3)'),
('113811','BPAG2','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('113811','COL17A1','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('114019','CDH14','Mental retardation, autosomal dominant 3, 612580 (3)'),
('114019','CDH15','Mental retardation, autosomal dominant 3, 612580 (3)'),
('114019','CDH3','Mental retardation, autosomal dominant 3, 612580 (3)'),
('114019','MRD3','Mental retardation, autosomal dominant 3, 612580 (3)'),
('114021','CDH3','(3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)'),
('114021','CDHP','(3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)'),
('114021','HJMD','(3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)'),
('114021','PCAD','(3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)'),
('114021','CDH3','Hypotrichosis, congenital, with juvenile macular dystrophy, 601553'),
('114021','CDHP','Hypotrichosis, congenital, with juvenile macular dystrophy, 601553'),
('114021','HJMD','Hypotrichosis, congenital, with juvenile macular dystrophy, 601553'),
('114021','PCAD','Hypotrichosis, congenital, with juvenile macular dystrophy, 601553'),
('114131','CALCR','{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)'),
('114131','CRT','{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)'),
('114200','CAMPD1','Camptodactyly 1 (2)'),
('114205','CACNA1C','Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)'),
('114205','CACNL1A1','Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)'),
('114205','CCHL1A1','Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)'),
('114205','TS','Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)'),
('114208','CACNA1S','hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)'),
('114208','CACNL1A3','hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)'),
('114208','CCHL1A3','hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)'),
('114208','HOKPP1','hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)'),
('114208','TTPP1','hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)'),
('114208','CACNA1S','Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant'),
('114208','CACNL1A3','Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant'),
('114208','CCHL1A3','Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant'),
('114208','HOKPP1','Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant'),
('114208','TTPP1','Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant'),
('114240','CANP3','Muscular dystrophy, limb-girdle, type 2A, 253600 (3)'),
('114240','CAPN3','Muscular dystrophy, limb-girdle, type 2A, 253600 (3)'),
('114251','CASQ2','Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)'),
('114350','CAIN','Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute'),
('114350','CAN','Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute'),
('114350','D9S46E','Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute'),
('114350','NUP214','Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute'),
('114350','CAIN','lymphoblastic (3)'),
('114350','CAN','lymphoblastic (3)'),
('114350','D9S46E','lymphoblastic (3)'),
('114350','NUP214','lymphoblastic (3)'),
('114580','CANDF1','Candidiasis, familial, 1, autosomal dominant (2)'),
('114580','CMCT','Candidiasis, familial, 1, autosomal dominant (2)'),
('114760','CA4','Retinitis pigmentosa 17, 600852 (3)'),
('114760','RP17','Retinitis pigmentosa 17, 600852 (3)'),
('114815','CA8','Cerebellar ataxia and mental retardation with or without'),
('114815','CALS','Cerebellar ataxia and mental retardation with or without'),
('114815','CAMRQ3','Cerebellar ataxia and mental retardation with or without'),
('114815','CARP','Cerebellar ataxia and mental retardation with or without'),
('114815','CA8','quadrupedal locomotion 3, 613227 (3)'),
('114815','CALS','quadrupedal locomotion 3, 613227 (3)'),
('114815','CAMRQ3','quadrupedal locomotion 3, 613227 (3)'),
('114815','CARP','quadrupedal locomotion 3, 613227 (3)'),
('114835','CES1','Carboxylesterase 1 deficiency (3)'),
('114835','SES1','Carboxylesterase 1 deficiency (3)'),
('114840','BSSL','Maturity-onset diabetes of the young, type VIII, 609812 (3)'),
('114840','CEL','Maturity-onset diabetes of the young, type VIII, 609812 (3)'),
('114840','CELL','Maturity-onset diabetes of the young, type VIII, 609812 (3)'),
('114840','MODY8','Maturity-onset diabetes of the young, type VIII, 609812 (3)'),
('115470','CECR','Cat eye syndrome (4)'),
('115470','CES','Cat eye syndrome (4)'),
('115500','CAT','Acatalasemia, 614097 (3)'),
('115501','CAS2','Albinism, oculocutaneous, type III, 203290 (3)'),
('115501','GP75','Albinism, oculocutaneous, type III, 203290 (3)'),
('115501','TYRP1','Albinism, oculocutaneous, type III, 203290 (3)'),
('115650','CTAA1','?Cataract, anterior polar-1 (2)'),
('115660','CCA1','Cataract, cerulean, type 1 (2)'),
('115665','CCV','Cataract, congenital, Volkmann type (2)'),
('116790','COMT','susceptibility to}, 167870 (3)'),
('116790','COMT','{Schizophrenia, susceptibility to}, 181500 (3); {Panic disorder,'),
('116806','CTNNB1','Colorectal cancer (3); Hepatoblastoma (3); Pilomatricoma, 132600 (3);'),
('116806','CTNNB1','Ovarian cancer, 167000 (3); Hepatocellular carcinoma, 114550 (3)'),
('116840','CLN10','Ceroid lipofuscinosis, neuronal, 10, 610127 (3)'),
('116840','CPSD','Ceroid lipofuscinosis, neuronal, 10, 610127 (3)'),
('116840','CTSD','Ceroid lipofuscinosis, neuronal, 10, 610127 (3)'),
('116897','CEBP','Leukemia, acute myeloid, 601626 (3)'),
('116897','CEBPA','Leukemia, acute myeloid, 601626 (3)'),
('116955','CNBP1','Myotonic dystrophy 2, 602668 (3)'),
('116955','DM2','Myotonic dystrophy 2, 602668 (3)'),
('116955','PROMM','Myotonic dystrophy 2, 602668 (3)'),
('116955','ZNF9','Myotonic dystrophy 2, 602668 (3)'),
('117100','BECTS','Centrotemporal epilepsy (2)'),
('117100','ECT','Centrotemporal epilepsy (2)'),
('117360','SCA29','Spinocerebellar ataxia 29 (2)'),
('117700','CP','Cerebellar ataxia, 604290 (3); Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)'),
('117700','CP','[Hypoceruloplasminemia, hereditary], 604290 (3);'),
('118190','HLD4','Leukodystrophy, hypomyelinating, 4, 612233 (3)'),
('118190','HSP60','Leukodystrophy, hypomyelinating, 4, 612233 (3)'),
('118190','HSPD1','Leukodystrophy, hypomyelinating, 4, 612233 (3)'),
('118190','SPG13','Leukodystrophy, hypomyelinating, 4, 612233 (3)'),
('118190','HLD4','Spastic paraplegia 13, autosomal dominant, 605280 (3);'),
('118190','HSP60','Spastic paraplegia 13, autosomal dominant, 605280 (3);'),
('118190','HSPD1','Spastic paraplegia 13, autosomal dominant, 605280 (3);'),
('118190','SPG13','Spastic paraplegia 13, autosomal dominant, 605280 (3);'),
('118423','ARHGAP2','Duane retraction syndrome 2, 604356 (3)'),
('118423','CHN','Duane retraction syndrome 2, 604356 (3)'),
('118423','CHN1','Duane retraction syndrome 2, 604356 (3)'),
('118423','DURS2','Duane retraction syndrome 2, 604356 (3)'),
('118423','RHOGAP2','Duane retraction syndrome 2, 604356 (3)'),
('118425','CLCN1','dominant, 160800 (3); Myotonia levior, recessive (3)'),
('118425','CLCN1','Myotonia congenita, recessive, 255700 (3); Myotonia congenita,'),
('118470','CETP','cholesterol level QTL 10], 143470 (3)'),
('118470','HDLCQ10','cholesterol level QTL 10], 143470 (3)'),
('118470','CETP','Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein'),
('118470','HDLCQ10','Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein'),
('118485','CYP11A','Adrenal insufficiency, congenital, with 46XY sex reversal, partial'),
('118485','P450SCC','Adrenal insufficiency, congenital, with 46XY sex reversal, partial'),
('118485','CYP11A','or complete, 613743 (3)'),
('118485','P450SCC','or complete, 613743 (3)'),
('118490','CHAT','254210 (3)'),
('118490','CMS1A2','254210 (3)'),
('118490','CHAT','Myasthenic syndrome, congenital, associated with episodic apnea,'),
('118490','CMS1A2','Myasthenic syndrome, congenital, associated with episodic apnea,'),
('118494','CHRM3','Eagle-Barrett syndrome, 100100 (3)'),
('118494','EGBRS','Eagle-Barrett syndrome, 100100 (3)'),
('118502','CHRNA2','Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)'),
('118503','CHRNA3','{Lung cancer susceptibility 2}, 612052 (3)'),
('118503','LNCR2','{Lung cancer susceptibility 2}, 612052 (3)'),
('118503','PAOD2','{Lung cancer susceptibility 2}, 612052 (3)'),
('118504','CHRNA4','addiction, susceptibility to}, 188890 (3)'),
('118504','ENFL1','addiction, susceptibility to}, 188890 (3)'),
('118504','CHRNA4','Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine'),
('118504','ENFL1','Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine'),
('118505','CHRNA5','susceptibility to}, 612052 (3)'),
('118505','LNCR2','susceptibility to}, 612052 (3)'),
('118505','CHRNA5','{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence,'),
('118505','LNCR2','{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence,'),
('118507','CHRNB2','Epilepsy, nocturnal frontal lobe, 3, 605375 (3)'),
('118507','EFNL3','Epilepsy, nocturnal frontal lobe, 3, 605375 (3)'),
('118511','CHRNA7','Schizophrenia, neurophysiologic defect in (2)'),
('118661','CSPG2','Wagner syndrome 1, 143200 (3)'),
('118661','ERVR','Wagner syndrome 1, 143200 (3)'),
('118661','VCAN','Wagner syndrome 1, 143200 (3)'),
('118661','WGN','Wagner syndrome 1, 143200 (3)'),
('118661','WGN1','Wagner syndrome 1, 143200 (3)'),
('119100','SHFL1','Split-hand/foot malformation with long bone deficiency 1 (2)'),
('119100','SHFLD','Split-hand/foot malformation with long bone deficiency 1 (2)'),
('119530','CL','Orofacial cleft-1 (2)'),
('119530','OFC1','Orofacial cleft-1 (2)'),
('120070','COL4A3','Alport syndrome, autosomal recessive, 203780 (3); Hematuria,'),
('120070','COL4A3','benign familial, 141200 (3); Alport syndrome, autosomal dominant, 120070 (3)'),
('120090','COL4A2','Porencephaly 2, 614483 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('120090','ICH','Porencephaly 2, 614483 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('120090','POREN2','Porencephaly 2, 614483 (3); {Stroke, hemorrhagic}, 614519 (3)'),
('120110','COL10A1','Metaphyseal chondrodysplasia, Schmid type, 156500 (3)'),
('120120','COL7A1','bullosa dystrophica, AR, 226600 (3); Epidermolysis bullosa, pretibial, 131850 (3); EBD, Bart type, 132000 (3); EBD, localisata variant (3); Transient bullous'),
('120120','COL7A1','Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis'),
('120120','COL7A1','of the newborn, 131705 (3); Epidermolysis bullosa pruriginosa, 604129 (3); Toenail dystrophy, isolated, 607523 (3); EBD inversa, 226600 (3)'),
('120130','COL4A1','anomaly, 607595 (3)'),
('120130','HANAC','anomaly, 607595 (3)'),
('120130','POREN1','anomaly, 607595 (3)'),
('120130','COL4A1','hemorrhage, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3); Brain small vessel disease with Axenfeld-Rieger'),
('120130','HANAC','hemorrhage, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3); Brain small vessel disease with Axenfeld-Rieger'),
('120130','POREN1','hemorrhage, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3); Brain small vessel disease with Axenfeld-Rieger'),
('120130','COL4A1','Porencephaly 1, 175780 (3); Brain small vessel disease with'),
('120130','HANAC','Porencephaly 1, 175780 (3); Brain small vessel disease with'),
('120130','POREN1','Porencephaly 1, 175780 (3); Brain small vessel disease with'),
('120131','COL4A4','Alport syndrome, autosomal recessive, 203780 (3); Hematuria,'),
('120131','COL4A4','familial benign (3)'),
('120140','COL2A1','(3); SMED Strudwick type, 184250 (3); Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3); Spondyloperipheral dysplasia, 271700 (3); SED, Namaqualand type (3); Osteoarthritis with mil'),
('120140','COL2A1','Achondrogenesis, type II or hypochondrogenesis, 200610 (3); SED congenita, 183900'),
('120140','COL2A1','Stickler syndrome, type I, 108300 (3); Kniest dysplasia, 156550 (3);'),
('120150','COL1A1','166710 (3); Caffey disease, 114000 (3); [Bone mineral density variation QTL], 166710 (3)'),
('120150','COL1A1','OI type III, 259420 (3); OI type IV, 166220 (3); Ehlers-Danlos syndrome, type I, 130000 (3); Ehlers-Danlos syndrome, type VIIA, 130060 (3); {Osteoporosis},'),
('120150','COL1A1','Osteogenesis imperfecta, type I, 166200 (3); OI type II, 166210 (3);'),
('120160','COL1A2','166710 (3); Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)'),
('120160','COL1A2','Ehlers-Danlos syndrome, type VIIB, 130060 (3); Osteogenesis'),
('120160','COL1A2','imperfecta, type IV, 166220 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type II, 166210 (3); {Osteoporosis, postmenopausal},'),
('120180','COL3A1','Ehlers-Danlos syndrome, type IV, 130050 (3); Ehlers-Danlos syndrome,'),
('120180','COL3A1','type III, 130020 (3)'),
('120190','COL5A2','Ehlers-Danlos syndrome, type I, 130000 (3)'),
('120210','COL9A1','Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome,'),
('120210','EDM6','Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome,'),
('120210','STL4','Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome,'),
('120210','COL9A1','type IV, 614134 (3)'),
('120210','EDM6','type IV, 614134 (3)'),
('120210','STL4','type IV, 614134 (3)'),
('120215','COL5A1','Ehlers-Danlos syndrome, type II, 130010 (3); Ehlers-Danlos syndrome,'),
('120215','COL5A1','type I, 130000 (3)'),
('120220','COL6A1','254090 (3); {Ossification of the posterior longitudinal spinal ligaments}, 602475 (2)'),
('120220','OPLL','254090 (3); {Ossification of the posterior longitudinal spinal ligaments}, 602475 (2)'),
('120220','COL6A1','Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,'),
('120220','OPLL','Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,'),
('120240','COL6A2','254090 (3); Myosclerosis, congenital, 255600 (3)'),
('120240','COL6A2','Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,'),
('120250','COL6A3','254090 (3)'),
('120250','COL6A3','Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,'),
('120252','COL8A2','Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal'),
('120252','FECD1','Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal'),
('120252','PPCD2','Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal'),
('120252','COL8A2','dystrophy polymorphous posterior, 2, 609140 (3)'),
('120252','FECD1','dystrophy polymorphous posterior, 2, 609140 (3)'),
('120252','PPCD2','dystrophy polymorphous posterior, 2, 609140 (3)'),
('120260','COL9A2','disc disease, susceptibility to}, 603932 (3); Stickler syndrome, type V, 614284 (3)'),
('120260','EDM2','disc disease, susceptibility to}, 603932 (3); Stickler syndrome, type V, 614284 (3)'),
('120260','STL5','disc disease, susceptibility to}, 603932 (3); Stickler syndrome, type V, 614284 (3)'),
('120260','COL9A2','Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral'),
('120260','EDM2','Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral'),
('120260','STL5','Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral'),
('120270','COL9A3','Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia,'),
('120270','EDM3','Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia,'),
('120270','IDD','Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia,'),
('120270','COL9A3','multiple, with myopathy (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)'),
('120270','EDM3','multiple, with myopathy (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)'),
('120270','IDD','multiple, with myopathy (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)'),
('120280','COL11A1','(3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis, 228520 (3)'),
('120280','STL2','(3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis, 228520 (3)'),
('120280','COL11A1','Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780'),
('120280','STL2','Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780'),
('120290','COL11A2','(3); Fibrochondrogenesis 2, 614524 (3)'),
('120290','DFNA13','(3); Fibrochondrogenesis 2, 614524 (3)'),
('120290','DFNB53','(3); Fibrochondrogenesis 2, 614524 (3)'),
('120290','FBCG2','(3); Fibrochondrogenesis 2, 614524 (3)'),
('120290','STL3','(3); Fibrochondrogenesis 2, 614524 (3)'),
('120290','COL11A2','dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706'),
('120290','DFNA13','dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706'),
('120290','DFNB53','dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706'),
('120290','FBCG2','dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706'),
('120290','STL3','dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706'),
('120290','COL11A2','Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal'),
('120290','DFNA13','Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal'),
('120290','DFNB53','Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal'),
('120290','FBCG2','Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal'),
('120290','STL3','Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal'),
('120328','COL18A1','Knobloch syndrome, type 1, 267750 (3)'),
('120328','KNO1','Knobloch syndrome, type 1, 267750 (3)'),
('120353','CLG','bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)'),
('120353','MMP1','bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)'),
('120353','CLG','COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis'),
('120353','MMP1','COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis'),
('120360','CLG4A','Torg-Winchester syndrome, 259600 (3)'),
('120360','MMP2','Torg-Winchester syndrome, 259600 (3)'),
('120360','MONA','Torg-Winchester syndrome, 259600 (3)'),
('120361','CLG4B','Metaphyseal anadysplasia 2, 613073 (3)'),
('120361','MANDP2','Metaphyseal anadysplasia 2, 613073 (3)'),
('120361','MMP9','Metaphyseal anadysplasia 2, 613073 (3)'),
('120436','COCA2','Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3);'),
('120436','HNPCC2','Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3);'),
('120436','MLH1','Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3);'),
('120436','COCA2','Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)'),
('120436','HNPCC2','Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)'),
('120436','MLH1','Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)'),
('120470','DCC','Colorectal cancer (3); Mirror movements, congenital, 157600 (3)'),
('120502','BOS2','Branchiootic syndrome 2 (2)'),
('120520','CALLA','glomerulonephritis, antenatal (1)'),
('120520','CD10','glomerulonephritis, antenatal (1)'),
('120520','MME','glomerulonephritis, antenatal (1)'),
('120520','NEP','glomerulonephritis, antenatal (1)'),
('120520','CALLA','[Neutral endopeptidase deficiency] (1); Membranous'),
('120520','CD10','[Neutral endopeptidase deficiency] (1); Membranous'),
('120520','MME','[Neutral endopeptidase deficiency] (1); Membranous'),
('120520','NEP','[Neutral endopeptidase deficiency] (1); Membranous'),
('120550','C1QA','C1q deficiency, 613652 (3)'),
('120570','C1QB','C1q deficiency, 613652 (3)'),
('120575','C1QC','C1q deficiency, 613652 (3)'),
('120575','C1QG','C1q deficiency, 613652 (3)'),
('120580','C1S','C1s deficiency, 613783 (3)'),
('120620','C3BR','CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops'),
('120620','CR1','CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops'),
('120620','C3BR','system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)'),
('120620','CR1','system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)'),
('120650','C3DR','{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)'),
('120650','CR2','{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)'),
('120650','SLEB9','{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)'),
('120700','AHUS5','C3 deficiency, 613779 (3);'),
('120700','ARMD9','C3 deficiency, 613779 (3);'),
('120700','C3','C3 deficiency, 613779 (3);'),
('120700','AHUS5','{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)'),
('120700','ARMD9','{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)'),
('120700','C3','{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)'),
('120810','C4A','?Systemic lupus erythematosus, susceptibility to or protection against}, 152700 (2)'),
('120810','C4AD','?Systemic lupus erythematosus, susceptibility to or protection against}, 152700 (2)'),
('120810','C4S','?Systemic lupus erythematosus, susceptibility to or protection against}, 152700 (2)'),
('120810','C4A','C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3);'),
('120810','C4AD','C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3);'),
('120810','C4S','C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3);'),
('120820','C4B','C4B deficiency, 614379 (3)'),
('120820','C4BD','C4B deficiency, 614379 (3)'),
('120820','C4F','C4B deficiency, 614379 (3)'),
('120900','C5','C5 deficiency, 609536 (3)'),
('120920','AHUS2','(3)'),
('120920','CD46','(3)'),
('120920','MCP','(3)'),
('120920','AHUS2','{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922'),
('120920','CD46','{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922'),
('120920','MCP','{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922'),
('120940','C9','613825 (3)'),
('120940','C9','C9 deficiency, 613825 (3); C9 deficiency with dermatomyositis,'),
('120950','C8A','C8 deficiency, type I, 613790 (3)'),
('120960','C8B','C8 deficiency, type II, 613789 (3)'),
('120980','CD11B','609939 (3)'),
('120980','CR3A','609939 (3)'),
('120980','ITGAM','609939 (3)'),
('120980','MAC1A','609939 (3)'),
('120980','SLEB6','609939 (3)'),
('120980','CD11B','{Systemic lupus erythematous, association with susceptibility to, 6},'),
('120980','CR3A','{Systemic lupus erythematous, association with susceptibility to, 6},'),
('120980','ITGAM','{Systemic lupus erythematous, association with susceptibility to, 6},'),
('120980','MAC1A','{Systemic lupus erythematous, association with susceptibility to, 6},'),
('120980','SLEB6','{Systemic lupus erythematous, association with susceptibility to, 6},'),
('121011','CX26','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','DFNA3A','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','DFNB1A','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','GJB2','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','HID','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','KID','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','PPK','Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal'),
('121011','CX26','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','DFNA3A','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','DFNB1A','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','GJB2','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','HID','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','KID','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','PPK','dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness'),
('121011','CX26','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','DFNA3A','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','DFNB1A','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','GJB2','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','HID','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','KID','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121011','PPK','syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)'),
('121013','ATFB11','Atrial fibrillation, familial, 11, 614049 (3)'),
('121013','CX40','Atrial fibrillation, familial, 11, 614049 (3)'),
('121013','GJA5','Atrial fibrillation, familial, 11, 614049 (3)'),
('121014','AVSD3','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','CX43','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','GJA1','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','HLHS1','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','HSS','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','ODDD','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','ODOD','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','SDTY3','186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive,'),
('121014','AVSD3','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','CX43','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','GJA1','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','HLHS1','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','HSS','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','ODDD','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','ODOD','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','SDTY3','257850 (3); Hallermann-Streiff syndrome, 234100 (3)'),
('121014','AVSD3','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','CX43','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','GJA1','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','HLHS1','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','HSS','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','ODDD','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','ODOD','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121014','SDTY3','Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,'),
('121015','CAE3','Cataract, zonular pulverulent-3, 601885 (3)'),
('121015','CX46','Cataract, zonular pulverulent-3, 601885 (3)'),
('121015','CZP3','Cataract, zonular pulverulent-3, 601885 (3)'),
('121015','GJA3','Cataract, zonular pulverulent-3, 601885 (3)'),
('121210','FEB1','Febrile seizures, familial, 1 (2)'),
('121360','CBFB','Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)'),
('121360','PEBP2B','Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)'),
('121700','CHED','Corneal endothelial dystrophy 1, autosomal dominant (2)'),
('121700','CHED1','Corneal endothelial dystrophy 1, autosomal dominant (2)'),
('122500','CBG','Corticosteroid-binding globulin deficiency, 611489 (3)'),
('122500','SERPINA6','Corticosteroid-binding globulin deficiency, 611489 (3)'),
('122720','CYP2A','Coumarin resistance, 122700 (3); {Nicotine addiction, protection'),
('122720','CYP2A3','Coumarin resistance, 122700 (3); {Nicotine addiction, protection'),
('122720','CYP2A6','Coumarin resistance, 122700 (3); {Nicotine addiction, protection'),
('122720','P450C2A','Coumarin resistance, 122700 (3); {Nicotine addiction, protection'),
('122720','CYP2A','from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)'),
('122720','CYP2A3','from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)'),
('122720','CYP2A6','from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)'),
('122720','P450C2A','from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)'),
('123101','CRS2','(3); Parietal foramina with cleidocranial dysplasia, 168550 (3)'),
('123101','HOX8','(3); Parietal foramina with cleidocranial dysplasia, 168550 (3)'),
('123101','MSX2','(3); Parietal foramina with cleidocranial dysplasia, 168550 (3)'),
('123101','CRS2','Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500'),
('123101','HOX8','Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500'),
('123101','MSX2','Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500'),
('123270','CKBE','[Creatine kinase, brain type, ectopic expression of] (2)'),
('123580','CRYA1','Cataract, congenital, autosomal recessive (3); Cataract, autosomal dominant nuclear (3)'),
('123580','CRYAA','Cataract, congenital, autosomal recessive (3); Cataract, autosomal dominant nuclear (3)'),
('123580','CRYA1','Cataract, zonular central nuclear, autosomal dominant (3);'),
('123580','CRYAA','Cataract, zonular central nuclear, autosomal dominant (3);'),
('123590','CRYA2','Cataract, posterior polar 2, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)'),
('123590','CRYAB','Cataract, posterior polar 2, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)'),
('123590','CTPP2','Cataract, posterior polar 2, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)'),
('123590','CRYA2','Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3);'),
('123590','CRYAB','Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3);'),
('123590','CTPP2','Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3);'),
('123610','CRYB1','Cataract, congenital zonular, with sutural opacities, 600881 (3)'),
('123610','CRYBA1','Cataract, congenital zonular, with sutural opacities, 600881 (3)'),
('123620','CRYB2','Cataract, cerulean, type 2, 601547 (3); Cataract, sutural, with'),
('123620','CRYBB2','Cataract, cerulean, type 2, 601547 (3); Cataract, sutural, with'),
('123620','CRYB2','punctate and cerulean opacities, 607133 (3); Cataract, Coppock-like, 604307 (3)'),
('123620','CRYBB2','punctate and cerulean opacities, 607133 (3); Cataract, Coppock-like, 604307 (3)'),
('123630','CATCN2','Cataract, congenital nuclear, 2, 609741 (3)'),
('123630','CRYB3','Cataract, congenital nuclear, 2, 609741 (3)'),
('123630','CRYBB3','Cataract, congenital nuclear, 2, 609741 (3)'),
('123631','CRYBA4','610426 (3)'),
('123631','MCOPCT4','610426 (3)'),
('123631','CRYBA4','Cataract, lamellar 2, 610425 (3); Microphthalmia with cataract 4,'),
('123631','MCOPCT4','Cataract, lamellar 2, 610425 (3); Microphthalmia with cataract 4,'),
('123680','CCL','Cataract, Coppock-like, 604307 (3); Cataract, variable zonular'),
('123680','CRYG3','Cataract, Coppock-like, 604307 (3); Cataract, variable zonular'),
('123680','CRYGC','Cataract, Coppock-like, 604307 (3); Cataract, variable zonular'),
('123680','CCL','pulverulent (3)'),
('123680','CRYG3','pulverulent (3)'),
('123680','CRYGC','pulverulent (3)'),
('123690','CCP','Cataracts, punctate, progressive juvenile-onset (3); Cataract,'),
('123690','CRYG4','Cataracts, punctate, progressive juvenile-onset (3); Cataract,'),
('123690','CRYGD','Cataracts, punctate, progressive juvenile-onset (3); Cataract,'),
('123690','CCP','crystalline aculeiform, 115700 (3); Cataract, congenital, cerulean type, 3, 608983 (3); Cataract, nonnuclear polymorphic congenital, 601286 (3)'),
('123690','CRYG4','crystalline aculeiform, 115700 (3); Cataract, congenital, cerulean type, 3, 608983 (3); Cataract, nonnuclear polymorphic congenital, 601286 (3)'),
('123690','CRYGD','crystalline aculeiform, 115700 (3); Cataract, congenital, cerulean type, 3, 608983 (3); Cataract, nonnuclear polymorphic congenital, 601286 (3)'),
('123730','CRYG8','Cataract, progressive polymorphic cortical (3)'),
('123730','CRYGS','Cataract, progressive polymorphic cortical (3)'),
('123740','CRYM','Deafness, autosomal dominant 40 (3)'),
('123740','DFNA40','Deafness, autosomal dominant 40 (3)'),
('123810','CREB1','Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)'),
('123825','CNCG1','Retinitis pigmentosa 49, 613756 (3)'),
('123825','CNGA1','Retinitis pigmentosa 49, 613756 (3)'),
('123825','RP49','Retinitis pigmentosa 49, 613756 (3)'),
('123829','CDK4','{Melanoma, cutaneous malignant, 3}, 609048 (3)'),
('123829','CMM3','{Melanoma, cutaneous malignant, 3}, 609048 (3)'),
('123841','CYPB','Osteogenesis imperfecta, type IX, 259440 (3)'),
('123841','OI9','Osteogenesis imperfecta, type IX, 259440 (3)'),
('123841','PPIB','Osteogenesis imperfecta, type IX, 259440 (3)'),
('123889','CRFB4','bowel disease 25, early onset, autosomal recessive, 612567 (3)'),
('123889','IBD25','bowel disease 25, early onset, autosomal recessive, 612567 (3)'),
('123889','CRFB4','{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory'),
('123889','IBD25','{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory'),
('123890','CELIAC3','autoimmune}, 140300 (3); {Diabetes mellitus, insulin-dependent, susceptibility to}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3)'),
('123890','CTLA4','autoimmune}, 140300 (3); {Diabetes mellitus, insulin-dependent, susceptibility to}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3)'),
('123890','GRD4','autoimmune}, 140300 (3); {Diabetes mellitus, insulin-dependent, susceptibility to}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3)'),
('123890','IDDM12','autoimmune}, 140300 (3); {Diabetes mellitus, insulin-dependent, susceptibility to}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3)'),
('123890','CELIAC3','{Graves disease, susceptibility to, 4} (3); {Hypothyroidism,'),
('123890','CTLA4','{Graves disease, susceptibility to, 4} (3); {Hypothyroidism,'),
('123890','GRD4','{Graves disease, susceptibility to, 4} (3); {Hypothyroidism,'),
('123890','IDDM12','{Graves disease, susceptibility to, 4} (3); {Hypothyroidism,'),
('123930','CYP2B','Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central'),
('123930','CYP2B6','Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central'),
('123930','EFVM','Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central'),
('123930','CYP2B','nervous system toxicity, susceptibility to}, 614546 (3)'),
('123930','CYP2B6','nervous system toxicity, susceptibility to}, 614546 (3)'),
('123930','EFVM','nervous system toxicity, susceptibility to}, 614546 (3)'),
('123940','CYK4','White sponge nevus, 193900 (3)'),
('123940','KRT4','White sponge nevus, 193900 (3)'),
('123970','CYC','Thrombocytopenia 4, 612004 (3)'),
('123970','CYCS','Thrombocytopenia 4, 612004 (3)'),
('123970','THC4','Thrombocytopenia 4, 612004 (3)'),
('124015','POR','Antley-Bixler syndrome with genital anomalies and disordered'),
('124015','POR','steroidogenesis, 201750 (3); Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)'),
('124020','CYP2C','Mephenytoin poor metabolizer, 609535 (3); Opremazole poor'),
('124020','CYP2C19','Mephenytoin poor metabolizer, 609535 (3); Opremazole poor'),
('124020','CYP2C','metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)'),
('124020','CYP2C19','metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)'),
('124030','CPD6','(3)'),
('124030','CYP2D6','(3)'),
('124030','P450DB1','(3)'),
('124030','CPD6','{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902'),
('124030','CYP2D6','{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902'),
('124030','P450DB1','{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902'),
('124050','DAMOX','{Schizophrenia}, 181500 (2)'),
('124050','DAO','{Schizophrenia}, 181500 (2)'),
('124080','CYP11B2','Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3); {Low renin hypertension, susceptibility to} (3); Aldosterone to renin ratio'),
('124080','CYP11B2','Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3);'),
('124080','CYP11B2','raised (3)'),
('124089','COX6B1','Cytochrome c oxidase deficiency, 220110 (3)'),
('124092','CSIF','protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)'),
('124092','GVHDS','protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)'),
('124092','IL10','protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)'),
('124092','CSIF','{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease,'),
('124092','GVHDS','{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease,'),
('124092','IL10','{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease,'),
('125240','CD55','[Blood group Cromer], 613793 (3)'),
('125240','CROM','[Blood group Cromer], 613793 (3)'),
('125240','DAF','[Blood group Cromer], 613793 (3)'),
('125255','CSCD','Corneal dystrophy, congenital stromal, 610048 (3)'),
('125255','DCN','Corneal dystrophy, congenital stromal, 610048 (3)'),
('125264','D6S231E','Leukemia, acute nonlymphocytic (2)'),
('125264','DEK','Leukemia, acute nonlymphocytic (2)'),
('125270','ALAD','Porphyria, acute hepatic, 612740 (3); {Lead poisoning,'),
('125270','ALADH','Porphyria, acute hepatic, 612740 (3); {Lead poisoning,'),
('125270','PBGS','Porphyria, acute hepatic, 612740 (3); {Lead poisoning,'),
('125270','ALAD','susceptibility to}, 612740 (3)'),
('125270','ALADH','susceptibility to}, 612740 (3)'),
('125270','PBGS','susceptibility to}, 612740 (3)'),
('125480','BPAD','{Major affective disorder 1} (2)'),
('125480','MAFD1','{Major affective disorder 1} (2)'),
('125480','MD1','{Major affective disorder 1} (2)'),
('125485','DFNA39','(3)'),
('125485','DGI1','(3)'),
('125485','DPP','(3)'),
('125485','DSPP','(3)'),
('125485','DTDP2','(3)'),
('125485','DFNA39','autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420'),
('125485','DGI1','autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420'),
('125485','DPP','autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420'),
('125485','DSPP','autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420'),
('125485','DTDP2','autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420'),
('125485','DFNA39','Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,'),
('125485','DGI1','Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,'),
('125485','DPP','Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,'),
('125485','DSPP','Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,'),
('125485','DTDP2','Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,'),
('125505','DNASE1','{Systemic lupus erythematosus, susceptibility to}, 152700 (3)'),
('125505','DNL1','{Systemic lupus erythematosus, susceptibility to}, 152700 (3)'),
('125520','ACF','Cayler cardiofacial syndrome (2)'),
('125645','ARVD11','Arrhythmogenic right ventricular dysplasia 11, 610476 (3)'),
('125645','DSC2','Arrhythmogenic right ventricular dysplasia 11, 610476 (3)'),
('125645','DSC3','Arrhythmogenic right ventricular dysplasia 11, 610476 (3)'),
('125647','DSP','607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3)'),
('125647','KPPS2','607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3)'),
('125647','PPKS2','607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3)'),
('125647','DSP','cardiomyopathy with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome,'),
('125647','KPPS2','cardiomyopathy with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome,'),
('125647','PPKS2','cardiomyopathy with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome,'),
('125647','DSP','Keratosis palmoplantaris striata II, 612908 (3); Dilated'),
('125647','KPPS2','Keratosis palmoplantaris striata II, 612908 (3); Dilated'),
('125647','PPKS2','Keratosis palmoplantaris striata II, 612908 (3); Dilated'),
('125660','CMD1I','Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)'),
('125660','DES','Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)'),
('125660','MFM1','Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)'),
('125660','SCPNK','Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)'),
('125660','CMD1I','Myopathy, myofibrillar, desmin-related, cardioskeletal, 601419 (3);'),
('125660','DES','Myopathy, myofibrillar, desmin-related, cardioskeletal, 601419 (3);'),
('125660','MFM1','Myopathy, myofibrillar, desmin-related, cardioskeletal, 601419 (3);'),
('125660','SCPNK','Myopathy, myofibrillar, desmin-related, cardioskeletal, 601419 (3);'),
('125670','DSG1','Keratosis palmoplantaris striata I, 148700 (3)'),
('125670','PPKS1','Keratosis palmoplantaris striata I, 148700 (3)'),
('125670','SPPK1','Keratosis palmoplantaris striata I, 148700 (3)'),
('125671','ARVC10','Arrhythmogenic right ventricular dysplasia 10, 610193 (3);'),
('125671','ARVD10','Arrhythmogenic right ventricular dysplasia 10, 610193 (3);'),
('125671','CMD1BB','Arrhythmogenic right ventricular dysplasia 10, 610193 (3);'),
('125671','DSG2','Arrhythmogenic right ventricular dysplasia 10, 610193 (3);'),
('125671','ARVC10','Cardiomyopathy, dilated, 1BB, 612877 (3)'),
('125671','ARVD10','Cardiomyopathy, dilated, 1BB, 612877 (3)'),
('125671','CMD1BB','Cardiomyopathy, dilated, 1BB, 612877 (3)'),
('125671','DSG2','Cardiomyopathy, dilated, 1BB, 612877 (3)'),
('125860','DIA4','post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)'),
('125860','NMOR1','post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)'),
('125860','NQO1','post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)'),
('125860','DIA4','{Benzene toxicity, susceptibility to} (3); {Leukemia,'),
('125860','NMOR1','{Benzene toxicity, susceptibility to} (3); {Leukemia,'),
('125860','NQO1','{Benzene toxicity, susceptibility to} (3); {Leukemia,'),
('126060','DHFR','613839 (3)'),
('126060','DHFR','Megaloblastic anemia due to dihydrofolate reductase deficiency,'),
('126064','DHODH','Miller syndrome, 263750 (3)'),
('126064','POADS','Miller syndrome, 263750 (3)'),
('126064','URA1','Miller syndrome, 263750 (3)'),
('126065','CYP24','Hypercalcemia, infantile, 143880 (3)'),
('126065','CYP24A1','Hypercalcemia, infantile, 143880 (3)'),
('126065','HCAI','Hypercalcemia, infantile, 143880 (3)'),
('126090','DCOH','Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)'),
('126090','PCBD','Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)'),
('126110','ARNT','Leukemia, acute myeloblastic (3)'),
('126141','DPP6','Ventricular fibrillation, paroxysmal familial, 2, 612956 (3)'),
('126141','VF2','Ventricular fibrillation, paroxysmal familial, 2, 612956 (3)'),
('126150','DTR','{Diphtheria, susceptibility to} (1)'),
('126150','DTSF','{Diphtheria, susceptibility to} (1)'),
('126150','HBEGF','{Diphtheria, susceptibility to} (1)'),
('126150','HEGFL','{Diphtheria, susceptibility to} (1)'),
('126337','CHOP10','Myxoid liposarcoma, 613488 (1)'),
('126337','DDIT3','Myxoid liposarcoma, 613488 (1)'),
('126337','GADD153','Myxoid liposarcoma, 613488 (1)'),
('126340','COFS2','601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)'),
('126340','EM9','601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)'),
('126340','ERCC2','601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)'),
('126340','XPD','601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)'),
('126340','COFS2','Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy,'),
('126340','EM9','Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy,'),
('126340','ERCC2','Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy,'),
('126340','XPD','Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy,'),
('126375','DNMT1','Neuropathy, hereditary sensory, type IE, 614116 (3)'),
('126375','HSN1E','Neuropathy, hereditary sensory, type IE, 614116 (3)'),
('126375','MCMT','Neuropathy, hereditary sensory, type IE, 614116 (3)'),
('126380','COFS4','Cerebrooculofacioskeletal syndrome 4, 610758 (3)'),
('126380','ERCC1','Cerebrooculofacioskeletal syndrome 4, 610758 (3)'),
('126380','UV20','Cerebrooculofacioskeletal syndrome 4, 610758 (3)'),
('126391','LIG1','DNA ligase I deficiency (3)'),
('126420','TOP1','DNA topoisomerase I, camptothecin-resistant (3)'),
('126430','TOP2','DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)'),
('126430','TOP2A','DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)'),
('126450','DRD2','Dystonia, myoclonic, 159900 (3)'),
('126451','DRD3','susceptibility to}, 190300 (3)'),
('126451','ETM1','susceptibility to}, 190300 (3)'),
('126451','FET1','susceptibility to}, 190300 (3)'),
('126451','DRD3','{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor,'),
('126451','ETM1','{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor,'),
('126451','FET1','{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor,'),
('126452','DRD4','Autonomic nervous system dysfunction (3); [Novelty seeking'),
('126452','DRD4','personality], 601696 (1); {Attention deficit-hyperactivity disorder}, 143465 (3)'),
('126453','DRD1B','cervical (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)'),
('126453','DRD1L2','cervical (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)'),
('126453','DRD5','cervical (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)'),
('126453','DRD1B','{Blepharospasm, primary benign}, 606798 (3); Dystonia, primary'),
('126453','DRD1L2','{Blepharospasm, primary benign}, 606798 (3); Dystonia, primary'),
('126453','DRD5','{Blepharospasm, primary benign}, 606798 (3); Dystonia, primary'),
('126455','DAT1','(2); {Nicotine dependence, protection against}, 188890 (3); {Major affective disorder}, 125480 (3); Parkinsonism-dystonia, infantile, 613135 (3)'),
('126455','SLC6A3','(2); {Nicotine dependence, protection against}, 188890 (3); {Major affective disorder}, 125480 (3); Parkinsonism-dystonia, infantile, 613135 (3)'),
('126455','DAT1','{Attention-deficit hyperactivity disorder, susceptibility to}, 143465'),
('126455','SLC6A3','{Attention-deficit hyperactivity disorder, susceptibility to}, 143465'),
('126650','CLD','214700 (3)'),
('126650','DRA','214700 (3)'),
('126650','SLC26A3','214700 (3)'),
('126650','CLD','?Colon cancer (1); Chloride diarrhea, congenital, Finnish type,'),
('126650','DRA','?Colon cancer (1); Chloride diarrhea, congenital, Finnish type,'),
('126650','SLC26A3','?Colon cancer (1); Chloride diarrhea, congenital, Finnish type,'),
('126800','DURS1','Duane syndrome (2)'),
('126800','DUS','Duane syndrome (2)'),
('126900','DUPC1','Dupuytren contracture 1 (2)'),
('127500','DUH','Dyschromatosis universalis hereditaria 1 (2)'),
('127500','DUH1','Dyschromatosis universalis hereditaria 1 (2)'),
('127600','DKBI','Dyskeratosis, hereditary benign intraepithelial (2)'),
('128239','DAG','613818 (3)'),
('128239','DAG1','613818 (3)'),
('128239','MDDGC7','613818 (3)'),
('128239','DAG','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7,'),
('128239','DAG1','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7,'),
('128239','MDDGC7','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7,'),
('128700','PAFC','?Preauricular fistulae, congenital (2)'),
('129010','EGR2','Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)'),
('129010','KROX20','Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)'),
('129010','EGR2','Neuropathy, congenital hypomyelinating, 1, 605253 (3);'),
('129010','KROX20','Neuropathy, congenital hypomyelinating, 1, 605253 (3);'),
('129190','NT5','Calcification of joints and arteries, 211800 (3)'),
('129190','NT5E','Calcification of joints and arteries, 211800 (3)'),
('129900','EEC1','?EEC syndrome-1 (2)'),
('130080','EDS8','Ehlers-Danlos syndrome, type VIII (2)'),
('130130','ELA2','autosomal dominant, 202700 (3)'),
('130130','ELANE','autosomal dominant, 202700 (3)'),
('130130','SCN1','autosomal dominant, 202700 (3)'),
('130130','ELA2','Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1,'),
('130130','ELANE','Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1,'),
('130130','SCN1','Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1,'),
('130160','ELN','Supravalvar aortic stenosis, 185500 (3); Cutis laxa, AD, 123700 (3)'),
('130410','ETFB','Glutaric acidemia IIB, 231680 (3)'),
('130410','MADD','Glutaric acidemia IIB, 231680 (3)'),
('130500','EL1','Elliptocytosis-1, 611804 (3)'),
('130500','EPB41','Elliptocytosis-1, 611804 (3)'),
('130620','EMTB','(3)'),
('130620','RPS14','(3)'),
('130620','EMTB','Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550'),
('130620','RPS14','Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550'),
('131195','END','Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)'),
('131195','ENG','Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)'),
('131195','HHT1','Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)'),
('131195','ORW','Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)'),
('131200','ENDO1','{Endometriosis, susceptibility to, 1} (2)'),
('131210','ELAM1','[Blood pressure regulation QTL], 145500 (2)'),
('131210','SELE','[Blood pressure regulation QTL], 145500 (2)'),
('131222','ECGF1','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131222','MEDPS1','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131222','MNGIE','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131222','MTDPS1','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131222','PDECGF','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131222','TYMP','Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)'),
('131230','ANXA5','{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)'),
('131230','ENX2','{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)'),
('131230','RPRGL3','{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)'),
('131240','EDN1','[High density lipoprotein cholesterol level QTL 7] (3)'),
('131240','HDLCQ7','[High density lipoprotein cholesterol level QTL 7] (3)'),
('131242','EDN3','syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)'),
('131242','HSCR4','syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)'),
('131242','WS4B','syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)'),
('131242','EDN3','Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation'),
('131242','HSCR4','Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation'),
('131242','WS4B','Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation'),
('131243','EDNRA','Migraine, resistance to, 157300 (3)'),
('131244','ABCDS','syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)'),
('131244','EDNRB','syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)'),
('131244','HSCR2','syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)'),
('131244','WS4A','syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)'),
('131244','ABCDS','{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD'),
('131244','EDNRB','{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD'),
('131244','HSCR2','{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD'),
('131244','WS4A','{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD'),
('131310','AUTS10','{Autism susceptibility 10}, 611016 (3)'),
('131310','EN2','{Autism susceptibility 10}, 611016 (3)'),
('131320','GATA3','146255 (3)'),
('131320','HDR','146255 (3)'),
('131320','HDRS','146255 (3)'),
('131320','GATA3','Hypoparathyroidism, sensorineural deafness, and renal dysplasia,'),
('131320','HDR','Hypoparathyroidism, sensorineural deafness, and renal dysplasia,'),
('131320','HDRS','Hypoparathyroidism, sensorineural deafness, and renal dysplasia,'),
('131340','PDYN','Spinocerebellar ataxia 23, 610245 (3)'),
('131340','SCA23','Spinocerebellar ataxia 23, 610245 (3)'),
('131370','ENO3','Glycogen storage disease XIII, 612932 (3)'),
('131370','GSD13','Glycogen storage disease XIII, 612932 (3)'),
('131399','EPX','Eosinophil peroxidase deficiency, 261500 (3)'),
('131400','EOS','Eosinophilia, familial (2)'),
('131530','EGF','Hypomagnesemia 4, renal, 611718 (3)'),
('131530','HOMG4','Hypomagnesemia 4, renal, 611718 (3)'),
('131530','URG','Hypomagnesemia 4, renal, 611718 (3)'),
('131550','EGFR','211980 (3); Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3); {Nonsmall cell lung cancer, susceptibility to}, 211980 (3)'),
('131550','EGFR','Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in,'),
('132100','PPR1','Photoparoxysmal response 1 (2)'),
('132810','EPHX1','?Fetal hydantoin syndrome (1); Diphenylhydantoin toxicity (1);'),
('132810','EPHX1','Hypercholanemia, familial, 607748 (3); {Preeclampsia, susceptibility to}, 189800 (3)'),
('132811','EPHX2','143890 (3)'),
('132811','EPHX2','{Hypercholesterolemia, familial, due to LDLR defect, modifier of},'),
('133090','EPB72','?Stomatocytosis I, 185000 (1)'),
('133170','EPO','{Microvascular complications of diabetes 2}, 612623 (3)'),
('133170','MVCD2','{Microvascular complications of diabetes 2}, 612623 (3)'),
('133171','EPOR','[Erythrocytosis, familial, 1], 133100 (3)'),
('133190','SCA34','Spinocerebellar ataxia 34 (2)'),
('133430','ESR','Breast cancer (1); Estrogen resistance (3); {HDL response to hormone'),
('133430','ESR1','Breast cancer (1); Estrogen resistance (3); {HDL response to hormone'),
('133430','ESR','replacement, augmented} (3); {Migraine, susceptibility to}, 157300 (3); {Atherosclerosis, susceptibility to} (3); {Myocardial infarction,'),
('133430','ESR1','replacement, augmented} (3); {Migraine, susceptibility to}, 157300 (3); {Atherosclerosis, susceptibility to} (3); {Myocardial infarction,'),
('133430','ESR','susceptibility to}, 608446 (3)'),
('133430','ESR1','susceptibility to}, 608446 (3)'),
('133450','EWS','Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)'),
('133450','EWSR1','Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)'),
('133510','ERCC3','601675 (3)'),
('133510','XPB','601675 (3)'),
('133510','ERCC3','Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy,'),
('133510','XPB','Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy,'),
('133520','ERCC4','610965 (3)'),
('133520','XPF','610965 (3)'),
('133520','ERCC4','Xeroderma pigmentosum, group F, 278760 (3); XFE progeroid syndrome,'),
('133520','XPF','Xeroderma pigmentosum, group F, 278760 (3); XFE progeroid syndrome,'),
('133530','COFS3','syndrome 3 (3)'),
('133530','ERCC5','syndrome 3 (3)'),
('133530','XPG','syndrome 3 (3)'),
('133530','COFS3','Xeroderma pigmentosum, group G, 278780 (3); Cerebrooculofacioskeletal'),
('133530','ERCC5','Xeroderma pigmentosum, group G, 278780 (3); Cerebrooculofacioskeletal'),
('133530','XPG','Xeroderma pigmentosum, group G, 278780 (3); Cerebrooculofacioskeletal'),
('133550','EAAC1','?Dicarboxylicaminoaciduria, 222730 (1)'),
('133550','SLC1A1','?Dicarboxylicaminoaciduria, 222730 (1)'),
('134350','ADN','Complement factor D deficiency, 613912 (3)'),
('134350','CFD','Complement factor D deficiency, 613912 (3)'),
('134370','AHUS1','(3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)'),
('134370','ARMD4','(3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)'),
('134370','CFH','(3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)'),
('134370','HF1','(3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)'),
('134370','HUS','(3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)'),
('134370','AHUS1','{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400'),
('134370','ARMD4','{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400'),
('134370','CFH','{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400'),
('134370','HF1','{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400'),
('134370','HUS','{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400'),
('134371','CFHL1','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('134371','CFHR1','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('134371','FHR1','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('134371','HFL1','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('134371','CFHL1','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('134371','CFHR1','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('134371','FHR1','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('134371','HFL1','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('134570','F13A','Factor XIIIA deficiency, 613225 (3); {Myocardial infarction,'),
('134570','F13A1','Factor XIIIA deficiency, 613225 (3); {Myocardial infarction,'),
('134570','F13A','protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)'),
('134570','F13A1','protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)'),
('134580','F13B','Factor XIIIB deficiency, 613235 (3)'),
('134600','FRTS','Fanconi renotubular syndrome 1 (2)'),
('134600','FRTS1','Fanconi renotubular syndrome 1 (2)'),
('134600','RFS','Fanconi renotubular syndrome 1 (2)'),
('134637','ALPS1A','cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)'),
('134637','APT1','cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)'),
('134637','CD95','cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)'),
('134637','FAS','cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)'),
('134637','TNFRSF6','cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)'),
('134637','ALPS1A','{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous'),
('134637','APT1','{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous'),
('134637','CD95','{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous'),
('134637','FAS','{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous'),
('134637','TNFRSF6','{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous'),
('134638','APT1LG1','{Systemic lupus erythematosus, susceptibility}, 152700 (3)'),
('134638','FASL','{Systemic lupus erythematosus, susceptibility}, 152700 (3)'),
('134638','TNFSF6','{Systemic lupus erythematosus, susceptibility}, 152700 (3)'),
('134770','FTH1','Iron overload, autosomal dominant (3)'),
('134770','FTHL6','Iron overload, autosomal dominant (3)'),
('134790','FTL','Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration'),
('134790','NBIA3','Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration'),
('134790','FTL','with brain iron accumulation 3, 606159 (3)'),
('134790','NBIA3','with brain iron accumulation 3, 606159 (3)'),
('134797','ACMICD','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','FBN1','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','GPHYSD2','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','MFS1','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','SSKS','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','WMS2','182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending,'),
('134797','ACMICD','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','FBN1','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','GPHYSD2','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','MFS1','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','SSKS','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','WMS2','and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)'),
('134797','ACMICD','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134797','FBN1','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134797','GPHYSD2','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134797','MFS1','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134797','SSKS','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134797','WMS2','Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,'),
('134820','FGA','Dysfibrinogenemia, alpha type, causing bleeding diathesis (3);'),
('134820','FGA','Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3); Amyloidosis, hereditary renal, 105200 (3); Afibrinogenemia, congenital, 202400 (3)'),
('134830','FGB','202400 (3); Thrombophilia, dysfibrinogenemic (3)'),
('134830','FGB','Dysfibrinogenemia, beta type (3); Afibrinogenemia, congenital,'),
('134850','FGG','Dysfibrinogenemia, gamma type (3); Hypofibrinogenemia, gamma'),
('134850','FGG','type (3); Thrombophilia, dysfibrinogenemic (3)'),
('134934','ACH','109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, keratinocytic, nonepidermolytic, 162900 (3); Th'),
('134934','FGFR3','109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, keratinocytic, nonepidermolytic, 162900 (3); Th'),
('134934','ACH','Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3);'),
('134934','FGFR3','Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3);'),
('134934','ACH','Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic,'),
('134934','FGFR3','Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic,'),
('134935','FGFR4','{Cancer progression/metastasis} (3)'),
('135400','DEL17q24','hyperplasia (4)'),
('135400','HTGH','hyperplasia (4)'),
('135400','DEL17q24','Hypertrichosis terminalis, generalized, with or without gingival'),
('135400','HTGH','Hypertrichosis terminalis, generalized, with or without gingival'),
('135500','ZLS','?Zimmermann-Laband syndrome (2)'),
('135600','FN','Glomerulopathy with fibronectin deposits 2, 601894 (3);'),
('135600','FN1','Glomerulopathy with fibronectin deposits 2, 601894 (3);'),
('135600','FNZ','Glomerulopathy with fibronectin deposits 2, 601894 (3);'),
('135600','GFND2','Glomerulopathy with fibronectin deposits 2, 601894 (3);'),
('135600','LETS','Glomerulopathy with fibronectin deposits 2, 601894 (3);'),
('135600','FN','Plasma fibronectin deficiency, 614101 (1)'),
('135600','FN1','Plasma fibronectin deficiency, 614101 (1)'),
('135600','FNZ','Plasma fibronectin deficiency, 614101 (1)'),
('135600','GFND2','Plasma fibronectin deficiency, 614101 (1)'),
('135600','LETS','Plasma fibronectin deficiency, 614101 (1)'),
('135750','TMIP','?Tetramelic mirror-image polydactyly (2)'),
('135820','FBLN1','synostoses, 608180 (3)'),
('135820','FBLN1','Synpolydactyly, 3/3\'4, associated with metacarpal and metatarsal'),
('135900','CSS','?Coffin-Siris syndrome (2)'),
('135940','ATOD2','Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility'),
('135940','FLG','Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility'),
('135940','ATOD2','to, 2}, 605803 (3)'),
('135940','FLG','to, 2}, 605803 (3)'),
('136132','FMO3','Trimethylaminuria, 602079 (3)'),
('136132','TMAU','Trimethylaminuria, 602079 (3)'),
('136350','FGFR1','Kallmann syndrome 2, 147950 (3); Hypogonadotropic hypogonadism, 146110 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3)'),
('136350','FLT2','Kallmann syndrome 2, 147950 (3); Hypogonadotropic hypogonadism, 146110 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3)'),
('136350','KAL2','Kallmann syndrome 2, 147950 (3); Hypogonadotropic hypogonadism, 146110 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3)'),
('136350','OGD','Kallmann syndrome 2, 147950 (3); Hypogonadotropic hypogonadism, 146110 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3)'),
('136350','FGFR1','Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3);'),
('136350','FLT2','Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3);'),
('136350','KAL2','Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3);'),
('136350','OGD','Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3);'),
('136351','FLT3','acute myeloid, 601626 (3); Leukemia, acute lymphoblastic (3)'),
('136351','FLT3','Leukemia, acute myeloid, reduced survival in (3); Leukemia,'),
('136352','FLT4','infantile, somatic, 602089 (3)'),
('136352','LMPH1A','infantile, somatic, 602089 (3)'),
('136352','PCL','infantile, somatic, 602089 (3)'),
('136352','VEGFR3','infantile, somatic, 602089 (3)'),
('136352','FLT4','Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary'),
('136352','LMPH1A','Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary'),
('136352','PCL','Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary'),
('136352','VEGFR3','Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary'),
('136430','FOLR1','613068 (3)'),
('136430','FOLR1','Neurodegeneration due to cerebral folate transport deficiency,'),
('136435','FSHR','Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH'),
('136435','ODG1','Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH'),
('136435','FSHR','stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)'),
('136435','ODG1','stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)'),
('136440','FVT1','Lymphoma/leukemia, B-cell, variant (1)'),
('136530','FSHB','Follicle-stimulating hormone deficiency, isolated, 229070 (3)'),
('136533','FKHR','Rhabdomyosarcoma, alveolar, 268220 (3)'),
('136533','FOXO1A','Rhabdomyosarcoma, alveolar, 268220 (3)'),
('136550','MCDR1','Macular dystrophy, North Carolina type (2)'),
('136570','C16DELp12.1','Chromosome 16p12.1 deletion syndrome, 520kb (4)'),
('136570','DEL16p12.1','Chromosome 16p12.1 deletion syndrome, 520kb (4)'),
('136836','FUT6','Fucosyltransferase 6 deficiency, 613852 (3)'),
('136850','FH','Fumarase deficiency, 606812 (3);'),
('136850','HLRCC','Fumarase deficiency, 606812 (3);'),
('136850','MCUL1','Fumarase deficiency, 606812 (3);'),
('136850','FH','Leiomyomatosis and renal cell cancer, 150800 (3)'),
('136850','HLRCC','Leiomyomatosis and renal cell cancer, 150800 (3)'),
('136850','MCUL1','Leiomyomatosis and renal cell cancer, 150800 (3)'),
('137060','B4GALT1','Congenital disorder of glycosylation, type IId, 607091 (3)'),
('137060','CDG2D','Congenital disorder of glycosylation, type IId, 607091 (3)'),
('137060','GGTB2','Congenital disorder of glycosylation, type IId, 607091 (3)'),
('137060','GT1','Congenital disorder of glycosylation, type IId, 607091 (3)'),
('137060','GTB','Congenital disorder of glycosylation, type IId, 607091 (3)'),
('137070','ALS6','Amyotrophic lateral sclerosis 6, autosomal recessive, with or without'),
('137070','FUS','Amyotrophic lateral sclerosis 6, autosomal recessive, with or without'),
('137070','TLS','Amyotrophic lateral sclerosis 6, autosomal recessive, with or without'),
('137070','ALS6','frontotemporal dementia, 608030 (3)'),
('137070','FUS','frontotemporal dementia, 608030 (3)'),
('137070','TLS','frontotemporal dementia, 608030 (3)'),
('137100','IGAD1','Immunoglobulin A deficiency (2)'),
('137140','GABRA2','{Alcohol dependence, susceptibility to}, 103780 (3)'),
('137150','ABAT','GABA-transaminase deficiency, 613163 (3)'),
('137150','GABAT','GABA-transaminase deficiency, 613163 (3)'),
('137160','ECA4','{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)'),
('137160','EJM5','{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)'),
('137160','GABRA1','{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)'),
('137160','ECA4','{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3);'),
('137160','EJM5','{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3);'),
('137160','GABRA1','{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3);'),
('137163','EIG10','susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)'),
('137163','EJM7','susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)'),
('137163','GABRD','susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)'),
('137163','GEFSP5','susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)'),
('137163','EIG10','{Generalized epilepsy with febrile seizures plus, type 5,'),
('137163','EJM7','{Generalized epilepsy with febrile seizures plus, type 5,'),
('137163','GABRD','{Generalized epilepsy with febrile seizures plus, type 5,'),
('137163','GEFSP5','{Generalized epilepsy with febrile seizures plus, type 5,'),
('137164','CAE2','(3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3); Dravet syndrome, 607208 (3)'),
('137164','ECA2','(3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3); Dravet syndrome, 607208 (3)'),
('137164','GABRG2','(3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3); Dravet syndrome, 607208 (3)'),
('137164','GEFSP3','(3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3); Dravet syndrome, 607208 (3)'),
('137164','CAE2','Epilepsy, generalized, with febrile seizures plus, type 3, 611277'),
('137164','ECA2','Epilepsy, generalized, with febrile seizures plus, type 3, 611277'),
('137164','GABRG2','Epilepsy, generalized, with febrile seizures plus, type 3, 611277'),
('137164','GEFSP3','Epilepsy, generalized, with febrile seizures plus, type 3, 611277'),
('137167','GGCX','Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)'),
('137167','GGCX','Vitamin K-dependent coagulation defect, 277450 (3);'),
('137181','GGT2','[Gamma-glutamyltransferase, familial high serum] (2)'),
('137192','ECA5','612269 (3)'),
('137192','GABRB3','612269 (3)'),
('137192','ECA5','Insomnia (3); {Epilepsy, childhood absence, susceptibility to, 5},'),
('137192','GABRB3','Insomnia (3); {Epilepsy, childhood absence, susceptibility to, 5},'),
('137241','GIPR','[Plasma glucose, 2-hour, QTL 2] (2)'),
('137241','PGQTL2','[Plasma glucose, 2-hour, QTL 2] (2)'),
('137290','M1S1','Corneal dystrophy, gelatinous drop-like, 204870 (3)'),
('137290','TACSTD2','Corneal dystrophy, gelatinous drop-like, 204870 (3)'),
('137290','TROP2','Corneal dystrophy, gelatinous drop-like, 204870 (3)'),
('137295','DCML','Dendritic cell, monocyte, B lymphocyte, and natural killer'),
('137295','GATA2','Dendritic cell, monocyte, B lymphocyte, and natural killer'),
('137295','MONOMAC','Dendritic cell, monocyte, B lymphocyte, and natural killer'),
('137295','DCML','lymphocyte deficiency, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute'),
('137295','GATA2','lymphocyte deficiency, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute'),
('137295','MONOMAC','lymphocyte deficiency, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute'),
('137295','DCML','myeloid, susceptibility to}, 601626 (3)'),
('137295','GATA2','myeloid, susceptibility to}, 601626 (3)'),
('137295','MONOMAC','myeloid, susceptibility to}, 601626 (3)'),
('137350','GSN','Amyloidosis, Finnish type, 105120 (3)'),
('137580','GTS','Tourette syndrome (2)'),
('137780','GFAP','Alexander disease, 203450 (3)'),
('137950','GFND1','Glomerulopathy with fibronectin deposits 1 (2)'),
('137960','MPV17','(3)'),
('137960','MTDPS6','(3)'),
('137960','MPV17','Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810'),
('137960','MTDPS6','Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810'),
('138030','GCG','[?Hyperproglucagonemia] (1)'),
('138033','GCGR','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('138040','GCR','Cortisol resistance (3)'),
('138040','GRL','Cortisol resistance (3)'),
('138040','NR3C1','Cortisol resistance (3)'),
('138079','GCK','late onset, 125853 (3); Diabetes mellitus, gestational, 125851 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus,'),
('138079','HHF3','late onset, 125853 (3); Diabetes mellitus, gestational, 125851 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus,'),
('138079','GCK','MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent,'),
('138079','HHF3','MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent,'),
('138079','GCK','permanent neonatal, 606176 (3)'),
('138079','HHF3','permanent neonatal, 606176 (3)'),
('138090','G6PDH','Cortisone reductase deficiency, 604931 (3)'),
('138090','GDH','Cortisone reductase deficiency, 604931 (3)'),
('138090','H6PD','Cortisone reductase deficiency, 604931 (3)'),
('138130','GLUD1','Hyperinsulinism-hyperammonemia syndrome, 606762 (3)'),
('138140','','2, 612126 (3)'),
('138140','DYT18','2, 612126 (3)'),
('138140','GLUT1','2, 612126 (3)'),
('138140','GLUT1DS','2, 612126 (3)'),
('138140','PED','2, 612126 (3)'),
('138140','SLC2A1','2, 612126 (3)'),
('138140','','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138140','DYT18','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138140','GLUT1','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138140','GLUT1DS','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138140','PED','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138140','SLC2A1','GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome'),
('138160','GLUT2','syndrome, 227810 (3)'),
('138160','SLC2A2','syndrome, 227810 (3)'),
('138160','GLUT2','{Diabetes mellitus, noninsulin-dependent} (3); Fanconi-Bickel'),
('138160','SLC2A2','{Diabetes mellitus, noninsulin-dependent} (3); Fanconi-Bickel'),
('138180','ASTQTL1','Aspartate aminotransferase, serum level of, QTL1, 614419 (3)'),
('138180','GOT1','Aspartate aminotransferase, serum level of, QTL1, 614419 (3)'),
('138190','GLUT4','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('138190','SLC2A4','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('138244','GLUR6','Mental retardation, autosomal recessive, 6, 611092 (3)'),
('138244','GRIK2','Mental retardation, autosomal recessive, 6, 611092 (3)'),
('138244','MRT6','Mental retardation, autosomal recessive, 6, 611092 (3)'),
('138249','GRIN1','Mental retardation, autosomal dominant 8, 614254 (3)'),
('138249','MRD8','Mental retardation, autosomal dominant 8, 614254 (3)'),
('138249','NMDAR1','Mental retardation, autosomal dominant 8, 614254 (3)'),
('138250','ALDH18A1','Cutis laxa, autosomal recessive, type IIIA, 219150 (3)'),
('138250','ARCL3A','Cutis laxa, autosomal recessive, type IIIA, 219150 (3)'),
('138250','GSAS','Cutis laxa, autosomal recessive, type IIIA, 219150 (3)'),
('138250','PYCS','Cutis laxa, autosomal recessive, type IIIA, 219150 (3)'),
('138252','GRIN2B','Mental retardation, autosomal dominant 6, 613970 (3)'),
('138252','MRD6','Mental retardation, autosomal dominant 6, 613970 (3)'),
('138252','NMDAR2B','Mental retardation, autosomal dominant 6, 613970 (3)'),
('138253','EPND','Epilepsy with neurodevelopmental defects, 613971 (3)'),
('138253','GRIN2A','Epilepsy with neurodevelopmental defects, 613971 (3)'),
('138253','NMDAR2A','Epilepsy with neurodevelopmental defects, 613971 (3)'),
('138290','GLNS','Glutamine deficiency, congenital, 610015 (3)'),
('138290','GLUL','Glutamine deficiency, congenital, 610015 (3)'),
('138292','GFAT1','Myasthenia, limb-girdle, with tubular aggregates, 610542 (3)'),
('138292','GFPT1','Myasthenia, limb-girdle, with tubular aggregates, 610542 (3)'),
('138292','GFPT1L','Myasthenia, limb-girdle, with tubular aggregates, 610542 (3)'),
('138292','MSLG','Myasthenia, limb-girdle, with tubular aggregates, 610542 (3)'),
('138300','GSR','Hemolytic anemia due to glutathione reductase deficiency (1)'),
('138320','GPX1','Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)'),
('138320','GPXD','Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)'),
('138420','GPD1','Hypertriglyceridemia, transient infantile, 614480 (3)'),
('138420','HTGTI','Hypertriglyceridemia, transient infantile, 614480 (3)'),
('138430','GPD2','{Diabetes, type 2, susceptibility to}, 125853 (3)'),
('138470','AHUS4','{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)'),
('138470','BF','{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)'),
('138470','CFB','{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)'),
('138470','GBG','{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)'),
('138470','AHUS4','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('138470','BF','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('138470','CFB','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('138470','GBG','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('138491','GLRA1','Startle disease, autosomal recessive (3); Hyperekplexia and spastic paraparesis (3)'),
('138491','STHE','Startle disease, autosomal recessive (3); Hyperekplexia and spastic paraparesis (3)'),
('138491','GLRA1','Startle disease/hyperekplexia, autosomal dominant, 149400 (3);'),
('138491','STHE','Startle disease/hyperekplexia, autosomal dominant, 149400 (3);'),
('138492','GLRB','Hyperekplexia, autosomal recessive, 149400 (3)'),
('138570','GYS','Glycogen storage disease 0, muscle, 611556 (3)'),
('138570','GYS1','Glycogen storage disease 0, muscle, 611556 (3)'),
('138571','GYS2','Glycogen storage disease, type 0, 240600 (3)'),
('138720','BDPLT1','Bernard-Soulier syndrome, type B, 231200 (3);'),
('138720','BS','Bernard-Soulier syndrome, type B, 231200 (3);'),
('138720','GP1BB','Bernard-Soulier syndrome, type B, 231200 (3);'),
('138720','BDPLT1','Giant platelet disorder, isolated, 231200 (3)'),
('138720','BS','Giant platelet disorder, isolated, 231200 (3)'),
('138720','GP1BB','Giant platelet disorder, isolated, 231200 (3)'),
('138760','GLO2','[Glyoxalase II deficiency], 614033 (1)'),
('138760','HAGH','[Glyoxalase II deficiency], 614033 (1)'),
('138850','GNRHR','(3)'),
('138850','LHRHR','(3)'),
('138850','GNRHR','Hypogonadotropic hypogonadism (3); Fertile eunuch syndrome, 228300'),
('138850','LHRHR','Hypogonadotropic hypogonadism (3); Fertile eunuch syndrome, 228300'),
('138945','GRN','607485 (3)'),
('138945','GRN','Frontotemporal lobar degeneration with ubiquitin-positive inclusions,'),
('138971','CSF3R','Neutrophilia, hereditary, 162830 (3)'),
('138971','GCSFR','Neutrophilia, hereditary, 162830 (3)'),
('138981','CSF2RB','Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)'),
('138981','SMDP5','Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)'),
('139130','GNB3','{Hypertension, essential, susceptibility to}, 145500 (3)'),
('139150','CMAVM','malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)'),
('139150','GAP','malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)'),
('139150','PKWS','malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)'),
('139150','RASA1','malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)'),
('139150','CMAVM','Parkes Weber slndrome, 608355 (3); Capillary'),
('139150','GAP','Parkes Weber slndrome, 608355 (3); Capillary'),
('139150','PKWS','Parkes Weber slndrome, 608355 (3); Capillary'),
('139150','RASA1','Parkes Weber slndrome, 608355 (3); Capillary'),
('139190','GHRF','?Isolated growth hormone deficiency due to defect in GHRF (1);'),
('139190','GHRH','?Isolated growth hormone deficiency due to defect in GHRF (1);'),
('139190','GHRF','Gigantism due to GHRF hypersecretion (1)'),
('139190','GHRH','Gigantism due to GHRF hypersecretion (1)'),
('139191','GHRFR','Growth hormone deficiency, isolated, type IB, 612781 (3)'),
('139191','GHRHR','Growth hormone deficiency, isolated, type IB, 612781 (3)'),
('139191','IGHD1B','Growth hormone deficiency, isolated, type IB, 612781 (3)'),
('139200','DBP','{Graves disease, susceptibility to, 3} (3)'),
('139200','GC','{Graves disease, susceptibility to, 3} (3)'),
('139200','GRD3','{Graves disease, susceptibility to, 3} (3)'),
('139250','GH1','Growth hormone deficiency, isolated, type IA, 262400 (3); Growth'),
('139250','GHN','Growth hormone deficiency, isolated, type IA, 262400 (3); Growth'),
('139250','IGHD1B','Growth hormone deficiency, isolated, type IA, 262400 (3); Growth'),
('139250','GH1','hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)'),
('139250','GHN','hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)'),
('139250','IGHD1B','hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)'),
('139320','AHO','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','GNAS','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','GNAS1','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','GPSA','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','PHP1A','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','PHP1B','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','PHP1C','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','POH','174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Prolonged'),
('139320','AHO','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','GNAS','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','GNAS1','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','GPSA','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','PHP1A','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','PHP1B','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','PHP1C','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','POH','bleeding time, brachydactyly and mental retardation (3); Acromegaly, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); Prolonged bleeding time, brachydactyly, and mental retardation (3); ACTH-in'),
('139320','AHO','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','GNAS','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','GNAS1','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','GPSA','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','PHP1A','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','PHP1B','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','PHP1C','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139320','POH','Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,'),
('139330','CSNBAD3','610444 (3)'),
('139330','GNAT1','610444 (3)'),
('139330','CSNBAD3','Night blindness, congenital stationary, autosomal dominant 3,'),
('139330','GNAT1','Night blindness, congenital stationary, autosomal dominant 3,'),
('139340','ACHM4','Achromatopsia-4, 613856 (3)'),
('139340','GNAT2','Achromatopsia-4, 613856 (3)'),
('139350','EHK','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('139350','EPPK','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('139350','KRT1','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('139350','NEPPK','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('139350','EHK','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3);'),
('139350','EPPK','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3);'),
('139350','KRT1','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3);'),
('139350','NEPPK','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3);'),
('139350','EHK','Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)'),
('139350','EPPK','Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)'),
('139350','KRT1','Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)'),
('139350','NEPPK','Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)'),
('139360','GIP','idiopathic, 192605 (3)'),
('139360','GNAI2','idiopathic, 192605 (3)'),
('139360','GNAI2B','idiopathic, 192605 (3)'),
('139360','GIP','Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia,'),
('139360','GNAI2','Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia,'),
('139360','GNAI2B','Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia,'),
('139450','HRM2','Hair, curly (2)'),
('139900','HSR','[Handedness] (2)'),
('140100','HP','[Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)'),
('140300','HT','Hashimoto thyroiditis (2)'),
('141250','HMOX1','chronic obstructive, susceptibility to}, 606963 (3)'),
('141250','HMOX1','Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease,'),
('141750','ATR1','Alpha-thalassemia/mental retardation syndrome, type 1 (4)'),
('141750','HBHR','Alpha-thalassemia/mental retardation syndrome, type 1 (4)'),
('141800','HBA1','Erythremias, alpha- (3); Heinz body anemias, alpha-, 140700 (3); Hemoglobin H disease, nondeletional, 613978 (3)'),
('141800','HBH','Erythremias, alpha- (3); Heinz body anemias, alpha-, 140700 (3); Hemoglobin H disease, nondeletional, 613978 (3)'),
('141800','HBA1','Thalassemias, alpha-, 604131 (3); Methemoglobinemias, alpha- (3);'),
('141800','HBH','Thalassemias, alpha-, 604131 (3); Methemoglobinemias, alpha- (3);'),
('141850','HBA2','Erythrocytosis (3); Hypochromic microcytic anemia (3); Hemoglobin H disease, nondeletional, 613978 (3)'),
('141850','HBH','Erythrocytosis (3); Hypochromic microcytic anemia (3); Hemoglobin H disease, nondeletional, 613978 (3)'),
('141850','HBA2','Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3);'),
('141850','HBH','Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3);'),
('141900','HBB','Erythremias, beta- (3); Methemoglobinemias, beta- (3); Heinz body anemias, beta-, 140700 (3); Thalassemia-beta, dominant inclusion-body, 603902 (3);'),
('141900','HBB','Hereditary persistence of fetal hemoglobin, 141749 (3); Delta-beta thalassemia, 141749 (3)'),
('141900','HBB','Sickle cell anemia, 603903 (3); Thalassemias, beta-, 613985 (3);'),
('142000','HBD','Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)'),
('142200','HBG1','Fetal hemoglobin quantitative trait locus 1, 141749 (3)'),
('142250','HBG2','Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis,'),
('142250','TNCY','Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis,'),
('142250','HBG2','transient neonatal, 613977 (3)'),
('142250','TNCY','transient neonatal, 613977 (3)'),
('142335','HBFQTL5','[Fetal hemoglobin QTL5] (2)'),
('142340','DIH1','Hernia, congenital diaphragmatic 1 (2)'),
('142340','HCD','Hernia, congenital diaphragmatic 1 (2)'),
('142360','HC2','Thrombophilia due to heparin cofactor II deficiency, 612356 (3)'),
('142360','HCF2','Thrombophilia due to heparin cofactor II deficiency, 612356 (3)'),
('142360','SERPIND1','Thrombophilia due to heparin cofactor II deficiency, 612356 (3)'),
('142360','THPH10','Thrombophilia due to heparin cofactor II deficiency, 612356 (3)'),
('142409','DFNB39','Deafness, autosomal recessive 39, 608265 (3)'),
('142409','HGF','Deafness, autosomal recessive 39, 608265 (3)'),
('142410','HNF1A','2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes'),
('142410','IDDM20','2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes'),
('142410','MODY3','2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes'),
('142410','TCF1','2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes'),
('142410','HNF1A','mellitus, insulin-dependent, 20, 612520 (3)'),
('142410','IDDM20','mellitus, insulin-dependent, 20, 612520 (3)'),
('142410','MODY3','mellitus, insulin-dependent, 20, 612520 (3)'),
('142410','TCF1','mellitus, insulin-dependent, 20, 612520 (3)'),
('142410','HNF1A','MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent,'),
('142410','IDDM20','MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent,'),
('142410','MODY3','MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent,'),
('142410','TCF1','MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent,'),
('142445','ARIA','{?Schizophrenia, susceptibility to}, 603013 (1)'),
('142445','HGL','{?Schizophrenia, susceptibility to}, 603013 (1)'),
('142445','HRGA','{?Schizophrenia, susceptibility to}, 603013 (1)'),
('142445','NRG1','{?Schizophrenia, susceptibility to}, 603013 (1)'),
('142461','HSPG2','Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,'),
('142461','PLC','Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,'),
('142461','SJA','Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,'),
('142461','SJS','Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,'),
('142461','SJS1','Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,'),
('142461','HSPG2','Silverman-Handmaker type, 224410 (3)'),
('142461','PLC','Silverman-Handmaker type, 224410 (3)'),
('142461','SJA','Silverman-Handmaker type, 224410 (3)'),
('142461','SJS','Silverman-Handmaker type, 224410 (3)'),
('142461','SJS1','Silverman-Handmaker type, 224410 (3)'),
('142470','FCP','Fetal hemoglobin quantitative trait locus 2 (2)'),
('142470','HBFQTL2','Fetal hemoglobin quantitative trait locus 2 (2)'),
('142600','HK1','Hemolytic anemia due to hexokinase deficiency, 235700 (3)'),
('142640','HRG','Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due'),
('142640','THPH11','Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due'),
('142640','HRG','to elevated HRG, 613116 (1)'),
('142640','THPH11','to elevated HRG, 613116 (1)'),
('142669','BFHD','Hip dysplasia, Beukes type (2)'),
('142669','BHD','Hip dysplasia, Beukes type (2)'),
('142700','ACTD','Acetabular dysplasia (2)'),
('142800','HLA-A','to}, 608579 (3)'),
('142800','HLA-A','{Hypersensitivity syndrome, carbamazepine-induced, susceptibility'),
('142810','HARS','Usher syndrome type 3B, 614504 (3)'),
('142810','USH3B','Usher syndrome type 3B, 614504 (3)'),
('142830','HLA-B','epidermal necrolysis, susceptibility to}, 608579 (3); {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)'),
('142830','SPDA1','epidermal necrolysis, susceptibility to}, 608579 (3); {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)'),
('142830','HLA-B','hypersensitivity, susceptibility to} (3); {Synovitis, chronic, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic'),
('142830','SPDA1','hypersensitivity, susceptibility to} (3); {Synovitis, chronic, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic'),
('142830','HLA-B','{Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir'),
('142830','SPDA1','{Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir'),
('142840','HLA-C','viremia, susceptibility to}, 609423 (3)'),
('142840','PSORS1','viremia, susceptibility to}, 609423 (3)'),
('142840','HLA-C','{Psoriasis susceptibility 1}, 177900 (3); {HIV-1'),
('142840','PSORS1','{Psoriasis susceptibility 1}, 177900 (3); {HIV-1'),
('142857','HLA-DRB1','l, 1}, 181000 (3); {Multiple sclerosis, susceptibility to}, 126200 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('142857','SS1','l, 1}, 181000 (3); {Multiple sclerosis, susceptibility to}, 126200 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('142857','HLA-DRB1','{Pemphigoid, susceptibility to} (2); {Sarcoidosis, susceptibility'),
('142857','SS1','{Pemphigoid, susceptibility to} (2); {Sarcoidosis, susceptibility'),
('142858','HLA-DPB1','{Beryllium disease, chronic, susceptibility to} (3)'),
('142871','HLA-G','{Asthma, susceptibility to}, 600807 (2)'),
('142910','HMGCR','lipoprotein cholesterol level QTL 3] (3)'),
('142910','LDLCQ3','lipoprotein cholesterol level QTL 3] (3)'),
('142910','HMGCR','[Statins, attenuated cholesterol lowering by] (3); [Low density'),
('142910','LDLCQ3','[Statins, attenuated cholesterol lowering by] (3); [Low density'),
('142955','BSAS','Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem'),
('142955','HOX1F','Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem'),
('142955','HOXA1','Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem'),
('142955','BSAS','dysgenesis syndrome, 601536 (3)'),
('142955','HOX1F','dysgenesis syndrome, 601536 (3)'),
('142955','HOXA1','dysgenesis syndrome, 601536 (3)'),
('142958','HOX1I','(3)'),
('142958','HOXA11','(3)'),
('142958','HOX1I','Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432'),
('142958','HOXA11','Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432'),
('142959','HOX1J','(3)'),
('142959','HOXA13','(3)'),
('142959','HOX1J','Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305'),
('142959','HOXA13','Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305'),
('142981','HOX4B','{Leukemia, acute lymphoblastic, susceptibility to} (3)'),
('142981','HOXD4','{Leukemia, acute lymphoblastic, susceptibility to} (3)'),
('142983','HOX7','(3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)'),
('142983','HYD1','(3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)'),
('142983','MSX1','(3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)'),
('142983','OFC5','(3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)'),
('142983','STHAG1','(3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)'),
('142983','HOX7','Tooth agenesis, selective, 1, with or without orofacial cleft, 106600'),
('142983','HYD1','Tooth agenesis, selective, 1, with or without orofacial cleft, 106600'),
('142983','MSX1','Tooth agenesis, selective, 1, with or without orofacial cleft, 106600'),
('142983','OFC5','Tooth agenesis, selective, 1, with or without orofacial cleft, 106600'),
('142983','STHAG1','Tooth agenesis, selective, 1, with or without orofacial cleft, 106600'),
('142984','HOX4D','disease, foot deformity of, 192950 (3)'),
('142984','HOXD10','disease, foot deformity of, 192950 (3)'),
('142984','HOX4D','Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth'),
('142984','HOXD10','Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth'),
('142989','BDSD','(3); Brachydactyly, type D, 113200 (3); Synpolydactyly with foot anomalies, 186000 (3); Syndactyly, type V, 186300 (3); Brachydactyly-syndactyly syndrome,'),
('142989','HOX4I','(3); Brachydactyly, type D, 113200 (3); Synpolydactyly with foot anomalies, 186000 (3); Syndactyly, type V, 186300 (3); Brachydactyly-syndactyly syndrome,'),
('142989','HOXD13','(3); Brachydactyly, type D, 113200 (3); Synpolydactyly with foot anomalies, 186000 (3); Syndactyly, type V, 186300 (3); Brachydactyly-syndactyly syndrome,'),
('142989','SPD','(3); Brachydactyly, type D, 113200 (3); Synpolydactyly with foot anomalies, 186000 (3); Syndactyly, type V, 186300 (3); Brachydactyly-syndactyly syndrome,'),
('142989','BDSD','610713 (3); VACTERL association, 192350 (3)'),
('142989','HOX4I','610713 (3); VACTERL association, 192350 (3)'),
('142989','HOXD13','610713 (3); VACTERL association, 192350 (3)'),
('142989','SPD','610713 (3); VACTERL association, 192350 (3)'),
('142989','BDSD','Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300'),
('142989','HOX4I','Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300'),
('142989','HOXD13','Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300'),
('142989','SPD','Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300'),
('142992','H6','Oculoauricular syndrome, 612109 (3)'),
('142992','HMX1','Oculoauricular syndrome, 612109 (3)'),
('142993','CHX10','Microphthalmia with coloboma 3, 610092 (3);'),
('142993','HOX10','Microphthalmia with coloboma 3, 610092 (3);'),
('142993','MCOP2','Microphthalmia with coloboma 3, 610092 (3);'),
('142993','MCOPCB3','Microphthalmia with coloboma 3, 610092 (3);'),
('142993','CHX10','Microphthalmia, isolated 2, 610093 (3)'),
('142993','HOX10','Microphthalmia, isolated 2, 610093 (3)'),
('142993','MCOP2','Microphthalmia, isolated 2, 610093 (3)'),
('142993','MCOPCB3','Microphthalmia, isolated 2, 610093 (3)'),
('142994','HLXB9','Currarino syndrome, 176450 (3)'),
('142994','HOXHB9','Currarino syndrome, 176450 (3)'),
('142994','MNX1','Currarino syndrome, 176450 (3)'),
('142994','SCRA1','Currarino syndrome, 176450 (3)'),
('143400','PUJO','Pelviureteric junction obstruction (2)'),
('143450','HADHB','Trifunctional protein deficiency, 609015 (3)'),
('143850','OHDS','Orthostatic hypotensive disorder of Streeten (2)'),
('144110','HHPP','Hyperhidrosis palmaris et plantaris (2)'),
('144120','IGHR','?Hyperimmunoglobulin G1 syndrome (2)'),
('145260','PHA2','Pseudohypoaldosteronism, type IIA (2)'),
('145260','PHA2A','Pseudohypoaldosteronism, type IIA (2)'),
('145410','BBBG2','Opitz GBBB syndrome, type II (4)'),
('145410','GBBB2','Opitz GBBB syndrome, type II (4)'),
('145410','OGS2','Opitz GBBB syndrome, type II (4)'),
('145505','ACSM3','{?Hypertension, essential} (1)'),
('145505','SAH','{?Hypertension, essential} (1)'),
('145701','ITC1','?Hypertrichosis universalis congenita, Ambras type (2)'),
('145750','HTGS','{Hypertriglyceridemia, susceptibility to} (2)'),
('145981','FHH2','Hypocalciuric hypercalcemia, type II (2)'),
('145981','HHC2','Hypocalciuric hypercalcemia, type II (2)'),
('146390','C18DELp','Chromosome 18p deletion syndrome (4)'),
('146390','DEL18p','Chromosome 18p deletion syndrome (4)'),
('146450','HYSP3','Hypospadias 3, autosomal (2)'),
('146661','CD127','killer cell-positive type, 608971 (3)'),
('146661','IL7R','killer cell-positive type, 608971 (3)'),
('146661','IL7RA','killer cell-positive type, 608971 (3)'),
('146661','CD127','Severe combined immunodeficiency, T-cell negative, B-cell/natural'),
('146661','IL7R','Severe combined immunodeficiency, T-cell negative, B-cell/natural'),
('146661','IL7RA','Severe combined immunodeficiency, T-cell negative, B-cell/natural'),
('146690','IMPDH1','613837 (3)'),
('146690','LCA11','613837 (3)'),
('146690','RP10','613837 (3)'),
('146690','IMPDH1','Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11,'),
('146690','LCA11','Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11,'),
('146690','RP10','Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11,'),
('146691','IMPD2','[IMPDH2 enzyme activity, variation in] (3)'),
('146691','IMPDH2','[IMPDH2 enzyme activity, variation in] (3)'),
('146738','INSL3','Cryptorchidism, idiopathic, 219050 (3)'),
('146740','CD16','(3)'),
('146740','FCGR3A','(3)'),
('146740','IGFR3','(3)'),
('146740','CD16','Neutropenia, alloimmune neonatal (3); {Viral infections, recurrent}'),
('146740','FCGR3A','Neutropenia, alloimmune neonatal (3); {Viral infections, recurrent}'),
('146740','IGFR3','Neutropenia, alloimmune neonatal (3); {Viral infections, recurrent}'),
('146760','CD64','[IgG receptor I, phagocytic, familial deficiency of] (3)'),
('146760','FCGR1A','[IgG receptor I, phagocytic, familial deficiency of] (3)'),
('146760','IGFR1','[IgG receptor I, phagocytic, familial deficiency of] (3)'),
('146770','AGM2','Agammaglobulinemia 2, 613500 (3)'),
('146770','IGL5','Agammaglobulinemia 2, 613500 (3)'),
('146770','IGLL1','Agammaglobulinemia 2, 613500 (3)'),
('146770','IGO','Agammaglobulinemia 2, 613500 (3)'),
('146770','VPREB2','Agammaglobulinemia 2, 613500 (3)'),
('146790','CD32','{Lupus nephritis, susceptibility to} (3)'),
('146790','FCGR2A','{Lupus nephritis, susceptibility to} (3)'),
('146790','IGFR2','{Lupus nephritis, susceptibility to} (3)'),
('146880','CELIAC1','{Celiac disease, susceptibility to}, 212750 (3)'),
('146880','HLA-DQA1','{Celiac disease, susceptibility to}, 212750 (3)'),
('146920','ADAR','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146920','DRADA','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146920','DSH','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146920','DSRAD','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146920','G1P1','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146920','IFI4','Dyschromatosis symmetrica hereditaria, 127400 (3)'),
('146929','CXCR1','{AIDS, slow progression to}, 609423 (3)'),
('146929','IL8RA','{AIDS, slow progression to}, 609423 (3)'),
('146933','IBD28','613148 (3)'),
('146933','IL10R','613148 (3)'),
('146933','IL10RA','613148 (3)'),
('146933','IBD28','Inflammatory bowel disease 28, early onset, autosomal recessive,'),
('146933','IL10R','Inflammatory bowel disease 28, early onset, autosomal recessive,'),
('146933','IL10RA','Inflammatory bowel disease 28, early onset, autosomal recessive,'),
('147020','AGM1','Agammaglobulinemia 1, 601495 (3)'),
('147020','IGHM','Agammaglobulinemia 1, 601495 (3)'),
('147020','MU','Agammaglobulinemia 1, 601495 (3)'),
('147061','IGES','{?Allergy and asthma susceptibility} (2)'),
('147110','IGHG2','IgG2 deficiency, selective (3)'),
('147138','FCER1B','{Atopy, susceptibility to}, 147050 (3)'),
('147138','MS4A2','{Atopy, susceptibility to}, 147050 (3)'),
('147141','E2A','Leukemia, acute lymphoblastic (1)'),
('147141','TCF3','Leukemia, acute lymphoblastic (1)'),
('147200','IGKC','[Kappa light chain deficiency], 614102 (3)'),
('147200','IGKCD','[Kappa light chain deficiency], 614102 (3)'),
('147245','AGM6','Agammaglobulinemia 6, 612692 (3)'),
('147245','B29','Agammaglobulinemia 6, 612692 (3)'),
('147245','CD79B','Agammaglobulinemia 6, 612692 (3)'),
('147245','IGB','Agammaglobulinemia 6, 612692 (3)'),
('147265','ITPR1','Spinocerebellar ataxia 15, 606658 (3)'),
('147265','SCA15','Spinocerebellar ataxia 15, 606658 (3)'),
('147265','SCA16','Spinocerebellar ataxia 15, 606658 (3)'),
('147267','ITPR3','{Diabetes, type 1, susceptibility to}, 222100 (2)'),
('147280','IGF2R','Hepatocellular carcinoma (3)'),
('147280','MPRI','Hepatocellular carcinoma (3)'),
('147370','IGF1R','Insulin-like growth factor I, resistance to, 270450 (3)'),
('147440','IGF1','Growth retardation with deafness and mental retardation due to'),
('147440','IGF1','IGF1 deficiency, 608747 (3)'),
('147450','ALS1','Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)'),
('147450','SOD1','Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)'),
('147460','MNSOD','{Microvascular complications of diabetes 6}, 612634 (3)'),
('147460','MVCD6','{Microvascular complications of diabetes 6}, 612634 (3)'),
('147460','SOD2','{Microvascular complications of diabetes 6}, 612634 (3)'),
('147470','IGF2','Intrauterine and postnatal growth retardation (1)'),
('147520','ITPA','[Inosine triphosphatase deficiency], 613850 (3)'),
('147545','IRS1','artery disease, susceptibility to} (3)'),
('147545','IRS1','{Diabetes mellitus, noninsulin-dependent}, 125853 (3); {Coronary'),
('147556','ITGA6','(3)'),
('147556','ITGA6','Epidermolysis bullosa, junctional, with pyloric stenosis, 226730'),
('147557','ITGB4','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa of hands and feet, 131800 (3)'),
('147557','ITGB4','Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3);'),
('147569','IFGR2','209950 (3)'),
('147569','IFNGR2','209950 (3)'),
('147569','IFNGT1','209950 (3)'),
('147569','IFGR2','{Mycobacterial infection, atypical, familial disseminated},'),
('147569','IFNGR2','{Mycobacterial infection, atypical, familial disseminated},'),
('147569','IFNGT1','{Mycobacterial infection, atypical, familial disseminated},'),
('147570','IFG','609532 (3)'),
('147570','IFI','609532 (3)'),
('147570','IFNG','609532 (3)'),
('147570','IFG','anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of},'),
('147570','IFI','anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of},'),
('147570','IFNG','anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of},'),
('147570','IFG','{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic'),
('147570','IFI','{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic'),
('147570','IFNG','{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic'),
('147575','IRF1','acute (3); Gastric cancer, somatic, 137215 (3); Nonsmall cell lung cancer, somatic, 211980 (3)'),
('147575','MAR','acute (3); Gastric cancer, somatic, 137215 (3); Nonsmall cell lung cancer, somatic, 211980 (3)'),
('147575','IRF1','Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia,'),
('147575','MAR','Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia,'),
('147620','BSF2','sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations,'),
('147620','HGF','sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations,'),
('147620','HSF','sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations,'),
('147620','IFNB2','sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations,'),
('147620','IL6','sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations,'),
('147620','BSF2','susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)'),
('147620','HGF','susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)'),
('147620','HSF','susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)'),
('147620','IFNB2','susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)'),
('147620','IL6','susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)'),
('147620','BSF2','{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi'),
('147620','HGF','{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi'),
('147620','HSF','{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi'),
('147620','IFNB2','{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi'),
('147620','IL6','{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi'),
('147650','D2HGA2','D-2-hydrosyglutaric aciduria 2, 613657 (3)'),
('147650','IDH2','D-2-hydrosyglutaric aciduria 2, 613657 (3)'),
('147650','IDPM','D-2-hydrosyglutaric aciduria 2, 613657 (3)'),
('147660','IFNA1','Interferon, alpha, deficiency (1)'),
('147660','IFNA@','Interferon, alpha, deficiency (1)'),
('147670','HHF5','Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)'),
('147670','INSR','Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)'),
('147670','HHF5','Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3);'),
('147670','INSR','Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3);'),
('147679','DIRA','{Gastric cancer risk after H. pylori infection}, 137215 (3);'),
('147679','IL1RN','{Gastric cancer risk after H. pylori infection}, 137215 (3);'),
('147679','MVCD4','{Gastric cancer risk after H. pylori infection}, 137215 (3);'),
('147679','DIRA','{Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)'),
('147679','IL1RN','{Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)'),
('147679','MVCD4','{Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)'),
('147680','IL2','Severe combined immunodeficiency due to IL2 deficiency (1)'),
('147683','ALRH','susceptibility to}, 607154 (3)'),
('147683','BHR1','susceptibility to}, 607154 (3)'),
('147683','IL13','susceptibility to}, 607154 (3)'),
('147683','ALRH','{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis,'),
('147683','BHR1','{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis,'),
('147683','IL13','{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis,'),
('147720','IL1B','{Gastric cancer risk after H. pylori infection}, 137215 (3)'),
('147730','IDDM10','Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3);'),
('147730','IL2R','Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3);'),
('147730','IL2RA','Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3);'),
('147730','IDDM10','{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)'),
('147730','IL2R','{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)'),
('147730','IL2RA','{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)'),
('147781','IL4R','609423 (3)'),
('147781','IL4RA','609423 (3)'),
('147781','IL4R','{Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to},'),
('147781','IL4RA','{Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to},'),
('147791','JBS','Jacobsen syndrome (4)'),
('147796','JAK2','erythrocytosis (3)'),
('147796','THCYT3','erythrocytosis (3)'),
('147796','JAK2','Myelofibrosis, idiopathic, 254450 (3); {Budd-Chiari syndrome}, 600880 (3); Leukemia, acute myelogenous, 601626 (3); Myeloproliferative disorder with'),
('147796','THCYT3','Myelofibrosis, idiopathic, 254450 (3); {Budd-Chiari syndrome}, 600880 (3); Leukemia, acute myelogenous, 601626 (3); Myeloproliferative disorder with'),
('147796','JAK2','Polycythemia vera, 263300 (3); Thrombocythemia 3, 614521 (3);'),
('147796','THCYT3','Polycythemia vera, 263300 (3); Thrombocythemia 3, 614521 (3);'),
('147840','ICAM1','{Malaria, cerebral, susceptibility to}, 611162 (3)'),
('147910','KLK1','[Kallikrein, decreased urinary activity of] (3)'),
('147910','KLKR','[Kallikrein, decreased urinary activity of] (3)'),
('148040','DDD','Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3);'),
('148040','KRT5','Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3);'),
('148040','DDD','Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex with'),
('148040','KRT5','Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex with'),
('148040','DDD','mottled pigmentation, 131960 (3); Dowling-Degos disease, 179850 (3); Epidermolysis bullosa simplex with migratory circinate erythema, 609352 (3)'),
('148040','KRT5','mottled pigmentation, 131960 (3); Dowling-Degos disease, 179850 (3); Epidermolysis bullosa simplex with migratory circinate erythema, 609352 (3)'),
('148041','KRT6A','Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)'),
('148042','KRT6B','Pachyonychia congenita, Jackson-Lawler type, 167210 (3)'),
('148042','PC2','Pachyonychia congenita, Jackson-Lawler type, 167210 (3)'),
('148043','KRT3','Meesmann corneal dystrophy, 122100 (3)'),
('148060','KRT8','Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic,'),
('148060','KRT8','susceptibility to}, 215600 (3)'),
('148065','KRT13','White sponge nevus, 193900 (3)'),
('148066','KRT14','Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3);'),
('148066','KRT14','Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, recessive, 601001 (3); Naegeli-Franceschetti-Jadassohn'),
('148066','KRT14','syndrome, 161000 (3); Dermatopathia pigmentosa reticularis, 125595 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)'),
('148067','FNEPPK','focal, 613000 (3)'),
('148067','KRT16','focal, 613000 (3)'),
('148067','FNEPPK','Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3);'),
('148067','KRT16','Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3);'),
('148067','FNEPPK','Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar verrucous nevus, unilateral, 144200 (3); Palmoplantar keratoderma, nonepidermolytic,'),
('148067','KRT16','Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar verrucous nevus, unilateral, 144200 (3); Palmoplantar keratoderma, nonepidermolytic,'),
('148069','KRT17','Pachyonychia congenita, Jackson-Lawler type, 167210 (3);'),
('148069','PC2','Pachyonychia congenita, Jackson-Lawler type, 167210 (3);'),
('148069','PCHC1','Pachyonychia congenita, Jackson-Lawler type, 167210 (3);'),
('148069','KRT17','Steatocystoma multiplex, 184500 (3)'),
('148069','PC2','Steatocystoma multiplex, 184500 (3)'),
('148069','PCHC1','Steatocystoma multiplex, 184500 (3)'),
('148070','KRT18','Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic,'),
('148070','KRT18','susceptibility to}, 215600 (3)'),
('148080','BCIE','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('148080','BIE','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('148080','EHK','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('148080','KRT10','Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with'),
('148080','BCIE','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)'),
('148080','BIE','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)'),
('148080','EHK','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)'),
('148080','KRT10','epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)'),
('148370','KWE','Keratolytic winter erythema (2)'),
('148500','TEC','Tylosis with esophageal cancer (2)'),
('148500','TOC','Tylosis with esophageal cancer (2)'),
('148600','PPKP1','Keratoderma, palmoplantar, punctate type 1 (2)'),
('148760','KIF11','mental retardation, 152950 (3)'),
('148760','KNSL1','mental retardation, 152950 (3)'),
('148760','MCLMR','mental retardation, 152950 (3)'),
('148760','KIF11','Microcephaly with or without chorioretinopathy, lymphedema, or'),
('148760','KNSL1','Microcephaly with or without chorioretinopathy, lymphedema, or'),
('148760','MCLMR','Microcephaly with or without chorioretinopathy, lymphedema, or'),
('149000','KTS','Klippel-Trenaunay-Weber syndrome (2)'),
('149000','KTWS','Klippel-Trenaunay-Weber syndrome (2)'),
('150000','GSD11','Glycogen storage disease XI, 612933 (3)'),
('150000','LDH1','Glycogen storage disease XI, 612933 (3)'),
('150000','LDHA','Glycogen storage disease XI, 612933 (3)'),
('150100','LDHB','Lactate dehydrogenase-B deficiency, 614128 (3)'),
('150100','LDHBD','Lactate dehydrogenase-B deficiency, 614128 (3)'),
('150200','CSA','[Placental lactogen deficiency] (1)'),
('150200','CSH1','[Placental lactogen deficiency] (1)'),
('150200','PL','[Placental lactogen deficiency] (1)'),
('150230','LGCR','Trichorhinophalangeal syndrome, type II (4)'),
('150230','LGS','Trichorhinophalangeal syndrome, type II (4)'),
('150230','TRPS2','Trichorhinophalangeal syndrome, type II (4)'),
('150240','LAMB1','?Cutis laxa, marfanoid neonatal type, 614100 (1)'),
('150270','LAP','?Laryngeal adductor paralysis (2)'),
('150292','LAMB2T','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('150292','LAMC2','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('150292','LAMNB2','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('150292','LAMB2T','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('150292','LAMC2','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('150292','LAMNB2','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('150310','LAMB3','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('150310','LAMB3','Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)'),
('150325','LAMB2','614199 (3); Pierson syndrome, 609049 (3)'),
('150325','LAMS','614199 (3); Pierson syndrome, 609049 (3)'),
('150325','NPHS5','614199 (3); Pierson syndrome, 609049 (3)'),
('150325','LAMB2','Nephrotic syndrome, type 5, with or without ocular abnormalities,'),
('150325','LAMS','Nephrotic syndrome, type 5, with or without ocular abnormalities,'),
('150325','NPHS5','Nephrotic syndrome, type 5, with or without ocular abnormalities,'),
('150330','CMD1A','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','EMD2','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','FPLD2','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','HGPS','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','LGMD1B','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','LMN1','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','LMNA','Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);'),
('150330','CMD1A','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','EMD2','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','FPLD2','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','HGPS','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','LGMD1B','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','LMN1','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','LMNA','Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease,'),
('150330','CMD1A','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','EMD2','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','FPLD2','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','HGPS','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','LGMD1B','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','LMN1','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150330','LMNA','type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); R'),
('150340','LMNB1','Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)'),
('150341','LMN2','{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)'),
('150341','LMNB2','{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)'),
('150370','LAMBR','?Arrhythmogenic right ventricular dysplasia 5, 604400 (1)'),
('150370','LAMR1','?Arrhythmogenic right ventricular dysplasia 5, 604400 (1)'),
('150571','LGALS2','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('151385','AML1','Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial,'),
('151385','CBFA2','Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial,'),
('151385','RUNX1','Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial,'),
('151385','AML1','with associated myeloid malignancy, 601399 (3)'),
('151385','CBFA2','with associated myeloid malignancy, 601399 (3)'),
('151385','RUNX1','with associated myeloid malignancy, 601399 (3)'),
('151410','ALL','613065 (3)'),
('151410','BCR','613065 (3)'),
('151410','CML','613065 (3)'),
('151410','PHL','613065 (3)'),
('151410','ALL','Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic,'),
('151410','BCR','Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic,'),
('151410','CML','Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic,'),
('151410','PHL','Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic,'),
('151430','BCL2','Leukemia/lymphoma, B-cell, 2 (3)'),
('151440','LYL1','Leukemia, T-cell acute lymphoblastoid (2)'),
('151443','LIFR','Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)'),
('151443','SJS2','Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)'),
('151443','STWS','Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)'),
('151443','SWS','Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)'),
('151450','LAG5','Neutropenia, neonatal alloimmune (1)'),
('151460','CD45','immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)'),
('151460','LCA','immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)'),
('151460','PTPRC','immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)'),
('151460','CD45','{Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined'),
('151460','LCA','{Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined'),
('151460','PTPRC','{Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined'),
('151670','HDLCQ12','[High density lipoprotein cholesterol level QTL 12], 612797 (3);'),
('151670','HL','[High density lipoprotein cholesterol level QTL 12], 612797 (3);'),
('151670','LIPC','[High density lipoprotein cholesterol level QTL 12], 612797 (3);'),
('151670','LIPH','[High density lipoprotein cholesterol level QTL 12], 612797 (3);'),
('151670','HDLCQ12','{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)'),
('151670','HL','{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)'),
('151670','LIPC','{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)'),
('151670','LIPH','{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)'),
('152200','LPA','congenital] (3)'),
('152200','LPA','{Coronary artery disease, susceptibility to} (1); [LPA deficiency,'),
('152390','ALOX5','response to antileukotriene treatment in}, 600807 (3)'),
('152390','ALOX5','{Atherosclerosis, susceptibility to} (3); {Asthma, diminished'),
('152424','LCRB','Thalassemia, Hispanic gamma-delta-beta, 613985 (3)'),
('152427','HERG','Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired,'),
('152427','KCNH2','Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired,'),
('152427','LQT2','Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired,'),
('152427','SQT1','Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired,'),
('152427','HERG','susceptibility to}, 613688 (3); Short QT syndrome-1, 609620 (3)'),
('152427','KCNH2','susceptibility to}, 613688 (3); Short QT syndrome-1, 609620 (3)'),
('152427','LQT2','susceptibility to}, 613688 (3); Short QT syndrome-1, 609620 (3)'),
('152427','SQT1','susceptibility to}, 613688 (3); Short QT syndrome-1, 609620 (3)'),
('152430','LGV1','[Longevity 1] (2)'),
('152445','LOR','Vohwinkel syndrome with ichthyosis, 604117 (3)'),
('152760','GNRH1','227200 (1)'),
('152760','LNRH','227200 (1)'),
('152760','GNRH1','?Hypogonadotropic hypogonadism due to GNRH deficiency,'),
('152760','LNRH','?Hypogonadotropic hypogonadism due to GNRH deficiency,'),
('152780','LHB','due to defective LH (1)'),
('152780','LHB','Hypogonadism, hypergonadotropic (3); ?Male pseudohermaphroditism'),
('152790','LCGR','female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)'),
('152790','LHCGR','female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)'),
('152790','LHR','female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)'),
('152790','LCGR','Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with'),
('152790','LHCGR','Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with'),
('152790','LHR','Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with'),
('152790','LCGR','pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance,'),
('152790','LHCGR','pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance,'),
('152790','LHR','pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance,'),
('153245','LEF1','Sebaceous tumors, somatic (3)'),
('153390','LCK','SCID due to LCK deficiency (1)'),
('153440','LTA','arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)'),
('153440','TNFB','arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)'),
('153440','LTA','{Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic'),
('153440','TNFB','{Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic'),
('153450','LYZ','Amyloidosis, renal, 105200 (3)'),
('153454','PLOD','(3)'),
('153454','PLOD1','(3)'),
('153454','PLOD','Ehlers-Danlos syndrome, type VI, 225400 (3); Nevo syndrome, 601451'),
('153454','PLOD1','Ehlers-Danlos syndrome, type VI, 225400 (3); Nevo syndrome, 601451'),
('153456','LOXL','{Exfoliation syndrome, susceptibility to}, 177650 (3)'),
('153456','LOXL1','{Exfoliation syndrome, susceptibility to}, 177650 (3)'),
('153600','WM1','{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)'),
('153620','MIF','604302 (3)'),
('153620','MIF','{Rheumatoid arthritis, systemic juvenile, susceptibility to},'),
('153622','MSR1','esophagus/esophageal adenocarcinoma, 614266 (3)'),
('153622','SCARA1','esophagus/esophageal adenocarcinoma, 614266 (3)'),
('153622','SRA','esophagus/esophageal adenocarcinoma, 614266 (3)'),
('153622','MSR1','Prostate cancer, hereditary, 176807 (3); Barrett'),
('153622','SCARA1','Prostate cancer, hereditary, 176807 (3); Barrett'),
('153622','SRA','Prostate cancer, hereditary, 176807 (3); Barrett'),
('153840','VMD1','Macular dystrophy, atypical vitelliform (2)'),
('153880','MDDC','Macular dystrophy, dominant cystoid (2)'),
('154045','LIM2','Cataract, cortical pulverulent, late-onset (3)'),
('154045','MP19','Cataract, cortical pulverulent, late-onset (3)'),
('154050','AQP0','Cataract, polymorphic and lamellar, 604219 (3)'),
('154050','MIP','Cataract, polymorphic and lamellar, 604219 (3)'),
('154230','C9DELp24.3','46XY sex reversal 4 (4)'),
('154230','DEL9p24.3','46XY sex reversal 4 (4)'),
('154230','SRXY4','46XY sex reversal 4 (4)'),
('154235','MAK','REtinitis pigmentosa 62, 614181 (3)'),
('154235','RP62','REtinitis pigmentosa 62, 614181 (3)'),
('154270','ME2','{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3);'),
('154270','ODS1','{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3);'),
('154270','ME2','{Opioid dependence, susceptibility to}, 610064 (3)'),
('154270','ODS1','{Opioid dependence, susceptibility to}, 610064 (3)'),
('154275','MHS2','{Malignant hyperthermia susceptibility 2} (2)'),
('154276','MHS3','{Malignant hyperthermia susceptibility 3} (2)'),
('154400','AFD1','?Acrofacial dysostosis, Nager type (2)'),
('154400','AFDN','?Acrofacial dysostosis, Nager type (2)'),
('154545','MBL','{Chronic infections, due to MBL deficiency}, 614372 (3)'),
('154545','MBL2','{Chronic infections, due to MBL deficiency}, 614372 (3)'),
('154545','MBL2D','{Chronic infections, due to MBL deficiency}, 614372 (3)'),
('154545','MBP1','{Chronic infections, due to MBL deficiency}, 614372 (3)'),
('154550','CDG1B','Congenital disorder of glycosylation, type Ib, 602579 (3)'),
('154550','MPI','Congenital disorder of glycosylation, type Ib, 602579 (3)'),
('154550','PMI1','Congenital disorder of glycosylation, type Ib, 602579 (3)'),
('154870','MGP','Keutel syndrome, 245150 (3); {Natural teeth remaining intact} (2)'),
('154870','NTI','Keutel syndrome, 245150 (3); {Natural teeth remaining intact} (2)'),
('154950','MAX','{Pheochromocytoma, susceptibility to}, 171300 (3)'),
('155540','BMIQ9','{Mycobacterium tuberculosis, protection against}, 607948 (3)'),
('155540','MC3R','{Mycobacterium tuberculosis, protection against}, 607948 (3)'),
('155540','BMIQ9','{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3);'),
('155540','MC3R','{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3);'),
('155541','MC4R','Obesity, autosomal dominant, 601665 (3)'),
('155555','CMM5','skin damage}, 266300 (3); {Oculocutaneous albinism, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)'),
('155555','MC1R','skin damage}, 266300 (3); {Oculocutaneous albinism, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)'),
('155555','SHEP2','skin damage}, 266300 (3); {Oculocutaneous albinism, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)'),
('155555','CMM5','[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced'),
('155555','MC1R','[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced'),
('155555','SHEP2','[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced'),
('155555','CMM5','[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3);'),
('155555','MC1R','[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3);'),
('155555','SHEP2','[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3);'),
('155600','CMM','{Melanoma, cutaneous malignant, 1} (2)'),
('155600','DNS','{Melanoma, cutaneous malignant, 1} (2)'),
('155600','MLM','{Melanoma, cutaneous malignant, 1} (2)'),
('155760','ACAN','Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)'),
('155760','AGC1','Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)'),
('155760','CSPG1','Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)'),
('155760','MSK16','Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)'),
('155760','SEDK','Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)'),
('155760','ACAN','Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);'),
('155760','AGC1','Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);'),
('155760','CSPG1','Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);'),
('155760','MSK16','Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);'),
('155760','SEDK','Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);'),
('155900','MROS','?Melkersson-Rosenthal syndrome (2)'),
('156100','MGCR','Meningioma, 607174 (3)'),
('156100','MN1','Meningioma, 607174 (3)'),
('156200','C2DELq23.1','Chromosome 2q23.1 deletion syndrome (4)'),
('156200','DEL2q23.1','Chromosome 2q23.1 deletion syndrome (4)'),
('156225','LAMA2','Muscular dystrophy, congenital merosin-deficient, 607855 (3);'),
('156225','LAMM','Muscular dystrophy, congenital merosin-deficient, 607855 (3);'),
('156225','LAMA2','Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)'),
('156225','LAMM','Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)'),
('156232','MDK','Mesomelic dysplasia, Kantaputra type (2)'),
('156232','MMDK','Mesomelic dysplasia, Kantaputra type (2)'),
('156240','MMS','{Malignant mesothelioma, susceptibility to} (2)'),
('156490','NM23','Neuroblastoma, 256700 (3)'),
('156490','NME1','Neuroblastoma, 256700 (3)'),
('156540','DMSMFH','112250 (3)'),
('156540','MTAP','112250 (3)'),
('156540','DMSMFH','Diaphyseal medullary stenosis with malignant fibrous histiocytoma,'),
('156540','MTAP','Diaphyseal medullary stenosis with malignant fibrous histiocytoma,'),
('156570','MTR','defects, folate-sensitive, susceptibility to}, 601634 (3)'),
('156570','MTR','Methylcobalamin deficiency, cblG type, 250940 (3); {Neural tube'),
('156600','MCOR','Microcoria, congenital (2)'),
('156845','CMM8','614456 (3)'),
('156845','MITF','614456 (3)'),
('156845','WS2A','614456 (3)'),
('156845','CMM8','syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8},'),
('156845','MITF','syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8},'),
('156845','WS2A','syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8},'),
('156845','CMM8','Waardenburg syndrome, type 2A, 193510 (3); Waardenburg'),
('156845','MITF','Waardenburg syndrome, type 2A, 193510 (3); Waardenburg'),
('156845','WS2A','Waardenburg syndrome, type 2A, 193510 (3); Waardenburg'),
('156850','MCOPCT1','Microphthalmia with cataract 1 (2)'),
('157140','DDPAC','Dementia, frontotemporal, with or without parkinsonism, 600274 (3);'),
('157140','MAPT','Dementia, frontotemporal, with or without parkinsonism, 600274 (3);'),
('157140','MSTD','Dementia, frontotemporal, with or without parkinsonism, 600274 (3);'),
('157140','MTBT1','Dementia, frontotemporal, with or without parkinsonism, 600274 (3);'),
('157140','DDPAC','Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease,'),
('157140','MAPT','Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease,'),
('157140','MSTD','Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease,'),
('157140','MTBT1','Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease,'),
('157140','DDPAC','susceptibility to}, 168600 (3); Tauopathy and respiratory failure (3)'),
('157140','MAPT','susceptibility to}, 168600 (3); Tauopathy and respiratory failure (3)'),
('157140','MSTD','susceptibility to}, 168600 (3); Tauopathy and respiratory failure (3)'),
('157140','MTBT1','susceptibility to}, 168600 (3); Tauopathy and respiratory failure (3)'),
('157145','HPC13','{Prostate cancer, hereditary, 13}, 611928 (3)'),
('157145','MSMB','{Prostate cancer, hereditary, 13}, 611928 (3)'),
('157147','MTP','Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection'),
('157147','MTP','against}, 605552 (3)'),
('157300','MA','{Migraine with or without aura, susceptibility to, 1} (2)'),
('157300','MGR1','{Migraine with or without aura, susceptibility to, 1} (2)'),
('157655','NDUFS1','Mitochondrial complex I deficiency, 252010 (3)'),
('157660','CHH','Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without'),
('157660','RMRP','Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without'),
('157660','RMRPR','Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without'),
('157660','CHH','hypotrichosis, 250460 (3); Anauxetic dysplasia, 607095 (3)'),
('157660','RMRP','hypotrichosis, 250460 (3); Anauxetic dysplasia, 607095 (3)'),
('157660','RMRPR','hypotrichosis, 250460 (3); Anauxetic dysplasia, 607095 (3)'),
('157700','MMVP1','Mitral valve prolapse, myxomatous 1 (2)'),
('157700','MVP','Mitral valve prolapse, myxomatous 1 (2)'),
('157700','PMV','Mitral valve prolapse, myxomatous 1 (2)'),
('157900','MBS','?Moebius syndrome (2)'),
('157900','MBS1','?Moebius syndrome (2)'),
('158105','CCL2','to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('158105','MCAF','to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('158105','MCP1','to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('158105','SCYA2','to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('158105','CCL2','{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility'),
('158105','MCAF','{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility'),
('158105','MCP1','{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility'),
('158105','SCYA2','{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility'),
('158170','C9DELp','Chromosome 9p deletion syndrome (4)'),
('158170','DEL9p','Chromosome 9p deletion syndrome (4)'),
('158375','MUC7','{Asthma, protection against}, 600807 (3)'),
('158378','GLVR2','Basal ganglia cancification, idiopathic, 3, 614540 (3)'),
('158378','IBGC3','Basal ganglia cancification, idiopathic, 3, 614540 (3)'),
('158378','MLVAR','Basal ganglia cancification, idiopathic, 3, 614540 (3)'),
('158378','SLC20A2','Basal ganglia cancification, idiopathic, 3, 614540 (3)'),
('158580','DHMNVP','Motor neuronopathy, distal hereditary, with vocal cord paralysis (2)'),
('158580','HMN7A','Motor neuronopathy, distal hereditary, with vocal cord paralysis (2)'),
('158600','SMALED','Spinal muscular atrophy, lower extremity, autosomal dominant (2)'),
('158900','FSHD1A','Facioscapulohumeral muscular dystrophy-1A (4)'),
('158900','FSHMD1A','Facioscapulohumeral muscular dystrophy-1A (4)'),
('159350','MCC','Colorectal cancer (3)'),
('159440','CHM','180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)'),
('159440','CMT1B','180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)'),
('159440','CMTDI3','180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)'),
('159440','DSS','180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)'),
('159440','MPZ','180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)'),
('159440','CHM','Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas'),
('159440','CMT1B','Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas'),
('159440','CMTDI3','Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas'),
('159440','DSS','Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas'),
('159440','MPZ','Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas'),
('159440','CHM','disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome,'),
('159440','CMT1B','disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome,'),
('159440','CMTDI3','disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome,'),
('159440','DSS','disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome,'),
('159440','MPZ','disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome,'),
('159465','MOG','Narcolepsy 7, 614250 (3)'),
('159465','NRCLP7','Narcolepsy 7, 614250 (3)'),
('159530','MPL','Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)'),
('159530','MPLV','Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)'),
('159530','THCYT2','Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)'),
('159530','TPOR','Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)'),
('159530','MPL','Thrombocytopenia, congenital amegakaryocytic, 604498 (3);'),
('159530','MPLV','Thrombocytopenia, congenital amegakaryocytic, 604498 (3);'),
('159530','THCYT2','Thrombocytopenia, congenital amegakaryocytic, 604498 (3);'),
('159530','TPOR','Thrombocytopenia, congenital amegakaryocytic, 604498 (3);'),
('159555','HRX','Leukemia, myeloid/lymphoid or mixed-lineage (2)'),
('159555','HTRX1','Leukemia, myeloid/lymphoid or mixed-lineage (2)'),
('159555','MLL','Leukemia, myeloid/lymphoid or mixed-lineage (2)'),
('159595','MST','Leukemia, transient, of Down syndrome (2)'),
('159595','TAM','Leukemia, transient, of Down syndrome (2)'),
('159991','CNM3','Myopathy, centronuclear, 3, 614408 (3)'),
('159991','MYF6','Myopathy, centronuclear, 3, 614408 (3)'),
('160700','MYP2','Myopia-2 (2)'),
('160710','ASD3','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','CMD1EE','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','CMH14','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','MYH6','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','MYHCA','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','SSS3','Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal'),
('160710','ASD3','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160710','CMD1EE','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160710','CMH14','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160710','MYH6','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160710','MYHCA','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160710','SSS3','defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)'),
('160720','MYH3','Arthrogryposis, distal, type 2A, 193700 (3); Arthrogryposis, distal,'),
('160720','MYH3','type 2B, 601680 (3)'),
('160740','MYH2','Inclusion body myopathy-3, 605637 (3)'),
('160741','MYH8','Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly'),
('160741','MYH8','syndrome, 158300 (3)'),
('160745','AAT4','Aortic aneurysm, familial thoracic 4, 132900 (3)'),
('160745','FAA4','Aortic aneurysm, familial thoracic 4, 132900 (3)'),
('160745','MYH11','Aortic aneurysm, familial thoracic 4, 132900 (3)'),
('160760','CMD1S','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','CMH1','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','MPD1','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','MYH7','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','SPMD','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','SPMM','Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,'),
('160760','CMD1S','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','CMH1','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','MPD1','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','MYH7','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','SPMD','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','SPMM','dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3);'),
('160760','CMD1S','Left ventricular noncompaction 5, 613426 (3)'),
('160760','CMH1','Left ventricular noncompaction 5, 613426 (3)'),
('160760','MPD1','Left ventricular noncompaction 5, 613426 (3)'),
('160760','MYH7','Left ventricular noncompaction 5, 613426 (3)'),
('160760','SPMD','Left ventricular noncompaction 5, 613426 (3)'),
('160760','SPMM','Left ventricular noncompaction 5, 613426 (3)'),
('160775','BDPLT6','May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);'),
('160775','DFNA17','May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);'),
('160775','FTNS','May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);'),
('160775','MHA','May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);'),
('160775','MYH9','May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);'),
('160775','BDPLT6','Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive'),
('160775','DFNA17','Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive'),
('160775','FTNS','Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive'),
('160775','MHA','Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive'),
('160775','MYH9','Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive'),
('160775','BDPLT6','sensorineural deafness, 600208 (3)'),
('160775','DFNA17','sensorineural deafness, 600208 (3)'),
('160775','FTNS','sensorineural deafness, 600208 (3)'),
('160775','MHA','sensorineural deafness, 600208 (3)'),
('160775','MYH9','sensorineural deafness, 600208 (3)'),
('160777','GS1','Griscelli syndrome, type 1, 214450 (3)'),
('160777','MYH12','Griscelli syndrome, type 1, 214450 (3)'),
('160777','MYO5A','Griscelli syndrome, type 1, 214450 (3)'),
('160781','CMH10','Cardiomyopathy, familial hypertrophic, 10, 608758 (3)'),
('160781','MYL2','Cardiomyopathy, familial hypertrophic, 10, 608758 (3)'),
('160790','CMH8','Cardiomyopathy, familial hypertrophic, 8, 608751 (3)'),
('160790','MYL3','Cardiomyopathy, familial hypertrophic, 8, 608751 (3)'),
('160794','MYBPC1','Arthrogryposis, distal, type 1B, 614335 (3)'),
('160998','NMOR2','{?Breast cancer susceptibility}, 114480 (1)'),
('160998','NQO2','{?Breast cancer susceptibility}, 114480 (1)'),
('161015','NDUFV1','Mitochondrial complex I deficiency, 252010 (3)'),
('161015','UQOR1','Mitochondrial complex I deficiency, 252010 (3)'),
('161550','NPCA2','{Nasopharyngeal carcinoma, susceptibility to, 2} (2)'),
('161561','IL12B','BCG and salmonella infection, disseminated, 209950 (1); {Asthma,'),
('161561','NKSF2','BCG and salmonella infection, disseminated, 209950 (1); {Asthma,'),
('161561','IL12B','susceptibility to}, 600807 (3)'),
('161561','NKSF2','susceptibility to}, 600807 (3)'),
('161650','NEB','Nemaline myopathy 2, autosomal recessive, 256030 (3)'),
('161650','NEM2','Nemaline myopathy 2, autosomal recessive, 256030 (3)'),
('161900','AORF','Nephropathy-hypertension (2)'),
('161900','RFH1','Nephropathy-hypertension (2)'),
('161950','IGAN1','Nephropathy, IgA type (2)'),
('162030','HSAN5','Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)'),
('162030','NGFB','Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)'),
('162080','D14S46E','autosomal recessive, clumped pigment type (3)'),
('162080','NRL','autosomal recessive, clumped pigment type (3)'),
('162080','RP27','autosomal recessive, clumped pigment type (3)'),
('162080','D14S46E','Retinitis pigmentosa 27, 613750 (3); Retinal degeneration,'),
('162080','NRL','Retinitis pigmentosa 27, 613750 (3); Retinal degeneration,'),
('162080','RP27','Retinitis pigmentosa 27, 613750 (3); Retinal degeneration,'),
('162150','BMIQ12','Obesity with impaired prohormone processing, 600955 (3); {Obesity,'),
('162150','NEC1','Obesity with impaired prohormone processing, 600955 (3); {Obesity,'),
('162150','PC1','Obesity with impaired prohormone processing, 600955 (3); {Obesity,'),
('162150','PC3','Obesity with impaired prohormone processing, 600955 (3); {Obesity,'),
('162150','PCSK1','Obesity with impaired prohormone processing, 600955 (3); {Obesity,'),
('162150','BMIQ12','susceptibility to, BMIQ12}, 612362 (3)'),
('162150','NEC1','susceptibility to, BMIQ12}, 612362 (3)'),
('162150','PC1','susceptibility to, BMIQ12}, 612362 (3)'),
('162150','PC3','susceptibility to, BMIQ12}, 612362 (3)'),
('162150','PCSK1','susceptibility to, BMIQ12}, 612362 (3)'),
('162230','NEFH','{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)'),
('162280','CMT1F','Charcot-Marie-Tooth disease, type 1F, 607734 (3)'),
('162280','CMT2E','Charcot-Marie-Tooth disease, type 1F, 607734 (3)'),
('162280','NEFL','Charcot-Marie-Tooth disease, type 1F, 607734 (3)'),
('162280','CMT1F','Charcot-Marie-Tooth disease, type 2E, 607684 (3);'),
('162280','CMT2E','Charcot-Marie-Tooth disease, type 2E, 607684 (3);'),
('162280','NEFL','Charcot-Marie-Tooth disease, type 2E, 607684 (3);'),
('162330','NKNB','Hypogonadotropic hypogonadism, 146110 (3)'),
('162330','TAC3','Hypogonadotropic hypogonadism, 146110 (3)'),
('162332','NK3R','Hypogonadotropic hypogonadism, 146110 (3)'),
('162332','TACR3','Hypogonadotropic hypogonadism, 146110 (3)'),
('162643','CXCR4','WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)'),
('162643','D2S201E','WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)'),
('162643','NPY3R','WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)'),
('162643','WHIM','WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)'),
('162662','GLC1O','Glaucoma 1, open angle, 1O, 613100 (3)'),
('162662','NT4','Glaucoma 1, open angle, 1O, 613100 (3)'),
('162662','NT5','Glaucoma 1, open angle, 1O, 613100 (3)'),
('162662','NTF4','Glaucoma 1, open angle, 1O, 613100 (3)'),
('162662','NTF5','Glaucoma 1, open angle, 1O, 613100 (3)'),
('163000','CMAL','Capillary malformations, hereditary (2)'),
('163729','NOS3','abruption} (3); {Ischemic stroke, susceptibility to}, 601367 (3)'),
('163729','NOS3','late-onset, susceptibility to}, 104300 (3); {Hypertension, susceptibility to}, 145500 (3); {Hypertension, pregnancy-induced}, 189800 (3); {Placental'),
('163729','NOS3','{Coronary artery spasm 1, susceptibility to} (3); {Alzheimer disease,'),
('163730','NOS2','to}, 611162 (3)'),
('163730','NOS2A','to}, 611162 (3)'),
('163730','NOS2','{Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance'),
('163730','NOS2A','{Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance'),
('163890','NACP','Parkinson disease 1, 168601 (3)'),
('163890','PARK1','Parkinson disease 1, 168601 (3)'),
('163890','PARK4','Parkinson disease 1, 168601 (3)'),
('163890','SNCA','Parkinson disease 1, 168601 (3)'),
('163890','NACP','Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3);'),
('163890','PARK1','Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3);'),
('163890','PARK4','Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3);'),
('163890','SNCA','Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3);'),
('163970','NAT1','Orthostatic intolerance, 604715 (3)'),
('163970','NET1','Orthostatic intolerance, 604715 (3)'),
('163970','SLC6A2','Orthostatic intolerance, 604715 (3)'),
('164008','IKBA','612132 (3)'),
('164008','NFKBIA','612132 (3)'),
('164008','IKBA','Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency,'),
('164008','NFKBIA','Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency,'),
('164009','NUMA1','Leukemia, acute promyelocytic, NUMA/RARA type (3)'),
('164015','MATR3','Myopathy, distal 2, 606070 (3)'),
('164015','MPD2','Myopathy, distal 2, 606070 (3)'),
('164040','NPM1','Leukemia, acute promyelocytic, NPM/RARA type (3); Leukemia, acute'),
('164040','NPM1','myeloid, 601626 (3)'),
('164050','NP','613179 (3)'),
('164050','PNP','613179 (3)'),
('164050','NP','Immunodeficiency due to purine nucleoside phosphorylase deficiency,'),
('164050','PNP','Immunodeficiency due to purine nucleoside phosphorylase deficiency,'),
('164100','NYS2','Nystagmus-2, autosomal dominant (2)'),
('164100','NYSA','Nystagmus-2, autosomal dominant (2)'),
('164160','LEP','hypogonadism (3)'),
('164160','OB','hypogonadism (3)'),
('164160','LEP','Obesity, severe, due to leptin deficiency (3); Obesity, morbid, with'),
('164160','OB','Obesity, severe, due to leptin deficiency (3); Obesity, morbid, with'),
('164210','HFM','Hemifacial microsomia (2)'),
('164350','OAS1','type 1, susceptibility to}, 222100 (3)'),
('164350','OIAS','type 1, susceptibility to}, 222100 (3)'),
('164350','OAS1','{Viral infection, susceptibility to} (3); {Diabetes mellitus,'),
('164350','OIAS','{Viral infection, susceptibility to} (3); {Diabetes mellitus,'),
('164690','ABL2','Leukemia, acute myeloid, with eosinophilia (1)'),
('164690','ABLL','Leukemia, acute myeloid, with eosinophilia (1)'),
('164690','ARG','Leukemia, acute myeloid, with eosinophilia (1)'),
('164730','AKT1','114500 (3); Ovarian cancer, somatic, 167000 (3); {Schizophrenia, susceptibility to}, 181500 (2); Proteus syndrome, somatic, 176920 (3)'),
('164730','AKT1','Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic,'),
('164731','AKT2','Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia'),
('164731','HIHGHH','Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia'),
('164731','AKT2','with hemihypertrophy, 240900 (3)'),
('164731','HIHGHH','with hemihypertrophy, 240900 (3)'),
('164757','BRAF','613706 (3); LEOPARD syndrome 3, 613707 (3)'),
('164757','NS7','613706 (3); LEOPARD syndrome 3, 613707 (3)'),
('164757','BRAF','Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7,'),
('164757','NS7','Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7,'),
('164757','BRAF','Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3);'),
('164757','NS7','Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3);'),
('164760','CRAF','Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3)'),
('164760','NS5','Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3)'),
('164760','RAF1','Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3)'),
('164761','HSCR1','carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3);'),
('164761','MEN2A','carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3);'),
('164761','RET','carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3);'),
('164761','HSCR1','Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid'),
('164761','MEN2A','Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid'),
('164761','RET','Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid'),
('164761','HSCR1','Renal agenesis, 191830 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3)'),
('164761','MEN2A','Renal agenesis, 191830 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3)'),
('164761','RET','Renal agenesis, 191830 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3)'),
('164770','CSF1R','Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)'),
('164770','FMS','Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)'),
('164770','HDLS','Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)'),
('164785','ACTFS','{Accelerated tumor formation, susceptibility to}, 614401 (3)'),
('164785','MDM2','{Accelerated tumor formation, susceptibility to}, 614401 (3)'),
('164790','ALPS4','188470 (3); Autoimmune lymphoproliferative syndrome type IV, 614470 (3); Noonan syndrome 6, 613224 (3)'),
('164790','NRAS','188470 (3); Autoimmune lymphoproliferative syndrome type IV, 614470 (3); Noonan syndrome 6, 613224 (3)'),
('164790','NS6','188470 (3); Autoimmune lymphoproliferative syndrome type IV, 614470 (3); Noonan syndrome 6, 613224 (3)'),
('164790','ALPS4','Colorectal cancer, 114500 (3); Thyroid carcinoma, follicular,'),
('164790','NRAS','Colorectal cancer, 114500 (3); Thyroid carcinoma, follicular,'),
('164790','NS6','Colorectal cancer, 114500 (3); Thyroid carcinoma, follicular,'),
('164840','MODED','Feingold syndrome, 164280 (3)'),
('164840','MYCN','Feingold syndrome, 164280 (3)'),
('164840','NMYC','Feingold syndrome, 164280 (3)'),
('164840','ODED','Feingold syndrome, 164280 (3)'),
('164860','AUTS9','Hepatocellular carcinoma, childhood type, 114550 (3); {Autism suseptibility 9}, 611015 (3)'),
('164860','MET','Hepatocellular carcinoma, childhood type, 114550 (3); {Autism suseptibility 9}, 611015 (3)'),
('164860','AUTS9','Renal cell carcinoma, papillary, familial and somatic, 605074 (3);'),
('164860','MET','Renal cell carcinoma, papillary, familial and somatic, 605074 (3);'),
('164870','ERBB2','137800 (3); Gastric cancer, somatic, 137215 (3); Ovarian cancer, somatic, (3)'),
('164870','HER2','137800 (3); Gastric cancer, somatic, 137215 (3); Ovarian cancer, somatic, (3)'),
('164870','NEU','137800 (3); Gastric cancer, somatic, 137215 (3); Ovarian cancer, somatic, (3)'),
('164870','NGL','137800 (3); Gastric cancer, somatic, 137215 (3); Ovarian cancer, somatic, (3)'),
('164870','ERBB2','Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic,'),
('164870','HER2','Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic,'),
('164870','NEU','Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic,'),
('164870','NGL','Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic,'),
('164874','BF1','Rett syndrome, congenital variant, 613454 (3)'),
('164874','FKH2','Rett syndrome, congenital variant, 613454 (3)'),
('164874','FKHL1','Rett syndrome, congenital variant, 613454 (3)'),
('164874','FOXG1','Rett syndrome, congenital variant, 613454 (3)'),
('164874','FOXG1B','Rett syndrome, congenital variant, 613454 (3)'),
('164874','QIN','Rett syndrome, congenital variant, 613454 (3)'),
('164920','KIT','601626 (3)'),
('164920','PBT','601626 (3)'),
('164920','KIT','hematologic disorder (3); Germ cell tumors, 273300 (3); Gastrointestinal stromal tumor, somatic, 606764 (3); Leukemia, acute myeloid,'),
('164920','PBT','hematologic disorder (3); Germ cell tumors, 273300 (3); Gastrointestinal stromal tumor, somatic, 606764 (3); Leukemia, acute myeloid,'),
('164920','KIT','Piebaldism (3); Mast cell leukemia (3); Mastocytosis with associated'),
('164920','PBT','Piebaldism (3); Mast cell leukemia (3); Mastocytosis with associated'),
('164950','FGF3','Deafness, congenital with inner ear agenesis, microtia, and'),
('164950','INT2','Deafness, congenital with inner ear agenesis, microtia, and'),
('164950','FGF3','microdontia, 610706 (3)'),
('164950','INT2','microdontia, 610706 (3)'),
('164953','D19S381E','Liposarcoma (1)'),
('164953','LPSA','Liposarcoma (1)'),
('164975','WNT5A','Robinow syndrome, autosomal dominant, 180700 (3)'),
('165215','EVI1','3q21q26 syndrome (1)'),
('165230','GLI2','Holoprosencephaly-9, 610829 (3)'),
('165230','HPE9','Holoprosencephaly-9, 610829 (3)'),
('165240','GLI3','Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall'),
('165240','PAPA','Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall'),
('165240','PAPB','Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall'),
('165240','GLI3','somatic}, 241800 (3)'),
('165240','PAPA','somatic}, 241800 (3)'),
('165240','PAPB','somatic}, 241800 (3)'),
('165240','GLI3','syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas,'),
('165240','PAPA','syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas,'),
('165240','PAPB','syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas,'),
('165320','LCO','?Hepatocellular carcinoma (1)'),
('165330','INT4','Tetra-amelia, autosomal recessive, 273395 (3)'),
('165330','WNT3','Tetra-amelia, autosomal recessive, 273395 (3)'),
('165360','CBL','meylomonocytic leukemia, 613563 (3)'),
('165360','CBL2','meylomonocytic leukemia, 613563 (3)'),
('165360','NSLL','meylomonocytic leukemia, 613563 (3)'),
('165360','CBL','Noonan syndrome-like disorder with or without juvenile'),
('165360','CBL2','Noonan syndrome-like disorder with or without juvenile'),
('165360','NSLL','Noonan syndrome-like disorder with or without juvenile'),
('165640','ODC1','{Colonic adenoma recurrence, reduced risk of}, 114500 (3)'),
('166750','C11DELq13','Otodental dysplasia chromsome deletion syndrome (4)'),
('166750','DEL11q13','Otodental dysplasia chromsome deletion syndrome (4)'),
('166750','OTDD','Otodental dysplasia chromsome deletion syndrome (4)'),
('166760','OMS','{Otitis media, susceptibility to} (2)'),
('166800','OTS','Otosclerosis 1 (2)'),
('166800','OTSC1','Otosclerosis 1 (2)'),
('167250','PDB','?Paget disease of bone (2)'),
('167409','PAX2','hypoplasia, isolated (3)'),
('167409','PAX2','Optic nerve coloboma with renal disease, 120330 (3); Renal'),
('167410','PAX7','Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('167410','RMS2','Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('167413','KPD','Diabetes mellitus, type 2, 125853 (3); Diabetes mellitus, ketosis-prone, 612227 (3)'),
('167413','MODY9','Diabetes mellitus, type 2, 125853 (3); Diabetes mellitus, ketosis-prone, 612227 (3)'),
('167413','PAX4','Diabetes mellitus, type 2, 125853 (3); Diabetes mellitus, ketosis-prone, 612227 (3)'),
('167413','KPD','Maturity-onset diabetes of the young, type IX, 612225 (3);'),
('167413','MODY9','Maturity-onset diabetes of the young, type IX, 612225 (3);'),
('167413','PAX4','Maturity-onset diabetes of the young, type IX, 612225 (3);'),
('167414','BSAP','Lymphoplasmacytoid lymphoma (1)'),
('167414','PAX5','Lymphoplasmacytoid lymphoma (1)'),
('167415','PAX8','hypoplasia, 218700 (3)'),
('167415','PAX8','Hypothyroidism, congenital, due to thyroid dysgenesis or'),
('167416','PAX9','Tooth agenesis, selective, 3, 604625 (3)'),
('167416','STHAG3','Tooth agenesis, selective, 3, 604625 (3)'),
('167420','AGOTC','Agnathia-otocephaly complex, 202650 (3)'),
('167420','PHOX1','Agnathia-otocephaly complex, 202650 (3)'),
('167420','PMX1','Agnathia-otocephaly complex, 202650 (3)'),
('167420','PRRX1','Agnathia-otocephaly complex, 202650 (3)'),
('167790','PCTT','diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)'),
('167790','PSTI','diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)'),
('167790','SPINK1','diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)'),
('167790','TATI','diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)'),
('167790','TCP','diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)'),
('167790','PCTT','Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic'),
('167790','PSTI','Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic'),
('167790','SPINK1','Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic'),
('167790','TATI','Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic'),
('167790','TCP','Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic'),
('167870','PAND1','Panic disorder syndrome 1 (2)'),
('168360','ELAVL4','Neuropathy, paraneoplastic sensory (1)'),
('168360','HUD','Neuropathy, paraneoplastic sensory (1)'),
('168360','PNEM','Neuropathy, paraneoplastic sensory (1)'),
('168450','PTH','Hypoparathyroidism, autosomal dominant, 146200 (3);'),
('168450','PTH','Hypoparathyroidism, autosomal recessive, 146200 (3)'),
('168461','BCL1','{Colorectal cancer, susceptibility to}, 114500 (3);'),
('168461','CCND1','{Colorectal cancer, susceptibility to}, 114500 (3);'),
('168461','PRAD1','{Colorectal cancer, susceptibility to}, 114500 (3);'),
('168461','BCL1','{von Hippel-Lindau disease, modification of}, 193300 (3)'),
('168461','CCND1','{von Hippel-Lindau disease, modification of}, 193300 (3)'),
('168461','PRAD1','{von Hippel-Lindau disease, modification of}, 193300 (3)'),
('168468','PFE','Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)'),
('168468','PTHR','Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)'),
('168468','PTHR1','Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)'),
('168468','PFE','Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3);'),
('168468','PTHR','Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3);'),
('168468','PTHR1','Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3);'),
('168470','BDE2','613382 (3)'),
('168470','PTHLH','613382 (3)'),
('168470','BDE2','Humoral hypercalcemia of malignancy (1); Brachydactyly, type E2,'),
('168470','PTHLH','Humoral hypercalcemia of malignancy (1); Brachydactyly, type E2,'),
('168820','ESA','spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)'),
('168820','MVCD5','spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)'),
('168820','PON','spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)'),
('168820','PON1','spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)'),
('168820','ESA','{Coronary artery disease, susceptibility to} (3); {Coronary artery'),
('168820','MVCD5','{Coronary artery disease, susceptibility to} (3); {Coronary artery'),
('168820','PON','{Coronary artery disease, susceptibility to} (3); {Coronary artery'),
('168820','PON1','{Coronary artery disease, susceptibility to} (3); {Coronary artery'),
('168860','FPAH','Patella aplasia or hypoplasia (2)'),
('168860','PTLAH','Patella aplasia or hypoplasia (2)'),
('170260','ABCB2','Bare lymphocyte syndrome, type I, 604571 (3)'),
('170260','PSF1','Bare lymphocyte syndrome, type I, 604571 (3)'),
('170260','RING4','Bare lymphocyte syndrome, type I, 604571 (3)'),
('170260','TAP1','Bare lymphocyte syndrome, type I, 604571 (3)'),
('170261','ABCB3','Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);'),
('170261','PSF2','Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);'),
('170261','RING11','Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);'),
('170261','TAP2','Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);'),
('170261','ABCB3','Wegener-like granulomatosis (3)'),
('170261','PSF2','Wegener-like granulomatosis (3)'),
('170261','RING11','Wegener-like granulomatosis (3)'),
('170261','TAP2','Wegener-like granulomatosis (3)'),
('170280','FLH2','Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3);'),
('170280','HPLH2','Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3);'),
('170280','PRF1','Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3);'),
('170280','FLH2','Lymphoma, non-Hodgkin, 605027 (3)'),
('170280','HPLH2','Lymphoma, non-Hodgkin, 605027 (3)'),
('170280','PRF1','Lymphoma, non-Hodgkin, 605027 (3)'),
('170290','FPLD4','Lipodystrophy, familial partial, type 4, 613877 (3)'),
('170290','PLIN','Lipodystrophy, familial partial, type 4, 613877 (3)'),
('170290','PLIN1','Lipodystrophy, familial partial, type 4, 613877 (3)'),
('170710','PRPH','{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)'),
('170993','PAF1','Zellweger syndrome-3 (3); Refsum disease, infantile, 266510 (3)'),
('170993','PEX2','Zellweger syndrome-3 (3); Refsum disease, infantile, 266510 (3)'),
('170993','PMP35','Zellweger syndrome-3 (3); Refsum disease, infantile, 266510 (3)'),
('170993','PXMP3','Zellweger syndrome-3 (3); Refsum disease, infantile, 266510 (3)'),
('170995','ABCD3','Zellweger syndrome-2 (3)'),
('170995','PMP70','Zellweger syndrome-2 (3)'),
('170995','PXMP1','Zellweger syndrome-2 (3)'),
('170998','PPAR','{Hyperapobetalipoproteinemia, susceptibility to} (3)'),
('170998','PPARA','{Hyperapobetalipoproteinemia, susceptibility to} (3)'),
('171050','ABCB1','612244 (3)'),
('171050','CLCs','612244 (3)'),
('171050','IBD13','612244 (3)'),
('171050','MDR1','612244 (3)'),
('171050','PGY1','612244 (3)'),
('171050','ABCB1','{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13},'),
('171050','CLCs','{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13},'),
('171050','IBD13','{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13},'),
('171050','MDR1','{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13},'),
('171050','PGY1','{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13},'),
('171060','ABCB4','Cholestasis, familial intrahepatic, of pregnancy, 147480 (3); Gallbladder disease 1, 600803 (3)'),
('171060','MDR3','Cholestasis, familial intrahepatic, of pregnancy, 147480 (3); Gallbladder disease 1, 600803 (3)'),
('171060','PGY3','Cholestasis, familial intrahepatic, of pregnancy, 147480 (3); Gallbladder disease 1, 600803 (3)'),
('171060','ABCB4','Cholestasis, progressive familial intrahepatic 3, 602347 (3);'),
('171060','MDR3','Cholestasis, progressive familial intrahepatic 3, 602347 (3);'),
('171060','PGY3','Cholestasis, progressive familial intrahepatic 3, 602347 (3);'),
('171190','PENT','?Hypertension, essential, 145500 (1)'),
('171190','PNMT','?Hypertension, essential, 145500 (1)'),
('171640','ACP5','Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)'),
('171640','SPENCDI','Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)'),
('171650','ACP2','?Lysosomal acid phosphatase deficiency, 200950 (1)'),
('171720','ALPQTL1','{Alkaline phosphatase, plasma level of, QTL1} (2)'),
('171760','ALPL','241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)'),
('171760','HOPS','241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)'),
('171760','TNSALP','241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)'),
('171760','ALPL','Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood,'),
('171760','HOPS','Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood,'),
('171760','TNSALP','Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood,'),
('171834','PIK3CA','(3); Colorectal cancer, somatic, 114500 (3); Gastric cancer, somatic, 137215 (3); Hepatocellular carcinoma, somatic, 114550 (3); Nonsmall cell lung cancer,'),
('171834','PIK3CA','Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480'),
('171834','PIK3CA','somatic, 211980 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, 162900 (3)'),
('171860','PFKL','Hemolytic anemia due to phosphofructokinase deficiency (1)'),
('171900','GSD14','Glycogen storage disease XIV, 612934 (3)'),
('171900','PGM1','Glycogen storage disease XIV, 612934 (3)'),
('172400','GPI','deficiency, 613470 (3)'),
('172400','GPI','Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase'),
('172405','CMD1P','Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial'),
('172405','CMH18','Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial'),
('172405','PLB','Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial'),
('172405','PLN','Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial'),
('172405','CMD1P','hypertrophic, 18, 613874 (3)'),
('172405','CMH18','hypertrophic, 18, 613874 (3)'),
('172405','PLB','hypertrophic, 18, 613874 (3)'),
('172405','PLN','hypertrophic, 18, 613874 (3)'),
('172411','MOM1','{Colorectal cancer}, 114500 (3)'),
('172411','PLA2B','{Colorectal cancer}, 114500 (3)'),
('172411','PLA2G2A','{Colorectal cancer}, 114500 (3)'),
('172411','PLA2L','{Colorectal cancer}, 114500 (3)'),
('172425','HDLCQ9','[High density lipoprotein cholesterol level QTL 9] (3)'),
('172425','PLTP','[High density lipoprotein cholesterol level QTL 9] (3)'),
('172430','ENO1','Enolase deficiency (1)'),
('172430','MPB1','Enolase deficiency (1)'),
('172430','PPH','Enolase deficiency (1)'),
('172460','MTHFC','{Abruptio placentae, susceptibility to} (3)'),
('172460','MTHFD','{Abruptio placentae, susceptibility to} (3)'),
('172460','MTHFC','{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3);'),
('172460','MTHFD','{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3);'),
('172471','GSD9C','Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver'),
('172471','PHKG2','Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver'),
('172471','GSD9C','phosphorylase kinase deficiency (3)'),
('172471','PHKG2','phosphorylase kinase deficiency (3)'),
('172480','PSP','Phosphoserine phosphatase deficiency, 614023 (3)'),
('172480','PSPHD','Phosphoserine phosphatase deficiency, 614023 (3)'),
('172490','PHKB','Phosphorylase kinase deficiency of liver and muscle, autosomal'),
('172490','PHKB','recessive, 261750 (3)'),
('172860','OI6','Osteogenesis imperfecta, type VI, 613982 (3)'),
('172860','PEDF','Osteogenesis imperfecta, type VI, 613982 (3)'),
('172860','SERPINF1','Osteogenesis imperfecta, type VI, 613982 (3)'),
('173110','CPHD1','Pituitary hormone deficiency, combined, 1, 613038 (3)'),
('173110','PIT1','Pituitary hormone deficiency, combined, 1, 613038 (3)'),
('173110','POU1F1','Pituitary hormone deficiency, combined, 1, 613038 (3)'),
('173321','DFNB91','Deafness, autosomal recessive 91, 613453 (3)'),
('173321','PI6','Deafness, autosomal recessive 91, 613453 (3)'),
('173321','PTI','Deafness, autosomal recessive 91, 613453 (3)'),
('173321','SERPINB6','Deafness, autosomal recessive 91, 613453 (3)'),
('173321','SPI3','Deafness, autosomal recessive 91, 613453 (3)'),
('173325','ARVD12','dysplasia 12, 611528 (3)'),
('173325','DP3','dysplasia 12, 611528 (3)'),
('173325','JUP','dysplasia 12, 611528 (3)'),
('173325','PDGB','dysplasia 12, 611528 (3)'),
('173325','ARVD12','Naxos disease, 601214 (3); Arrhythmogenic right ventricular'),
('173325','DP3','Naxos disease, 601214 (3); Arrhythmogenic right ventricular'),
('173325','JUP','Naxos disease, 601214 (3); Arrhythmogenic right ventricular'),
('173325','PDGB','Naxos disease, 601214 (3); Arrhythmogenic right ventricular'),
('173335','ARHR2','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','ENPP1','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','M6S1','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','NPPS','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','PCA1','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','PDNP1','of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)'),
('173335','ARHR2','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','ENPP1','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','M6S1','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','NPPS','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','PCA1','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','PDNP1','Ossification of posterior longitudinal ligament of spine, 602475 (3);'),
('173335','ARHR2','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173335','ENPP1','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173335','M6S1','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173335','NPPS','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173335','PCA1','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173335','PDNP1','{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized,'),
('173350','PLG','(1); Plasminogen deficiency, types I and II (1); Conjunctivitis, ligneous, 217090 (3)'),
('173350','PLG','Plasminogen Tochigi disease (3); Thrombophilia, dysplasminogenemic'),
('173360','PAI1','Plasminogen activator inhibitor-1 deficiency, 613329 (3);'),
('173360','PLANH1','Plasminogen activator inhibitor-1 deficiency, 613329 (3);'),
('173360','SERPINE1','Plasminogen activator inhibitor-1 deficiency, 613329 (3);'),
('173360','PAI1','{Transcription of plasminogen activator inhibitor, modulator of} (3)'),
('173360','PLANH1','{Transcription of plasminogen activator inhibitor, modulator of} (3)'),
('173360','SERPINE1','{Transcription of plasminogen activator inhibitor, modulator of} (3)'),
('173370','PLAT','(1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)'),
('173370','TPA','(1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)'),
('173370','PLAT','Thrombophilia, familial, due to decreased release of PLAT, 612348'),
('173370','TPA','Thrombophilia, familial, due to decreased release of PLAT, 612348'),
('173410','PDGFR','Myelomonocytic leukemia, chronic (3)'),
('173410','PDGFRB','Myelomonocytic leukemia, chronic (3)'),
('173410','PDGFR','Myeloproliferative disorder with eosinophilia, 131440 (3);'),
('173410','PDGFRB','Myeloproliferative disorder with eosinophilia, 131440 (3);'),
('173470','BDPLT2','alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3)'),
('173470','GP3A','alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3)'),
('173470','GT','alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3)'),
('173470','ITGB3','alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3)'),
('173470','BDPLT2','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal'),
('173470','GP3A','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal'),
('173470','GT','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal'),
('173470','ITGB3','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal'),
('173490','PDGFRA','Gastrointestinal stromal tumor, somatic, 606764 (3);'),
('173490','PDGFRA','Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)'),
('173510','BDPLT10','608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility'),
('173510','CD36','608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility'),
('173510','CHDS7','608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility'),
('173510','BDPLT10','to, 7}, 610938 (3)'),
('173510','CD36','to, 7}, 610938 (3)'),
('173510','CHDS7','to, 7}, 610938 (3)'),
('173510','BDPLT10','[Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency,'),
('173510','CD36','[Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency,'),
('173510','CHDS7','[Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency,'),
('173515','GP9','Bernard-Soulier syndrome, type C, 231200 (3)'),
('173610','GRMP','Platelet alpha/delta storage pool deficiency (1); {Atopy,'),
('173610','SELP','Platelet alpha/delta storage pool deficiency (1); {Atopy,'),
('173610','GRMP','susceptibility to}, 147050 (3)'),
('173610','SELP','susceptibility to}, 147050 (3)'),
('173870','ADPRT','?Xeroderma pigmentosum (1)'),
('173870','PARP','?Xeroderma pigmentosum (1)'),
('173870','PARP1','?Xeroderma pigmentosum (1)'),
('173870','PPOL','?Xeroderma pigmentosum (1)'),
('173910','PKD2','Polycystic kidney disease 2, 613095 (3)'),
('174000','MCKD1','Medullary cystic kidney disease 1 (2)'),
('174763','MIRAS','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','MTDPS4A','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','MTDPS4B','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','PEO','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','POLG','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','POLG1','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','POLGA','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','SANDO','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','SCAE','(3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial'),
('174763','MIRAS','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','MTDPS4A','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','MTDPS4B','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','PEO','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','POLG','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','POLG1','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','POLGA','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','SANDO','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','SCAE','DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)'),
('174763','MIRAS','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','MTDPS4A','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','MTDPS4B','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','PEO','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','POLG','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','POLG1','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','POLGA','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','SANDO','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('174763','SCAE','Progressive external ophthalmoplegia, autosomal recessive, 258450'),
('175850','PPPD1','Porokeratosis, palmar, plantar, and disseminated 1 (2)'),
('176260','AEMK','Episodic ataxia/myokymia syndrome, 160120 (3)'),
('176260','EA1','Episodic ataxia/myokymia syndrome, 160120 (3)'),
('176260','KCNA1','Episodic ataxia/myokymia syndrome, 160120 (3)'),
('176261','JLNS','613695 (3)'),
('176261','JLNS2','613695 (3)'),
('176261','KCNE1','613695 (3)'),
('176261','LQT5','613695 (3)'),
('176261','JLNS','Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5,'),
('176261','JLNS2','Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5,'),
('176261','KCNE1','Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5,'),
('176261','LQT5','Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5,'),
('176264','KCNC3','Spinocerebellar ataxia 13, 605259 (3)'),
('176264','SCA13','Spinocerebellar ataxia 13, 605259 (3)'),
('176267','ATFB7','Atrial fibrillation, familial, 7, 612240 (3)'),
('176267','KCNA5','Atrial fibrillation, familial, 7, 612240 (3)'),
('176300','PALB','Amyloidosis, hereditary, transthyretin-related, 105210 (3);'),
('176300','TTR','Amyloidosis, hereditary, transthyretin-related, 105210 (3);'),
('176300','PALB','[Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)'),
('176300','TTR','[Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)'),
('176310','PBX1','Leukemia, acute pre-B-cell (2)'),
('176640','CJD','137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3);'),
('176640','KURU','137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3);'),
('176640','PRIP','137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3);'),
('176640','PRNP','137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3);'),
('176640','CJD','Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease,'),
('176640','KURU','Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease,'),
('176640','PRIP','Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease,'),
('176640','PRNP','Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease,'),
('176640','CJD','{Kuru, susceptibility to}, 245300 (3)'),
('176640','KURU','{Kuru, susceptibility to}, 245300 (3)'),
('176640','PRIP','{Kuru, susceptibility to}, 245300 (3)'),
('176640','PRNP','{Kuru, susceptibility to}, 245300 (3)'),
('176705','PHB','{Breast cancer, susceptibility to}, 114480 (3)'),
('176730','IDDM2','Diabetes mellitus, insulin-dependent, 2, 125852 (3)'),
('176730','INS','Diabetes mellitus, insulin-dependent, 2, 125852 (3)'),
('176730','MODY10','Diabetes mellitus, insulin-dependent, 2, 125852 (3)'),
('176730','IDDM2','Hyperproinsulinemia, familial, with or without diabetes (3);'),
('176730','INS','Hyperproinsulinemia, familial, with or without diabetes (3);'),
('176730','MODY10','Hyperproinsulinemia, familial, with or without diabetes (3);'),
('176730','IDDM2','Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal, 606176 (3); Diabetes mellitus, type 1, 125852 (3);'),
('176730','INS','Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal, 606176 (3); Diabetes mellitus, type 1, 125852 (3);'),
('176730','MODY10','Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal, 606176 (3); Diabetes mellitus, type 1, 125852 (3);'),
('176780','PVOP1','{Pelvic organ prolapse, susceptibility to, 1} (2)'),
('176797','PLZF','genital hypoplasia, and mental retardation, 612447 (3)'),
('176797','ZBTB16','genital hypoplasia, and mental retardation, 612447 (3)'),
('176797','ZNF145','genital hypoplasia, and mental retardation, 612447 (3)'),
('176797','PLZF','Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects,'),
('176797','ZBTB16','Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects,'),
('176797','ZNF145','Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects,'),
('176801','PSAP','Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)'),
('176801','SAP1','Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)'),
('176801','PSAP','Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3);'),
('176801','SAP1','Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3);'),
('176804','PTGER2','{Asthma, aspirin-induced, susceptibility to}, 208550 (3)'),
('176830','POMC','609734 (3); {Obesity, early-onset, susceptibility to}, 601665 (3)'),
('176830','POMC','Obesity, adrenal insufficiency, and red hair due to POMC deficiency,'),
('176872','MAP2K1','Cardiofaciocutaneous syndrome, 115150 (3)'),
('176872','MEK1','Cardiofaciocutaneous syndrome, 115150 (3)'),
('176872','MKK1','Cardiofaciocutaneous syndrome, 115150 (3)'),
('176872','PRKMK1','Cardiofaciocutaneous syndrome, 115150 (3)'),
('176876','NS1','Leukemia, juvenile myelomonocytic, 607785 (3); Metachondromatosis, 156250 (3)'),
('176876','PTP2C','Leukemia, juvenile myelomonocytic, 607785 (3); Metachondromatosis, 156250 (3)'),
('176876','PTPN11','Leukemia, juvenile myelomonocytic, 607785 (3); Metachondromatosis, 156250 (3)'),
('176876','SHP2','Leukemia, juvenile myelomonocytic, 607785 (3); Metachondromatosis, 156250 (3)'),
('176876','NS1','Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3);'),
('176876','PTP2C','Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3);'),
('176876','PTPN11','Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3);'),
('176876','SHP2','Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3);'),
('176880','PROS1','612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)'),
('176880','THPH5','612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)'),
('176880','THPH6','612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)'),
('176880','PROS1','Thrombophilia due to protein S deficiency, autosomal dominant,'),
('176880','THPH5','Thrombophilia due to protein S deficiency, autosomal dominant,'),
('176880','THPH6','Thrombophilia due to protein S deficiency, autosomal dominant,'),
('176885','PTP1B','{Insulin resistance, susceptibility to}, 125853 (3)'),
('176885','PTPN1','{Insulin resistance, susceptibility to}, 125853 (3)'),
('176891','PTP18','{H. pylori infection, susceptibility to}, 600263 (1)'),
('176891','PTPRZ1','{H. pylori infection, susceptibility to}, 600263 (1)'),
('176895','PROZ','[Protein Z deficiency], 614024 (1)'),
('176895','PZ','[Protein Z deficiency], 614024 (1)'),
('176930','F2','Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3);'),
('176930','RPRGL2','Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3);'),
('176930','THPH1','Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3);'),
('176930','F2','Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility'),
('176930','RPRGL2','Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility'),
('176930','THPH1','Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility'),
('176930','F2','to, 2}, 614390 (3)'),
('176930','RPRGL2','to, 2}, 614390 (3)'),
('176930','THPH1','to, 2}, 614390 (3)');
INSERT INTO omim VALUES
('176941','TYK2','Tyrosine kinase 2 deficiency, 611521 (3)'),
('176943','BBDS','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','BEK','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','CFD1','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','FGFR2','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','JWS','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','TK14','(3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3);'),
('176943','BBDS','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','BEK','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','CFD1','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','FGFR2','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','JWS','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','TK14','Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis'),
('176943','BBDS','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176943','BEK','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176943','CFD1','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176943','FGFR2','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176943','JWS','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176943','TK14','Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600'),
('176946','ARCC2','Cataract, posterior polar, 1, 116600 (3); Cataract, age-related'),
('176946','CTPA','Cataract, posterior polar, 1, 116600 (3); Cataract, age-related'),
('176946','CTPP1','Cataract, posterior polar, 1, 116600 (3); Cataract, age-related'),
('176946','ECK','Cataract, posterior polar, 1, 116600 (3); Cataract, age-related'),
('176946','EPHA2','Cataract, posterior polar, 1, 116600 (3); Cataract, age-related'),
('176946','ARCC2','cortical, 2, 613020 (3)'),
('176946','CTPA','cortical, 2, 613020 (3)'),
('176946','CTPP1','cortical, 2, 613020 (3)'),
('176946','ECK','cortical, 2, 613020 (3)'),
('176946','EPHA2','cortical, 2, 613020 (3)'),
('176947','SRK','Selective T-cell defect (3)'),
('176947','STD','Selective T-cell defect (3)'),
('176947','ZAP70','Selective T-cell defect (3)'),
('176960','PKCA','Pituitary tumor, invasive (3)'),
('176960','PRKCA','Pituitary tumor, invasive (3)'),
('176980','PKCC','Spinocerebellar ataxia 14, 605361 (3)'),
('176980','PKCG','Spinocerebellar ataxia 14, 605361 (3)'),
('176980','PRKCG','Spinocerebellar ataxia 14, 605361 (3)'),
('176980','SCA14','Spinocerebellar ataxia 14, 605361 (3)'),
('177046','ALDD','256040 (3)'),
('177046','JMP','256040 (3)'),
('177046','LMP7','256040 (3)'),
('177046','NKJO','256040 (3)'),
('177046','PSMB8','256040 (3)'),
('177046','RING10','256040 (3)'),
('177046','ALDD','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177046','JMP','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177046','LMP7','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177046','NKJO','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177046','PSMB8','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177046','RING10','Autoinflammation, lipodystrophy, and dermatosis syndrome,'),
('177060','G19P1','Polycystic liver disease, 174050 (3)'),
('177060','PCLD','Polycystic liver disease, 174050 (3)'),
('177060','PRKCSH','Polycystic liver disease, 174050 (3)'),
('177070','EPB42','Spherocytosis, hereditary, type 5, 612690 (3)'),
('177070','SPH5','Spherocytosis, hereditary, type 5, 612690 (3)'),
('177075','CCA4','610202 (3)'),
('177075','MAF','610202 (3)'),
('177075','CCA4','Cataract, pulverulent or cerulean, with or without microcornea,'),
('177075','MAF','Cataract, pulverulent or cerulean, with or without microcornea,'),
('177400','BCHE','Apnea, postanesthetic (3)'),
('177400','CHE1','Apnea, postanesthetic (3)'),
('178300','PTOS1','Ptosis, hereditary congenital, 1 (2)'),
('178620','SFTP2','Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)'),
('178620','SFTPC','Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)'),
('178620','SMDP2','Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)'),
('178630','SFTP1','{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('178630','SFTPA1','{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('178640','SFTB3','Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)'),
('178640','SFTPB','Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)'),
('178640','SMDP1','Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)'),
('178642','COLEC5','Pulmonary fibrosis, idiopathic, 178500 (3)'),
('178642','SFTPA2','Pulmonary fibrosis, idiopathic, 178500 (3)'),
('178642','SPA2','Pulmonary fibrosis, idiopathic, 178500 (3)'),
('179010','IHPS','Pyloric stenosis, infantile hypertrophic 1 (2)'),
('179010','IHPS1','Pyloric stenosis, infantile hypertrophic 1 (2)'),
('179035','ARCL2B','Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis'),
('179035','ARCL3B','Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis'),
('179035','PRO3','Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis'),
('179035','PYCR1','Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis'),
('179035','ARCL2B','laxa, autosomal recessive, type IIIB, 614438 (3)'),
('179035','ARCL3B','laxa, autosomal recessive, type IIIB, 614438 (3)'),
('179035','PRO3','laxa, autosomal recessive, type IIIB, 614438 (3)'),
('179035','PYCR1','laxa, autosomal recessive, type IIIB, 614438 (3)'),
('179060','PDHB','Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)'),
('179060','PDHBD','Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)'),
('179095','RAD6B','?Male infertility (1)'),
('179095','UBE2B','?Male infertility (1)'),
('179410','DFNB24','Deafness, autosomal recessive 24, 611022 (3)'),
('179410','RDX','Deafness, autosomal recessive 24, 611022 (3)'),
('179450','RWS','?Ragweed sensitivity (2)'),
('179502','RAP1GDS1','Lymphocytic leukemia, acute T-cell (3)'),
('179605','AOFMD','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','AVMD','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','CACD2','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','DS','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','PRPH','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','PRPH2','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','RP7','136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal'),
('179605','AOFMD','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','AVMD','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','CACD2','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','DS','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','PRPH','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','PRPH2','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','RP7','neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)'),
('179605','AOFMD','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','AVMD','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','CACD2','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','DS','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','PRPH','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','PRPH2','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179605','RP7','Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,'),
('179615','RAG1','(3); Combined cellular and humoral immune defects with granulomas, 233650 (3)'),
('179615','RAG1','Omenn syndrome,  603554 (3); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889'),
('179615','RAG1','Severe combined immunodeficiency, B cell-negative, 601457 (3);'),
('179616','RAG2','Omenn syndrome, 603554 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)'),
('179616','RAG2','Severe combined immunodeficiency, B cell-negative, 601457 (3);'),
('179617','MRMV2','614508 (3)'),
('179617','RAD51A','614508 (3)'),
('179617','RECA','614508 (3)'),
('179617','MRMV2','{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2,'),
('179617','RAD51A','{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2,'),
('179617','RECA','{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2,'),
('179755','PRCC','Renal cell carcinoma, papillary, 605074 (3)'),
('179755','RCCP1','Renal cell carcinoma, papillary, 605074 (3)'),
('179820','HNFJ2','Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)'),
('179820','REN','Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)'),
('179820','HNFJ2','[Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3);'),
('179820','REN','[Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3);'),
('180020','RCD1','?Retinal cone dystrophy-1 (2)'),
('180040','C1orf36','Leber congenital amaurosis 12, 610612 (3)'),
('180040','LCA12','Leber congenital amaurosis 12, 610612 (3)'),
('180040','RD3','Leber congenital amaurosis 12, 610612 (3)'),
('180069','LCA2','613794 (3)'),
('180069','RP20','613794 (3)'),
('180069','RPE65','613794 (3)'),
('180069','LCA2','Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20,'),
('180069','RP20','Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20,'),
('180069','RPE65','Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20,'),
('180071','PDE6A','Retinitis pigmentosa 43, 613810 (3)'),
('180071','PDEA','Retinitis pigmentosa 43, 613810 (3)'),
('180071','RP43','Retinitis pigmentosa 43, 613810 (3)'),
('180072','CSNBAD2','(3); Retinitis pigmentosa-40, 613801 (3)'),
('180072','PDE6B','(3); Retinitis pigmentosa-40, 613801 (3)'),
('180072','PDEB','(3); Retinitis pigmentosa-40, 613801 (3)'),
('180072','RP40','(3); Retinitis pigmentosa-40, 613801 (3)'),
('180072','CSNBAD2','Night blindness, congenital stationary, autosomal dominant 2, 163500'),
('180072','PDE6B','Night blindness, congenital stationary, autosomal dominant 2, 163500'),
('180072','PDEB','Night blindness, congenital stationary, autosomal dominant 2, 163500'),
('180072','RP40','Night blindness, congenital stationary, autosomal dominant 2, 163500'),
('180073','PDE6G','Retinitis pigmentosa 57, 613582 (3)'),
('180073','PDEG','Retinitis pigmentosa 57, 613582 (3)'),
('180073','RP57','Retinitis pigmentosa 57, 613582 (3)'),
('180090','RLBP1','136880 (3); Newfoundland rod-cone dystrophy, 607476 (3); Bothnia retinal dystrophy, 607475 (3)'),
('180090','RLBP1','Fundus albipunctatus, 136880 (3); Retinitis punctata albescens,'),
('180240','RARA','Leukemia, acute promyelocytic, 612376 (1)'),
('180250','RBP4','Retinol binding protein, deficiency of (3)'),
('180297','RH50A','Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Rh-mod'),
('180297','RHAG','Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Rh-mod'),
('180297','RH50A','syndrome (3)'),
('180297','RHAG','syndrome (3)'),
('180300','RA','{Rheumatoid arthritis, susceptibility to} (2)'),
('180380','CSNBAD1','Night blindness, congenital stationery, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)'),
('180380','OPN2','Night blindness, congenital stationery, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)'),
('180380','RHO','Night blindness, congenital stationery, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)'),
('180380','RP4','Night blindness, congenital stationery, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)'),
('180380','CSNBAD1','Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3);'),
('180380','OPN2','Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3);'),
('180380','RHO','Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3);'),
('180380','RP4','Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3);'),
('180381','GRK1','Oguchi disease-2, 613411 (3)'),
('180381','RHOK','Oguchi disease-2, 613411 (3)'),
('180381','RK','Oguchi disease-2, 613411 (3)'),
('180385','LMO2','Leukemia, acute T-cell (2)'),
('180385','RBTNL1','Leukemia, acute T-cell (2)'),
('180385','RHOM2','Leukemia, acute T-cell (2)'),
('180385','TTG2','Leukemia, acute T-cell (2)'),
('180430','RPI','Ribose 5-phosphate isomerase deficiency, 608611 (3)'),
('180430','RPIA','Ribose 5-phosphate isomerase deficiency, 608611 (3)'),
('180435','HPC1','Prostate cancer 1, 601518 (3)'),
('180435','PRCA1','Prostate cancer 1, 601518 (3)'),
('180435','RNASEL','Prostate cancer 1, 601518 (3)'),
('180435','RNS4','Prostate cancer 1, 601518 (3)'),
('180468','DBA5','Diamond-Blackfan anemia 5, 612528 (3)'),
('180468','RPL35A','Diamond-Blackfan anemia 5, 612528 (3)'),
('180472','DBA4','Diamond-Blackfan anemia 4, 612527 (3)'),
('180472','RPS17','Diamond-Blackfan anemia 4, 612527 (3)'),
('180472','RPS17L1','Diamond-Blackfan anemia 4, 612527 (3)'),
('180472','RPS17L2','Diamond-Blackfan anemia 4, 612527 (3)'),
('180721','ROM1','Retinitis pigmentosa 7, digenic (3)'),
('180721','ROSP1','Retinitis pigmentosa 7, digenic (3)'),
('180721','RP7','Retinitis pigmentosa 7, digenic (3)'),
('180860','RSS','Silver-Russell syndrome (4)'),
('180860','SRS','Silver-Russell syndrome (4)'),
('180901','CCO','disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)'),
('180901','MHS','disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)'),
('180901','RYR1','disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)'),
('180901','CCO','{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core'),
('180901','MHS','{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core'),
('180901','RYR1','{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core'),
('180902','ARVC2','(3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)'),
('180902','ARVD2','(3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)'),
('180902','RYR2','(3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)'),
('180902','VTSIP','(3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)'),
('180902','ARVC2','Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772'),
('180902','ARVD2','Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772'),
('180902','RYR2','Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772'),
('180902','VTSIP','Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772'),
('180960','AHCY','hydrolase, 613752 (3)'),
('180960','SAHH','hydrolase, 613752 (3)'),
('180960','AHCY','Hypermethioninemia with deficiency of S-adenosylhomocysteine'),
('180960','SAHH','Hypermethioninemia with deficiency of S-adenosylhomocysteine'),
('181031','RP47','Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)'),
('181031','SAG','Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)'),
('181460','SM1','{Schistosoma mansoni infection, susceptibility/resistance to} (2)'),
('181510','SCZD1','{Schizophrenia}, 181500 (2)'),
('181590','MCPH7','Microcephaly, primary autosomal recessive, 7, 612703 (3)'),
('181590','SIL','Microcephaly, primary autosomal recessive, 7, 612703 (3)'),
('181590','STIL','Microcephaly, primary autosomal recessive, 7, 612703 (3)'),
('181600','HRZ','Huriez syndrome (2)'),
('181600','TYS','Huriez syndrome (2)'),
('181800','AIS','Scoliosis, idiopathic 1 (2)'),
('181800','IS1','Scoliosis, idiopathic 1 (2)'),
('182100','B12QTL1','(3); {Vitamin B12 plasma level QTL1}, 612542 (3)'),
('182100','FUT2','(3); {Vitamin B12 plasma level QTL1}, 612542 (3)'),
('182100','SE','(3); {Vitamin B12 plasma level QTL1}, 612542 (3)'),
('182100','B12QTL1','{Norwalk virus infection, resistance to} (3); [Bombay phenotype]'),
('182100','FUT2','{Norwalk virus infection, resistance to} (3); [Bombay phenotype]'),
('182100','SE','{Norwalk virus infection, resistance to} (3); [Bombay phenotype]'),
('182125','SPR','612716 (3)'),
('182125','SPR','Dystonia, dopa-responsive, due to sepiapterin reductase deficiency,'),
('182135','HTR2A','(3); {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3)'),
('182135','HTR2A','disorder, susceptibility to}, 164230 (3); {Seasonal affective disorder, susceptibility to}, 608516 (3); {Alcohol dependence, susceptibility to}, 103780'),
('182135','HTR2A','{Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive'),
('182138','HTT','{Anxiety-related personality traits}, 607834 (3);'),
('182138','OCD1','{Anxiety-related personality traits}, 607834 (3);'),
('182138','SLC6A4','{Anxiety-related personality traits}, 607834 (3);'),
('182138','HTT','{Obsessive-compulsive disorder}, 164230 (3)'),
('182138','OCD1','{Obsessive-compulsive disorder}, 164230 (3)'),
('182138','SLC6A4','{Obsessive-compulsive disorder}, 164230 (3)'),
('182279','SNRPN','Prader-Willi syndrome, 176270 (3)'),
('182280','SCLC1','Small-cell cancer of lung (2)'),
('182283','CCL3','{HIV infection, resistance to}, 609423 (2)'),
('182283','MIP1A','{HIV infection, resistance to}, 609423 (2)'),
('182283','SCYA3','{HIV infection, resistance to}, 609423 (2)'),
('182309','FRTS2','Fanconi renotubular syndrome 2, 613388 (3)'),
('182309','NPHLOP1','Fanconi renotubular syndrome 2, 613388 (3)'),
('182309','NPT2','Fanconi renotubular syndrome 2, 613388 (3)'),
('182309','SLC17A2','Fanconi renotubular syndrome 2, 613388 (3)'),
('182309','SLC34A1','Fanconi renotubular syndrome 2, 613388 (3)'),
('182309','FRTS2','Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);'),
('182309','NPHLOP1','Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);'),
('182309','NPT2','Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);'),
('182309','SLC17A2','Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);'),
('182309','SLC34A1','Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);'),
('182330','ATP1B1','[Blood pressure regulation QTL], 145500 (2)'),
('182340','ATP1A2','hemiplegia of childhood, 104290 (3); Migraine, familial basilar, 602481 (3)'),
('182340','FHM2','hemiplegia of childhood, 104290 (3); Migraine, familial basilar, 602481 (3)'),
('182340','MHP2','hemiplegia of childhood, 104290 (3); Migraine, familial basilar, 602481 (3)'),
('182340','ATP1A2','Migraine, familial hemiplegic, 2, 602481 (3); Alternating'),
('182340','FHM2','Migraine, familial hemiplegic, 2, 602481 (3); Alternating'),
('182340','MHP2','Migraine, familial hemiplegic, 2, 602481 (3); Alternating'),
('182350','ATP1A3','Dystonia-12, 128235 (3)'),
('182350','DYT12','Dystonia-12, 128235 (3)'),
('182350','RDP','Dystonia-12, 128235 (3)'),
('182380','SGLT1','Glucose/galactose malabsorption, 606824 (3)'),
('182380','SLC5A1','Glucose/galactose malabsorption, 606824 (3)'),
('182381','SGLT2','Renal glucosuria, 233100 (3)'),
('182381','SLC5A2','Renal glucosuria, 233100 (3)'),
('182389','EIEE6','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','FEB3A','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','FHM3','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','GEFSP2','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','SCN1A','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','SMEI','(3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)'),
('182389','EIEE6','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182389','FEB3A','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182389','FHM3','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182389','GEFSP2','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182389','SCN1A','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182389','SMEI','Epilepsy, generalized, with febrile seizures plus, type 2, 604403'),
('182390','BFIC3','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','BFIS3','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','BFNIS','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','EIEE11','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','SCN2A','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','SCN2A1','encephalopathy, early infantile, 11, 613721 (3)'),
('182390','BFIC3','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182390','BFIS3','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182390','BFNIS','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182390','EIEE11','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182390','SCN2A','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182390','SCN2A1','Seizures, benign familial infantile, 3, 607745 (3); Epileptic'),
('182455','SSTR5','Somatostatin analog, resistance to, 102200 (3)'),
('182500','SORD','?Cataract, congenital (2)'),
('182500','SORD1','?Cataract, congenital (2)'),
('182530','GF1','Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)'),
('182530','GINGF','Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)'),
('182530','HGF','Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)'),
('182530','NS4','Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)'),
('182530','SOS1','Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)'),
('182810','EIEE5','Epileptic encephalopathy, early infantile, 5, 613477 (3)'),
('182810','NEAS','Epileptic encephalopathy, early infantile, 5, 613477 (3)'),
('182810','SPTAN1','Epileptic encephalopathy, early infantile, 5, 613477 (3)'),
('182860','EL2','Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);'),
('182860','HPP','Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);'),
('182860','HS3','Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);'),
('182860','SPH3','Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);'),
('182860','SPTA1','Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);'),
('182860','EL2','Spherocytosis, type 3, 270970 (3)'),
('182860','HPP','Spherocytosis, type 3, 270970 (3)'),
('182860','HS3','Spherocytosis, type 3, 270970 (3)'),
('182860','SPH3','Spherocytosis, type 3, 270970 (3)'),
('182860','SPTA1','Spherocytosis, type 3, 270970 (3)'),
('182870','EL3','Elliptocytosis-3 (3); Spherocytosis, type 2 (3); Anemia, neonatal'),
('182870','HS2','Elliptocytosis-3 (3); Spherocytosis, type 2 (3); Anemia, neonatal'),
('182870','SPH2','Elliptocytosis-3 (3); Spherocytosis, type 2 (3); Anemia, neonatal'),
('182870','SPTB','Elliptocytosis-3 (3); Spherocytosis, type 2 (3); Anemia, neonatal'),
('182870','EL3','hemolytic, fatal and near-fatal (3)'),
('182870','HS2','hemolytic, fatal and near-fatal (3)'),
('182870','SPH2','hemolytic, fatal and near-fatal (3)'),
('182870','SPTB','hemolytic, fatal and near-fatal (3)'),
('183600','SHFD1','Split hand/foot malformation 1 (4)'),
('183600','SHFM1','Split hand/foot malformation 1 (4)'),
('183600','SHSF1','Split hand/foot malformation 1 (4)'),
('183840','SPDA2','{Spondyloarthropathy, susceptibility to, 2} (2)'),
('184429','MCOPS3','and abnormalities of the central nervous system, 206900 (3)'),
('184429','SOX2','and abnormalities of the central nervous system, 206900 (3)'),
('184429','MCOPS3','Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia'),
('184429','SOX2','Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia'),
('184450','STUT1','Stuttering, familial persistent 1 (2)'),
('184600','AREI','Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of'),
('184600','CSTA','Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of'),
('184600','STF1','Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of'),
('184600','STFA','Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of'),
('184600','AREI','Siemens-like, 607936 (3)'),
('184600','CSTA','Siemens-like, 607936 (3)'),
('184600','STF1','Siemens-like, 607936 (3)'),
('184600','STFA','Siemens-like, 607936 (3)'),
('184700','PCO','Polycystic ovary syndrome 1 (2)'),
('184700','PCO1','Polycystic ovary syndrome 1 (2)'),
('184700','PCOS1','Polycystic ovary syndrome 1 (2)'),
('184745','KITLG','Hyperpigmentation, familial progressive, 2, 145250 (3)'),
('184745','MGF','Hyperpigmentation, familial progressive, 2, 145250 (3)'),
('184745','SCF','Hyperpigmentation, familial progressive, 2, 145250 (3)'),
('184745','SF','Hyperpigmentation, familial progressive, 2, 145250 (3)'),
('184745','SHEP7','Hyperpigmentation, familial progressive, 2, 145250 (3)'),
('184745','KITLG','[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);'),
('184745','MGF','[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);'),
('184745','SCF','[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);'),
('184745','SF','[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);'),
('184745','SHEP7','[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);'),
('184755','SCP2','Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)'),
('184757','AD4BP','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','FTZ1','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','FTZF1','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','NR5A1','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','POF7','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','SF1','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','SPGF8','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','SRXY3','(3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)'),
('184757','AD4BP','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','FTZ1','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','FTZF1','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','NR5A1','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','POF7','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','SF1','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','SPGF8','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('184757','SRXY3','46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964'),
('185100','STBMS1','{Strabismus, susceptibility to, 1} (2)'),
('185250','CHDS6','{Coronary heart disease, susceptibility to, 6}, 614466 (3)'),
('185250','MMP3','{Coronary heart disease, susceptibility to, 6}, 614466 (3)'),
('185250','STMY1','{Coronary heart disease, susceptibility to, 6}, 614466 (3)'),
('185470','PGL4','Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('185470','SDH2','Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('185470','SDHB','Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('185470','SDHIP','Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('185470','PGL4','Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3);'),
('185470','SDH2','Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3);'),
('185470','SDHB','Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3);'),
('185470','SDHIP','Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3);'),
('185490','SOD3','[Superoxide dismutase, elevated extracellular] (3)'),
('185535','ACSTD1','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','DIAR5','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','EPCAM','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','HNPCC8','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','M4S1','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','MIC18','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','TROP1','Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)'),
('185535','ACSTD1','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','DIAR5','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','EPCAM','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','HNPCC8','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','M4S1','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','MIC18','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185535','TROP1','Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);'),
('185620','SURF1','Leigh syndrome, due to COX deficiency, 256000 (3)'),
('185900','SD1','Syndactyly, type 1 (2)'),
('185900','SDTY1','Syndactyly, type 1 (2)'),
('186357','SDC3','{Obesity, association with}, 601665 (3)'),
('186357','SDCN','{Obesity, association with}, 601665 (3)'),
('186357','SYND3','{Obesity, association with}, 601665 (3)'),
('186740','CD3G','Immunodeficiency due to defect in CD3-gamma (3)'),
('186780','CD247','Immunodeficiency due to defect in CD3-zeta, 610163 (3)'),
('186780','CD3Z','Immunodeficiency due to defect in CD3-zeta, 610163 (3)'),
('186780','TCRZ','Immunodeficiency due to defect in CD3-zeta, 610163 (3)'),
('186790','CD3D','killer-cell positive, 608971 (3)'),
('186790','T3D','killer-cell positive, 608971 (3)'),
('186790','CD3D','Severe combined immunodeficiency, T cell-negative, B-cell/natural'),
('186790','T3D','Severe combined immunodeficiency, T cell-negative, B-cell/natural'),
('186830','CD3E','Immunodeficiency due to defect in CD3-epsilon (3); Severe combined'),
('186830','CD3E','immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)'),
('186845','CD81','Immunodeficiency, common variable, 6, 613496 (3)'),
('186845','CVID6','Immunodeficiency, common variable, 6, 613496 (3)'),
('186845','TAPA1','Immunodeficiency, common variable, 6, 613496 (3)'),
('186855','TAL2','Leukemia-2, T-cell acute lymphoblastic (3)'),
('186860','TCL4','Leukemia/lymphoma, T-cell (2)'),
('186880','TCRA','Leukemia/lymphoma, T-cell (3)'),
('186910','CD8A','CD8 deficiency, familial, 608957 (3)'),
('186921','LMO1','Leukemia, T-cell acute lymphoblastic (2)'),
('186921','RBTN1','Leukemia, T-cell acute lymphoblastic (2)'),
('186921','RHOM1','Leukemia, T-cell acute lymphoblastic (2)'),
('186940','CD4','OKT4 epitope deficiency, 613949 (3)'),
('186960','TCL1','Leukemia/lymphoma, T-cell (2)'),
('186960','TCL1A','Leukemia/lymphoma, T-cell (2)'),
('186973','EMT','(3)'),
('186973','ITK','(3)'),
('186973','EMT','Lymphoproliferative syndrome, EBV-associated, autosomal, 1, 613011'),
('186973','ITK','Lymphoproliferative syndrome, EBV-associated, autosomal, 1, 613011'),
('187011','CCL5','progression of} (3)'),
('187011','D17S136E','progression of} (3)'),
('187011','SCYA5','progression of} (3)'),
('187011','TCP228','progression of} (3)'),
('187011','CCL5','{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid'),
('187011','D17S136E','{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid'),
('187011','SCYA5','{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid'),
('187011','TCP228','{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid'),
('187040','SCL','Leukemia-1, T-cell acute lymphocytic (3)'),
('187040','TAL1','Leukemia-1, T-cell acute lymphocytic (3)'),
('187040','TCL5','Leukemia-1, T-cell acute lymphocytic (3)'),
('187270','DKCA2','4, 613989 (3); {Coronary artery disease, susceptiblity to} (3)'),
('187270','DKCB4','4, 613989 (3); {Coronary artery disease, susceptiblity to} (3)'),
('187270','EST2','4, 613989 (3); {Coronary artery disease, susceptiblity to} (3)'),
('187270','TCS1','4, 613989 (3); {Coronary artery disease, susceptiblity to} (3)'),
('187270','TERT','4, 613989 (3); {Coronary artery disease, susceptiblity to} (3)'),
('187270','DKCA2','fibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, autosomal dominant 2, 613989 (3); Dyskeratosis congenita, autosomal recessive'),
('187270','DKCB4','fibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, autosomal dominant 2, 613989 (3); Dyskeratosis congenita, autosomal recessive'),
('187270','EST2','fibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, autosomal dominant 2, 613989 (3); Dyskeratosis congenita, autosomal recessive'),
('187270','TCS1','fibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, autosomal dominant 2, 613989 (3); Dyskeratosis congenita, autosomal recessive'),
('187270','TERT','fibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, autosomal dominant 2, 613989 (3); Dyskeratosis congenita, autosomal recessive'),
('187270','DKCA2','{Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary'),
('187270','DKCB4','{Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary'),
('187270','EST2','{Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary'),
('187270','TCS1','{Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary'),
('187270','TERT','{Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary'),
('187395','TDGF1','Forebrain defects (3)'),
('187680','TPMT','6-mercaptopurine sensitivity, 610460 (3)'),
('188025','TCPT','?Thrombocytopenia, Paris-Trousseau type (4)'),
('188040','AHUS6','Thrombophilia due to thrombomodulin defect, 614486 (3);'),
('188040','THBD','Thrombophilia due to thrombomodulin defect, 614486 (3);'),
('188040','THPH12','Thrombophilia due to thrombomodulin defect, 614486 (3);'),
('188040','THRM','Thrombophilia due to thrombomodulin defect, 614486 (3);'),
('188040','AHUS6','{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)'),
('188040','THBD','{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)'),
('188040','THPH12','{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)'),
('188040','THRM','{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)'),
('188061','THBS2','{Lumbar disc herniation, susceptibility to}, 603932 (3)'),
('188070','BDPLT13','(3)'),
('188070','TBXA2R','(3)'),
('188070','BDPLT13','{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009'),
('188070','TBXA2R','{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009'),
('188250','MTDPS2','Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)'),
('188250','TK2','Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)'),
('188380','CMD1T','Cardiomyopathy, dilated, 1T, 613740 (3)'),
('188380','LAP2','Cardiomyopathy, dilated, 1T, 613740 (3)'),
('188380','TMPO','Cardiomyopathy, dilated, 1T, 613740 (3)'),
('188450','AITD3','susceptibility to, 3}, 608175 (3)'),
('188450','TDH3','susceptibility to, 3}, 608175 (3)'),
('188450','TG','susceptibility to, 3}, 608175 (3)'),
('188450','AITD3','Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease,'),
('188450','TDH3','Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease,'),
('188450','TG','Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease,'),
('188540','CHNG4','Hypothryoidism, congenital, nongoitrous 4, 275100 (3)'),
('188540','TSHB','Hypothryoidism, congenital, nongoitrous 4, 275100 (3)'),
('188545','TRHR','Thyrotropin-releasing hormone resistance, generalized (3)'),
('188826','SFD','Sorsby fundus dystrophy, 136900 (3)'),
('188826','TIMP3','Sorsby fundus dystrophy, 136900 (3)'),
('188830','ACRDYS1','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','CAR','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','CNC1','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','PPNAD1','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','PRKAR1A','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','TSE1','(3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)'),
('188830','ACRDYS1','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','CAR','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','CNC1','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','PPNAD1','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','PRKAR1A','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','TSE1','Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);'),
('188830','ACRDYS1','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188830','CAR','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188830','CNC1','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188830','PPNAD1','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188830','PRKAR1A','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188830','TSE1','Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic,'),
('188840','CMD1G','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','EOMFC','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','HMERF','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','LGMD2J','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','MPRM','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','TMD','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','TTN','Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,'),
('188840','CMD1G','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','EOMFC','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','HMERF','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','LGMD2J','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','MPRM','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','TMD','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','TTN','dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal,'),
('188840','CMD1G','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','EOMFC','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','HMERF','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','LGMD2J','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','MPRM','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','TMD','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('188840','TTN','with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)'),
('189800','PEE1','Preeclampsia/eclampsia 1 (2)'),
('189800','PREG1','Preeclampsia/eclampsia 1 (2)'),
('189907','FJHN','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','HNF1B','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','HNF2','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','HPC11','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','MODY5','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','TCF2','noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)'),
('189907','FJHN','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189907','HNF1B','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189907','HNF2','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189907','HPC11','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189907','MODY5','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189907','TCF2','Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,'),
('189909','FECD6','Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal'),
('189909','NIL2A','Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal'),
('189909','PPCD3','Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal'),
('189909','TCF8','Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal'),
('189909','ZEB1','Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal'),
('189909','FECD6','dystrophy, Fuchs endothelial, 6, 613270 (3)'),
('189909','NIL2A','dystrophy, Fuchs endothelial, 6, 613270 (3)'),
('189909','PPCD3','dystrophy, Fuchs endothelial, 6, 613270 (3)'),
('189909','TCF8','dystrophy, Fuchs endothelial, 6, 613270 (3)'),
('189909','ZEB1','dystrophy, Fuchs endothelial, 6, 613270 (3)'),
('189967','REF1','Sveinsson choreoretinal atrophy, 108985 (3)'),
('189967','TCF13','Sveinsson choreoretinal atrophy, 108985 (3)'),
('189967','TEAD1','Sveinsson choreoretinal atrophy, 108985 (3)'),
('189980','ABL1','Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)'),
('189990','MYB','{T-cell acute lymphoblastic leukemia} (3)'),
('190000','TF','Atransferrinemia, 209300 (3)'),
('190000','TFQTL1','Atransferrinemia, 209300 (3)'),
('190020','HRAS','{Bladder cancer, somatic}, 109800 (3); Costello syndrome, 218040 (3);'),
('190020','HRAS','{Thyroid carcinoma, follicular, somatic}, 188470 (3)'),
('190040','PDGFB','Giant-cell fibroblastoma (3)'),
('190040','SIS','Giant-cell fibroblastoma (3)'),
('190040','PDGFB','Meningioma, SIS-related (3); Dermatofibrosarcoma protuberans (3);'),
('190040','SIS','Meningioma, SIS-related (3); Dermatofibrosarcoma protuberans (3);'),
('190070','KRAS','(3); Cardiofaciocutaneous syndrome, 115150 (3)'),
('190070','KRAS2','(3); Cardiofaciocutaneous syndrome, 115150 (3)'),
('190070','NS','(3); Cardiofaciocutaneous syndrome, 115150 (3)'),
('190070','RASK2','(3); Cardiofaciocutaneous syndrome, 115150 (3)'),
('190070','KRAS','Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer,'),
('190070','KRAS2','Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer,'),
('190070','NS','Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer,'),
('190070','RASK2','Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer,'),
('190070','KRAS','somatic, 114480 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, 137215 (3); Leukemia, acute myelogenous (3); Noonan syndrome 3, 609942'),
('190070','KRAS2','somatic, 114480 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, 137215 (3); Leukemia, acute myelogenous (3); Noonan syndrome 3, 609942'),
('190070','NS','somatic, 114480 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, 137215 (3); Leukemia, acute myelogenous (3); Noonan syndrome 3, 609942'),
('190070','RASK2','somatic, 114480 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, 137215 (3); Leukemia, acute myelogenous (3); Noonan syndrome 3, 609942'),
('190080','MYC','Burkitt lymphoma, 113970 (3)'),
('190090','ASV','Colon cancer, advanced (3)'),
('190090','SRC','Colon cancer, advanced (3)'),
('190090','SRC1','Colon cancer, advanced (3)'),
('190100','GSM1','Geniospasm (2)'),
('190100','GSP','Geniospasm (2)'),
('190120','CHNG6','Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)'),
('190120','ERBA1','Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)'),
('190120','THRA','Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)'),
('190120','THRA1','Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)'),
('190151','ERBB3','Lethal congenital contractural syndrome 2, 607598 (3)'),
('190151','LCCS2','Lethal congenital contractural syndrome 2, 607598 (3)'),
('190160','ERBA2','autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)'),
('190160','PRTH','autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)'),
('190160','THR1','autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)'),
('190160','THRB','autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)'),
('190160','ERBA2','Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance,'),
('190160','PRTH','Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance,'),
('190160','THR1','Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance,'),
('190160','THRB','Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance,'),
('190180','CED','Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung'),
('190180','DPD1','Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung'),
('190180','TGFB1','Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung'),
('190180','CED','disease, modifier of}, 219700 (3)'),
('190180','DPD1','disease, modifier of}, 219700 (3)'),
('190180','TGFB1','disease, modifier of}, 219700 (3)'),
('190181','AAT5','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','ALK5','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','LDS1A','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','LDS2A','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','MSSE','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','TGFBR1','Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,'),
('190181','AAT5','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190181','ALK5','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190181','LDS1A','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190181','LDS2A','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190181','MSSE','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190181','TGFBR1','type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)'),
('190182','AAT3','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','HNPCC6','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','LDS1B','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','LDS2B','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','MFS2','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','TGFBR2','Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);'),
('190182','AAT3','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190182','HNPCC6','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190182','LDS1B','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190182','LDS2B','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190182','MFS2','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190182','TGFBR2','Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)'),
('190195','ICR2','erythroderma, congenital, 242100 (3); Self-healing collodion baby, 242300 (3)'),
('190195','LI1','erythroderma, congenital, 242100 (3); Self-healing collodion baby, 242300 (3)'),
('190195','TGM1','erythroderma, congenital, 242100 (3); Self-healing collodion baby, 242300 (3)'),
('190195','ICR2','Ichthyosis, lamellar, autosomal recessive, 242300 (3); Ichthyosiform'),
('190195','LI1','Ichthyosis, lamellar, autosomal recessive, 242300 (3); Ichthyosiform'),
('190195','TGM1','Ichthyosis, lamellar, autosomal recessive, 242300 (3); Ichthyosiform'),
('190198','NOTCH1','Aortic valve disease, 109730 (3); Leukemia, T-cell acute'),
('190198','TAN1','Aortic valve disease, 109730 (3); Leukemia, T-cell acute'),
('190198','NOTCH1','lymphoblastic (2)'),
('190198','TAN1','lymphoblastic (2)'),
('190230','TGFB3','Arrhythmogenic right ventricular dysplasia 1, 107970 (3)'),
('190450','TPI1','Hemolytic anemia due to triosephosphate isomerase deficiency (3)'),
('190685','DCR','Down syndrome (4)'),
('190685','DSCR','Down syndrome (4)'),
('190990','AMCD1','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','DA1','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','DA2B','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','NEM4','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','TMSB','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','TPM2','Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);'),
('190990','AMCD1','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('190990','DA1','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('190990','DA2B','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('190990','NEM4','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('190990','TMSB','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('190990','TPM2','Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)'),
('191010','CMD1Y','Cardiomyopathy, familial hypertrophic, 3, 115196 (3); Cardiomyopathy,'),
('191010','CMH3','Cardiomyopathy, familial hypertrophic, 3, 115196 (3); Cardiomyopathy,'),
('191010','TPM1','Cardiomyopathy, familial hypertrophic, 3, 115196 (3); Cardiomyopathy,'),
('191010','CMD1Y','dilated, 1Y, 611878 (3)'),
('191010','CMH3','dilated, 1Y, 611878 (3)'),
('191010','TPM1','dilated, 1Y, 611878 (3)'),
('191030','CFTD','congenital, with fiber-type disproportion, 255310 (3); CAP myopathy, 609284 (3)'),
('191030','NEM1','congenital, with fiber-type disproportion, 255310 (3); CAP myopathy, 609284 (3)'),
('191030','TPM3','congenital, with fiber-type disproportion, 255310 (3); CAP myopathy, 609284 (3)'),
('191030','CFTD','Nemaline myopathy 1, autosomal dominant, 609284 (3); Myopathy,'),
('191030','NEM1','Nemaline myopathy 1, autosomal dominant, 609284 (3); Myopathy,'),
('191030','TPM3','Nemaline myopathy 1, autosomal dominant, 609284 (3); Myopathy,'),
('191040','CMD1Z','Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, familial'),
('191040','CMH13','Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, familial'),
('191040','TNNC1','Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, familial'),
('191040','CMD1Z','hypertrophic, 13, 613243 (3)'),
('191040','CMH13','hypertrophic, 13, 613243 (3)'),
('191040','TNNC1','hypertrophic, 13, 613243 (3)'),
('191041','ANM','Nemaline myopathy, Amish type, 605355 (3)'),
('191041','TNNT1','Nemaline myopathy, Amish type, 605355 (3)'),
('191043','AMCD2B','Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)'),
('191043','DA2B','Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)'),
('191043','FSSV','Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)'),
('191043','TNNI2','Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)'),
('191044','CMD1FF','Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,'),
('191044','CMD2A','Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,'),
('191044','CMH7','Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,'),
('191044','RCM1','Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,'),
('191044','TNNI3','Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,'),
('191044','CMD1FF','familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)'),
('191044','CMD2A','familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)'),
('191044','CMH7','familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)'),
('191044','RCM1','familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)'),
('191044','TNNI3','familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)'),
('191045','CMD1D','Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,'),
('191045','CMH2','Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,'),
('191045','LVNC6','Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,'),
('191045','RCM3','Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,'),
('191045','TNNT2','Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,'),
('191045','CMD1D','dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)'),
('191045','CMH2','dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)'),
('191045','LVNC6','dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)'),
('191045','RCM3','dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)'),
('191045','TNNT2','dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)'),
('191092','LAM','somatic, 606690 (3)'),
('191092','TSC2','somatic, 606690 (3)'),
('191092','LAM','Tuberous sclerosis-2, 191100 (3); Lymphangioleiomyomatosis,'),
('191092','TSC2','Tuberous sclerosis-2, 191100 (3); Lymphangioleiomyomatosis,'),
('191160','TNF','157300 (3)'),
('191160','TNFA','157300 (3)'),
('191160','TNF','susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to},'),
('191160','TNFA','susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to},'),
('191160','TNF','{Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock,'),
('191160','TNFA','{Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock,'),
('191170','LFS1','260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); Li-Fraumeni-like syndrome, 151623 (3)'),
('191170','P53','260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); Li-Fraumeni-like syndrome, 151623 (3)'),
('191170','TP53','260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); Li-Fraumeni-like syndrome, 151623 (3)'),
('191170','LFS1','Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3);'),
('191170','P53','Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3);'),
('191170','TP53','Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3);'),
('191170','LFS1','Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer,'),
('191170','P53','Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer,'),
('191170','TP53','Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer,'),
('191181','ST3','Cervical carcinoma (2)'),
('191190','FPF','Periodic fever, familial, 142680 (3)'),
('191190','TNFAR','Periodic fever, familial, 142680 (3)'),
('191190','TNFR1','Periodic fever, familial, 142680 (3)'),
('191190','TNFRSF1A','Periodic fever, familial, 142680 (3)'),
('191195','COT','Lung cancer, somatic, 211980 (3)'),
('191195','EST','Lung cancer, somatic, 211980 (3)'),
('191195','MAP3K8','Lung cancer, somatic, 211980 (3)'),
('191195','TPL2','Lung cancer, somatic, 211980 (3)'),
('191290','TH','Segawa syndrome, recessive, 605407 (3)'),
('191290','TYH','Segawa syndrome, recessive, 605407 (3)'),
('191305','BLK','Maturity-onset diabetes of the young, type 11, 613375 (3)'),
('191305','MODY11','Maturity-onset diabetes of the young, type 11, 613375 (3)'),
('191306','KDR','capillary infantile, susceptibility to}, 602089 (3)'),
('191306','KDR','Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma,'),
('191311','DDR2','Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)'),
('191311','NTRKR3','Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)'),
('191311','TKT','Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)'),
('191315','MTC','Insensitivity to pain, congenital, with anhidrosis, 256800 (3);'),
('191315','NTRK1','Insensitivity to pain, congenital, with anhidrosis, 256800 (3);'),
('191315','TRKA','Insensitivity to pain, congenital, with anhidrosis, 256800 (3);'),
('191315','MTC','Medullary thyroid carcinoma, familial, 155240 (3)'),
('191315','NTRK1','Medullary thyroid carcinoma, familial, 155240 (3)'),
('191315','TRKA','Medullary thyroid carcinoma, familial, 155240 (3)'),
('191330','QPC','Mitochondrial complex III deficiency, 124000 (3)'),
('191330','UQBP','Mitochondrial complex III deficiency, 124000 (3)'),
('191330','UQCRB','Mitochondrial complex III deficiency, 124000 (3)'),
('191339','UBB','Cleft palate, isolated, 119540 (2)'),
('191342','PARK5','{Parkinson disease 5, susceptibility to}, 613643 (3)'),
('191342','UCHL1','{Parkinson disease 5, susceptibility to}, 613643 (3)'),
('191350','CDG1J','Congenital disorder of glycosylation, type Ij, 608093 (3)'),
('191350','DGPT','Congenital disorder of glycosylation, type Ij, 608093 (3)'),
('191350','DPAGT2','Congenital disorder of glycosylation, type Ij, 608093 (3)'),
('191390','IBD11','{Inflammatory bowel disease 11} (2)'),
('191523','HYPLIP1','{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)'),
('191523','USF1','{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)'),
('191525','DGU','Immunodeficiency with hyper IgM, type 4, 608106 (3)'),
('191525','HIGM4','Immunodeficiency with hyper IgM, type 4, 608106 (3)'),
('191525','UNG','Immunodeficiency with hyper IgM, type 4, 608106 (3)'),
('191540','UOX','[Urate oxidase deficiency] (1)'),
('191740','BILIQTL1','143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transcient neonatal, 237900 (3); [Bilirubin, serum'),
('191740','GNT1','143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transcient neonatal, 237900 (3); [Bilirubin, serum'),
('191740','UGT1','143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transcient neonatal, 237900 (3); [Bilirubin, serum'),
('191740','UGT1A1','143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transcient neonatal, 237900 (3); [Bilirubin, serum'),
('191740','BILIQTL1','Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome],'),
('191740','GNT1','Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome],'),
('191740','UGT1','Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome],'),
('191740','UGT1A1','Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome],'),
('191740','BILIQTL1','level of, QTL1], 601816 (3)'),
('191740','GNT1','level of, QTL1], 601816 (3)'),
('191740','UGT1','level of, QTL1], 601816 (3)'),
('191740','UGT1A1','level of, QTL1], 601816 (3)'),
('191840','BDPLT5','Quebec platelet disorder, 601709 (3)'),
('191840','PLAU','Quebec platelet disorder, 601709 (3)'),
('191840','QPD','Quebec platelet disorder, 601709 (3)'),
('191840','URK','Quebec platelet disorder, 601709 (3)'),
('191840','BDPLT5','{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);'),
('191840','PLAU','{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);'),
('191840','QPD','{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);'),
('191840','URK','{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);'),
('191845','ADMCKD2','Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);'),
('191845','FJHN','Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);'),
('191845','HNFJ1','Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);'),
('191845','MCKD2','Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);'),
('191845','UMOD','Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);'),
('191845','ADMCKD2','Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)'),
('191845','FJHN','Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)'),
('191845','HNFJ1','Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)'),
('191845','MCKD2','Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)'),
('191845','UMOD','Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)'),
('192020','CC10','{Asthma, susceptibility to}, 600807 (3)'),
('192020','CCSP','{Asthma, susceptibility to}, 600807 (3)'),
('192020','SCGB1A1','{Asthma, susceptibility to}, 600807 (3)'),
('192020','UGB','{Asthma, susceptibility to}, 600807 (3)'),
('192090','CDH1','Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma,'),
('192090','ECAD','Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma,'),
('192090','LCAM','Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma,'),
('192090','UVO','Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma,'),
('192090','CDH1','somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3);'),
('192090','ECAD','somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3);'),
('192090','LCAM','somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3);'),
('192090','UVO','somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3);'),
('192090','CDH1','{Prostate cancer, susceptibility to}, 176807 (3)'),
('192090','ECAD','{Prostate cancer, susceptibility to}, 176807 (3)'),
('192090','LCAM','{Prostate cancer, susceptibility to}, 176807 (3)'),
('192090','UVO','{Prostate cancer, susceptibility to}, 176807 (3)'),
('192132','ATP6B1','Renal tubular acidosis with deafness, 267300 (3)'),
('192132','VPP3','Renal tubular acidosis with deafness, 267300 (3)'),
('192240','MVCD1','{Microvascular complications of diabetes 1}, 603933 (3)'),
('192240','VEGF','{Microvascular complications of diabetes 1}, 603933 (3)'),
('192340','AVP','Diabetes insipidus, neurohypophyseal, 125700 (3)'),
('192340','AVRP','Diabetes insipidus, neurohypophyseal, 125700 (3)'),
('192340','VP','Diabetes insipidus, neurohypophyseal, 125700 (3)'),
('192974','BDPLT9','?Glycoprotein Ia deficiency, 614200 (1)'),
('192974','BR','?Glycoprotein Ia deficiency, 614200 (1)'),
('192974','CD49B','?Glycoprotein Ia deficiency, 614200 (1)'),
('192974','ITGA2','?Glycoprotein Ia deficiency, 614200 (1)'),
('192977','CARMQ1','Cerebellar hypoplasia and mental retardation with or without'),
('192977','VLDLR','Cerebellar hypoplasia and mental retardation with or without'),
('192977','CARMQ1','quadrupedal locomotion 1, 224050 (3)'),
('192977','VLDLR','quadrupedal locomotion 1, 224050 (3)'),
('193000','VUR','Vesicoureteral reflux (2)'),
('193003','NYS4','Nystagmus 4, congenital (2)'),
('193007','BPPV','Vestibulopathy, familial (2)'),
('193040','VIL1','Cholestasis, progressive canalicular (1)'),
('193060','VIM','Cataract, pulverulent, autosomal dominant (3)'),
('193065','CMD1W','Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, familial'),
('193065','CMH15','Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, familial'),
('193065','VCL','Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, familial'),
('193065','CMD1W','hypertrophic, 15, 613255 (3)'),
('193065','CMH15','hypertrophic, 15, 613255 (3)'),
('193065','VCL','hypertrophic, 15, 613255 (3)'),
('193200','VAMAS6','{Vitiligo-associated multiple autoimmune disease susceptiblity 6} (2)'),
('193235','VRNI','Vitreoretinopathy, neovascular inflammatory (2)'),
('194050','C7DELq11','Williams-Beuren syndrome (4)'),
('194050','DEL7q11','Williams-Beuren syndrome (4)'),
('194050','WBS','Williams-Beuren syndrome (4)'),
('194050','WMS','Williams-Beuren syndrome (4)'),
('194050','WS','Williams-Beuren syndrome (4)'),
('194072','C11DELp13','syndrome (4)'),
('194072','DEL11p13','syndrome (4)'),
('194072','WAGR','syndrome (4)'),
('194072','C11DELp13','Wilms tumor, aniridia, genitourinary anomalies and mental retardation'),
('194072','DEL11p13','Wilms tumor, aniridia, genitourinary anomalies and mental retardation'),
('194072','WAGR','Wilms tumor, aniridia, genitourinary anomalies and mental retardation'),
('194090','WT3','Wilms tumor, type 3 (2)'),
('194190','WHS','Wolf-Hirschhorn syndrome (4)'),
('194355','XBP1','{Major affective disorder-7, susceptibility to}, 612371 (3)'),
('194355','XBP2','{Major affective disorder-7, susceptibility to}, 612371 (3)'),
('194380','DHS','Dehydrated hereditary stomatocytosis (2); Pseudohyperkalemia,'),
('194380','DHS','familial, 177720 (2); Dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema, 603528 (2)'),
('200350','ACAC','Acetyl-CoA carboxylase deficiency, 613933 (1)'),
('200350','ACACA','Acetyl-CoA carboxylase deficiency, 613933 (1)'),
('200350','ACACAD','Acetyl-CoA carboxylase deficiency, 613933 (1)'),
('200350','ACC1','Acetyl-CoA carboxylase deficiency, 613933 (1)'),
('203650','APMR1','Alopecia with mental retardation syndrome 1 (2)'),
('208100','AMCN','Arthrogryposis multiplex congenita, neurogenic (2)'),
('208100','AMCN1','Arthrogryposis multiplex congenita, neurogenic (2)'),
('208500','ATD1','Asphyxiating thoracic dystrophy 1 (2)'),
('209850','AUTS1','{Autism susceptibility 1} (2)'),
('209901','BBS1','Bardet-Biedl syndrome 1, 209900 (3)'),
('211100','FUT1','[Bombay phenotype] (3)'),
('211100','H','[Bombay phenotype] (3)'),
('211100','HH','[Bombay phenotype] (3)'),
('212200','CNSN','Carnosinemia (2)'),
('213200','CPD3','Spinocerebellar ataxia, autosomal recessive 2 (2)'),
('213200','SCAR2','Spinocerebellar ataxia, autosomal recessive 2 (2)'),
('213600','IBGC1','Basal ganglia calcification, idiopathic (2)'),
('214300','KFM','?Klippel-Feil syndrome 2, autosomal recessive (2)'),
('214300','KFS2','?Klippel-Feil syndrome 2, autosomal recessive (2)'),
('214900','CHLS','Cholestasis-lymphedema syndrome (2)'),
('214900','LCS1','Cholestasis-lymphedema syndrome (2)'),
('215400','CHDM','{Chordoma, susceptibility to} (4)'),
('215500','CACD1','Choroidal dystrophy, central areolar 1 (2)'),
('217030','AHUS3','Complement factor I deficiency, 610984 (3); {Hemolytic uremic'),
('217030','CFI','Complement factor I deficiency, 610984 (3); {Hemolytic uremic'),
('217030','FI','Complement factor I deficiency, 610984 (3); {Hemolytic uremic'),
('217030','AHUS3','syndrome, atypical, susceptibility to, 3}, 612923 (3)'),
('217030','CFI','syndrome, atypical, susceptibility to, 3}, 612923 (3)'),
('217030','FI','syndrome, atypical, susceptibility to, 3}, 612923 (3)'),
('217050','C6','C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)'),
('217070','C7','C7 deficiency, 610102 (3)'),
('218400','CMDR','Craniometaphyseal dysplasia, autosomal recessive (2)'),
('220200','C3DELq22q24','Dandy-Walker syndrome (4)'),
('220200','DEL3q22q24','Dandy-Walker syndrome (4)'),
('220200','DWS','Dandy-Walker syndrome (4)'),
('221820','GPSC','Gliosis, familial progressive subcortical (2)'),
('221900','NCRNA','Retinal nonattachment, nonsyndromic congenital (2)'),
('221900','RNANC','Retinal nonattachment, nonsyndromic congenital (2)'),
('222100','IDDM1','{Diabetes mellitus, insulin-dependent-1} (2)'),
('222400','DIH2','Hernia, congenital diaphragmatic 2 (2)'),
('222745','DECR1','?DECR deficiency (2)'),
('227050','TEC','Transient erythroblastopenia of childhood (2)'),
('229000','KLK3','Fletcher factor deficiency, 612423 (3)'),
('229000','KLKB1','Fletcher factor deficiency, 612423 (3)'),
('231675','ETFDH','Glutaric acidemia IIC, 231680 (3)'),
('231675','MADD','Glutaric acidemia IIC, 231680 (3)'),
('231950','GGT1','Glutathioninuria (1)'),
('231950','GTG','Glutathioninuria (1)'),
('232000','PCCA','Propionicacidemia, 606054 (3)'),
('232050','PCCB','Propionicacidemia, 606054 (3)'),
('235000','HHP','Hemihypertrophy (2)'),
('235000','IH','Hemihypertrophy (2)'),
('236100','HPE1','Holoprosencephaly-1 (2)'),
('238300','GCE','Glycine encephalopathy, 605899 (3)'),
('238300','GCSP','Glycine encephalopathy, 605899 (3)'),
('238300','GLDC','Glycine encephalopathy, 605899 (3)'),
('238300','HYGN1','Glycine encephalopathy, 605899 (3)'),
('238300','NKH','Glycine encephalopathy, 605899 (3)'),
('238310','AMT','Glycine encephalopathy, 605899 (3)'),
('238310','GCE','Glycine encephalopathy, 605899 (3)'),
('238310','NKH','Glycine encephalopathy, 605899 (3)'),
('238330','GCSH','Glycine encephalopathy, 605899 (3)'),
('238330','NKH','Glycine encephalopathy, 605899 (3)'),
('238331','DLD','256000 (3)'),
('238331','LAD','256000 (3)'),
('238331','PHE3','256000 (3)'),
('238331','DLD','Maple syrup urine disease, type III, 248600 (3); Leigh syndrome,'),
('238331','LAD','Maple syrup urine disease, type III, 248600 (3); Leigh syndrome,'),
('238331','PHE3','Maple syrup urine disease, type III, 248600 (3); Leigh syndrome,'),
('240400','GULO','Scurvy (3)'),
('240400','GULOP','Scurvy (3)'),
('243305','INV','Nephronophthisis 2, infantile, 602088 (3)'),
('243305','INVS','Nephronophthisis 2, infantile, 602088 (3)'),
('243305','NPH2','Nephronophthisis 2, infantile, 602088 (3)'),
('243305','NPHP2','Nephronophthisis 2, infantile, 602088 (3)'),
('246530','LTC4S','Leukotriene C4 synthase deficiency, 614037 (1)'),
('246560','C10DUPq24','Split-hand/foot malformation 3, gene duplication syndrome (4)'),
('246560','DUP10q24','Split-hand/foot malformation 3, gene duplication syndrome (4)'),
('246560','SHFM3','Split-hand/foot malformation 3, gene duplication syndrome (4)'),
('246560','SHSF3','Split-hand/foot malformation 3, gene duplication syndrome (4)'),
('246600','PNLIP','Pancreatic lipase deficiency, 614338 (1)'),
('246600','PNLIPD','Pancreatic lipase deficiency, 614338 (1)'),
('247200','C17DELp13.3','Miller-Dieker lissencephaly syndrome (4)'),
('247200','DEL17p13.3','Miller-Dieker lissencephaly syndrome (4)'),
('247200','MDCR','Miller-Dieker lissencephaly syndrome (4)'),
('247200','MDLS','Miller-Dieker lissencephaly syndrome (4)'),
('247200','MDS','Miller-Dieker lissencephaly syndrome (4)'),
('247640','LALL','Leukemia, acute lymphoblastic (2)'),
('248310','PFBI','{Malaria, intensity of infection} (2)'),
('248610','BCATE2','Maple syrup urine disease, type II, 248600 (3)'),
('248610','DBT','Maple syrup urine disease, type II, 248600 (3)'),
('248611','BCKDHB','Maple syrup urine disease, type Ib, 248600 (3)'),
('248611','E1B','Maple syrup urine disease, type Ib, 248600 (3)'),
('251170','MVK','Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3)'),
('251170','MVLK','Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3)'),
('251600','MCOP1','Microphthalmia, isolated 1 (2)'),
('252270','C7DELq','Myelodysplasia and leukemia syndrome with monosomy 7 (4)'),
('252270','DEL7q','Myelodysplasia and leukemia syndrome with monosomy 7 (4)'),
('252270','MLSM7','Myelodysplasia and leukemia syndrome with monosomy 7 (4)'),
('252350','MYMY','Moyamoya disease (2)'),
('252350','MYMY1','Moyamoya disease (2)'),
('252800','IDA','607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)'),
('252800','IDUA','607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)'),
('252800','IDA','Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is,'),
('252800','IDUA','Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is,'),
('255160','MHB','Myopathy, hyaline body (2)'),
('255500','MYP18','Myopia 18 (2)'),
('257550','COMA','Oculomotor apraxia, congenital, Cogan-type (2)'),
('258500','OPA6','Optic atrophy 6 (2)'),
('259450','BRKS1','Bruck syndrome 1 (2)'),
('261800','PRBNS','Pierre Robin syndrome (2)'),
('264900','F11','deficiency, autosomal dominant, 612416 (3)'),
('264900','F11','Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI'),
('267700','FHL1','Hemophagocytic lymphohistiocytosis, familial, 1 (2)'),
('267700','HLH1','Hemophagocytic lymphohistiocytosis, familial, 1 (2)'),
('267700','HPLH1','Hemophagocytic lymphohistiocytosis, familial, 1 (2)'),
('271250','SCABD','Spinocerebellar ataxia, autosomal recessive 3 (2)'),
('271250','SCAR3','Spinocerebellar ataxia, autosomal recessive 3 (2)'),
('273300','MGCT','Male germ cell tumor (2)'),
('274180','BDPLT14','deficiency, 614158 (1)'),
('274180','CYP5','deficiency, 614158 (1)'),
('274180','GHOSAL','deficiency, 614158 (1)'),
('274180','TBXAS1','deficiency, 614158 (1)'),
('274180','BDPLT14','Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase'),
('274180','CYP5','Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase'),
('274180','GHOSAL','Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase'),
('274180','TBXAS1','Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase'),
('275000','GRD1','{Graves disease, susceptibility to, 1} (2)'),
('275220','THM','?Tibial hemimelia (2)'),
('275360','TREH','Trehalase deficiency, 612119 (1)'),
('276000','PRSS1','Pancreatitis, hereditary, 167800 (3);'),
('276000','TRY1','Pancreatitis, hereditary, 167800 (3);'),
('276000','PRSS1','Trypsinogen deficiency, 614044 (1)'),
('276000','TRY1','Trypsinogen deficiency, 614044 (1)'),
('276903','DFNA11','600060 (3); Deafness, autosomal dominant 11, 601317 (3)'),
('276903','DFNB2','600060 (3); Deafness, autosomal dominant 11, 601317 (3)'),
('276903','MYO7A','600060 (3); Deafness, autosomal dominant 11, 601317 (3)'),
('276903','USH1B','600060 (3); Deafness, autosomal dominant 11, 601317 (3)'),
('276903','DFNA11','Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2,'),
('276903','DFNB2','Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2,'),
('276903','MYO7A','Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2,'),
('276903','USH1B','Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2,'),
('278850','DEL17q24.3','46XX sex reversal 2, 278850 (4)'),
('278850','DUP17q24.3','46XX sex reversal 2, 278850 (4)'),
('278850','SRXX2','46XX sex reversal 2, 278850 (4)'),
('300005','AUTSX3','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','MECP2','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','MRX16','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','MRX79','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','MRXS13','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','MRXSL','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','PPMX','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','RTT','13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked'),
('300005','AUTSX3','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','MECP2','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','MRX16','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','MRX79','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','MRXS13','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','MRXSL','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','PPMX','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','RTT','3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)'),
('300005','AUTSX3','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','MECP2','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','MRX16','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','MRX79','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','MRXS13','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','MRXSL','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','PPMX','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300005','RTT','Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic'),
('300008','CLCK2','Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);'),
('300008','CLCN5','Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);'),
('300008','DENTS','Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);'),
('300008','NPHL1','Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);'),
('300008','NPHL2','Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);'),
('300008','CLCK2','Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)'),
('300008','CLCN5','Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)'),
('300008','DENTS','Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)'),
('300008','NPHL1','Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)'),
('300008','NPHL2','Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)'),
('300011','ATP7A','Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);'),
('300011','MK','Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);'),
('300011','MNK','Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);'),
('300011','OHS','Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);'),
('300011','SMAX3','Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);'),
('300011','ATP7A','Spinal muscular atrophy, distal, X-linked 3, 300489 (3)'),
('300011','MK','Spinal muscular atrophy, distal, X-linked 3, 300489 (3)'),
('300011','MNK','Spinal muscular atrophy, distal, X-linked 3, 300489 (3)'),
('300011','OHS','Spinal muscular atrophy, distal, X-linked 3, 300489 (3)'),
('300011','SMAX3','Spinal muscular atrophy, distal, X-linked 3, 300489 (3)'),
('300013','ARD1','N-terminal acetyltransferase deficiency, 300855 (3)'),
('300013','ARD1A','N-terminal acetyltransferase deficiency, 300855 (3)'),
('300013','NAA10','N-terminal acetyltransferase deficiency, 300855 (3)'),
('300013','NATD','N-terminal acetyltransferase deficiency, 300855 (3)'),
('300013','TE2','N-terminal acetyltransferase deficiency, 300855 (3)'),
('300017','CVD1','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','FLN1','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','FLNA','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','FMD','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','MNS','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','NHBP','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','OPD1','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','OPD2','Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, '),
('300017','CVD1','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','FLN1','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','FLNA','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','FMD','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','MNS','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','NHBP','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','OPD1','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','OPD2','Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,'),
('300017','CVD1','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','FLN1','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','FLNA','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','FMD','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','MNS','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','NHBP','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','OPD1','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300017','OPD2','type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);'),
('300030','DFN4','Deafness, X-linked 3 (2)'),
('300030','DFNX3','Deafness, X-linked 3 (2)'),
('300032','ATRX','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','MRXHF1','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','SFM1','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','SHS','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','XH2','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','XNP','Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)'),
('300032','ATRX','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300032','MRXHF1','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300032','SFM1','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300032','SHS','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300032','XH2','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300032','XNP','Alpha-thalassemia/mental retardation syndrome, 301040 (3);'),
('300034','AGTR2','Mental retardation, X-linked 88, 300852 (3)'),
('300034','MRX88','Mental retardation, X-linked 88, 300852 (3)'),
('300035','CFND','Craniofrontonasal dysplasia, 304110 (3)'),
('300035','CFNS','Craniofrontonasal dysplasia, 304110 (3)'),
('300035','EFNB1','Craniofrontonasal dysplasia, 304110 (3)'),
('300035','EPLG2','Craniofrontonasal dysplasia, 304110 (3)'),
('300036','CRTR','Creatine deficiency syndrome, X-linked, 300352 (3)'),
('300036','SLC6A8','Creatine deficiency syndrome, X-linked, 300352 (3)'),
('300037','GPC3','Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor,'),
('300037','SDYS','Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor,'),
('300037','SGBS1','Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor,'),
('300037','GPC3','somatic, 194070 (3)'),
('300037','SDYS','somatic, 194070 (3)'),
('300037','SGBS1','somatic, 194070 (3)'),
('300039','DFN3','Deafness, X-linked 2, 304400 (3)'),
('300039','DFNX2','Deafness, X-linked 2, 304400 (3)'),
('300039','POU3F4','Deafness, X-linked 2, 304400 (3)'),
('300040','CDLS2','Cornelia de Lange syndrome 2, 300590 (3)'),
('300040','DXS423E','Cornelia de Lange syndrome 2, 300590 (3)'),
('300040','SMC1','Cornelia de Lange syndrome 2, 300590 (3)'),
('300046','MRX23','Mental retardation, X-linked 23 (2)'),
('300047','MRX20','Mental retardation, X-linked 20 (2)'),
('300056','HCCS','Microphthalmia, syndromic 7, 309801 (3)'),
('300056','MCOPS7','Microphthalmia, syndromic 7, 309801 (3)'),
('300062','MRX14','Mental retardation, X-linked 14 (2)'),
('300075','MRX19','19, 300844 (3)'),
('300075','RPS6KA3','19, 300844 (3)'),
('300075','RSK2','19, 300844 (3)'),
('300075','MRX19','Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked'),
('300075','RPS6KA3','Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked'),
('300075','RSK2','Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked'),
('300076','INDX','Wood neuroimmunologic syndrome (2)'),
('300077','MRX29','Mental retardation, X-linked 29 (2)'),
('300078','MWFE','Mitochondrial complex I deficiency, 252010 (3)'),
('300078','NDUFA1','Mitochondrial complex I deficiency, 252010 (3)'),
('300079','API3','Lymphoproliferative syndrome, X-linked, 2, 300635 (3)'),
('300079','BIRC4','Lymphoproliferative syndrome, X-linked, 2, 300635 (3)'),
('300079','XIAP','Lymphoproliferative syndrome, X-linked, 2, 300635 (3)'),
('300079','XLP2','Lymphoproliferative syndrome, X-linked, 2, 300635 (3)'),
('300080','DXS8237E','TARP syndrome, 311900 (3)'),
('300080','KIAA0122','TARP syndrome, 311900 (3)'),
('300080','RBM10','TARP syndrome, 311900 (3)'),
('300080','TARPS','TARP syndrome, 311900 (3)'),
('300082','CGF1','[Social cognition] (2)'),
('300085','COD2','Cone dystrophy, progressive X-linked, 2 (2)'),
('300095','DXS128','Allan-Herndon-Dudley syndrome, 300523 (3)'),
('300095','SLC16A2','Allan-Herndon-Dudley syndrome, 300523 (3)'),
('300095','XPCT','Allan-Herndon-Dudley syndrome, 300523 (3)'),
('300096','A15','Mental retardation, X-linked 58, 300210 (3)'),
('300096','MRX58','Mental retardation, X-linked 58, 300210 (3)'),
('300096','MXS1','Mental retardation, X-linked 58, 300210 (3)'),
('300096','TM4SF2','Mental retardation, X-linked 58, 300210 (3)'),
('300096','TSPAN7','Mental retardation, X-linked 58, 300210 (3)'),
('300104','GDI1','Mental retardation, X-linked 41, 300849 (3)'),
('300104','MRX41','Mental retardation, X-linked 41, 300849 (3)'),
('300104','MRX48','Mental retardation, X-linked 41, 300849 (3)'),
('300104','RABGD1A','Mental retardation, X-linked 41, 300849 (3)'),
('300105','MRSR','Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)'),
('300105','SMS','Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)'),
('300105','SRS','Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)'),
('300108','DIA','Premature ovarian failure, 300511 (3)'),
('300108','DIAPH2','Premature ovarian failure, 300511 (3)'),
('300108','POF2','Premature ovarian failure, 300511 (3)'),
('300110','AIED','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','CACNA1F','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','CORDX3','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','CSNB2','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','CSNB2A','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','OA2','(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)'),
('300110','AIED','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300110','CACNA1F','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300110','CORDX3','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300110','CSNB2','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300110','CSNB2A','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300110','OA2','Night blindness, congenital stationary, X-linked, type 2A, 300071'),
('300114','MRX49','Mental retardation, X-linked 49 (2)'),
('300115','MRX50','Mental retardation, X-linked 50 (2)'),
('300120','CXorf6','Hypospadias 2, X-linked, 300758 (3)'),
('300120','F18','Hypospadias 2, X-linked, 300758 (3)'),
('300120','HYSP2','Hypospadias 2, X-linked, 300758 (3)'),
('300120','MAMLD1','Hypospadias 2, X-linked, 300758 (3)'),
('300121','DBCN','heteropia, X-linked, 300067 (3)'),
('300121','DCX','heteropia, X-linked, 300067 (3)'),
('300121','LISX','heteropia, X-linked, 300067 (3)'),
('300121','DBCN','Lissencephaly, X-linked, 300067 (3); Subcortical laminal'),
('300121','DCX','Lissencephaly, X-linked, 300067 (3); Subcortical laminal'),
('300121','LISX','Lissencephaly, X-linked, 300067 (3); Subcortical laminal'),
('300125','MGR2','{Migraine, familial typical, susceptibility to, 2} (2)'),
('300126','DKC1','Dyskeratosis congenita, X-linked, 305000 (3);'),
('300126','DKCX','Dyskeratosis congenita, X-linked, 305000 (3);'),
('300126','DKC1','Hoyeraal-Hreidarsson syndrome, 300240 (3)'),
('300126','DKCX','Hoyeraal-Hreidarsson syndrome, 300240 (3)'),
('300127','MRX60','distinctive facial appearance, 300486 (3)'),
('300127','OPHN1','distinctive facial appearance, 300486 (3)'),
('300127','MRX60','Mental retardation, X-linked, with cerebellar hypoplasia and'),
('300127','OPHN1','Mental retardation, X-linked, with cerebellar hypoplasia and'),
('300128','KABUK2','Kabuki syndrome 2, 300867 (3)'),
('300128','KDM6A','Kabuki syndrome 2, 300867 (3)'),
('300128','UTX','Kabuki syndrome 2, 300867 (3)'),
('300135','ABC7','Anemia, sideroblastic, with ataxia, 301310 (3)'),
('300135','ABCB7','Anemia, sideroblastic, with ataxia, 301310 (3)'),
('300135','ASAT','Anemia, sideroblastic, with ataxia, 301310 (3)'),
('300136','IDDMX','{Diabetes mellitus, insulin-dependent, X-linked} (2)'),
('300139','IGBP1','coloboma and micrognathia, 300472 (3)'),
('300139','IGBP1','Corpus callosum, agenesis of, with mental retardation, ocular'),
('300142','MRX30','Mental retardation, X-linked 30/47, 300558 (3)'),
('300142','MRX47','Mental retardation, X-linked 30/47, 300558 (3)'),
('300142','PAK3','Mental retardation, X-linked 30/47, 300558 (3)'),
('300145','XPNPEP2','{Angioedema induced by ACE inhibitors, susceptibility to} (3)'),
('300147','HPCX1','{Prostate cancer, hereditary, X-linked 1} (2)'),
('300148','MEHMO','MEHMO syndrome (2)'),
('300155','RP24','Retinitis pigmentosa 24 (2)'),
('300157','ACS4','Mental retardation, X-linked 63, 300387 (3)'),
('300157','ACSL4','Mental retardation, X-linked 63, 300387 (3)'),
('300157','FACL4','Mental retardation, X-linked 63, 300387 (3)'),
('300157','MRX63','Mental retardation, X-linked 63, 300387 (3)'),
('300163','FHL1','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','FHL1A','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','FHL1B','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','KYOT','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','SLIM1','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','XMPMA','childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)'),
('300163','FHL1','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','FHL1A','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','FHL1B','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','KYOT','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','SLIM1','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','XMPMA','Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,'),
('300163','FHL1','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300163','FHL1A','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300163','FHL1B','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300163','KYOT','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300163','SLIM1','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300163','XMPMA','X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,'),
('300169','AIF','Combined oxidative phosphorylation deficiency 6, 300816 (3)'),
('300169','AIFM1','Combined oxidative phosphorylation deficiency 6, 300816 (3)'),
('300169','COXPD6','Combined oxidative phosphorylation deficiency 6, 300816 (3)'),
('300169','PDCD8','Combined oxidative phosphorylation deficiency 6, 300816 (3)'),
('300170','CXorf5','Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel'),
('300170','JBTS10','Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel'),
('300170','OFD1','Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel'),
('300170','SGBS2','Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel'),
('300170','CXorf5','syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)'),
('300170','JBTS10','syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)'),
('300170','OFD1','syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)'),
('300170','SGBS2','syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)'),
('300172','CASK','hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)'),
('300172','CMG','hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)'),
('300172','FGS4','hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)'),
('300172','MICPCH','hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)'),
('300172','MRXSNA','hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)'),
('300172','CASK','Mental retardation and microcephaly with pontine and cerebellar'),
('300172','CMG','Mental retardation and microcephaly with pontine and cerebellar'),
('300172','FGS4','Mental retardation and microcephaly with pontine and cerebellar'),
('300172','MICPCH','Mental retardation and microcephaly with pontine and cerebellar'),
('300172','MRXSNA','Mental retardation and microcephaly with pontine and cerebellar'),
('300179','SXI2','X inactivation, familial skewed, 2 (2)'),
('300180','ARSE','Chondrodysplasia punctata, X-linked recessive, 302950 (3)'),
('300180','CDPX1','Chondrodysplasia punctata, X-linked recessive, 302950 (3)'),
('300180','CDPXR','Chondrodysplasia punctata, X-linked recessive, 302950 (3)'),
('300188','FGS1','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','HOPA','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','KIAA0192','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','MED12','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','OKS','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','TNRC11','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300188','TRAP230','Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)'),
('300189','DLG3','Mental retardation, X-linked 90, 300850 (3)'),
('300189','MRX90','Mental retardation, X-linked 90, 300850 (3)'),
('300189','NEDLG','Mental retardation, X-linked 90, 300850 (3)'),
('300189','SAP102','Mental retardation, X-linked 90, 300850 (3)'),
('300192','SSX2','Sarcoma, synovial (3)'),
('300194','AMMEC','Alport syndrome, mental retardation, midface hypoplasia, and'),
('300194','CXDELq22.3','Alport syndrome, mental retardation, midface hypoplasia, and'),
('300194','DELXq22.3','Alport syndrome, mental retardation, midface hypoplasia, and'),
('300194','AMMEC','elliptocytosis (4)'),
('300194','CXDELq22.3','elliptocytosis (4)'),
('300194','DELXq22.3','elliptocytosis (4)'),
('300202','SEDL','Spondyloepiphyseal dysplasia tarda, 313400 (3)'),
('300202','SEDT','Spondyloepiphyseal dysplasia tarda, 313400 (3)'),
('300202','TRAPPC2','Spondyloepiphyseal dysplasia tarda, 313400 (3)'),
('300203','CDKL5','Angelman syndrome-like, 105830 (3)'),
('300203','EIEE2','Angelman syndrome-like, 105830 (3)'),
('300203','ISSX','Angelman syndrome-like, 105830 (3)'),
('300203','STK9','Angelman syndrome-like, 105830 (3)'),
('300203','CDKL5','Epileptic encephalopathy, early infantile, 2, 300672 (3);'),
('300203','EIEE2','Epileptic encephalopathy, early infantile, 2, 300672 (3);'),
('300203','ISSX','Epileptic encephalopathy, early infantile, 2, 300672 (3);'),
('300203','STK9','Epileptic encephalopathy, early infantile, 2, 300672 (3);'),
('300205','CDPX2','Chondrodysplasia punctata, X-linked dominant, 302960 (3)'),
('300205','CPX','Chondrodysplasia punctata, X-linked dominant, 302960 (3)'),
('300205','CPXD','Chondrodysplasia punctata, X-linked dominant, 302960 (3)'),
('300205','EBP','Chondrodysplasia punctata, X-linked dominant, 302960 (3)'),
('300206','IL1R8','Mental retardation, X-linked 21/34, 300143 (3)'),
('300206','IL1RAPL1','Mental retardation, X-linked 21/34, 300143 (3)'),
('300206','MRX21','Mental retardation, X-linked 21/34, 300143 (3)'),
('300206','MRX34','Mental retardation, X-linked 21/34, 300143 (3)'),
('300211','EMWX','Episodic muscle weakness, X-linked (2)'),
('300218','MRXS7','Mental retardation, X-linked syndromic 7 (2)'),
('300221','HDPA','{Hodgkin disease susceptibility, pseudoautosomal} (2)'),
('300226','DFNX4','Deafness, X-linked 4, 300066 (3)'),
('300226','SMPX','Deafness, X-linked 4, 300066 (3)'),
('300228','TGCT1','Testicular germ cell tumor (2)'),
('300231','NHE6','Mental retardation, X-linked syndromic, Christianson type, 300243 (3)'),
('300231','SLC9A6','Mental retardation, X-linked syndromic, Christianson type, 300243 (3)'),
('300238','MRXS11','Mental retardation, X-linked syndromic, Shashi type (2)'),
('300238','SMRXS','Mental retardation, X-linked syndromic, Shashi type (2)'),
('300245','PTOS2','Ptosis, hereditary congenital 2 (2)'),
('300245','PTOSX','Ptosis, hereditary congenital 2 (2)'),
('300247','BMP15','300510 (3)'),
('300247','GDF9B','300510 (3)'),
('300247','ODG2','300510 (3)'),
('300247','POF4','300510 (3)'),
('300247','BMP15','Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4,'),
('300247','GDF9B','Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4,'),
('300247','ODG2','Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4,'),
('300247','POF4','Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4,'),
('300248','AMCBX1','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','FIP3','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','IKBKG','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','IP2','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','IPD2','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','NEMO','hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,'),
('300248','AMCBX1','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','FIP3','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','IKBKG','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','IP2','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','IPD2','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','NEMO','Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,'),
('300248','AMCBX1','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300248','FIP3','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300248','IKBKG','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300248','IP2','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300248','IPD2','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300248','NEMO','isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)'),
('300256','DUPXp11.22','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','ERAB','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','HADH2','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','HSD17B10','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','MRX17','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','MRX31','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','MRXS10','17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);'),
('300256','DUPXp11.22','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','ERAB','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','HADH2','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','HSD17B10','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','MRX17','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','MRX31','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300256','MRXS10','Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)'),
('300258','RFMN','Roifman syndrome (2)'),
('300261','MRXSA','Mental retardation syndrome, X-linked, Armfield type (2)'),
('300262','MRXSAB','Mental retardation, X-linked syndromic, Abidi type (2)'),
('300264','ALS15','Amyotrophic lateral sclerosis 15, with or without frontotemporal'),
('300264','CHAP1','Amyotrophic lateral sclerosis 15, with or without frontotemporal'),
('300264','PLIC2','Amyotrophic lateral sclerosis 15, with or without frontotemporal'),
('300264','UBQLN2','Amyotrophic lateral sclerosis 15, with or without frontotemporal'),
('300264','ALS15','dementia, 300857 (3)'),
('300264','CHAP1','dementia, 300857 (3)'),
('300264','PLIC2','dementia, 300857 (3)'),
('300264','UBQLN2','dementia, 300857 (3)'),
('300265','HTX','defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)'),
('300265','HTX1','defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)'),
('300265','VACTERLX','defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)'),
('300265','ZIC3','defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)'),
('300265','HTX','Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart'),
('300265','HTX1','Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart'),
('300265','VACTERLX','Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart'),
('300265','ZIC3','Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart'),
('300266','SPG16','Spastic paraplegia 16, X-linked, complicated (2)'),
('300267','ARHGEF6','Mental retardation, X-linked 46, 300436 (3)'),
('300267','COOL2','Mental retardation, X-linked 46, 300436 (3)'),
('300267','MRX46','Mental retardation, X-linked 46, 300436 (3)'),
('300273','MNG2','Goiter, multinodular, 2 (2)'),
('300275','NSDHL','CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)'),
('300278','CSNB1A','Night blindness, congenital stationary, type 1A, 310500 (3)'),
('300278','NBM1','Night blindness, congenital stationary, type 1A, 310500 (3)'),
('300278','NYX','Night blindness, congenital stationary, type 1A, 310500 (3)'),
('300290','IMAGE','IMAGE syndrome (2)'),
('300292','AIID','304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)'),
('300292','FOXP3','304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)'),
('300292','IPEX','304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)'),
('300292','PIDX','304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)'),
('300292','XPID','304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)'),
('300292','AIID','Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,'),
('300292','FOXP3','Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,'),
('300292','IPEX','Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,'),
('300292','PIDX','Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,'),
('300292','XPID','Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,'),
('300294','IFAP','(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)'),
('300294','KFSDX','(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)'),
('300294','MBTPS2','(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)'),
('300294','S2P','(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)'),
('300294','IFAP','IFAP syndrome with or without BRESHECK syndrome, 308205'),
('300294','KFSDX','IFAP syndrome with or without BRESHECK syndrome, 308205'),
('300294','MBTPS2','IFAP syndrome with or without BRESHECK syndrome, 308205'),
('300294','S2P','IFAP syndrome with or without BRESHECK syndrome, 308205'),
('300298','MRXS14','Mental retardation, X-linked, syndromic 14, 300676 (3)'),
('300298','RENT3B','Mental retardation, X-linked, syndromic 14, 300676 (3)'),
('300298','UPF3B','Mental retardation, X-linked, syndromic 14, 300676 (3)'),
('300300','AGMX1','Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia'),
('300300','AT','Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia'),
('300300','BTK','Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia'),
('300300','IMD1','Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia'),
('300300','XLA','Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia'),
('300300','AGMX1','and isolated hormone deficiency, 307200 (3)'),
('300300','AT','and isolated hormone deficiency, 307200 (3)'),
('300300','BTK','and isolated hormone deficiency, 307200 (3)'),
('300300','IMD1','and isolated hormone deficiency, 307200 (3)'),
('300300','XLA','and isolated hormone deficiency, 307200 (3)'),
('300304','CUL4B','Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)'),
('300304','MRXHF2','Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)'),
('300304','MRXS15','Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)'),
('300304','MRXSC','Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)'),
('300304','SFM2','Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)'),
('300307','CPX','Cleft palate with ankyloglossia, 303400 (3)'),
('300307','TBX22','Cleft palate with ankyloglossia, 303400 (3)'),
('300310','AGMX2','Agammaglobulinemia, X-linked 2 (2)'),
('300310','IMD6','Agammaglobulinemia, X-linked 2 (2)'),
('300310','XLA2','Agammaglobulinemia, X-linked 2 (2)'),
('300324','MRX53','Mental retardation, X-linked 53 (2)'),
('300326','SSX4','Sarcoma, synovial (1)'),
('300331','THCYTX','Thrombocythemia, X-linked (2)'),
('300336','ASPGX1','{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)'),
('300336','AUTSX1','{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)'),
('300336','NLGN3','{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)'),
('300336','ASPGX1','{Autism susceptibility, X-linked 1}, 300425 (3);'),
('300336','AUTSX1','{Autism susceptibility, X-linked 1}, 300425 (3);'),
('300336','NLGN3','{Autism susceptibility, X-linked 1}, 300425 (3);'),
('300345','MCOPCB1','Microphthalmia with coloboma 1 (2)'),
('300350','CHRDL1','Megalocornea 1, X-linked 309300 (3)'),
('300350','MGC1','Megalocornea 1, X-linked 309300 (3)'),
('300350','VOPT','Megalocornea 1, X-linked 309300 (3)'),
('300351','GD3','{Graves disease, susceptibility to, X-linked} (2)'),
('300351','GRDX','{Graves disease, susceptibility to, X-linked} (2)'),
('300356','DDP','304700 (3); Jensen syndrome, 311150 (3)'),
('300356','DDP1','304700 (3); Jensen syndrome, 311150 (3)'),
('300356','DFN1','304700 (3); Jensen syndrome, 311150 (3)'),
('300356','MTS','304700 (3); Jensen syndrome, 311150 (3)'),
('300356','TIMM8A','304700 (3); Jensen syndrome, 311150 (3)'),
('300356','DDP','Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,'),
('300356','DDP1','Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,'),
('300356','DFN1','Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,'),
('300356','MTS','Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,'),
('300356','TIMM8A','Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,'),
('300360','MRSS','Mental retardation, X-linked, with short stature (2)'),
('300371','ABCD1','Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)'),
('300371','ALD','Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)'),
('300371','AMN','Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)'),
('300372','MRX42','Mental retardation, X-linked 42 (2)'),
('300377','BMD','300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)'),
('300377','CMD3B','300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)'),
('300377','DMD','300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)'),
('300377','BMD','Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,'),
('300377','CMD3B','Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,'),
('300377','DMD','Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,'),
('300378','RRDX','Radial ray deficiency (2)'),
('300382','ARX','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','ISSX','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX29','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX32','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX36','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX43','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX54','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRX87','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','MRXS1','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','PRTS','(3); Hydranencephaly with abnormal genitalia, 300215 (3)'),
('300382','ARX','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','ISSX','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX29','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX32','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX36','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX43','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX54','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRX87','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','MRXS1','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','PRTS','Epileptic encephalopathy, early infantile, 1, 308350 (3);'),
('300382','ARX','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','ISSX','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX29','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX32','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX36','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX43','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX54','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRX87','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','MRXS1','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300382','PRTS','Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510'),
('300383','PFC','Properdin deficiency, X-linked, 312060 (3)'),
('300383','PFD','Properdin deficiency, X-linked, 312060 (3)'),
('300384','EDMD','Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)'),
('300384','EMD','Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)'),
('300384','STA','Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)'),
('300386','CD40LG','Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)'),
('300386','HIGM1','Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)'),
('300386','IGM','Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)'),
('300386','TNFSF5','Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)'),
('300388','BPP','Polymicrogyria, bilateral perisylvian (2)'),
('300388','CBPS','Polymicrogyria, bilateral perisylvian (2)'),
('300388','PMGX','Polymicrogyria, bilateral perisylvian (2)'),
('300390','CHM','Choroideremia, 303100 (3)'),
('300390','TCD','Choroideremia, 303100 (3)'),
('300391','AI1E','(3)'),
('300391','AIH1','(3)'),
('300391','AMELX','(3)'),
('300391','AMG','(3)'),
('300391','AMGX','(3)'),
('300391','AI1E','Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200'),
('300391','AIH1','Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200'),
('300391','AMELX','Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200'),
('300391','AMG','Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200'),
('300391','AMGX','Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200'),
('300392','IMD2','Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia,'),
('300392','SCNX','Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia,'),
('300392','THC1','Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia,'),
('300392','WAS','Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia,'),
('300392','IMD2','Wiskott-Aldrich syndrome, 301000 (3);'),
('300392','SCNX','Wiskott-Aldrich syndrome, 301000 (3);'),
('300392','THC1','Wiskott-Aldrich syndrome, 301000 (3);'),
('300392','WAS','Wiskott-Aldrich syndrome, 301000 (3);'),
('300392','IMD2','X-linked, intermittent, 313900 (3)'),
('300392','SCNX','X-linked, intermittent, 313900 (3)'),
('300392','THC1','X-linked, intermittent, 313900 (3)'),
('300392','WAS','X-linked, intermittent, 313900 (3)'),
('300394','BTHS','Barth syndrome, 302060 (3);'),
('300394','CMD3A','Barth syndrome, 302060 (3);'),
('300394','EFE2','Barth syndrome, 302060 (3);'),
('300394','LVNCX','Barth syndrome, 302060 (3);'),
('300394','TAZ','Barth syndrome, 302060 (3);'),
('300394','BTHS','Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)'),
('300394','CMD3A','Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)'),
('300394','EFE2','Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)'),
('300394','LVNCX','Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)'),
('300394','TAZ','Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)'),
('300401','HLD1','312920 (3)'),
('300401','PLP1','312920 (3)'),
('300401','PMD','312920 (3)'),
('300401','HLD1','Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,'),
('300401','PLP1','Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,'),
('300401','PMD','Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,'),
('300405','RAB40AL','Mental retardation, profound (2)'),
('300405','RLGP','Mental retardation, profound (2)'),
('300406','FGS3','FG syndrome 3 (2)'),
('300414','BFLS','Borjeson-Forssman-Lehmann syndrome, 301900 (3)'),
('300414','PHF6','Borjeson-Forssman-Lehmann syndrome, 301900 (3)'),
('300415','MTM1','Myotubular myopathy, X-linked, 310400 (3)'),
('300415','MTMX','Myotubular myopathy, X-linked, 310400 (3)'),
('300424','RP23','Retinitis pigmentosa 23 (2)'),
('300427','ASPGX2','syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)'),
('300427','AUTSX2','syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)'),
('300427','KIAA1260','syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)'),
('300427','NLGN4','syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)'),
('300427','ASPGX2','{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger'),
('300427','AUTSX2','{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger'),
('300427','KIAA1260','{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger'),
('300427','NLGN4','{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger'),
('300428','MRX2','Mental retardation, X-linked 2 (2)'),
('300429','ARHGEF9','Epileptic encephalopathy, early infantile, 8, 300607 (3)'),
('300429','EIEE8','Epileptic encephalopathy, early infantile, 8, 300607 (3)'),
('300429','KIAA0424','Epileptic encephalopathy, early infantile, 8, 300607 (3)'),
('300429','PEM2','Epileptic encephalopathy, early infantile, 8, 300607 (3)'),
('300433','MRX81','Mental retardation, X-linked 81 (2)'),
('300444','BMIQ11','{Obesity, susceptibility to, BMIQ11}, 300306 (3)'),
('300444','OBX','{Obesity, susceptibility to, BMIQ11}, 300306 (3)'),
('300444','SLC6A14','{Obesity, susceptibility to, BMIQ11}, 300306 (3)'),
('300451','ED1','agenesis, selective, X-linked 1, 313500 (3)'),
('300451','EDA','agenesis, selective, X-linked 1, 313500 (3)'),
('300451','HED','agenesis, selective, X-linked 1, 313500 (3)'),
('300451','STHAGX1','agenesis, selective, X-linked 1, 313500 (3)'),
('300451','ED1','Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth'),
('300451','EDA','Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth'),
('300451','HED','Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth'),
('300451','STHAGX1','Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth'),
('300454','MRX77','Mental retardation, X-linked 77 (2)'),
('300457','CXN','302200 (3)'),
('300457','NHS','302200 (3)'),
('300457','CXN','Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,'),
('300457','NHS','Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,'),
('300460','EFMR','Epileptic encephalopathy, early infantile, 9, 300088 (3)'),
('300460','EIEE9','Epileptic encephalopathy, early infantile, 9, 300088 (3)'),
('300460','KIAA1313','Epileptic encephalopathy, early infantile, 9, 300088 (3)'),
('300460','PCDH19','Epileptic encephalopathy, early infantile, 9, 300088 (3)'),
('300461','OTC','Ornithine transcarbamylase deficiency, 311250 (3)'),
('300463','MRX55','Renpenning syndrome, 309500 (3)'),
('300463','MRXS3','Renpenning syndrome, 309500 (3)'),
('300463','MRXS8','Renpenning syndrome, 309500 (3)'),
('300463','NPW38','Renpenning syndrome, 309500 (3)'),
('300463','PQBP1','Renpenning syndrome, 309500 (3)'),
('300463','RENS1','Renpenning syndrome, 309500 (3)'),
('300463','SHS','Renpenning syndrome, 309500 (3)'),
('300464','CHDS3','{Coronary heart disease, susceptibility to, 3} (2)'),
('300471','CVMRF','Cubitus valgus with mental retardation and unusual facies (2)'),
('300473','AHC','300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)'),
('300473','AHX','300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)'),
('300473','DAX1','300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)'),
('300473','NROB1','300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)'),
('300473','SRXY2','300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)'),
('300473','AHC','Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,'),
('300473','AHX','Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,'),
('300473','DAX1','Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,'),
('300473','NROB1','Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,'),
('300473','SRXY2','Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,'),
('300474','GK','Glycerol kinase deficiency, 307030 (3)'),
('300475','DELXq28','Chromosome Xq28 microdeletion syndrome (4)'),
('300475','MICRODELXq28','Chromosome Xq28 microdeletion syndrome (4)'),
('300481','AMCBX2','Chronic granulomatous disease, X-linked, 306400 (3); Atypical'),
('300481','CGD','Chronic granulomatous disease, X-linked, 306400 (3); Atypical'),
('300481','CYBB','Chronic granulomatous disease, X-linked, 306400 (3); Atypical'),
('300481','AMCBX2','mycobacteriosis, familial, X-linked 2, 300645 (3)'),
('300481','CGD','mycobacteriosis, familial, X-linked 2, 300645 (3)'),
('300481','CYBB','mycobacteriosis, familial, X-linked 2, 300645 (3)'),
('300485','ANOP2','Microphthalmia, syndromic 2, 300166 (3)'),
('300485','BCOR','Microphthalmia, syndromic 2, 300166 (3)'),
('300485','KIAA1575','Microphthalmia, syndromic 2, 300166 (3)'),
('300485','MAA2','Microphthalmia, syndromic 2, 300166 (3)'),
('300485','MCOPS2','Microphthalmia, syndromic 2, 300166 (3)'),
('300488','MENOQ1','{Menopause, natural, age at, QTL1} (2)'),
('300490','IMD5','Lymphoproliferative syndrome, X-linked, 308240 (3)'),
('300490','LYP','Lymphoproliferative syndrome, X-linked, 308240 (3)'),
('300490','SH2D1A','Lymphoproliferative syndrome, X-linked, 308240 (3)'),
('300490','XLP','Lymphoproliferative syndrome, X-linked, 308240 (3)'),
('300490','XLPD','Lymphoproliferative syndrome, X-linked, 308240 (3)'),
('300499','FTSJ1','Mental retardation, X-linked 9, 309549 (3)'),
('300499','JM23','Mental retardation, X-linked 9, 309549 (3)'),
('300499','MRX44','Mental retardation, X-linked 9, 309549 (3)'),
('300499','MRX9','Mental retardation, X-linked 9, 309549 (3)'),
('300499','SPB1','Mental retardation, X-linked 9, 309549 (3)'),
('300502','PDHA1','Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3); Leigh'),
('300502','PHE1A','Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3); Leigh'),
('300502','PDHA1','syndrome, X-linked, 308930 (3)'),
('300502','PHE1A','syndrome, X-linked, 308930 (3)'),
('300504','MRX52','Mental retardation, X-linked 52 (2)'),
('300505','MRX84','Mental retardation, X-linked 84 (2)'),
('300509','DYX9','{Dyslexia, susceptibility to, 9} (2)'),
('300515','FAAP90','Fanconi anemia, complementation group B, 300514 (3)'),
('300515','FAAP95','Fanconi anemia, complementation group B, 300514 (3)'),
('300515','FANCB','Fanconi anemia, complementation group B, 300514 (3)'),
('300515','FLJ34064','Fanconi anemia, complementation group B, 300514 (3)'),
('300518','MRX82','Mental retardation, X-linked 82 (2)'),
('300519','MPDMRS','Martin-Probst deafness-mental retardation syndrome (2)'),
('300522','IQSEC2','Mental retardation, X-linked 1, 309530 (3)'),
('300522','KIAA0522','Mental retardation, X-linked 1, 309530 (3)'),
('300522','MRX1','Mental retardation, X-linked 1, 309530 (3)'),
('300524','KIAA2022','?Mental retardation, nonsyndromic, X-linked (2)'),
('300535','LOCR','Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)'),
('300535','NPHL2','Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)'),
('300535','OCRL','Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)'),
('300535','OCRL1','Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)'),
('300536','BMND4','[Bone mineral density QTL 4] (2)'),
('300538','ADHR','Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome'),
('300538','AVPR2','Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome'),
('300538','DI1','Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome'),
('300538','DIR','Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome'),
('300538','ADHR','of inappropriate antidiuresis, 300539 (3)'),
('300538','AVPR2','of inappropriate antidiuresis, 300539 (3)'),
('300538','DI1','of inappropriate antidiuresis, 300539 (3)'),
('300538','DIR','of inappropriate antidiuresis, 300539 (3)'),
('300546','AAS','Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked'),
('300546','FGD1','Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked'),
('300546','FGDY','Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked'),
('300546','MRXS16','Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked'),
('300546','AAS','syndromic 16, 305400 (3)'),
('300546','FGD1','syndromic 16, 305400 (3)'),
('300546','FGDY','syndromic 16, 305400 (3)'),
('300546','MRXS16','syndromic 16, 305400 (3)'),
('300550','HPDR1','Hypophosphatemic rickets, X-linked dominant, 307800 (3)'),
('300550','HYP','Hypophosphatemic rickets, X-linked dominant, 307800 (3)'),
('300550','LXHR','Hypophosphatemic rickets, X-linked dominant, 307800 (3)'),
('300550','PHEX','Hypophosphatemic rickets, X-linked dominant, 307800 (3)'),
('300551','MRX78','Mental retardation, X-linked 78 (2)'),
('300552','BBBG1','Opitz GBBB syndrome, type I, 300000 (3)'),
('300552','FXY','Opitz GBBB syndrome, type I, 300000 (3)'),
('300552','MID1','Opitz GBBB syndrome, type I, 300000 (3)'),
('300552','OGS1','Opitz GBBB syndrome, type I, 300000 (3)'),
('300552','OSX','Opitz GBBB syndrome, type I, 300000 (3)'),
('300553','BRWD3','Mental retardation, X-linked 93, 300659 (3)'),
('300553','MRX93','Mental retardation, X-linked 93, 300659 (3)'),
('300556','ATP6AP2','Mental retardation, X-linked, with epilepsy, 300423 (3)'),
('300556','ATP6M8-9','Mental retardation, X-linked, with epilepsy, 300423 (3)'),
('300556','MRXE','Mental retardation, X-linked, with epilepsy, 300423 (3)'),
('300556','XMRE','Mental retardation, X-linked, with epilepsy, 300423 (3)'),
('300557','PARK12','Parkinson disease 12 (2)'),
('300560','KIAA1111','Mental retardation syndrome, X-linked, Siderius type, 300263 (3)'),
('300560','MRXSSD','Mental retardation syndrome, X-linked, Siderius type, 300263 (3)'),
('300560','PHF8','Mental retardation syndrome, X-linked, Siderius type, 300263 (3)'),
('300560','ZNF422','Mental retardation syndrome, X-linked, Siderius type, 300263 (3)'),
('300573','MRX92','Mental retardation, X-linked 92, 300851 (3)'),
('300573','ZNF674','Mental retardation, X-linked 92, 300851 (3)'),
('300576','MRX91','Mental retardation, X-linked 91, 300577 (3)'),
('300576','ZDHHC15','Mental retardation, X-linked 91, 300577 (3)'),
('300578','CXDELp11.3','Chromosome Xp11.3 deletion syndrome (4)'),
('300578','DELXp11.3','Chromosome Xp11.3 deletion syndrome (4)'),
('300579','KIAA1202','Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)');
INSERT INTO omim VALUES
('300579','SDSX','Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)'),
('300579','SHROOM4','Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)'),
('300580','CFTDX','Myopathy, congenital, with fiber-type disproportion, X-linked (2)'),
('300581','FGS5','FG syndrome 5 (2)'),
('300589','NYS5','Nystagmus 5, congenital, X-linked (2)'),
('300591','STQTL6','{Stature QTL 6} (2)'),
('300603','FLJ22792','Premature ovarian failure 2B, 300604 (3)'),
('300603','POF1B','Premature ovarian failure 2B, 300604 (3)'),
('300603','POF2B','Premature ovarian failure 2B, 300604 (3)'),
('300605','RP34','Retinitis pigmentosa 34 (2)'),
('300611','C1GALT1C1','Tn syndrome, 300622 (3)'),
('300611','C1GALT2','Tn syndrome, 300622 (3)'),
('300611','COSMC','Tn syndrome, 300622 (3)'),
('300613','MYP13','Myopia 13 (2)'),
('300614','AUNX1','Deafness, X-linked 5 (2)'),
('300614','DFNX5','Deafness, X-linked 5 (2)'),
('300628','FRMD7','Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile'),
('300628','NYS1','Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile'),
('300628','XIPAN','Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile'),
('300628','FRMD7','periodic alternating, X-linked, 310700 (3)'),
('300628','NYS1','periodic alternating, X-linked, 310700 (3)'),
('300628','XIPAN','periodic alternating, X-linked, 310700 (3)'),
('300629','AP1S2','Mental retardation, X-linked syndromic, Fried type, 300630 (3)'),
('300629','MRX59','Mental retardation, X-linked syndromic, Fried type, 300630 (3)'),
('300629','MRXS21','Mental retardation, X-linked syndromic, Fried type, 300630 (3)'),
('300629','MRXSF','Mental retardation, X-linked syndromic, Fried type, 300630 (3)'),
('300642','RESDX','(3)'),
('300642','SRPUL','(3)'),
('300642','SRPX2','(3)'),
('300642','RESDX','Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643'),
('300642','SRPUL','Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643'),
('300642','SRPX2','Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643'),
('300644','GLA','Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)'),
('300646','DHHC9','Mental retardation, X-linked syndromic, Raymond type, 300799 (3)'),
('300646','MRXSZ','Mental retardation, X-linked syndromic, Raymond type, 300799 (3)'),
('300646','ZDHHC9','Mental retardation, X-linked syndromic, Raymond type, 300799 (3)'),
('300647','FAM123B','Osteopathia striata with cranial sclerosis, 300373 (3)'),
('300647','FLJ39827','Osteopathia striata with cranial sclerosis, 300373 (3)'),
('300647','OSCS','Osteopathia striata with cranial sclerosis, 300373 (3)'),
('300647','WTX','Osteopathia striata with cranial sclerosis, 300373 (3)'),
('300650','OASD','Ocular albinism with sensorineural deafness (2)'),
('300651','DHOF','Focal dermal hypoplasia, 305600 (3)'),
('300651','FODH','Focal dermal hypoplasia, 305600 (3)'),
('300651','PORC','Focal dermal hypoplasia, 305600 (3)'),
('300651','PORCN','Focal dermal hypoplasia, 305600 (3)'),
('300652','AGSPX','Angio serpiginosum (2)'),
('300658','ND','305390 (3)'),
('300658','NDP','305390 (3)'),
('300658','ND','Norrie disease, 310600 (3); Exudative vitreoretinopathy, X-linked,'),
('300658','NDP','Norrie disease, 310600 (3); Exudative vitreoretinopathy, X-linked,'),
('300660','LKMCD','Leukoencephalopathy with metaphyseal chondrodysplasia (2)'),
('300679','CXDELp21','Chromosome Xp21 deletion syndrome (4)'),
('300679','DELXp21','Chromosome Xp21 deletion syndrome (4)'),
('300697','HUWE1','Mental retardation, X-linked syndromic, Turner type, 300706 (3)'),
('300697','KIAA0312','Mental retardation, X-linked syndromic, Turner type, 300706 (3)'),
('300697','LASU1','Mental retardation, X-linked syndromic, Turner type, 300706 (3)'),
('300697','UREB1','Mental retardation, X-linked syndromic, Turner type, 300706 (3)'),
('300700','ADFN','Albinism-deafness syndrome (2)'),
('300700','ALDS','Albinism-deafness syndrome (2)'),
('300703','SCAX5','Spinocerebellar ataxia, X-linked 5 (2)'),
('300704','HPCX2','{Prostate cancer, hereditary, X-linked 2} (2)'),
('300708','FAM58A','STAR syndrome, 300707 (3)'),
('300708','STAR','STAR syndrome, 300707 (3)'),
('300709','MRXS9','Mental retardation, X-linked, syndromic 9 (2)'),
('300710','AGA2','Alopecia, androgenetic, 2 (2)'),
('300711','IHPS4','Pyloric stenosis, infantile hypertrophic, 4 (2)'),
('300712','CFSS','?Craniofacioskeletal syndrome (2)'),
('300715','IAP','Mental retardation, X-linked 95, 300716 (3); Immunodeficiency,'),
('300715','MAGT1','Mental retardation, X-linked 95, 300716 (3); Immunodeficiency,'),
('300715','XMEN','Mental retardation, X-linked 95, 300716 (3); Immunodeficiency,'),
('300715','IAP','X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)'),
('300715','MAGT1','X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)'),
('300715','XMEN','X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)'),
('300719','DFCTRPS','Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)'),
('300746','F9','Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3);'),
('300746','HEMB','Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3);'),
('300746','THPH8','Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3);'),
('300746','F9','Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)'),
('300746','HEMB','Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)'),
('300746','THPH8','Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)'),
('300747','ARSC','Ichthyosis, X-linked, 308100 (3)'),
('300747','ARSC1','Ichthyosis, X-linked, 308100 (3)'),
('300747','SSDD','Ichthyosis, X-linked, 308100 (3)'),
('300747','STS','Ichthyosis, X-linked, 308100 (3)'),
('300747','XLI','Ichthyosis, X-linked, 308100 (3)'),
('300750','SPG34','Spastic paraplegia 34, X-linked (2)'),
('300756','AD16','{Alzheimer disease 16} (2)'),
('300757','RP2','Retinitis pigmentosa 2, 312600 (3)'),
('300774','MRX72','Mental retardation, X-linked 72, 300271 (3)'),
('300774','RAB39B','Mental retardation, X-linked 72, 300271 (3)'),
('300778','LECD','Corneal dystrophy, Lisch epithelial (2)'),
('300779','XECD','Corneal dystrophy, endothelial, X-linked (2)'),
('300798','GSD9A','disease, type IXa2, 306000 (3)'),
('300798','PHK','disease, type IXa2, 306000 (3)'),
('300798','PHKA2','disease, type IXa2, 306000 (3)'),
('300798','PYKL','disease, type IXa2, 306000 (3)'),
('300798','XLG','disease, type IXa2, 306000 (3)'),
('300798','GSD9A','Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage'),
('300798','PHK','Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage'),
('300798','PHKA2','Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage'),
('300798','PYKL','Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage'),
('300798','XLG','Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage'),
('300801','CXDUPp11.23p11.22','Chromosome Xp11.23-p11.22 duplication syndrome (4)'),
('300801','DUPXp11.23p11.22','Chromosome Xp11.23-p11.22 duplication syndrome (4)'),
('300806','AFF2','Mental retardation, X-linked, FRAXE type, 309548 (3)'),
('300806','FMR2','Mental retardation, X-linked, FRAXE type, 309548 (3)'),
('300806','FRAXE','Mental retardation, X-linked, FRAXE type, 309548 (3)'),
('300806','MRX2','Mental retardation, X-linked, FRAXE type, 309548 (3)'),
('300808','GPR143','Nystagmus 6, congenital, X-linked, 300814 (3)'),
('300808','NYS6','Nystagmus 6, congenital, X-linked, 300814 (3)'),
('300808','OA1','Nystagmus 6, congenital, X-linked, 300814 (3)'),
('300808','GPR143','Ocular albinism, type I, Nettleship-Falls type, 300500 (3);'),
('300808','NYS6','Ocular albinism, type I, Nettleship-Falls type, 300500 (3);'),
('300808','OA1','Ocular albinism, type I, Nettleship-Falls type, 300500 (3);'),
('300809','SLEB15','{Systemic lupus erthematosus, susceptibility to, 15} (2)'),
('300815','CXq28','Chromosome Xq28 duplication syndrome (4)'),
('300815','DUPXq28','Chromosome Xq28 duplication syndrome (4)'),
('300821','CBBM','(3)'),
('300821','CBD','(3)'),
('300821','GCP','(3)'),
('300821','OPN1MW','(3)'),
('300821','CBBM','Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700'),
('300821','CBD','Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700'),
('300821','GCP','Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700'),
('300821','OPN1MW','Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700'),
('300822','CBBM','(3)'),
('300822','CBP','(3)'),
('300822','OPN1LW','(3)'),
('300822','RCP','(3)'),
('300822','CBBM','Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700'),
('300822','CBP','Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700'),
('300822','OPN1LW','Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700'),
('300822','RCP','Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700'),
('300823','IDS','Mucopolysaccharidosis II, 309900 (3)'),
('300823','MPS2','Mucopolysaccharidosis II, 309900 (3)'),
('300823','SIDS','Mucopolysaccharidosis II, 309900 (3)'),
('300830','AUTSX4','{Autism susceptibility, X-linked 4} (4)'),
('300830','CXDELp22.11','{Autism susceptibility, X-linked 4} (4)'),
('300830','DELXp22.11','{Autism susceptibility, X-linked 4} (4)'),
('300833','SRXX3','46XX sex reversal 3 (4)'),
('300836','ADMLX','Kallmann syndrome, 308700 (3)'),
('300836','KAL1','Kallmann syndrome, 308700 (3)'),
('300836','KMS','Kallmann syndrome, 308700 (3)'),
('300839','RS1','Retinoschisis, 312700 (3)'),
('300839','XLRS1','Retinoschisis, 312700 (3)'),
('300841','F8','Hemophilia A, 306700 (3)'),
('300841','F8C','Hemophilia A, 306700 (3)'),
('300841','HEMA','Hemophilia A, 306700 (3)'),
('300843','BED','Bornholm eye disease (2)'),
('300845','CXDELq38','Moyamoya disease 4 (4)'),
('300845','MYMY4','Moyamoya disease 4 (4)'),
('300856','HYSP4','{Hypospadias 4, X-linked, susceptibilty to} (2)'),
('300858','MRXS17','Mental retardation, X-linked, syndromic 17 (2)'),
('300861','MRXSCS','Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)'),
('300863','CPBHM','Chondrodysplasia with platyspondyly, distinctive brachydactyly,'),
('300863','CPBHM','hydrocephaly, and microphthalmia (2)'),
('300864','CCCSX','Cerebral-cerebellar-coloboma syndrome, X-linked (2)'),
('300869','CXDUPq27.3q28','Chromosome Xq27.3-q28 duplication syndrome (4)'),
('300869','DUPXq27.3q28','Chromosome Xq27.3-q28 duplication syndrome (4)'),
('301201','AIH3','?Amelogenesis imperfecta-3, hypoplastic type (2)'),
('301220','PDR','Pigment disorder, reticulate (2)'),
('301300','ALAS2','Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,'),
('301300','ANH1','Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,'),
('301300','ASB','Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,'),
('301300','XLEPP','Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,'),
('301300','XLSA','Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,'),
('301300','ALAS2','erythropoietic, X-linked, 300752 (3)'),
('301300','ANH1','erythropoietic, X-linked, 300752 (3)'),
('301300','ASB','erythropoietic, X-linked, 300752 (3)'),
('301300','XLEPP','erythropoietic, X-linked, 300752 (3)'),
('301300','XLSA','erythropoietic, X-linked, 300752 (3)'),
('301590','ANOP1','?Microphthalmia, syndromic 4 (2)'),
('301590','MCOPS4','?Microphthalmia, syndromic 4 (2)'),
('301845','BZX','Bazex syndrome (2)'),
('302380','CATMANS','Catel-Manzke syndrome (2)'),
('302500','CLA2','Spinocerebellar ataxia, X-linked 1 (2)'),
('302500','OPCA','Spinocerebellar ataxia, X-linked 1 (2)'),
('302500','SCAX1','Spinocerebellar ataxia, X-linked 1 (2)'),
('302801','CMTX2','Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)'),
('302802','CMTX3','Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)'),
('303630','ASLN','Alport syndrome, 301050 (3)'),
('303630','ATS','Alport syndrome, 301050 (3)'),
('303630','COL4A5','Alport syndrome, 301050 (3)'),
('303631','COL4A6','Leiomyomatosis, diffuse, with Alport syndrome, 308940 (4)'),
('303631','CXDELq22.3','Leiomyomatosis, diffuse, with Alport syndrome, 308940 (4)'),
('303631','DELXq22.3','Leiomyomatosis, diffuse, with Alport syndrome, 308940 (4)'),
('304040','CMTX1','Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)'),
('304040','CX32','Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)'),
('304040','GJB1','Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)'),
('304050','AIC','Aicardi syndrome (2)'),
('304340','MRXS5','Pettigrew syndrome (2)'),
('304340','PGS','Pettigrew syndrome (2)'),
('304730','CND','Dermoids of cornea (2)'),
('305371','ERYF1','(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)'),
('305371','GATA1','(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)'),
('305371','GF1','(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)'),
('305371','NFE1','(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)'),
('305371','XLTT','(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)'),
('305371','ERYF1','Dyserythropoietic anemia with thrombocytopenia, 300367 (3);'),
('305371','GATA1','Dyserythropoietic anemia with thrombocytopenia, 300367 (3);'),
('305371','GF1','Dyserythropoietic anemia with thrombocytopenia, 300367 (3);'),
('305371','NFE1','Dyserythropoietic anemia with thrombocytopenia, 300367 (3);'),
('305371','XLTT','Dyserythropoietic anemia with thrombocytopenia, 300367 (3);'),
('305371','ERYF1','Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685'),
('305371','GATA1','Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685'),
('305371','GF1','Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685'),
('305371','NFE1','Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685'),
('305371','XLTT','Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685'),
('305435','FCP','Fetal hemoglobin quantitative trait locus 3 (2)'),
('305435','FCP1','Fetal hemoglobin quantitative trait locus 3 (2)'),
('305435','FCPX','Fetal hemoglobin quantitative trait locus 3 (2)'),
('305435','HBFQTL3','Fetal hemoglobin quantitative trait locus 3 (2)'),
('305900','G6PD','G6PD deficiency (3); Favism (3); Hemolytic anemia due'),
('305900','G6PD1','G6PD deficiency (3); Favism (3); Hemolytic anemia due'),
('305900','G6PD','to G6PD deficiency (3)'),
('305900','G6PD1','to G6PD deficiency (3)'),
('305915','GLUR3','Mental retardation, X-linked 94, 300699 (3)'),
('305915','GRIA3','Mental retardation, X-linked 94, 300699 (3)'),
('305915','MRX94','Mental retardation, X-linked 94, 300699 (3)'),
('306100','GDXY','Gonadal dysgenesis, XY female type (2)'),
('306100','SRVX','Gonadal dysgenesis, XY female type (2)'),
('306100','TDFX','Gonadal dysgenesis, XY female type (2)'),
('306250','CSF2RA','Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)'),
('306250','SMDP4','Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)'),
('306995','GAY1','[?Homosexuality, male] (2)'),
('306995','HMS1','[?Homosexuality, male] (2)'),
('307150','','Hypertrichosis, congenital generalized (4)'),
('307150','CGH','Hypertrichosis, congenital generalized (4)'),
('307150','CXINSq27.1','Hypertrichosis, congenital generalized (4)'),
('307150','HCG','Hypertrichosis, congenital generalized (4)'),
('307150','HTC2','Hypertrichosis, congenital generalized (4)'),
('307700','HPT','Hypoparathyroidism, X-linked (2)'),
('307700','HPTX','Hypoparathyroidism, X-linked (2)'),
('307700','HYPX','Hypoparathyroidism, X-linked (2)'),
('308000','HPRT','Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)'),
('308000','HPRT1','Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)'),
('308380','IL2RG','immunodeficiency, X-linked, moderate, 312863 (3)'),
('308380','IMD4','immunodeficiency, X-linked, moderate, 312863 (3)'),
('308380','SCIDX','immunodeficiency, X-linked, moderate, 312863 (3)'),
('308380','SCIDX1','immunodeficiency, X-linked, moderate, 312863 (3)'),
('308380','IL2RG','Severe combined immunodeficiency, X-linked, 300400 (3); Combined'),
('308380','IMD4','Severe combined immunodeficiency, X-linked, 300400 (3); Combined'),
('308380','SCIDX','Severe combined immunodeficiency, X-linked, 300400 (3); Combined'),
('308380','SCIDX1','Severe combined immunodeficiency, X-linked, 300400 (3); Combined'),
('308840','CAML1','303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal'),
('308840','HSAS1','303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal'),
('308840','L1CAM','303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal'),
('308840','CAML1','Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,'),
('308840','HSAS1','Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,'),
('308840','L1CAM','Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,'),
('308840','CAML1','pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)'),
('308840','HSAS1','pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)'),
('308840','L1CAM','pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)'),
('308905','LOAS','{Leber optic atrophy, susceptibility to} (2)'),
('309060','LAMP2','Danon disease, 300257 (3)'),
('309060','LAMPB','Danon disease, 300257 (3)'),
('309060','LGP110','Danon disease, 300257 (3)'),
('309120','SPGFX2','Spermatogenic failure, X-linked, 2 (2)'),
('309200','MAFD2','{?Major affective disorder 2} (2)'),
('309200','MDX','{?Major affective disorder 2} (2)'),
('309541','MRX3','Mental retardation, X-linked 3 (2)'),
('309545','MRXS12','?Mental retardation, X-linked, syndromic 12 (2)'),
('309550','FMR1','300623 (3); Premature ovarian failure 1, 311360 (3)'),
('309550','FRAXA','300623 (3); Premature ovarian failure 1, 311360 (3)'),
('309550','POF1','300623 (3); Premature ovarian failure 1, 311360 (3)'),
('309550','FMR1','Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,'),
('309550','FRAXA','Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,'),
('309550','POF1','Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,'),
('309555','GUST','Gustavson syndrome (2)'),
('309585','MRXS6','Mental retardation syndrome, X-linked 6, with gynecomastia and'),
('309585','WTS','Mental retardation syndrome, X-linked 6, with gynecomastia and'),
('309585','MRXS6','obesity (2)'),
('309585','WTS','obesity (2)'),
('309605','MCS','Miles-Carpenter syndrome (2)'),
('309605','MRXS4','Miles-Carpenter syndrome (2)'),
('309610','MRXS2','Prieto syndrome (2)'),
('309610','PRS','Prieto syndrome (2)'),
('309620','CHRS','Mental retardation-skeletal dysplasia (2)'),
('309620','MRSD','Mental retardation-skeletal dysplasia (2)'),
('309800','LZMS','Microphthalmia, syndromic 1 (2)'),
('309800','MAA','Microphthalmia, syndromic 1 (2)'),
('309800','MCOPS1','Microphthalmia, syndromic 1 (2)'),
('309850','MAOA','Brunner syndrome, 300615 (3)'),
('310440','MEAX','Myopathy, X-linked, with excessive autophagy (2)'),
('310440','XMEA','Myopathy, X-linked, with excessive autophagy (2)'),
('310460','MYP1','Myopia-1 (2)'),
('310490','NADMR','Cowchock syndrome (2)'),
('310490','NAMSD','Cowchock syndrome (2)'),
('311050','OPA2','Optic atrophy 2, X-linked (2)'),
('311510','BGMR','Waisman parkinsonism-mental retardation syndrome (2)'),
('311510','WSN','Waisman parkinsonism-mental retardation syndrome (2)'),
('311770','MCAHS2','congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)'),
('311770','PIGA','congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)'),
('311770','MCAHS2','Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple'),
('311770','PIGA','Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple'),
('311800','PGK1','Phosphoglycerate kinase 1 deficiency, 300653 (3)'),
('311800','PGKA','Phosphoglycerate kinase 1 deficiency, 300653 (3)'),
('311850','CMTX5','304500 (3)'),
('311850','DFN2','304500 (3)'),
('311850','DFNX1','304500 (3)'),
('311850','PRPS1','304500 (3)'),
('311850','CMTX5','Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate'),
('311850','DFN2','Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate'),
('311850','DFNX1','Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate'),
('311850','PRPS1','Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate'),
('311850','CMTX5','synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1,'),
('311850','DFN2','synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1,'),
('311850','DFNX1','synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1,'),
('311850','PRPS1','synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1,'),
('311870','PHKA1','Muscle glycogenosis, 300559 (3)'),
('312040','POLA1','?N syndrome, 310465 (1)'),
('312173','AUTSX5','{Autism, susceptibility to, X-linked 5}, 300847 (3)'),
('312173','DXS648','{Autism, susceptibility to, X-linked 5}, 300847 (3)'),
('312173','QM','{Autism, susceptibility to, X-linked 5}, 300847 (3)'),
('312173','RPL10','{Autism, susceptibility to, X-linked 5}, 300847 (3)'),
('312180','MRXS30','Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)'),
('312180','MRXSN','Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)'),
('312180','RAD6A','Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)'),
('312180','UBE2A','Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)'),
('312610','COD1','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','CORDX1','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','CRD','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','RP15','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','RP3','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','RPGR','Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);'),
('312610','COD1','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312610','CORDX1','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312610','CRD','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312610','RP15','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312610','RP3','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312610','RPGR','Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)'),
('312612','RP6','?Retinitis pigmentosa, X-linked recessive, 6 (2)'),
('312865','GCFX','dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)'),
('312865','PHOG','dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)'),
('312865','SHOX','dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)'),
('312865','SS','dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)'),
('312865','GCFX','Short stature, idiopathic familial, 300582 (3); Leri-Weill'),
('312865','PHOG','Short stature, idiopathic familial, 300582 (3); Leri-Weill'),
('312865','SHOX','Short stature, idiopathic familial, 300582 (3); Leri-Weill'),
('312865','SS','Short stature, idiopathic familial, 300582 (3); Leri-Weill'),
('313000','VSPA','Turner syndrome-associated neurocognitive phenotype (2);'),
('313000','VSPA','[Visuospatial/perceptual abilities] (2)'),
('313020','KFSD','Keratosis follicularis spinulosa decalvans, 308800 (3)'),
('313020','KFSDX','Keratosis follicularis spinulosa decalvans, 308800 (3)'),
('313020','SAT1','Keratosis follicularis spinulosa decalvans, 308800 (3)'),
('313020','SSAT','Keratosis follicularis spinulosa decalvans, 308800 (3)'),
('313350','SHFD2','Split hand/foot malformation 2 (2)'),
('313350','SHFM2','Split hand/foot malformation 2 (2)'),
('313430','MRGH','deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)'),
('313430','SOX3','deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)'),
('313430','MRGH','Mental retardation, X-linked, with isolated growth hormone'),
('313430','SOX3','Mental retardation, X-linked, with isolated growth hormone'),
('313440','SYN1','behavior disorders, 300491 (3)'),
('313440','SYN1','Epilepsy, X-linked, with variable learning disabilities and'),
('313475','MRXSYP','Mental retardation, X-linked 96, 300802 (3)'),
('313475','SYP','Mental retardation, X-linked 96, 300802 (3)'),
('313650','BA2R','Dystonia-Parkinsonism, X-linked, 314250 (3)'),
('313650','CCG1','Dystonia-Parkinsonism, X-linked, 314250 (3)'),
('313650','DYT3','Dystonia-Parkinsonism, X-linked, 314250 (3)'),
('313650','TAF1','Dystonia-Parkinsonism, X-linked, 314250 (3)'),
('313650','TAF2A','Dystonia-Parkinsonism, X-linked, 314250 (3)'),
('313700','AR','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','DHTR','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','HYSP1','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','KD','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','SBMA','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','SMAX1','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','TFM','176807 (3); Hypospadias 1, X-linked, 300633 (3)'),
('313700','AR','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','DHTR','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','HYSP1','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','KD','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','SBMA','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','SMAX1','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','TFM','Androgen insensitivity, 300068 (3); Spinal and bulbar muscular'),
('313700','AR','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','DHTR','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','HYSP1','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','KD','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','SBMA','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','SMAX1','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313700','TFM','atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},'),
('313850','TAS','Thoracoabdominal syndrome (2)'),
('313850','THAS','Thoracoabdominal syndrome (2)'),
('314200','TBG','Thyroxine-binding globulin deficiency (3)'),
('314300','TKC','Goeminne TKCR syndrome (2)'),
('314300','TKCR','Goeminne TKCR syndrome (2)'),
('314310','RCCX1','Renal cell carcinoma, papillary, 1, 300854 (3)'),
('314310','TFE3','Renal cell carcinoma, papillary, 1, 300854 (3)'),
('314370','A1ST','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314370','AMCX1','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314370','GXP1','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314370','SMAX2','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314370','UBA1','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314370','UBE1','Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)'),
('314580','WWS','Wieacker-Wolff syndrome (2)'),
('314670','SXI1','X-inactivation, familial skewed, 300087 (3)'),
('314670','XCE','X-inactivation, familial skewed, 300087 (3)'),
('314670','XIC','X-inactivation, familial skewed, 300087 (3)'),
('314670','XIST','X-inactivation, familial skewed, 300087 (3)'),
('314690','DXS1272E','(3)'),
('314690','JARID1C','(3)'),
('314690','KDM5C','(3)'),
('314690','MRXSCJ','(3)'),
('314690','SMCX','(3)'),
('314690','XE169','(3)'),
('314690','DXS1272E','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314690','JARID1C','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314690','KDM5C','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314690','MRXSCJ','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314690','SMCX','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314690','XE169','Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534'),
('314700','XG','[Blood group, XG system] (3)'),
('314850','MCLDS','300842 (3)'),
('314850','XK','300842 (3)'),
('314850','MCLDS','McLeod syndrome with or without chronic granulomatous disease,'),
('314850','XK','McLeod syndrome with or without chronic granulomatous disease,'),
('314990','CMPX1','Mental retardation, X-linked 97, 300803 (3)'),
('314990','MRX97','Mental retardation, X-linked 97, 300803 (3)'),
('314990','ZNF6','Mental retardation, X-linked 97, 300803 (3)'),
('314990','ZNF711','Mental retardation, X-linked 97, 300803 (3)'),
('314995','MRX89','Mental retardation, X-linked 89, 300848 (3)'),
('314995','ZNF41','Mental retardation, X-linked 89, 300848 (3)'),
('314998','MRX45','Mental retardation, X-linked 45, 300498 (3)'),
('314998','ZNF81','Mental retardation, X-linked 45, 300498 (3)'),
('400003','DAZ','?Sertoli-cell-only syndrome (1)'),
('400004','RPY','Retinitis pigmentosa, Y-linked (2)'),
('400005','DFFRY','Spermatogenic failure, Y-linked, 2, 415000 (3)'),
('400005','SPGFY2','Spermatogenic failure, Y-linked, 2, 415000 (3)'),
('400005','USP9Y','Spermatogenic failure, Y-linked, 2, 415000 (3)'),
('400020','SHOXY','dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)'),
('400020','SHOXY','Short stature, idiopathic familial, 300582 (3); Leri-Weill'),
('400042','CYDELq11','Spermatogenic failure, Y-linked, 1 (4)'),
('400042','DELYq11','Spermatogenic failure, Y-linked, 1 (4)'),
('400042','SPGFY1','Spermatogenic failure, Y-linked, 1 (4)'),
('400043','DFNY1','Deafness, Y-linked 1 (1)'),
('425500','HEY','?Hairy ears, Y-linked (2)'),
('480000','SRXX1','46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)'),
('480000','SRXY1','46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)'),
('480000','SRY','46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)'),
('480000','TDF','46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)'),
('480000','TDY','46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)'),
('600003','CACNB2','Brugada syndrome 4, 611876 (3)'),
('600005','C2TA','(3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('600005','MHC2TA','(3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('600005','C2TA','Bare lymphocyte syndrome, type II, complementation group A, 209920'),
('600005','MHC2TA','Bare lymphocyte syndrome, type II, complementation group A, 209920'),
('600008','NNMT','Homocysteine plasma level (2)'),
('600014','NCBRS','Nicolaides-Baraitser syndrome, 601358 (3)'),
('600014','SMARCA2','Nicolaides-Baraitser syndrome, 601358 (3)'),
('600014','SNF2L2','Nicolaides-Baraitser syndrome, 601358 (3)'),
('600016','CNTN1','Myopathy, congenital, Compton-North, 612540 (3)'),
('600020','MXI1','Neurofibrosarcoma (3);'),
('600020','MXI1','{Prostate cancer, susceptibility to}, 176807 (3)'),
('600024','LBR','Pelger-Huet anomaly, 169400 (3); HEM skeletal dysplasia, 215140 (3);'),
('600024','PHA','Pelger-Huet anomaly, 169400 (3); HEM skeletal dysplasia, 215140 (3);'),
('600024','LBR','Reynolds syndrome, 613471 (3)'),
('600024','PHA','Reynolds syndrome, 613471 (3)'),
('600028','DLX5','220600 (3)'),
('600028','SHFM1D','220600 (3)'),
('600028','DLX5','Split-hand/foot malformation 1 with sensorineural hearing loss,'),
('600028','SHFM1D','Split-hand/foot malformation 1 with sensorineural hearing loss,'),
('600031','CHIT','[Chitotriosidase deficiency], 614122 (3)'),
('600031','CHITD','[Chitotriosidase deficiency], 614122 (3)'),
('600035','EMX2','Schizencephaly, 269160 (3)'),
('600037','CPHD6','deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, and pituitary dysfunction, 610125 (3)'),
('600037','MCOPS5','deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, and pituitary dysfunction, 610125 (3)'),
('600037','OTX2','deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, and pituitary dysfunction, 610125 (3)'),
('600037','CPHD6','Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone'),
('600037','MCOPS5','Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone'),
('600037','OTX2','Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone'),
('600040','BAX','Colorectal cancer (3); T-cell acute lymphoblastic leukemia (3)'),
('600044','MGDF','Thrombocythemia 1, 187950 (3)'),
('600044','MPLLG','Thrombocythemia 1, 187950 (3)'),
('600044','THCYT1','Thrombocythemia 1, 187950 (3)'),
('600044','THPO','Thrombocythemia 1, 187950 (3)'),
('600044','TPO','Thrombocythemia 1, 187950 (3)'),
('600045','DDB1','Xeroderma pigmentosum, group E, subtype 2 (1)'),
('600046','ABC1','Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3);'),
('600046','ABCA1','Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3);'),
('600046','HDLDT1','Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3);'),
('600046','TGD','Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3);'),
('600046','ABC1','{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)'),
('600046','ABCA1','{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)'),
('600046','HDLDT1','{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)'),
('600046','TGD','{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)'),
('600048','BRCATA','Breast cancer, 11:22 translocation associated (1)'),
('600049','MDS1','Myelodysplasia syndrome-1 (3)'),
('600053','ACHM2','Achromatopsia-2, 216900 (3)'),
('600053','CNG3','Achromatopsia-2, 216900 (3)'),
('600053','CNGA3','Achromatopsia-2, 216900 (3)'),
('600065','CD18','Leukocyte adhesion deficiency, 116920 (3)'),
('600065','ITGB2','Leukocyte adhesion deficiency, 116920 (3)'),
('600065','LAD','Leukocyte adhesion deficiency, 116920 (3)'),
('600065','LCAMB','Leukocyte adhesion deficiency, 116920 (3)'),
('600073','DBS','Donnai-Barrow syndrome, 222448 (3)'),
('600073','LRP2','Donnai-Barrow syndrome, 222448 (3)'),
('600074','CD24','{Multiple sclerosis, susceptibility to}, 126200 (3)'),
('600075','HDL4','Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease,'),
('600075','SCA17','Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease,'),
('600075','TBP','Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease,'),
('600075','HDL4','susceptibility to}, 168600 (3)'),
('600075','SCA17','susceptibility to}, 168600 (3)'),
('600075','TBP','susceptibility to}, 168600 (3)'),
('600079','PTPG1','Colon cancer (3)'),
('600079','PTPN12','Colon cancer (3)'),
('600089','PBCA','?Diabetes mellitus, insulin-dependent, neonatal (2)'),
('600098','RRAS2','Ovarian carcinoma (3)'),
('600098','TC21','Ovarian carcinoma (3)'),
('600108','CLG3','Metaphyseal anadysplasia 1, 602111 (3)'),
('600108','MANDP1','Metaphyseal anadysplasia 1, 602111 (3)'),
('600108','MMP13','Metaphyseal anadysplasia 1, 602111 (3)'),
('600108','CLG3','Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3);'),
('600108','MANDP1','Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3);'),
('600108','MMP13','Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3);'),
('600111','EA6','Episodic ataxia, type 6, 612656 (3)'),
('600111','EAAT1','Episodic ataxia, type 6, 612656 (3)'),
('600111','SLC1A3','Episodic ataxia, type 6, 612656 (3)'),
('600112','CMT20','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','DNCL','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','DNECL','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','DYNC1H1','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','MRD13','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','SMALED','Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3);'),
('600112','CMT20','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600112','DNCL','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600112','DNECL','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600112','DYNC1H1','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600112','MRD13','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600112','SMALED','Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)'),
('600119','ADL','Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,'),
('600119','DAG2','Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,'),
('600119','DMDA2','Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,'),
('600119','LGMD2D','Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,'),
('600119','SGCA','Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,'),
('600119','ADL','primary (1)'),
('600119','DAG2','primary (1)'),
('600119','DMDA2','primary (1)'),
('600119','LGMD2D','primary (1)'),
('600119','SGCA','primary (1)'),
('600129','ACRDYS2','with or without hormone resistance, 614613 (3)'),
('600129','DPDE3','with or without hormone resistance, 614613 (3)'),
('600129','PDE4D','with or without hormone resistance, 614613 (3)'),
('600129','STRK1','with or without hormone resistance, 614613 (3)'),
('600129','ACRDYS2','{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2,'),
('600129','DPDE3','{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2,'),
('600129','PDE4D','{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2,'),
('600129','STRK1','{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2,'),
('600131','ECA1','Epilepsy, childhood absence, 1 (2)'),
('600140','CBP','Rubinstein-Taybi syndrome, 180849 (3)'),
('600140','CREBBP','Rubinstein-Taybi syndrome, 180849 (3)'),
('600140','RSTS','Rubinstein-Taybi syndrome, 180849 (3)'),
('600150','KCNMA1','Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)'),
('600150','SLO','Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)'),
('600156','HSCR5','{Hirschsprung disease, susceptibility to, 5} (2)'),
('600160','CDKN2A','(3)'),
('600160','CMM2','(3)'),
('600160','MLM','(3)'),
('600160','MTS1','(3)'),
('600160','P16','(3)'),
('600160','CDKN2A','151623 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple,'),
('600160','CMM2','151623 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple,'),
('600160','MLM','151623 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple,'),
('600160','MTS1','151623 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple,'),
('600160','P16','151623 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple,'),
('600160','CDKN2A','{Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,'),
('600160','CMM2','{Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,'),
('600160','MLM','{Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,'),
('600160','MTS1','{Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,'),
('600160','P16','{Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,'),
('600163','CDCD2','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','CMD1E','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','HB1','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','LQT3','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','SCN5A','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','SSS1','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','VF1','block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus'),
('600163','CDCD2','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','CMD1E','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','HB1','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','LQT3','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','SCN5A','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','SSS1','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','VF1','Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart'),
('600163','CDCD2','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','CMD1E','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','HB1','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','LQT3','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','SCN5A','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','SSS1','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600163','VF1','syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)'),
('600165','NNO1','Nanophthalmos-1 (2)'),
('600170','AQP3','[Blood group GIL], 607457 (3)'),
('600173','JAK3','SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)'),
('600173','JAKL','SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)'),
('600175','SMAL','(2)'),
('600175','SMAL','Spinal muscular atrophy, congenital nonprogressive, of lower limbs'),
('600179','CORD6','601777(3)'),
('600179','GUC2D','601777(3)'),
('600179','GUCY2D','601777(3)'),
('600179','LCA1','601777(3)'),
('600179','RCD2','601777(3)'),
('600179','CORD6','Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,'),
('600179','GUC2D','Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,'),
('600179','GUCY2D','Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,'),
('600179','LCA1','Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,'),
('600179','RCD2','Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,'),
('600184','CAT1','?Carnitine acetyltransferase deficiency (1)'),
('600184','CRAT','?Carnitine acetyltransferase deficiency (1)'),
('600185','BRCA2','complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3);'),
('600185','BROVCA2','complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3);'),
('600185','FANCD1','complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3);'),
('600185','GLM3','complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3);'),
('600185','PNCA2','complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3);'),
('600185','BRCA2','{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,'),
('600185','BROVCA2','{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,'),
('600185','FANCD1','{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,'),
('600185','GLM3','{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,'),
('600185','PNCA2','{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,'),
('600185','BRCA2','{Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)'),
('600185','BROVCA2','{Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)'),
('600185','FANCD1','{Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)'),
('600185','GLM3','{Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)'),
('600185','PNCA2','{Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)'),
('600192','SS18','Sarcoma, synovial (1)'),
('600192','SSXT','Sarcoma, synovial (1)'),
('600192','SYT','Sarcoma, synovial (1)'),
('600193','WS2B','Waardenburg syndrome, type 2B (2)'),
('600194','KRT2','Ichthyosis bullosa of Siemens, 146800 (3)'),
('600194','KRT2A','Ichthyosis bullosa of Siemens, 146800 (3)'),
('600194','KRT2E','Ichthyosis bullosa of Siemens, 146800 (3)'),
('600201','AGTIL','[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)'),
('600201','ASIP','[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)'),
('600201','SHEP9','[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)'),
('600201','AGTIL','[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3);'),
('600201','ASIP','[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3);'),
('600201','SHEP9','[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3);'),
('600209','EXT3','Exostoses, multiple, type 3 (2)'),
('600211','AML3','Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)'),
('600211','CBFA1','Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)'),
('600211','PEBP2A1','Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)'),
('600211','RUNX2','Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)'),
('600220','FCAS3','Familial cold autoinflammatory syndrome 3, 614468 (3)'),
('600220','PLCG2','Familial cold autoinflammatory syndrome 3, 614468 (3)'),
('600221','TEK','Venous malformations, multiple cutaneous and mucosal, 600195 (3)'),
('600221','TIE2','Venous malformations, multiple cutaneous and mucosal, 600195 (3)'),
('600221','VMCM','Venous malformations, multiple cutaneous and mucosal, 600195 (3)'),
('600223','SCA4','Spinocerebellar ataxia 4 (2)'),
('600225','DYT5','128230 (3); Hyperpehnylalaninemia, BH4-deficient, B, 233910 (3)'),
('600225','GCH1','128230 (3); Hyperpehnylalaninemia, BH4-deficient, B, 233910 (3)'),
('600225','HPABH4B','128230 (3); Hyperpehnylalaninemia, BH4-deficient, B, 233910 (3)'),
('600225','DYT5','Dystonia, DOPA-responsive, with or without hyperphenylalainemia,'),
('600225','GCH1','Dystonia, DOPA-responsive, with or without hyperphenylalainemia,'),
('600225','HPABH4B','Dystonia, DOPA-responsive, with or without hyperphenylalainemia,'),
('600228','BESC2','or without elevated sweat chloride 2, 613021 (3)'),
('600228','SCNN1A','or without elevated sweat chloride 2, 613021 (3)'),
('600228','BESC2','Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with'),
('600228','SCNN1A','Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with'),
('600231','PPKB','Palmoplantar keratoderma, Bothnia type (2)'),
('600234','HMGCS2','HMG-CoA synthase-2 deficiency, 605911 (3)'),
('600235','GEFSP1','Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3)'),
('600235','SCN1B','Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3)'),
('600235','GEFSP1','Generalized epilepsy with febrile seizures plus, type 1, 604233 (3);'),
('600235','SCN1B','Generalized epilepsy with febrile seizures plus, type 1, 604233 (3);'),
('600244','PDCD1','{Multiple sclerosis, disease progression, modifier of}, 126200 (3)'),
('600244','SLEB2','{Multiple sclerosis, disease progression, modifier of}, 126200 (3)'),
('600244','PDCD1','{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3);'),
('600244','SLEB2','{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3);'),
('600257','C8DELq12q21','Bor-Duane hydrocephalus contiguous gene syndrome'),
('600257','DEL8q12q21','Bor-Duane hydrocephalus contiguous gene syndrome'),
('600259','HNPCC4','hereditary nonpolyposis, type 4, 614337 (3)'),
('600259','PMS2','hereditary nonpolyposis, type 4, 614337 (3)'),
('600259','PMSL2','hereditary nonpolyposis, type 4, 614337 (3)'),
('600259','HNPCC4','Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer,'),
('600259','PMS2','Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer,'),
('600259','PMSL2','Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer,'),
('600266','NRAMP','(3); {Buruli ulcer, susceptibility to}, 610446 (3)'),
('600266','NRAMP1','(3); {Buruli ulcer, susceptibility to}, 610446 (3)'),
('600266','SLC11A1','(3); {Buruli ulcer, susceptibility to}, 610446 (3)'),
('600266','NRAMP','{Mycobacterium tuberculosis, susceptibility to infection by}, 607948'),
('600266','NRAMP1','{Mycobacterium tuberculosis, susceptibility to infection by}, 607948'),
('600266','SLC11A1','{Mycobacterium tuberculosis, susceptibility to infection by}, 607948'),
('600271','DSC3','Hypotrichosis and recurrent skin vesicles, 613102 (3)'),
('600271','DSC4','Hypotrichosis and recurrent skin vesicles, 613102 (3)'),
('600273','PKDTS','(4)'),
('600273','PKDTS','Polycystic kidney disease, infantile severe, with tuberous sclerosis'),
('600275','AGS2','Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)'),
('600275','HJCYS','Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)'),
('600275','NOTCH2','Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)'),
('600276','CADASIL','Cerebral arteriopathy with subcortical infarcts and'),
('600276','CASIL','Cerebral arteriopathy with subcortical infarcts and'),
('600276','NOTCH3','Cerebral arteriopathy with subcortical infarcts and'),
('600276','CADASIL','leukoencephalopathy, 125310 (3)'),
('600276','CASIL','leukoencephalopathy, 125310 (3)'),
('600276','NOTCH3','leukoencephalopathy, 125310 (3)'),
('600279','D1S2223E','Zellweger syndrome, 214100 (3)'),
('600279','HK33','Zellweger syndrome, 214100 (3)'),
('600279','PEX19','Zellweger syndrome, 214100 (3)'),
('600279','PXF','Zellweger syndrome, 214100 (3)'),
('600281','HNF4A','125853 (3)'),
('600281','MODY1','125853 (3)'),
('600281','TCF14','125853 (3)'),
('600281','HNF4A','MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent},'),
('600281','MODY1','MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent},'),
('600281','TCF14','MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent},'),
('600287','CMT2D','Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal'),
('600287','GARS','Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal'),
('600287','HMN5','Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal'),
('600287','SMAD1','Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal'),
('600287','CMT2D','hereditary motor, type V, 600794 (3)'),
('600287','GARS','hereditary motor, type V, 600794 (3)'),
('600287','HMN5','hereditary motor, type V, 600794 (3)'),
('600287','SMAD1','hereditary motor, type V, 600794 (3)'),
('600299','PCM1','Thyroid carcinoma, papillary, 188550 (3)'),
('600299','PTC4','Thyroid carcinoma, papillary, 188550 (3)'),
('600301','ACADSB','2-methylbutyrylglycinuria, 610006 (3)'),
('600301','SBCAD','2-methylbutyrylglycinuria, 610006 (3)'),
('600310','COMP','132400 (3)'),
('600310','EDM1','132400 (3)'),
('600310','MED','132400 (3)'),
('600310','PSACH','132400 (3)'),
('600310','COMP','Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1,'),
('600310','EDM1','Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1,'),
('600310','MED','Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1,'),
('600310','PSACH','Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1,'),
('600318','IDDM3','{Diabetes mellitus, insulin-dependent, 3} (2)'),
('600319','IDDM4','{Diabetes mellitus, insulin-dependent, 4} (2)'),
('600321','IDDM7','{Diabetes mellitus, insulin-dependent, 7} (2)'),
('600332','RMD1','Rippling muscle disease-1 (2)'),
('600342','RGR','Retinitis pigmentosa 44, 613769 (3)'),
('600342','RP44','Retinitis pigmentosa 44, 613769 (3)'),
('600354','SMA1','253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)'),
('600354','SMA2','253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)'),
('600354','SMA3','253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)'),
('600354','SMA4','253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)'),
('600354','SMN1','253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)'),
('600354','SMA1','Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,'),
('600354','SMA2','Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,'),
('600354','SMA3','Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,'),
('600354','SMA4','Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,'),
('600354','SMN1','Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,'),
('600358','GMPS','Leukemia, acute myelogenous, 601626 (3)'),
('600359','KCNJ1','Bartter syndrome, type 2, 241200 (3)'),
('600359','ROMK1','Bartter syndrome, type 2, 241200 (3)'),
('600364','COD3','Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)'),
('600364','CORD14','Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)'),
('600364','GCAP','Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)'),
('600364','GUCA1A','Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)'),
('600370','PHC','Micochondrial phosphate carrier deficiency, 610773 (3)'),
('600370','SLC25A3','Micochondrial phosphate carrier deficiency, 610773 (3)'),
('600374','BBS4','Bardet-Biedl syndrome 4, 209900 (3)'),
('600383','C8DELq13','Mesomelia-synostoses syndrome (4)'),
('600383','DEL8q13','Mesomelia-synostoses syndrome (4)'),
('600414','PEX5','214100 (3)'),
('600414','PTS1R','214100 (3)'),
('600414','PXR1','214100 (3)'),
('600414','PEX5','Adrenoleukodystrophy, neonatal, 202370 (3); Zellweger syndrome,'),
('600414','PTS1R','Adrenoleukodystrophy, neonatal, 202370 (3); Zellweger syndrome,'),
('600414','PXR1','Adrenoleukodystrophy, neonatal, 202370 (3); Zellweger syndrome,'),
('600415','AVED','Ataxia with isolated vitamin E deficiency, 277460 (3)'),
('600415','TTP1','Ataxia with isolated vitamin E deficiency, 277460 (3)'),
('600415','TTPA','Ataxia with isolated vitamin E deficiency, 277460 (3)'),
('600423','ECE1','613870 (3); {Hypertension, essential, susceptibility to}, 145500 (3)'),
('600423','ECE1','Hirschsprung disease, cardiac defects, and autonomic dysfunction,'),
('600429','GCNT2','cataract, 110800 (3); Adult i phenotype without cataract, 110800 (3)'),
('600429','GCNT2','[Blood group, Ii], 110800 (3); Adult i phenotype with congenital'),
('600450','AKR1C2','Obesity, hyperphagia, and developmental delay (3); 46XY sex'),
('600450','DD2','Obesity, hyperphagia, and developmental delay (3); 46XY sex'),
('600450','DDH2','Obesity, hyperphagia, and developmental delay (3); 46XY sex'),
('600450','HAKRD','Obesity, hyperphagia, and developmental delay (3); 46XY sex'),
('600450','SRXY8','Obesity, hyperphagia, and developmental delay (3); 46XY sex'),
('600450','AKR1C2','reversal 8, 614279 (3)'),
('600450','DD2','reversal 8, 614279 (3)'),
('600450','DDH2','reversal 8, 614279 (3)'),
('600450','HAKRD','reversal 8, 614279 (3)'),
('600450','SRXY8','reversal 8, 614279 (3)'),
('600451','AKR1C4','{46XY sex reversal 8, modifier of}, 614279 (3)'),
('600451','CDR','{46XY sex reversal 8, modifier of}, 614279 (3)'),
('600451','CHDR','{46XY sex reversal 8, modifier of}, 614279 (3)'),
('600451','DD4','{46XY sex reversal 8, modifier of}, 614279 (3)'),
('600451','HAKRA','{46XY sex reversal 8, modifier of}, 614279 (3)'),
('600456','NTRK2','Obesity, hyperphagia, and developmental delay, 613886 (3)'),
('600456','TRKB','Obesity, hyperphagia, and developmental delay, 613886 (3)'),
('600467','MHS4','{Malignant hyperthermia susceptibility 4} (2)'),
('600478','SKI2','Trichohepatoenteric syndrome 2, 614602 (3)'),
('600478','SKI2W','Trichohepatoenteric syndrome 2, 614602 (3)'),
('600478','SKIV2L','Trichohepatoenteric syndrome 2, 614602 (3)'),
('600478','THES2','Trichohepatoenteric syndrome 2, 614602 (3)'),
('600483','FGF8','Kallmann syndrome 6, 612702 (3)'),
('600483','KAL6','Kallmann syndrome 6, 612702 (3)'),
('600495','EIF4G','Parkinson disease 18, 614251 (3)'),
('600495','EIF4G1','Parkinson disease 18, 614251 (3)'),
('600495','PARK18','Parkinson disease 18, 614251 (3)'),
('600502','CATF1','Neuronopathy, distal hereditary motor, type VI, 604320 (3)'),
('600502','HMN6','Neuronopathy, distal hereditary motor, type VI, 604320 (3)'),
('600502','IGHMBP2','Neuronopathy, distal hereditary motor, type VI, 604320 (3)'),
('600502','SMARD1','Neuronopathy, distal hereditary motor, type VI, 604320 (3)'),
('600502','SMUBP2','Neuronopathy, distal hereditary motor, type VI, 604320 (3)'),
('600509','ABCC8','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','HHF1','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','PHHI','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','SUR','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','SUR1','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','TNDM2','125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)'),
('600509','ABCC8','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','HHF1','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','PHHI','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','SUR','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','SUR1','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','TNDM2','Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);'),
('600509','ABCC8','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600509','HHF1','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600509','PHHI','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600509','SUR','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600509','SUR1','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600509','TNDM2','Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2,  610374 (3); Diabetes mellitus, noninsulin-dependent,'),
('600510','GPDS1','Pigment dispersion syndrome (2)'),
('600510','PDS1','Pigment dispersion syndrome (2)'),
('600511','SCZD3','{Schizophrenia}, 181500 (2)'),
('600514','LIS2','Lissencephaly 2 (Norman-Roberts type), 257320 (3)'),
('600514','RELN','Lissencephaly 2 (Norman-Roberts type), 257320 (3)'),
('600514','RL','Lissencephaly 2 (Norman-Roberts type), 257320 (3)'),
('600515','BDPLT8','Bleeding disorder, platelet-type, 8, 609821 (3)'),
('600515','P2RY12','Bleeding disorder, platelet-type, 8, 609821 (3)'),
('600515','P2Y12','Bleeding disorder, platelet-type, 8, 609821 (3)'),
('600521','3MC1','3MC syndrome 1, 257920 (3)'),
('600521','CRARF','3MC syndrome 1, 257920 (3)'),
('600521','MASP1','3MC syndrome 1, 257920 (3)'),
('600522','PLA2G4','Phospholipase A2, group IV A, deficiency of (3)'),
('600522','PLA2G4A','Phospholipase A2, group IV A, deficiency of (3)'),
('600523','NRAMP2','Anemia, hypochromic microcytic, 206100 (3)'),
('600525','AI4','hypomaturation-hypoplastic type, with taurodontism, 104510 (3)'),
('600525','DLX3','hypomaturation-hypoplastic type, with taurodontism, 104510 (3)'),
('600525','TDO','hypomaturation-hypoplastic type, with taurodontism, 104510 (3)'),
('600525','AI4','Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta,'),
('600525','DLX3','Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta,'),
('600525','TDO','Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta,'),
('600528','CPT1A','CPT deficiency, hepatic, type IA, 255120 (3)'),
('600529','AUH','3-methylglutaconic aciduria, type I, 250950 (3)'),
('600532','NDUFV2','Mitochondrial complex I deficiency, 252010 (3)'),
('600536','ITGA7','Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)'),
('600542','CSMF','Chondrosarcoma, extraskeletal myxoid, 612237 (3)'),
('600555','CANDF7','Mycobacterial and viral infections, susceptibility to, autosomal recessive, 613796 (3); Candidiasis, familial, 7, 614162 (3)'),
('600555','STAT1','Mycobacterial and viral infections, susceptibility to, autosomal recessive, 613796 (3); Candidiasis, familial, 7, 614162 (3)'),
('600555','CANDF7','Mycobacterial infection, atypical, familial disseminated, 209950 (3);'),
('600555','STAT1','Mycobacterial infection, atypical, familial disseminated, 209950 (3);'),
('600564','ITIH4','{Hypercholesterolemia, susceptibility to}, 143890 (3)'),
('600564','ITIHL1','{Hypercholesterolemia, susceptibility to}, 143890 (3)'),
('600564','PK120','{Hypercholesterolemia, susceptibility to}, 143890 (3)'),
('600565','NRXN1','Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia,'),
('600565','PTHSL2','Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia,'),
('600565','SCZD17','Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia,'),
('600565','NRXN1','susceptibility to, 17}, 614332 (3)'),
('600565','PTHSL2','susceptibility to, 17}, 614332 (3)'),
('600565','SCZD17','susceptibility to, 17}, 614332 (3)'),
('600570','CLCN2','{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)'),
('600570','ECA2','{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)'),
('600570','EGI11','{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)'),
('600570','EGMA','{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)'),
('600570','EJM8','{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)'),
('600570','CLCN2','{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);'),
('600570','ECA2','{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);'),
('600570','EGI11','{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);'),
('600570','EGMA','{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);'),
('600570','EJM8','{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);'),
('600576','ASD2','614429 (3); Atrioventricular septal defect 4, 614430 (3)'),
('600576','GATA4','614429 (3); Atrioventricular septal defect 4, 614430 (3)'),
('600576','VSD1','614429 (3); Atrioventricular septal defect 4, 614430 (3)'),
('600576','ASD2','Atrial septal defect 2, 607941 (3); Ventricular septal defect 1,'),
('600576','GATA4','Atrial septal defect 2, 607941 (3); Ventricular septal defect 1,'),
('600576','VSD1','Atrial septal defect 2, 607941 (3); Ventricular septal defect 1,'),
('600577','CPHD3','Pituitary hormone deficiency, combined, 3, 221750 (3)'),
('600577','LHX3','Pituitary hormone deficiency, combined, 3, 221750 (3)'),
('600579','GLEPP1','Nephrotic syndrome, type 6, 614196 (3)'),
('600579','NPHS6','Nephrotic syndrome, type 6, 614196 (3)'),
('600579','PTPRO','Nephrotic syndrome, type 6, 614196 (3)'),
('600584','CHNG5','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','CSX','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','HLHS2','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','NKX2-5','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','NKX2E','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','VSD3','108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3);'),
('600584','CHNG5','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','CSX','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','HLHS2','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','NKX2-5','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','NKX2E','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','VSD3','Atrial septal defect 7, with or without AV conduction defects,'),
('600584','CHNG5','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600584','CSX','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600584','HLHS2','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600584','NKX2-5','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600584','NKX2E','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600584','VSD3','Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)'),
('600593','CRS3','Craniosynostosis, Adelaide type (2)'),
('600593','CRSA','Craniosynostosis, Adelaide type (2)'),
('600599','EKLF','Blood group--Lutheran inhibitor, 111150 (3); [Hereditary'),
('600599','HBFQTL6','Blood group--Lutheran inhibitor, 111150 (3); [Hereditary'),
('600599','INLU','Blood group--Lutheran inhibitor, 111150 (3); [Hereditary'),
('600599','KLF1','Blood group--Lutheran inhibitor, 111150 (3); [Hereditary'),
('600599','EKLF','persistence of fetal hemoglobin], 613566 (3); Anemia, dyserythropoietic congenital, type IV, 613673 (3)'),
('600599','HBFQTL6','persistence of fetal hemoglobin], 613566 (3); Anemia, dyserythropoietic congenital, type IV, 613673 (3)'),
('600599','INLU','persistence of fetal hemoglobin], 613566 (3); Anemia, dyserythropoietic congenital, type IV, 613673 (3)'),
('600599','KLF1','persistence of fetal hemoglobin], 613566 (3); Anemia, dyserythropoietic congenital, type IV, 613673 (3)'),
('600617','STAR','Lipoid adrenal hyperplasia, 201710 (3)'),
('600618','ETV6','Leukemia, acute myeloid, somatic, 601626 (3)'),
('600618','TEL','Leukemia, acute myeloid, somatic, 601626 (3)'),
('600623','CD82','{Prostate cancer, susceptibility to}, 176807 (2)'),
('600623','KAI1','{Prostate cancer, susceptibility to}, 176807 (2)'),
('600623','SAR2','{Prostate cancer, susceptibility to}, 176807 (2)'),
('600623','ST6','{Prostate cancer, susceptibility to}, 176807 (2)'),
('600624','CORD1','Cone-rod retinal dystrophy-1 (2)'),
('600624','CRD1','Cone-rod retinal dystrophy-1 (2)'),
('600631','ENUR1','Enuresis, nocturnal, 1 (2)'),
('600632','OPCML','{Ovarian cancer, somatic}, 167000 (3)'),
('600635','NKX2-1','benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)'),
('600635','NKX2A','benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)'),
('600635','TITF1','benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)'),
('600635','TTF1','benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)'),
('600635','NKX2-1','Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary'),
('600635','NKX2A','Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary'),
('600635','TITF1','Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary'),
('600635','TTF1','Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary'),
('600644','CLPED1','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','ED4','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','HVEC','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','OFC7','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','PRR1','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','PVRL1','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','PVRR1','Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);'),
('600644','CLPED1','Orofacial cleft 7, 225060 (3)'),
('600644','ED4','Orofacial cleft 7, 225060 (3)'),
('600644','HVEC','Orofacial cleft 7, 225060 (3)'),
('600644','OFC7','Orofacial cleft 7, 225060 (3)'),
('600644','PRR1','Orofacial cleft 7, 225060 (3)'),
('600644','PVRL1','Orofacial cleft 7, 225060 (3)'),
('600644','PVRR1','Orofacial cleft 7, 225060 (3)'),
('600650','CPT2','hepatic, type II, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)'),
('600650','IIAE4','hepatic, type II, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)'),
('600650','CPT2','Myopathy due to CPT II deficiency, 255110 (3); CPT deficiency,'),
('600650','IIAE4','Myopathy due to CPT II deficiency, 255110 (3); CPT deficiency,'),
('600660','ADCAD1','{Coronary artery disease, autosomal dominant, 1}, 608320 (3)'),
('600660','MEF2A','{Coronary artery disease, autosomal dominant, 1}, 608320 (3)'),
('600662','C5DELq14.3; DEL5q14.','cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)'),
('600662','MEF2C','cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)'),
('600662','C5DELq14.3; DEL5q14.','Mental retardation, stereotypic movements, epilepsy, and/or'),
('600662','MEF2C','Mental retardation, stereotypic movements, epilepsy, and/or'),
('600664','CHUK','Cocoon syndrome, 613630 (3)'),
('600664','IKBKA','Cocoon syndrome, 613630 (3)'),
('600664','IKK1','Cocoon syndrome, 613630 (3)'),
('600664','IKKA','Cocoon syndrome, 613630 (3)'),
('600664','NFKBIKA','Cocoon syndrome, 613630 (3)'),
('600668','CCAL1','Chondrocalcinosis with early-onset osteoarthritis (2)'),
('600669','EIG1','{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)'),
('600675','CMM6','susceptibility to}, 114480 (3)'),
('600675','XRCC3','susceptibility to}, 114480 (3)'),
('600675','CMM6','{Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer,'),
('600675','XRCC3','{Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer,'),
('600678','GTBP','Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3);'),
('600678','HNPCC5','Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3);'),
('600678','MSH6','Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3);'),
('600678','GTBP','Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('600678','HNPCC5','Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('600678','MSH6','Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('600681','ATFB9','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','HHIRK1','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','IRK1','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','KCNJ2','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','KIR2.1','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','LQT7','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','SQT3','Atrial fibrillation, familial, 9, 613980 (3)'),
('600681','ATFB9','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','HHIRK1','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','IRK1','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','KCNJ2','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','KIR2.1','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','LQT7','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600681','SQT3','Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);'),
('600682','HHF7','Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic'),
('600682','MCT1','Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic'),
('600682','SLC16A1','Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic'),
('600682','HHF7','hypoglycemia, familial, 7, 610021 (3)'),
('600682','MCT1','hypoglycemia, familial, 7, 610021 (3)'),
('600682','SLC16A1','hypoglycemia, familial, 7, 610021 (3)'),
('600692','AMCD2B','Arthyrgryposis, distal, type 2B, 601680 (3)'),
('600692','DA2B','Arthyrgryposis, distal, type 2B, 601680 (3)'),
('600692','FSSV','Arthyrgryposis, distal, type 2B, 601680 (3)'),
('600692','TNNT3','Arthyrgryposis, distal, type 2B, 601680 (3)'),
('600698','BABL','Leiomyoma, uterine, somatic, 150699 (2)'),
('600698','HMGA2','Leiomyoma, uterine, somatic, 150699 (2)'),
('600698','HMGIC','Leiomyoma, uterine, somatic, 150699 (2)'),
('600700','LPP','Lipoma (3); Leukemia, acute myeloid, 601626 (3)'),
('600701','HMGA1','125853 (3)'),
('600701','HMGIY','125853 (3)'),
('600701','HMGA1','{Diabetes mellitus, noninsulin-dependent, susceptibility to},'),
('600701','HMGIY','{Diabetes mellitus, noninsulin-dependent, susceptibility to},'),
('600702','CIAT','Cognitive impairment with or without cerebellar ataxia, 614306 (3);'),
('600702','EIEE13','Cognitive impairment with or without cerebellar ataxia, 614306 (3);'),
('600702','SCN8A','Cognitive impairment with or without cerebellar ataxia, 614306 (3);'),
('600702','CIAT','Epileptic encephalopathy, early infantile, 13, 614558 (3)'),
('600702','EIEE13','Epileptic encephalopathy, early infantile, 13, 614558 (3)'),
('600702','SCN8A','Epileptic encephalopathy, early infantile, 13, 614558 (3)'),
('600713','HSD11','Cortisone reductase deficiency, 604931 (3)'),
('600713','HSD11B1','Cortisone reductase deficiency, 604931 (3)'),
('600713','HSD11L','Cortisone reductase deficiency, 604931 (3)'),
('600716','LYP','arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)'),
('600716','PEP','arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)'),
('600716','PTPN22','arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)'),
('600716','PTPN8','arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)'),
('600716','LYP','{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid'),
('600716','PEP','{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid'),
('600716','PTPN22','{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid'),
('600716','PTPN8','{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid'),
('600722','CLN1','Ceroid lipofuscinosis, neuronal, 1, 256730 (3)'),
('600722','PPT1','Ceroid lipofuscinosis, neuronal, 1, 256730 (3)'),
('600724','CNCG2','Retinitis pigmentosa 45, 613767 (3)'),
('600724','CNCG3L','Retinitis pigmentosa 45, 613767 (3)'),
('600724','CNGB1','Retinitis pigmentosa 45, 613767 (3)'),
('600724','RP45','Retinitis pigmentosa 45, 613767 (3)'),
('600725','HLP3','Holoprosencephaly-3, 142945 (3); Single median maxillary central'),
('600725','HPE3','Holoprosencephaly-3, 142945 (3); Single median maxillary central'),
('600725','MCOPCB5','Holoprosencephaly-3, 142945 (3); Single median maxillary central'),
('600725','SHH','Holoprosencephaly-3, 142945 (3); Single median maxillary central'),
('600725','SMMCI','Holoprosencephaly-3, 142945 (3); Single median maxillary central'),
('600725','HLP3','incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)'),
('600725','HPE3','incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)'),
('600725','MCOPCB5','incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)'),
('600725','SHH','incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)'),
('600725','SMMCI','incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)'),
('600726','BDA1','112500 (3)'),
('600726','IHH','112500 (3)'),
('600726','BDA1','Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1,'),
('600726','IHH','Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1,'),
('600733','IPF1','mellitus, type II, susceptibility to}, 125853 (3)'),
('600733','MODY4','mellitus, type II, susceptibility to}, 125853 (3)'),
('600733','IPF1','Pancreatic agenesis, 260370 (3); MODY, type IV, 606392 (3); {Diabetes'),
('600733','MODY4','Pancreatic agenesis, 260370 (3); MODY, type IV, 606392 (3); {Diabetes'),
('600734','GIRK4','III, 613677 (3)'),
('600734','KATP1','III, 613677 (3)'),
('600734','KCNJ5','III, 613677 (3)'),
('600734','LQT13','III, 613677 (3)'),
('600734','GIRK4','Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type'),
('600734','KATP1','Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type'),
('600734','KCNJ5','Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type'),
('600734','LQT13','Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type'),
('600740','FBH3','Hypercalciuric hypercalcemia, type III (2)'),
('600740','HHC3','Hypercalciuric hypercalcemia, type III (2)'),
('600749','CEBPE','Specific granule deficiency, 245480 (3)'),
('600749','CRP1','Specific granule deficiency, 245480 (3)'),
('600755','SYN2','{Schizophrenia, susceptibility to}, 181500 (3)'),
('600757','OFC3','Orofacial cleft-3 (2)'),
('600759','AD4','(3)'),
('600759','CMD1V','(3)'),
('600759','PSEN2','(3)'),
('600759','STM2','(3)'),
('600759','AD4','Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697'),
('600759','CMD1V','Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697'),
('600759','PSEN2','Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697'),
('600759','STM2','Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697'),
('600760','BESC1','(3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)'),
('600760','SCNN1B','(3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)'),
('600760','BESC1','Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350'),
('600760','SCNN1B','Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350'),
('600761','BESC3','(3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)'),
('600761','PHA1','(3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)'),
('600761','SCNN1G','(3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)'),
('600761','BESC3','Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350'),
('600761','PHA1','Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350'),
('600761','SCNN1G','Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350'),
('600770','MUC5B','{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('600778','CDKN1B','Multiple endocrine neoplasia, type IV, 610755 (3)'),
('600778','CDKN4','Multiple endocrine neoplasia, type IV, 610755 (3)'),
('600778','KIP1','Multiple endocrine neoplasia, type IV, 610755 (3)'),
('600778','MEN4','Multiple endocrine neoplasia, type IV, 610755 (3)'),
('600781','PYY','{Obesity}, 601665 (3)'),
('600790','CRAPB','Chorioretinal atrophy, progressive bifocal (2)'),
('600790','PBCRA','Chorioretinal atrophy, progressive bifocal (2)'),
('600792','DFNB5','Deafness, autosomal recessive 5 (2)'),
('600797','IRS2','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('600799','BMPR2','Pulmonary hypertension, familial primary, 178600 (3); Pulmonary'),
('600799','PPH1','Pulmonary hypertension, familial primary, 178600 (3); Pulmonary'),
('600799','BMPR2','venoocclusive disease, 265450 (3); Pulmonary hypertension, primary, fenfluramine-associated, 178600 (3)'),
('600799','PPH1','venoocclusive disease, 265450 (3); Pulmonary hypertension, primary, fenfluramine-associated, 178600 (3)'),
('600804','MTNR1B','{Diabetes mellitus, type 2, susceptiblity to}, 125853 (3)'),
('600805','LAMA3','Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)'),
('600805','LOCS','Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)'),
('600805','LAMA3','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('600805','LOCS','Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);'),
('600808','ENUR2','Enuresis, nocturnal, 2 (2)'),
('600811','DDB2','Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)'),
('600814','ATLD','Ataxia-telangiectasia-like disorder, 604391 (3)'),
('600814','MRE11','Ataxia-telangiectasia-like disorder, 604391 (3)'),
('600814','MRE11A','Ataxia-telangiectasia-like disorder, 604391 (3)'),
('600824','CLP','Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,'),
('600824','CMD1M','Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,'),
('600824','CMH12','Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,'),
('600824','CRP3','Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,'),
('600824','CSRP3','Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,'),
('600824','CLP','familial hypertrophic, 12, 612124 (3)'),
('600824','CMD1M','familial hypertrophic, 12, 612124 (3)'),
('600824','CMH12','familial hypertrophic, 12, 612124 (3)'),
('600824','CRP3','familial hypertrophic, 12, 612124 (3)'),
('600824','CSRP3','familial hypertrophic, 12, 612124 (3)'),
('600827','COD4','Cone dystrophy 4, 613093 (3)'),
('600827','PDE6C','Cone dystrophy 4, 613093 (3)'),
('600827','PDEA2','Cone dystrophy 4, 613093 (3)'),
('600835','CXCL12','{AIDS, resistance to}, 609423 (3)'),
('600835','SDF1','{AIDS, resistance to}, 609423 (3)'),
('600837','GDNF','Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma,'),
('600837','HSCR3','Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma,'),
('600837','GDNF','modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)'),
('600837','HSCR3','modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)'),
('600838','FOXN1','601705 (3)'),
('600838','WHN','601705 (3)'),
('600838','FOXN1','T-cell immunodeficiency, congenital alopecia, and nail dystrophy,'),
('600838','WHN','T-cell immunodeficiency, congenital alopecia, and nail dystrophy,'),
('600839','NKCC2','Bartter syndrome, type 1, 601678 (3)'),
('600839','SLC12A1','Bartter syndrome, type 1, 601678 (3)'),
('600842','FGQTL5','[Fasting plasma glucose level QTL 5], 613463 (3)'),
('600842','GCKR','[Fasting plasma glucose level QTL 5], 613463 (3)'),
('600842','GKRP','[Fasting plasma glucose level QTL 5], 613463 (3)'),
('600845','P2RX1','Bleeding disorder due to P2RX1 defect (3)'),
('600845','P2X1','Bleeding disorder due to P2RX1 defect (3)'),
('600855','DYRK1A','Mental retardation, autosomal dominant 7, 614104 (3)'),
('600855','MNB','Mental retardation, autosomal dominant 7, 614104 (3)'),
('600855','MNBH','Mental retardation, autosomal dominant 7, 614104 (3)'),
('600855','MRD7','Mental retardation, autosomal dominant 7, 614104 (3)'),
('600856','BWS','Beckwith-Wiedemann syndrome, 130650 (3)'),
('600856','CDKN1C','Beckwith-Wiedemann syndrome, 130650 (3)'),
('600856','KIP2','Beckwith-Wiedemann syndrome, 130650 (3)'),
('600857','CMD1GG','II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)'),
('600857','PGL5','II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)'),
('600857','SDH1','II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)'),
('600857','SDHA','II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)'),
('600857','SDHF','II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)'),
('600857','CMD1GG','Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex'),
('600857','PGL5','Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex'),
('600857','SDH1','Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex'),
('600857','SDHA','Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex'),
('600857','SDHF','Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex'),
('600871','GFI1','Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)'),
('600871','SCN2','Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)'),
('600871','ZNF163','Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)'),
('600871','GFI1','Neutropenia, severe congenital 2, autosomal dominant, 613107 (3);'),
('600871','SCN2','Neutropenia, severe congenital 2, autosomal dominant, 613107 (3);'),
('600871','ZNF163','Neutropenia, severe congenital 2, autosomal dominant, 613107 (3);'),
('600883','IDDM8','{Diabetes mellitus, insulin-dependent, 8} (2)'),
('600884','CMD1B','Cardiomyopathy, dilated 1B (2)'),
('600884','CMPD1','Cardiomyopathy, dilated 1B (2)'),
('600884','FDC','Cardiomyopathy, dilated 1B (2)'),
('600887','MSH3','Endometrial carcinoma (3)'),
('600890','HADHA','609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)'),
('600890','MTPA','609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)'),
('600890','HADHA','LCHAD deficiency, 609016 (3); Trifunctional protein deficiency,'),
('600890','MTPA','LCHAD deficiency, 609016 (3); Trifunctional protein deficiency,'),
('600897','CAE1','Cataract, zonular pulverulent-1, 116200 (3); Cataract, nuclear'),
('600897','CX50','Cataract, zonular pulverulent-1, 116200 (3); Cataract, nuclear'),
('600897','GJA8','Cataract, zonular pulverulent-1, 116200 (3); Cataract, nuclear'),
('600897','CAE1','progressive (3); Cataract-microcornea syndrome, 116150 (3); Cataract, nuclear pulverulent (3)'),
('600897','CX50','progressive (3); Cataract-microcornea syndrome, 116150 (3); Cataract, nuclear pulverulent (3)'),
('600897','GJA8','progressive (3); Cataract-microcornea syndrome, 116150 (3); Cataract, nuclear pulverulent (3)'),
('600900','LGMD2E','Muscular dystrophy, limb-girdle, type 2E, 604286 (3)'),
('600900','SGCB','Muscular dystrophy, limb-girdle, type 2E, 604286 (3)'),
('600917','PPP1R3','Insulin resistance, severe, digenic, 604367 (3)'),
('600917','PPP1R3A','Insulin resistance, severe, digenic, 604367 (3)'),
('600921','FGF9','Multiple synostoses syndrome 3, 612961 (3)'),
('600921','SYNS3','Multiple synostoses syndrome 3, 612961 (3)'),
('600922','AAT7','Aortic aneurysm, familial thoracic 7, 613780 (3)'),
('600922','MLCK','Aortic aneurysm, familial thoracic 7, 613780 (3)'),
('600922','MYLK','Aortic aneurysm, familial thoracic 7, 613780 (3)'),
('600923','PPOX','Porphyria variegata, 176200 (3)'),
('600924','ALR','hearing loss, and developmental delay, 613076 (3)'),
('600924','ERV1','hearing loss, and developmental delay, 613076 (3)'),
('600924','GFER','hearing loss, and developmental delay, 613076 (3)'),
('600924','ALR','Myopathy, mitochondrial progressive, with congenital cataract,'),
('600924','ERV1','Myopathy, mitochondrial progressive, with congenital cataract,'),
('600924','GFER','Myopathy, mitochondrial progressive, with congenital cataract,'),
('600925','DEP1','Colon cancer, somatic, 114500 (3)'),
('600925','PTPRJ','Colon cancer, somatic, 114500 (3)'),
('600929','CATCN3','Cataract, pulverulent (3); Cataract, congenital nuclear, autosomal'),
('600929','CRYBB1','Cataract, pulverulent (3); Cataract, congenital nuclear, autosomal'),
('600929','CATCN3','recessive 3, 611544 (3)'),
('600929','CRYBB1','recessive 3, 611544 (3)'),
('600935','KCNJ8','?Prinzmetal angina (1)'),
('600936','HMMR','{Breast cancer, susceptibility to}, 114480 (3)'),
('600937','BIR','Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2,'),
('600937','HHF2','Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2,'),
('600937','KCNJ11','Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2,'),
('600937','PHHI','Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2,'),
('600937','TNDM3','Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2,'),
('600937','BIR','Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);'),
('600937','HHF2','Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);'),
('600937','KCNJ11','Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);'),
('600937','PHHI','Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);'),
('600937','TNDM3','Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);'),
('600937','BIR','susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)'),
('600937','HHF2','susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)'),
('600937','KCNJ11','susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)'),
('600937','PHHI','susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)'),
('600937','TNDM3','susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)'),
('600939','CRSDA','Craniosynostosis and dental anomalies, 614188 (3)'),
('600939','IL11RA','Craniosynostosis and dental anomalies, 614188 (3)'),
('600943','CBP1','610504 (3); Osteogenesis imperfecta, type X, 613848 (3)'),
('600943','CBP2','610504 (3); Osteogenesis imperfecta, type X, 613848 (3)'),
('600943','OI10','610504 (3); Osteogenesis imperfecta, type X, 613848 (3)'),
('600943','PPROM','610504 (3); Osteogenesis imperfecta, type X, 613848 (3)'),
('600943','SERPINH2','610504 (3); Osteogenesis imperfecta, type X, 613848 (3)'),
('600943','CBP1','{Preterm premature rupture of the membranes, susceptibility to},'),
('600943','CBP2','{Preterm premature rupture of the membranes, susceptibility to},'),
('600943','OI10','{Preterm premature rupture of the membranes, susceptibility to},'),
('600943','PPROM','{Preterm premature rupture of the membranes, susceptibility to},'),
('600943','SERPINH2','{Preterm premature rupture of the membranes, susceptibility to},'),
('600946','GHR','Laron dwarfism, 262500 (3); Short stature, 604271 (3);'),
('600946','GHR','{Hypercholesterolemia, familial, modification of}, 143890 (3); Increased responsiveness to growth hormone (3)'),
('600950','AANAT','{Delayed sleep phase syndrome, susceptibility to}, 614163 (3)'),
('600950','DSPS','{Delayed sleep phase syndrome, susceptibility to}, 614163 (3)'),
('600950','SNAT','{Delayed sleep phase syndrome, susceptibility to}, 614163 (3)'),
('600956','AMHR','Persistent Mullerian duct syndrome, type II, 261550 (3)'),
('600956','AMHR2','Persistent Mullerian duct syndrome, type II, 261550 (3)'),
('600957','AMH','Persistent Mullerian duct syndrome, type I, 261550 (3)'),
('600957','MIF','Persistent Mullerian duct syndrome, type I, 261550 (3)'),
('600958','CMH4','?Cardiomyopathy, dilated, 115200 (3)'),
('600958','MYBPC3','?Cardiomyopathy, dilated, 115200 (3)'),
('600958','CMH4','Cardiomyopathy, familial hypertrophic, 4, 115197 (3);'),
('600958','MYBPC3','Cardiomyopathy, familial hypertrophic, 4, 115197 (3);'),
('600963','BOR2','Branchiootorenal syndrome 2, 610896 (3)'),
('600963','DMAHP','Branchiootorenal syndrome 2, 610896 (3)'),
('600963','SIX5','Branchiootorenal syndrome 2, 610896 (3)'),
('600964','RDPA','Refsum disease, adult, with increased pipecolicacidemia (2)'),
('600968','NCCT','Gitelman syndrome, 263800 (3)'),
('600968','SLC12A3','Gitelman syndrome, 263800 (3)'),
('600968','TSC','Gitelman syndrome, 263800 (3)'),
('600970','DFNA22','Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal'),
('600970','DFNB37','Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal'),
('600970','MYO6','Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal'),
('600970','DFNA22','recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)'),
('600970','DFNB37','recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)'),
('600970','MYO6','recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)'),
('600975','GLC3B','Glaucoma 3, primary infantile, B (2)'),
('600980','ARHP','Hypophosphatemic rickets, AR, 241520 (3)'),
('600980','ARHR','Hypophosphatemic rickets, AR, 241520 (3)'),
('600980','DMP1','Hypophosphatemic rickets, AR, 241520 (3)'),
('600982','MAP3K1','46XY sex reversal 6, 613762 (3)'),
('600982','MEKK','46XY sex reversal 6, 613762 (3)'),
('600982','MEKK1','46XY sex reversal 6, 613762 (3)'),
('600982','SRXY6','46XY sex reversal 6, 613762 (3)'),
('600983','MCR','Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)'),
('600983','MLR','Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)'),
('600983','NR3C2','Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)'),
('600983','MCR','Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3);'),
('600983','MLR','Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3);'),
('600983','NR3C2','Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3);'),
('600985','EDS3','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','TNX','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','TNXB','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','TNXB1','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','TNXB2','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','TNXBS','deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)'),
('600985','EDS3','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600985','TNX','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600985','TNXB','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600985','TNXB1','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600985','TNXB2','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600985','TNXBS','Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X'),
('600993','DPC4','Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)'),
('600993','JIP','Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)'),
('600993','MADH4','Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)'),
('600993','MYHRS','Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)'),
('600993','SMAD4','Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)'),
('600993','DPC4','Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);'),
('600993','JIP','Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);'),
('600993','MADH4','Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);'),
('600993','MYHRS','Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);'),
('600993','SMAD4','Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);'),
('600997','CAPB','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600997','DRT','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600997','EPHB2','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600997','EPHT3','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600997','ERK','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600997','PCBC','Prostate cancer, progression and metastasis of, 603688 (3)'),
('600998','GNAQ','Bleeding diathesis due to GNAQ deficiency (1)'),
('601002','GSHS','(3); Glutathione synthetase deficiency, 266130 (3)'),
('601002','GSS','(3); Glutathione synthetase deficiency, 266130 (3)'),
('601002','GSHS','Hemolytic anemia due to glutathione synthetase deficiency, 231900'),
('601002','GSS','Hemolytic anemia due to glutathione synthetase deficiency, 231900'),
('601007','LEPR','Obesity, morbid, with hypogonadism (3)'),
('601007','OBR','Obesity, morbid, with hypogonadism (3)'),
('601011','CACNA1A','2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)'),
('601011','CACNL1A4','2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)'),
('601011','SCA6','2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)'),
('601011','CACNA1A','Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type'),
('601011','CACNL1A4','Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type'),
('601011','SCA6','Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type'),
('601015','HE1','Niemann-pick disease, type C2, 607625 (3)'),
('601015','NPC2','Niemann-pick disease, type C2, 607625 (3)'),
('601017','LQT12','Long QT syndrome 12, 612955 (3)'),
('601017','SNT1','Long QT syndrome 12, 612955 (3)'),
('601021','NUP98','Leukemia, lymphocytic, acute T-cell (1)'),
('601022','NFKBIL1','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('601023','ALS14','frontotemporal dementia, 167320 (3); Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)'),
('601023','IBMPFD','frontotemporal dementia, 167320 (3); Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)'),
('601023','VCP','frontotemporal dementia, 167320 (3); Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)'),
('601023','ALS14','Inclusion body myopathy with early-onset Paget disease and'),
('601023','IBMPFD','Inclusion body myopathy with early-onset Paget disease and'),
('601023','VCP','Inclusion body myopathy with early-onset Paget disease and'),
('601040','CD36L1','[High density lipoprotien cholesterol level QTL6], 610762 (3)'),
('601040','CLA1','[High density lipoprotien cholesterol level QTL6], 610762 (3)'),
('601040','HDLQTL6','[High density lipoprotien cholesterol level QTL6], 610762 (3)'),
('601040','SCARB1','[High density lipoprotien cholesterol level QTL6], 610762 (3)'),
('601042','CSE','Choreoathetosis/spasticity, episodic (2)'),
('601042','DYT9','Choreoathetosis/spasticity, episodic (2)'),
('601047','BSCL3','Lipodystrophy, congenital generalized, type 3, 612526 (3)'),
('601047','CAV1','Lipodystrophy, congenital generalized, type 3, 612526 (3)'),
('601047','CGL3','Lipodystrophy, congenital generalized, type 3, 612526 (3)'),
('601065','AARS','Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (2)'),
('601065','CMT2N','Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (2)'),
('601068','BAFME1','Epilepsy, myoclonic, adult familial, 1 (2)'),
('601068','FAME1','Epilepsy, myoclonic, adult familial, 1 (2)'),
('601068','MEBA','Epilepsy, myoclonic, adult familial, 1 (2)'),
('601089','ACDMPV','265380 (3)'),
('601089','FKHL5','265380 (3)'),
('601089','FOXF1','265380 (3)'),
('601089','ACDMPV','Alveolar capillary dysplasia with misalignment of pulmonary veins,'),
('601089','FKHL5','Alveolar capillary dysplasia with misalignment of pulmonary veins,'),
('601089','FOXF1','Alveolar capillary dysplasia with misalignment of pulmonary veins,'),
('601090','FKHL7','anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)'),
('601090','FOXC1','anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)'),
('601090','FREAC3','anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)'),
('601090','IRID1','anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)'),
('601090','RIEG3','anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)'),
('601090','FKHL7','Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld'),
('601090','FOXC1','Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld'),
('601090','FREAC3','Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld'),
('601090','IRID1','Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld'),
('601090','RIEG3','Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld'),
('601093','FKHL10','Enlarged vestibular aqueduct, 600791 (3)'),
('601093','FOXI1','Enlarged vestibular aqueduct, 600791 (3)'),
('601093','FREAC6','Enlarged vestibular aqueduct, 600791 (3)'),
('601094','ASMD','Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia,'),
('601094','FKHL12','Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia,'),
('601094','FOXE3','Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia,'),
('601094','ASMD','congenital primary, 610256 (3)'),
('601094','FKHL12','congenital primary, 610256 (3)'),
('601094','FOXE3','congenital primary, 610256 (3)'),
('601097','CMT1A','Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas'),
('601097','CMT1E','Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas'),
('601097','DSS','Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas'),
('601097','PMP22','Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas'),
('601097','CMT1A','disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3);'),
('601097','CMT1E','disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3);'),
('601097','DSS','disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3);'),
('601097','PMP22','disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3);'),
('601097','CMT1A','Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)'),
('601097','CMT1E','Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)'),
('601097','DSS','Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)'),
('601097','PMP22','Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)'),
('601101','HHT3','Telangiectasia, hereditary hemorrhagic, type 3 (2)'),
('601101','ORW3','Telangiectasia, hereditary hemorrhagic, type 3 (2)'),
('601105','CTSK','Pycnodysostosis, 265800 (3)'),
('601107','ABCC2','Dubin-Johnson syndrome, 237500 (3)'),
('601107','CMOAT','Dubin-Johnson syndrome, 237500 (3)'),
('601129','CYP2C8','Rhabdomyolysis, cerivastatin-induced (3)'),
('601130','CYP2C9','Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)'),
('601143','DCTN1','Neuropathy, distal hereditary motor, type VIIB, 607641 (3);'),
('601143','HMN7B','Neuropathy, distal hereditary motor, type VIIB, 607641 (3);'),
('601143','DCTN1','{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)'),
('601143','HMN7B','{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)'),
('601145','CSTB','254800 (3)'),
('601145','EPM1','254800 (3)'),
('601145','EPM1A','254800 (3)'),
('601145','PME','254800 (3)'),
('601145','STFB','254800 (3)'),
('601145','ULD','254800 (3)'),
('601145','CSTB','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601145','EPM1','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601145','EPM1A','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601145','PME','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601145','STFB','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601145','ULD','Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),'),
('601146','CDMP1','A2, 112600 (3); Symphalangism, proximal, 185800 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis}, 612400 (3)'),
('601146','GDF5','A2, 112600 (3); Symphalangism, proximal, 185800 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis}, 612400 (3)'),
('601146','OS5','A2, 112600 (3); Symphalangism, proximal, 185800 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis}, 612400 (3)'),
('601146','SYNS2','A2, 112600 (3); Symphalangism, proximal, 185800 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis}, 612400 (3)'),
('601146','CDMP1','Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3);'),
('601146','GDF5','Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3);'),
('601146','OS5','Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3);'),
('601146','SYNS2','Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3);'),
('601146','CDMP1','Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Fibular hypoplasia and complex brachydactyly, 228900 (3); Brachydactyly, type'),
('601146','GDF5','Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Fibular hypoplasia and complex brachydactyly, 228900 (3); Brachydactyly, type'),
('601146','OS5','Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Fibular hypoplasia and complex brachydactyly, 228900 (3); Brachydactyly, type'),
('601146','SYNS2','Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Fibular hypoplasia and complex brachydactyly, 228900 (3); Brachydactyly, type'),
('601147','GDF6','Klippel-Feil syndrome 1, autosomal dominant, 118100 (3);'),
('601147','KFS1','Klippel-Feil syndrome 1, autosomal dominant, 118100 (3);'),
('601147','MCOP4','Klippel-Feil syndrome 1, autosomal dominant, 118100 (3);'),
('601147','MCOPCB6','Klippel-Feil syndrome 1, autosomal dominant, 118100 (3);'),
('601147','GDF6','Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3)'),
('601147','KFS1','Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3)'),
('601147','MCOP4','Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3)'),
('601147','MCOPCB6','Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3)'),
('601150','CHLR1','Warsaw breakage syndrome, 613398 (3)'),
('601150','DDX11','Warsaw breakage syndrome, 613398 (3)'),
('601150','KRG2','Warsaw breakage syndrome, 613398 (3)'),
('601156','CCL11','600807 (3)'),
('601156','SCYA11','600807 (3)'),
('601156','CCL11','{HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to},'),
('601156','SCYA11','{HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to},'),
('601162','SPG9','Spastic paraplegia 9, autosomal dominant (2)'),
('601176','GCLM','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('601176','GLCLR','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('601181','ANE1','608033 (3)'),
('601181','IIAE3','608033 (3)'),
('601181','NUP358','608033 (3)'),
('601181','RANBP2','608033 (3)'),
('601181','ANE1','{Encephalopathy, acute, infection-induced, 3, susceptibility to},'),
('601181','IIAE3','{Encephalopathy, acute, infection-induced, 3, susceptibility to},'),
('601181','NUP358','{Encephalopathy, acute, infection-induced, 3, susceptibility to},'),
('601181','RANBP2','{Encephalopathy, acute, infection-induced, 3, susceptibility to},'),
('601188','PAC1','Prostate adenocarcinoma (2)'),
('601188','ST12','Prostate adenocarcinoma (2)'),
('601190','PDE6H','Retinal cone dystrophy 3, 610024 (3)'),
('601190','RCD3','Retinal cone dystrophy 3, 610024 (3)'),
('601192','FRFB','Fleck retina, familial benign, 228980 (3)'),
('601192','PLA2G5','Fleck retina, familial benign, 228980 (3)'),
('601194','TIL. LPRS5','to, 5}, 613223 (3)'),
('601194','TLR1','to, 5}, 613223 (3)'),
('601194','TIL. LPRS5','{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility'),
('601194','TLR1','{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility'),
('601199','CASR','Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,'),
('601199','EIG8','Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,'),
('601199','FIH','Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,'),
('601199','HHC1','Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,'),
('601199','PCAR1','Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,'),
('601199','CASR','idiopathic generalized, susceptibility to, 8}, 612899 (3)'),
('601199','EIG8','idiopathic generalized, susceptibility to, 8}, 612899 (3)'),
('601199','FIH','idiopathic generalized, susceptibility to, 8}, 612899 (3)'),
('601199','HHC1','idiopathic generalized, susceptibility to, 8}, 612899 (3)'),
('601199','PCAR1','idiopathic generalized, susceptibility to, 8}, 612899 (3)'),
('601199','CASR','neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 146200 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome (3); {Epilepsy,'),
('601199','EIG8','neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 146200 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome (3); {Epilepsy,'),
('601199','FIH','neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 146200 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome (3); {Epilepsy,'),
('601199','HHC1','neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 146200 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome (3); {Epilepsy,'),
('601199','PCAR1','neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 146200 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome (3); {Epilepsy,'),
('601202','CTAA2','Cataract, anterior polar-2 (2)'),
('601205','BOS3','605192 (3)'),
('601205','DFNA23','605192 (3)'),
('601205','SIX1','605192 (3)'),
('601205','BOS3','Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23,'),
('601205','DFNA23','Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23,'),
('601205','SIX1','Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23,'),
('601208','IDDM11','{Diabetes mellitus, insulin-dependent, 11} (2)'),
('601215','ATR','cancer syndrome, familial, 614564 (3)'),
('601215','FCTCS','cancer syndrome, familial, 614564 (3)'),
('601215','FRP1','cancer syndrome, familial, 614564 (3)'),
('601215','SCKL1','cancer syndrome, familial, 614564 (3)'),
('601215','ATR','Seckel syndrome 1, 210600 (3); Cutaneous telangiectasia and'),
('601215','FCTCS','Seckel syndrome 1, 210600 (3); Cutaneous telangiectasia and'),
('601215','FRP1','Seckel syndrome 1, 210600 (3); Cutaneous telangiectasia and'),
('601215','SCKL1','Seckel syndrome 1, 210600 (3); Cutaneous telangiectasia and'),
('601224','PSS','Potocki-Shaffer syndrome (4)'),
('601228','CRAC1','Polyposis syndrome, mixed hereditary 1 (2); {Colorectal cancer,'),
('601228','CRCS4','Polyposis syndrome, mixed hereditary 1 (2); {Colorectal cancer,'),
('601228','HMPS1','Polyposis syndrome, mixed hereditary 1 (2); {Colorectal cancer,'),
('601228','CRAC1','susceptibility to, 4} (1)'),
('601228','CRCS4','susceptibility to, 4} (1)'),
('601228','HMPS1','susceptibility to, 4} (1)'),
('601239','D18S892E','defects, 604169 (3)'),
('601239','DRP3','defects, 604169 (3)'),
('601239','DTNA','defects, 604169 (3)'),
('601239','LVNC1','defects, 604169 (3)'),
('601239','D18S892E','Left ventricular noncompaction 1, with or without congenital heart'),
('601239','DRP3','Left ventricular noncompaction 1, with or without congenital heart'),
('601239','DTNA','Left ventricular noncompaction 1, with or without congenital heart'),
('601239','LVNC1','Left ventricular noncompaction 1, with or without congenital heart'),
('601240','GAMT','GAMT deficiency, 612736 (3)'),
('601248','AMPHL','Myopathy, centronuclear, autosomal recessive, 255200 (3)'),
('601248','BIN1','Myopathy, centronuclear, autosomal recessive, 255200 (3)'),
('601253','CAV3','hypertrophic, 192600 (3); Long QT syndrome-9, 611818 (3)'),
('601253','LGMD1C','hypertrophic, 192600 (3); Long QT syndrome-9, 611818 (3)'),
('601253','LQT9','hypertrophic, 192600 (3); Long QT syndrome-9, 611818 (3)'),
('601253','CAV3','muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial'),
('601253','LGMD1C','muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial'),
('601253','LQT9','muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial'),
('601253','CAV3','Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling'),
('601253','LGMD1C','Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling'),
('601253','LQT9','Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling'),
('601255','ATSV','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','HSN2C','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','KIF1A','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','MRD9','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','SPG30','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','UNC104','hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)'),
('601255','ATSV','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601255','HSN2C','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601255','KIF1A','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601255','MRD9','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601255','SPG30','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601255','UNC104','Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,'),
('601263','MAP2K2','Cardiofaciocutaneous syndrome, 115150 (3)'),
('601263','MEK2','Cardiofaciocutaneous syndrome, 115150 (3)'),
('601263','MKK2','Cardiofaciocutaneous syndrome, 115150 (3)'),
('601263','PRKMK2','Cardiofaciocutaneous syndrome, 115150 (3)'),
('601265','HTX5','Heterotaxy, visceral, 5, 270100 (3)'),
('601265','NODAL','Heterotaxy, visceral, 5, 270100 (3)'),
('601267','CCR2','{HIV infection, susceptibility/resistance to} (3)'),
('601267','CMKBR2','{HIV infection, susceptibility/resistance to} (3)'),
('601282','EBS1','Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle,'),
('601282','LGMD2Q','Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle,'),
('601282','PLEC','Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle,'),
('601282','PLEC1','Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle,'),
('601282','PLTN','Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle,'),
('601282','EBS1','Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);'),
('601282','LGMD2Q','Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);'),
('601282','PLEC','Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);'),
('601282','PLEC1','Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);'),
('601282','PLTN','Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);'),
('601282','EBS1','type 2Q, 613723 (3)'),
('601282','LGMD2Q','type 2Q, 613723 (3)'),
('601282','PLEC','type 2Q, 613723 (3)'),
('601282','PLEC1','type 2Q, 613723 (3)'),
('601282','PLTN','type 2Q, 613723 (3)'),
('601284','ACVRL1','Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)'),
('601284','ACVRLK1','Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)'),
('601284','ALK1','Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)'),
('601284','HHT2','Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)'),
('601295','NTCP2','Bile acid malabsorption, primary, 613291 (3)'),
('601295','PBAM','Bile acid malabsorption, primary, 613291 (3)'),
('601295','SLC10A2','Bile acid malabsorption, primary, 613291 (3)'),
('601296','MUSK','Myasthenic syndrome, congenital, associated with acetylcholine'),
('601296','MUSK','receptor deficiency, 608931 (3)'),
('601299','ACVRLK3','hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)'),
('601299','ALK3','hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)'),
('601299','BMPR1A','hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)'),
('601299','ACVRLK3','Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome,'),
('601299','ALK3','Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome,'),
('601299','BMPR1A','Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome,'),
('601300','ACVR1B','Pancreatic cancer, somatic (3)'),
('601300','ACVRLK4','Pancreatic cancer, somatic (3)'),
('601300','ALK4','Pancreatic cancer, somatic (3)'),
('601309','BCNS','Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma,'),
('601309','HPE7','Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma,'),
('601309','NBCCS','Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma,'),
('601309','PTCH1','Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma,'),
('601309','BCNS','somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)'),
('601309','HPE7','somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)'),
('601309','NBCCS','somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)'),
('601309','PTCH1','somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)'),
('601313','PKD1','Polycystic kidney disease, adult type I, 173900 (3)'),
('601318','IDDM13','{Diabetes mellitus, insulin-dependent, 13} (2)'),
('601330','DIAR6','Diarrhea 6, 614616 (3)'),
('601330','GUC2C','Diarrhea 6, 614616 (3)'),
('601330','GUCY2C','Diarrhea 6, 614616 (3)'),
('601336','CDG2B','Congenital disorder of glycosylation, type IIb, 606056 (3)'),
('601336','GCS1','Congenital disorder of glycosylation, type IIb, 606056 (3)'),
('601349','MCOPS8','Microphthalmia, syndromic 8 (2)'),
('601349','MMEP','Microphthalmia, syndromic 8 (2)'),
('601362','DGCR2','DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)'),
('601362','DGS2','DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)'),
('601363','WT4','Wilms tumor, type 4 (2)'),
('601373','CCCKR5','susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)'),
('601373','CCR5','susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)'),
('601373','CMKBR5','susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)'),
('601373','IDDM22','susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)'),
('601373','CCCKR5','{HIV infection, susceptibility/resistance to} (3); {West nile virus,'),
('601373','CCR5','{HIV infection, susceptibility/resistance to} (3); {West nile virus,'),
('601373','CMKBR5','{HIV infection, susceptibility/resistance to} (3); {West nile virus,'),
('601373','IDDM22','{HIV infection, susceptibility/resistance to} (3); {West nile virus,'),
('601385','D8S1992','Mental retardation, autosomal recessive 7, 611093 (3)'),
('601385','M33','Mental retardation, autosomal recessive 7, 611093 (3)'),
('601385','MRT22','Mental retardation, autosomal recessive 7, 611093 (3)'),
('601385','MRT7','Mental retardation, autosomal recessive 7, 611093 (3)'),
('601385','TUSC3','Mental retardation, autosomal recessive 7, 611093 (3)'),
('601387','TSG101','Breast cancer, somatic, 114480 (3)'),
('601395','CCL3L1','{HIV/AIDS, susceptibility to}, 609423 (3)'),
('601395','LD78','{HIV/AIDS, susceptibility to}, 609423 (3)'),
('601395','SCYA3L1','{HIV/AIDS, susceptibility to}, 609423 (3)'),
('601397','T','{Neural tube defects, susceptibility to}, 182940 (3)'),
('601397','TFT','{Neural tube defects, susceptibility to}, 182940 (3)'),
('601402','MLF1','Leukemia, acute myeloid, 601626 (1)'),
('601405','CLCR','{Pancreatitis, chronic, susceptibility to}, 167800 (3)'),
('601405','CTRC','{Pancreatitis, chronic, susceptibility to}, 167800 (3)'),
('601406','BCL7','B-cell non-Hodgkin lymphoma, high-grade (3)'),
('601406','BCL7A','B-cell non-Hodgkin lymphoma, high-grade (3)'),
('601407','NIDDM2','Diabetes mellitus, noninsulin-dependent, 2 (2)'),
('601411','CMD1L','dilated, 1L, 606685 (3)'),
('601411','LGMD2F','dilated, 1L, 606685 (3)'),
('601411','SGCD','dilated, 1L, 606685 (3)'),
('601411','SGD','dilated, 1L, 606685 (3)'),
('601411','CMD1L','Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy,'),
('601411','LGMD2F','Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy,'),
('601411','SGCD','Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy,'),
('601411','SGD','Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy,'),
('601412','DFNA7','Deafness, autosomal dominant 7 (2)'),
('601421','CMTRIB','Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)'),
('601421','KARS','Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)'),
('601424','OXCT','Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)'),
('601424','OXCT1','Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)'),
('601424','SCOT','Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)'),
('601428','MOPD1','(3)'),
('601428','RNU4ATAC','(3)'),
('601428','TALS','(3)'),
('601428','U4ATAC','(3)'),
('601428','MOPD1','Microcephalic osteodysplastic primordial dwarfism, type I, 210710'),
('601428','RNU4ATAC','Microcephalic osteodysplastic primordial dwarfism, type I, 210710'),
('601428','TALS','Microcephalic osteodysplastic primordial dwarfism, type I, 210710'),
('601428','U4ATAC','Microcephalic osteodysplastic primordial dwarfism, type I, 210710'),
('601439','ABCC9','Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation,'),
('601439','ATFB12','Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation,'),
('601439','CMD1O','Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation,'),
('601439','SUR2','Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation,'),
('601439','ABCC9','familial, 12, 614050 (3)'),
('601439','ATFB12','familial, 12, 614050 (3)'),
('601439','CMD1O','familial, 12, 614050 (3)'),
('601439','SUR2','familial, 12, 614050 (3)'),
('601443','CFL2','Nemaline myopathy 7, 610687 (3)'),
('601443','NEM7','Nemaline myopathy 7, 610687 (3)'),
('601454','PSORS3','{Psoriasis susceptibility 3} (2)'),
('601458','IBD2','{Inflammatory bowel disease 2} (2)'),
('601460','OATP2A1','614441 (3)'),
('601460','PGT','614441 (3)'),
('601460','PHOAR2','614441 (3)'),
('601460','SLC21A2','614441 (3)'),
('601460','SLCO2A1','614441 (3)'),
('601460','OATP2A1','Hypertrophic osteoarthropathy, primary, autosomal recessive 2,'),
('601460','PGT','Hypertrophic osteoarthropathy, primary, autosomal recessive 2,'),
('601460','PHOAR2','Hypertrophic osteoarthropathy, primary, autosomal recessive 2,'),
('601460','SLC21A2','Hypertrophic osteoarthropathy, primary, autosomal recessive 2,'),
('601460','SLCO2A1','Hypertrophic osteoarthropathy, primary, autosomal recessive 2,'),
('601465','DGK','251880 (3)'),
('601465','DGUOK','251880 (3)'),
('601465','MTDPS3','251880 (3)'),
('601465','DGK','Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),'),
('601465','DGUOK','Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),'),
('601465','MTDPS3','Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),'),
('601470','CX3CR1','{Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)'),
('601470','GPR13','{Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)'),
('601470','V28','{Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)'),
('601470','CX3CR1','{Rapid progression to AIDS from HIV1 infection}, 609423 (3);'),
('601470','GPR13','{Rapid progression to AIDS from HIV1 infection}, 609423 (3);'),
('601470','V28','{Rapid progression to AIDS from HIV1 infection}, 609423 (3);'),
('601471','HCFP1','Facial paresis, hereditary congenital, 1 (2)'),
('601471','MBS2','Facial paresis, hereditary congenital, 1 (2)'),
('601478','DFNA48','Deafness, autosomal dominant 48, 607841 (3)'),
('601478','MYO1A','Deafness, autosomal dominant 48, 607841 (3)'),
('601479','FSGS6','Glomerulosclerosis, focal segmental, 6, 614131 (3)'),
('601479','MYO1C','Glomerulosclerosis, focal segmental, 6, 614131 (3)'),
('601479','MYO1E','Glomerulosclerosis, focal segmental, 6, 614131 (3)'),
('601486','DAZH','{Spermatogenic failure, susceptibility to}  (3)'),
('601486','DAZL','{Spermatogenic failure, susceptibility to}  (3)'),
('601486','SPGYLA','{Spermatogenic failure, susceptibility to}  (3)'),
('601487','CIMT1','Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)'),
('601487','GLM1','Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)'),
('601487','PPARG','Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)'),
('601487','PPARG1','Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)'),
('601487','PPARG2','Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)'),
('601487','CIMT1','Obesity, severe, 601665 (3); [Obesity, resistance to] (3);'),
('601487','GLM1','Obesity, severe, 601665 (3); [Obesity, resistance to] (3);'),
('601487','PPARG','Obesity, severe, 601665 (3); [Obesity, resistance to] (3);'),
('601487','PPARG1','Obesity, severe, 601665 (3); [Obesity, resistance to] (3);'),
('601487','PPARG2','Obesity, severe, 601665 (3); [Obesity, resistance to] (3);'),
('601487','CIMT1','{Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3);'),
('601487','GLM1','{Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3);'),
('601487','PPARG','{Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3);'),
('601487','PPARG1','{Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3);'),
('601487','PPARG2','{Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3);'),
('601488','NCF4','b-positive, type III, 613960 (3)'),
('601488','P40PHOX','b-positive, type III, 613960 (3)'),
('601488','NCF4','Granulomatous disease, chronic, autosomal recessive, cytochrome'),
('601488','P40PHOX','Granulomatous disease, chronic, autosomal recessive, cytochrome'),
('601489','ALS','Acid-labile subunit, deficiency of (3)'),
('601489','IGFALS','Acid-labile subunit, deficiency of (3)'),
('601498','PAF2','Peroxisomal biogenesis disorder, complementation group 4 (3);'),
('601498','PEX6','Peroxisomal biogenesis disorder, complementation group 4 (3);'),
('601498','PXAAA1','Peroxisomal biogenesis disorder, complementation group 4 (3);'),
('601498','PAF2','Peroxisomal biogenesis disorder, complementation group 6 (3)'),
('601498','PEX6','Peroxisomal biogenesis disorder, complementation group 6 (3)'),
('601498','PXAAA1','Peroxisomal biogenesis disorder, complementation group 6 (3)'),
('601499','RGS2','Rieger syndrome, type 2 (2)'),
('601499','RIEG2','Rieger syndrome, type 2 (2)'),
('601500','SMO','Basal cell carcinoma, somatic (3)'),
('601500','SMOH','Basal cell carcinoma, somatic (3)'),
('601501','MEM3','Parkinson disease 17, 614203 (3)'),
('601501','PARK17','Parkinson disease 17, 614203 (3)'),
('601501','VPS35','Parkinson disease 17, 614203 (3)'),
('601515','FGF14','Spinocerebellar ataxia 27, 609307 (3)'),
('601515','FHF4','Spinocerebellar ataxia 27, 609307 (3)'),
('601515','SCA27','Spinocerebellar ataxia 27, 609307 (3)'),
('601517','ATX2','Spinocerebellar ataxia 2, 183090 (3)'),
('601517','ATXN2','Spinocerebellar ataxia 2, 183090 (3)'),
('601517','SCA2','Spinocerebellar ataxia 2, 183090 (3)'),
('601525','ASRT7','traits, susceptibility to, 7}, 611960 (3)'),
('601525','CHI3L1','traits, susceptibility to, 7}, 611960 (3)'),
('601525','GP39','traits, susceptibility to, 7}, 611960 (3)'),
('601525','YKL40','traits, susceptibility to, 7}, 611960 (3)'),
('601525','ASRT7','{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related'),
('601525','CHI3L1','{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related'),
('601525','GP39','{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related'),
('601525','YKL40','{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related'),
('601527','ALX1','Frontonasal dysplasia 3, 613456 (3)'),
('601527','CART1','Frontonasal dysplasia 3, 613456 (3)'),
('601527','FND3','Frontonasal dysplasia 3, 613456 (3)'),
('601530','P62','Paget disease of bone, 602080 (3)'),
('601530','PDB3','Paget disease of bone, 602080 (3)'),
('601530','SQSTM1','Paget disease of bone, 602080 (3)'),
('601538','CPHD2','Pituitary hormone deficiency, combined, 2, 262600 (3)'),
('601538','PROP1','Pituitary hormone deficiency, combined, 2, 262600 (3)'),
('601542','IDG2','Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,'),
('601542','IGDS2','Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,'),
('601542','PITX2','Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,'),
('601542','RGS','Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,'),
('601542','RIEG1','Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,'),
('601542','IDG2','type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)'),
('601542','IGDS2','type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)'),
('601542','PITX2','type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)'),
('601542','RGS','type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)'),
('601542','RIEG1','type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)'),
('601545','LIS1','(3)'),
('601545','PAFAH1B1','(3)'),
('601545','LIS1','Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432'),
('601545','PAFAH1B1','Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432'),
('601548','DHRD','Doyne honeycomb degeneration of retina, 126600 (3)'),
('601548','EFEMP1','Doyne honeycomb degeneration of retina, 126600 (3)'),
('601548','FBNL','Doyne honeycomb degeneration of retina, 126600 (3)'),
('601556','ATX1','Spinocerebellar ataxia 1, 164400 (3)'),
('601556','ATXN1','Spinocerebellar ataxia 1, 164400 (3)'),
('601556','SCA1','Spinocerebellar ataxia 1, 164400 (3)'),
('601564','PRSS2','{Pancreatitis, chronic, protection against}, 167800 (3)'),
('601564','TRY2','{Pancreatitis, chronic, protection against}, 167800 (3)'),
('601566','ING1','Squamous cell carcinoma, head and neck, somatic, 275355 (3)'),
('601567','ERGIC53','Combined factor V and VIII deficiency, 227300 (3)'),
('601567','F5F8D','Combined factor V and VIII deficiency, 227300 (3)'),
('601567','LMAN1','Combined factor V and VIII deficiency, 227300 (3)'),
('601567','MCFD1','Combined factor V and VIII deficiency, 227300 (3)'),
('601570','WNT7A','Fuhrmann syndrome, 228930 (3)'),
('601570','WNT7A','Ulna and fibula, absence of, with sever limb deficiency, 276820 (3);'),
('601573','EZH1','Weaver syndrome 2, 614421 (3)'),
('601573','EZH2','Weaver syndrome 2, 614421 (3)'),
('601573','WVS2','Weaver syndrome 2, 614421 (3)'),
('601574','RBP56','Chondrosarcoma, extraskeletal myxoid, 612237 (1)'),
('601574','TAF15','Chondrosarcoma, extraskeletal myxoid, 612237 (1)'),
('601574','TAF2N','Chondrosarcoma, extraskeletal myxoid, 612237 (1)'),
('601592','CMS1D','Fetal akinesia deformation sequence, 208150 (3)'),
('601592','CMS1E','Fetal akinesia deformation sequence, 208150 (3)'),
('601592','RAPSN','Fetal akinesia deformation sequence, 208150 (3)'),
('601592','CMS1D','Myasthenic syndrome, congenital, associated with acetylcholine'),
('601592','CMS1E','Myasthenic syndrome, congenital, associated with acetylcholine'),
('601592','RAPSN','Myasthenic syndrome, congenital, associated with acetylcholine'),
('601592','CMS1D','receptor deficiency, 608931 (3); Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3);'),
('601592','CMS1E','receptor deficiency, 608931 (3); Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3);'),
('601592','RAPSN','receptor deficiency, 608931 (3); Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3);'),
('601593','BARD1','{Breast cancer, susceptibility to}, 114480 (3)'),
('601601','CHAR','Char syndrome, 169100 (3)'),
('601601','TFAP2B','Char syndrome, 169100 (3)'),
('601604','IL12RB1','(3)'),
('601604','IL12RB1','{Mycobacterial and salmonella infections, susceptibility to}, 209950'),
('601607','INI1','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','MRD15','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','RDT','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','RTPS1','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','SMARCB1','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','SNF5','Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition'),
('601607','INI1','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)');
INSERT INTO omim VALUES
('601607','MRD15','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)'),
('601607','RDT','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)'),
('601607','RTPS1','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)'),
('601607','SMARCB1','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)'),
('601607','SNF5','syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)'),
('601609','HADHSC','3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);'),
('601609','HHF4','3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);'),
('601609','SCHAD','3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);'),
('601609','HADHSC','Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)'),
('601609','HHF4','Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)'),
('601609','SCHAD','Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)'),
('601615','ABC3','Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)'),
('601615','ABCA3','Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)'),
('601615','SMDP3','Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)'),
('601617','RDH5','Fundus albipunctatus, 136880 (3)'),
('601618','HLTS','Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)'),
('601618','SOX18','Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)'),
('601620','TBX5','Holt-Oram syndrome, 142900 (3)'),
('601621','TBX3','Ulnar-mammary syndrome, 181450 (3)'),
('601622','ACS3','eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)'),
('601622','CRS1','eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)'),
('601622','SCS','eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)'),
('601622','TWIST1','eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)'),
('601622','ACS3','Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with'),
('601622','CRS1','Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with'),
('601622','SCS','Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with'),
('601622','TWIST1','Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with'),
('601623','ANCR','Angelman syndrome, 105830 (3)'),
('601623','UBE3A','Angelman syndrome, 105830 (3)'),
('601627','SMN2','{Spinal muscular atrophy, type III, modifier of}, 253400 (3)'),
('601652','GLC1A','Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);'),
('601652','GPOA','Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);'),
('601652','JOAG','Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);'),
('601652','MYOC','Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);'),
('601652','TIGR','Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);'),
('601652','GLC1A','Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)'),
('601652','GPOA','Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)'),
('601652','JOAG','Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)'),
('601652','MYOC','Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)'),
('601652','TIGR','Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)'),
('601653','BOR','166780 (3)'),
('601653','BOS1','166780 (3)'),
('601653','EYA1','166780 (3)'),
('601653','BOR','Anterior segment anomalies with or without cataract, 113650 (3); Branchiootic syndrome 1, 602588 (3); Otofaciocervical syndrome,'),
('601653','BOS1','Anterior segment anomalies with or without cataract, 113650 (3); Branchiootic syndrome 1, 602588 (3); Otofaciocervical syndrome,'),
('601653','EYA1','Anterior segment anomalies with or without cataract, 113650 (3); Branchiootic syndrome 1, 602588 (3); Otofaciocervical syndrome,'),
('601653','BOR','Branchiootorenal syndrome 1, with or without cataracts, 113650 (3);'),
('601653','BOS1','Branchiootorenal syndrome 1, with or without cataracts, 113650 (3);'),
('601653','EYA1','Branchiootorenal syndrome 1, with or without cataracts, 113650 (3);'),
('601656','ASD9','614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)'),
('601656','AVSD5','614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)'),
('601656','GATA6','614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)'),
('601656','PACHD','614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)'),
('601656','ASD9','Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9,'),
('601656','AVSD5','Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9,'),
('601656','GATA6','Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9,'),
('601656','PACHD','Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9,'),
('601664','ASCC3L1','Retinitis pigmentosa 33, 610359 (3)'),
('601664','KIAA0788','Retinitis pigmentosa 33, 610359 (3)'),
('601664','RP33','Retinitis pigmentosa 33, 610359 (3)'),
('601664','SNRNP200','Retinitis pigmentosa 33, 610359 (3)'),
('601666','IDDM15','{Diabetes mellitus, insulin-dependent, 15} (2)'),
('601676','AIR','Acute insulin response (2)'),
('601682','GLC1C','Glaucoma 1C, primary open angle (2)'),
('601687','KRT12','Meesmann corneal dystrophy, 122100 (3)'),
('601688','HPGD','Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy,'),
('601688','PGDH1','Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy,'),
('601688','PHOAR1','Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy,'),
('601688','HPGD','primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)'),
('601688','PGDH1','primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)'),
('601688','PHOAR1','primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)'),
('601690','PAFAD','Platelet-activating factor acetylhydrolase deficiency, 614278 (3);'),
('601690','PAFAH','Platelet-activating factor acetylhydrolase deficiency, 614278 (3);'),
('601690','PLA2G7','Platelet-activating factor acetylhydrolase deficiency, 614278 (3);'),
('601690','PAFAD','{Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)'),
('601690','PAFAH','{Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)'),
('601690','PLA2G7','{Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)'),
('601691','ABCA4','248200 (3)'),
('601691','ABCR','248200 (3)'),
('601691','ARMD2','248200 (3)'),
('601691','CORD3','248200 (3)'),
('601691','FFM','248200 (3)'),
('601691','RP19','248200 (3)'),
('601691','STGD1','248200 (3)'),
('601691','ABCA4','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','ABCR','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','ARMD2','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','CORD3','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','FFM','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','RP19','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','STGD1','Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe,'),
('601691','ABCA4','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','ABCR','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','ARMD2','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','CORD3','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','FFM','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','RP19','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601691','STGD1','Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);'),
('601692','BIGH3','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','CDG2','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','CDGG1','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','CSD','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','CSD2','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','EBMD','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','TGFBI','Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,'),
('601692','BIGH3','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','CDG2','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','CDGG1','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','CSD','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','CSD2','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','EBMD','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','TGFBI','IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)'),
('601692','BIGH3','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','CDG2','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','CDGG1','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','CSD','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','CSD2','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','EBMD','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601692','TGFBI','lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type'),
('601693','BMIQ4','{Obesity, susceptibility to, BMIQ4}, 607447 (3)'),
('601693','UCP2','{Obesity, susceptibility to, BMIQ4}, 607447 (3)'),
('601694','LEPQTL1','[Leptin serum levels QTL1] (2)'),
('601694','LSL','[Leptin serum levels QTL1] (2)'),
('601699','CYP8','Hypertension, essential, 145500 (3)'),
('601699','CYP8A1','Hypertension, essential, 145500 (3)'),
('601699','PGIS','Hypertension, essential, 145500 (3)'),
('601699','PTGIS','Hypertension, essential, 145500 (3)'),
('601717','FHL5','Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)'),
('601717','STXBP2','Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)'),
('601717','UNC18B','Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)'),
('601719','TBX4','Small patella syndrome, 147891 (3)'),
('601724','NEUROD1','Maturity-onset diabetes of the young 6, 606394 (3)'),
('601724','NIDDM','Maturity-onset diabetes of the young 6, 606394 (3)'),
('601724','NEUROD1','{Diabetes mellitus, noninsulin-dependent}, 125853 (3);'),
('601724','NIDDM','{Diabetes mellitus, noninsulin-dependent}, 125853 (3);'),
('601728','GLM2','Cowden disease, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3);'),
('601728','MMAC1','Cowden disease, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3);'),
('601728','PTEN','Cowden disease, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3);'),
('601728','GLM2','{Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); PTEN hamartoma tumor syndrome (3); VATER association with macrocephaly and ventriculomegaly, 276950 (3);'),
('601728','MMAC1','{Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); PTEN hamartoma tumor syndrome (3); VATER association with macrocephaly and ventriculomegaly, 276950 (3);'),
('601728','PTEN','{Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); PTEN hamartoma tumor syndrome (3); VATER association with macrocephaly and ventriculomegaly, 276950 (3);'),
('601728','GLM2','{Prostate cancer, somatic}, 176807 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Malignant melanoma, somatic, 155600 (3); Endometrial carcinoma, somatic, 608089 (3); Squamous cell carcinoma'),
('601728','MMAC1','{Prostate cancer, somatic}, 176807 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Malignant melanoma, somatic, 155600 (3); Endometrial carcinoma, somatic, 608089 (3); Squamous cell carcinoma'),
('601728','PTEN','{Prostate cancer, somatic}, 176807 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Malignant melanoma, somatic, 155600 (3); Endometrial carcinoma, somatic, 608089 (3); Squamous cell carcinoma'),
('601731','AICAR','AICA-ribosiduria due to ATIC deficiency, 608688 (3)'),
('601731','ATIC','AICA-ribosiduria due to ATIC deficiency, 608688 (3)'),
('601731','PURH','AICA-ribosiduria due to ATIC deficiency, 608688 (3)'),
('601743','OSMR','Amyloidosis, primary localized cutaneous, 1, 105250 (3)'),
('601743','OSMRB','Amyloidosis, primary localized cutaneous, 1, 105250 (3)'),
('601743','PLCA1','Amyloidosis, primary localized cutaneous, 1, 105250 (3)'),
('601749','GLML','Glomuvenous malformations, 138000 (3)'),
('601749','GVM','Glomuvenous malformations, 138000 (3)'),
('601749','VMGLOM','Glomuvenous malformations, 138000 (3)'),
('601756','GALNT3','Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('601756','HFTC','Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('601756','HHS','Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('601757','PEX7','disease, 266500 (3)'),
('601757','RCDP1','disease, 266500 (3)'),
('601757','PEX7','Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Refsum'),
('601757','RCDP1','Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Refsum'),
('601758','PEX12','Peroxisome biogenesis factor 12 (3)'),
('601762','ALPS2','Autoimmune lymphoproliferative syndrome, type II, 603909 (3);'),
('601762','CASP10','Autoimmune lymphoproliferative syndrome, type II, 603909 (3);'),
('601762','MCH4','Autoimmune lymphoproliferative syndrome, type II, 603909 (3);'),
('601762','ALPS2','Non-Hodgkin lymphoma, somatic, 605027 (3); Gastric cancer, somatic, 137215 (3)'),
('601762','CASP10','Non-Hodgkin lymphoma, somatic, 605027 (3); Gastric cancer, somatic, 137215 (3)'),
('601762','MCH4','Non-Hodgkin lymphoma, somatic, 605027 (3); Gastric cancer, somatic, 137215 (3)'),
('601763','ALPS2B','Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)'),
('601763','CASP8','Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)'),
('601763','MCH5','Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)'),
('601763','ALPS2B','Immunodeficiency due to CASP8 deficiency, 607271 (3);'),
('601763','CASP8','Immunodeficiency due to CASP8 deficiency, 607271 (3);'),
('601763','MCH5','Immunodeficiency due to CASP8 deficiency, 607271 (3);'),
('601764','BFIC1','Seizures, benign familial infantile, 1 (2)'),
('601764','BFIS1','Seizures, benign familial infantile, 1 (2)'),
('601767','HIP1','{Prostate cancer, progression of}, 176807 (1)'),
('601768','EEN','Leukemia, acute myeloid, 601626 (1)'),
('601768','SH3GL1','Leukemia, acute myeloid, 601626 (1)'),
('601769','VDR','?Osteoporosis, involutional, 166710 (1)'),
('601769','VDR','Rickets, vitamin D-resistant, type IIA, 277440 (3);'),
('601771','CYP1B1','(3)'),
('601771','GLC3A','(3)'),
('601771','CYP1B1','(3); Glaucoma, early-onset, digenic (3); Glaucoma, primary open angle, adult-onset, 137760 (3); Glaucoma, primary open angle, juvenile-onset, 137750'),
('601771','GLC3A','(3); Glaucoma, early-onset, digenic (3); Glaucoma, primary open angle, adult-onset, 137760 (3); Glaucoma, primary open angle, juvenile-onset, 137750'),
('601771','CYP1B1','Glaucoma 3A, primary congenital, 231300 (3); Peters anomaly, 604229'),
('601771','GLC3A','Glaucoma 3A, primary congenital, 231300 (3); Peters anomaly, 604229'),
('601785','CDG1A','Congenital disorder of glycosylation, type Ia, 212065 (3)'),
('601785','PMM2','Congenital disorder of glycosylation, type Ia, 212065 (3)'),
('601788','GDF8','Muscle hypertrophy, 614160 (3)'),
('601788','MSLHP','Muscle hypertrophy, 614160 (3)'),
('601788','MSTN','Muscle hypertrophy, 614160 (3)'),
('601789','NALD','202370 (3)'),
('601789','PEX13','202370 (3)'),
('601789','ZWS','202370 (3)'),
('601789','NALD','Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('601789','PEX13','Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('601789','ZWS','Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('601791','PEX14','Zellweger syndrome, 214100 (3)'),
('601802','CPHD5','combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)'),
('601802','HESX1','combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)'),
('601802','RPX','combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)'),
('601802','CPHD5','Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency,'),
('601802','HESX1','Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency,'),
('601802','RPX','Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency,'),
('601803','PKS','Pallister-Killian syndrome (4)'),
('601806','MCM6','Lactase persistance/nonpersistance, 223100 (3)'),
('601808','DEL18q','Chromosome 18q deletion syndrome (4)'),
('601814','ATP1G1','Hypomagnesemia-2, renal, 154020 (3)'),
('601814','FXYD2','Hypomagnesemia-2, renal, 154020 (3)'),
('601814','HOMG2','Hypomagnesemia-2, renal, 154020 (3)'),
('601825','NDUFS7','Leigh syndrome, 256000 (3)'),
('601825','PSST','Leigh syndrome, 256000 (3)'),
('601837','LIG4','(3); Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)'),
('601837','LIG4','LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500'),
('601843','NIS','Thyroid dyshormonogenesis 1, 274400 (3)'),
('601843','SLC5A5','Thyroid dyshormonogenesis 1, 274400 (3)'),
('601843','TDH1','Thyroid dyshormonogenesis 1, 274400 (3)'),
('601844','PHA2B','Pseudohypoaldosteronism, type IIB, 614491 (3)'),
('601844','PRKWNK4','Pseudohypoaldosteronism, type IIB, 614491 (3)'),
('601844','WNK4','Pseudohypoaldosteronism, type IIB, 614491 (3)'),
('601846','MDRV','Muscular dystrophy with rimmed vacuoles (2)'),
('601860','HSD17B4','233400 (3)'),
('601860','HSD17B4','D-bifunctional protein deficiency, 261515 (3); Perrault syndrome,'),
('601861','RFXAP','(3)'),
('601861','RFXAP','Bare lymphocyte syndrome, type II, complementation group D, 209920'),
('601863','RFX5','(3); Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)'),
('601863','RFX5','Bare lymphocyte syndrome, type II, complementation group C, 209920'),
('601865','LH2','Bruck syndrome 2, 609220 (3)'),
('601865','PLOD2','Bruck syndrome 2, 609220 (3)'),
('601865','TLH','Bruck syndrome 2, 609220 (3)'),
('601877','EBAF','Left-right axis malformations (3)'),
('601877','LEFTA','Left-right axis malformations (3)'),
('601877','LEFTY2','Left-right axis malformations (3)'),
('601877','LEFTYA','Left-right axis malformations (3)'),
('601877','TGFB4','Left-right axis malformations (3)'),
('601881','MCOP3','Microphthalmia, isolated 3, 611038 (3)'),
('601881','RAX','Microphthalmia, isolated 3, 611038 (3)'),
('601881','RX','Microphthalmia, isolated 3, 611038 (3)'),
('601888','MHS6','{Malignant hyperthermia susceptibility 6} (2)'),
('601889','BCL8','Lymphoma, diffuse large cell (3)'),
('601898','GHSR','Short stature, 604271 (3)'),
('601900','IRF4','Multiple myeloma, 254500 (3)'),
('601900','LSIRF','Multiple myeloma, 254500 (3)'),
('601902','ORC1','Meier-Gorlin syndrome 1, 224690 (3)'),
('601902','ORC1L','Meier-Gorlin syndrome 1, 224690 (3)'),
('601906','SHFM6','Split-hand/foot malformation 6, 225300 (3)'),
('601906','WNT10B','Split-hand/foot malformation 6, 225300 (3)'),
('601912','OFC10','Orofacial cleft 10, 613705 (3)'),
('601912','SMT3','Orofacial cleft 10, 613705 (3)'),
('601912','SUMO1','Orofacial cleft 10, 613705 (3)'),
('601912','UBL1','Orofacial cleft 10, 613705 (3)'),
('601920','AGS','Alagille syndrome, 118450 (3); Tetralogy of Fallot, 187500 (3);'),
('601920','AHD','Alagille syndrome, 118450 (3); Tetralogy of Fallot, 187500 (3);'),
('601920','JAG1','Alagille syndrome, 118450 (3); Tetralogy of Fallot, 187500 (3);'),
('601920','AGS','Deafness, congenital heart defects, and posterior embryotoxon (3)'),
('601920','AHD','Deafness, congenital heart defects, and posterior embryotoxon (3)'),
('601920','JAG1','Deafness, congenital heart defects, and posterior embryotoxon (3)'),
('601928','HB6','Monilethrix, 158000 (3)'),
('601928','KRT86','Monilethrix, 158000 (3)'),
('601928','KRTHB6','Monilethrix, 158000 (3)'),
('601941','IDDM6','{Diabetes mellitus, insulin-dependent, 6} (2)'),
('601949','CACNB4','{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)'),
('601949','EA5','{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)'),
('601949','EIG9','{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)'),
('601949','EJM6','{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)'),
('601949','CACNB4','{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);'),
('601949','EA5','{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);'),
('601949','EIG9','{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);'),
('601949','EJM6','{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);'),
('601962','TAPBP','Bare lymphocyte syndrome, type I, 604571 (3)'),
('601962','TPSN','Bare lymphocyte syndrome, type I, 604571 (3)'),
('601975','PKP1','Ectodermal dysplasia/skin fragility syndrome, 604536 (3)'),
('601978','ALS16','Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)'),
('601978','SIGMAR1','Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)'),
('601978','SRBP','Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)'),
('601982','OGG1','Renal cell carcinoma, clear cell, somatic, 144700 (3)'),
('601984','ELE1','Thyroid carcinoma, papillary, 188550 (3)'),
('601984','NCOA4','Thyroid carcinoma, papillary, 188550 (3)'),
('601984','PTC3','Thyroid carcinoma, papillary, 188550 (3)'),
('601985','CCDC6','Thyroid papillary carcinoma, 188550 (1)'),
('601985','D10S170','Thyroid papillary carcinoma, 188550 (1)'),
('601985','H4','Thyroid papillary carcinoma, 188550 (1)'),
('601985','PTC','Thyroid papillary carcinoma, 188550 (1)'),
('601985','TPC','Thyroid papillary carcinoma, 188550 (1)'),
('601985','TST1','Thyroid papillary carcinoma, 188550 (1)'),
('601990','TP73','?Neuroblastoma (1)'),
('601992','FRDA2','Friedreich ataxia 2 (2)'),
('602005','LR11','{Alzheimer disease, pathogenesis, association with}, 104300 (3)'),
('602005','SORL1','{Alzheimer disease, pathogenesis, association with}, 104300 (3)'),
('602005','SORLA','{Alzheimer disease, pathogenesis, association with}, 104300 (3)'),
('602011','PETS1','?Pancreatic endocrine tumors (1)'),
('602011','ST11','?Pancreatic endocrine tumors (1)'),
('602023','CLCNKB','Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4,'),
('602023','CLCNKB','digenic, 602522 (3)'),
('602024','CLCNKA','Bartter syndrome, type 4b, digenic, 613090 (3)'),
('602026','PAHX','Refsum disease, 266500 (3)'),
('602026','PHYH','Refsum disease, 266500 (3)'),
('602044','UCP3','{Obesity, severe, and type II diabetes}, 601665 (3)'),
('602049','RAC2','Neutrophil immunodeficiency syndrome, 608203 (3)'),
('602053','BCD1','137215 (3)'),
('602053','COPEB','137215 (3)'),
('602053','KLF6','137215 (3)'),
('602053','ZF9','137215 (3)'),
('602053','BCD1','Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic,'),
('602053','COPEB','Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic,'),
('602053','KLF6','Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic,'),
('602053','ZF9','Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic,'),
('602054','CAFS','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','CTHM','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','DGCR','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','DGS','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','DORV','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','TBX1','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','TGA','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','VCFS','188400 (3); Velocardiofacial syndrome, 192430 (3)'),
('602054','CAFS','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','CTHM','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','DGCR','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','DGS','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','DORV','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','TBX1','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','TGA','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602054','VCFS','Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,'),
('602063','TALDO1','Transaldolase deficiency, 606003 (3)'),
('602066','ICCA','Convulsions, infantile and paroxysmal choreoathetosis (2)'),
('602067','CDCD3','Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy'),
('602067','CMD1F','Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy'),
('602067','LGMD1D','Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy'),
('602067','CDCD3','type 1D (2)'),
('602067','CMD1F','type 1D (2)'),
('602067','LGMD1D','type 1D (2)'),
('602082','CDB2','Corneal dystrophy, Thiel-Behnke type (2)'),
('602082','CDTB','Corneal dystrophy, Thiel-Behnke type (2)'),
('602085','PAPA2','Postaxial polydactyly, type A2 (2)'),
('602086','ARVD3','Arrhythmogenic right ventricular dysplasia 3 (2)'),
('602087','ARVD4','Arrhythmogenic right ventricular dysplasia 4 (2)'),
('602090','LTBP2','Tooth agenesis, selective, 6, 613097 (3)'),
('602090','LTBP3','Tooth agenesis, selective, 6, 613097 (3)'),
('602090','STHAG6','Tooth agenesis, selective, 6, 613097 (3)'),
('602091','GLC3D','251750 (3)'),
('602091','LTBP2','251750 (3)'),
('602091','LTBP3','251750 (3)'),
('602091','MSPKA','251750 (3)'),
('602091','GLC3D','Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia,'),
('602091','LTBP2','Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia,'),
('602091','LTBP3','Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia,'),
('602091','MSPKA','Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia,'),
('602096','AD5','Alzheimer disease-5, 104300 (2)'),
('602097','USH1E','Usher syndrome, type 1E (2)'),
('602099','ALS5','Amyotrophic lateral sclerosis-5, juvenile recessive (2)'),
('602104','CRPM','Cherubism, 118400 (3)'),
('602104','SH3BP2','Cherubism, 118400 (3)'),
('602109','EDM5','Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis'),
('602109','HOA','Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis'),
('602109','MATN3','Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis'),
('602109','OS2','Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis'),
('602109','EDM5','susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)'),
('602109','HOA','susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)'),
('602109','MATN3','susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)'),
('602109','OS2','susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)'),
('602113','ALR','Kabuki syndrome 1, 147920 (3)'),
('602113','KABUK1','Kabuki syndrome 1, 147920 (3)'),
('602113','MLL2','Kabuki syndrome 1, 147920 (3)'),
('602115','FGF10','149730 (3)'),
('602115','FGF10','Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome,'),
('602117','NDN','Prader-Willi syndrome, 176270 (3)'),
('602121','DFNA1','Deafness, autosomal dominant 1, 124900 (3)'),
('602121','DIAPH1','Deafness, autosomal dominant 1, 124900 (3)'),
('602121','LFHL1','Deafness, autosomal dominant 1, 124900 (3)'),
('602124','DYT7','Dystonia-7, torsion (2)'),
('602125','COX10','Encephalopathy, progressive mitochondrial, with proximal renal'),
('602125','COX10','tubulopathy due to cytochrome c oxidase deficiency (3)'),
('602129','CELIAC4','{Celiac disease, susceptibility to, 4}, 609753 (3)'),
('602129','MYO9B','{Celiac disease, susceptibility to, 4}, 609753 (3)'),
('602129','MYR5','{Celiac disease, susceptibility to, 4}, 609753 (3)'),
('602134','ETM','Tremor, hereditary essential, 2 (2)'),
('602134','ETM2','Tremor, hereditary essential, 2 (2)'),
('602136','PEX1','202370 (3); Refsum disease, infantile, 266510 (3)'),
('602136','ZWS1','202370 (3); Refsum disease, infantile, 266510 (3)'),
('602136','PEX1','Zellweger syndrome-1, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('602136','ZWS1','Zellweger syndrome-1, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('602137','NDUFA2','Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)'),
('602141','NDUFS8','Leigh syndrome, 256000 (3)'),
('602142','NDNC3','Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)'),
('602142','PLCD1','Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)'),
('602146','CPHD4','Pituitary hormone deficiency, combined, 4, 262700 (3)'),
('602146','LHX4','Pituitary hormone deficiency, combined, 4, 262700 (3)'),
('602149','BFT','Clubfoot, congenital, 119800 (3)'),
('602149','CCF','Clubfoot, congenital, 119800 (3)'),
('602149','PITX1','Clubfoot, congenital, 119800 (3)'),
('602149','POTX','Clubfoot, congenital, 119800 (3)'),
('602149','PTX1','Clubfoot, congenital, 119800 (3)'),
('602150','SLUG','Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)'),
('602150','SNAI2','Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)'),
('602150','WS2D','Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)'),
('602153','HB1','Monilethrix, 158000 (3)'),
('602153','KRT81','Monilethrix, 158000 (3)'),
('602153','KRTHB1','Monilethrix, 158000 (3)'),
('602167','DFNB35','Deafness, autosomal recessive 35, 608565 (3)'),
('602167','ESRL2','Deafness, autosomal recessive 35, 608565 (3)'),
('602167','ESRRB','Deafness, autosomal recessive 35, 608565 (3)'),
('602168','PCH1','Pontocerebellar hypoplasia type 1, 607596 (3)'),
('602168','VRK1','Pontocerebellar hypoplasia type 1, 607596 (3)'),
('602170','MYD88','612260 (3)'),
('602170','MYD88D','612260 (3)'),
('602170','MYD88','Pyogenic bacterial infections, recurrent, due to MYD88 deficiency,'),
('602170','MYD88D','Pyogenic bacterial infections, recurrent, due to MYD88 deficiency,'),
('602180','SIPA1','Metastasis efficiency, modification of (1)'),
('602180','SPA1','Metastasis efficiency, modification of (1)'),
('602183','BAPX1','Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)'),
('602183','NKX3-2','Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)'),
('602183','SMMD','Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)'),
('602194','ARMD7','degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3)'),
('602194','CARASIL','degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3)'),
('602194','HTRA1','degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3)'),
('602194','PRSS11','degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3)'),
('602194','ARMD7','{Macular degeneration, age-related, 7}, 610149 (3); {Macular'),
('602194','CARASIL','{Macular degeneration, age-related, 7}, 610149 (3); {Macular'),
('602194','HTRA1','{Macular degeneration, age-related, 7}, 610149 (3); {Macular'),
('602194','PRSS11','{Macular degeneration, age-related, 7}, 610149 (3); {Macular'),
('602195','CMT2F','Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)'),
('602195','HMN2B','Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)'),
('602195','HSP27','Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)'),
('602195','HSPB1','Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)'),
('602195','CMT2F','Neuropathy, distal hereditary motor, type IIB, 608634 (3);'),
('602195','HMN2B','Neuropathy, distal hereditary motor, type IIB, 608634 (3);'),
('602195','HSP27','Neuropathy, distal hereditary motor, type IIB, 608634 (3);'),
('602195','HSPB1','Neuropathy, distal hereditary motor, type IIB, 608634 (3);'),
('602201','ECM1','Lipoid proteinosis, 247100 (3)'),
('602202','CDG1R','Congenital disorder of glycosylation, type Ir, 614507 (3)'),
('602202','DDOST','Congenital disorder of glycosylation, type Ir, 614507 (3)'),
('602202','OST','Congenital disorder of glycosylation, type Ir, 614507 (3)'),
('602202','OST48','Congenital disorder of glycosylation, type Ir, 614507 (3)'),
('602207','RAB18','Warburg micro syndrome 3, 614222 (3)'),
('602207','WARBM3','Warburg micro syndrome 3, 614222 (3)'),
('602208','KCNJ10','600791 (3)'),
('602208','SESAME','600791 (3)'),
('602208','KCNJ10','SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic,'),
('602208','SESAME','SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic,'),
('602216','LKB1','Pancreatic cancer, sporadic (3); Testicular tumor, sporadic, 273300 (3)'),
('602216','PJS','Pancreatic cancer, sporadic (3); Testicular tumor, sporadic, 273300 (3)'),
('602216','STK11','Pancreatic cancer, sporadic (3); Testicular tumor, sporadic, 273300 (3)'),
('602216','LKB1','Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant sporadic (3);'),
('602216','PJS','Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant sporadic (3);'),
('602216','STK11','Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant sporadic (3);'),
('602218','HSAL1','branchiootorenal-like syndrome, 107480 (3)'),
('602218','SALL1','branchiootorenal-like syndrome, 107480 (3)'),
('602218','TBS','branchiootorenal-like syndrome, 107480 (3)'),
('602218','HSAL1','Townes-Brocks syndrome, 107480 (3); Townes-Brocks'),
('602218','SALL1','Townes-Brocks syndrome, 107480 (3); Townes-Brocks'),
('602218','TBS','Townes-Brocks syndrome, 107480 (3); Townes-Brocks'),
('602225','CORD2','amaurosis 7, 613829 (3)'),
('602225','CRD','amaurosis 7, 613829 (3)'),
('602225','CRX','amaurosis 7, 613829 (3)'),
('602225','LCA7','amaurosis 7, 613829 (3)'),
('602225','CORD2','Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital'),
('602225','CRD','Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital'),
('602225','CRX','Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital'),
('602225','LCA7','Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital'),
('602228','TCF4','{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)'),
('602228','TCF7L2','{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)'),
('602229','PCWH','type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)'),
('602229','SOX10','type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)'),
('602229','WS4','type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)'),
('602229','WS4C','type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)'),
('602229','PCWH','Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome,'),
('602229','SOX10','Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome,'),
('602229','WS4','Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome,'),
('602229','WS4C','Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome,'),
('602232','BFNC2','Seizures, benign neonatal, type 2, 121201 (3)'),
('602232','EBN2','Seizures, benign neonatal, type 2, 121201 (3)'),
('602232','KCNQ3','Seizures, benign neonatal, type 2, 121201 (3)'),
('602235','BFNS1','Epileptic encephalopathy, early infantile, 7, 613720 (3)'),
('602235','EBN1','Epileptic encephalopathy, early infantile, 7, 613720 (3)'),
('602235','EIEE7','Epileptic encephalopathy, early infantile, 7, 613720 (3)'),
('602235','KCNQ2','Epileptic encephalopathy, early infantile, 7, 613720 (3)'),
('602235','BFNS1','Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3);'),
('602235','EBN1','Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3);'),
('602235','EIEE7','Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3);'),
('602235','KCNQ2','Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3);'),
('602243','CD151','609057 (3); [Blood group, Raph], 179620 (3)'),
('602243','MER2','609057 (3); [Blood group, Raph], 179620 (3)'),
('602243','PETA3','609057 (3); [Blood group, Raph], 179620 (3)'),
('602243','SFA1','609057 (3); [Blood group, Raph], 179620 (3)'),
('602243','CD151','Nephropathy with pretibial epidermolysis bullosa and deafness,'),
('602243','MER2','Nephropathy with pretibial epidermolysis bullosa and deafness,'),
('602243','PETA3','Nephropathy with pretibial epidermolysis bullosa and deafness,'),
('602243','SFA1','Nephropathy with pretibial epidermolysis bullosa and deafness,'),
('602244','DNASE1L3','Systemic lupus erythematosus 16, 614420 (3)'),
('602244','SLEB16','Systemic lupus erythematosus 16, 614420 (3)'),
('602257','AMRF','254900 (3)'),
('602257','CD36L2','254900 (3)'),
('602257','EPM4','254900 (3)'),
('602257','LIMPII','254900 (3)'),
('602257','SCARB2','254900 (3)'),
('602257','AMRF','Epilepsy, progressive myoclonic 4, with or without renal failure,'),
('602257','CD36L2','Epilepsy, progressive myoclonic 4, with or without renal failure,'),
('602257','EPM4','Epilepsy, progressive myoclonic 4, with or without renal failure,'),
('602257','LIMPII','Epilepsy, progressive myoclonic 4, with or without renal failure,'),
('602257','SCARB2','Epilepsy, progressive myoclonic 4, with or without renal failure,'),
('602272','ITF2','Pitt-Hopkins syndrome, 610954 (3)'),
('602272','PTHS','Pitt-Hopkins syndrome, 610954 (3)'),
('602272','SEF2','Pitt-Hopkins syndrome, 610954 (3)'),
('602272','TCF4','Pitt-Hopkins syndrome, 610954 (3)'),
('602275','GCAP2','Retinitis pigmentosa 48, 613827 (3)'),
('602275','GUCA1B','Retinitis pigmentosa 48, 613827 (3)'),
('602275','GUCA2','Retinitis pigmentosa 48, 613827 (3)'),
('602275','RP48','Retinitis pigmentosa 48, 613827 (3)'),
('602279','PAB2','Oculopharyngeal muscular dystrophy, 164300 (3)'),
('602279','PABP2','Oculopharyngeal muscular dystrophy, 164300 (3)'),
('602279','PABPN1','Oculopharyngeal muscular dystrophy, 164300 (3)'),
('602280','LCA15','613843 (3)'),
('602280','RP14','613843 (3)'),
('602280','TULP1','613843 (3)'),
('602280','LCA15','Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15,'),
('602280','RP14','Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15,'),
('602280','TULP1','Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15,'),
('602286','ERG3','Lathosterolosis, 607330 (3)'),
('602286','SC5DL','Lathosterolosis, 607330 (3)'),
('602290','BBS11','Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl'),
('602290','HT2A','Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl'),
('602290','LGMD2H','Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl'),
('602290','TRIM32','Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl'),
('602290','BBS11','syndrome 11, 209900 (3)'),
('602290','HT2A','syndrome 11, 209900 (3)'),
('602290','LGMD2H','syndrome 11, 209900 (3)'),
('602290','TRIM32','syndrome 11, 209900 (3)'),
('602296','AP4M1','Spastic paraplegia 50, autosomal recessive, 612936 (3)'),
('602296','CPSQ3','Spastic paraplegia 50, autosomal recessive, 612936 (3)'),
('602296','SPG50','Spastic paraplegia 50, autosomal recessive, 612936 (3)'),
('602298','CMT2B','Charcot-Marie-Tooth disease, type 2B, 600882 (3)'),
('602298','PSN','Charcot-Marie-Tooth disease, type 2B, 600882 (3)'),
('602298','RAB7','Charcot-Marie-Tooth disease, type 2B, 600882 (3)'),
('602302','AU','209500 (3); Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)'),
('602302','HR','209500 (3); Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)'),
('602302','MUHH1','209500 (3); Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)'),
('602302','AU','Alopecia universalis, 203655 (3); Atrichia with papular lesions,'),
('602302','HR','Alopecia universalis, 203655 (3); Atrichia with papular lesions,'),
('602302','MUHH1','Alopecia universalis, 203655 (3); Atrichia with papular lesions,'),
('602311','AGRP','{Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)'),
('602311','AGRT','{Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)'),
('602311','ART','{Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)'),
('602322','DKCA1','anemia, 609135 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('602322','TERC','anemia, 609135 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('602322','TR','anemia, 609135 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('602322','TRC3','anemia, 609135 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)'),
('602322','DKCA1','Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic'),
('602322','TERC','Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic'),
('602322','TR','Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic'),
('602322','TRC3','Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic'),
('602337','BDB','Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal'),
('602337','BDB1','Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal'),
('602337','NTRKR2','Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal'),
('602337','ROR2','Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal'),
('602337','BDB','recessive, 268310 (3)'),
('602337','BDB1','recessive, 268310 (3)'),
('602337','NTRKR2','recessive, 268310 (3)'),
('602337','ROR2','recessive, 268310 (3)'),
('602357','WASPIP','Wiskott-Aldrich syndrome 2, 614493 (3)'),
('602357','WIP','Wiskott-Aldrich syndrome 2, 614493 (3)'),
('602357','WIPF1','Wiskott-Aldrich syndrome 2, 614493 (3)'),
('602358','HCRT','Narcolepsy 1, 161400 (3)'),
('602358','NRCLP1','Narcolepsy 1, 161400 (3)'),
('602358','OX','Narcolepsy 1, 161400 (3)'),
('602360','AGAT','AGAT deficiency, 612718 (3)'),
('602360','GATM','AGAT deficiency, 612718 (3)'),
('602365','CPPI','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','CTSC','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','HMS','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','JPD','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','PALS','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','PLS','(3); Periodontitis, juvenile, 170650 (3)'),
('602365','CPPI','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602365','CTSC','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602365','HMS','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602365','JPD','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602365','PALS','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602365','PLS','Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010'),
('602376','IFNAR2','{Hepatitis B virus, susceptibility to}, 610424 (3)'),
('602378','CMT2M','Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);'),
('602378','CMTDI1','Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);'),
('602378','CMTDIB','Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);'),
('602378','DNM2','Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);'),
('602378','CMT2M','Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)'),
('602378','CMTDI1','Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)'),
('602378','CMTDIB','Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)'),
('602378','DNM2','Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)'),
('602389','COXPD4','Combined oxidative phosphorylation deficiency 4, 610678 (3)'),
('602389','EFTU','Combined oxidative phosphorylation deficiency 4, 610678 (3)'),
('602389','TUFM','Combined oxidative phosphorylation deficiency 4, 610678 (3)'),
('602397','ATP8B1','Cholestasis, benign recurrent intrahepatic, 243300 (3)'),
('602397','BRIC','Cholestasis, benign recurrent intrahepatic, 243300 (3)'),
('602397','FIC1','Cholestasis, benign recurrent intrahepatic, 243300 (3)'),
('602397','PFIC1','Cholestasis, benign recurrent intrahepatic, 243300 (3)'),
('602397','ATP8B1','Cholestasis, progressive familial intrahepatic 1, 211600 (3);'),
('602397','BRIC','Cholestasis, progressive familial intrahepatic 1, 211600 (3);'),
('602397','FIC1','Cholestasis, progressive familial intrahepatic 1, 211600 (3);'),
('602397','PFIC1','Cholestasis, progressive familial intrahepatic 1, 211600 (3);'),
('602402','FKHL14','Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis'),
('602402','FOXC2','Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis'),
('602402','MFH1','Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis'),
('602402','FKHL14','syndrome with renal disease and diabetes mellitus, 153400 (3)'),
('602402','FOXC2','syndrome with renal disease and diabetes mellitus, 153400 (3)'),
('602402','MFH1','syndrome with renal disease and diabetes mellitus, 153400 (3)'),
('602403','BLMH','{Alzheimer disease, susceptibility to}, 104300 (3)'),
('602403','BMH','{Alzheimer disease, susceptibility to}, 104300 (3)'),
('602404','PARK3','Parkinson disease 3 (2)'),
('602409','AF10','Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell'),
('602409','AF10','lymphoblastic (3)'),
('602412','DBA3','Diamond-blackfan anemia 3, 610629 (3)'),
('602412','RPS24','Diamond-blackfan anemia 3, 610629 (3)'),
('602413','PGL3','and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('602413','SDHC','and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)'),
('602413','PGL3','Paragangliomas 3, 605373 (3); Paraganglioma'),
('602413','SDHC','Paragangliomas 3, 605373 (3); Paraganglioma'),
('602421','ABCC7','Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas'),
('602421','CF','Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas'),
('602421','CFTR','Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas'),
('602421','MRP7','Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas'),
('602421','ABCC7','deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3);'),
('602421','CF','deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3);'),
('602421','CFTR','deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3);'),
('602421','MRP7','deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3);'),
('602421','ABCC7','{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)'),
('602421','CF','{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)'),
('602421','CFTR','{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)'),
('602421','MRP7','{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)'),
('602429','GLC1D','Glaucoma 1D, primary open angle (2)'),
('602431','KIAA1568','Vesicoureteral reflux 2, 610878 (3)'),
('602431','ROBO2','Vesicoureteral reflux 2, 610878 (3)'),
('602431','SAX3','Vesicoureteral reflux 2, 610878 (3)'),
('602432','ALS12','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','FIP2','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','GLC1E','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','HYPL','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','NRP','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','OPTN','Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,'),
('602432','ALS12','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602432','FIP2','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602432','GLC1E','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602432','HYPL','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602432','NRP','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602432','OPTN','susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)'),
('602438','CTM','Cataract, Marner type, 116800 (3); Cataract, lamellar, 116800 (3)'),
('602438','HSF4','Cataract, Marner type, 116800 (3); Cataract, lamellar, 116800 (3)'),
('602439','AMLCR2','Leukemia, acute myelogenous, 601626 (2)'),
('602441','BACTS2','susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)'),
('602441','CISH','susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)'),
('602441','BACTS2','{Tuberculosis, susceptibility to}, 607948 (3); {Malaria,'),
('602441','CISH','{Tuberculosis, susceptibility to}, 607948 (3); {Malaria,'),
('602445','PI12','(3)'),
('602445','SERPINI1','(3)'),
('602445','PI12','Encephalopathy, familial, with neuroserpin inclusion bodies, 604218'),
('602445','SERPINI1','Encephalopathy, familial, with neuroserpin inclusion bodies, 604218'),
('602447','PON2','{Coronary artery disease, susceptibility to} (3)'),
('602452','BUB1','Colorectal cancer with chromosomal instability (3)'),
('602457','FADD','and cardiovasuclar malforamtions, 613759 (3)'),
('602457','FADD','Infections, recurrent, with encephalopathy, hepatic dysfunction,'),
('602458','LDLCQ6','[Low density lipoprotein cholesterol level QTL6], 613589 (3)'),
('602458','NT3','[Low density lipoprotein cholesterol level QTL6], 613589 (3)'),
('602458','SORT1','[Low density lipoprotein cholesterol level QTL6], 613589 (3)'),
('602460','BRN3C','Deafness, autosomal dominant 15, 602459 (3)'),
('602460','POU4F3','Deafness, autosomal dominant 15, 602459 (3)'),
('602477','FEB2','Febrile seizures, familial, 2 (2)'),
('602483','ARCODS','Ariculocondylar syndrome (2)'),
('602498','TFG','Chondrosarcoma, extraskeletal myxoid, 612237 (1)'),
('602529','LIS3','Lissencephaly 3, 611603 (3)'),
('602529','TUBA1A','Lissencephaly 3, 611603 (3)'),
('602529','TUBA3','Lissencephaly 3, 611603 (3)'),
('602533','DJ1','Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3)'),
('602533','PARK7','Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3)'),
('602533','DJ1','Parkinson disease 7, autosomal recessive early-onset, 606324 (3);'),
('602533','PARK7','Parkinson disease 7, autosomal recessive early-onset, 606324 (3);'),
('602536','P130','Warburg micro syndrome 1, 600118 (3)'),
('602536','RAB3GAP1','Warburg micro syndrome 1, 600118 (3)'),
('602536','WARBM1','Warburg micro syndrome 1, 600118 (3)'),
('602544','LPRS2','lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)'),
('602544','PARK2','lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)'),
('602544','PDJ','lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)'),
('602544','PRKN','lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)'),
('602544','LPRS2','Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of'),
('602544','PARK2','Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of'),
('602544','PDJ','Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of'),
('602544','PRKN','Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of'),
('602568','MTRR','Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);'),
('602568','MTRR','{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)'),
('602569','SNCB','Dementia, Lewy body, 127750 (3)'),
('602574','DFNA12','Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal'),
('602574','DFNA8','Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal'),
('602574','DFNB21','Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal'),
('602574','TECTA','Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal'),
('602574','DFNA12','recessive 21, 603629 (3)'),
('602574','DFNA8','recessive 21, 603629 (3)'),
('602574','DFNB21','recessive 21, 603629 (3)'),
('602574','TECTA','recessive 21, 603629 (3)'),
('602575','LMX1B','Nail-patella syndrome, 161200 (3)'),
('602575','NPS1','Nail-patella syndrome, 161200 (3)'),
('602576','LFNG','Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)'),
('602576','SCDO3','Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)'),
('602593','CDSN','270300 (3)'),
('602593','HTSS1','270300 (3)'),
('602593','PSS','270300 (3)'),
('602593','CDSN','Hypotrichosis simplex of scalp 1, 146520 (3); Peeling skin syndrome,'),
('602593','HTSS1','Hypotrichosis simplex of scalp 1, 146520 (3); Peeling skin syndrome,'),
('602593','PSS','Hypotrichosis simplex of scalp 1, 146520 (3); Peeling skin syndrome,'),
('602594','RP22','Retinitis pigmentosa 22 (2)'),
('602600','APOER2','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('602600','LRP8','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('602600','MCI1','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('602601','LOX1','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('602601','OLR1','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('602606','CART','{Obesity, susceptibility to}, 601665 (3)'),
('602616','CDG2A','Congenital disorder of glycosylation, type IIa, 212066 (3)'),
('602616','CDGS2','Congenital disorder of glycosylation, type IIa, 212066 (3)'),
('602616','MGAT2','Congenital disorder of glycosylation, type IIa, 212066 (3)'),
('602617','FKHL15','Bamforth-Lazarus syndrome, 241850 (3)'),
('602617','FOXE1','Bamforth-Lazarus syndrome, 241850 (3)'),
('602617','TITF2','Bamforth-Lazarus syndrome, 241850 (3)'),
('602617','TTF2','Bamforth-Lazarus syndrome, 241850 (3)'),
('602623','FKBP5','drug treatment}, 608516 (3)'),
('602623','FKBP51','drug treatment}, 608516 (3)'),
('602623','FKBP5','{Major depressive disorder and accelerated response to antidepressant'),
('602623','FKBP51','{Major depressive disorder and accelerated response to antidepressant'),
('602627','CDC18L','Meier-Gorlin syndrome 5, 613805 (3)'),
('602627','CDC6','Meier-Gorlin syndrome 5, 613805 (3)'),
('602630','HPE4','Holoprosencephaly-4, 142946 (3)'),
('602630','TGIF','Holoprosencephaly-4, 142946 (3)'),
('602631','BWSCR1A','(3); Lung cancer, somatic, 211980 (3)'),
('602631','IMPT1','(3); Lung cancer, somatic, 211980 (3)'),
('602631','SLC22A1L','(3); Lung cancer, somatic, 211980 (3)'),
('602631','BWSCR1A','Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210'),
('602631','IMPT1','Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210'),
('602631','SLC22A1L','Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210'),
('602639','HYD2','Tooth agenesis, selective, 2 (2)'),
('602639','STHAG2','Tooth agenesis, selective, 2 (2)'),
('602642','OPGL','Osteopetrosis, autosomal recessive 2, 259710 (3)'),
('602642','OPTB2','Osteopetrosis, autosomal recessive 2, 259710 (3)'),
('602642','TNFSF11','Osteopetrosis, autosomal recessive 2, 259710 (3)'),
('602642','TRANCE','Osteopetrosis, autosomal recessive 2, 259710 (3)'),
('602643','OCIF','Paget disease, juvenile, 239000 (3)'),
('602643','OPG','Paget disease, juvenile, 239000 (3)'),
('602643','TNFRSF11B','Paget disease, juvenile, 239000 (3)'),
('602661','CDCBM','Cortical dysplasia, complex, with other brain malformations, 614039 (3)'),
('602661','CFEOM3A','Cortical dysplasia, complex, with other brain malformations, 614039 (3)'),
('602661','TUBB3','Cortical dysplasia, complex, with other brain malformations, 614039 (3)'),
('602661','TUBB4','Cortical dysplasia, complex, with other brain malformations, 614039 (3)'),
('602661','CDCBM','Fibrosis of extraocular muscles, congenital, 3A, 600638 (3);'),
('602661','CFEOM3A','Fibrosis of extraocular muscles, congenital, 3A, 600638 (3);'),
('602661','TUBB3','Fibrosis of extraocular muscles, congenital, 3A, 600638 (3);'),
('602661','TUBB4','Fibrosis of extraocular muscles, congenital, 3A, 600638 (3);'),
('602666','DFNB3','Deafness, autosomal recessive 3, 600316 (3)'),
('602666','MYO15A','Deafness, autosomal recessive 3, 600316 (3)'),
('602667','NBS','lymphoblastic (3)'),
('602667','NBS1','lymphoblastic (3)'),
('602667','NBS','Nijmegen breakage syndrome, 251260 (3); Leukemia, acute'),
('602667','NBS1','Nijmegen breakage syndrome, 251260 (3); Leukemia, acute'),
('602669','CTPP4','Anterior segment mesenchymal dysgenesis, 107250 (3); Cataract,'),
('602669','PITX3','Anterior segment mesenchymal dysgenesis, 107250 (3); Cataract,'),
('602669','CTPP4','posterior polar, 4, 610623 (3); Cataract, congenital (3); Cataract, posterior polar, 4, syndromic, 610623 (3)'),
('602669','PITX3','posterior polar, 4, 610623 (3); Cataract, congenital (3); Cataract, posterior polar, 4, syndromic, 610623 (3)'),
('602671','G6PT1','232240 (3)'),
('602671','SLC37A4','232240 (3)'),
('602671','G6PT1','Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic,'),
('602671','SLC37A4','Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic,'),
('602685','MRST','degeneration (2)'),
('602685','MRST','Mental retardation, severe, with spasticity and tapetoretinal'),
('602686','MAD1L1','Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)'),
('602686','TXBP181','Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)'),
('602690','PGL1','Paragangliomas 1, with or without deafness, 168000 (3);'),
('602690','SDHD','Paragangliomas 1, with or without deafness, 168000 (3);'),
('602690','PGL1','Pheochromocytoma, 171300 (3); Carcinoid tumors, intestinal, 114900 (3); Merkel cell carcinoma, somatic (3); Paraganglioma and gastric stromal'),
('602690','SDHD','Pheochromocytoma, 171300 (3); Carcinoid tumors, intestinal, 114900 (3); Merkel cell carcinoma, somatic (3); Paraganglioma and gastric stromal'),
('602690','PGL1','sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3)'),
('602690','SDHD','sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3)'),
('602694','AQDQ','252010 (3)'),
('602694','NDUFS4','252010 (3)'),
('602694','AQDQ','Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency,'),
('602694','NDUFS4','Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency,'),
('602700','EP300','(3)'),
('602700','RSTS2','(3)'),
('602700','EP300','Colorectal cancer, 114500 (3); Rubinstein-Taybi syndrome 2, 613684'),
('602700','RSTS2','Colorectal cancer, 114500 (3); Rubinstein-Taybi syndrome 2, 613684'),
('602710','APBB2','{Alzheimer disease, late-onset}, 104300 (3)'),
('602710','FE65L1','{Alzheimer disease, late-onset}, 104300 (3)'),
('602713','ADAM9','Cone-rod dystrophy 9, 612775 (3)'),
('602713','CORD9','Cone-rod dystrophy 9, 612775 (3)'),
('602713','MCMP','Cone-rod dystrophy 9, 612775 (3)'),
('602713','MDC9','Cone-rod dystrophy 9, 612775 (3)'),
('602716','NPHN','Nephrotic syndrome, type 1, 256300 (3)'),
('602716','NPHS1','Nephrotic syndrome, type 1, 256300 (3)'),
('602723','PSORS2','{Psoriasis susceptibility 2} (2)'),
('602723','PSS1','{Psoriasis susceptibility 2} (2)'),
('602727','CLC7','autosomal dominant 2, 166600 (3)'),
('602727','CLCN7','autosomal dominant 2, 166600 (3)'),
('602727','OPTA2','autosomal dominant 2, 166600 (3)'),
('602727','OPTB4','autosomal dominant 2, 166600 (3)'),
('602727','CLC7','Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis,'),
('602727','CLCN7','Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis,'),
('602727','OPTA2','Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis,'),
('602727','OPTB4','Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis,'),
('602730','ACTRIIB','Heterotaxy, visceral, 4, autosomal, 613751 (3)'),
('602730','ACVR2B','Heterotaxy, visceral, 4, autosomal, 613751 (3)'),
('602730','HTX4','Heterotaxy, visceral, 4, autosomal, 613751 (3)'),
('602743','CMH6','hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)'),
('602743','PRKAG2','hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)'),
('602743','WPWS','hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)'),
('602743','CMH6','Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, familial'),
('602743','PRKAG2','Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, familial'),
('602743','WPWS','Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, familial'),
('602744','DHAPAT','Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)'),
('602744','GNPAT','Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)'),
('602753','ARIX','Fibrosis of extraocular muscles, congenital, 2, 602078 (3)'),
('602753','CFEOM2','Fibrosis of extraocular muscles, congenital, 2, 602078 (3)'),
('602753','PHOX2A','Fibrosis of extraocular muscles, congenital, 2, 602078 (3)'),
('602759','PCAP','{Prostate cancer, susceptibility to}, 176807 (2)'),
('602765','HB3','Monilethrix, 158000 (3)'),
('602765','KRT83','Monilethrix, 158000 (3)'),
('602765','KRTHB3','Monilethrix, 158000 (3)'),
('602767','HB5','Ectodermal dysplasia, \'pure\' hair-nail type, 602032 (3)'),
('602767','KRT85','Ectodermal dysplasia, \'pure\' hair-nail type, 602032 (3)'),
('602767','KRTHB5','Ectodermal dysplasia, \'pure\' hair-nail type, 602032 (3)'),
('602768','DLL3','Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)'),
('602768','SCDO1','Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)'),
('602770','CBX2','46XY sex reversal 5, 613080 (3)'),
('602770','M33','46XY sex reversal 5, 613080 (3)'),
('602770','SRXY5','46XY sex reversal 5, 613080 (3)'),
('602773','DIRC2','Renal cell carcinoma, 144700 (2)'),
('602773','RCC4','Renal cell carcinoma, 144700 (2)'),
('602774','BROVCA3','cancer, familial, susceptibility to, 3}, 613399 (3)'),
('602774','FANCO','cancer, familial, susceptibility to, 3}, 613399 (3)'),
('602774','RAD51C','cancer, familial, susceptibility to, 3}, 613399 (3)'),
('602774','BROVCA3','Fanconi anemia, complementation group 0, 613390 (3); {Breast-ovarian'),
('602774','FANCO','Fanconi anemia, complementation group 0, 613390 (3); {Breast-ovarian'),
('602774','RAD51C','Fanconi anemia, complementation group 0, 613390 (3); {Breast-ovarian'),
('602775','SHOC2','Noonan-like syndrome with loose anagen hair, 607721 (3)'),
('602775','SIAA0862','Noonan-like syndrome with loose anagen hair, 607721 (3)'),
('602775','SOC2','Noonan-like syndrome with loose anagen hair, 607721 (3)'),
('602775','SUR8','Noonan-like syndrome with loose anagen hair, 607721 (3)'),
('602782','HCLAP','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('602782','HJCD','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('602783','CAR','Spastic paraplegia 7, autosomal recessive, 607259 (3)'),
('602783','CMAR','Spastic paraplegia 7, autosomal recessive, 607259 (3)'),
('602783','PGN','Spastic paraplegia 7, autosomal recessive, 607259 (3)'),
('602783','SPG7','Spastic paraplegia 7, autosomal recessive, 607259 (3)'),
('602821','KIF5A','Spastic paraplegia 10, autosomal dominant, 604187 (3)'),
('602821','NKHC','Spastic paraplegia 10, autosomal dominant, 604187 (3)'),
('602821','SPG10','Spastic paraplegia 10, autosomal dominant, 604187 (3)'),
('602851','FEB4','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','GPR98','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','KIAA0686','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','MASS1','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','USH2C','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','VLGR1','2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)'),
('602851','FEB4','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602851','GPR98','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602851','KIAA0686','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602851','MASS1','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602851','USH2C','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602851','VLGR1','Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type'),
('602855','P27K','{Myocardial infarcation, susceptibility to}, 608446 (3)'),
('602855','PROS27','{Myocardial infarcation, susceptibility to}, 608446 (3)'),
('602855','PSMA6','{Myocardial infarcation, susceptibility to}, 608446 (3)'),
('602858','DHCR7','Smith-Lemli-Opitz syndrome, 270400 (3)'),
('602858','SLOS','Smith-Lemli-Opitz syndrome, 270400 (3)'),
('602859','NALD','202370 (3)'),
('602859','PEX10','202370 (3)'),
('602859','NALD','Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('602859','PEX10','Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,'),
('602860','BUB1B','257300 (3); [Premature chromatid separation trait], 176430 (3)'),
('602860','BUBR1','257300 (3); [Premature chromatid separation trait], 176430 (3)'),
('602860','BUB1B','Colorectal cancer, 114500 (3); Mosaic variegated aneuploidy syndrome,'),
('602860','BUBR1','Colorectal cancer, 114500 (3); Mosaic variegated aneuploidy syndrome,'),
('602861','ARVD9','Arrhythmogenic right ventricular dysplasia 9, 609040 (3)'),
('602861','PKP2','Arrhythmogenic right ventricular dysplasia 9, 609040 (3)'),
('602867','IGFBP7','614224 (3)'),
('602867','MAC25','614224 (3)'),
('602867','RAMSVPS','614224 (3)'),
('602867','IGFBP7','Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,'),
('602867','MAC25','Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,'),
('602867','RAMSVPS','Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,'),
('602876','BLCPMG','Band-like calcification with simplified gyration and'),
('602876','OCLN','Band-like calcification with simplified gyration and'),
('602876','BLCPMG','polymicrogyria, 251290 (3)'),
('602876','OCLN','polymicrogyria, 251290 (3)'),
('602879','EPB41L1','Mental retardation, autosomal dominant 11, 614257 (3)'),
('602879','MRD11','Mental retardation, autosomal dominant 11, 614257 (3)'),
('602880','DORV','187500 (3); Transposition of great arteries, dextro-looped 3, 613854 (3)'),
('602880','DTGA3','187500 (3); Transposition of great arteries, dextro-looped 3, 613854 (3)'),
('602880','GDF1','187500 (3); Transposition of great arteries, dextro-looped 3, 613854 (3)'),
('602880','DORV','Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot,'),
('602880','DTGA3','Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot,'),
('602880','GDF1','Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot,'),
('602897','JNK3','Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)'),
('602897','MAPK10','Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)'),
('602897','PRKM10','Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)'),
('602900','DNMT3B','242860 (3)'),
('602900','ICF1','242860 (3)'),
('602900','DNMT3B','Immunodeficiency-centromeric instability-facial anomalies syndrome 1,'),
('602900','ICF1','Immunodeficiency-centromeric instability-facial anomalies syndrome 1,'),
('602911','CACNG2','Mental retardation, autosomal dominant 10, 614256 (3)'),
('602911','MRD10','Mental retardation, autosomal dominant 10, 614256 (3)'),
('602926','EIEE4','Epileptic encephalopathy, early infantile, 4, 612164 (2)'),
('602926','STXBP1','Epileptic encephalopathy, early infantile, 4, 612164 (2)'),
('602926','UNC18','Epileptic encephalopathy, early infantile, 4, 612164 (2)'),
('602932','CRCS3','{Colorectal cancer, susceptibility to, 3}, 612229 (3)'),
('602932','MADH7','{Colorectal cancer, susceptibility to, 3}, 612229 (3)'),
('602932','SMAD7','{Colorectal cancer, susceptibility to, 3}, 612229 (3)'),
('602935','FAAH','{Drug addiction, susceptibility to} (3)'),
('602937','ASD8','614433 (3)'),
('602937','CITED2','614433 (3)'),
('602937','MRG1','614433 (3)'),
('602937','P35SRJ','614433 (3)'),
('602937','VSD2','614433 (3)'),
('602937','ASD8','Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,'),
('602937','CITED2','Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,'),
('602937','MRG1','Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,'),
('602937','P35SRJ','Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,'),
('602937','VSD2','Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,'),
('602938','BAAT','Hypercholanemia, familial, 607748 (3)'),
('602954','BROVCA4','{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)'),
('602954','RAD51D','{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)'),
('602954','RAD51L3','{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)'),
('602956','FANCG','Fanconi anemia, complementation group G, 614082 (3)'),
('602956','XRCC9','Fanconi anemia, complementation group G, 614082 (3)'),
('602966','OFC2','Orofacial cleft-2 (2)'),
('602974','AQP7','[Glycerol quantitative trait locus], 614411 (3)'),
('602974','GLYCQTL','[Glycerol quantitative trait locus], 614411 (3)'),
('602985','NDUFS2','Mitochondrial complex I deficiency, 252010 (3)'),
('602991','NOG','186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumb and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)'),
('602991','SYM1','186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumb and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)'),
('602991','SYNS1','186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumb and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)'),
('602991','NOG','Symphalangism, proximal, 185800 (3); Multiple synostosis syndrome 1,'),
('602991','SYM1','Symphalangism, proximal, 185800 (3); Multiple synostosis syndrome 1,'),
('602991','SYNS1','Symphalangism, proximal, 185800 (3); Multiple synostosis syndrome 1,'),
('602997','CUBN','Megaloblastic anemia-1, Finnish type, 261100 (3)'),
('602997','IFCR','Megaloblastic anemia-1, Finnish type, 261100 (3)'),
('602997','MGA1','Megaloblastic anemia-1, Finnish type, 261100 (3)'),
('603005','ATPSK2','SEMD, Pakistani type, 612847 (3)'),
('603005','PAPSS2','SEMD, Pakistani type, 612847 (3)'),
('603009','DYSF','Muscular dystrophy, limb-girdle, type 2B, 253601 (3);'),
('603009','LGMD2B','Muscular dystrophy, limb-girdle, type 2B, 253601 (3);'),
('603009','MMD1','Muscular dystrophy, limb-girdle, type 2B, 253601 (3);'),
('603009','DYSF','Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)'),
('603009','LGMD2B','Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)'),
('603009','MMD1','Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)'),
('603010','DFNB17','Deafness, autosomal recessive 17 (2)'),
('603013','SCZD6','{Schizophrenia}, 181500 (2)'),
('603023','IK1','Leukemia, acute lymphoblastic (3)'),
('603023','IKZF1','Leukemia, acute lymphoblastic (3)'),
('603023','LYF1','Leukemia, acute lymphoblastic (3)'),
('603023','ZNFN1A1','Leukemia, acute lymphoblastic (3)'),
('603024','ARID1A','Mental retardation, autosomal dominant 14, 614607 (3)'),
('603024','B120','Mental retardation, autosomal dominant 14, 614607 (3)'),
('603024','C1orf4','Mental retardation, autosomal dominant 14, 614607 (3)'),
('603024','MRD14','Mental retardation, autosomal dominant 14, 614607 (3)'),
('603024','SMARCF1','Mental retardation, autosomal dominant 14, 614607 (3)'),
('603025','CALM','Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell'),
('603025','CLTH','Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell'),
('603025','LAP','Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell'),
('603025','PICALM','Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell'),
('603025','CALM','lymphoblastic (3)'),
('603025','CLTH','lymphoblastic (3)'),
('603025','LAP','lymphoblastic (3)'),
('603025','PICALM','lymphoblastic (3)'),
('603026','PLAG1','Adenomas, salivary gland pleomorphic, 181030 (3)'),
('603026','PSA','Adenomas, salivary gland pleomorphic, 181030 (3)'),
('603026','SGPA','Adenomas, salivary gland pleomorphic, 181030 (3)'),
('603028','TIL4','susceptibility to}, 114500 (3)'),
('603028','TLR2','susceptibility to}, 114500 (3)'),
('603028','TIL4','{Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer,'),
('603028','TLR2','{Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer,'),
('603029','IIAE2','Herpes simplex encephalitis, susceptibility to, 2, 613002 (3)'),
('603029','TLR3','Herpes simplex encephalitis, susceptibility to, 2, 613002 (3)'),
('603030','ARMD10','10}, 611488 (3); {Colorectal cancer, susceptibility to}, 114500 (3)'),
('603030','TLR4','10}, 611488 (3); {Colorectal cancer, susceptibility to}, 114500 (3)'),
('603030','ARMD10','Endotoxin hyporesponsiveness (3); {Macular degeneration, age-related,'),
('603030','TLR4','Endotoxin hyporesponsiveness (3); {Macular degeneration, age-related,'),
('603031','SLEB1','lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (2)'),
('603031','TIL3','lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (2)'),
('603031','TLR5','lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (2)'),
('603031','SLEB1','{Legionaire disease, susceptibility to}, 608556 (3); {Systemic'),
('603031','TIL3','{Legionaire disease, susceptibility to}, 608556 (3); {Systemic'),
('603031','TLR5','{Legionaire disease, susceptibility to}, 608556 (3); {Systemic'),
('603033','COLQ','Endplate acetylcholinesterase deficiency, 603034 (3)'),
('603033','EAD','Endplate acetylcholinesterase deficiency, 603034 (3)'),
('603040','TSG11','{Nonsmall cell lung cancer} (2)'),
('603044','LOT1','{Diabetes mellitus, transient neonatal}, 601410 (1)'),
('603044','PLAGL1','{Diabetes mellitus, transient neonatal}, 601410 (1)'),
('603044','ZAC','{Diabetes mellitus, transient neonatal}, 601410 (1)'),
('603046','RCA1','Renal cell carcinoma, 144700 (3)'),
('603046','RNF139','Renal cell carcinoma, 144700 (3)'),
('603046','TRC8','Renal cell carcinoma, 144700 (3)'),
('603051','ADHAPS','Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)'),
('603051','AGPS','Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)'),
('603056','ORC4','Meier-Gorlin syndrome 2, 613800 (3)'),
('603056','ORC4L','Meier-Gorlin syndrome 2, 613800 (3)'),
('603066','LH3','Lysyl hydroxylase 3 deficiency, 612394 (3)'),
('603066','PLOD3','Lysyl hydroxylase 3 deficiency, 612394 (3)'),
('603072','AIK','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','ARK1','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','AURKA','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','AURORA2','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','BTAK','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','STK15','{Colon cancer, susceptibility to}, 114500 (3)'),
('603072','STK6','{Colon cancer, susceptibility to}, 114500 (3)'),
('603073','HPE5','Holoprosencephaly-5, 609637 (3)'),
('603073','ZIC2','Holoprosencephaly-5, 609637 (3)'),
('603089','BAP1','Tumor predisposition syndrome, 614327 (3)'),
('603089','TPDS','Tumor predisposition syndrome, 614327 (3)'),
('603094','B3GALT3','susceptibility to} (1)'),
('603094','GLCT3','susceptibility to} (1)'),
('603094','P','susceptibility to} (1)'),
('603094','B3GALT3','[Blood group, P system], 111400 (3); {Urinary tract infection,'),
('603094','GLCT3','[Blood group, P system], 111400 (3); {Urinary tract infection,'),
('603094','P','[Blood group, P system], 111400 (3); {Urinary tract infection,'),
('603098','DFNB13','Deafness, autosomal recessive 13 (2)'),
('603100','AGPAT2','Lipodystrophy, congenital generalized, type 1, 608594 (3)'),
('603100','BSCL','Lipodystrophy, congenital generalized, type 1, 608594 (3)'),
('603100','BSCL1','Lipodystrophy, congenital generalized, type 1, 608594 (3)'),
('603100','LPAAB','Lipodystrophy, congenital generalized, type 1, 608594 (3)'),
('603103','CPN','Carboxypeptidase N deficiency, 212070 (3)'),
('603103','CPN1','Carboxypeptidase N deficiency, 212070 (3)'),
('603103','SCPN','Carboxypeptidase N deficiency, 212070 (3)'),
('603109','LDS1C','Loeys-Dietz syndrome, type 1C, 613795 (3)'),
('603109','MADH3','Loeys-Dietz syndrome, type 1C, 613795 (3)'),
('603109','SMAD3','Loeys-Dietz syndrome, type 1C, 613795 (3)'),
('603113','PPP2R1B','Lung cancer, 211980 (3)'),
('603116','CDAGS','CDAGS syndrome (2)'),
('603128','SIM1','Obesity, severe, 601665 (3)'),
('603136','CUL3','Pseudohypoaldosteronism, type IIE, 614496 (3)'),
('603136','PHA2E','Pseudohypoaldosteronism, type IIE, 614496 (3)'),
('603155','PEZ','Choanal atresia and lymphedema, 613611 (3)'),
('603155','PTPN14','Choanal atresia and lymphedema, 613611 (3)'),
('603164','PEX3','Zellweger syndrome, complementation group G, 214100 (3)'),
('603165','ATOD1','{Dermatitis, atopic, susceptibility to, 1} (2)'),
('603175','SCZD5','{Schizophrenia}, 181500 (2)'),
('603176','SCZD7','{Schizophrenia}, 181500 (2)'),
('603178','ALDH6A1','Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)'),
('603178','MMSDH','Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)'),
('603183','NSPL1','Spastic paraplegia 12, autosomal dominant, 604805 (3)'),
('603183','RTN2','Spastic paraplegia 12, autosomal dominant, 604805 (3)'),
('603183','SPG12','Spastic paraplegia 12, autosomal dominant, 604805 (3)'),
('603188','BMIQ8','{Obesity, susceptibility to, BMIQ8} (2)'),
('603196','COCH','Deafness, autosomal dominant 9, 601369 (3)'),
('603196','DFNA9','Deafness, autosomal dominant 9, 601369 (3)'),
('603197','NTE','Spastic paraplegia 39, autosomal recessive, 612020 (3)'),
('603197','NTEMND','Spastic paraplegia 39, autosomal recessive, 612020 (3)'),
('603197','PNPLA6','Spastic paraplegia 39, autosomal recessive, 612020 (3)'),
('603197','SPG39','Spastic paraplegia 39, autosomal recessive, 612020 (3)'),
('603198','CAVIN','Lipodystrophy, congenital generalized, type 4, 613327 (3)'),
('603198','CGL4','Lipodystrophy, congenital generalized, type 4, 613327 (3)'),
('603198','PTRF','Lipodystrophy, congenital generalized, type 4, 613327 (3)'),
('603200','RFXANK','MHC class II deficiency, complementation group B, 209920 (3)'),
('603201','ABCB11','Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)'),
('603201','BRIC2','Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)'),
('603201','BSEP','Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)'),
('603201','PFIC2','Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)'),
('603201','SPGP','Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)'),
('603201','ABCB11','Cholestasis, progressive familial intrahepatic 2, 601847 (3);'),
('603201','BRIC2','Cholestasis, progressive familial intrahepatic 2, 601847 (3);'),
('603201','BSEP','Cholestasis, progressive familial intrahepatic 2, 601847 (3);'),
('603201','PFIC2','Cholestasis, progressive familial intrahepatic 2, 601847 (3);'),
('603201','SPGP','Cholestasis, progressive familial intrahepatic 2, 601847 (3);'),
('603202','LAC','Lactase deficiency, congenital, 223000 (3)'),
('603202','LCT','Lactase deficiency, congenital, 223000 (3)'),
('603202','LPH','Lactase deficiency, congenital, 223000 (3)'),
('603204','ENFL2','Epilepsy, nocturnal frontal lobe, type 2 (2)'),
('603206','SCZD8','{Schizophrenia}, 181500 (2)'),
('603208','KCNJ13','amaurosis 16, 614186 (3)'),
('603208','LCA16','amaurosis 16, 614186 (3)'),
('603208','SVD','amaurosis 16, 614186 (3)'),
('603208','KCNJ13','Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital'),
('603208','LCA16','Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital'),
('603208','SVD','Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital'),
('603212','BFSP2','(3); Cataract, autosomal dominant, multiple types 1, 611597 (3)'),
('603212','CP47','(3); Cataract, autosomal dominant, multiple types 1, 611597 (3)'),
('603212','CP49','(3); Cataract, autosomal dominant, multiple types 1, 611597 (3)'),
('603212','BFSP2','Cataract, juvenile-onset, 604219 (3); Cataract, congenital, 604219'),
('603212','CP47','Cataract, juvenile-onset, 604219 (3); Cataract, congenital, 604219'),
('603212','CP49','Cataract, juvenile-onset, 604219 (3); Cataract, congenital, 604219'),
('603213','KID','603546 (3)'),
('603213','KIF22','603546 (3)'),
('603213','KNSL4','603546 (3)'),
('603213','OBP','603546 (3)'),
('603213','SEMDJL2','603546 (3)'),
('603213','KID','Spondyloepimetaphyseal dysplasia with joint laxity, type 2,'),
('603213','KIF22','Spondyloepimetaphyseal dysplasia with joint laxity, type 2,'),
('603213','KNSL4','Spondyloepimetaphyseal dysplasia with joint laxity, type 2,'),
('603213','OBP','Spondyloepimetaphyseal dysplasia with joint laxity, type 2,'),
('603213','SEMDJL2','Spondyloepimetaphyseal dysplasia with joint laxity, type 2,'),
('603221','MYP3','Myopia-3 (2)'),
('603234','ABC34','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','ABCC6','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','ARA','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','GACI2','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','MLP1','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','PXE','forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)'),
('603234','ABC34','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603234','ABCC6','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603234','ARA','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603234','GACI2','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603234','MLP1','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603234','PXE','Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,'),
('603248','ALK6','Brachydactyly, type A2, 112600 (3); Chrondrodysplasia, acromesomelic,'),
('603248','BMPR1B','Brachydactyly, type A2, 112600 (3); Chrondrodysplasia, acromesomelic,'),
('603248','ALK6','with genital anomalies, 609441 (3)'),
('603248','BMPR1B','with genital anomalies, 609441 (3)'),
('603254','BRG1','retardation, autosomal dominant 16, 614609 (3)'),
('603254','MRD16','retardation, autosomal dominant 16, 614609 (3)'),
('603254','RTPS2','retardation, autosomal dominant 16, 614609 (3)'),
('603254','SMARCA4','retardation, autosomal dominant 16, 614609 (3)'),
('603254','BRG1','Rhabdoid tumor predisposition syndrome 2, 613325 (3); Mental'),
('603254','MRD16','Rhabdoid tumor predisposition syndrome 2, 613325 (3); Mental'),
('603254','RTPS2','Rhabdoid tumor predisposition syndrome 2, 613325 (3); Mental'),
('603254','SMARCA4','Rhabdoid tumor predisposition syndrome 2, 613325 (3); Mental'),
('603263','CA12','Hyperchlorhidrosis, isolated, 143860 (3)'),
('603266','IDDM17','{Diabetes mellitus, insulin-dependent, 17} (2)'),
('603273','EEC3','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','KET','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','LMS','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','OFC8','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','RHS','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','SHFM4','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','TP63','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','TP73L','3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome,'),
('603273','EEC3','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','KET','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','LMS','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','OFC8','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','RHS','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','SHFM4','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','TP63','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','TP73L','603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)'),
('603273','EEC3','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','KET','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','LMS','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','OFC8','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','RHS','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','SHFM4','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','TP63','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603273','TP73L','Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome'),
('603276','RGS5','[Blood pressure regulation QTL], 145500 (2)'),
('603286','KISS1','Hypogonadotropic hypogonadism, 146110 (3)'),
('603287','PNPO','Pyridoxamine 5\'-phosphate oxidase deficiency, 610090 (3)'),
('603288','CNA2','Cornea plana congenita, recessive, 217300 (3)'),
('603288','KERA','Cornea plana congenita, recessive, 217300 (3)'),
('603290','AUTS17','{Autism susceptibility 17}, 613436 (3)'),
('603290','CORTBP1','{Autism susceptibility 17}, 613436 (3)'),
('603290','SHANK2','{Autism susceptibility 17}, 613436 (3)'),
('603295','MADH6','Pulmonary hypertension, primary, 178600 (3)'),
('603295','MADH9','Pulmonary hypertension, primary, 178600 (3)'),
('603295','SMAD9','Pulmonary hypertension, primary, 178600 (3)'),
('603297','ATD3','Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly'),
('603297','DHC2','Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly'),
('603297','DNCH2','Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly'),
('603297','DYNC2H1','Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly'),
('603297','ATD3','syndrome, type III, 263510 (3); Short rib-polydactyly syndrome, type II, digenic, 263520 (3)'),
('603297','DHC2','syndrome, type III, 263510 (3); Short rib-polydactyly syndrome, type II, digenic, 263520 (3)'),
('603297','DNCH2','syndrome, type III, 263510 (3); Short rib-polydactyly syndrome, type II, digenic, 263520 (3)'),
('603297','DYNC2H1','syndrome, type III, 263510 (3); Short rib-polydactyly syndrome, type II, digenic, 263520 (3)'),
('603301','FKLF','Maturity-onset diabetes of the young, type VII, 610508 (3)'),
('603301','FKLF1','Maturity-onset diabetes of the young, type VII, 610508 (3)'),
('603301','KLF11','Maturity-onset diabetes of the young, type VII, 610508 (3)'),
('603301','MODY7','Maturity-onset diabetes of the young, type VII, 610508 (3)'),
('603301','TIEG2','Maturity-onset diabetes of the young, type VII, 610508 (3)'),
('603307','BFSP1','Cataract, cortical, juvenile-onset, 611391 (3)'),
('603307','CP115','Cataract, cortical, juvenile-onset, 611391 (3)'),
('603313','ALG10','{Acquired long QT syndrome, reduced susceptibility to}, 613688 (3)'),
('603313','KCR1','{Acquired long QT syndrome, reduced susceptibility to}, 613688 (3)'),
('603317','DFNB84','Deafness, autosomal recessive 84, 613391 (3)'),
('603317','PTPGMC1','Deafness, autosomal recessive 84, 613391 (3)'),
('603317','PTPRQ','Deafness, autosomal recessive 84, 613391 (3)'),
('603324','CX31','autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic,'),
('603324','DFNA2B','autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic,'),
('603324','GJB3','autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic,'),
('603324','CX31','Erythrokeratodermia variabilis et progressiva, 133200 (3); Deafness,'),
('603324','DFNA2B','Erythrokeratodermia variabilis et progressiva, 133200 (3); Deafness,'),
('603324','GJB3','Erythrokeratodermia variabilis et progressiva, 133200 (3); Deafness,'),
('603324','CX31','GJB2/GJB3, 220290 (3)'),
('603324','DFNA2B','GJB2/GJB3, 220290 (3)'),
('603324','GJB3','GJB2/GJB3, 220290 (3)'),
('603335','CILD3','608644 (3)'),
('603335','DNAH5','608644 (3)'),
('603335','HL1','608644 (3)'),
('603335','PCD','608644 (3)'),
('603335','CILD3','Ciliary dyskinesia, primary, 3, with or without situs inversus,'),
('603335','DNAH5','Ciliary dyskinesia, primary, 3, with or without situs inversus,'),
('603335','HL1','Ciliary dyskinesia, primary, 3, with or without situs inversus,'),
('603335','PCD','Ciliary dyskinesia, primary, 3, with or without situs inversus,'),
('603339','CILD7','611884 (3)'),
('603339','DNAH11','611884 (3)'),
('603339','DNAHBL','611884 (3)'),
('603339','DNAHC11','611884 (3)'),
('603339','CILD7','Ciliary dyskinesia, primary, 7, with or without situs inversus,'),
('603339','DNAH11','Ciliary dyskinesia, primary, 7, with or without situs inversus,'),
('603339','DNAHBL','Ciliary dyskinesia, primary, 7, with or without situs inversus,'),
('603339','DNAHC11','Ciliary dyskinesia, primary, 7, with or without situs inversus,'),
('603342','SCZD2','{?Schizophrenia}, 181500 (2)'),
('603345','KNBC','604278 (3)'),
('603345','NBC1','604278 (3)'),
('603345','SLC4A4','604278 (3)'),
('603345','SLC4A5','604278 (3)'),
('603345','KNBC','Renal tubular acidosis, proximal, with ocular abnormalities,'),
('603345','NBC1','Renal tubular acidosis, proximal, with ocular abnormalities,'),
('603345','SLC4A4','Renal tubular acidosis, proximal, with ocular abnormalities,'),
('603345','SLC4A5','Renal tubular acidosis, proximal, with ocular abnormalities,'),
('603349','ECYT4','Erythrocytosis, familial, 4, 611783 (3)'),
('603349','EPAS1','Erythrocytosis, familial, 4, 611783 (3)'),
('603349','HIF2A','Erythrocytosis, familial, 4, 611783 (3)'),
('603349','MOP2','Erythrocytosis, familial, 4, 611783 (3)'),
('603360','PEX16','Zellweger syndrome, complementation group 9 (3)'),
('603371','GLE1','Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis,'),
('603371','GLE1L','Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis,'),
('603371','LCCS','Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis,'),
('603371','LCCS1','Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis,'),
('603371','GLE1','lethal, with anterior horn cell disease, 611890 (3)'),
('603371','GLE1L','lethal, with anterior horn cell disease, 611890 (3)'),
('603371','LCCS','lethal, with anterior horn cell disease, 611890 (3)'),
('603371','LCCS1','lethal, with anterior horn cell disease, 611890 (3)'),
('603372','CHNG1','adenoma, hyperfunctioning, somatic (3); Hyperthyroidism, nonautoimmune, 609152 (3); Thyroid carcinoma with thyrotoxicosis (3); Hyperthyroidism, familial'),
('603372','TSHR','adenoma, hyperfunctioning, somatic (3); Hyperthyroidism, nonautoimmune, 609152 (3); Thyroid carcinoma with thyrotoxicosis (3); Hyperthyroidism, familial'),
('603372','CHNG1','gestational, 603373 (3)'),
('603372','TSHR','gestational, 603373 (3)'),
('603372','CHNG1','Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid'),
('603372','TSHR','Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid'),
('603377','CDSP','Carnitine deficiency, systemic primary, 212140 (3)'),
('603377','OCTN2','Carnitine deficiency, systemic primary, 212140 (3)'),
('603377','SCD','Carnitine deficiency, systemic primary, 212140 (3)'),
('603377','SLC22A5','Carnitine deficiency, systemic primary, 212140 (3)'),
('603381','AOI','150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)'),
('603381','FLNB','150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)'),
('603381','LRS1','150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)'),
('603381','SCT','150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)'),
('603381','AOI','Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome,'),
('603381','FLNB','Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome,'),
('603381','LRS1','Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome,'),
('603381','SCT','Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome,'),
('603383','GLC1F','Glaucoma 1F (2)'),
('603384','MRD5','Mental retardation, autosomal dominant 5, 612621 (3)'),
('603384','SYNGAP','Mental retardation, autosomal dominant 5, 612621 (3)'),
('603386','TCO','Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)'),
('603388','GRD2','{Graves disease, susceptibility to, 2} (2)'),
('603390','ADSD','Pigmented nodular adrenocortical disease, primary, 3, 614190 (3);'),
('603390','PDE8B','Pigmented nodular adrenocortical disease, primary, 3, 614190 (3);'),
('603390','PPNAD3','Pigmented nodular adrenocortical disease, primary, 3, 614190 (3);'),
('603390','ADSD','Striatal degeneration, autosomal dominant, 609161 (3)'),
('603390','PDE8B','Striatal degeneration, autosomal dominant, 609161 (3)'),
('603390','PPNAD3','Striatal degeneration, autosomal dominant, 609161 (3)'),
('603400','PPAC','Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3);'),
('603400','PPD','Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3);'),
('603400','WISP3','Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3);'),
('603400','PPAC','Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)'),
('603400','PPD','Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)'),
('603400','WISP3','Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)'),
('603401','ADTB3A','Hermansky-Pudlak syndrome 2, 608233 (3)'),
('603401','AP3B1','Hermansky-Pudlak syndrome 2, 608233 (3)'),
('603401','HPS2','Hermansky-Pudlak syndrome 2, 608233 (3)'),
('603406','PTC6','Thyroid carcinoma, papillary, 188550 (3)'),
('603406','TIF1','Thyroid carcinoma, papillary, 188550 (3)'),
('603406','TIF1A','Thyroid carcinoma, papillary, 188550 (3)'),
('603406','TRIM24','Thyroid carcinoma, papillary, 188550 (3)'),
('603409','FZD6','614157 (3)'),
('603409','NDNC10','614157 (3)'),
('603409','FZD6','Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails),'),
('603409','NDNC10','Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails),'),
('603415','FEB3B','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','GEFSP7','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','NENA','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','PN1','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','SCN9A','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','SFNP','channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized,'),
('603415','FEB3B','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','GEFSP7','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','NENA','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','PN1','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','SCN9A','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','SFNP','Erythermalgia, primary, 133020 (3); Insensitivity to pain,'),
('603415','FEB3B','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603415','GEFSP7','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603415','NENA','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603415','PN1','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603415','SCN9A','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603415','SFNP','with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)'),
('603422','RIL','{Osteoporosis, susceptibility to}, 166710 (3)'),
('603424','DYT16','Dystonia 16, 612067 (3)'),
('603424','PACT','Dystonia 16, 612067 (3)'),
('603424','PRKRA','Dystonia 16, 612067 (3)'),
('603424','RAX','Dystonia 16, 612067 (3)'),
('603426','FASPS','Advanced sleep phase syndrome, familial, 604348 (3)'),
('603426','KIAA0347','Advanced sleep phase syndrome, familial, 604348 (3)'),
('603426','PER2','Advanced sleep phase syndrome, familial, 604348 (3)'),
('603454','CRADD','Mental retardation, autosomal recessive 34, 614499 (3)'),
('603454','MRT34','Mental retardation, autosomal recessive 34, 614499 (3)'),
('603454','RAIDD','Mental retardation, autosomal recessive 34, 614499 (3)'),
('603470','ASS','Citrullinemia, 215700 (3)'),
('603470','ASS1','Citrullinemia, 215700 (3)'),
('603474','DBA','Diamond-Blackfan anemia 1, 105650 (3)'),
('603474','DBA1','Diamond-Blackfan anemia 1, 105650 (3)'),
('603474','RPS19','Diamond-Blackfan anemia 1, 105650 (3)'),
('603489','CILP','{Lumbar disc disease, susceptibility to}, 603932 (3)'),
('603490','SERKAL','158330 (3)'),
('603490','WNT4','158330 (3)'),
('603490','SERKAL','SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism,'),
('603490','WNT4','SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism,'),
('603495','AIE2','Spermatogenic failure 5, 243060 (3)'),
('603495','SPGF5','Spermatogenic failure 5, 243060 (3)'),
('603495','STK13','Spermatogenic failure 5, 243060 (3)'),
('603499','ODFR','602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)'),
('603499','OFE','602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)'),
('603499','OPTB7','602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)'),
('603499','RANK','602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)'),
('603499','TNFRSF11A','602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)'),
('603499','ODFR','Osteolysis, familial expansile, 174810 (3); Paget disease of bone,'),
('603499','OFE','Osteolysis, familial expansile, 174810 (3); Paget disease of bone,'),
('603499','OPTB7','Osteolysis, familial expansile, 174810 (3); Paget disease of bone,'),
('603499','RANK','Osteolysis, familial expansile, 174810 (3); Paget disease of bone,'),
('603499','TNFRSF11A','Osteolysis, familial expansile, 174810 (3); Paget disease of bone,'),
('603503','CDGIE','Congenital disorder of glycosylation, type Ie, 608799 (3)'),
('603503','DPM1','Congenital disorder of glycosylation, type Ie, 608799 (3)'),
('603503','MPDS','Congenital disorder of glycosylation, type Ie, 608799 (3)'),
('603506','BMND1','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','EVR4','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','LR3','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','LRP5','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','LRP7','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','OPPG','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','OPTA1','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','VBCH2','(3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)'),
('603506','BMND1','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','EVR4','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','LR3','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','LRP5','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','LRP7','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','OPPG','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','OPTA1','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','VBCH2','Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density'),
('603506','BMND1','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','EVR4','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','LR3','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','LRP5','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','LRP7','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','OPPG','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','OPTA1','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603506','VBCH2','variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710'),
('603507','ADCAD2','{Coronary artery disease, autosomal dominant, 2}, 610947 (3)'),
('603507','LRP6','{Coronary artery disease, autosomal dominant, 2}, 610947 (3)'),
('603517','BCL10','613024 (3); {Male germ cell tumor, somatic}, 273300, (3); {Sezary syndrome, somatic}, (3); Colon cancer, somatic, 114500 (3);'),
('603517','BCL10','Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic},'),
('603517','BCL10','{Mesothelioma, somatic}, 156240 (3)'),
('603537','DFNA2A','Deafness, autosomal dominant 2A, 600101 (3)'),
('603537','KCNQ4','Deafness, autosomal dominant 2A, 600101 (3)'),
('603550','CMD1J','1J, 605362 (3)'),
('603550','DFNA10','1J, 605362 (3)'),
('603550','EYA4','1J, 605362 (3)'),
('603550','CMD1J','Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated,'),
('603550','DFNA10','Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated,'),
('603550','EYA4','Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated,'),
('603557','CMT4B1','Charcot-Marie-Tooth disease, type 4B1, 601382 (3)'),
('603557','MTMR2','Charcot-Marie-Tooth disease, type 4B1, 601382 (3)'),
('603570','HDLCQ8','[High density lipoprotein cholesterol level QTL 8] (3)'),
('603570','VNN1','[High density lipoprotein cholesterol level QTL 8] (3)'),
('603576','CSNB1C','Night blindness, congenital stationary, type 1C, 613216 (3)'),
('603576','MLSN1','Night blindness, congenital stationary, type 1C, 613216 (3)'),
('603576','TRPM1','Night blindness, congenital stationary, type 1C, 613216 (3)'),
('603590','KIAA0609','anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)'),
('603590','LARGE','anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)'),
('603590','MDC1D','anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)'),
('603590','MDDGA6','anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)'),
('603590','MDDGB6','anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)'),
('603590','KIAA0609','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('603590','LARGE','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('603590','MDC1D','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('603590','MDDGA6','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('603590','MDDGB6','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('603593','LPI','Lysinuric protein intolerance, 222700 (3)'),
('603593','SLC7A7','Lysinuric protein intolerance, 222700 (3)'),
('603594','GP34','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('603594','OX4OL','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('603594','TNFSF4','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('603604','INAD1','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','IPLA2','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','NBIA2A','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','NBIA2B','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','PARK14','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','PLA2G6','Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration'),
('603604','INAD1','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603604','IPLA2','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603604','NBIA2A','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603604','NBIA2B','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603604','PARK14','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603604','PLA2G6','with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)'),
('603605','AIMP1','Leukodystrophy, hypomyelinating, 3, 260600 (3)'),
('603605','EMAP2','Leukodystrophy, hypomyelinating, 3, 260600 (3)'),
('603605','EMAPII','Leukodystrophy, hypomyelinating, 3, 260600 (3)'),
('603605','HLD3','Leukodystrophy, hypomyelinating, 3, 260600 (3)'),
('603605','SCYE1','Leukodystrophy, hypomyelinating, 3, 260600 (3)'),
('603612','DR5','Squamous cell carcinoma, head and neck, 275355 (3)'),
('603612','TNFRSF10B','Squamous cell carcinoma, head and neck, 275355 (3)'),
('603612','TRAILR2','Squamous cell carcinoma, head and neck, 275355 (3)'),
('603615','HR54','somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)'),
('603615','HRAD54','somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)'),
('603615','RAD54L','somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)'),
('603615','HR54','{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin,'),
('603615','HRAD54','{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin,'),
('603615','RAD54L','{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin,'),
('603617','CSNB1D','Night blindness, congenital stationary, type 1D, 613830 (3)'),
('603617','NCKX1','Night blindness, congenital stationary, type 1D, 613830 (3)'),
('603617','SLC24A1','Night blindness, congenital stationary, type 1D, 613830 (3)'),
('603623','CMTDIC','Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)'),
('603623','TYRRS','Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)'),
('603623','YARS','Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)'),
('603623','YRS','Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)'),
('603623','YTS','Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)'),
('603632','DBA9','Diamond-Blackfan anemia 9, 613308 (3)'),
('603632','RPS10','Diamond-Blackfan anemia 9, 613308 (3)'),
('603634','DBA6','Diamond-Blackfan anemia 6, 612561 (3)'),
('603634','RPL5','Diamond-Blackfan anemia 6, 612561 (3)'),
('603639','ADAM17','Inflammatory skin and bowel disease, neonatal, 614328 (3)'),
('603639','NISBD','Inflammatory skin and bowel disease, neonatal, 614328 (3)'),
('603639','TACE','Inflammatory skin and bowel disease, neonatal, 614328 (3)'),
('603644','SCO1','Hepatic failure, early onset, and neurologic disorder (3)'),
('603644','SCOD1','Hepatic failure, early onset, and neurologic disorder (3)'),
('603646','COX15','Cardiomyopathy, hypertrophic, early-onset fatal (3); Leigh syndrome'),
('603646','COX15','due to cytochrome c oxidase deficiency, 256000 (3)'),
('603647','BCS1L','603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)'),
('603647','BJS','603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)'),
('603647','FLNMS','603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)'),
('603647','GRACILE','603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)'),
('603647','PTD','603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)'),
('603647','BCS1L','Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,'),
('603647','BJS','Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,'),
('603647','FLNMS','Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,'),
('603647','GRACILE','Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,'),
('603647','PTD','Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,'),
('603650','BBS5','Bardet-Biedl syndrome 5, 209900 (3)'),
('603652','FSGS2','Glomerulosclerosis, focal segmental, 2, 603965 (3)'),
('603652','TRP6','Glomerulosclerosis, focal segmental, 2, 603965 (3)'),
('603652','TRPC6','Glomerulosclerosis, focal segmental, 2, 603965 (3)'),
('603658','DBA8','Diamond-Blackfan anemia 8, 612563 (3)'),
('603658','RPS7','Diamond-Blackfan anemia 8, 612563 (3)'),
('603663','MHW1','{Mental health wellness-1} (2)'),
('603664','MHW2','{Mental health wellness-2} (2)'),
('603666','STX16','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('603666','SYN16','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('603667','ARALAR','Hypomyelination, global cerebral, 612949 (3)'),
('603667','SLC25A12','Hypomyelination, global cerebral, 612949 (3)'),
('603673','PTCH2','(3)'),
('603673','PTCH2','Medulloblastoma, 155255 (3); Basal cell carcinoma, somatic, 605462'),
('603678','DFNB14','Deafness, autosomal recessive 14 (2)'),
('603680','ATXN8OS','Spinocerebellar ataxia 8, 608768 (3)'),
('603680','KLHL1AS','Spinocerebellar ataxia 8, 608768 (3)'),
('603680','SCA8','Spinocerebellar ataxia 8, 608768 (3)'),
('603681','AUNB1','autosomal recessive, 1, 601071 (3)'),
('603681','DFNB9','autosomal recessive, 1, 601071 (3)'),
('603681','NSRD9','autosomal recessive, 1, 601071 (3)'),
('603681','OTOF','autosomal recessive, 1, 601071 (3)'),
('603681','AUNB1','Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy,'),
('603681','DFNB9','Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy,'),
('603681','NSRD9','Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy,'),
('603681','OTOF','Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy,'),
('603690','ACATN','Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)'),
('603690','AT1','Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)'),
('603690','CCHLND','Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)'),
('603690','SLC33A1','Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)'),
('603690','SPG42','Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)'),
('603690','ACATN','Spastic paraplegia 42, autosomal dominant, 612539 (3);'),
('603690','AT1','Spastic paraplegia 42, autosomal dominant, 612539 (3);'),
('603690','CCHLND','Spastic paraplegia 42, autosomal dominant, 612539 (3);'),
('603690','SLC33A1','Spastic paraplegia 42, autosomal dominant, 612539 (3);'),
('603690','SPG42','Spastic paraplegia 42, autosomal dominant, 612539 (3);'),
('603693','DIH3','Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3)'),
('603693','FOG2','Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3)'),
('603693','ZFPM2','Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3)'),
('603694','NIDDM3','{Diabetes mellitus, noninsulin-dependent}, 125853 (2)'),
('603700','ALOX5AP','{Stroke, susceptibility to}, 601367 (3)'),
('603700','FLAP','{Stroke, susceptibility to}, 601367 (3)'),
('603701','DBA10','Diamond-Blackfan anemia 10, 613309 (3)'),
('603701','RPS26','Diamond-Blackfan anemia 10, 613309 (3)'),
('603707','MOCOD','Molybdenum cofactor deficiency, type A, 252150 (3)'),
('603707','MOCS1','Molybdenum cofactor deficiency, type A, 252150 (3)'),
('603708','MOCS2','Molybdenum cofactor deficiency, type B, 252150 (3)'),
('603708','MPTS','Molybdenum cofactor deficiency, type B, 252150 (3)'),
('603711','CBAS3','Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic'),
('603711','CYP7B1','Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic'),
('603711','SPG5A','Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic'),
('603711','CBAS3','paraplegia 5A, autosomal recessive, 270800 (3)'),
('603711','CYP7B1','paraplegia 5A, autosomal recessive, 270800 (3)'),
('603711','SPG5A','paraplegia 5A, autosomal recessive, 270800 (3)'),
('603714','HPE2','Holoprosencephaly-2, 157170 (3); Schizensephaly, 269160 (3)'),
('603714','SIX3','Holoprosencephaly-2, 157170 (3); Schizensephaly, 269160 (3)'),
('603716','GCMB','Hypoparathyroidism, familial isolated, 146200 (3)'),
('603718','CLDN1','607626 (3)'),
('603718','ILVASC','607626 (3)'),
('603718','SEMP1','607626 (3)'),
('603718','CLDN1','Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis,'),
('603718','ILVASC','Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis,'),
('603718','SEMP1','Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis,'),
('603722','IKAP','Dysautonomia, familial, 223900 (3)'),
('603722','IKBKAP','Dysautonomia, familial, 223900 (3)'),
('603741','ALOX12B','Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)'),
('603743','APOL1','612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)'),
('603743','FSGS4','612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)'),
('603743','APOL1','{Glomerulosclerosis, focal segmental, 4, susceptibility to},'),
('603743','FSGS4','{Glomerulosclerosis, focal segmental, 4, susceptibility to},'),
('603756','ABCG2','serum, QTL1], 138900 (3)'),
('603756','ABCP','serum, QTL1], 138900 (3)'),
('603756','BCRP','serum, QTL1], 138900 (3)'),
('603756','GOUT1','serum, QTL1], 138900 (3)'),
('603756','UAQTL1','serum, QTL1], 138900 (3)'),
('603756','ABCG2','[Junior blood group system], 614490 (3); [Uric acid concentration,'),
('603756','ABCP','[Junior blood group system], 614490 (3); [Uric acid concentration,'),
('603756','BCRP','[Junior blood group system], 614490 (3); [Uric acid concentration,'),
('603756','GOUT1','[Junior blood group system], 614490 (3); [Uric acid concentration,'),
('603756','UAQTL1','[Junior blood group system], 614490 (3); [Uric acid concentration,'),
('603758','GSTZ1','Tyrosinemia, type Ib (1)'),
('603758','MAAI','Tyrosinemia, type Ib (1)'),
('603767','AI2A1','Amelogenesis imperfecta, type IIA1, 204700 (3)'),
('603767','EMSP1','Amelogenesis imperfecta, type IIA1, 204700 (3)'),
('603767','KLK4','Amelogenesis imperfecta, type IIA1, 204700 (3)'),
('603767','PRSS17','Amelogenesis imperfecta, type IIA1, 204700 (3)'),
('603769','TCL1B','Leukemia/lymphoma, T-cell (2)'),
('603769','TML1','Leukemia/lymphoma, T-cell (2)'),
('603780','RECQ4','(3); Baller-Gerold syndrome, 218600 (3)'),
('603780','RECQL4','(3); Baller-Gerold syndrome, 218600 (3)'),
('603780','RTS','(3); Baller-Gerold syndrome, 218600 (3)'),
('603780','RECQ4','Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280'),
('603780','RECQL4','Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280'),
('603780','RTS','Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280'),
('603783','INTLQ1','{Intelligence QTL1} (2)'),
('603786','STGD4','Stargardt disease 4 (2)'),
('603795','CMT1C','Charcot-Marie-Tooth disease, type 1C, 601098 (3)'),
('603795','LITAF','Charcot-Marie-Tooth disease, type 1C, 601098 (3)'),
('603796','ATFB4','611493 (3)'),
('603796','KCNE2','611493 (3)'),
('603796','LQT6','611493 (3)'),
('603796','MIRP1','611493 (3)'),
('603796','ATFB4','Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4,'),
('603796','KCNE2','Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4,'),
('603796','LQT6','Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4,'),
('603796','MIRP1','Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4,'),
('603799','C6ST','143095 (3)'),
('603799','C6ST1','143095 (3)'),
('603799','CHST3','143095 (3)'),
('603799','HSD','143095 (3)'),
('603799','C6ST','Spondyloepiphyseal dysplasia with congenital joint dislocations,'),
('603799','C6ST1','Spondyloepiphyseal dysplasia with congenital joint dislocations,'),
('603799','CHST3','Spondyloepiphyseal dysplasia with congenital joint dislocations,'),
('603799','HSD','Spondyloepiphyseal dysplasia with congenital joint dislocations,'),
('603805','TGM5','Peeling skin syndrome, acral type, 609796 (3)'),
('603805','TGX','Peeling skin syndrome, acral type, 609796 (3)'),
('603810','CRSP6','atrophy, 613668 (3)'),
('603810','CRSP77','atrophy, 613668 (3)'),
('603810','DRIP80','atrophy, 613668 (3)'),
('603810','MED17','atrophy, 613668 (3)'),
('603810','TRAP80','atrophy, 613668 (3)'),
('603810','CRSP6','Microcephaly, postnatal progressive, with seizures and brain'),
('603810','CRSP77','Microcephaly, postnatal progressive, with seizures and brain'),
('603810','DRIP80','Microcephaly, postnatal progressive, with seizures and brain'),
('603810','MED17','Microcephaly, postnatal progressive, with seizures and brain'),
('603810','TRAP80','Microcephaly, postnatal progressive, with seizures and brain'),
('603811','BAF','Nestor-Guillermo progeria syndrome, 614008 (3)'),
('603811','BANF1','Nestor-Guillermo progeria syndrome, 614008 (3)'),
('603811','NGPS','Nestor-Guillermo progeria syndrome, 614008 (3)'),
('603816','AXIN','anomaly, 607864 (3)'),
('603816','AXIN1','anomaly, 607864 (3)'),
('603816','AXIN','Hepatocellular carcinoma, somatic, 114550 (3); Caudal duplication'),
('603816','AXIN1','Hepatocellular carcinoma, somatic, 114550 (3); Caudal duplication'),
('603824','DMRV','600737 (3); Nonaka myopathy, 605820 (3)'),
('603824','GLCNE','600737 (3); Nonaka myopathy, 605820 (3)'),
('603824','GNE','600737 (3); Nonaka myopathy, 605820 (3)'),
('603824','IBM2','600737 (3); Nonaka myopathy, 605820 (3)'),
('603824','NM','600737 (3); Nonaka myopathy, 605820 (3)'),
('603824','DMRV','Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,'),
('603824','GLCNE','Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,'),
('603824','GNE','Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,'),
('603824','IBM2','Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,'),
('603824','NM','Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,'),
('603834','NDUFA9','(3)'),
('603834','NDUFA9','Leigh syndrome due to mitochondrial complex I deficiency, 256000'),
('603835','NDUFA10','Leigh syndrome, 256000 (3)'),
('603839','NDUFB3','Mitochondrial complex I deficiency, 252010 (3)'),
('603846','NDUFS3','Leigh syndrome, 256000 (3)'),
('603848','NDUFS6','Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)'),
('603850','DNM1L','Encephalopahty, lethal, due to defective mitochondrial peroxisomal'),
('603850','DRP1','Encephalopahty, lethal, due to defective mitochondrial peroxisomal'),
('603850','DVLP','Encephalopahty, lethal, due to defective mitochondrial peroxisomal'),
('603850','DYMPLE','Encephalopahty, lethal, due to defective mitochondrial peroxisomal'),
('603850','EMPF','Encephalopahty, lethal, due to defective mitochondrial peroxisomal'),
('603850','DNM1L','fission, 614388 (3)'),
('603850','DRP1','fission, 614388 (3)'),
('603850','DVLP','fission, 614388 (3)'),
('603850','DYMPLE','fission, 614388 (3)'),
('603850','EMPF','fission, 614388 (3)'),
('603851','NBLST2','Central hypoventilation syndrome, congenital, with or without'),
('603851','NBPHOX','Central hypoventilation syndrome, congenital, with or without'),
('603851','PHOX2B','Central hypoventilation syndrome, congenital, with or without'),
('603851','PMX2B','Central hypoventilation syndrome, congenital, with or without'),
('603851','NBLST2','Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)'),
('603851','NBPHOX','Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)'),
('603851','PHOX2B','Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)'),
('603851','PMX2B','Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)'),
('603855','CFM1','{Meconium ileus in cystic fibrosis, susceptibility to} (2)'),
('603859','CTLN2','Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia,'),
('603859','SLC25A13','Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia,'),
('603859','CTLN2','type II, neonatal-onset, 605814 (3)'),
('603859','SLC25A13','type II, neonatal-onset, 605814 (3)'),
('603861','HHH','(3)'),
('603861','ORNT1','(3)'),
('603861','SLC25A15','(3)'),
('603861','HHH','Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970'),
('603861','ORNT1','Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970'),
('603861','SLC25A15','Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970'),
('603868','GS2','Griscelli syndrome, type 2, 607624 (3)'),
('603868','RAB27A','Griscelli syndrome, type 2, 607624 (3)'),
('603868','RAM','Griscelli syndrome, type 2, 607624 (3)'),
('603883','BAG3','dilated, 1HH, 613881 (3)'),
('603883','BAG3','Myopathy, myofibrillar, BAG3-related, 612954 (3); Cardiomyopathy,'),
('603892','EFTUD2','Mandibulofacial dysostosis with microcephaly, 610536 (3)'),
('603892','KIAA0031','Mandibulofacial dysostosis with microcephaly, 610536 (3)'),
('603892','MFDM','Mandibulofacial dysostosis with microcephaly, 610536 (3)'),
('603904','ABRI','117300 (3)'),
('603904','BRI','117300 (3)'),
('603904','FBD','117300 (3)'),
('603904','ITM2B','117300 (3)'),
('603904','ABRI','Dementia, familial British, 176500 (3); Dementia, familial Danish,'),
('603904','BRI','Dementia, familial British, 176500 (3); Dementia, familial Danish,'),
('603904','FBD','Dementia, familial British, 176500 (3); Dementia, familial Danish,'),
('603904','ITM2B','Dementia, familial British, 176500 (3); Dementia, familial Danish,'),
('603918','HYT1','{Hypertension, essential, susceptibility to, 1}, 145500 (2)'),
('603921','MTDPS5','methylmalonic aciduria), 612073 (3)'),
('603921','SUCLA2','methylmalonic aciduria), 612073 (3)'),
('603921','MTDPS5','Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with'),
('603921','SUCLA2','Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with'),
('603924','FSAP','susceptibility to}, 188050 (3)'),
('603924','HABP2','susceptibility to}, 188050 (3)'),
('603924','HGFAL','susceptibility to}, 188050 (3)'),
('603924','PHBP','susceptibility to}, 188050 (3)'),
('603924','FSAP','{Carotid stenosis, susceptibility to} (3); {Venous thromboembolism,'),
('603924','HABP2','{Carotid stenosis, susceptibility to} (3); {Venous thromboembolism,'),
('603924','HGFAL','{Carotid stenosis, susceptibility to} (3); {Venous thromboembolism,'),
('603924','PHBP','{Carotid stenosis, susceptibility to} (3); {Venous thromboembolism,'),
('603930','GEPH','149400 (3)'),
('603930','GPH','149400 (3)'),
('603930','GPHN','149400 (3)'),
('603930','KIAA1385','149400 (3)'),
('603930','GEPH','Molybdenum cofactor deficiency, type C, 252150 (3); Hyperekplexia,'),
('603930','GPH','Molybdenum cofactor deficiency, type C, 252150 (3); Hyperekplexia,'),
('603930','GPHN','Molybdenum cofactor deficiency, type C, 252150 (3); Hyperekplexia,'),
('603930','KIAA1385','Molybdenum cofactor deficiency, type C, 252150 (3); Hyperekplexia,'),
('603935','PSORS4','{Psoriasis susceptibility 4} (2)'),
('603937','ORP1','Retinitis pigmentosa 1, 180100 (3); {Hypertriglyceridemia,'),
('603937','RP1','Retinitis pigmentosa 1, 180100 (3); {Hypertriglyceridemia,'),
('603937','ORP1','susceptibility to}, 145750 (3)'),
('603937','RP1','susceptibility to}, 145750 (3)'),
('603941','SLC19A2','Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)'),
('603941','THMD1','Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)'),
('603941','THTR1','Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)'),
('603941','TRMA','Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)'),
('603942','GSD15','Glycogen storage disease XV, 613507 (3)'),
('603942','GYG1','Glycogen storage disease XV, 613507 (3)'),
('603945','CACH','Leukoencephalopathy with vanishing white matter, 603896 (3);'),
('603945','CLE','Leukoencephalopathy with vanishing white matter, 603896 (3);'),
('603945','EIF2B5','Leukoencephalopathy with vanishing white matter, 603896 (3);'),
('603945','LVWM','Leukoencephalopathy with vanishing white matter, 603896 (3);'),
('603945','CACH','Ovarioleukodystrophy, 603896 (3)'),
('603945','CLE','Ovarioleukodystrophy, 603896 (3)'),
('603945','EIF2B5','Ovarioleukodystrophy, 603896 (3)'),
('603945','LVWM','Ovarioleukodystrophy, 603896 (3)'),
('603951','KCNMB1','{Hypertension, diastolic, resistance to}, 608622 (3)'),
('603959','CLDN16','Hypomagnesemia 3, renal, 248250 (3)'),
('603959','HOMG3','Hypomagnesemia 3, renal, 248250 (3)'),
('603959','PCLN1','Hypomagnesemia 3, renal, 248250 (3)'),
('603964','DFNA16','Deafness, autosomal dominant 16 (2)'),
('603967','HOKPP2','congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, acetazolamide-responsive, 614198 (3);'),
('603967','HYPP','congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, acetazolamide-responsive, 614198 (3);'),
('603967','NAC1A','congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, acetazolamide-responsive, 614198 (3);'),
('603967','SCN4A','congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, acetazolamide-responsive, 614198 (3);'),
('603967','HOKPP2','Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia'),
('603967','HYPP','Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia'),
('603967','NAC1A','Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia'),
('603967','SCN4A','Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia'),
('603967','HOKPP2','Hypokalemic periodic paralysis, type 2, 613345 (3)'),
('603967','HYPP','Hypokalemic periodic paralysis, type 2, 613345 (3)');
INSERT INTO omim VALUES
('603967','NAC1A','Hypokalemic periodic paralysis, type 2, 613345 (3)'),
('603967','SCN4A','Hypokalemic periodic paralysis, type 2, 613345 (3)'),
('603968','POLH','Xeroderma pigmentosum, variant type, 278750 (3)'),
('603968','XPV','Xeroderma pigmentosum, variant type, 278750 (3)'),
('604001','AKAP450','Long QT syndrome-11, 611820 (3)'),
('604001','AKAP9','Long QT syndrome-11, 611820 (3)'),
('604001','YOTIAO','Long QT syndrome-11, 611820 (3)'),
('604011','HRG4','Cone-rod dystrophy (3)'),
('604011','UNC119','Cone-rod dystrophy (3)'),
('604025','AXIN2','Colorectal cancer, 114500 (3); Oligodontia-colorectal cancer'),
('604025','AXIN2','syndrome, 608615 (3)'),
('604027','EPM6','Epilepsy, progressive myoclonic 6, 614018 (3)'),
('604027','GOSR2','Epilepsy, progressive myoclonic 6, 614018 (3)'),
('604027','GS27','Epilepsy, progressive myoclonic 6, 614018 (3)'),
('604032','EIF2AK3','Wolcott-Rallison syndrome, 226980 (3)'),
('604032','PEK','Wolcott-Rallison syndrome, 226980 (3)'),
('604032','PERK','Wolcott-Rallison syndrome, 226980 (3)'),
('604032','WRS','Wolcott-Rallison syndrome, 226980 (3)'),
('604040','NBSLD','Nijmegen breakage syndrome-like disorder, 613078 (3)'),
('604040','RAD50','Nijmegen breakage syndrome-like disorder, 613078 (3)'),
('604041','CDGIF','Congenital disorder of glycosylation, type If, 609180 (3)'),
('604041','MPDU1','Congenital disorder of glycosylation, type If, 609180 (3)'),
('604041','SL15','Congenital disorder of glycosylation, type If, 609180 (3)'),
('604050','DLC1','Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)'),
('604050','DLEC1','Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)'),
('604060','DFNB20','Deafness, autosomal recessive 20 (2)'),
('604061','MSF','Amyotrophy, hereditary neuralgic, 162100 (3)'),
('604061','MSF1','Amyotrophy, hereditary neuralgic, 162100 (3)'),
('604061','NAPB','Amyotrophy, hereditary neuralgic, 162100 (3)'),
('604061','SEPT9','Amyotrophy, hereditary neuralgic, 162100 (3)'),
('604061','MSF','Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);'),
('604061','MSF1','Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);'),
('604061','NAPB','Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);'),
('604061','SEPT9','Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);'),
('604067','PERRS','Bradyopsia, 608415 (3)'),
('604067','RGS9','Bradyopsia, 608415 (3)'),
('604088','GSBS','{Hypercholesterolemia, susceptibility to}, 143890 (3)'),
('604095','DL','Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);'),
('604095','ED3','Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);'),
('604095','EDA3','Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);'),
('604095','EDAR','Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);'),
('604095','HRM1','Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);'),
('604095','DL','Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)'),
('604095','ED3','Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)'),
('604095','EDA3','Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)'),
('604095','EDAR','Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)'),
('604095','HRM1','Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)'),
('604096','CSNB1B','Night blindness, congenital stationary, type 1B, 257270 (3)'),
('604096','GRM6','Night blindness, congenital stationary, type 1B, 257270 (3)'),
('604096','MGLUR6','Night blindness, congenital stationary, type 1B, 257270 (3)'),
('604103','MYOT','609200 (3); Myopathy, spheroid body, 182920 (3)'),
('604103','TTID','609200 (3); Myopathy, spheroid body, 182920 (3)'),
('604103','MYOT','Muscular dystrophy, limb-girdle, type 1A, 159000 (3); Myotilinopathy,'),
('604103','TTID','Muscular dystrophy, limb-girdle, type 1A, 159000 (3); Myotilinopathy,'),
('604110','BFPP','Polymicrogyria, bilateral frontoparietal, 606854 (3)'),
('604110','GPR56','Polymicrogyria, bilateral frontoparietal, 606854 (3)'),
('604110','TM7XN1','Polymicrogyria, bilateral frontoparietal, 606854 (3)'),
('604114','PLCB2','Platelet PLC beta-2 deficiency (1)'),
('604115','KCNQ10T1','Beckwith-Wiedemann syndrome, 130650 (3)'),
('604115','LIT1','Beckwith-Wiedemann syndrome, 130650 (3)'),
('604124','JWDS','Jawad syndrome, 251255 (3)'),
('604124','RBBP8','Jawad syndrome, 251255 (3)'),
('604124','RIM','Jawad syndrome, 251255 (3)'),
('604124','SCKL2','Jawad syndrome, 251255 (3)'),
('604124','JWDS','Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3);'),
('604124','RBBP8','Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3);'),
('604124','RIM','Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3);'),
('604124','SCKL2','Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3);'),
('604127','TBX15','Cousin syndrome, 260660 (3)'),
('604134','ADAMTS13','Thrombotic thrombocytopenic purpura, familial, 274150 (3)'),
('604134','TTP','Thrombotic thrombocytopenic purpura, familial, 274150 (3)'),
('604134','VWFCP','Thrombotic thrombocytopenic purpura, familial, 274150 (3)'),
('604142','DAP12','Nasu-Hakola disease, 221770 (3)'),
('604142','PLOSL','Nasu-Hakola disease, 221770 (3)'),
('604142','TYROBP','Nasu-Hakola disease, 221770 (3)'),
('604144','CSNU3','Cystinuria, 220100 (3)'),
('604144','SLC7A9','Cystinuria, 220100 (3)'),
('604149','DYT11','Dystonia-11, myoclonic, 159900 (3)'),
('604149','SGCE','Dystonia-11, myoclonic, 159900 (3)'),
('604159','GLYT2','Hyperekplexia, 149400 (3)'),
('604159','SLC6A5','Hyperekplexia, 149400 (3)'),
('604161','GPR54','central, 176400 (3)'),
('604161','KISS1R','central, 176400 (3)'),
('604161','GPR54','Hypogonadotropic hypogonadism, 146110 (3); Precocious puberty,'),
('604161','KISS1R','Hypogonadotropic hypogonadism, 146110 (3); Precocious puberty,'),
('604175','DBA7','Diamond-Blackfan anemia 7, 612562 (3)'),
('604175','RPL11','Diamond-Blackfan anemia 7, 612562 (3)'),
('604185','MBS3','Moebius syndrome-3 (2)'),
('604190','OCTN1','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('604190','SLC22A4','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('604194','FATP4','Ichthyosis prematurity syndrome, 608649 (3)'),
('604194','IPS','Ichthyosis prematurity syndrome, 608649 (3)'),
('604194','SLC27A4','Ichthyosis prematurity syndrome, 608649 (3)'),
('604201','SM2','infection} (2)'),
('604201','SM2','{Hepatic fibrosis susceptibility due to Schistosoma mansoni'),
('604202','CEDNIK','Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar'),
('604202','SNAP29','Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar'),
('604202','CEDNIK','keratoderma syndrome, 609528 (3)'),
('604202','SNAP29','keratoderma syndrome, 609528 (3)'),
('604210','CRB1','Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)'),
('604210','LCA8','Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)'),
('604210','RP12','Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)'),
('604210','CRB1','Retinitis pigmentosa-12, autosomal recessive, 600105 (3);'),
('604210','LCA8','Retinitis pigmentosa-12, autosomal recessive, 600105 (3);'),
('604210','RP12','Retinitis pigmentosa-12, autosomal recessive, 600105 (3);'),
('604214','CAM','(3)'),
('604214','CCM1','(3)'),
('604214','KRIT1','(3)'),
('604214','CAM','Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic'),
('604214','CCM1','Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic'),
('604214','KRIT1','Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic'),
('604214','CAM','cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860'),
('604214','CCM1','cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860'),
('604214','KRIT1','cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860'),
('604217','SLC34A2','microlithiasis, 610441 (3)'),
('604217','SLC34A2','Pulmonary alveolar microlithiasis, 265100 (3); ?Testicular'),
('604237','CISS','601378 (3)'),
('604237','CRLF1','601378 (3)'),
('604237','CISS','Cold-induced sweating syndrome, 272430 (3); Crisponi syndrome,'),
('604237','CRLF1','Cold-induced sweating syndrome, 272430 (3); Crisponi syndrome,'),
('604241','CD2AP','Glomerulosclerosis, focal segmental, 3, 607832 (3)'),
('604241','CMS','Glomerulosclerosis, focal segmental, 3, 607832 (3)'),
('604242','RNF6','Esophageal carcinoma, somatic, 133239 (3)'),
('604254','DYX3','{Dyslexia, susceptibility to, 3} (2)'),
('604258','DLC1','Colorectal cancer, somatic (3)'),
('604260','STAT5B','insensitivity with immunodeficiency, 245590 (3)'),
('604260','STAT5B','Leukemia, acute promyelocytic, STAT5B/RARA type (3); Growth hormone'),
('604270','CLSS','614305 (3)'),
('604270','LRP4','614305 (3)'),
('604270','MEGF7','614305 (3)'),
('604270','SOST2','614305 (3)'),
('604270','CLSS','Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2,'),
('604270','LRP4','Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2,'),
('604270','MEGF7','Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2,'),
('604270','SOST2','Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2,'),
('604272','SCO2','Cardioencephalomyopathy, fatal infantile, due to cytochrome c'),
('604272','SCO2','oxidase deficiency, 604377 (3)'),
('604275','CTNND2','Mental retardation in cri-du-chat syndrome, 123450 (2)'),
('604275','NPRAP','Mental retardation in cri-du-chat syndrome, 123450 (2)'),
('604277','SPAST','Spastic paraplegia 4, autosomal dominant, 182601 (3)'),
('604277','SPG4','Spastic paraplegia 4, autosomal dominant, 182601 (3)'),
('604283','CACP','Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)'),
('604283','HAPO','Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)'),
('604283','MSF','Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)'),
('604283','PRG4','Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)'),
('604283','SZP','Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)'),
('604285','AGXT','Hyperoxaluria, primary, type 1, 259900 (3)'),
('604285','SPAT','Hyperoxaluria, primary, type 1, 259900 (3)'),
('604288','CMD1H','Cardiomyopathy, dilated, 1H (2)'),
('604289','RAD54B','Lymphoma, non-Hodgkin (3); Colon adenocarcinoma (3)'),
('604296','GLXR','Hyperoxaluria, primary, type II, 260000 (3)'),
('604296','GRHPR','Hyperoxaluria, primary, type II, 260000 (3)'),
('604305','CELIAC1','{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3);'),
('604305','HLA-DQB1','{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3);'),
('604305','CELIAC1','{Multiple sclerosis, susceptibility to}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)'),
('604305','HLA-DQB1','{Multiple sclerosis, susceptibility to}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)'),
('604310','HPS9','Hermansky-pudlak syndrome 9, 614171 (3)'),
('604310','PA','Hermansky-pudlak syndrome 9, 614171 (3)'),
('604310','PLDN','Hermansky-pudlak syndrome 9, 614171 (3)'),
('604312','ARMD11','age-related, 11, 611953 (3)'),
('604312','CST3','age-related, 11, 611953 (3)'),
('604312','ARMD11','Cerebral amyloid angiopathy, 105150 (3); Macular degeneration,'),
('604312','CST3','Cerebral amyloid angiopathy, 105150 (3); Macular degeneration,'),
('604313','GALK1','Galactokinase deficiency with cataracts, 230200 (3)'),
('604316','PSORS5','{Psoriasis susceptibility 5} (2)'),
('604319','DKCA3','Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz'),
('604319','TIN2','Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz'),
('604319','TINF2','Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz'),
('604319','DKCA3','syndrome, 268130 (3)'),
('604319','TIN2','syndrome, 268130 (3)'),
('604319','TINF2','syndrome, 268130 (3)'),
('604322','SIASD','269920 (3)'),
('604322','SLC17A5','269920 (3)'),
('604322','SLD','269920 (3)'),
('604322','SIASD','Salla disease, 604369 (3); Sialic acid storage disorder, infantile,'),
('604322','SLC17A5','Salla disease, 604369 (3); Sialic acid storage disorder, infantile,'),
('604322','SLD','Salla disease, 604369 (3); Sialic acid storage disorder, infantile,'),
('604325','PPP2R2B','Spinocerebellar ataxia 12, 604326 (3)'),
('604327','B4GALT7','Ehlers-Danlos syndrome, progeroid form, 130070 (3)'),
('604327','XGALT1','Ehlers-Danlos syndrome, progeroid form, 130070 (3)'),
('604327','XGPT1','Ehlers-Danlos syndrome, progeroid form, 130070 (3)'),
('604329','HYT2','{Hypertension, essential, susceptibility to, 2}, 145500 (2)'),
('604331','DDX26','{Nonsmall cell lung cancer} (2)'),
('604331','DICE1','{Nonsmall cell lung cancer} (2)'),
('604332','BTL','{Leukemia, acute myeloid}, 601626 (3)'),
('604332','CHIC2','{Leukemia, acute myeloid}, 601626 (3)'),
('604346','MAN1B1','Mental retardation, autosomal recessive 15, 614202 (3)'),
('604346','MRT15','Mental retardation, autosomal recessive 15, 614202 (3)'),
('604349','LAMC3','Cortical malformations, occipital, 614115 (3)'),
('604349','OCCM','Cortical malformations, occipital, 614115 (3)'),
('604364','FPEVF','Epilepsy, partial, with variable foci (2)'),
('604365','AC133','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','CD133','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','CORD12','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','MCDR2','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','PROM1','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','PROML1','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','RP41','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','STGD4','(3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)'),
('604365','AC133','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','CD133','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','CORD12','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','MCDR2','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','PROM1','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','PROML1','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','RP41','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604365','STGD4','Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657'),
('604366','CILD1','244400 (3)'),
('604366','DNAI1','244400 (3)'),
('604366','ICS','244400 (3)'),
('604366','PCD','244400 (3)'),
('604366','CILD1','Ciliary dyskinesia, primary, 1, with or without situs inversus,'),
('604366','DNAI1','Ciliary dyskinesia, primary, 1, with or without situs inversus,'),
('604366','ICS','Ciliary dyskinesia, primary, 1, with or without situs inversus,'),
('604366','PCD','Ciliary dyskinesia, primary, 1, with or without situs inversus,'),
('604373','CDS1','Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);'),
('604373','CHEK2','Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);'),
('604373','CHK2','Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);'),
('604373','LFS2','Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);'),
('604373','RAD53','Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);'),
('604373','CDS1','to} (3)'),
('604373','CHEK2','to} (3)'),
('604373','CHK2','to} (3)'),
('604373','LFS2','to} (3)'),
('604373','RAD53','to} (3)'),
('604373','CDS1','{Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility'),
('604373','CHEK2','{Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility'),
('604373','CHK2','{Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility'),
('604373','LFS2','{Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility'),
('604373','RAD53','{Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility'),
('604384','ATP2C1','Hailey-Hailey disease, 169600 (3)'),
('604384','BCPM','Hailey-Hailey disease, 169600 (3)'),
('604384','HHD','Hailey-Hailey disease, 169600 (3)'),
('604386','TRPS1','Trichorhinophalangeal syndrome, type I, 190350 (3);'),
('604386','TRPS1','Trichorhinophalangeal syndrome, type III, 190351 (3)'),
('604392','AIPL1','juvenile (3); Cone-rod dystrophy (3)'),
('604392','LCA4','juvenile (3); Cone-rod dystrophy (3)'),
('604392','AIPL1','Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa,'),
('604392','LCA4','Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa,'),
('604395','HNPCC7','Colorectal cancer, somatic, 114500 (3); Colon cancer, hereditary'),
('604395','MLH3','Colorectal cancer, somatic, 114500 (3); Colon cancer, hereditary'),
('604395','HNPCC7','nonpolyposis, type 7, 614385 (3); Endometrial cancer, 608089 (3)'),
('604395','MLH3','nonpolyposis, type 7, 614385 (3); Endometrial cancer, 608089 (3)'),
('604401','ARVD6','Arrhythmogenic right ventricular dysplasia 6 (2)'),
('604402','SIAT9','Amish infantile epilepsy syndrome, 609056 (3)'),
('604402','ST3GALV','Amish infantile epilepsy syndrome, 609056 (3)'),
('604404','GPC6','Omodysplasia 1, 258315 (3)'),
('604404','OMIMD1','Omodysplasia 1, 258315 (3)'),
('604418','CX30','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','DFNA3B','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','DFNB1B','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','ED2','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','GJB6','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','HED','Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,'),
('604418','CX30','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604418','DFNA3B','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604418','DFNB1B','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604418','ED2','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604418','GJB6','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604418','HED','hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)'),
('604433','HOKPP','Brugada syndrome 6, 613119 (3)'),
('604433','HYPP','Brugada syndrome 6, 613119 (3)'),
('604433','KCNE3','Brugada syndrome 6, 613119 (3)'),
('604443','ACS2','Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)'),
('604443','ACSL6','Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)'),
('604443','FACL6','Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)'),
('604454','WDM','Welander distal myopathy (2)'),
('604455','SAR','[Sarcosinemia], 268900 (2)'),
('604455','SARD','[Sarcosinemia], 268900 (2)'),
('604455','SARDH','[Sarcosinemia], 268900 (2)'),
('604457','IFI41','Hepatic venoocclusive disease with immunodeficiency, 235550 (3);'),
('604457','IFI75','Hepatic venoocclusive disease with immunodeficiency, 235550 (3);'),
('604457','SP110','Hepatic venoocclusive disease with immunodeficiency, 235550 (3);'),
('604457','VODI','Hepatic venoocclusive disease with immunodeficiency, 235550 (3);'),
('604457','IFI41','{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604457','IFI75','{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604457','SP110','{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604457','VODI','{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604459','ASRT5','{Asthma susceptibility 5}, 611064 (3)'),
('604459','IRAK3','{Asthma susceptibility 5}, 611064 (3)'),
('604459','IRAKM','{Asthma susceptibility 5}, 611064 (3)'),
('604484','HMSNO','Neuropathy, hereditary motor and sensory, Okinawa type (2)'),
('604484','HMSNP','Neuropathy, hereditary motor and sensory, Okinawa type (2)'),
('604485','ESCS','611131 (3)'),
('604485','NR2E3','611131 (3)'),
('604485','PNR','611131 (3)'),
('604485','RP37','611131 (3)'),
('604485','ESCS','Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37,'),
('604485','NR2E3','Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37,'),
('604485','PNR','Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37,'),
('604485','RP37','Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37,'),
('604488','CMD1N','Cardiomyopathy, dilated, 1N, 607487 (3)'),
('604488','LGMD2G','Cardiomyopathy, dilated, 1N, 607487 (3)'),
('604488','TCAP','Cardiomyopathy, dilated, 1N, 607487 (3)'),
('604488','CMD1N','Muscular dystrophy, limb-girdle, type 2G, 601954 (3);'),
('604488','LGMD2G','Muscular dystrophy, limb-girdle, type 2G, 601954 (3);'),
('604488','TCAP','Muscular dystrophy, limb-girdle, type 2G, 601954 (3);'),
('604489','AMACR','Alpha-methylacyl-CoA racemase deficiency, 614307 (3);'),
('604489','AMACRD','Alpha-methylacyl-CoA racemase deficiency, 614307 (3);'),
('604489','CBAS4','Alpha-methylacyl-CoA racemase deficiency, 614307 (3);'),
('604489','AMACR','Bile acid synthesis defect, congenital, 4, 214950 (3)'),
('604489','AMACRD','Bile acid synthesis defect, congenital, 4, 214950 (3)'),
('604489','CBAS4','Bile acid synthesis defect, congenital, 4, 214950 (3)'),
('604490','ARSACS','Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)'),
('604490','SACS','Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)'),
('604499','HYPLIP2','Hyperlipidemia, combined, 2 (2)'),
('604505','ACG1A','Achondrogenesis, type IA, 200600 (3)'),
('604505','CEV14','Achondrogenesis, type IA, 200600 (3)'),
('604505','TRIP11','Achondrogenesis, type IA, 200600 (3)'),
('604505','TRIP230','Achondrogenesis, type IA, 200600 (3)'),
('604515','AGM4','Agammaglobulinemia 4, 613502 (3)'),
('604515','BLNK','Agammaglobulinemia 4, 613502 (3)'),
('604515','SLP65','Agammaglobulinemia 4, 613502 (3)'),
('604519','IBD3','{Inflammatory bowel disease 3} (2)'),
('604526','IDH3B','Retinitis pigmentosa 46, 612572 (3)'),
('604526','RP46','Retinitis pigmentosa 46, 612572 (3)'),
('604539','ADAMTS2','Ehlers-Danlos syndrome, type VIIC, 225410 (3)'),
('604539','NPI','Ehlers-Danlos syndrome, type VIIC, 225410 (3)'),
('604558','AILIM','Immunodeficiency, common variable, 1, 607594 (3)'),
('604558','CVID1','Immunodeficiency, common variable, 1, 607594 (3)'),
('604558','ICOS','Immunodeficiency, common variable, 1, 607594 (3)'),
('604566','ALG6','Congenital disorder of glycosylation, type Ic, 603147 (3)'),
('604566','CDG1C','Congenital disorder of glycosylation, type Ic, 603147 (3)'),
('604569','AUTS15','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','CASPR2','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','CDFE','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','CNTNAP2','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','NRXN4','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','PTHSL1','Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism'),
('604569','AUTS15','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604569','CASPR2','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604569','CDFE','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604569','CNTNAP2','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604569','NRXN4','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604569','PTHSL1','susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)'),
('604579','EVR1','133780 (3)'),
('604579','FZD4','133780 (3)'),
('604579','EVR1','Exudative vitreoretinopathy, 133780 (3); Retinopathy of prematurity,'),
('604579','FZD4','Exudative vitreoretinopathy, 133780 (3); Retinopathy of prematurity,'),
('604580','ADCL2','autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3)'),
('604580','ARCL1A','autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3)'),
('604580','ARMD3','autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3)'),
('604580','FBLN5','autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3)'),
('604580','ADCL2','Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa,'),
('604580','ARCL1A','Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa,'),
('604580','ARMD3','Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa,'),
('604580','FBLN5','Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa,'),
('604581','AFG3L2','autosomal recessive, 614487 (3)'),
('604581','SCA28','autosomal recessive, 614487 (3)'),
('604581','SPAX5','autosomal recessive, 614487 (3)'),
('604581','AFG3L2','Spinocerebellar ataxia 28, 610246 (3); Ataxia, spastic, 5,'),
('604581','SCA28','Spinocerebellar ataxia 28, 610246 (3); Ataxia, spastic, 5,'),
('604581','SPAX5','Spinocerebellar ataxia 28, 610246 (3); Ataxia, spastic, 5,'),
('604584','PDGFRL','Hepatocellular cancer, 114550 (3); Colorectal cancer, 114500 (3)'),
('604584','PDGRL','Hepatocellular cancer, 114550 (3); Colorectal cancer, 114500 (3)'),
('604584','PRLTS','Hepatocellular cancer, 114550 (3); Colorectal cancer, 114500 (3)'),
('604588','NEK1','Short rib-polydactyly syndorme, type II, 263520 (3)'),
('604588','SRPS2','Short rib-polydactyly syndorme, type II, 263520 (3)'),
('604590','CD32','{Malaria, resistance to}, 611162 (3)'),
('604590','FCGR2B','{Malaria, resistance to}, 611162 (3)'),
('604590','CD32','{Systemic lupus erythematosus, susceptibility to}, 152700 (3);'),
('604590','FCGR2B','{Systemic lupus erythematosus, susceptibility to}, 152700 (3);'),
('604592','OC116','Osteopetrosis, autosomal recessive 1, 259700 (3)'),
('604592','OPTB1','Osteopetrosis, autosomal recessive 1, 259700 (3)'),
('604592','TCIRG1','Osteopetrosis, autosomal recessive 1, 259700 (3)'),
('604592','TIRC7','Osteopetrosis, autosomal recessive 1, 259700 (3)'),
('604595','CLF','[Cholesterol level QTL 1] (2)'),
('604595','CLQTL1','[Cholesterol level QTL 1] (2)'),
('604605','CHDS5','{Coronary heart disease, susceptibility to, 5}, 608901 (3)'),
('604605','DUO','{Coronary heart disease, susceptibility to, 5}, 608901 (3)'),
('604605','HAPIP','{Coronary heart disease, susceptibility to, 5}, 608901 (3)'),
('604605','KALRN','{Coronary heart disease, susceptibility to, 5}, 608901 (3)'),
('604610','BLM','Bloom syndrome, 210900 (3)'),
('604610','BS','Bloom syndrome, 210900 (3)'),
('604610','RECQ2','Bloom syndrome, 210900 (3)'),
('604610','RECQL3','Bloom syndrome, 210900 (3)'),
('604611','RECQ3','Werner syndrome, 277700 (3)'),
('604611','RECQL2','Werner syndrome, 277700 (3)'),
('604611','WRN','Werner syndrome, 277700 (3)'),
('604614','TBX19','Adrenocorticotropic hormone deficiency, 201400 (3)'),
('604619','ADLTE','Epilepsy, familial temporal lobe, 1, 600512 (3)'),
('604619','ADPAEF','Epilepsy, familial temporal lobe, 1, 600512 (3)'),
('604619','EPT','Epilepsy, familial temporal lobe, 1, 600512 (3)'),
('604619','ETL1','Epilepsy, familial temporal lobe, 1, 600512 (3)'),
('604619','LGI1','Epilepsy, familial temporal lobe, 1, 600512 (3)'),
('604624','DHMN2C','Neuronopathy, distal hereditary motor, type IIC, 613376 (3)'),
('604624','HMN2C','Neuronopathy, distal hereditary motor, type IIC, 613376 (3)'),
('604624','HSPB3','Neuronopathy, distal hereditary motor, type IIC, 613376 (3)'),
('604624','HSPL27','Neuronopathy, distal hereditary motor, type IIC, 613376 (3)'),
('604629','AI2A2','Amelogenesis imperfecta, type IIA2, 612529 (3)'),
('604629','MMP20','Amelogenesis imperfecta, type IIA2, 612529 (3)'),
('604630','NR0B2','Obesity, mild, early-onset, 601665 (3)'),
('604630','SHP','Obesity, mild, early-onset, 601665 (3)'),
('604633','ARCL1B','Cutis laxa, autosomal recessive, type IB, 614437 (3)'),
('604633','EFEMP2','Cutis laxa, autosomal recessive, type IB, 614437 (3)'),
('604633','FBLN4','Cutis laxa, autosomal recessive, type IB, 614437 (3)'),
('604633','UPH1','Cutis laxa, autosomal recessive, type IB, 614437 (3)'),
('604638','ACTN4','Glomerulosclerosis, focal segmental, 1, 603278 (3)'),
('604638','FSGS','Glomerulosclerosis, focal segmental, 1, 603278 (3)'),
('604638','FSGS1','Glomerulosclerosis, focal segmental, 1, 603278 (3)'),
('604641','IB1','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('604641','MAPK8IP1','{Diabetes mellitus, noninsulin-dependent}, 125853 (3)'),
('604653','FPN1','Hemochromatosis, type 4, 606069 (3)'),
('604653','HFE4','Hemochromatosis, type 4, 606069 (3)'),
('604653','IREG1','Hemochromatosis, type 4, 606069 (3)'),
('604653','SLC11A3','Hemochromatosis, type 4, 606069 (3)'),
('604653','SLC40A1','Hemochromatosis, type 4, 606069 (3)'),
('604672','CD209','susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604672','CDSIGN','susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)'),
('604672','CD209','{Dengue fever, protection against}, 614371 (3); {HIV type 1,'),
('604672','CDSIGN','{Dengue fever, protection against}, 614371 (3); {HIV type 1,'),
('604684','AF1Q','Leukemia, acute myelomonocytic (3)'),
('604684','MLLT11','Leukemia, acute myelomonocytic (3)'),
('604685','HOXA2','Microtia, hearing impairment, and cleft palate, 612290 (3)'),
('604687','AS1','{Asthma, susceptibility to, 1}, 607277 (3)'),
('604687','ASRT1','{Asthma, susceptibility to, 1}, 607277 (3)'),
('604687','PTGDR','{Asthma, susceptibility to, 1}, 607277 (3)'),
('604694','AKAP10','{Cardiac conduction defect, susceptibility to}, 115080 (3)'),
('604705','MERTK','Retinitis pigmentosa 38, 613862 (3)'),
('604705','RP38','Retinitis pigmentosa 38, 613862 (3)'),
('604710','LTBP4','abnormalities, 613177 (3)'),
('604710','LTBP4L','abnormalities, 613177 (3)'),
('604710','LTBP4S','abnormalities, 613177 (3)'),
('604710','LTBP4','Cutis laxa with severe pulmonary, gastrointestinal, and urinary'),
('604710','LTBP4L','Cutis laxa with severe pulmonary, gastrointestinal, and urinary'),
('604710','LTBP4S','Cutis laxa with severe pulmonary, gastrointestinal, and urinary'),
('604712','MTDPS8A','DNA depletion syndrome 8B (MNGIE type), 612075 (3)'),
('604712','MTDPS8B','DNA depletion syndrome 8B (MNGIE type), 612075 (3)'),
('604712','P53R2','DNA depletion syndrome 8B (MNGIE type), 612075 (3)'),
('604712','PEOA5','DNA depletion syndrome 8B (MNGIE type), 612075 (3)'),
('604712','RRM2B','DNA depletion syndrome 8B (MNGIE type), 612075 (3)'),
('604712','MTDPS8A','Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type'),
('604712','MTDPS8B','Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type'),
('604712','P53R2','Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type'),
('604712','PEOA5','Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type'),
('604712','RRM2B','Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type'),
('604712','MTDPS8A','with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial'),
('604712','MTDPS8B','with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial'),
('604712','P53R2','with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial'),
('604712','PEOA5','with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial'),
('604712','RRM2B','with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial'),
('604714','SIDDT','(3)'),
('604714','TSPYL','(3)'),
('604714','TSPYL1','(3)'),
('604714','SIDDT','Sudden infant death with dysgenesis of the testes syndrome, 608800'),
('604714','TSPYL','Sudden infant death with dysgenesis of the testes syndrome, 608800'),
('604714','TSPYL1','Sudden infant death with dysgenesis of the testes syndrome, 608800'),
('604720','HFE3','Hemochromatosis, type 3, 604250 (3)'),
('604720','TFR2','Hemochromatosis, type 3, 604250 (3)'),
('604723','COXPD3','Combined oxidative phosphorylation deficiency 3, 610505 (3)'),
('604723','TSFM','Combined oxidative phosphorylation deficiency 3, 610505 (3)'),
('604741','AKR1D1','Bile acid synthesis defect, congenital, 2, 235555 (3)'),
('604741','CBAS2','Bile acid synthesis defect, congenital, 2, 235555 (3)'),
('604741','SRD5B1','Bile acid synthesis defect, congenital, 2, 235555 (3)'),
('604759','COR1','Spermatogenic failure 4, 270960 (3); {Pregnancy loss,'),
('604759','SCP3','Spermatogenic failure 4, 270960 (3); {Pregnancy loss,'),
('604759','SPGF4','Spermatogenic failure 4, 270960 (3); {Pregnancy loss,'),
('604759','SYCP3','Spermatogenic failure 4, 270960 (3); {Pregnancy loss,'),
('604759','COR1','susceptibility to} (3)'),
('604759','SCP3','susceptibility to} (3)'),
('604759','SPGF4','susceptibility to} (3)'),
('604759','SYCP3','susceptibility to} (3)'),
('604763','ARHGEF12','Leukemia, acute myeloid, 601626 (3)'),
('604763','KIAA0382','Leukemia, acute myeloid, 601626 (3)'),
('604763','LARG','Leukemia, acute myeloid, 601626 (3)'),
('604766','NPHS2','Nephrotic syndrome, type 2, 600995 (3)'),
('604766','PDCN','Nephrotic syndrome, type 2, 600995 (3)'),
('604766','SRN1','Nephrotic syndrome, type 2, 600995 (3)'),
('604767','DEC1','Esophageal squamous cell carcinoma, 133239 (1)'),
('604773','ACAD8','Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)'),
('604774','ANGPT5','Hypobetalipoproteinemia, familial, 2, 605019 (3)'),
('604774','ANGPTL3','Hypobetalipoproteinemia, familial, 2, 605019 (3)'),
('604774','FHBL2','Hypobetalipoproteinemia, familial, 2, 605019 (3)'),
('604780','ABHD5','Chanarin-Dorfman syndrome, 275630 (3)'),
('604780','CGI58','Chanarin-Dorfman syndrome, 275630 (3)'),
('604780','IECN2','Chanarin-Dorfman syndrome, 275630 (3)'),
('604780','NCIE2','Chanarin-Dorfman syndrome, 275630 (3)'),
('604781','INLNE','Ichthyosis, nonlamellar and nonerythrodermic, congenital (2)'),
('604801','MDC1B','Muscular dystrophy, congenital, 1B (2)'),
('604802','HDL3','Huntington disease-like 3 (2)'),
('604802','HLN2','Huntington disease-like 3 (2)'),
('604809','PBLT','Panbronchiolitis, diffuse (2)'),
('604824','KL','hyperphosphatemic, 211900 (3)'),
('604824','KLOTHO','hyperphosphatemic, 211900 (3)'),
('604824','KL','{Coronary artery disease, susceptibility to} (3); Tumoral calcinosis,'),
('604824','KLOTHO','{Coronary artery disease, susceptibility to} (3); Tumoral calcinosis,'),
('604827','EIG7','Epilepsy, juvenile myoclonic (2)'),
('604827','EJM2','Epilepsy, juvenile myoclonic (2)'),
('604827','EIG7','{Epilepsy, idiopathic generalized, susceptibility to, 7} (2);'),
('604827','EJM2','{Epilepsy, idiopathic generalized, susceptibility to, 7} (2);'),
('604831','EVC','193530 (3)'),
('604831','EVC','Ellis-van Creveld syndrome, 225500 (3); Weyers acrodental dysostosis,'),
('604843','HBLRR','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604843','LST1','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604843','OATP1B1','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604843','OATP2','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604843','OATPC','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604843','SLCO1B1','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('604860','MALT1','MALT lymphoma (3)'),
('604860','MLT','MALT lymphoma (3)'),
('604862','CD207','[Birbeck granule deficiency], 613393 (3)'),
('604862','CLEC4K','[Birbeck granule deficiency], 613393 (3)'),
('604862','LANGERIN','[Birbeck granule deficiency], 613393 (3)'),
('604863','LCA14','amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)'),
('604863','LRAT','amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)'),
('604863','LCA14','Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital'),
('604863','LRAT','Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital'),
('604867','T2R16','{Alcohol dependence}, 103780 (3)'),
('604867','TAS2R16','{Alcohol dependence}, 103780 (3)'),
('604878','ACCPN','(3)'),
('604878','KCC3','(3)'),
('604878','KCC3A','(3)'),
('604878','KCC3B','(3)'),
('604878','SLC12A6','(3)'),
('604878','ACCPN','Agenesis of the corpus callosum with peripheral neuropathy, 218000'),
('604878','KCC3','Agenesis of the corpus callosum with peripheral neuropathy, 218000'),
('604878','KCC3A','Agenesis of the corpus callosum with peripheral neuropathy, 218000'),
('604878','KCC3B','Agenesis of the corpus callosum with peripheral neuropathy, 218000'),
('604878','SLC12A6','Agenesis of the corpus callosum with peripheral neuropathy, 218000'),
('604882','ATOH5','Diarrhea 4, malabsorptive, congenital, 610370 (3)'),
('604882','NEUROG3','Diarrhea 4, malabsorptive, congenital, 610370 (3)'),
('604882','NGN3','Diarrhea 4, malabsorptive, congenital, 610370 (3)'),
('604895','TBET','nasal polyps, 208550 (3)'),
('604895','TBX21','nasal polyps, 208550 (3)'),
('604895','TBET','{Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and'),
('604895','TBX21','{Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and'),
('604896','BBS6','209900 (3)'),
('604896','HMCS','209900 (3)'),
('604896','KMS','209900 (3)'),
('604896','MKKS','209900 (3)'),
('604896','MKS','209900 (3)'),
('604896','BBS6','McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,'),
('604896','HMCS','McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,'),
('604896','KMS','McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,'),
('604896','MKKS','McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,'),
('604896','MKS','McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,'),
('604907','CVID2','Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common'),
('604907','TACI','Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common'),
('604907','TNFRSF13B','Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common'),
('604907','CVID2','variable, 2, 240500 (3)'),
('604907','TACI','variable, 2, 240500 (3)'),
('604907','TNFRSF13B','variable, 2, 240500 (3)'),
('604927','CCFDN','Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)'),
('604927','CTDP1','Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)'),
('604927','FCP1','Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)'),
('604933','MUTYH','137215 (3); Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)'),
('604933','MYH','137215 (3); Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)'),
('604933','MUTYH','Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic,'),
('604933','MYH','Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic,'),
('604934','HRD','Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)'),
('604934','KCS','Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)'),
('604934','KCS1','Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)'),
('604934','TBCE','Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)'),
('604934','HRD','Kenny-Caffey syndrome-1, 244460 (3);'),
('604934','KCS','Kenny-Caffey syndrome-1, 244460 (3);'),
('604934','KCS1','Kenny-Caffey syndrome-1, 244460 (3);'),
('604934','TBCE','Kenny-Caffey syndrome-1, 244460 (3);'),
('604943','PRES','Deafness, autosomal recessive 61, 613865 (3)'),
('604943','SLC26A5','Deafness, autosomal recessive 61, 613865 (3)'),
('604946','AMB11','{AIDS, delayed/rapid progression to}, 609423 (3)'),
('604946','KIR3DL1','{AIDS, delayed/rapid progression to}, 609423 (3)'),
('604946','KIR3DS1','{AIDS, delayed/rapid progression to}, 609423 (3)'),
('604946','NKAT3','{AIDS, delayed/rapid progression to}, 609423 (3)'),
('604946','NKB1','{AIDS, delayed/rapid progression to}, 609423 (3)'),
('604961','PDE11A','Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)'),
('604961','PDE11A1','Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)'),
('604961','PDE11A2','Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)'),
('604961','PDE11A3','Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)'),
('604961','PPNAD2','Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)'),
('604973','FCN3','Immunodeficiency due to ficolin 3 deficiency, 613860 (3)'),
('604973','HAKA1','Immunodeficiency due to ficolin 3 deficiency, 613860 (3)'),
('604982','HPS1','Hermansky-Pudlak syndrome 1, 203300 (3)'),
('604983','PEOA4','deletions, autosomal dominant 4, 610131 (3)'),
('604983','POLG2','deletions, autosomal dominant 4, 610131 (3)'),
('604983','POLGB','deletions, autosomal dominant 4, 610131 (3)'),
('604983','PEOA4','Progressive external ophthalmoplegia with mitochondrial DNA'),
('604983','POLG2','Progressive external ophthalmoplegia with mitochondrial DNA'),
('604983','POLGB','Progressive external ophthalmoplegia with mitochondrial DNA'),
('604985','SCA5','Spinocerebellar ataxia 5, 600224 (3)'),
('604985','SPTBN2','Spinocerebellar ataxia 5, 600224 (3)'),
('604990','EBP50','Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)'),
('604990','NHERF1','Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)'),
('604990','NPHLOP2','Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)'),
('604990','SLC9A3R1','Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)'),
('605010','LEKTI','Netherton syndrome, 256500 (3); Atopy, 147050 (3)'),
('605010','SPINK5','Netherton syndrome, 256500 (3); Atopy, 147050 (3)'),
('605013','MHAC','Microhydranencephaly (2)'),
('605014','FHL4','Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)'),
('605014','HLH4','Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)'),
('605014','HPLH4','Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)'),
('605014','STX11','Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)'),
('605018','BRSS','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','CDMT','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','CYLD','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','EAC','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','KIAA0849','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','MFT1','605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)'),
('605018','BRSS','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605018','CDMT','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605018','CYLD','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605018','EAC','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605018','KIAA0849','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605018','MFT1','Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,'),
('605020','CAASDS','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','KTCN1','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','PPCD','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','PPD','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','RINX','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','VSX1','Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous'),
('605020','CAASDS','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605020','KTCN1','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605020','PPCD','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605020','PPD','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605020','RINX','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605020','VSX1','posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)'),
('605041','SBS','Spiegler-Brooke syndrome (2)'),
('605042','MED23','Mental retardation, autosomal recessive 18, 614249 (3)'),
('605042','MRT18','Mental retardation, autosomal recessive 18, 614249 (3)'),
('605073','KIAA0898','Mulibrey nanism, 253250 (3)'),
('605073','MUL','Mulibrey nanism, 253250 (3)'),
('605073','TRIM37','Mulibrey nanism, 253250 (3)'),
('605075','RCCP3','Renal cell carcinoma, papillary, 3 (2)'),
('605078','ALS10','Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3);'),
('605078','TARDBP','Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3);'),
('605078','TDP43','Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3);'),
('605078','ALS10','Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)'),
('605078','TARDBP','Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)'),
('605078','TDP43','Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)'),
('605080','ACHM1','(3)'),
('605080','ACHM3','(3)'),
('605080','CNGB3','(3)'),
('605080','ACHM1','Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200'),
('605080','ACHM3','Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200'),
('605080','CNGB3','Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200'),
('605082','RASSF1','Lung cancer, 211980 (2)'),
('605083','FRZB','{Osteoarthritis susceptibility 1}, 165720 (3)'),
('605083','FRZB1','{Osteoarthritis susceptibility 1}, 165720 (3)'),
('605083','OS1','{Osteoarthritis susceptibility 1}, 165720 (3)'),
('605083','SRFP3','{Osteoarthritis susceptibility 1}, 165720 (3)'),
('605086','TREM2','Nasu-Hakola disease, 221770 (3)'),
('605093','LNK','187950 (3); Erythrocytosis, somatic, 133100 (3)'),
('605093','SH2B3','187950 (3); Erythrocytosis, somatic, 133100 (3)'),
('605093','LNK','Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic,'),
('605093','SH2B3','Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic,'),
('605100','PPM1D','Breast cancer, 114480 (3)'),
('605100','WIP1','Breast cancer, 114480 (3)'),
('605101','CHTD2','Congenital heart disease, nonsyndromic, 2, 612863 (3)'),
('605101','KIAA0733','Congenital heart disease, nonsyndromic, 2, 612863 (3)'),
('605101','MAP3K7IP2','Congenital heart disease, nonsyndromic, 2, 612863 (3)'),
('605101','TAB2','Congenital heart disease, nonsyndromic, 2, 612863 (3)'),
('605102','MASP2','MASP2 deficiency, 613791 (3)'),
('605113','AASS','Hyperlysinemia, 238700 (3); Saccharopinuria, 268700 (1)'),
('605124','DIAR3','Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)'),
('605124','HAI2','Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)'),
('605124','SPINT2','Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)'),
('605131','FOR','Esophageal squamous cell carcinoma, 133239 (3)'),
('605131','WWOX','Esophageal squamous cell carcinoma, 133239 (3)'),
('605145','ANK','118600 (3)'),
('605145','ANKH','118600 (3)'),
('605145','CCAL2','118600 (3)'),
('605145','CMDJ','118600 (3)'),
('605145','CPPDD','118600 (3)'),
('605145','HANK','118600 (3)'),
('605145','ANK','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605145','ANKH','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605145','CCAL2','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605145','CMDJ','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605145','CPPDD','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605145','HANK','Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,'),
('605193','ARHI','Ovarian cancer (1)'),
('605194','CFC1','Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right'),
('605194','CRYPTIC','Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right'),
('605194','DTGA2','Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right'),
('605194','HTX2','Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right'),
('605194','CFC1','ventricle, 217095 (3); Transposition of the great arteries, dextro-looped 2, 613853 (3)'),
('605194','CRYPTIC','ventricle, 217095 (3); Transposition of the great arteries, dextro-looped 2, 613853 (3)'),
('605194','DTGA2','ventricle, 217095 (3); Transposition of the great arteries, dextro-looped 2, 613853 (3)'),
('605194','HTX2','ventricle, 217095 (3); Transposition of the great arteries, dextro-looped 2, 613853 (3)'),
('605195','MESP2','Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)'),
('605195','SCDO2','Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)'),
('605201','HDLD3','Hypoalphalipoproteinemia, primary (2)'),
('605201','HYALP','Hypoalphalipoproteinemia, primary (2)'),
('605204','DYT1','Dystonia-1, torsion, 128100 (3); Dystonia, early-onset atypical,'),
('605204','TOR1A','Dystonia-1, torsion, 128100 (3); Dystonia, early-onset atypical,'),
('605204','DYT1','with myoclonic features (3); {Dystonia-1, modifier of} (3)'),
('605204','TOR1A','with myoclonic features (3); {Dystonia-1, modifier of} (3)'),
('605205','HCA2','{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)'),
('605205','SAC','{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)'),
('605206','HCN4','Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)'),
('605206','SSS2','Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)'),
('605207','CYP26A2','craniofacial anomalies, 614416 (3)'),
('605207','CYP26B1','craniofacial anomalies, 614416 (3)'),
('605207','P450RAI2','craniofacial anomalies, 614416 (3)'),
('605207','RHFCA','craniofacial anomalies, 614416 (3)'),
('605207','CYP26A2','Craniosynostosis with radiohumeral fusions and other skeletal and'),
('605207','CYP26B1','Craniosynostosis with radiohumeral fusions and other skeletal and'),
('605207','P450RAI2','Craniosynostosis with radiohumeral fusions and other skeletal and'),
('605207','RHFCA','Craniosynostosis with radiohumeral fusions and other skeletal and'),
('605210','DISC1','disorder, susceptibility to}, 181500 (3)'),
('605210','SCZD9','disorder, susceptibility to}, 181500 (3)'),
('605210','DISC1','{Schizophrenia, susceptibility to}, 604906 (3); {Schizoaffective'),
('605210','SCZD9','{Schizophrenia, susceptibility to}, 604906 (3); {Schizoaffective'),
('605219','DFNA64','Deafness, autosomal dominant 64, 614152 (3)'),
('605219','DIABLO','Deafness, autosomal dominant 64, 614152 (3)'),
('605219','SMAC','Deafness, autosomal dominant 64, 614152 (3)'),
('605225','IBD7','{Inflammatory bowel disease 7} (2)'),
('605229','SPG14','Spastic paraplegia 14, autosomal recessive (2)'),
('605232','HSAN2','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','HSN2','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','KDP','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','PHA2C','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','PRKWNK1','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','WNK1','hereditary sensory and autonomic, type II, 201300 (3)'),
('605232','HSAN2','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605232','HSN2','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605232','KDP','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605232','PHA2C','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605232','PRKWNK1','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605232','WNK1','Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,'),
('605236','ATC2','Preeclampsia/eclampsia 5, 614595 (3)'),
('605236','CORIN','Preeclampsia/eclampsia 5, 614595 (3)'),
('605236','CRN','Preeclampsia/eclampsia 5, 614595 (3)'),
('605236','PEE5','Preeclampsia/eclampsia 5, 614595 (3)'),
('605236','TMPRSS10','Preeclampsia/eclampsia 5, 614595 (3)'),
('605238','HNMT','{Asthma, susceptibility to}, 600807 (3)'),
('605239','ATP6N1B','Renal tubular acidosis, distal, autosomal recessive, 602722 (3)'),
('605239','ATP6V0A4','Renal tubular acidosis, distal, autosomal recessive, 602722 (3)'),
('605239','RTA1C','Renal tubular acidosis, distal, autosomal recessive, 602722 (3)'),
('605239','RTADR','Renal tubular acidosis, distal, autosomal recessive, 602722 (3)'),
('605239','VPP2','Renal tubular acidosis, distal, autosomal recessive, 602722 (3)'),
('605242','DFNB18','18, 602092 (3)'),
('605242','USH1C','18, 602092 (3)'),
('605242','DFNB18','Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive'),
('605242','USH1C','Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive'),
('605244','CNC2','Carney complex, type II (2)'),
('605248','MCOLN1','Mucolipidosis IV, 252650 (3)'),
('605248','ML4','Mucolipidosis IV, 252650 (3)'),
('605254','NCSTN','Acne inversa, familial, 1, 142690 (3)'),
('605257','AICDA','Immunodeficiency with hyper-IgM, type 2, 605258 (3)'),
('605257','AID','Immunodeficiency with hyper-IgM, type 2, 605258 (3)'),
('605257','HIGM2','Immunodeficiency with hyper-IgM, type 2, 605258 (3)'),
('605262','CMT4D','Charcot-Marie-Tooth disease, type 4D, 601455 (3)'),
('605262','HMSNL','Charcot-Marie-Tooth disease, type 4D, 601455 (3)'),
('605262','NDRG1','Charcot-Marie-Tooth disease, type 4D, 601455 (3)'),
('605267','CMH17','Cardiomyopathy, familial hypertrophic 17, 613873 (3)'),
('605267','JP2','Cardiomyopathy, familial hypertrophic 17, 613873 (3)'),
('605267','JPH2','Cardiomyopathy, familial hypertrophic 17, 613873 (3)'),
('605268','HDL2','Huntington disease-like 2, 606438 (3)'),
('605268','JP3','Huntington disease-like 2, 606438 (3)'),
('605268','JPH3','Huntington disease-like 2, 606438 (3)'),
('605270','MPS3A','Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)'),
('605270','SFMD','Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)'),
('605270','SGSH','Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)'),
('605271','SERPINA10','{Venous thrombosis, susceptibility to} (3)'),
('605271','ZPI','{Venous thrombosis, susceptibility to} (3)'),
('605284','LAM','(3); Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)'),
('605284','TSC1','(3); Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)'),
('605284','LAM','Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690'),
('605284','TSC1','Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690'),
('605285','HMSNR','Neuropathy, motor and sensory, Russe type (2)'),
('605285','NMSR','Neuropathy, motor and sensory, Russe type (2)'),
('605286','CAPN10','{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)'),
('605286','NIDDM1','{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)'),
('605290','NPG','Optic atrophy 1, 165500 (3); {Glaucoma, normal tension,'),
('605290','NTG','Optic atrophy 1, 165500 (3); {Glaucoma, normal tension,'),
('605290','OPA1','Optic atrophy 1, 165500 (3); {Glaucoma, normal tension,'),
('605290','NPG','susceptibility to}, 606657 (3); Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)'),
('605290','NTG','susceptibility to}, 606657 (3); Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)'),
('605290','OPA1','susceptibility to}, 606657 (3); Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)'),
('605293','OPA4','Optic atrophy-4 (2)'),
('605294','CHST6','Macular corneal dystrophy, 217800 (3)'),
('605294','MCDC1','Macular corneal dystrophy, 217800 (3)'),
('605303','TACC3','{?Bladder cancer susceptibility}, 109800 (2)'),
('605313','C1DELq21.1','Thrombocytopenia-absent radius syndrome, 274000 (3)'),
('605313','DEL1q21.1','Thrombocytopenia-absent radius syndrome, 274000 (3)'),
('605313','RBM8A','Thrombocytopenia-absent radius syndrome, 274000 (3)'),
('605313','RBM8B','Thrombocytopenia-absent radius syndrome, 274000 (3)'),
('605313','TAR','Thrombocytopenia-absent radius syndrome, 274000 (3)'),
('605314','AHO3','Brachydacytly-mental retardation syndrome, 600430 (3)'),
('605314','BDMR','Brachydacytly-mental retardation syndrome, 600430 (3)'),
('605314','HDAC4','Brachydacytly-mental retardation syndrome, 600430 (3)'),
('605314','HDACA','Brachydacytly-mental retardation syndrome, 600430 (3)'),
('605317','CAGH44','Speech-language disorder-1, 602081 (3)'),
('605317','FOXP2','Speech-language disorder-1, 602081 (3)'),
('605317','SPCH1','Speech-language disorder-1, 602081 (3)'),
('605317','TNRC10','Speech-language disorder-1, 602081 (3)'),
('605325','CYP3A5','(3)'),
('605325','P450PCN3','(3)'),
('605325','CYP3A5','{Hypertension, salt-sensitive essential, susceptibility to}, 145500'),
('605325','P450PCN3','{Hypertension, salt-sensitive essential, susceptibility to}, 145500'),
('605336','CFHL3','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('605336','CFHR3','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('605336','FHR3','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('605336','HLF4','{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)'),
('605336','CFHL3','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('605336','CFHR3','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('605336','FHR3','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('605336','HLF4','{Macular degeneration, age-related, reduced risk of}, 603075 (3);'),
('605347','PAD','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605347','PADI4','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605347','PADI5','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605352','MASL1','Malignant fibrous histiocytoma (2)'),
('605352','MFHAS1','Malignant fibrous histiocytoma (2)'),
('605353','GHRL','{Obesity, susceptibility to}, 601665 (3)'),
('605363','CPSQ1','Cerebral palsy, spastic quadriplegic, 1, 603513 (3)'),
('605363','GAD1','Cerebral palsy, spastic quadriplegic, 1, 603513 (3)'),
('605363','SCP','Cerebral palsy, spastic quadriplegic, 1, 603513 (3)'),
('605364','PSORS6','{Psoriasis susceptibility 6} (3)'),
('605365','BRCA3','?Breast cancer, type 3 (2)'),
('605365','BRCAX','?Breast cancer, type 3 (2)'),
('605367','ELAC2','{Prostate cancer, susceptibility to}, 176807 (3)'),
('605367','HPC2','{Prostate cancer, susceptibility to}, 176807 (3)'),
('605370','ARHGAP26','Leukemia, juvenile myelomonocytic, 607785 (3)'),
('605370','GRAF','Leukemia, juvenile myelomonocytic, 607785 (3)'),
('605371','ARFGEF2','Periventricular heterotopia with microcephaly, 608097 (3)'),
('605371','BIG2','Periventricular heterotopia with microcephaly, 608097 (3)'),
('605371','PVNH2','Periventricular heterotopia with microcephaly, 608097 (3)'),
('605377','DM','Myotonic dystrophy 1, 160900 (3)'),
('605377','DMK','Myotonic dystrophy 1, 160900 (3)'),
('605377','DMPK','Myotonic dystrophy 1, 160900 (3)'),
('605378','AAA','Achalasia-addisonianism-alacrimia syndrome, 231550 (3)'),
('605378','AAAS','Achalasia-addisonianism-alacrimia syndrome, 231550 (3)'),
('605379','GAN','Giant axonal neuropathy-1, 256850 (3)'),
('605379','GAN1','Giant axonal neuropathy-1, 256850 (3)'),
('605380','ADHR','Hypophosphatemic rickets, autosomal dominant, 193100 (3);'),
('605380','FGF23','Hypophosphatemic rickets, autosomal dominant, 193100 (3);'),
('605380','HPDR2','Hypophosphatemic rickets, autosomal dominant, 193100 (3);'),
('605380','PHPTC','Hypophosphatemic rickets, autosomal dominant, 193100 (3);'),
('605380','ADHR','Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('605380','FGF23','Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('605380','HPDR2','Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('605380','PHPTC','Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)'),
('605383','IL21R','147050 (3)'),
('605383','IL21R','Lymphoma, diffuse large B-cell (2); [IgE, elevated level of],'),
('605388','ACP','Cerebral palsy, ataxic, autosomal recessive (2)'),
('605391','HIPER1','Thyroid carcinoma, follicular, 188470 (3)'),
('605391','MINPP1','Thyroid carcinoma, follicular, 188470 (3)'),
('605392','FGFR1OP','Myeloproliferative disorder (2)'),
('605392','FOP','Myeloproliferative disorder (2)'),
('605419','SCZD10','{Schizophrenia}, 181500 (2)'),
('605420','ALX4','Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)'),
('605420','FND2','Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)'),
('605420','FPP','Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)'),
('605420','PFM2','Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)'),
('605423','DHH','46XY partial gonadal dysgenesis, with minifascicular neuropathy,'),
('605423','GDXYM','46XY partial gonadal dysgenesis, with minifascicular neuropathy,'),
('605423','SRXY7','46XY partial gonadal dysgenesis, with minifascicular neuropathy,'),
('605423','DHH','607080 (3); 46XY sex reversal 7, 233420 (3)'),
('605423','GDXYM','607080 (3); 46XY sex reversal 7, 233420 (3)'),
('605423','SRXY7','607080 (3); 46XY sex reversal 7, 233420 (3)'),
('605425','CX30.3','133200 (3)'),
('605425','GJB4','133200 (3)'),
('605425','CX30.3','Erythrokeratodermia variabilis with erythema gyratum repens,'),
('605425','GJB4','Erythrokeratodermia variabilis with erythema gyratum repens,'),
('605427','CMT2C','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','HMSN2C','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','SPSMA','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','SSQTL1','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','TRPV4','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','VROAC','Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,'),
('605427','CMT2C','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','HMSN2C','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','SPSMA','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','SSQTL1','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','TRPV4','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','VROAC','Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal'),
('605427','CMT2C','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605427','HMSN2C','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605427','SPSMA','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605427','SSQTL1','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605427','TRPV4','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605427','VROAC','muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, '),
('605428','DFNB26','Deafness, autosomal recessive 26 (2)'),
('605429','DFNM1','{Deafness, nonsyndromic, modifier 1} (2)'),
('605437','PKCL','{Cerebral infarction, susceptibility to}, 601367 (3)'),
('605437','PRKCH','{Cerebral infarction, susceptibility to}, 601367 (3)'),
('605437','PRKCL','{Cerebral infarction, susceptibility to}, 601367 (3)'),
('605441','ADIPOQ','Adiponectin deficiency, 612556 (3)'),
('605441','ADIPQTL1','Adiponectin deficiency, 612556 (3)'),
('605441','APM1','Adiponectin deficiency, 612556 (3)'),
('605441','GBP28','Adiponectin deficiency, 612556 (3)'),
('605446','CORD13','608194 (3)'),
('605446','LCA6','608194 (3)'),
('605446','RPGRIP1','608194 (3)'),
('605446','CORD13','Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13,'),
('605446','LCA6','Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13,'),
('605446','RPGRIP1','Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13,'),
('605452','ABCB6','group, Langereis system], 111600 (3)'),
('605452','LAN','group, Langereis system], 111600 (3)'),
('605452','MCOPCB7','group, Langereis system], 111600 (3)'),
('605452','MTABC3','group, Langereis system], 111600 (3)'),
('605452','ABCB6','Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood'),
('605452','LAN','Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood'),
('605452','MCOPCB7','Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood'),
('605452','MTABC3','Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood'),
('605459','ABCG5','Sitosterolemia, 210250 (3)'),
('605460','ABCG8','Sitosterolemia, 210250 (3); Gallbladder disease 4, 611465 (3)'),
('605460','GBD4','Sitosterolemia, 210250 (3); Gallbladder disease 4, 611465 (3)'),
('605461','CANDF5','Candidiasis, familial, 5, autosomal recessive, 613953 (3)'),
('605461','IL17R','Candidiasis, familial, 5, autosomal recessive, 613953 (3)'),
('605461','IL17RA','Candidiasis, familial, 5, autosomal recessive, 613953 (3)'),
('605462','BCC1','{Basal cell carcinoma, susceptibility to, 1} (2)'),
('605463','RSCIS','dominant (1)'),
('605463','RSCIS','Radiation sensitivity/chromosome instability syndrome, autosomal'),
('605480','SLEB3','{Systemic lupus erythematosus, susceptibility to, 3} (2)'),
('605481','ASPM','Microcephaly, primary autosomal recessive, 5, 608716 (3)'),
('605481','MCPH5','Microcephaly, primary autosomal recessive, 5, 608716 (3)'),
('605483','CILD9','612444 (3)'),
('605483','DNAI2','612444 (3)'),
('605483','CILD9','Ciliary dyskinesia, primary, 9, with or without situs inversus,'),
('605483','DNAI2','Ciliary dyskinesia, primary, 9, with or without situs inversus,'),
('605495','HBLRR','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('605495','OATP1B3','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('605495','OATP8','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('605495','SLC21A8','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('605495','SLCO1B3','Hyperbilirubinemia, Rotor type, digenic, 237450 (3)'),
('605497','CASP','Osteogenesis imperfecta, type VII, 610682 (3)'),
('605497','CRTAP','Osteogenesis imperfecta, type VII, 610682 (3)'),
('605497','OI7','Osteogenesis imperfecta, type VII, 610682 (3)'),
('605507','FIL1D','Psoriasis, generalized pustular, 614204 (3)'),
('605507','IL1F5','Psoriasis, generalized pustular, 614204 (3)'),
('605507','IL1HY1','Psoriasis, generalized pustular, 614204 (3)'),
('605507','IL1RP3','Psoriasis, generalized pustular, 614204 (3)'),
('605507','IL36RN','Psoriasis, generalized pustular, 614204 (3)'),
('605507','PSORP','Psoriasis, generalized pustular, 614204 (3)'),
('605511','DFNB10','Deafness, autosomal recessive 10, congenital, 605316 (3)'),
('605511','DFNB8','Deafness, autosomal recessive 10, congenital, 605316 (3)'),
('605511','ECHOS1','Deafness, autosomal recessive 10, congenital, 605316 (3)'),
('605511','TMPRSS3','Deafness, autosomal recessive 10, congenital, 605316 (3)'),
('605511','DFNB10','Deafness, autosomal recessive 8, childhood onset, 601072 (3);'),
('605511','DFNB8','Deafness, autosomal recessive 8, childhood onset, 601072 (3);'),
('605511','ECHOS1','Deafness, autosomal recessive 8, childhood onset, 601072 (3);'),
('605511','TMPRSS3','Deafness, autosomal recessive 8, childhood onset, 601072 (3);'),
('605512','ADMD','dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)'),
('605512','ELOVL4','dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)'),
('605512','ISQMR','dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)'),
('605512','STGD2','dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)'),
('605512','STGD3','dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)'),
('605512','ADMD','Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal'),
('605512','ELOVL4','Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal'),
('605512','ISQMR','Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal'),
('605512','STGD2','Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal'),
('605512','STGD3','Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal'),
('605514','DFNB23','23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)'),
('605514','PCDH15','23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)'),
('605514','USH1F','23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)'),
('605514','DFNB23','Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive'),
('605514','PCDH15','Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive'),
('605514','USH1F','Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive'),
('605515','FOXP1','613670 (3)'),
('605515','QRF1','613670 (3)'),
('605515','FOXP1','Mental retardation with language impairment and autistic features,'),
('605515','QRF1','Mental retardation with language impairment and autistic features,'),
('605516','CDH23','12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3)'),
('605516','USH1D','12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3)'),
('605516','CDH23','Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive'),
('605516','USH1D','Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive'),
('605518','LPIN1','Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)'),
('605519','LPIN2','Majeed syndrome, 609628 (3)'),
('605522','ACHP','Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3);'),
('605522','C7orf2','Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3);'),
('605522','LMBR1','Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3);'),
('605522','PPD2','Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3);'),
('605522','ACHP','Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3)'),
('605522','C7orf2','Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3)'),
('605522','LMBR1','Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3)'),
('605522','PPD2','Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3)'),
('605525','CDT1','Meier-Gorlin syndrome 4, 613804 (3)'),
('605526','AD6','Alzheimer disease 6, 104300 (2)'),
('605544','GGF2','Fibromatosis, gingival, 2 (2)'),
('605544','GINGF2','Fibromatosis, gingival, 2 (2)'),
('605544','HGF2','Fibromatosis, gingival, 2 (2)'),
('605546','BDPLT11','Bleeding disorder, platelet-type, 11, 614201 (3)'),
('605546','GP6','Bleeding disorder, platelet-type, 11, 614201 (3)'),
('605546','GPIV','Bleeding disorder, platelet-type, 11, 614201 (3)'),
('605549','CORD8','Cone-rod dystrophy 8 (2)'),
('605552','AOMS1','Abdominal obesity-metabolic syndrome (2)'),
('605552','SYNX','Abdominal obesity-metabolic syndrome (2)'),
('605554','CD244','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605554','NAIL','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605554','NKR2B4','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605554','SLAMF4','{Rheumatoid arthritis, susceptibility to}, 180300 (3)'),
('605555','AIP','Pituitary adenoma, growth hormone-secreting, 102200 (3);'),
('605555','ARA9','Pituitary adenoma, growth hormone-secreting, 102200 (3);'),
('605555','XAP2','Pituitary adenoma, growth hormone-secreting, 102200 (3);'),
('605555','AIP','Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)'),
('605555','ARA9','Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)'),
('605555','XAP2','Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)'),
('605565','FIZZ3','(3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)'),
('605565','RETN','(3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)'),
('605565','RSTN','(3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)'),
('605565','FIZZ3','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('605565','RETN','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('605565','RSTN','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('605566','NOGOR','{Schizophrenia, susceptibility to}, 181500 (3)'),
('605566','RTN4R','{Schizophrenia, susceptibility to}, 181500 (3)'),
('605572','AOMS2','Abdominal obesity-metabolic syndrome (2)'),
('605573','EDH17B3','Pseudohermaphroditism, male, with gynecomastia, 264300 (3)'),
('605573','HSD17B3','Pseudohermaphroditism, male, with gynecomastia, 264300 (3)'),
('605582','CMD1K','Cardiomyopathy, dilated, 1K (2)'),
('605590','MDS','Myelodysplastic syndrome, somatic, 614286 (3)'),
('605590','SAP155','Myelodysplastic syndrome, somatic, 614286 (3)'),
('605590','SF3B1','Myelodysplastic syndrome, somatic, 614286 (3)'),
('605590','SF3B155','Myelodysplastic syndrome, somatic, 614286 (3)'),
('605597','BPES','(3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)'),
('605597','BPES1','(3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)'),
('605597','FOXL2','(3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)'),
('605597','PFRK','(3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)'),
('605597','POF3','(3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)'),
('605597','BPES','Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100'),
('605597','BPES1','Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100'),
('605597','FOXL2','Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100'),
('605597','PFRK','Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100'),
('605597','POF3','Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100'),
('605598','IDDM18','{Diabetes mellitus, insulin-dependent, 18} (2)'),
('605602','CMH16','Cardiomyopathy, familial hypertrophic, 16, 613838 (3)'),
('605602','MYOZ2','Cardiomyopathy, familial hypertrophic, 16, 613838 (3)'),
('605606','PSORS7','{Psoriasis susceptibility 7} (2)'),
('605608','CLDN14','Deafness, autosomal recessive 29, 614035 (3)'),
('605608','DFNB29','Deafness, autosomal recessive 29, 614035 (3)'),
('605610','EIEE10','Epileptic encephalopathy, early infantile, 10, 613402 (3)'),
('605610','MCSZ','Epileptic encephalopathy, early infantile, 10, 613402 (3)'),
('605610','PNK','Epileptic encephalopathy, early infantile, 10, 613402 (3)'),
('605610','PNKP','Epileptic encephalopathy, early infantile, 10, 613402 (3)'),
('605616','SLC6A20','Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)'),
('605616','XT3','Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)'),
('605634','CDG2F','Congenital disorder of glycosylation, type IIf, 603585 (3)'),
('605634','CST','Congenital disorder of glycosylation, type IIf, 603585 (3)'),
('605634','SLC35A1','Congenital disorder of glycosylation, type IIf, 603585 (3)'),
('605635','FHII','Hyperaldosteronism, familial, type II (2)'),
('605642','PRN1','Thyroid carcinoma, papillary, with papillary renal neoplasia (2)'),
('605642','PTCPRN','Thyroid carcinoma, papillary, with papillary renal neoplasia (2)'),
('605646','DFNB4','(3)'),
('605646','EVA','(3)'),
('605646','PDS','(3)'),
('605646','SLC26A4','(3)'),
('605646','TDH2B','(3)'),
('605646','DFNB4','Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791'),
('605646','EVA','Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791'),
('605646','PDS','Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791'),
('605646','SLC26A4','Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791'),
('605646','TDH2B','Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791'),
('605648','FBX','Parkinson disease 15, autosomal recessive, 260300 (3)'),
('605648','FBX7','Parkinson disease 15, autosomal recessive, 260300 (3)'),
('605648','FBXO7','Parkinson disease 15, autosomal recessive, 260300 (3)'),
('605648','PARK15','Parkinson disease 15, autosomal recessive, 260300 (3)'),
('605648','PKPS','Parkinson disease 15, autosomal recessive, 260300 (3)'),
('605692','CHAK','susceptibility to}, 105500 (3)'),
('605692','LTRPC7','susceptibility to}, 105500 (3)'),
('605692','TRPM7','susceptibility to}, 105500 (3)'),
('605692','CHAK','{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1,'),
('605692','LTRPC7','{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1,'),
('605692','TRPM7','{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1,'),
('605704','ALS8','Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular'),
('605704','VAPB','Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular'),
('605704','VAPC','Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular'),
('605704','ALS8','atrophy, late-onset, Finkel type, 182980 (3)'),
('605704','VAPB','atrophy, late-onset, Finkel type, 182980 (3)'),
('605704','VAPC','atrophy, late-onset, Finkel type, 182980 (3)'),
('605706','DIK','Popliteal pterygium syndrome, lethal type, 263650 (3)'),
('605706','NKRD3','Popliteal pterygium syndrome, lethal type, 263650 (3)'),
('605706','RIPK4','Popliteal pterygium syndrome, lethal type, 263650 (3)'),
('605712','HSAN','Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)'),
('605712','HSN1','Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)'),
('605712','LBC1','Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)'),
('605712','SPT1','Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)'),
('605712','SPTLC1','Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)'),
('605713','HSN1C','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605713','KIAA0526','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605713','LCB2','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605713','NSAN1C','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605713','SPT2','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605713','SPTLC2','Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)'),
('605725','CMT4F','Charcot-Marie-Tooth disease, type 4F, 145900 (3)'),
('605725','PRX','Charcot-Marie-Tooth disease, type 4F, 145900 (3)'),
('605725','CMT4F','Dejerine-Sottas disease, autosomal recessive, 145900 (3);'),
('605725','PRX','Dejerine-Sottas disease, autosomal recessive, 145900 (3);'),
('605726','HMNJ','Neuropathy, distal hereditary motor, Jerash type (2)'),
('605726','MNDJ','Neuropathy, distal hereditary motor, Jerash type (2)'),
('605727','OTSC2','Otosclerosis 2 (2)'),
('605728','CCSSO','Cataract, central saccular, with sutural opacities (2)'),
('605738','MCOPCB2','Microphthalmia with coloboma 2 (2)'),
('605740','SOST','Sclerosteosis, 269500 (3); Van Buchem disease, 239100 (3)'),
('605740','VBCH','Sclerosteosis, 269500 (3); Van Buchem disease, 239100 (3)'),
('605742','TUBA8','Polymicrogyria with optic nerve hypoplasia, 613180 (3)'),
('605742','TUBAL2','Polymicrogyria with optic nerve hypoplasia, 613180 (3)'),
('605746','ANMA','Anisomastia (2)'),
('605747','ARH','Hypercholesterolemia, familial, autosomal recessive, 603813 (3)'),
('605747','FHCB1','Hypercholesterolemia, familial, autosomal recessive, 603813 (3)'),
('605747','FHCB2','Hypercholesterolemia, familial, autosomal recessive, 603813 (3)'),
('605747','LDLRAP1','Hypercholesterolemia, familial, autosomal recessive, 603813 (3)'),
('605748','BCDO','115300 (3)'),
('605748','BCMO1','115300 (3)'),
('605748','BCO1','115300 (3)'),
('605748','BCDO','Hypercarotenemia and vitamin A deficiency, autosomal dominant,'),
('605748','BCMO1','Hypercarotenemia and vitamin A deficiency, autosomal dominant,'),
('605748','BCO1','Hypercarotenemia and vitamin A deficiency, autosomal dominant,'),
('605749','CAAR','Cataract, autosomal recessive, early-onset, pulverulent (2)'),
('605750','EVR3','Exudative vitreoretinopathy-3 (2)'),
('605751','BFIC2','Seizures, benign familial infantile, 2 (2)'),
('605751','BFIS2','Seizures, benign familial infantile, 2 (2)'),
('605769','PTC7','Thyroid carcinoma, papillary, 188550 (3)'),
('605769','RFG7','Thyroid carcinoma, papillary, 188550 (3)'),
('605769','TIF1G','Thyroid carcinoma, papillary, 188550 (3)'),
('605769','TRIM33','Thyroid carcinoma, papillary, 188550 (3)'),
('605775','KLHL3','Pseudohypoaldosteronism, type IID, 614495 (3)'),
('605775','PHA2D','Pseudohypoaldosteronism, type IID, 614495 (3)'),
('605779','NDIC','Nail dysplasia, isolated congenital (2)'),
('605799','AMN','Megaloblastic anemia-1, Norwegian type, 261100 (3)'),
('605802','SIP1','Mowat-Wilson syndrome, 235730 (3)'),
('605802','SMADIP1','Mowat-Wilson syndrome, 235730 (3)'),
('605802','ZEB2','Mowat-Wilson syndrome, 235730 (3)'),
('605802','ZFHX1B','Mowat-Wilson syndrome, 235730 (3)'),
('605804','ATOD3','{Dermatitis, atopic, susceptibility to, 3} (2)'),
('605805','ATOD4','{Dermatitis, atopic, susceptibility to, 4} (2)'),
('605809','CMS1A1','Myasthenia, familial infantile, 1 (2)'),
('605809','FIM1','Myasthenia, familial infantile, 1 (2)'),
('605810','C3orf5','Combined oxidative phosphorylation deficiency 5, 611719 (3)'),
('605810','COXPD5','Combined oxidative phosphorylation deficiency 5, 611719 (3)'),
('605810','MRPS22','Combined oxidative phosphorylation deficiency 5, 611719 (3)'),
('605815','IBSN','Striatonigral degeneration, infantile, 271930 (3)'),
('605815','NUP62','Striatonigral degeneration, infantile, 271930 (3)'),
('605815','SNDI','Striatonigral degeneration, infantile, 271930 (3)'),
('605818','DFNB27','Deafness, autosomal recessive 27 (2)'),
('605828','EV1','Epidermodysplasia verruciformis, 226400 (3)'),
('605828','EVER1','Epidermodysplasia verruciformis, 226400 (3)'),
('605828','TMC6','Epidermodysplasia verruciformis, 226400 (3)'),
('605829','EV2','Epidermodysplasia verruciformis, 226400 (3)'),
('605829','EVER2','Epidermodysplasia verruciformis, 226400 (3)'),
('605829','TMC8','Epidermodysplasia verruciformis, 226400 (3)'),
('605833','BMND2','[Bone mineral density QTL 2] (2)'),
('605837','HERC2','[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('605837','SHEP1','[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('605837','HERC2','[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3);'),
('605837','SHEP1','[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3);'),
('605841','NRCLP2','Narcolepsy 2 (2)'),
('605844','ATOD5','{Dermatitis, atopic, susceptibility to, 5} (2)'),
('605845','ATOD6','{Dermatitis, atopic, susceptibility to, 6} (2)'),
('605849','DMGDH','Dimethylglycine dehydrogenase deficiency, 605850 (3)'),
('605849','DMGDHD','Dimethylglycine dehydrogenase deficiency, 605850 (3)'),
('605872','CD209L','SARS infection, protection against (2)'),
('605872','CLEC4M','SARS infection, protection against (2)'),
('605872','DCSIGNR','SARS infection, protection against (2)'),
('605872','LSIGN','SARS infection, protection against (2)'),
('605874','KCNK9','Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)'),
('605874','TASK3','Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)'),
('605880','GTPTS','SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)'),
('605880','KAT6B','SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)'),
('605880','MORF','SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)'),
('605880','MYST4','SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)'),
('605881','CDG2C','Congenital disorder of glycosylation, type IIc, 266265 (3)'),
('605881','FUCT1','Congenital disorder of glycosylation, type IIc, 266265 (3)'),
('605881','SLC35C1','Congenital disorder of glycosylation, type IIc, 266265 (3)'),
('605882','BACH1','Breast cancer, early-onset, 114480 (3); Fanconi anemia,'),
('605882','BRIP1','Breast cancer, early-onset, 114480 (3); Fanconi anemia,'),
('605882','FANCJ','Breast cancer, early-onset, 114480 (3); Fanconi anemia,'),
('605882','BACH1','complementation group J, 609054 (3)'),
('605882','BRIP1','complementation group J, 609054 (3)'),
('605882','FANCJ','complementation group J, 609054 (3)'),
('605906','CMD1C','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','CYPHER','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','KIAA01613','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','LDB3','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','LVNC3','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','ZASP','dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)'),
('605906','CMD1C','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605906','CYPHER','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605906','KIAA01613','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605906','LDB3','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605906','LVNC3','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605906','ZASP','Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,'),
('605907','ALG1','Congenital disorder of glycosylation, type Ik, 608540 (3)'),
('605907','CDG1K','Congenital disorder of glycosylation, type Ik, 608540 (3)'),
('605907','HMAT1','Congenital disorder of glycosylation, type Ik, 608540 (3)'),
('605907','HMT1','Congenital disorder of glycosylation, type Ik, 608540 (3)'),
('605908','LVM','(3)'),
('605908','MLC1','(3)'),
('605908','VL','(3)'),
('605908','LVM','Megalencephalic leukoencephalopathy with subcortical cysts, 604004'),
('605908','MLC1','Megalencephalic leukoencephalopathy with subcortical cysts, 604004'),
('605908','VL','Megalencephalic leukoencephalopathy with subcortical cysts, 604004'),
('605910','ANGPTL4','{Reduced triglycerides, susceptibility to} (3)'),
('605910','FIAF','{Reduced triglycerides, susceptibility to} (3)'),
('605910','HFARP','{Reduced triglycerides, susceptibility to} (3)'),
('605910','PGAR','{Reduced triglycerides, susceptibility to} (3)'),
('605913','BDET','Bleeding disorder, east Texas type (2)'),
('605921','STIM1','defect 2, 612783 (3)'),
('605921','STIM1','Immune dysfunction, with T-cell inactivation due to calcium entry'),
('605925','KEN','(3)'),
('605925','MOPD2','(3)'),
('605925','PCNT','(3)'),
('605925','PCNT2','(3)'),
('605925','SCKL4','(3)'),
('605925','KEN','Microcephalic osteodysplastic primordial dwarfism, type II, 210720'),
('605925','MOPD2','Microcephalic osteodysplastic primordial dwarfism, type II, 210720'),
('605925','PCNT','Microcephalic osteodysplastic primordial dwarfism, type II, 210720'),
('605925','PCNT2','Microcephalic osteodysplastic primordial dwarfism, type II, 210720'),
('605925','SCKL4','Microcephalic osteodysplastic primordial dwarfism, type II, 210720'),
('605934','HPE6','Holoprosencephaly-6 (2)'),
('605947','CHIME','CHIME syndrome, 280000 (3)'),
('605947','PIGL','CHIME syndrome, 280000 (3)'),
('605951','CDG1O','Congenital disorder of glycosylation, type Io, 612937 (3)'),
('605951','DPM3','Congenital disorder of glycosylation, type Io, 612937 (3)'),
('605956','ACUG','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','CARD15','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','CD','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','IBD1','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','NOD2','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','PSORAS1','(3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)'),
('605956','ACUG','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605956','CARD15','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605956','CD','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605956','IBD1','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605956','NOD2','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605956','PSORAS1','{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580'),
('605967','ACRPS','Acropectoral syndrome (2)'),
('605978','CHAC','Choreoacanthocytosis, 200150 (3)'),
('605978','VPS13A','Choreoacanthocytosis, 200150 (3)'),
('605981','JBS','Johanson-Blizzard syndrome, 243800 (3)'),
('605981','UBR1','Johanson-Blizzard syndrome, 243800 (3)'),
('605988','ARTEMIS','Omenn syndrome, 603554 (3)'),
('605988','DCLRE1C','Omenn syndrome, 603554 (3)'),
('605988','SCIDA','Omenn syndrome, 603554 (3)'),
('605988','ARTEMIS','Severe combined immunodeficiency, Athabascan type, 602450 (3);'),
('605988','DCLRE1C','Severe combined immunodeficiency, Athabascan type, 602450 (3);'),
('605988','SCIDA','Severe combined immunodeficiency, Athabascan type, 602450 (3);'),
('605993','PDP1','Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)'),
('605993','PDPC','Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)'),
('605993','PPM2C','Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)'),
('605995','CMT2A','171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)'),
('605995','CMT2A1','171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)'),
('605995','KIF1B','171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)'),
('605995','NBLST1','171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)'),
('605995','CMT2A','Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma,'),
('605995','CMT2A1','Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma,'),
('605995','KIF1B','Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma,'),
('605995','NBLST1','Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma,'),
('605998','HAX1','Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)'),
('605998','SCN3','Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)'),
('606000','BTNL2','{Sarcoidosis, susceptibility to, 2}, 612387 (3)'),
('606000','SS2','{Sarcoidosis, susceptibility to, 2}, 612387 (3)'),
('606012','DFNA18','Deafness, autosomal dominant 18 (2)'),
('606014','ALX3','Frontonasal dysplasia 1, 136760 (3)'),
('606014','FND1','Frontonasal dysplasia 1, 136760 (3)'),
('606034','AGS4','Aicardi-Goutieres syndrome 4, 610333 (3)'),
('606034','RNASEH2A','Aicardi-Goutieres syndrome 4, 610333 (3)'),
('606034','RNHIA','Aicardi-Goutieres syndrome 4, 610333 (3)'),
('606035','FIQTL1','[Fasting insulin level quantitative trait locus 1] (2)'),
('606037','CD96','C syndrome, 211750 (3)'),
('606037','TACTILE','C syndrome, 211750 (3)'),
('606045','CED','Cranioectodermal dysplasia, 218330 (3)'),
('606045','IFT122','Cranioectodermal dysplasia, 218330 (3)'),
('606045','WDR10','Cranioectodermal dysplasia, 218330 (3)'),
('606049','AOCH','Acromegaloid features, overgrowth, cleft palate, and hernia (2)'),
('606053','AUTS5','{Autism susceptibility 5} (2)'),
('606061','ASD4','Atrial septal defect 4, 611363 (3)'),
('606061','TBX20','Atrial septal defect 4, 611363 (3)'),
('606062','BAM','Cornelia de Lange syndrome 3, 610759 (3)'),
('606062','CDLS3','Cornelia de Lange syndrome 3, 610759 (3)'),
('606062','CSPG6','Cornelia de Lange syndrome 3, 610759 (3)'),
('606062','HCAP','Cornelia de Lange syndrome 3, 610759 (3)'),
('606062','SMC3','Cornelia de Lange syndrome 3, 610759 (3)'),
('606075','C10orf2','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','IOSCA','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','MTDPS7','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','PEO1','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','PEOA3','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','TWINKLE','(3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)'),
('606075','C10orf2','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606075','IOSCA','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606075','MTDPS7','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606075','PEO1','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606075','PEOA3','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606075','TWINKLE','Progressive external ophthalmoplegia, autosomal dominant, 3, 609286'),
('606077','OTT','Megakaryoblastic leukemia, acute (2)'),
('606077','RBM15','Megakaryoblastic leukemia, acute (2)'),
('606077','SPEN','Megakaryoblastic leukemia, acute (2)'),
('606078','AMKL','Megakaryoblastic leukemia, acute (3)'),
('606078','MAL','Megakaryoblastic leukemia, acute (3)'),
('606078','MKL1','Megakaryoblastic leukemia, acute (3)'),
('606082','MNG3','Goiter, multinodular, 3 (2)'),
('606097','MCAHS1','614080 (3)'),
('606097','PIGN','614080 (3)'),
('606097','MCAHS1','Multiple congenital anomalies-hypotonia-seizures syndrome 1,'),
('606097','PIGN','Multiple congenital anomalies-hypotonia-seizures syndrome 1,'),
('606102','LCCS3','Lethal congenital contractural syndrome 3, 611369 (3)'),
('606102','PIP5K1C','Lethal congenital contractural syndrome 3, 611369 (3)'),
('606118','HPS3','Hermansky-Pudlak syndrome 3, 614072 (3)'),
('606119','MDM','Meleda disease, 248300 (3)'),
('606119','SLURP1','Meleda disease, 248300 (3)'),
('606129','DBA2','Diamond-Blackfan anemia 2 (2)'),
('606142','GLUT9','renal, 2, 612076 (3)'),
('606142','SLC2A9','renal, 2, 612076 (3)'),
('606142','UAQTL2','renal, 2, 612076 (3)'),
('606142','GLUT9','{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia,'),
('606142','SLC2A9','{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia,'),
('606142','UAQTL2','{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia,'),
('606144','RAB23','Carpenter syndrome, 201000 (3)'),
('606145','ATS','Arterial tortuosity syndrome, 208050 (3)'),
('606145','GLUT10','Arterial tortuosity syndrome, 208050 (3)'),
('606145','SLC2A10','Arterial tortuosity syndrome, 208050 (3)'),
('606151','BBS2','Bardet-Biedl syndrome 2, 209900 (3)'),
('606152','BBGD','Thiamine metabolism dysfunction syndrome 2 (biotin- or'),
('606152','SLC19A3','Thiamine metabolism dysfunction syndrome 2 (biotin- or'),
('606152','THMD2','Thiamine metabolism dysfunction syndrome 2 (biotin- or'),
('606152','BBGD','thiamine-responsive encephalopathy type 2), 607483 (3)'),
('606152','SLC19A3','thiamine-responsive encephalopathy type 2), 607483 (3)'),
('606152','THMD2','thiamine-responsive encephalopathy type 2), 607483 (3)'),
('606153','ATP5E','614053 (3)'),
('606153','MC5DN3','614053 (3)'),
('606153','ATP5E','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3,'),
('606153','MC5DN3','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3,'),
('606157','HARP','HARP syndrome, 607236 (3)'),
('606157','NBIA1','HARP syndrome, 607236 (3)'),
('606157','PANK2','HARP syndrome, 607236 (3)'),
('606157','PKAN','HARP syndrome, 607236 (3)'),
('606157','HARP','Neurodegeneration with brain iron accumulation 1, 234200 (3);'),
('606157','NBIA1','Neurodegeneration with brain iron accumulation 1, 234200 (3);'),
('606157','PANK2','Neurodegeneration with brain iron accumulation 1, 234200 (3);'),
('606157','PKAN','Neurodegeneration with brain iron accumulation 1, 234200 (3);'),
('606158','BSCL2','Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver'),
('606158','HMN5','Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver'),
('606158','SPG17','Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver'),
('606158','BSCL2','spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type V, 600794 (3)'),
('606158','HMN5','spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type V, 600794 (3)'),
('606158','SPG17','spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type V, 600794 (3)'),
('606179','ANBC','Aneurysmal bone cysts (2)'),
('606187','AD7','Alzheimer disease-7 (2)'),
('606190','MNRI','Meningioma, radiation-induced (2)'),
('606200','BHLHB3','[Short sleeper], 612975 (3)'),
('606200','BHLHE41','[Short sleeper], 612975 (3)'),
('606200','DEC2','[Short sleeper], 612975 (3)'),
('606200','SHARP1','[Short sleeper], 612975 (3)'),
('606201','DFNA14','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','DFNA38','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','DFNA6','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','WFRS','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','WFS','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','WFS1','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','WFSL','600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)'),
('606201','DFNA14','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','DFNA38','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','DFNA6','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','WFRS','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','WFS','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','WFS1','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606201','WFSL','Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,'),
('606202','AIM1','eyes], 227240 (3)'),
('606202','MATP','eyes], 227240 (3)'),
('606202','SHEP5','eyes], 227240 (3)'),
('606202','SLC45A2','eyes], 227240 (3)'),
('606202','AIM1','Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye'),
('606202','MATP','Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye'),
('606202','SHEP5','Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye'),
('606202','SLC45A2','Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye'),
('606202','AIM1','pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light'),
('606202','MATP','pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light'),
('606202','SHEP5','pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light'),
('606202','SLC45A2','pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light'),
('606210','CFTD','Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital,'),
('606210','RSMD1','Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital,'),
('606210','SELN','Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital,'),
('606210','SEPN1','Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital,'),
('606210','CFTD','with fiber-type disproportion, 255310 (3)'),
('606210','RSMD1','with fiber-type disproportion, 255310 (3)'),
('606210','SELN','with fiber-type disproportion, 255310 (3)'),
('606210','SEPN1','with fiber-type disproportion, 255310 (3)'),
('606215','AVCD','{Atrioventricular septal defect, susceptibility to, 1} (2)'),
('606215','AVSD1','{Atrioventricular septal defect, susceptibility to, 1} (2)'),
('606224','NT5C3','Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)'),
('606224','PSN1','Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)'),
('606224','UMPH1','Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)'),
('606227','MCOP5','Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)'),
('606227','MFRP','Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)'),
('606227','NNO2','Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)'),
('606230','DEL22q13.3','613950 (3)'),
('606230','KIAA1650','613950 (3)'),
('606230','PROSAP2','613950 (3)'),
('606230','PSAP2','613950 (3)'),
('606230','SCZD15','613950 (3)'),
('606230','SHANK3','613950 (3)'),
('606230','DEL22q13.3','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606230','KIAA1650','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606230','PROSAP2','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606230','PSAP2','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606230','SCZD15','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606230','SHANK3','Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15},'),
('606236','ASPL','Alveolar soft-part sarcoma, 606243 (3)'),
('606236','ASPS','Alveolar soft-part sarcoma, 606243 (3)'),
('606236','ASPSCR1','Alveolar soft-part sarcoma, 606243 (3)'),
('606236','RCC17','Alveolar soft-part sarcoma, 606243 (3)'),
('606240','NMTC1','Thyroid carcinoma, nonmedullary, 1 (2)'),
('606241','DICER1','or without Sertoli-Leydig cell tumors, 138800 (3)'),
('606241','HERNA','or without Sertoli-Leydig cell tumors, 138800 (3)'),
('606241','KIAA0928','or without Sertoli-Leydig cell tumors, 138800 (3)'),
('606241','MNG1','or without Sertoli-Leydig cell tumors, 138800 (3)'),
('606241','DICER1','Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with'),
('606241','HERNA','Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with'),
('606241','KIAA0928','Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with'),
('606241','MNG1','Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with'),
('606242','KONDS','Kondoh syndrome (2)'),
('606245','JJAZ1','Endometrial stromal tumors (2)'),
('606245','KIAA0160','Endometrial stromal tumors (2)'),
('606246','JAZF1','Endometrial stromal tumors (2)'),
('606246','TIP27','Endometrial stromal tumors (2)'),
('606252','BACTS1','{Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)'),
('606252','TIRAP','{Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)'),
('606252','BACTS1','{Pneumococcal disease, invasive, protection against}, 610799 (3);'),
('606252','TIRAP','{Pneumococcal disease, invasive, protection against}, 610799 (3);'),
('606255','STQTL1','{Stature QTL 1} (2)'),
('606256','STQTL2','{Stature QTL 2} (2)'),
('606257','STQTL3','{Stature QTL 3} (2)'),
('606258','STQTL4','{Stature QTL 4} (2)'),
('606263','PDB4','Paget disease of bone, 602080 (2)'),
('606264','CANDF4','Candidiasis, familial, 4, autosomal dominant, 613108 (3);'),
('606264','CLEC7A','Candidiasis, familial, 4, autosomal dominant, 613108 (3);'),
('606264','CLECSF12','Candidiasis, familial, 4, autosomal dominant, 613108 (3);'),
('606264','DECTIN1','Candidiasis, familial, 4, autosomal dominant, 613108 (3);'),
('606264','CANDF4','{Aspergillosis, susceptibility to}, 614079 (3)'),
('606264','CLEC7A','{Aspergillosis, susceptibility to}, 614079 (3)'),
('606264','CLECSF12','{Aspergillosis, susceptibility to}, 614079 (3)'),
('606264','DECTIN1','{Aspergillosis, susceptibility to}, 614079 (3)'),
('606268','OODD','Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge'),
('606268','SSPS','Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge'),
('606268','STHAG4','Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge'),
('606268','WNT10A','Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge'),
('606268','OODD','syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)'),
('606268','SSPS','syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)'),
('606268','STHAG4','syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)'),
('606268','WNT10A','syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)'),
('606269','BAFFR','Immunodeficiency, common variable, 4, 613494 (3)'),
('606269','CVID4','Immunodeficiency, common variable, 4, 613494 (3)'),
('606269','TNFRSF13C','Immunodeficiency, common variable, 4, 613494 (3)'),
('606271','DISC2','Schizophrenia, 181500 (2)'),
('606272','CTNS','Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular'),
('606272','CTNS','nonnephropathic, 219750 (3); Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3); Cystinosis, atypical nephropathic (3)'),
('606273','EIF2B3','Leukoencephalopathy with vanishing white matter, 603896 (3)'),
('606282','DFNA24','Deafness, autosomal dominant 24 (2)'),
('606325','HTX3','?Heterotaxy, visceral, 3, autosomal (2)'),
('606326','MCOPCT2','Microphthalmia with cataract 2, 212550 (3)'),
('606326','SIX6','Microphthalmia with cataract 2, 212550 (3)'),
('606347','CD2BP1','(3)'),
('606347','PAPAS','(3)'),
('606347','PSTPIP','(3)'),
('606347','PSTPIP1','(3)'),
('606347','CD2BP1','Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416'),
('606347','PAPAS','Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416'),
('606347','PSTPIP','Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416'),
('606347','PSTPIP1','Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416'),
('606348','IBD5','{Inflammatory bowel disease 5} (2)'),
('606350','AOA','208920 (3); Coenzyme Q10 deficiency, 607426 (3)'),
('606350','AOA1','208920 (3); Coenzyme Q10 deficiency, 607426 (3)'),
('606350','APTX','208920 (3); Coenzyme Q10 deficiency, 607426 (3)'),
('606350','AOA','Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia,'),
('606350','AOA1','Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia,'),
('606350','APTX','Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia,'),
('606351','ESPN','Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory,'),
('606351','ESPN','without vestibular involvement, autosomal dominant (3)'),
('606352','ALS2','Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary'),
('606352','ALSJ','Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary'),
('606352','IAHSP','Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary'),
('606352','PLSJ','Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary'),
('606352','ALS2','lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)'),
('606352','ALSJ','lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)'),
('606352','IAHSP','lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)'),
('606352','PLSJ','lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)'),
('606368','APOA5','Hyperchylomicronemia, late-onset, 144650 (3)'),
('606368','APOA5','{Hypertriglyceridemia, susceptibility to}, 145750 (3);'),
('606370','THMD5','encephalopathy type), 614458 (3)'),
('606370','TPK1','encephalopathy type), 614458 (3)'),
('606370','THMD5','Thiamine metabolism dysfunction syndrome 5 (episodic'),
('606370','TPK1','Thiamine metabolism dysfunction syndrome 5 (episodic'),
('606374','B3GAT3','and congenital heart defects, 245600 (3)'),
('606374','GLCATI','and congenital heart defects, 245600 (3)'),
('606374','B3GAT3','Multiple joint dislocations, short stature, craniofacial dysmorphism,'),
('606374','GLCATI','Multiple joint dislocations, short stature, craniofacial dysmorphism,'),
('606389','CATSPER','Spermatogenic failure 7, 612997 (3)'),
('606389','CATSPER1','Spermatogenic failure 7, 612997 (3)'),
('606389','SPGF7','Spermatogenic failure 7, 612997 (3)'),
('606397','CLRN1','(3)'),
('606397','RP61','(3)'),
('606397','USH3','(3)'),
('606397','USH3A','(3)'),
('606397','CLRN1','Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180'),
('606397','RP61','Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180'),
('606397','USH3','Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180'),
('606397','USH3A','Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180'),
('606407','C2DELp21','Hypotonia-cystinuria syndrome (4)'),
('606407','DEL2p21','Hypotonia-cystinuria syndrome (4)'),
('606409','AIP4','Autoimmune disease, syndromic multisystem, 613385 (3)'),
('606409','ITCH','Autoimmune disease, syndromic multisystem, 613385 (3)'),
('606409','NAPP1','Autoimmune disease, syndromic multisystem, 613385 (3)'),
('606410','ANTXR1','{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)'),
('606410','ATR','{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)'),
('606410','TEM8','{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)'),
('606412','BSND','Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with'),
('606412','BSND','mild renal dysfunction, 602522 (3)'),
('606416','CIAS1','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','FCAS','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','FCU','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','NALP3','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','NLRP3','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','PYPAF1','Cold-induced autoinflammatory syndrome, familial, 120100 (3);'),
('606416','CIAS1','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606416','FCAS','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606416','FCU','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606416','NALP3','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606416','NLRP3','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606416','PYPAF1','Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)'),
('606418','DHCR24','Desmosterolosis, 602398 (3)'),
('606418','KIAA0018','Desmosterolosis, 602398 (3)'),
('606419','PRP31','Retinitis pigmentosa 11, 600138 (3)'),
('606419','PRPF31','Retinitis pigmentosa 11, 600138 (3)'),
('606419','RP11','Retinitis pigmentosa 11, 600138 (3)'),
('606425','C1orf12','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','ECYT3','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','EGLN1','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','HIFPH2','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','PHD2','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','SM20','Erythrocytosis, familial, 3, 609820 (3)'),
('606425','ZMYND6','Erythrocytosis, familial, 3, 609820 (3)'),
('606439','ATL1','Neuropathy, hereditary sensory, type ID, 613708 (3)'),
('606439','HSN1D','Neuropathy, hereditary sensory, type ID, 613708 (3)'),
('606439','SPG3A','Neuropathy, hereditary sensory, type ID, 613708 (3)'),
('606439','ATL1','Spastic paraplegia 3A, autosomal dominant, 182600 (3);'),
('606439','HSN1D','Spastic paraplegia 3A, autosomal dominant, 182600 (3);'),
('606439','SPG3A','Spastic paraplegia 3A, autosomal dominant, 182600 (3);'),
('606440','DFNB16','Deafness, autosomal recessive 16, 603720 (3)'),
('606440','STRC','Deafness, autosomal recessive 16, 603720 (3)'),
('606441','HTRA2','Parkinson disease 13, 610297 (3)'),
('606441','OMI','Parkinson disease 13, 610297 (3)'),
('606441','PARK13','Parkinson disease 13, 610297 (3)'),
('606441','PRSS25','Parkinson disease 13, 610297 (3)'),
('606451','DFNA30','Deafness, autosomal dominant 30 (2)'),
('606454','EIF2B2','Leukoencephalopathy with vanishing white matter, 603896 (3);'),
('606454','EIF2B2','Ovarioleukodystrophy, 603896 (3)'),
('606460','LGV2','[Longevity 2] (2)'),
('606463','GBA','(3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3); {Parkinson disease,'),
('606463','GBA','Gaucher disease, type I, 230800(3); Gaucher disease, type II, 230900'),
('606463','GBA','late-onset, susceptibility to}, 168600 (3); {Lewy body dementia, susceptibility to}, 127750 (3)'),
('606464','HAMP','Hemochromatosis, type 2B, 613313 (3)'),
('606464','HEPC','Hemochromatosis, type 2B, 613313 (3)'),
('606464','HFE2B','Hemochromatosis, type 2B, 613313 (3)'),
('606464','LEAP1','Hemochromatosis, type 2B, 613313 (3)'),
('606470','DKCB2','Dyskeratosis congenita, autosomal recessive 2, 613987 (3)'),
('606470','NHP2','Dyskeratosis congenita, autosomal recessive 2, 613987 (3)'),
('606470','NOLA2','Dyskeratosis congenita, autosomal recessive 2, 613987 (3)'),
('606471','DKCB1','Dyskeratosis congenita, autosomal recessive 1, 224230 (3)'),
('606471','NOLA3','Dyskeratosis congenita, autosomal recessive 1, 224230 (3)'),
('606471','NOP10','Dyskeratosis congenita, autosomal recessive 1, 224230 (3)'),
('606475','8D6','613646 (3)'),
('606475','8D6A','613646 (3)'),
('606475','CD320','613646 (3)'),
('606475','TCBLR','613646 (3)'),
('606475','8D6','Methylmalonic aciduria due to transcobalamin receptor defect,'),
('606475','8D6A','Methylmalonic aciduria due to transcobalamin receptor defect,'),
('606475','CD320','Methylmalonic aciduria due to transcobalamin receptor defect,'),
('606475','TCBLR','Methylmalonic aciduria due to transcobalamin receptor defect,'),
('606476','ITPKC','{Kawasaki disease, susceptibility to}, 611775 (3)'),
('606480','FACE1','Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);'),
('606480','MADB','Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);'),
('606480','STE24','Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);'),
('606480','ZMPSTE24','Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);'),
('606480','FACE1','Restrictive dermopathy, lethal, 275210 (3)'),
('606480','MADB','Restrictive dermopathy, lethal, 275210 (3)'),
('606480','STE24','Restrictive dermopathy, lethal, 275210 (3)'),
('606480','ZMPSTE24','Restrictive dermopathy, lethal, 275210 (3)'),
('606483','CMTDI2','Charcot-Marie-Tooth disease, dominant intermediate 2 (2)'),
('606494','MRT12','Mental retardation, autosomal recessive 12, 611090 (3)'),
('606494','SIAT6','Mental retardation, autosomal recessive 12, 611090 (3)'),
('606494','ST3GAL3','Mental retardation, autosomal recessive 12, 611090 (3)'),
('606494','ST3GALII','Mental retardation, autosomal recessive 12, 611090 (3)'),
('606496','CANDF6','Candidiasis, familial, 6, autosomal dominant, 613956 (3)'),
('606496','IL17F','Candidiasis, familial, 6, autosomal dominant, 613956 (3)'),
('606496','ML1','Candidiasis, familial, 6, autosomal dominant, 613956 (3)'),
('606518','HAVCR','{Atopy, resistance to}, 147050 (3)'),
('606518','HAVCR1','{Atopy, resistance to}, 147050 (3)'),
('606521','DNC','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','MCPHA','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','MUP1','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','SLC25A19','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','THMD3','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','THMD4','Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction'),
('606521','DNC','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606521','MCPHA','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606521','MUP1','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606521','SLC25A19','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606521','THMD3','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606521','THMD4','syndrome 4 (progressive polyneuropathy type), 613710 (3)'),
('606522','GDF3','Klippel-Feil syndrome 3, autosomal dominant, 613702 (3);'),
('606522','KFS3','Klippel-Feil syndrome 3, autosomal dominant, 613702 (3);'),
('606522','MCOP7','Klippel-Feil syndrome 3, autosomal dominant, 613702 (3);'),
('606522','MCOPCB6','Klippel-Feil syndrome 3, autosomal dominant, 613702 (3);'),
('606522','GDF3','Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)'),
('606522','KFS3','Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)'),
('606522','MCOP7','Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)'),
('606522','MCOPCB6','Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)'),
('606526','MLPH','Griscelli syndrome, type 3, 609227 (3)'),
('606528','C11DELp15p14','Chromosome 11p15-p14 deletion syndrome (4)'),
('606528','DEL11p15p14','Chromosome 11p15-p14 deletion syndrome (4)'),
('606530','CTX','Cerebrotendinous xanthomatosis, 213700 (3)'),
('606530','CYP27','Cerebrotendinous xanthomatosis, 213700 (3)'),
('606530','CYP27A1','Cerebrotendinous xanthomatosis, 213700 (3)'),
('606531','SCGB3A2','{Asthma, susceptibility to}, 600807 (3)'),
('606531','UGRP1','{Asthma, susceptibility to}, 600807 (3)'),
('606540','KIAA1119','Microvillus inclusion disease, 251850 (3)'),
('606540','MYO5B','Microvillus inclusion disease, 251850 (3)'),
('606545','LI5','Ichthyosis, lamellar, 5 (2)'),
('606551','F37','Esophageal squamous cell carcinoma, 133239 (3)'),
('606551','FEZ1','Esophageal squamous cell carcinoma, 133239 (3)'),
('606551','LZTS1','Esophageal squamous cell carcinoma, 133239 (3)'),
('606554','EA3','Episodic ataxia, type 3 (2)'),
('606566','MLCK','Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)'),
('606566','MYLK2','Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)'),
('606580','MGA3','3 with cataract, 165300 (3)'),
('606580','OPA3','3 with cataract, 165300 (3)'),
('606580','MGA3','3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy'),
('606580','OPA3','3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy'),
('606585','AI1C','Amelogenesis imperfecta, type IB, 104500 (3);'),
('606585','AIH2','Amelogenesis imperfecta, type IB, 104500 (3);'),
('606585','ENAM','Amelogenesis imperfecta, type IB, 104500 (3);'),
('606585','AI1C','Amelogenesis imperfecta, type IC, 204650 (3)'),
('606585','AIH2','Amelogenesis imperfecta, type IC, 204650 (3)'),
('606585','ENAM','Amelogenesis imperfecta, type IC, 204650 (3)'),
('606596','FKRP','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','LGMD2I','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','MDC1C','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','MDDGA5','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','MDDGB5','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','MDDGC5','anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3);'),
('606596','FKRP','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','LGMD2I','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','MDC1C','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','MDDGA5','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','MDDGB5','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','MDDGC5','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606596','FKRP','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606596','LGMD2I','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606596','MDC1C','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606596','MDDGA5','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606596','MDDGB5','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606596','MDDGC5','Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)'),
('606597','CDHS','3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('606597','HUP2','3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('606597','PAX3','3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('606597','WS1','3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('606597','WS3','3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)'),
('606597','CDHS','Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type'),
('606597','HUP2','Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type'),
('606597','PAX3','Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type'),
('606597','WS1','Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type'),
('606597','WS3','Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type'),
('606598','CMT2K','Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth'),
('606598','CMT4A','Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth'),
('606598','CMTRIA','Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth'),
('606598','GDAP1','Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth'),
('606598','CMT2K','disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive'),
('606598','CMT4A','disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive'),
('606598','CMTRIA','disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive'),
('606598','GDAP1','disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive'),
('606598','CMT2K','intermediate, A, 608340 (3)'),
('606598','CMT4A','intermediate, A, 608340 (3)'),
('606598','CMTRIA','intermediate, A, 608340 (3)'),
('606598','GDAP1','intermediate, A, 608340 (3)'),
('606603','ED3','Ectodermal dysplasia, anhidrotic, autosomal dominant, 129490 (3)'),
('606603','EDA3','Ectodermal dysplasia, anhidrotic, autosomal dominant, 129490 (3)'),
('606603','EDARADD','Ectodermal dysplasia, anhidrotic, autosomal dominant, 129490 (3)'),
('606603','ED3','Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3);'),
('606603','EDA3','Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3);'),
('606603','EDARADD','Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3);'),
('606609','AGS1','152700 (3)'),
('606609','CRV','152700 (3)'),
('606609','HERNS','152700 (3)'),
('606609','TREX1','152700 (3)'),
('606609','AGS1','Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3);'),
('606609','CRV','Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3);'),
('606609','HERNS','Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3);'),
('606609','TREX1','Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3);'),
('606609','AGS1','Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to},'),
('606609','CRV','Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to},'),
('606609','HERNS','Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to},'),
('606609','TREX1','Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to},'),
('606613','HDLCQ1','[High density lipoprotein cholesterol level QTL 1] (2)'),
('606616','DYX6','{Dyslexia, susceptibility to, 6} (2)'),
('606616','DYXQTL18','{Dyslexia, susceptibility to, 6} (2)'),
('606622','HARP','Schimke immunoosseous dysplasia, 242900 (3)'),
('606622','SIOD','Schimke immunoosseous dysplasia, 242900 (3)'),
('606622','SMARCAL1','Schimke immunoosseous dysplasia, 242900 (3)'),
('606628','GNMT','Glycine N-methyltransferase deficiency, 606664 (3)'),
('606629','CORD7','Cone-rod dystrophy 7, 603649 (3)'),
('606629','KIAA0340','Cone-rod dystrophy 7, 603649 (3)'),
('606629','RIM','Cone-rod dystrophy 7, 603649 (3)'),
('606629','RIM1','Cone-rod dystrophy 7, 603649 (3)'),
('606629','RIMS1','Cone-rod dystrophy 7, 603649 (3)'),
('606633','OI12','Osteogenesis imperfecta, type XII, 613849 (3)'),
('606633','OSX','Osteogenesis imperfecta, type XII, 613849 (3)'),
('606633','SP7','Osteogenesis imperfecta, type XII, 613849 (3)'),
('606635','ENTK','Enterokinase deficiency, 226200 (3)'),
('606635','PRSS7','Enterokinase deficiency, 226200 (3)'),
('606636','CARD7','606579 (3)'),
('606636','DEFCAP','606579 (3)'),
('606636','KIAA0926','606579 (3)'),
('606636','NALP1','606579 (3)'),
('606636','SLEV1','606579 (3)'),
('606636','VAMAS1','606579 (3)'),
('606636','CARD7','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606636','DEFCAP','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606636','KIAA0926','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606636','NALP1','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606636','SLEV1','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606636','VAMAS1','{Vitiligo-associated multiple autoimmune disease susceptibility 1},'),
('606639','COXPD1','Combined oxidative phosphorylation deficiency 1, 609060 (3)'),
('606639','EFG1','Combined oxidative phosphorylation deficiency 1, 609060 (3)'),
('606639','GFM','Combined oxidative phosphorylation deficiency 1, 609060 (3)'),
('606639','GFM1','Combined oxidative phosphorylation deficiency 1, 609060 (3)'),
('606640','ALS3','Amyotrophic lateral sclerosis 3 (2)'),
('606641','BMIQ1','[Body mass index QTL1] (2)'),
('606643','BMIQ2','[Body mass index QTL2] (2)'),
('606655','GREAT','Cryptorchidism, bilateral, 219050 (3)'),
('606655','LGR8','Cryptorchidism, bilateral, 219050 (3)'),
('606656','IBGC2','Basal ganglia calcification, idiopathic, 2 (2)'),
('606660','UVM1','{Melanoma, uveal, susceptibility to, 1} (2)'),
('606661','UBM2','{Melanoma, uveal, susceptibility to, 2} (2)'),
('606662','WS2C','Waardenburg syndrome, type 2C (2)'),
('606666','GPR48','{Schizophrenia, susceptibility to}, 181500 (3)'),
('606666','LGR4','{Schizophrenia, susceptibility to}, 181500 (3)'),
('606668','IBD8','{Inflammatory bowel disease 8} (2)'),
('606672','BDPLT1','Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);'),
('606672','BDPLT3','Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);'),
('606672','BSS','Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);'),
('606672','GP1BA','Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);'),
('606672','VWDP','Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);'),
('606672','BDPLT1','disease, platelet-type, 177820 (3)'),
('606672','BDPLT3','disease, platelet-type, 177820 (3)'),
('606672','BSS','disease, platelet-type, 177820 (3)'),
('606672','GP1BA','disease, platelet-type, 177820 (3)'),
('606672','VWDP','disease, platelet-type, 177820 (3)'),
('606672','BDPLT1','{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand'),
('606672','BDPLT3','{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand'),
('606672','BSS','{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand'),
('606672','GP1BA','{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand'),
('606672','VWDP','{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand'),
('606673','BUP1','Beta-ureidopropionase deficiency, 613161 (3)'),
('606673','UPB1','Beta-ureidopropionase deficiency, 613161 (3)'),
('606674','IBD6','{Inflammatory bowel disease 6} (2)'),
('606675','IBD4','{Inflammatory bowel disease 4} (2)'),
('606681','ARA267','Sotos syndrome, 117550 (3); Leukemia, acute myeloid, 601626 (1);'),
('606681','NSD1','Sotos syndrome, 117550 (3); Leukemia, acute myeloid, 601626 (1);'),
('606681','STO','Sotos syndrome, 117550 (3); Leukemia, acute myeloid, 601626 (1);'),
('606681','ARA267','Weaver syndrome, 277590 (3); Beckwith-Wiedemann syndrome, 130650 (3)'),
('606681','NSD1','Weaver syndrome, 277590 (3); Beckwith-Wiedemann syndrome, 130650 (3)'),
('606681','STO','Weaver syndrome, 277590 (3); Beckwith-Wiedemann syndrome, 130650 (3)'),
('606682','HPS4','Hermansky-Pudlak syndrome 4, 614073 (3)'),
('606686','EIF2B1','Leukoencephalopathy with vanishing white matter, 603896 (3)'),
('606686','EIF2BA','Leukoencephalopathy with vanishing white matter, 603896 (3)'),
('606687','EIF2B4','Leukoencephaly with vanishing white matter, 603896 (3);'),
('606687','EIF2B4','Ovarioleukodystrophy, 603896 (3)'),
('606689','GLC1B','Glaucoma 1B, primary open angle, adult onset, 137760 (2)'),
('606702','ARPKD','Polycystic kidney and hepatic disease, 263200 (3)'),
('606702','FCYT','Polycystic kidney and hepatic disease, 263200 (3)'),
('606702','PKHD1','Polycystic kidney and hepatic disease, 263200 (3)'),
('606706','DFNA36','Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal'),
('606706','DFNB11','Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal'),
('606706','DFNB7','Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal'),
('606706','TMC1','Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal'),
('606706','DFNA36','dominant 36, 606705 (3)'),
('606706','DFNB11','dominant 36, 606705 (3)'),
('606706','DFNB7','dominant 36, 606705 (3)'),
('606706','TMC1','dominant 36, 606705 (3)'),
('606708','SHFM5','Split-hand/foot malformation 5 (2)'),
('606709','BSSP3','Mental retardation, autosomal recessive 1, 249500 (3)'),
('606709','MRT1','Mental retardation, autosomal recessive 1, 249500 (3)'),
('606709','PRSS12','Mental retardation, autosomal recessive 1, 249500 (3)'),
('606711','SLI1','Specific language impairment QTL, 1 (2)'),
('606712','SLI2','Specific language impairment QTL, 2 (2)'),
('606718','D5S1708','Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la'),
('606718','DTD','Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la'),
('606718','DTDST','Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la'),
('606718','EDM4','Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la'),
('606718','SLC26A2','Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la'),
('606718','D5S1708','Chapelle dysplasia, 256050 (3)'),
('606718','DTD','Chapelle dysplasia, 256050 (3)'),
('606718','DTDST','Chapelle dysplasia, 256050 (3)'),
('606718','EDM4','Chapelle dysplasia, 256050 (3)'),
('606718','SLC26A2','Chapelle dysplasia, 256050 (3)'),
('606718','D5S1708','Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);'),
('606718','DTD','Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);'),
('606718','DTDST','Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);'),
('606718','EDM4','Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);'),
('606718','SLC26A2','Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);'),
('606725','CLN4A','Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid'),
('606725','CLN6','Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid'),
('606725','CLN4A','lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)'),
('606725','CLN6','lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)'),
('606742','ASD6','Atrial septal defect 6, 613087 (3)'),
('606742','TLL','Atrial septal defect 6, 613087 (3)'),
('606742','TLL1','Atrial septal defect 6, 613087 (3)'),
('606754','AGS5','(3)'),
('606754','CHBL2','(3)'),
('606754','DCIP','(3)'),
('606754','SAMHD1','(3)'),
('606754','AGS5','Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415'),
('606754','CHBL2','Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415'),
('606754','DCIP','Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415'),
('606754','SAMHD1','Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415'),
('606759','DUOX2','Thryoid dyshormonogenesis 6, 607200 (3)'),
('606759','TDH6','Thryoid dyshormonogenesis 6, 607200 (3)'),
('606759','THOX2','Thryoid dyshormonogenesis 6, 607200 (3)'),
('606761','MCD','Malonyl-CoA decarboxylase deficiency, 248360 (3)'),
('606761','MLYCD','Malonyl-CoA decarboxylase deficiency, 248360 (3)'),
('606765','TDH2A','Thyroid dyshormonogenesis 2A, 274500 (3)'),
('606765','TPO','Thyroid dyshormonogenesis 2A, 274500 (3)'),
('606765','TPX','Thyroid dyshormonogenesis 2A, 274500 (3)'),
('606766','AZON','Spermatogenic failure 3 (2)'),
('606766','SPGF3','Spermatogenic failure 3 (2)'),
('606770','ADIPQTL2','{Adiponectin, serum level of, QTL2} (2)'),
('606770','CAQ5','{Adiponectin, serum level of, QTL2} (2)'),
('606771','ADIPQTL3','{Adiponectin, serum level of, QTL3} (2)'),
('606771','CAQ14','{Adiponectin, serum level of, QTL3} (2)'),
('606787','PAOD1','Peripheral arterial occlusive disease 1 (2)'),
('606788','ANON1','{Anorexia nervosa, susceptibility to, 1} (2)'),
('606789','HBFQTL4','Fetal hemoglobin quantitative trait locus 4 (2)'),
('606797','MTSP1','Ichthyosis with hypotrichosis, 610765 (3)'),
('606797','ST14','Ichthyosis with hypotrichosis, 610765 (3)'),
('606800','GAA','Glycogen storage disease II, 232300 (3)'),
('606806','FTCD','Glutamate formiminotransferase deficiency, 229100 (3)'),
('606808','DFNB30','Deafness, autosomal recessive 30, 607101 (3)'),
('606808','MYO3A','Deafness, autosomal recessive 30, 607101 (3)'),
('606810','PRODH','Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility'),
('606810','PRODH2','Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility'),
('606810','SCZD4','Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility'),
('606810','PRODH','to, 4}, 600850 (3)'),
('606810','PRODH2','to, 4}, 600850 (3)'),
('606810','SCZD4','to, 4}, 600850 (3)'),
('606811','ALDH4','Hyperprolinemia, type II, 239510 (3)'),
('606811','ALDH4A1','Hyperprolinemia, type II, 239510 (3)'),
('606811','P5CDH','Hyperprolinemia, type II, 239510 (3)'),
('606821','CDG2I','Congenital disorder of glycosylation, type IIi, 613612 (3)'),
('606821','COG5','Congenital disorder of glycosylation, type IIi, 613612 (3)'),
('606821','GOLTC1','Congenital disorder of glycosylation, type IIi, 613612 (3)'),
('606821','GTC90','Congenital disorder of glycosylation, type IIi, 613612 (3)'),
('606822','MDDGA3','anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular'),
('606822','MDDGB3','anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular'),
('606822','MDDGC3','anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular'),
('606822','MEB','anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular'),
('606822','POMGNT1','anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular'),
('606822','MDDGA3','dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)'),
('606822','MDDGB3','dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)'),
('606822','MDDGC3','dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)'),
('606822','MEB','dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)'),
('606822','POMGNT1','dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)'),
('606822','MDDGA3','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606822','MDDGB3','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606822','MDDGC3','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606822','MEB','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606822','POMGNT1','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('606829','FARR','Friedreich ataxia, 229300 (3); Friedreich ataxia with retained'),
('606829','FRDA','Friedreich ataxia, 229300 (3); Friedreich ataxia with retained'),
('606829','FXN','Friedreich ataxia, 229300 (3); Friedreich ataxia with retained'),
('606829','X25','Friedreich ataxia, 229300 (3); Friedreich ataxia with retained'),
('606829','FARR','reflexes, 229300 (3)'),
('606829','FRDA','reflexes, 229300 (3)'),
('606829','FXN','reflexes, 229300 (3)'),
('606829','X25','reflexes, 229300 (3)'),
('606837','CC1','Breast cancer, somatic, 114480 (3)'),
('606837','KIAA0203','Breast cancer, somatic, 114480 (3)'),
('606837','RB1CC1','Breast cancer, somatic, 114480 (3)'),
('606844','ALMS1','Alstrom syndrome, 203800 (3)'),
('606844','ALSS','Alstrom syndrome, 203800 (3)'),
('606844','KIAA0328','Alstrom syndrome, 203800 (3)'),
('606845','CAL','?Globozoospermia, 102530 (1)'),
('606845','FIG','?Globozoospermia, 102530 (1)'),
('606845','GOPC','?Globozoospermia, 102530 (1)'),
('606845','PIST','?Globozoospermia, 102530 (1)'),
('606847','MFD1','Treacher Collins syndrome 1, 154500 (3)'),
('606847','TCOF1','Treacher Collins syndrome 1, 154500 (3)'),
('606847','TCS1','Treacher Collins syndrome 1, 154500 (3)'),
('606850','MIPOL1','Mirror-image polydactyly, 135750 (1)'),
('606852','AAOPD','Parkinson disease 10 (2)'),
('606852','PARK10','Parkinson disease 10 (2)'),
('606857','GCLC','230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)'),
('606857','GLCLC','230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)'),
('606857','GCLC','Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,'),
('606857','GLCLC','Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,'),
('606860','C1NH','Angioedema, hereditary, types I and II, 106100 (3); Complement'),
('606860','HAE1','Angioedema, hereditary, types I and II, 106100 (3); Complement'),
('606860','HAE2','Angioedema, hereditary, types I and II, 106100 (3); Complement'),
('606860','SERPING1','Angioedema, hereditary, types I and II, 106100 (3); Complement'),
('606860','C1NH','component 4, partial deficiency of, 120790 (3)'),
('606860','HAE1','component 4, partial deficiency of, 120790 (3)'),
('606860','HAE2','component 4, partial deficiency of, 120790 (3)'),
('606860','SERPING1','component 4, partial deficiency of, 120790 (3)'),
('606869','HEXA','272800 (3); [Hex A pseudodeficiency], 272800 (3)'),
('606869','TSD','272800 (3); [Hex A pseudodeficiency], 272800 (3)'),
('606869','HEXA','Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms,'),
('606869','TSD','Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms,'),
('606871','JAM3','and cataracts, 613730 (3)'),
('606871','JAM3','Hemorrhagic destruction of the brain, subependymal calcification,'),
('606873','HEXB','Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)'),
('606874','HSCR6','{Hirschsprung disease, susceptibility to, 6} (2)'),
('606875','HSCR7','{Hirschsprung disease, susceptibility to, 7} (2)'),
('606879','PHGDH','Phosphoglycerate dehydrogenase deficiency, 601815 (3)'),
('606882','ATP7B','Wilson disease, 277900 (3)'),
('606882','WND','Wilson disease, 277900 (3)'),
('606883','IPD1','IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease,'),
('606883','IRAK4','IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease,'),
('606883','REN64','IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease,'),
('606883','IPD1','recurrent isolated, 1, 610799 (3)'),
('606883','IRAK4','recurrent isolated, 1, 610799 (3)'),
('606883','REN64','recurrent isolated, 1, 610799 (3)'),
('606885','ACADS','Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)'),
('606885','SCAD','Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)'),
('606887','SUOX','Sulfite oxidase deficiency, 272300 (3)'),
('606890','GALC','Krabbe disease, 245200 (3)'),
('606896','DYX5','{Dyslexia, susceptibility to, 5} (2)'),
('606897','CHS1','Chediak-Higashi syndrome, 214500 (3)'),
('606897','LYST','Chediak-Higashi syndrome, 214500 (3)'),
('606918','GOLGA5','Thyroid carcinoma, papillary, 188550 (3)'),
('606918','PTC5','Thyroid carcinoma, papillary, 188550 (3)'),
('606918','RFG5','Thyroid carcinoma, papillary, 188550 (3)'),
('606928','BMND3','[Bone mineral density QTL 3] (2)'),
('606933','CMM8','(3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)'),
('606933','SHEP3','(3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)'),
('606933','TYR','(3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)'),
('606933','CMM8','Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg'),
('606933','SHEP3','Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg'),
('606933','TYR','Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg'),
('606933','CMM8','syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800'),
('606933','SHEP3','syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800'),
('606933','TYR','syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800'),
('606934','CGI65','Mitochondrial complex I deficiency, 252010 (3)'),
('606934','CIA30','Mitochondrial complex I deficiency, 252010 (3)'),
('606934','NDUFAF1','Mitochondrial complex I deficiency, 252010 (3)'),
('606936','PFHB1B','Progressive familial heart block, type IB, 604559 (3)'),
('606936','TRPM4','Progressive familial heart block, type IB, 604559 (3)'),
('606938','UROS','Porphyria, congenital erythropoietic, 263700 (3)'),
('606940','ZFH4','?Ptosis, congenital, 178300 (2)'),
('606940','ZFHX4','?Ptosis, congenital, 178300 (2)'),
('606941','ALG9','Congenital disorder of glycosylation, type Il, 608776 (3)'),
('606941','CDG1L','Congenital disorder of glycosylation, type Il, 608776 (3)'),
('606941','DIBD1','Congenital disorder of glycosylation, type Il, 608776 (3)'),
('606945','FH','Hypercholesterolemia, familial, 143890 (3); LDL cholesterol'),
('606945','FHC','Hypercholesterolemia, familial, 143890 (3); LDL cholesterol'),
('606945','LDLCQ2','Hypercholesterolemia, familial, 143890 (3); LDL cholesterol'),
('606945','LDLR','Hypercholesterolemia, familial, 143890 (3); LDL cholesterol'),
('606945','FH','level QTL2, 143890 (3)'),
('606945','FHC','level QTL2, 143890 (3)'),
('606945','LDLCQ2','level QTL2, 143890 (3)'),
('606945','LDLR','level QTL2, 143890 (3)'),
('606953','GALE','Galactose epimerase deficiency, 230350 (3)'),
('606960','ITS','Insulinoma (1)');
INSERT INTO omim VALUES
('606963','COPD','Pulmonary disease, chronic obstructive, severe early-onset (2)'),
('606967','LCAT','Norum disease, 245900 (3); Fish-eye disease, 136120 (3)'),
('606972','EIG2','{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)'),
('606973','CDG2G','Congenital disorder of glycosylation, type IIg, 611209 (3)'),
('606973','COG1','Congenital disorder of glycosylation, type IIg, 611209 (3)'),
('606973','KIAA1381','Congenital disorder of glycosylation, type IIg, 611209 (3)'),
('606973','LDLB','Congenital disorder of glycosylation, type IIg, 611209 (3)'),
('606976','CDG2J','Congenital disorder of glycosylation, type IIj, 613489 (3)'),
('606976','COD1','Congenital disorder of glycosylation, type IIj, 613489 (3)'),
('606976','COG4','Congenital disorder of glycosylation, type IIj, 613489 (3)'),
('606977','CDG2L','Congenital disorder of glycosylation, type IIl, 614576 (3)'),
('606977','COD2','Congenital disorder of glycosylation, type IIl, 614576 (3)'),
('606977','COG6','Congenital disorder of glycosylation, type IIl, 614576 (3)'),
('606977','KIAA1134','Congenital disorder of glycosylation, type IIl, 614576 (3)'),
('606978','CDG2E','Congenital disorder of glycosylation, type IIe, 608779 (3)'),
('606978','COG7','Congenital disorder of glycosylation, type IIe, 608779 (3)'),
('606979','CDG2H','Congenital disorder of glycosylation, type IIh, 611182 (3)'),
('606979','COG8','Congenital disorder of glycosylation, type IIh, 611182 (3)'),
('606979','DOR1','Congenital disorder of glycosylation, type IIh, 611182 (3)'),
('606980','ADCK3','autosomal recessive 9, 612016 (3)'),
('606980','ARCA2','autosomal recessive 9, 612016 (3)'),
('606980','CABC1','autosomal recessive 9, 612016 (3)'),
('606980','COQ8','autosomal recessive 9, 612016 (3)'),
('606980','SCAR9','autosomal recessive 9, 612016 (3)'),
('606980','ADCK3','Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,'),
('606980','ARCA2','Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,'),
('606980','CABC1','Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,'),
('606980','COQ8','Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,'),
('606980','SCAR9','Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,'),
('606989','MPO','Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease,'),
('606989','MPO','susceptibility to}, 104300 (3); {Lung cancer, protection against, in smokers} (3)'),
('606995','SLSN3','Senior-Loken syndrome 3 (2)'),
('606999','GALT','Galactosemia, 230400 (3)'),
('607001','DEL9q34','Kleefstra syndrome, 610253 (3)'),
('607001','EHMT1','Kleefstra syndrome, 610253 (3)'),
('607001','EUHMTASE1','Kleefstra syndrome, 610253 (3)'),
('607002','BV8','146110 (3)'),
('607002','KAL4','146110 (3)'),
('607002','PK2','146110 (3)'),
('607002','PROK2','146110 (3)'),
('607002','BV8','Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic,'),
('607002','KAL4','Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic,'),
('607002','PK2','Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic,'),
('607002','PROK2','Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic,'),
('607004','BDA1B','Brachydactyly, type A1, 112500 (2)'),
('607008','ACADM','Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)'),
('607008','MCAD','Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)'),
('607009','CHAK2','Hypomagnesemia 1, intestinal, 602014 (3)'),
('607009','HOMG1','Hypomagnesemia 1, intestinal, 602014 (3)'),
('607009','TRPM6','Hypomagnesemia 1, intestinal, 602014 (3)'),
('607017','DFNA21','Deafness, autosomal dominant 21 (2)'),
('607031','LIAS','Pyruvate dehydrogenase lipoic acid synthetase deficiency, 614462 (3)'),
('607031','PDHLD','Pyruvate dehydrogenase lipoic acid synthetase deficiency, 614462 (3)'),
('607035','SUFU','Medulloblastoma, desmoplastic, 155255 (3)'),
('607035','SUFUH','Medulloblastoma, desmoplastic, 155255 (3)'),
('607035','SUFUXL','Medulloblastoma, desmoplastic, 155255 (3)'),
('607036','IVD','Isovaleric acidemia, 243500 (3)'),
('607038','DFNB22','Deafness, autosomal recessive 22, 607039 (3)'),
('607038','OTOA','Deafness, autosomal recessive 22, 607039 (3)'),
('607040','ABCC11','117800 (3); [Colostrum secretion, variation in], 117800 (3)'),
('607040','EWWD','117800 (3); [Colostrum secretion, variation in], 117800 (3)'),
('607040','MRP8','117800 (3); [Colostrum secretion, variation in], 117800 (3)'),
('607040','WW','117800 (3); [Colostrum secretion, variation in], 117800 (3)'),
('607040','ABCC11','[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in],'),
('607040','EWWD','[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in],'),
('607040','MRP8','[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in],'),
('607040','WW','[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in],'),
('607042','BTS','Ceroid lipofuscinosis, neuronal, 3, 204200 (3)'),
('607042','CLN3','Ceroid lipofuscinosis, neuronal, 3, 204200 (3)'),
('607043','ACT1','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','C6orf4','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','C6orf5','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','C6orf6','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','CIKS','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','PSORS13','{Psoriasis susceptibility 13}, 614070 (3)'),
('607043','TRAF3IP2','{Psoriasis susceptibility 13}, 614070 (3)'),
('607047','ATXN3','Machado-Joseph disease, 109150 (3)'),
('607047','MJD','Machado-Joseph disease, 109150 (3)'),
('607047','SCA3','Machado-Joseph disease, 109150 (3)'),
('607053','HDLCQ2','[High density lipoprotein cholesterol level QTL 2] (2)'),
('607056','IMPG2','613581 (3)'),
('607056','IPM200','613581 (3)'),
('607056','RP56','613581 (3)'),
('607056','IMPG2','Retinitis pigmentosa 56, 613581 (3); Maculopathy, IMPG2-related,'),
('607056','IPM200','Retinitis pigmentosa 56, 613581 (3); Maculopathy, IMPG2-related,'),
('607056','RP56','Retinitis pigmentosa 56, 613581 (3); Maculopathy, IMPG2-related,'),
('607059','SLC39A4','Acrodermatitis enteropathica, 201100 (3)'),
('607059','ZIP4','Acrodermatitis enteropathica, 201100 (3)'),
('607063','FKBP10','Osteogenesis imperfecta, type XI, 610968 (3)'),
('607063','FKBP65','Osteogenesis imperfecta, type XI, 610968 (3)'),
('607063','OI11','Osteogenesis imperfecta, type XI, 610968 (3)'),
('607066','OLMS','Olmsted syndrome, 614594 (3)'),
('607066','TRPV3','Olmsted syndrome, 614594 (3)'),
('607071','HYAL1','Mucopolysaccharidosis type IX, 601492 (3)'),
('607083','NSD3','Leukemia, acute myeloid, 601626 (3)'),
('607083','WHSC1L1','Leukemia, acute myeloid, 601626 (3)'),
('607085','MYAS1','Myasthenia gravis with thymus hyperplasia (2)'),
('607086','AAT1','Aortic aneurysm, familial thoracic 1 (2)'),
('607086','FAA1','Aortic aneurysm, familial thoracic 1 (2)'),
('607087','AAT2','Aortic aneurysm, familial thoracic 2 (2)'),
('607087','FAA2','Aortic aneurysm, familial thoracic 2 (2)'),
('607088','SMAR','Spinal muscular atrophy, chronic distal, autosomal recessive (2)'),
('607093','MTHFR','Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia,'),
('607093','MTHFR','susceptibility to}, 181500 (3); {Vascular disease, susceptibility to} (3); {Neural tube defects, susceptibility to}, 601634 (3); {Thromboembolism,'),
('607093','MTHFR','susceptibility to}, 188050 (3)'),
('607096','OAT4L','Hypouricemia, renal, 220150 (3)'),
('607096','SLC22A12','Hypouricemia, renal, 220150 (3)'),
('607096','URAT1','Hypouricemia, renal, 220150 (3)'),
('607100','JBTS4','266900 (3); Joubert syndrome 4, 609583 (3)'),
('607100','NPH1','266900 (3); Joubert syndrome 4, 609583 (3)'),
('607100','NPHP1','266900 (3); Joubert syndrome 4, 609583 (3)'),
('607100','SLSN1','266900 (3); Joubert syndrome 4, 609583 (3)'),
('607100','JBTS4','Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1,'),
('607100','NPH1','Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1,'),
('607100','NPHP1','Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1,'),
('607100','SLSN1','Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1,'),
('607102','NPHS4','Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)'),
('607102','WT1','Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)'),
('607102','NPHS4','Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3);'),
('607102','WT1','Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3);'),
('607107','NPC1','{Nasopharyngeal carcinoma 1} (2)'),
('607107','NPCA1','{Nasopharyngeal carcinoma 1} (2)'),
('607108','AN2','Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with'),
('607108','MGDA','Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with'),
('607108','PAX6','Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with'),
('607108','AN2','hypoplasia, 165550 (3); Coloboma, ocular, 120200 (3); Coloboma of optic nerve, 120430 (3); Gillespie syndrome, 206700 (3)'),
('607108','MGDA','hypoplasia, 165550 (3); Coloboma, ocular, 120200 (3); Coloboma of optic nerve, 120430 (3); Gillespie syndrome, 206700 (3)'),
('607108','PAX6','hypoplasia, 165550 (3); Coloboma, ocular, 120200 (3); Coloboma of optic nerve, 120430 (3); Gillespie syndrome, 206700 (3)'),
('607108','AN2','late-onset corneal dystrophy, 604219 (3); Keratitis, 148190 (3); Foveal hyperplasia, 136520 (3); Morning glory disc anomaly, 120430 (3); Optic nerve'),
('607108','MGDA','late-onset corneal dystrophy, 604219 (3); Keratitis, 148190 (3); Foveal hyperplasia, 136520 (3); Morning glory disc anomaly, 120430 (3); Optic nerve'),
('607108','PAX6','late-onset corneal dystrophy, 604219 (3); Keratitis, 148190 (3); Foveal hyperplasia, 136520 (3); Morning glory disc anomaly, 120430 (3); Optic nerve'),
('607111','SPG20','Troyer syndrome, 275900 (3)'),
('607116','AD8','Alzheimer disease 8, 104300 (2)'),
('607117','MCPH1','Microcephaly, primary autosomal recessive, 1, 251200 (3)'),
('607118','COXPD9','Combined oxidative phosphorylation deficiency 9, 614582 (3)'),
('607118','MRL3','Combined oxidative phosphorylation deficiency 9, 614582 (3)'),
('607118','MRPL3','Combined oxidative phosphorylation deficiency 9, 614582 (3)'),
('607120','EIEE12','Epileptic encephalopathy, early infantile, 12, 613722 (3)'),
('607120','KIAA0581','Epileptic encephalopathy, early infantile, 12, 613722 (3)'),
('607120','PLCB1','Epileptic encephalopathy, early infantile, 12, 613722 (3)'),
('607120','PLCB1A','Epileptic encephalopathy, early infantile, 12, 613722 (3)'),
('607120','PLCB1B','Epileptic encephalopathy, early infantile, 12, 613722 (3)'),
('607123','GPR73L1','Kallmann syndrome 3, 244200 (3)'),
('607123','KAL3','Kallmann syndrome 3, 244200 (3)'),
('607123','PKR2','Kallmann syndrome 3, 244200 (3)'),
('607123','PROKR2','Kallmann syndrome 3, 244200 (3)'),
('607131','MMEDF','facies (2)'),
('607131','MMEDF','Macrocephaly with multiple epiphyseal dysplasia and distinctive'),
('607134','SLI3','Specific language impairment QTL, 3 (2)'),
('607135','CRCL','Creatinine clearance QTL (2)'),
('607139','FA','Fanconi anemia, complementation group A, 227650 (3)'),
('607139','FA1','Fanconi anemia, complementation group A, 227650 (3)'),
('607139','FAA','Fanconi anemia, complementation group A, 227650 (3)'),
('607139','FACA','Fanconi anemia, complementation group A, 227650 (3)'),
('607139','FANCA','Fanconi anemia, complementation group A, 227650 (3)'),
('607144','ALG12','Congenital disorder of glycosylation, type Ig, 607143 (3)'),
('607144','CDG1G','Congenital disorder of glycosylation, type Ig, 607143 (3)'),
('607145','DTNBP1','{Schizophrenia}, 181500 (2); Hermansky-Pudlak syndrome 7, 614076 (3)'),
('607145','HPS7','{Schizophrenia}, 181500 (2); Hermansky-Pudlak syndrome 7, 614076 (3)'),
('607152','SPG19','Spastic paraplegia 19, autosomal dominant (2)'),
('607170','AVSD2','Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)'),
('607170','CRELD1','Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)'),
('607170','AVSD2','{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3);'),
('607170','CRELD1','{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3);'),
('607182','CATC2','Cataract, autosomal recessive congenital 2, 610019 (3)'),
('607182','FYCO1','Cataract, autosomal recessive congenital 2, 610019 (3)'),
('607194','PTF1A','609069 (3)'),
('607194','PTF1A','Diabetes mellitus, permanent neonatal, with cerebellar agenesis,'),
('607198','TDP1','607250 (3)'),
('607198','TDP1','Spinocerebellar ataxia, autosomal recessive with axonal neuropathy,'),
('607199','IRF6','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','LPS','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','OFC6','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','PIT','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','PPS','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','VWS','119500 (3); Orofacial cleft 6, 608864 (3)'),
('607199','IRF6','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607199','LPS','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607199','OFC6','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607199','PIT','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607199','PPS','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607199','VWS','van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,'),
('607202','CELIAC5','{Celiac disease, susceptibility to, 5} (2)'),
('607202','GSES','{Celiac disease, susceptibility to, 5} (2)'),
('607206','ALOXE3','Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)'),
('607212','CANDF2','212050 (3)'),
('607212','CARD9','212050 (3)'),
('607212','CANDF2','Candidiasis, familial, 2, autosomal recessive, 212050 (3)'),
('607212','CARD9','Candidiasis, familial, 2, autosomal recessive, 212050 (3)'),
('607213','ORC6','Meier-Gorlin syndrome 3, 613803 (3)'),
('607213','ORC6L','Meier-Gorlin syndrome 3, 613803 (3)'),
('607215','NPHP4','Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)'),
('607215','SLSN4','Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)'),
('607218','IBD14','{Inflammatory bowel disease 14}, 612245 (3);'),
('607218','IRF5','{Inflammatory bowel disease 14}, 612245 (3);'),
('607218','SLEB10','{Inflammatory bowel disease 14}, 612245 (3);'),
('607218','IBD14','{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)'),
('607218','IRF5','{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)'),
('607218','SLEB10','{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)'),
('607221','EPPS','Epilepsy, partial, with pericentral spikes (2)'),
('607223','DTDP1','125400 (3)'),
('607223','SMAP2','125400 (3)'),
('607223','SMOC2','125400 (3)'),
('607223','DTDP1','Dentin dysplasia, type I, with microdontia and misshapen teeth,'),
('607223','SMAP2','Dentin dysplasia, type I, with microdontia and misshapen teeth,'),
('607223','SMOC2','Dentin dysplasia, type I, with microdontia and misshapen teeth,'),
('607237','DFNB6','Deafness, autosomal recessive 6, 600971 (3)'),
('607237','TMIE','Deafness, autosomal recessive 6, 600971 (3)'),
('607239','DFNB33','Deafness, autosomal recessive 33 (2)'),
('607243','AP4S1','Spastic paraplegia 52, autosomal recessive, 614067 (3)'),
('607243','CPSQ6','Spastic paraplegia 52, autosomal recessive, 614067 (3)'),
('607243','SPG52','Spastic paraplegia 52, autosomal recessive, 614067 (3)'),
('607244','AP4E1','Spastic paraplegia 51, autosomal recessive, 613744 (3)'),
('607244','CPSQ4','Spastic paraplegia 51, autosomal recessive, 613744 (3)'),
('607244','SPG51','Spastic paraplegia 51, autosomal recessive, 613744 (3)'),
('607245','AP4B1','Spastic paraplegia 47, autosomal recessive, 614066 (3)'),
('607245','CPSQ5','Spastic paraplegia 47, autosomal recessive, 614066 (3)'),
('607245','SPG47','Spastic paraplegia 47, autosomal recessive, 614066 (3)'),
('607248','GLM4','{Glioma susceptibility 4} (2)'),
('607252','APOL2','{Schizophrenia}, 181500 (1)'),
('607254','APOL4','{Schizophrenia}, 181500 (1)'),
('607258','HCA1','Hypercalciuria, absorptive (2)'),
('607261','EVC2','Ellis-van Creveld syndrome, 225500 (3)'),
('607261','LBN','Ellis-van Creveld syndrome, 225500 (3)'),
('607273','BHD','Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary'),
('607273','FLCN','Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary'),
('607273','BHD','spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)'),
('607273','FLCN','spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)'),
('607279','SLEH1','{Systemic lupus erythematosus with hemolytic anemia} (2)'),
('607292','CORD10','(3)'),
('607292','RP35','(3)'),
('607292','SEMA4A','(3)'),
('607292','SEMB','(3)'),
('607292','CORD10','Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283'),
('607292','RP35','Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283'),
('607292','SEMA4A','Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283'),
('607292','SEMB','Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283'),
('607300','PRPC8','Retinitis pigmentosa 13, 600059 (3)'),
('607300','PRPF8','Retinitis pigmentosa 13, 600059 (3)'),
('607300','RP13','Retinitis pigmentosa 13, 600059 (3)'),
('607301','HPRP3','Retinitis pigmentosa 18, 601414 (3)'),
('607301','RP18','Retinitis pigmentosa 18, 601414 (3)'),
('607304','CCNP','Cataract, nuclear progressive (2)'),
('607306','SRD5A2','Pseudovaginal perineoscrotal hypospadias, 264600 (3)'),
('607311','PGR','?Progesterone resistance, 264080 (2)'),
('607317','SCAR4','Spinocerebellar ataxia, autosomal recessive 4 (2)'),
('607317','SCASI','Spinocerebellar ataxia, autosomal recessive 4 (2)'),
('607324','PAPA3','Polydactyly, postaxial, type A3 (2)'),
('607329','HYT3','{Hypertension, essential, susceptibility to, 3}, 145500 (2)'),
('607331','RP9','Retinitis pigmentosa 9, 180104 (3)'),
('607339','CHDS1','{Coronary heart disease, susceptibility to} (2)'),
('607340','GABBR2','dependence, protection against}, 188890 (3)'),
('607340','GPR51','dependence, protection against}, 188890 (3)'),
('607340','GABBR2','{Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine'),
('607340','GPR51','{Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine'),
('607343','HSAL4','Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)'),
('607343','SALL4','Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)'),
('607346','SCA19','Spinocerebellar ataxia 19 (2)'),
('607354','AIS2','Scoliosis, idiopathic 2 (2)'),
('607354','IS2','Scoliosis, idiopathic 2 (2)'),
('607358','AIRE','Autoimmune polyendocrinopathy syndrome , type I, with or without'),
('607358','APECED','Autoimmune polyendocrinopathy syndrome , type I, with or without'),
('607358','APS1','Autoimmune polyendocrinopathy syndrome , type I, with or without'),
('607358','AIRE','reversible metaphyseal dysplasia, 240300 (3)'),
('607358','APECED','reversible metaphyseal dysplasia, 240300 (3)'),
('607358','APS1','reversible metaphyseal dysplasia, 240300 (3)'),
('607365','ARWH2','Hypotrichosis, localized, autosomal recessive 2, 604379 (3);'),
('607365','LAH2','Hypotrichosis, localized, autosomal recessive 2, 604379 (3);'),
('607365','LIPH','Hypotrichosis, localized, autosomal recessive 2, 604379 (3);'),
('607365','ARWH2','Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)'),
('607365','LAH2','Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)'),
('607365','LIPH','Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)'),
('607373','AUTS8','{Autism susceptibility 8} (2)'),
('607379','NF2','Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related,'),
('607379','NF2','somatic, 607174 (3); Schwannomatosis, 162091 (3)'),
('607393','C1orf28','Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)'),
('607393','HRPT2','Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)'),
('607393','C1orf28','Hyperparathyroidism-jaw tumor syndrome, 145001 (3);'),
('607393','HRPT2','Hyperparathyroidism-jaw tumor syndrome, 145001 (3);'),
('607397','MC2R','Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)'),
('607402','IL28B','{Hepatitis C virus infection, response to therapy of}, 609532 (3)'),
('607408','DAOA','{Schizophrenia}, 181500 (2)'),
('607408','G72','{Schizophrenia}, 181500 (2)'),
('607421','CILD6','Ciliary dyskinesia, primary, 6, 610852 (3)'),
('607421','SPTRX2','Ciliary dyskinesia, primary, 6, 610852 (3)'),
('607421','TXNDC3','Ciliary dyskinesia, primary, 6, 610852 (3)'),
('607423','MDDGA1','anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular'),
('607423','MDDGB1','anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular'),
('607423','MDDGC1','anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular'),
('607423','POMT1','anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular'),
('607423','MDDGA1','dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)'),
('607423','MDDGB1','dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)'),
('607423','MDDGC1','dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)'),
('607423','POMT1','dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)'),
('607423','MDDGA1','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607423','MDDGB1','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607423','MDDGC1','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607423','POMT1','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607429','COQ1','Coenzyme Q10 deficiency, 607426 (3)'),
('607429','PDSS1','Coenzyme Q10 deficiency, 607426 (3)'),
('607429','TPT','Coenzyme Q10 deficiency, 607426 (3)'),
('607439','MDDGA2','anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular'),
('607439','MDDGB2','anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular'),
('607439','MDDGC2','anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular'),
('607439','POMT2','anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular'),
('607439','MDDGA2','dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)'),
('607439','MDDGB2','dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)'),
('607439','MDDGC2','dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)'),
('607439','POMT2','dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)'),
('607439','MDDGA2','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607439','MDDGB2','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607439','MDDGC2','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607439','POMT2','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','CMD1X','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','FCMD','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','FKTN','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','LGMD2M','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','MDDGA4','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','MDDGB4','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','MDDGC4','anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy,'),
('607440','CMD1X','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','FCMD','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','FKTN','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','LGMD2M','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','MDDGA4','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','MDDGB4','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','MDDGC4','dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)'),
('607440','CMD1X','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','FCMD','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','FKTN','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','LGMD2M','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','MDDGA4','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','MDDGB4','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607440','MDDGC4','Muscular dystrophy-dystroglycanopathy (congenital with brain and eye'),
('607444','SBDS','Shwachman-Bodian-Diamond syndrome, 260400 (3)'),
('607444','SDS','Shwachman-Bodian-Diamond syndrome, 260400 (3)'),
('607446','BMIQ3','[Body mass index QTL3] (2)'),
('607454','SCA21','Spinocerebellar ataxia 21 (2)'),
('607456','CIRH1A','Cirrhosis, North American Indian childhood type, 604901 (3)'),
('607456','KIAA1988','Cirrhosis, North American Indian childhood type, 604901 (3)'),
('607456','NAIC','Cirrhosis, North American Indian childhood type, 604901 (3)'),
('607456','TEX292','Cirrhosis, North American Indian childhood type, 604901 (3)'),
('607458','SCA18','Spinocerebellar ataxia 18 (2)'),
('607458','SMNA','Spinocerebellar ataxia 18 (2)'),
('607461','DMC','607326 (3)'),
('607461','DYM','607326 (3)'),
('607461','FLJ90130','607326 (3)'),
('607461','SMC','607326 (3)'),
('607461','DMC','Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia,'),
('607461','DYM','Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia,'),
('607461','FLJ90130','Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia,'),
('607461','SMC','Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia,'),
('607462','ATN1','Dentatorubro-pallidoluysian atrophy, 125370 (3)'),
('607462','DRPLA','Dentatorubro-pallidoluysian atrophy, 125370 (3)'),
('607462','HRS','Dentatorubro-pallidoluysian atrophy, 125370 (3)'),
('607462','NOD','Dentatorubro-pallidoluysian atrophy, 125370 (3)'),
('607465','CDA1','Anemia, congenital dyserythropoietic, type I, 224120 (3)'),
('607465','CDAN1','Anemia, congenital dyserythropoietic, type I, 224120 (3)'),
('607474','AKU','Alkaptonuria, 203500 (3)'),
('607474','HGD','Alkaptonuria, 203500 (3)'),
('607478','ADHD7','deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)'),
('607478','NTPH','deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)'),
('607478','TPH2','deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)'),
('607478','ADHD7','{Unipolar depression, susceptibility to}, 608516 (3); {Attention'),
('607478','NTPH','{Unipolar depression, susceptibility to}, 608516 (3); {Attention'),
('607478','TPH2','{Unipolar depression, susceptibility to}, 608516 (3); {Attention'),
('607479','APCDD1','Hypotrichosis simplex, 605389 (3)'),
('607479','HHS','Hypotrichosis simplex, 605389 (3)'),
('607479','HTS','Hypotrichosis simplex, 605389 (3)'),
('607481','MMAA','Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)'),
('607488','DYT15','Dystonia-15, myoclonic (2)'),
('607498','MGR3','{Migraine with or without aura, susceptibility to, 3} (2)'),
('607499','BULN','{Bulimia nervosa, susceptibility to} (2)'),
('607501','MGOA','{Migraine without aura, susceptibility to, 4} (2)'),
('607501','MGR4','{Migraine without aura, susceptibility to, 4} (2)'),
('607508','MGR5','{Migraine with or without aura, susceptibility to, 5} (2)'),
('607511','ADAMTS17','Weill-Marchesani-like syndrome, 613195 (3)'),
('607512','ADAMTS18','Knobloch syndrome 2, 608454 (3)'),
('607512','KNO2','Knobloch syndrome 2, 608454 (3)'),
('607514','BMIQ10','{Obesity, susceptibility to, BMIQ10} (2)'),
('607516','FHM3','Migraine, familial hemiplegic (2); Migraine with or without aura,'),
('607516','MGR6','Migraine, familial hemiplegic (2); Migraine with or without aura,'),
('607516','FHM3','susceptibility to (2)'),
('607516','MGR6','susceptibility to (2)'),
('607521','HPS5','Hermansky-Pudlak syndrome 5, 614074 (3)'),
('607521','KIAA1017','Hermansky-Pudlak syndrome 5, 614074 (3)'),
('607521','RU2','Hermansky-Pudlak syndrome 5, 614074 (3)'),
('607522','HPS6','Hermansky-Pudlak syndrome 6, 614075 (3)'),
('607522','RU','Hermansky-Pudlak syndrome 6, 614075 (3)'),
('607536','CRTC1','Mucoepidermoid salivary gland carcinoma (3)'),
('607536','FLJ14027','Mucoepidermoid salivary gland carcinoma (3)'),
('607536','KIAA0616','Mucoepidermoid salivary gland carcinoma (3)'),
('607536','MECT1','Mucoepidermoid salivary gland carcinoma (3)'),
('607537','MAM3','Mucoepidermoid salivary gland carcinoma (3)'),
('607537','MAML2','Mucoepidermoid salivary gland carcinoma (3)'),
('607542','ATFB3','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','KCNA9','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','KCNQ1','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','KVLQT1','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','LQT1','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','SQT2','220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)'),
('607542','ATFB3','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607542','KCNA9','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607542','KCNQ1','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607542','KVLQT1','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607542','LQT1','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607542','SQT2','Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,'),
('607544','LRP130','Leigh syndrome, French-Canadian type, 220111 (3)'),
('607544','LRPPRC','Leigh syndrome, French-Canadian type, 220111 (3)'),
('607544','LSFC','Leigh syndrome, French-Canadian type, 220111 (3)'),
('607556','DERMO1','Setleis syndrome, 227260 (3)'),
('607556','SETLSS','Setleis syndrome, 227260 (3)'),
('607556','TWIST2','Setleis syndrome, 227260 (3)'),
('607557','DFNA25','Deafness, autosomal dominant 25, 605583 (3)'),
('607557','SLC17A8','Deafness, autosomal dominant 25, 605583 (3)'),
('607557','VGLUT3','Deafness, autosomal dominant 25, 605583 (3)'),
('607562','IBD17','{Inflammatory bowel disease 17, protection against}, 612261 (3);'),
('607562','IL23R','{Inflammatory bowel disease 17, protection against}, 612261 (3);'),
('607562','IBD17','{Psoriasis, protection against}, 605606 (3)'),
('607562','IL23R','{Psoriasis, protection against}, 605606 (3)'),
('607566','EPM2','Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)'),
('607566','EPM2A','Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)'),
('607566','MELF','Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)'),
('607568','MMAB','Methylmalonic aciduria, vitamin B12-responsive, due to defect in'),
('607568','MMAB','synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)'),
('607574','ARSA','Metachromatic leukodystrophy, 250100 (3)'),
('607584','SPG24','Spastic paraplegia 24, autosomal recessive (2)'),
('607585','AT1','Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin,'),
('607585','ATA','Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin,'),
('607585','ATM','Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin,'),
('607585','AT1','somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell (3); T-cell prolymphocytic leukemia, sporadic (3)'),
('607585','ATA','somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell (3); T-cell prolymphocytic leukemia, sporadic (3)'),
('607585','ATM','somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell (3); T-cell prolymphocytic leukemia, sporadic (3)'),
('607590','BBS7','Bardet-Biedl syndrome 7, 209900 (3)'),
('607592','HPCQTL19','{Prostate cancer aggressiveness QTL}, 176807 (2)'),
('607604','KCNV2','Retinal cone dystrophy 3B, 610356 (3)'),
('607604','KV11.1','Retinal cone dystrophy 3B, 610356 (3)'),
('607604','RCD3B','Retinal cone dystrophy 3B, 610356 (3)'),
('607606','EPPK','Epidermolytic palmoplantar keratoderma, 144200 (3)'),
('607606','KRT9','Epidermolytic palmoplantar keratoderma, 144200 (3)'),
('607608','NPD','B, 607616 (3)'),
('607608','SMPD1','B, 607616 (3)'),
('607608','NPD','Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type'),
('607608','SMPD1','Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type'),
('607623','NPC','Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease,'),
('607623','NPC1','Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease,'),
('607623','NPC','type D, 257220 (3)'),
('607623','NPC1','type D, 257220 (3)'),
('607632','PEN2','Acne inversa, familial, 2, 613736 (3)'),
('607632','PSENEN','Acne inversa, familial, 2, 613736 (3)'),
('607633','XDH','Xanthinuria, type I, 278300 (3)'),
('607640','ATXN7','Spinocerebellar ataxia 7, 164500 (3)'),
('607640','OPCA3','Spinocerebellar ataxia 7, 164500 (3)'),
('607640','SCA7','Spinocerebellar ataxia 7, 164500 (3)'),
('607642','RAI1','Smith-Magenis syndrome, 182290 (3)'),
('607642','SMCR','Smith-Magenis syndrome, 182290 (3)'),
('607642','SMS','Smith-Magenis syndrome, 182290 (3)'),
('607643','FSCN2','Retinitis pigmentosa 30, 607921 (3)'),
('607643','RFSN','Retinitis pigmentosa 30, 607921 (3)'),
('607643','RP30','Retinitis pigmentosa 30, 607921 (3)'),
('607644','CANDF3','Candidiasis, familial, 3 (2)'),
('607644','CANDN1','Candidiasis, familial, 3 (2)'),
('607644','FCNC','Candidiasis, familial, 3 (2)'),
('607649','GL','Osteopetrosis, autosomal recessive 5, 259720 (3)'),
('607649','OPTB5','Osteopetrosis, autosomal recessive 5, 259720 (3)'),
('607649','OSTM1','Osteopetrosis, autosomal recessive 5, 259720 (3)'),
('607657','CTH','(3)'),
('607657','CTH','Cystathioninuria, 219500 (3); Homocysteine, total plasma, elevated'),
('607664','G6S','Mucopolysaccharidosis type IIID, 252940 (3)'),
('607664','GNS','Mucopolysaccharidosis type IIID, 252940 (3)'),
('607671','DYT13','Dystonia 13, torsion (2)'),
('607672','BSF3','Cold-induced sweating syndrome 1, 610313 (3)'),
('607672','CLC','Cold-induced sweating syndrome 1, 610313 (3)'),
('607672','CLCF1','Cold-induced sweating syndrome 1, 610313 (3)'),
('607683','DFNA52','Deafness, autosomal dominant 52 (2)'),
('607687','HDLC3','{High density lipoprotein cholesterol, low serum, 3} (2)'),
('607690','ANDD','Chylomicron retention disease, 246700 (3)'),
('607690','CMRD','Chylomicron retention disease, 246700 (3)'),
('607690','SAR1B','Chylomicron retention disease, 246700 (3)'),
('607690','SARA2','Chylomicron retention disease, 246700 (3)'),
('607693','SBP2','Thyroid hormone metabolism, abnormal, 609698 (3)'),
('607693','SECISBP2','Thyroid hormone metabolism, abnormal, 609698 (3)'),
('607696','SANS','Usher syndrome, type 1G, 606943 (3)'),
('607696','USH1G','Usher syndrome, type 1G, 606943 (3)'),
('607697','CMT4B2','Charcot-Marie-Tooth disease, type 4B2, 604563 (3)'),
('607697','MTMR13','Charcot-Marie-Tooth disease, type 4B2, 604563 (3)'),
('607697','SBF2','Charcot-Marie-Tooth disease, type 4B2, 604563 (3)'),
('607704','ANKRD15','Cerebral palsy, spastic quadriplegic, 2, 612900 (3)'),
('607704','CPSQ2','Cerebral palsy, spastic quadriplegic, 2, 612900 (3)'),
('607704','KANK','Cerebral palsy, spastic quadriplegic, 2, 612900 (3)'),
('607704','KANK1','Cerebral palsy, spastic quadriplegic, 2, 612900 (3)'),
('607704','KIAA0172','Cerebral palsy, spastic quadriplegic, 2, 612900 (3)'),
('607709','TJP2','Hypercholanemia, familial, 607748 (3)'),
('607709','ZO2','Hypercholanemia, familial, 607748 (3)'),
('607728','DSAP2','Porokeratosis, disseminated superficial actinic, 2 (2)'),
('607751','PTC','[Phenylthiocarbamide tasting], 171200 (3)'),
('607751','T2R61','[Phenylthiocarbamide tasting], 171200 (3)'),
('607751','TAS2R38','[Phenylthiocarbamide tasting], 171200 (3)'),
('607759','BDPLT2','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,'),
('607759','CD41B','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,'),
('607759','GP2B','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,'),
('607759','GT','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,'),
('607759','ITGA2B','Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,'),
('607759','BDPLT2','neonatal alloimmune, BAK antigen related (3)'),
('607759','CD41B','neonatal alloimmune, BAK antigen related (3)'),
('607759','GP2B','neonatal alloimmune, BAK antigen related (3)'),
('607759','GT','neonatal alloimmune, BAK antigen related (3)'),
('607759','ITGA2B','neonatal alloimmune, BAK antigen related (3)'),
('607761','KIAA1867','Mental retardation, autosomal dominant 4, 612581 (3)'),
('607761','KIRRE','Mental retardation, autosomal dominant 4, 612581 (3)'),
('607761','KIRREL3','Mental retardation, autosomal dominant 4, 612581 (3)'),
('607761','MRD4','Mental retardation, autosomal dominant 4, 612581 (3)'),
('607761','NEPH2','Mental retardation, autosomal dominant 4, 612581 (3)'),
('607764','CBAS1','Bile acid synthesis defect, congenital, 1, 607765 (3)'),
('607764','HSD3B7','Bile acid synthesis defect, congenital, 1, 607765 (3)'),
('607772','PLEKHA1','{Age-related maculopathy, susceptibility to}, 603075 (2)'),
('607772','TAPP1','{Age-related maculopathy, susceptibility to}, 603075 (2)'),
('607786','FH3','Hypercholesterolemia, familial, 3, 603776 (3); {Low density'),
('607786','HCHOLA3','Hypercholesterolemia, familial, 3, 603776 (3); {Low density'),
('607786','LDLCQ1','Hypercholesterolemia, familial, 3, 603776 (3); {Low density'),
('607786','NARC1','Hypercholesterolemia, familial, 3, 603776 (3); {Low density'),
('607786','PCSK9','Hypercholesterolemia, familial, 3, 603776 (3); {Low density'),
('607786','FH3','lipoprotein cholesterol level QTL 1}, 603776 (3)'),
('607786','HCHOLA3','lipoprotein cholesterol level QTL 1}, 603776 (3)'),
('607786','LDLCQ1','lipoprotein cholesterol level QTL 1}, 603776 (3)'),
('607786','NARC1','lipoprotein cholesterol level QTL 1}, 603776 (3)'),
('607786','PCSK9','lipoprotein cholesterol level QTL 1}, 603776 (3)'),
('607788','F5F8D2','Factor V and factor VIII, combined deficiency of, 613625 (3)'),
('607788','MCFD2','Factor V and factor VIII, combined deficiency of, 613625 (3)'),
('607796','NYREN34','[IgE levels QTL], 147050 (3); {Asthma}, 600807 (3)'),
('607796','PHF11','[IgE levels QTL], 147050 (3); {Asthma}, 600807 (3)'),
('607800','ABCA12','Ichthyosis, lamellar 2, 601277 (3); Ichthyosis, harlequin, 242500 (3)'),
('607800','ICR2B','Ichthyosis, lamellar 2, 601277 (3); Ichthyosis, harlequin, 242500 (3)'),
('607800','LI2','Ichthyosis, lamellar 2, 601277 (3); Ichthyosis, harlequin, 242500 (3)'),
('607803','ACDP2','Hypomagnesemia 6, renal, 613882 (3)'),
('607803','CNNM2','Hypomagnesemia 6, renal, 613882 (3)'),
('607805','ACDP4','Jalili syndrome, 217080 (3)'),
('607805','CNNM4','Jalili syndrome, 217080 (3)'),
('607809','ACAT1','Alpha-methylacetoacetic aciduria, 203750 (3)'),
('607814','PERRS','Bradyopsia, 608415 (3)'),
('607814','R9AP','Bradyopsia, 608415 (3)'),
('607814','RGS9','Bradyopsia, 608415 (3)'),
('607814','RGS9BP','Bradyopsia, 608415 (3)'),
('607817','COH1','Cohen syndrome, 216550 (3)'),
('607818','UAN','{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)'),
('607818','ZNF365','{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)'),
('607829','MMVP2','Mitral valve prolapse, myxomatous 2 (2)'),
('607830','FRAS1','Fraser syndrome, 219000 (3)'),
('607837','CLN8','Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid'),
('607837','EPMR','Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid'),
('607837','CLN8','lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)'),
('607837','EPMR','lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)'),
('607838','GNPTAG','Mucolipidosis III gamma, 252605 (3)'),
('607839','GBE1','Glycogen storage disease IV, 232500 (3)'),
('607840','GNPTA','alpha/beta, 252500 (3)'),
('607840','GNPTAB','alpha/beta, 252500 (3)'),
('607840','GNPTA','Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II'),
('607840','GNPTAB','Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II'),
('607842','CAA','Aural atresia, congenital (2)'),
('607844','LEMD3','Melorheostosis with osteopoikilosis, 155950 (3)'),
('607844','MAN1','Melorheostosis with osteopoikilosis, 155950 (3)'),
('607844','LEMD3','Osteopoikilosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3);'),
('607844','MAN1','Osteopoikilosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3);'),
('607853','PAND2','Panic disorder 2 (2)'),
('607854','ARB','Best macular dystrophy, 153700 (3); Maculopathy, bull\'s-eye (3);'),
('607854','BEST1','Best macular dystrophy, 153700 (3); Maculopathy, bull\'s-eye (3);'),
('607854','RP50','Best macular dystrophy, 153700 (3); Maculopathy, bull\'s-eye (3);'),
('607854','VMD2','Best macular dystrophy, 153700 (3); Maculopathy, bull\'s-eye (3);'),
('607854','ARB','dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)'),
('607854','BEST1','dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)'),
('607854','RP50','dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)'),
('607854','VMD2','dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)'),
('607854','ARB','Vitelliform macular dystrophy, adult-onset, 608161 (3); Bestrophinopathy, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone'),
('607854','BEST1','Vitelliform macular dystrophy, adult-onset, 608161 (3); Bestrophinopathy, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone'),
('607854','RP50','Vitelliform macular dystrophy, adult-onset, 608161 (3); Bestrophinopathy, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone'),
('607854','VMD2','Vitelliform macular dystrophy, adult-onset, 608161 (3); Bestrophinopathy, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone'),
('607857','PSORS9','{Psoraisis susceptibility 9} (2)'),
('607867','CLLD7','susceptibility to}, 103780 (3)'),
('607867','GLP','susceptibility to}, 103780 (3)'),
('607867','RCBTB1','susceptibility to}, 103780 (3)'),
('607867','CLLD7','[Beta-glycopyranoside tasting] (3); {Alcohol dependence,'),
('607867','GLP','[Beta-glycopyranoside tasting] (3); {Alcohol dependence,'),
('607867','RCBTB1','[Beta-glycopyranoside tasting] (3); {Alcohol dependence,'),
('607872','C1DELp36','Chromosome 1p36 deletion syndrome (4)'),
('607872','DEL1p36','Chromosome 1p36 deletion syndrome (4)'),
('607876','ADCME','Epilepsy, myoclonic, adult familial, 2 (2)'),
('607876','BAFME2','Epilepsy, myoclonic, adult familial, 2 (2)'),
('607876','FAME2','Epilepsy, myoclonic, adult familial, 2 (2)'),
('607892','DSG4','Hypotrichosis, localized, autosomal recessive, 607903 (3)'),
('607892','LAH','Hypotrichosis, localized, autosomal recessive, 607903 (3)'),
('607893','OVCAS1','{Ovarian cancer, susceptibility to} (2)'),
('607900','C20orf42','Kindler syndrome, 173650 (3)'),
('607900','KIND1','Kindler syndrome, 173650 (3)'),
('607900','URP1','Kindler syndrome, 173650 (3)'),
('607901','FERMT3','Leukocyte adhesion deficiency, type III, 612840 (3)'),
('607901','KIND3','Leukocyte adhesion deficiency, type III, 612840 (3)'),
('607901','MIG2B','Leukocyte adhesion deficiency, type III, 612840 (3)'),
('607901','URP2','Leukocyte adhesion deficiency, type III, 612840 (3)'),
('607904','CACNA1H','{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)'),
('607904','ECA6','{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)'),
('607904','EIG6','{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)'),
('607904','CACNA1H','{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);'),
('607904','ECA6','{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);'),
('607904','EIG6','{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);'),
('607905','ALG2','Congenital disorder of glycosylation, type Ii,  607906 (3)'),
('607905','CDGII','Congenital disorder of glycosylation, type Ii,  607906 (3)'),
('607922','A4GALT','[Blood group, P system], 111400 (3)'),
('607922','PK','[Blood group, P system], 111400 (3)'),
('607928','CIP98','2D, 611383 (3)'),
('607928','DFNB31','2D, 611383 (3)'),
('607928','KIAA1526','2D, 611383 (3)'),
('607928','USH2D','2D, 611383 (3)'),
('607928','WHRN','2D, 611383 (3)'),
('607928','CIP98','Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type'),
('607928','DFNB31','Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type'),
('607928','KIAA1526','Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type'),
('607928','USH2D','Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type'),
('607928','WHRN','Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type'),
('607929','C7orf22','Cerebral cavernous malformations-2, 603284 (3)'),
('607929','CCM2','Cerebral cavernous malformations-2, 603284 (3)'),
('607929','MGC4067','Cerebral cavernous malformations-2, 603284 (3)'),
('607939','FGE','Multiple sulfatase deficiency, 272200 (3)'),
('607939','SUMF1','Multiple sulfatase deficiency, 272200 (3)'),
('607949','MTBS1','{Tuberculosis, susceptibility to} (2)'),
('607951','CEP57','Mosaic variegated aneuploidy syndrome 2, 614114 (3)'),
('607951','KIAA0092','Mosaic variegated aneuploidy syndrome 2, 614114 (3)'),
('607951','MVA2','Mosaic variegated aneuploidy syndrome 2, 614114 (3)'),
('607951','PIG8','Mosaic variegated aneuploidy syndrome 2, 614114 (3)'),
('607951','TSP57','Mosaic variegated aneuploidy syndrome 2, 614114 (3)'),
('607961','CDW108','[Blood group, John-Milton-Hagen] (3)'),
('607961','JMH','[Blood group, John-Milton-Hagen] (3)'),
('607961','SEMA7A','[Blood group, John-Milton-Hagen] (3)'),
('607961','SEMAK1','[Blood group, John-Milton-Hagen] (3)'),
('607961','SEMAL','[Blood group, John-Milton-Hagen] (3)'),
('607965','SLEN1','(2)'),
('607965','SLEN1','{Systemic lupus erythematosus with nephritis, susceptibility to, 1}'),
('607966','SLEN2','(2)'),
('607966','SLEN2','{Systemic lupus erythematosus with nephritis, susceptibility to, 2}'),
('607967','SLEN3','(2)'),
('607967','SLEN3','{Systemic lupus erythematosus with nephritis, susceptibility to, 3}'),
('607968','BBS9','Bardet-Biedl syndrome 9, 209900 (3)'),
('607968','PTHB1','Bardet-Biedl syndrome 9, 209900 (3)'),
('607976','COX4I2','calvarial hyperostosis, 612714 (3)'),
('607976','COX4I2','Exocrine pancreatic insufficiency, dyserythropoietic anemia, and'),
('607983','GO','Geroderma osteodysplasticum, 231070 (3)'),
('607983','GORAB','Geroderma osteodysplasticum, 231070 (3)'),
('607983','NTKLBP1','Geroderma osteodysplasticum, 231070 (3)'),
('607983','SCYL1BP1','Geroderma osteodysplasticum, 231070 (3)'),
('607998','CLN2','Ceroid lipofuscinosis, neuronal, 2, 204500 (3)'),
('607998','TPP1','Ceroid lipofuscinosis, neuronal, 2, 204500 (3)'),
('608002','MKS7','208540 (3); Meckel syndrome 7, 267010 (3)'),
('608002','NPH3','208540 (3); Meckel syndrome 7, 267010 (3)'),
('608002','NPHP3','208540 (3); Meckel syndrome 7, 267010 (3)'),
('608002','RHPD','208540 (3); Meckel syndrome 7, 267010 (3)'),
('608002','MKS7','Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia,'),
('608002','NPH3','Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia,'),
('608002','NPHP3','Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia,'),
('608002','RHPD','Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia,'),
('608005','BAP','Marinesco-Sjogren syndrome, 248800 (3)'),
('608005','MSS','Marinesco-Sjogren syndrome, 248800 (3)'),
('608005','SIL1','Marinesco-Sjogren syndrome, 248800 (3)'),
('608010','NPC1L1','[Ezetimibe, nonresponse to] (3)'),
('608014','CMT2L','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','DHMN2','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','E2IG1','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','H11','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','HMN2A','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','HSPB8','Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)'),
('608014','CMT2L','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608014','DHMN2','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608014','E2IG1','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608014','H11','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608014','HMN2A','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608014','HSPB8','Neuropathy, distal hereditary motor, type IIA, 158590 (3);'),
('608026','HNP1','Hypertensive nephropathy (2)'),
('608027','CLAM','Pontocerebellar hypoplasia, type 3 (2)'),
('608027','PCH3','Pontocerebellar hypoplasia, type 3 (2)'),
('608029','CLA3','Spinocerebellar ataxia, autosomal recessive 6 (2)'),
('608029','SCAR6','Spinocerebellar ataxia, autosomal recessive 6 (2)'),
('608031','ALS7','Amyotrophic lateral sclerosis 7 (2)'),
('608034','ASPA','Canavan disease, 271900 (3)'),
('608035','CMM4','{Melanoma, cutaneous malignant, 4} (2)'),
('608036','NIDDM4','{Diabetes mellitus, noninsulin-dependent}, 125853 (2)'),
('608041','ANTXR2','Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile'),
('608041','CMG2','Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile'),
('608041','ISH','Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile'),
('608041','JHF','Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile'),
('608041','ANTXR2','systemic, 236490 (3)'),
('608041','CMG2','systemic, 236490 (3)'),
('608041','ISH','systemic, 236490 (3)'),
('608041','JHF','systemic, 236490 (3)'),
('608049','AUTS3','{Autism susceptibility 3} (2)'),
('608053','ETFA','Glutaric acidemia IIA, 231680 (3)'),
('608053','GA2','Glutaric acidemia IIA, 231680 (3)'),
('608053','MADD','Glutaric acidemia IIA, 231680 (3)'),
('608059','HES7','Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)'),
('608059','SCDO4','Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)'),
('608072','EPM2A','Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)'),
('608072','EPM2B','Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)'),
('608072','NHLRC1','Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)'),
('608078','SCZD11','{Schizophrenia}, 181500 (2)'),
('608083','APOC2','Hyperlipoproteinemia, type Ib, 207750 (3)'),
('608088','HSN1B','Neuropathy, hereditary sensory, type IB (2)'),
('608092','KIAA0992','{Pancreatic cancer, susceptibility to, 1}, 606856 (3)'),
('608092','PALLD','{Pancreatic cancer, susceptibility to, 1}, 606856 (3)'),
('608092','PNCA1','{Pancreatic cancer, susceptibility to, 1}, 606856 (3)'),
('608096','ETL2','Epilepsy, familial temporal lobe, 2 (2)'),
('608096','FTLE','Epilepsy, familial temporal lobe, 2 (2)'),
('608098','PVNH3','Periventricular nodular heterotopia 3 (2)'),
('608100','HIRIP','Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)'),
('608100','MMDS1','Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)'),
('608100','NFU1','Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)'),
('608102','CLN5','Ceroid lipofuscinosis, neuronal, 5, 256731 (3)'),
('608103','ALG8','Congenital disorder of glycosylation, type Ih, 608104 (3)'),
('608103','CDG1H','Congenital disorder of glycosylation, type Ih, 608104 (3)'),
('608105','EPRPDC','Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and'),
('608105','EPRPDC','writer\'s cramp (2)'),
('608107','FMF','Familial Mediterranean fever, AR, 249100 (3); Familial'),
('608107','MEF','Familial Mediterranean fever, AR, 249100 (3); Familial'),
('608107','MEFV','Familial Mediterranean fever, AR, 249100 (3); Familial'),
('608107','FMF','Mediterranean fever, AD, 134610 (3)'),
('608107','MEF','Mediterranean fever, AD, 134610 (3)'),
('608107','MEFV','Mediterranean fever, AD, 134610 (3)'),
('608109','MLASA1','Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3)'),
('608109','PUS1','Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3)'),
('608111','FANCL','Fanconi anemia, complementation group L, 614083 (3)'),
('608111','PHF9','Fanconi anemia, complementation group L, 614083 (3)'),
('608124','XT1','{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)'),
('608124','XYLT1','{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)'),
('608125','XT2','{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)'),
('608125','XYLT2','{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)'),
('608132','BBS8','613464 (3)'),
('608132','RP51','613464 (3)'),
('608132','TTC8','613464 (3)'),
('608132','BBS8','Bardet-Biedl syndrome 8, 209900 (3); Retinitis pigmentosa 51,'),
('608132','RP51','Bardet-Biedl syndrome 8, 209900 (3); Retinitis pigmentosa 51,'),
('608132','TTC8','Bardet-Biedl syndrome 8, 209900 (3); Retinitis pigmentosa 51,'),
('608135','ASPN','degeneration}, 603932 (3)'),
('608135','OS3','degeneration}, 603932 (3)'),
('608135','PLAP1','degeneration}, 603932 (3)'),
('608135','ASPN','{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc'),
('608135','OS3','{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc'),
('608135','PLAP1','{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc'),
('608136','ARHGEF10','Slowed nerve conduction velocity, AD, 608236 (3)'),
('608136','KIAA0294','Slowed nerve conduction velocity, AD, 608236 (3)'),
('608137','NELF','Hypogonadotropic hypogonadism, 146110 (3)'),
('608145','NIPA1','Spastic paraplegia 6, autosomal dominant, 600363 (3)'),
('608145','SPG6','Spastic paraplegia 6, autosomal dominant, 600363 (3)'),
('608148','KIAA1034','Cleft palate and mental retardation, 119540 (3)'),
('608148','SATB2','Cleft palate and mental retardation, 119540 (3)'),
('608151','ATD5','614377 (3); Cranioectodermal dysplasia 4, 614378 (3)'),
('608151','CED4','614377 (3); Cranioectodermal dysplasia 4, 614378 (3)'),
('608151','NPHP13','614377 (3); Cranioectodermal dysplasia 4, 614378 (3)'),
('608151','WDR19','614377 (3); Cranioectodermal dysplasia 4, 614378 (3)'),
('608151','ATD5','Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13,'),
('608151','CED4','Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13,'),
('608151','NPHP13','Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13,'),
('608151','WDR19','Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13,'),
('608156','C8DELq22.1','Nablus mask-like facial syndrome (4)'),
('608156','DEL8q22.1','Nablus mask-like facial syndrome (4)'),
('608156','NMLFS','Nablus mask-like facial syndrome (4)'),
('608160','CMD1','Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)'),
('608160','SOX9','Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)'),
('608160','SRA1','Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)'),
('608160','CMD1','Campomelic dysplasia with autosomal sex reversal, 114290 (3);'),
('608160','SOX9','Campomelic dysplasia with autosomal sex reversal, 114290 (3);'),
('608160','SRA1','Campomelic dysplasia with autosomal sex reversal, 114290 (3);'),
('608166','KIAA0331','CHARGE syndrome, 214800 (3)'),
('608166','SEMA3E','CHARGE syndrome, 214800 (3)'),
('608166','SEMAH','CHARGE syndrome, 214800 (3)'),
('608171','CACNA2D4','Retinal cone dystrophy 4, 610478 (3)'),
('608171','RCD4','Retinal cone dystrophy 4, 610478 (3)'),
('608172','DHDDS','Retinitis pigmentosa 59, 613861 (3)'),
('608172','HDS','Retinitis pigmentosa 59, 613861 (3)'),
('608172','RP59','Retinitis pigmentosa 59, 613861 (3)'),
('608173','AITD1','{Autoimmune thyroid disease, susceptibility to, 1} (2)'),
('608174','AITD2','{Autoimmune thyroid disease, susceptibility to, 2} (2)'),
('608176','AITD4','{Autoimmune thyroid disease, susceptibility to, 4} (2)'),
('608177','EXT1','Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)'),
('608179','ATCAY','Ataxia, cerebellar, Cayman type, 601238 (3)'),
('608179','CLAC','Ataxia, cerebellar, Cayman type, 601238 (3)'),
('608179','KIAA1872','Ataxia, cerebellar, Cayman type, 601238 (3)'),
('608181','ACP33','Mast syndrome, 248900 (3)'),
('608181','MAST','Mast syndrome, 248900 (3)'),
('608181','SPG21','Mast syndrome, 248900 (3)'),
('608183','CHSY1','Temtamy preaxial brachydactyly syndrome, 605282 (3)'),
('608183','KIAA0990','Temtamy preaxial brachydactyly syndrome, 605282 (3)'),
('608183','TPBS','Temtamy preaxial brachydactyly syndrome, 605282 (3)'),
('608201','CDK5RAP2','Microcephaly, primary autosomal recessive, 3, 604804 (3)'),
('608201','KIAA1633','Microcephaly, primary autosomal recessive, 3, 604804 (3)'),
('608201','MCPH3','Microcephaly, primary autosomal recessive, 3, 604804 (3)'),
('608204','IIAE1','Herpes simplex encephalitis, susceptibility to, 1, 610551 (3)'),
('608204','UNC93B1','Herpes simplex encephalitis, susceptibility to, 1, 610551 (3)'),
('608206','KIAA1985','Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of'),
('608206','MNMN','Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of'),
('608206','SH3TC2','Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of'),
('608206','KIAA1985','the median nerve, mild, 613353 (3)'),
('608206','MNMN','the median nerve, mild, 613353 (3)'),
('608206','SH3TC2','the median nerve, mild, 613353 (3)'),
('608207','KAZA','{Kala-azar, susceptibility to} (2)'),
('608210','EXT2','Exostoses, multiple, type 2, 133701 (3)'),
('608212','IBD19','Inflammatory bowel disease 19, 612278 (3)'),
('608212','IFI1','Inflammatory bowel disease 19, 612278 (3)'),
('608212','IRGM','Inflammatory bowel disease 19, 612278 (3)'),
('608212','LRG47','Inflammatory bowel disease 19, 612278 (3)'),
('608212','IBD19','{Mycobacterium tuberculosis, protection against}, 607948 (3);'),
('608212','IFI1','{Mycobacterium tuberculosis, protection against}, 607948 (3);'),
('608212','IRGM','{Mycobacterium tuberculosis, protection against}, 607948 (3);'),
('608212','LRG47','{Mycobacterium tuberculosis, protection against}, 607948 (3);'),
('608214','SCN3B','Brugada syndrome 7, 613120 (3)'),
('608214','SCNB3','Brugada syndrome 7, 613120 (3)'),
('608219','DFNB38','Deafness, autosomal recessive 38 (2)'),
('608220','SPG25','Spastic paraplegia 25, autosomal recessive (2)'),
('608221','FLJ14813','Thrombocytopenia-2, 188000 (3)'),
('608221','GWL','Thrombocytopenia-2, 188000 (3)'),
('608221','MASTL','Thrombocytopenia-2, 188000 (3)'),
('608221','THC2','Thrombocytopenia-2, 188000 (3)'),
('608222','ADSL','Adenylosuccinase deficiency, 103050 (3)'),
('608224','DFNA41','Deafness, autosomal dominant 41 (2)'),
('608241','PMRED','614501 (3)'),
('608241','SNIP1','614501 (3)'),
('608241','PMRED','Psychomotor retardation, epilepsy, and craniofacial dysmorphism,'),
('608241','SNIP1','Psychomotor retardation, epilepsy, and craniofacial dysmorphism,'),
('608244','OTSC3','Otosclerosis 3 (2)'),
('608248','HTSS2','of the scalp 2, 613981 (3)'),
('608248','K6IRS4','of the scalp 2, 613981 (3)'),
('608248','KRT6IRS4','of the scalp 2, 613981 (3)'),
('608248','KRT74','of the scalp 2, 613981 (3)'),
('608248','HTSS2','Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex'),
('608248','K6IRS4','Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex'),
('608248','KRT6IRS4','Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex'),
('608248','KRT74','Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex'),
('608251','PHOBS','Phobia, specific (2)'),
('608254','PACIP1','{Alzheimer disease, susceptibility to}, 104300 (3)'),
('608254','PAXIP1L','{Alzheimer disease, susceptibility to}, 104300 (3)'),
('608254','PTIP','{Alzheimer disease, susceptibility to}, 104300 (3)'),
('608256','SCN4B','Long QT syndrome-10, 611819 (3)'),
('608264','DFNB40','Deafness, autosomal recessive 40 (2)'),
('608272','NEU','Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)'),
('608272','NEU1','Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)'),
('608272','SIAL1','Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)'),
('608283','CFEOM1','Fibrosis of extraocular muscles, congenital, 1, 135700 (3);'),
('608283','CFEOM3B','Fibrosis of extraocular muscles, congenital, 1, 135700 (3);'),
('608283','FEOM1','Fibrosis of extraocular muscles, congenital, 1, 135700 (3);'),
('608283','KIAA1708','Fibrosis of extraocular muscles, congenital, 1, 135700 (3);'),
('608283','KIF21A','Fibrosis of extraocular muscles, congenital, 1, 135700 (3);'),
('608283','CFEOM1','Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)'),
('608283','CFEOM3B','Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)'),
('608283','FEOM1','Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)'),
('608283','KIAA1708','Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)'),
('608283','KIF21A','Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)'),
('608289','IGF2BP2','(3)'),
('608289','IMP2','(3)'),
('608289','IGF2BP2','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('608289','IMP2','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('608300','NAGS','N-acetylglutamate synthase deficiency, 237310 (3)'),
('608307','CPS1','Carbamoylphosphate synthetase I deficiency, 237300 (3); {Pulmonary'),
('608307','CPS1','hypertension, familial persistent, of the newborn}, 265380 (3); {Venoocclusive disease after bone marrow transplantation} (3)'),
('608309','PARK6','Parkinson disease 6, early onset, 605909 (3)'),
('608309','PINK1','Parkinson disease 6, early onset, 605909 (3)'),
('608310','ASL','Argininosuccinic aciduria, 207900 (3)'),
('608313','ARG1','Argininemia, 207800 (3)'),
('608316','CHDS2','{Coronary heart disease, susceptibility to, 2} (2)'),
('608318','CHDS4','{Coronary heart disease, susceptibility to, 4} (2)'),
('608331','PAT2','Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)'),
('608331','SLC36A2','Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)'),
('608345','NYS3','Nystagmus 3, congenital (2)'),
('608347','DCXR','Pentosuria, 260800 (1)'),
('608347','P34H','Pentosuria, 260800 (1)'),
('608348','BCKDHA','Maple syrup urine disease, type Ia, 248600 (3)'),
('608348','MSUD1','Maple syrup urine disease, type Ia, 248600 (3)'),
('608360','AGM5','Agammaglobulinemia 5, 613506 (3)'),
('608360','KIAA1437','Agammaglobulinemia 5, 613506 (3)'),
('608360','LRRC8A','Agammaglobulinemia 5, 613506 (3)'),
('608363','DUP22q11.2','Chromosome 22q11.2 microduplication syndrome (4)'),
('608366','KIAA1199','?Deafness, nonsyndromic (3)'),
('608367','MYP17','Myopia 17 (2)'),
('608367','MYP4','Myopia 17 (2)'),
('608371','OFC4','Orofacial cleft 4 (2)'),
('608372','DFNA49','Deafness, autosomal dominant 49 (2)'),
('608374','HFE2A','Hemochromatosis, type 2A, 602390 (3)'),
('608374','HJV','Hemochromatosis, type 2A, 602390 (3)'),
('608381','CERKL','Retinitis pigmentosa 26, 608380 (3)'),
('608381','RP26','Retinitis pigmentosa 26, 608380 (3)'),
('608391','AIS2','{Autoimmune disease, susceptibility to, 2} (2)'),
('608391','VAMAS3','{Autoimmune disease, susceptibility to, 2} (2)'),
('608392','AIS3','{Autoimmune disease, susceptibility to, 3} (2)'),
('608392','VAMAS4','{Autoimmune disease, susceptibility to, 3} (2)'),
('608394','DFNA43','Deafness, autosomal dominant 43 (2)'),
('608396','AUTS16','{Autism susceptibility 16}, 613410 (3)'),
('608396','SLC9A9','{Autism susceptibility 16}, 613410 (3)'),
('608400','RP39','(3)'),
('608400','USH2A','(3)'),
('608400','RP39','Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809'),
('608400','USH2A','Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809'),
('608410','BMIQ7','{Obesity, susceptibility to, BMIQ7} (2)'),
('608414','KIAA1516','Nephrotic syndrome, type 3, 610725 (3)'),
('608414','NPHS3','Nephrotic syndrome, type 3, 610725 (3)'),
('608414','PLCE1','Nephrotic syndrome, type 3, 610725 (3)'),
('608419','MCEE','Methylmalonyl-CoA epimerase deficiency, 251120 (3)'),
('608423','LGMD1F','Muscular dystrophy, limb-girdle, type 1F (2)'),
('608429','ATCS','Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)'),
('608429','CHST14','Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)'),
('608429','D4ST1','Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)'),
('608437','SLEB4','{Systemic lupus erythematosus, susceptibility to, 4} (2)'),
('608441','EDMD4','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','KIAA0796','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','KIAA1262','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','KIAA1756','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','SCAR8','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','SYNE1','Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)'),
('608441','EDMD4','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608441','KIAA0796','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608441','KIAA1262','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608441','KIAA1756','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608441','SCAR8','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608441','SYNE1','Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);'),
('608442','EDMD5','Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)'),
('608442','KIAA1011','Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)'),
('608442','NUANCE','Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)'),
('608442','SYNE2','Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)'),
('608445','SSD','{Speech-sound disorder} (2)'),
('608447','CIMT','Carotid intimal medial thickness (2)'),
('608448','IBD9','{Inflammatory bowel disease 9} (2)'),
('608451','D83198','Ethylmalonic encephalopathy, 602473 (3)'),
('608451','ETHE1','Ethylmalonic encephalopathy, 602473 (3)'),
('608451','HSCO','Ethylmalonic encephalopathy, 602473 (3)'),
('608455','PYGM','McArdle disease, 232600 (3)'),
('608462','HSCR8','{Hirschsprung disease, susceptibility to, 8} (2)'),
('608465','ALS4','4, juvenile, 602433 (3)'),
('608465','AOA2','4, juvenile, 602433 (3)'),
('608465','SCAR1','4, juvenile, 602433 (3)'),
('608465','SETX','4, juvenile, 602433 (3)'),
('608465','ALS4','Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis'),
('608465','AOA2','Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis'),
('608465','SCAR1','Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis'),
('608465','SETX','Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis'),
('608474','MYP5','Myopia 5 (2)'),
('608488','OAS','Microphthalmia with limb anomalies, 206920 (3)'),
('608488','SMOC1','Microphthalmia with limb anomalies, 206920 (3)'),
('608500','EPM1B','Epilepsy, progressive myoclonic 1B, 612437 (3)'),
('608500','PRICKLE1','Epilepsy, progressive myoclonic 1B, 612437 (3)'),
('608500','RILP','Epilepsy, progressive myoclonic 1B, 612437 (3)'),
('608501','EPM5','Epilepsy, progressive myoclonic 5, 613832 (3)'),
('608501','PRICKLE2','Epilepsy, progressive myoclonic 5, 613832 (3)'),
('608507','CMT2A2','and sensory neuropathy VI, 601152 (3)'),
('608507','KIAA0214','and sensory neuropathy VI, 601152 (3)'),
('608507','MFN2','and sensory neuropathy VI, 601152 (3)'),
('608507','CMT2A2','Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor'),
('608507','KIAA0214','Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor'),
('608507','MFN2','Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor'),
('608508','CYBA','233690 (3)'),
('608508','CYBA','Chronic granulomatous disease, autosomal, due to deficiency of CYBA,'),
('608512','NCF1','Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)'),
('608515','NCF2','Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)'),
('608520','MDD1','Major depressive disorder 1, 608516 (2)'),
('608526','PDON2','Periodontitis, aggressive, 2 (2)'),
('608537','VHL','somatic, 144700 (3); Pheochromocytoma, 171300 (3); Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3)'),
('608537','VHL','von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma,'),
('608539','GLIS2','Nephronophthisis 7, 611498 (3)'),
('608539','NPHP7','Nephronophthisis 7, 611498 (3)'),
('608542','ANIB2','Aneurysm, intracranial berry, 2 (2)'),
('608543','SCZD12','{Schizophrenia 12}, 181500 (2)'),
('608545','LRSL','Larsen-like syndrome (2)'),
('608547','FLJ00289','607473 (3); Warfarin resistance, 122700 (3)'),
('608547','VKCFD2','607473 (3); Warfarin resistance, 122700 (3)'),
('608547','VKOR','607473 (3); Warfarin resistance, 122700 (3)'),
('608547','VKORC1','607473 (3); Warfarin resistance, 122700 (3)'),
('608547','FLJ00289','Vitamin K-dependent clotting factors, combined deficiency of, 2,'),
('608547','VKCFD2','Vitamin K-dependent clotting factors, combined deficiency of, 2,'),
('608547','VKOR','Vitamin K-dependent clotting factors, combined deficiency of, 2,'),
('608547','VKORC1','Vitamin K-dependent clotting factors, combined deficiency of, 2,'),
('608548','ARMD1','{Macular degeneration, age-related, 1}, 603075 (3)'),
('608548','FBLN6','{Macular degeneration, age-related, 1}, 603075 (3)'),
('608548','FIBL6','{Macular degeneration, age-related, 1}, 603075 (3)'),
('608548','HMCN1','{Macular degeneration, age-related, 1}, 603075 (3)'),
('608552','VPS33B','Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)'),
('608553','LCA9','Leber congenital amaurosis 9 (2)'),
('608557','MCI2','{Myocardial infarction, susceptibility to, 2} (2)'),
('608558','BMIQ5','[Body mass index QTL5] (2)'),
('608559','BMIQ6','[Body mass index QTL6] (2)'),
('608562','PAPA4','Polydactyly, postaxial, type A4 (2)'),
('608568','DFNA4A','Deafness, autosomal dominant 4A, 600652 (3); Peripheral neuropathy,'),
('608568','KIAA2034','Deafness, autosomal dominant 4A, 600652 (3); Peripheral neuropathy,'),
('608568','MYH14','Deafness, autosomal dominant 4A, 600652 (3); Peripheral neuropathy,'),
('608568','PNMHH','Deafness, autosomal dominant 4A, 600652 (3); Peripheral neuropathy,'),
('608568','DFNA4A','myopathy, hoarseness, and hearing loss, 614369 (3)'),
('608568','KIAA2034','myopathy, hoarseness, and hearing loss, 614369 (3)'),
('608568','MYH14','myopathy, hoarseness, and hearing loss, 614369 (3)'),
('608568','PNMHH','myopathy, hoarseness, and hearing loss, 614369 (3)'),
('608576','DFNA28','Deafness, autosomal dominant 28, 608641 (3)'),
('608576','GRHL2','Deafness, autosomal dominant 28, 608641 (3)'),
('608576','TFCP2L3','Deafness, autosomal dominant 28, 608641 (3)'),
('608581','RP1L1','Occult macular dystrophy, 613587 (3)'),
('608583','ATFB1','Atrial fibrillation, familial, 1 (2)'),
('608586','KTCN3','Keratoconus 3 (2)'),
('608591','CMT2G','Charcot-Marie-Tooth disease, axonal, type 2G (2)'),
('608595','ASRT2','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608595','GPR154','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608595','GPRA','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608595','NPSR1','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608595','PGR14','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608595','VRR1','{Asthma, susceptibility to, 2}, 608584 (3)'),
('608614','BCD','Bietti crystalline corneoretinal dystrophy, 210370 (3)'),
('608614','CYP4V2','Bietti crystalline corneoretinal dystrophy, 210370 (3)'),
('608626','LYK5','Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)'),
('608626','STRAD','Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)'),
('608626','STRADA','Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)'),
('608630','HGPPS','Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)'),
('608630','RBIG1','Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)'),
('608630','RIG1','Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)'),
('608630','ROBO3','Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)'),
('608631','ASPG2','{Asperger syndrome susceptibility 2} (2)'),
('608633','CASP12','{Sepsis, susceptibility to} (3)'),
('608633','CASP12P1','{Sepsis, susceptibility to} (3)'),
('608636','AUTS4','{Autism susceptibility 4} (2)'),
('608638','ASPG1','{Asperger syndrome susceptibility 1} (2)'),
('608645','DFNA31','Deafness, autosomal dominant 31 (2)'),
('608646','CILD4','Ciliary dyskinesia, primary, 4 (2)'),
('608647','CILD5','Ciliary dyskinesia, primary, 5 (2)'),
('608648','SEC63','Polycystic liver disease, 174050 (3)'),
('608652','DFNA47','Deafness, autosomal dominant 47 (2)'),
('608652','DFNB83','Deafness, autosomal dominant 47 (2)'),
('608656','HPC3','{Prostate cancer, susceptibility to, 3}, 176807 (2)'),
('608658','HPC4','{Prostate cancer, susceptibility to, 4}, 176807 (2)'),
('608662','ANO5','Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy,'),
('608662','GDD1','Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy,'),
('608662','LGMD2L','Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy,'),
('608662','TMEM16E','Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy,'),
('608662','ANO5','limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)'),
('608662','GDD1','limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)'),
('608662','LGMD2L','limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)'),
('608662','TMEM16E','limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)'),
('608663','ANO6','Scott syndrome, 262890 (3)'),
('608663','BDPLT7','Scott syndrome, 262890 (3)'),
('608663','SCTS','Scott syndrome, 262890 (3)'),
('608663','TMEM16F','Scott syndrome, 262890 (3)'),
('608664','SCKL3','Seckel syndrome 3 (2)'),
('608665','GT198','Ovarian dysgenesis 3, 614324 (3)'),
('608665','HOP2','Ovarian dysgenesis 3, 614324 (3)'),
('608665','ODG3','Ovarian dysgenesis 3, 614324 (3)'),
('608665','PSMC3IP','Ovarian dysgenesis 3, 614324 (3)'),
('608665','TBPIP','Ovarian dysgenesis 3, 614324 (3)'),
('608666','PEX26','Adrenoleukodystrophy, neonatal, 202370 (3); Refsum disease,'),
('608666','PEX26','infantile, 266510 (3); Zellweger syndrome, 214100 (3)'),
('608667','CDLS1','Cornelia de Lange syndrome 1, 122470 (3)'),
('608667','NIPBL','Cornelia de Lange syndrome 1, 122470 (3)'),
('608687','C11DUPq12','Spinocerebellar ataxia 20 (4)'),
('608687','DUP11q12','Spinocerebellar ataxia 20 (4)'),
('608687','SCA20','Spinocerebellar ataxia 20 (4)'),
('608691','MDD2','Major depressive disorder 2, 608516 (2)'),
('608695','JOAG2','Glaucoma, primary open angle, juvenile-onset, 2 (2)'),
('608696','GLC1K','Glaucoma 1K, primary open angle, juvenile-onset (2)'),
('608696','JOAG3','Glaucoma 1K, primary open angle, juvenile-onset (2)'),
('608697','FIGLA','Premature ovarian failure 6, 612310 (3)'),
('608697','POF6','Premature ovarian failure 6, 612310 (3)'),
('608699','BMPER','Diaphanospondylodysostosis, 608022 (3)'),
('608699','CV2','Diaphanospondylodysostosis, 608022 (3)'),
('608703','SCA25','Spinocerebellar ataxia 25 (2)'),
('608706','DYX1','{Dyslexia, susceptibility to, 1}, 127700 (3)'),
('608706','DYX1C1','{Dyslexia, susceptibility to, 1}, 127700 (3)'),
('608706','DYXC1','{Dyslexia, susceptibility to, 1}, 127700 (3)'),
('608707','CDO','Holoprosencephaly 11, 614226 (3)'),
('608707','CDON','Holoprosencephaly 11, 614226 (3)'),
('608707','HPE11','Holoprosencephaly 11, 614226 (3)'),
('608710','WG','Wegener granulomatosis (2)'),
('608713','CYP2R1','Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)'),
('608735','SLC39A13','Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)'),
('608742','HYT4','{Hypertension, essential, susceptibility to, 4}, 145500 (2)'),
('608750','ALG3','Congenital disorder of glycosylation, type Id, 601110 (3)'),
('608750','CDG1D','Congenital disorder of glycosylation, type Id, 601110 (3)'),
('608750','CDGS4','Congenital disorder of glycosylation, type Id, 601110 (3)'),
('608750','NOT56L','Congenital disorder of glycosylation, type Id, 601110 (3)'),
('608752','C1QTNF5','Retinal degeneration, late-onset, autosomal dominant, 605670 (3)'),
('608752','CTRP5','Retinal degeneration, late-onset, autosomal dominant, 605670 (3)'),
('608752','LORD','Retinal degeneration, late-onset, autosomal dominant, 605670 (3)'),
('608753','PCH2B','Pontocerebellar hypoplasia type 2B, 612389 (3)'),
('608753','SEN2','Pontocerebellar hypoplasia type 2B, 612389 (3)'),
('608753','TSEN2','Pontocerebellar hypoplasia type 2B, 612389 (3)'),
('608754','LENG5','Pontocerebellar hypoplasia type 2C, 612390 (3)'),
('608754','PCH2C','Pontocerebellar hypoplasia type 2C, 612390 (3)'),
('608754','SEN34','Pontocerebellar hypoplasia type 2C, 612390 (3)'),
('608754','TSEN34','Pontocerebellar hypoplasia type 2C, 612390 (3)'),
('608755','PCH2A','hypoplasia type 4, 225753 (3)'),
('608755','PCH4','hypoplasia type 4, 225753 (3)'),
('608755','SEN54','hypoplasia type 4, 225753 (3)'),
('608755','TSEN54','hypoplasia type 4, 225753 (3)'),
('608755','PCH2A','Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar'),
('608755','PCH4','Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar'),
('608755','SEN54','Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar'),
('608755','TSEN54','Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar'),
('608762','EIG3','{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)'),
('608769','PDX1','Lacticacidemia due to PDX1 deficiency, 245349 (3)'),
('608770','DLAT','Pyruvate dehydrogenase E2 deficiency, 245348 (3)'),
('608770','PDCE2','Pyruvate dehydrogenase E2 deficiency, 245348 (3)'),
('608771','KIAA1025','Transposition of the great arteries, dextro-looped 1, 608808 (3)'),
('608771','MED13L','Transposition of the great arteries, dextro-looped 1, 608808 (3)'),
('608771','PROSIT240','Transposition of the great arteries, dextro-looped 1, 608808 (3)'),
('608771','THRAP2','Transposition of the great arteries, dextro-looped 1, 608808 (3)'),
('608771','TRAP240L','Transposition of the great arteries, dextro-looped 1, 608808 (3)'),
('608774','ANKK1','Dopamine receptor D2, reduced brain density of (3)'),
('608780','C6orf175','Trichothiodystrophy, complementation group A, 601675 (3)'),
('608780','GTF2H5','Trichothiodystrophy, complementation group A, 601675 (3)'),
('608780','TFB5','Trichothiodystrophy, complementation group A, 601675 (3)'),
('608780','TTDA','Trichothiodystrophy, complementation group A, 601675 (3)'),
('608781','ASPG3','{Asperger syndrome susceptibility 3} (2)'),
('608786','PC','Pyruvate carboxylase deficiency, 266150 (3)'),
('608787','OTSC5','Otosclerosis 5 (2)'),
('608792','DFNB15','Deafness, autosomal recessive 15, 601869 (3)'),
('608792','DFNB72','Deafness, autosomal recessive 15, 601869 (3)'),
('608792','DFNB95','Deafness, autosomal recessive 15, 601869 (3)'),
('608792','GIPC3','Deafness, autosomal recessive 15, 601869 (3)'),
('608796','MYMY3','Moyamoya disease 3 (3)'),
('608798','DFNA5','Deafness, autosomal dominant 5, 600994 (3)'),
('608801','GCDH','Glutaricaciduria, type I, 231670 (3)'),
('608803','CX47','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','GJA12','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','GJC2','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','HLD2','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','LMPH1C','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','PMLDAR','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','SPG44','Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic'),
('608803','CX47','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','GJA12','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','GJC2','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','HLD2','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','LMPH1C','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','PMLDAR','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608803','SPG44','paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)'),
('608815','EFHC1','{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)'),
('608815','EJA1','{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)'),
('608815','EJM1','{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)'),
('608815','FLJ10466','{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)'),
('608815','JAE','{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)'),
('608815','EFHC1','{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);'),
('608815','EJA1','{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);'),
('608815','EJM1','{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);'),
('608815','FLJ10466','{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);'),
('608815','JAE','{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);'),
('608816','EJM3','Epilepsy, juvenile myoclonic 3 (2)'),
('608829','IDDM5','{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)'),
('608829','SUMO4','{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)'),
('608830','LCA13','Leber congenital amaurosis 13, 612712 (3)'),
('608830','RDH12','Leber congenital amaurosis 13, 612712 (3)'),
('608831','RLS2','{Restless legs syndrome 2} (2)'),
('608845','ARL6','Bardet-Biedl syndrome 3, 209900 (3); {Bardet-Biedl syndrome 1,'),
('608845','BBS3','Bardet-Biedl syndrome 3, 209900 (3); {Bardet-Biedl syndrome 1,'),
('608845','RP55','Bardet-Biedl syndrome 3, 209900 (3); {Bardet-Biedl syndrome 1,'),
('608845','ARL6','modifier of}, 209900 (3); Retinitis pigmentosa 55, 613575 (3)'),
('608845','BBS3','modifier of}, 209900 (3); Retinitis pigmentosa 55, 613575 (3)'),
('608845','RP55','modifier of}, 209900 (3); Retinitis pigmentosa 55, 613575 (3)'),
('608850','MCDR3','Macular dystrophy, retinal, 3 (2)'),
('608852','PLF','{Pulmonary function} (2)'),
('608875','GEVQ1','{Gene expression, variation in, QTL} (2)'),
('608878','GEVQ2','{Gene expression, variation in, QTL} (2)'),
('608886','PERC','{Obesity, variation in}, 601665 (3)'),
('608886','PGC1B','{Obesity, variation in}, 601665 (3)'),
('608886','PPARGC1B','{Obesity, variation in}, 601665 (3)'),
('608892','CHD7','CHARGE syndrome, 214800 (3); {Scoliosis, idiopathic 3}, 608765 (3);'),
('608892','IS3','CHARGE syndrome, 214800 (3); {Scoliosis, idiopathic 3}, 608765 (3);'),
('608892','KAL5','CHARGE syndrome, 214800 (3); {Scoliosis, idiopathic 3}, 608765 (3);'),
('608892','CHD7','Kallmann syndrome 5, 612370 (3); Hypogonadotropic hypogonadism, 146110 (3)'),
('608892','IS3','Kallmann syndrome 5, 612370 (3); Hypogonadotropic hypogonadism, 146110 (3)'),
('608892','KAL5','Kallmann syndrome 5, 612370 (3); Hypogonadotropic hypogonadism, 146110 (3)'),
('608893','HND','Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3);'),
('608893','SLC6A19','Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3);'),
('608893','HND','Hyperglycinuria, 138500 (3)'),
('608893','SLC6A19','Hyperglycinuria, 138500 (3)'),
('608894','AHI1','Joubert syndrome-3, 608629 (3)'),
('608896','DMDA1','Muscular dystrophy, limb-girdle, type 2C, 253700 (3)'),
('608896','LGMD2C','Muscular dystrophy, limb-girdle, type 2C, 253700 (3)'),
('608896','SCG3','Muscular dystrophy, limb-girdle, type 2C, 253700 (3)'),
('608896','SGCG','Muscular dystrophy, limb-girdle, type 2C, 253700 (3)'),
('608897','FHL3','Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)'),
('608897','HLH3','Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)'),
('608897','HPLH3','Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)'),
('608897','MUNC13-4','Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)'),
('608897','UNC13D','Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)'),
('608903','ADHD1','{Attention deficit-hyperactivity disorder}, 143465 (2)'),
('608904','ADHD2','{Attention deficit-hyperactivity disorder}, 143465 (2)'),
('608905','ADHD3','{Attention deficit-hyperactivity disorder}, 143465 (2)'),
('608906','ADHD4','{Attention deficit-hyperactivity disorder}, 143465 (2)'),
('608907','AD9','{Alzheimer disease 9, late onset, susceptibility to}, 104300 (2)'),
('608908','MYP6','Myopia-6 (2)'),
('608918','ATP12','604273 (3)'),
('608918','ATPAF2','604273 (3)'),
('608918','MC5DN1','604273 (3)'),
('608918','ATP12','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,'),
('608918','ATPAF2','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,'),
('608918','MC5DN1','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,'),
('608921','CORD5','Cone-rod dystrophy 5, 600977 (3)'),
('608921','NIR1','Cone-rod dystrophy 5, 600977 (3)'),
('608921','PITPNM3','Cone-rod dystrophy 5, 600977 (3)'),
('608922','ARL13B','Joubert syndrome 8, 612291 (3)'),
('608922','ARL2L1','Joubert syndrome 8, 612291 (3)'),
('608922','JBTS8','Joubert syndrome 8, 612291 (3)'),
('608932','KTCN2','Keratoconus 2 (2)'),
('608935','LNCR1','{Lung cancer susceptibility} (2)'),
('608944','BNAR','Bifid nose with or without anorectal and renal anomalies, 608980 (3);'),
('608944','C9orf154','Bifid nose with or without anorectal and renal anomalies, 608980 (3);'),
('608944','FREM1','Bifid nose with or without anorectal and renal anomalies, 608980 (3);'),
('608944','MOTA','Bifid nose with or without anorectal and renal anomalies, 608980 (3);'),
('608944','TRIGNO2','Bifid nose with or without anorectal and renal anomalies, 608980 (3);'),
('608944','BNAR','Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)'),
('608944','C9orf154','Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)'),
('608944','FREM1','Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)'),
('608944','MOTA','Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)'),
('608944','TRIGNO2','Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)'),
('608945','FREM2','Fraser syndrome, 219000 (3)'),
('608958','ADA','Adenosine deaminase deficiency, partial, 102700 (3)'),
('608958','ADA','Severe combined immunodeficiency due to ADA deficiency, 102700 (3);'),
('608965','CABP4','Night blindness, congenital stationary, type 2B, 610427 (3)'),
('608965','CSNB2B','Night blindness, congenital stationary, type 2B, 610427 (3)'),
('608968','KRML','Multicentric carpotarsal osteolysis syndrome, 166300 (3)'),
('608968','MAFB','Multicentric carpotarsal osteolysis syndrome, 166300 (3)'),
('608968','MCTO','Multicentric carpotarsal osteolysis syndrome, 166300 (3)'),
('608977','DNAJC19','3-methylglutaconic aciduria, type V, 610198 (3)'),
('608977','TIM14','3-methylglutaconic aciduria, type V, 610198 (3)'),
('608982','STQTL5','{Stature QTL 5} (2)'),
('608984','ADSA','Ataxia, sensory, autosomal dominant (2)'),
('608984','SNAX1','Ataxia, sensory, autosomal dominant (2)'),
('608988','ATFB2','Atrial fibrillation, familial, 2 (2)'),
('608990','ADAMTS10','Weill-Marchesani syndrome 1, recessive, 277600 (3)'),
('608990','WMS1','Weill-Marchesani syndrome 1, recessive, 277600 (3)'),
('608995','DYX8','{Dyslexia, susceptibility to, 8} (2)'),
('609007','LRRK2','Parkinson disease-8, 607060 (3)'),
('609007','PARK8','Parkinson disease-8, 607060 (3)'),
('609010','MCCA','3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)'),
('609010','MCCC1','3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)'),
('609014','MCCB','3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)'),
('609014','MCCC2','3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)'),
('609017','ERMAP','111620 (3)'),
('609017','RD','111620 (3)'),
('609017','SC','111620 (3)'),
('609017','ERMAP','[Blood group, Scianna system], 111750 (3); [Blood group, Radin],'),
('609017','RD','[Blood group, Scianna system], 111750 (3); [Blood group, Radin],'),
('609017','SC','[Blood group, Scianna system], 111750 (3); [Blood group, Radin],'),
('609018','HCS','Holocarboxylase synthetase deficiency, 253270 (3)'),
('609018','HLCS','Holocarboxylase synthetase deficiency, 253270 (3)'),
('609019','BTD','Biotinidase deficiency, 253260 (3)'),
('609023','BRP17','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','DYT8','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','FPD1','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','KIPP1184','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','MR1','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','PDC','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','PNKD','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609023','TAHCCP2','Paroxysmal nonkinesigenic dyskinesia, 118800 (3)'),
('609025','K6HF','{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)'),
('609025','KRT75','{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)'),
('609025','PFB','{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)'),
('609026','ARCC1','{Cataract, age-related cortical, susceptibility to} (2)'),
('609029','DER22t11-22','Emanuel syndrome (4)'),
('609039','NRCLP3','Narcolepsy 3 (2)'),
('609041','SPG27','Spastic paraplegia 27, autosomal recessive (2)'),
('609044','BMIQ10','{Obesity, susceptibility to}, 607514 (3)'),
('609044','GPR120','{Obesity, susceptibility to}, 607514 (3)'),
('609044','O3FAR1','{Obesity, susceptibility to}, 607514 (3)'),
('609044','PGR4','{Obesity, susceptibility to}, 607514 (3)'),
('609058','MCM','Methylmalonic aciduria, mut(0) type, 251000 (3)'),
('609058','MUT','Methylmalonic aciduria, mut(0) type, 251000 (3)'),
('609059','ATGL','Neutral lipid storage disease with myopathy, 610717 (3)'),
('609059','PNPLA2','Neutral lipid storage disease with myopathy, 610717 (3)'),
('609059','TTS2','Neutral lipid storage disease with myopathy, 610717 (3)'),
('609062','POU6F2','{Wilms tumor susceptibility-5}, 601583 (3)'),
('609062','WT5','{Wilms tumor susceptibility-5}, 601583 (3)'),
('609062','WTSL','{Wilms tumor susceptibility-5}, 601583 (3)'),
('609103','BMND12','[Bone mineral density QTL 12], 612560 (3)'),
('609103','FBX33','[Bone mineral density QTL 12], 612560 (3)'),
('609103','FBXO33','[Bone mineral density QTL 12], 612560 (3)'),
('609113','TELM','[Telomere length, mean leukocyte] (2)'),
('609115','LGMD1G','Limb-girdle muscular dystrophy, type 1G (2)'),
('609116','RRIS','[Respiratory rhythmicity in sleep] (2)'),
('609118','CCM3','Cerebral cavernous malformations 3, 603285 (3)'),
('609118','PDCD10','Cerebral cavernous malformations 3, 603285 (3)'),
('609118','TFAR15','Cerebral cavernous malformations 3, 603285 (3)'),
('609122','ANIB3','Aneurysm, intracranial berry, 3 (2)'),
('609139','C2ORF23','Spastic paraplegia 31, autosomal dominant, 610250 (3)'),
('609139','REEP1','Spastic paraplegia 31, autosomal dominant, 610250 (3)'),
('609139','SPG31','Spastic paraplegia 31, autosomal dominant, 610250 (3)'),
('609144','AXPC1','Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)'),
('609144','FLVCR1','Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)'),
('609144','PCARP','Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)'),
('609153','PSHK2','Pseudohyperkalemia, familial, 2, due to red cell leak (2)'),
('609160','ARVC7','Arrhythmogenic right ventricular dysplasia 7 (2)'),
('609160','ARVD7','Arrhythmogenic right ventricular dysplasia 7 (2)'),
('609179','MGR7','{Migraine with aura, susceptibility to, 7} (2)'),
('609186','D2HGD','D-2-hydroxyglutaric aciduria, 600721 (3)'),
('609186','D2HGDH','D-2-hydroxyglutaric aciduria, 600721 (3)'),
('609187','C7orf10','[Glutaric aciduria III], 231690 (3)'),
('609188','ABHS','Trichothiodystrophy, nonphotosensitive 1, 234050 (3)'),
('609188','C7orf11','Trichothiodystrophy, nonphotosensitive 1, 234050 (3)'),
('609188','TTDN1','Trichothiodystrophy, nonphotosensitive 1, 234050 (3)'),
('609195','SPG26','Spastic paraplegia 26, autosomal recessive (2)'),
('609196','C21orf61','Glucocorticoid deficiency 2, 607398 (3)'),
('609196','FALP','Glucocorticoid deficiency 2, 607398 (3)'),
('609196','FGD2','Glucocorticoid deficiency 2, 607398 (3)'),
('609196','GCCD2','Glucocorticoid deficiency 2, 607398 (3)'),
('609196','MRAP','Glucocorticoid deficiency 2, 607398 (3)'),
('609197','FGD3','Glucocorticoid deficiency 3 (2)'),
('609197','GCCD2','Glucocorticoid deficiency 3 (2)'),
('609197','GCCD3','Glucocorticoid deficiency 3 (2)'),
('609204','COXPD2','Combined oxidative phosphorylation deficiency 2, 610498 (3)'),
('609204','MRPS16','Combined oxidative phosphorylation deficiency 2, 610498 (3)'),
('609218','FHASD','Foveal hypoplasia and anterior segment dysgenesis (2)'),
('609237','IQCB1','Senior-Loken syndrome 5, 609254 (3)'),
('609237','KIAA0036','Senior-Loken syndrome 5, 609254 (3)'),
('609237','NPHP5','Senior-Loken syndrome 5, 609254 (3)'),
('609239','ARWH1','Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,'),
('609239','LAH3','Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,'),
('609239','LPAR6','Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,'),
('609239','P2RY5','Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,'),
('609239','P2Y5','Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,'),
('609239','ARWH1','with or without hypotrichosis, 278150 (3)'),
('609239','LAH3','with or without hypotrichosis, 278150 (3)'),
('609239','LPAR6','with or without hypotrichosis, 278150 (3)'),
('609239','P2RY5','with or without hypotrichosis, 278150 (3)'),
('609239','P2Y5','with or without hypotrichosis, 278150 (3)'),
('609245','DFNB82','Deafness, autosomal recessive 82, 613557 (3)'),
('609245','GPSM2','Deafness, autosomal recessive 82, 613557 (3)'),
('609245','LGN','Deafness, autosomal recessive 82, 613557 (3)'),
('609245','PINS','Deafness, autosomal recessive 82, 613557 (3)'),
('609252','LIPI','{Hypertriglyceridemia, susceptibility to}, 145750 (3)'),
('609252','LPDL','{Hypertriglyceridemia, susceptibility to}, 145750 (3)'),
('609252','PRED5','{Hypertriglyceridemia, susceptibility to}, 145750 (3)'),
('609253','FEB6','Febrile seizures, familial, 6 (2)'),
('609255','FEB5','Febrile seizures, familial, 5 (2)'),
('609256','MYP7','Myopia 7 (2)'),
('609257','MYP8','Myopia 8 (2)'),
('609258','MYP9','Myopia 9 (2)'),
('609259','MYP10','Myopia 10 (2)'),
('609261','STUT2','Stuttering, familial persistent 2 (2)'),
('609262','CRBN','Mental retardation, autosomal recessive 2, 607417 (3)'),
('609262','MRT2','Mental retardation, autosomal recessive 2, 607417 (3)'),
('609266','LFS3','Li-Fraumeni syndrome 3 (2)'),
('609269','DLX2','{Dyslexia, susceptibility to, 2}, 600202 (3)'),
('609269','DYLX2','{Dyslexia, susceptibility to, 2}, 600202 (3)'),
('609269','DYX2','{Dyslexia, susceptibility to, 2}, 600202 (3)'),
('609269','KIAA0319','{Dyslexia, susceptibility to, 2}, 600202 (3)'),
('609270','SCAR7','Spinocerebellar ataxia, autosomal recessive 7 (2)'),
('609271','KTCN4','Keratoconus 4 (2)'),
('609275','KIAA0839','Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)'),
('609275','p150','Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)'),
('609275','RAB3GAP150','Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)'),
('609275','RAB3GAP2','Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)'),
('609275','WARBM2','Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)'),
('609279','CENPJ','Microcephaly, primary autosomal recessive, 6, 608393 (3);'),
('609279','CPAP','Microcephaly, primary autosomal recessive, 6, 608393 (3);'),
('609279','MCPH6','Microcephaly, primary autosomal recessive, 6, 608393 (3);'),
('609279','SCKL4','Microcephaly, primary autosomal recessive, 6, 608393 (3);'),
('609279','CENPJ','Seckel syndrome 4, 613676 (3)'),
('609279','CPAP','Seckel syndrome 4, 613676 (3)'),
('609279','MCPH6','Seckel syndrome 4, 613676 (3)'),
('609279','SCKL4','Seckel syndrome 4, 613676 (3)'),
('609291','NFLS','Legius syndrome, 611431 (3)'),
('609291','SPRED1','Legius syndrome, 611431 (3)'),
('609299','HPC5','{Prostate cancer, hereditary, 5}, 176807 (2)'),
('609300','CYP17','17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase'),
('609300','CYP17A1','17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase'),
('609300','P450C17','17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase'),
('609300','CYP17','deficiency, isolated, 202110 (3)'),
('609300','CYP17A1','deficiency, isolated, 202110 (3)'),
('609300','P450C17','deficiency, isolated, 202110 (3)'),
('609302','EIEE3','Epileptic encephalopathy, early infantile, 3, 609304 (3)'),
('609302','GC1','Epileptic encephalopathy, early infantile, 3, 609304 (3)'),
('609302','SLC25A22','Epileptic encephalopathy, early infantile, 3, 609304 (3)'),
('609306','SCA26','Spinocerebellar ataxia 26 (2)'),
('609309','COCA1','Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);'),
('609309','FCC1','Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);'),
('609309','HNPCC1','Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);'),
('609309','MSH2','Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);'),
('609309','COCA1','Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('609309','FCC1','Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('609309','HNPCC1','Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('609309','MSH2','Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)'),
('609312','DBH','Dopamine beta-hydroxylase deficiency, 223360 (3)'),
('609312','DBH','[Dopamine-beta-hydroxylase activity levels, plasma] (3);'),
('609313','EKV3','Erythrokeratodermia variabilis 3 (2)'),
('609319','HCHGQ1','[Hematocrit/hemoglobin quantitative trait locus 1] (2)'),
('609320','HCHGQ2','[Hematocrit/hemoglobin quantitative trait locus 2] (2)'),
('609334','DUP18pDEL18q','Chromosome 18 pericentric inversion (4)'),
('609334','DUP81qDEL18p','Chromosome 18 pericentric inversion (4)'),
('609340','SPG28','Spastic paraplegia 28, autosomal recessive (2)'),
('609342','GIF','Intrinsic factor deficiency, 261000 (3)'),
('609342','IF','Intrinsic factor deficiency, 261000 (3)'),
('609353','ESCO2','Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)'),
('609354','BMND5','[Bone mineral density QTL 5] (2)'),
('609367','KIAA1279','Goldberg-Shprintzen megacolon syndrome, 609460 (3)'),
('609376','CATCN1','Cataract, congenital nuclear, 1 (2)'),
('609378','AUTS6','{Autism susceptibility 6} (2)'),
('609382','IER3IP1','Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)'),
('609382','MEDS','Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)'),
('609383','ICHYN','Ichthyosis, congenital, autosomal recessive, 612281 (3)'),
('609383','NIPAL4','Ichthyosis, congenital, autosomal recessive, 612281 (3)'),
('609384','CFEOM3C','Fibrosis of extraocular muscles, congenital, 3C (2)'),
('609384','FEOM4','Fibrosis of extraocular muscles, congenital, 3C (2)'),
('609390','ALS11','Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral'),
('609390','FIG4','Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral'),
('609390','KIAA0274','Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral'),
('609390','SAC3','Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral'),
('609390','ALS11','sclerosis 11, 612577 (3)'),
('609390','FIG4','sclerosis 11, 612577 (3)'),
('609390','KIAA0274','sclerosis 11, 612577 (3)'),
('609390','SAC3','sclerosis 11, 612577 (3)'),
('609397','PEE4','Preeclampsia/eclampsia 4, 609404 (3)'),
('609397','STOX1','Preeclampsia/eclampsia 4, 609404 (3)'),
('609400','AIS4','{Autoimmune disease, susceptibility to, 4} (2)'),
('609400','VAMAS5','{Autoimmune disease, susceptibility to, 4} (2)'),
('609402','PEE2','Preeclampsia/eclampsia 2 (2)'),
('609403','PEE3','Preeclampsia/eclampsia 3 (2)'),
('609408','HPE8','Holoprosencephaly-8 (2)'),
('609412','CKN1','Cockayne syndrome, type A, 216400 (3)'),
('609412','CSA','Cockayne syndrome, type A, 216400 (3)'),
('609412','ERCC8','Cockayne syndrome, type A, 216400 (3)'),
('609413','ARMD5','Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal'),
('609413','CKN2','Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal'),
('609413','COFS1','Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal'),
('609413','CSB','Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal'),
('609413','ERCC6','Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal'),
('609413','ARMD5','syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive'),
('609413','CKN2','syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive'),
('609413','COFS1','syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive'),
('609413','CSB','syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive'),
('609413','ERCC6','syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive'),
('609413','ARMD5','syndrome, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)'),
('609413','CKN2','syndrome, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)'),
('609413','COFS1','syndrome, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)'),
('609413','CSB','syndrome, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)'),
('609413','ERCC6','syndrome, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)'),
('609414','PIKFYVE','Corneal fleck dystrophy, 121850 (3)'),
('609414','PIP5K3','Corneal fleck dystrophy, 121850 (3)'),
('609415','C13orf25','Feingold syndrome 2, 614326 (3)'),
('609415','FGLDS2','Feingold syndrome 2, 614326 (3)'),
('609415','MIHG1','Feingold syndrome 2, 614326 (3)'),
('609415','MIR17HG','Feingold syndrome 2, 614326 (3)'),
('609415','MIRH1','Feingold syndrome 2, 614326 (3)'),
('609415','MIRHG1','Feingold syndrome 2, 614326 (3)'),
('609425','DEL3q29','Chromosome 3q29 microdeletion syndrome (4)'),
('609425','MICRODEL3q29','Chromosome 3q29 microdeletion syndrome (4)'),
('609427','DFNB67','Deafness, autosomal recessive 67, 610265 (3)'),
('609427','LHFPL5','Deafness, autosomal recessive 67, 610265 (3)'),
('609427','TMHS','Deafness, autosomal recessive 67, 610265 (3)'),
('609428','TUKLS','Tukel syndrome (2)'),
('609435','GRIM19','{Thyroid carcinoma, Hurthle cell}, 607464 (3)'),
('609435','NDUFA13','{Thyroid carcinoma, Hurthle cell}, 607464 (3)'),
('609449','LIS4','Lissencephaly 4 (with microcephaly), 614019 (3)'),
('609449','NDE1','Lissencephaly 4 (with microcephaly), 614019 (3)'),
('609449','NUDE','Lissencephaly 4 (with microcephaly), 614019 (3)'),
('609454','PSNP2','Supranuclear palsy, progressive, 2 (2)'),
('609456','MDCMP','Muscular dystrophy, congenital, merosin-positive (2)'),
('609457','HAL','[Histidinemia], 235800 (3)'),
('609457','HSTD','[Histidinemia], 235800 (3)'),
('609458','MAN2B1','Mannosidosis, alpha-, types I and II, 248500 (3)'),
('609458','MANB','Mannosidosis, alpha-, types I and II, 248500 (3)'),
('609469','NEDE','Nephropathy, progressive, with deafness (2)'),
('609470','LVNC2','Left ventricular noncompaction 2 (2)'),
('609489','MANB1','Mannosidosis, beta, 248510 (3)'),
('609489','MANBA','Mannosidosis, beta, 248510 (3)'),
('609502','CDHR1','Cone-rod dystrophy 15, 613660 (3)'),
('609502','CORD15','Cone-rod dystrophy 15, 613660 (3)'),
('609502','PCDH21','Cone-rod dystrophy 15, 613660 (3)'),
('609502','PRCAD','Cone-rod dystrophy 15, 613660 (3)'),
('609506','CYP27B1','Vitamin D-dependent rickets, type I, 264700 (3)'),
('609506','PDDR','Vitamin D-dependent rickets, type I, 264700 (3)'),
('609506','VDD1','Vitamin D-dependent rickets, type I, 264700 (3)'),
('609507','LUN','Retinitis pigmentosa 31, 609923 (3)'),
('609507','P53BP3','Retinitis pigmentosa 31, 609923 (3)'),
('609507','RP31','Retinitis pigmentosa 31, 609923 (3)'),
('609507','TOPORS','Retinitis pigmentosa 31, 609923 (3)'),
('609510','GLMR','Amyloidosis, primary localized cutaneous, 2, 613955 (3)'),
('609510','GPL','Amyloidosis, primary localized cutaneous, 2, 613955 (3)'),
('609510','IL31RA','Amyloidosis, primary localized cutaneous, 2, 613955 (3)'),
('609510','PLCA2','Amyloidosis, primary localized cutaneous, 2, 613955 (3)'),
('609512','CHMP2B','Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral'),
('609512','DMT1','Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral'),
('609512','VPS2B','Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral'),
('609512','CHMP2B','sclerosis, CHMP2B-related (3)'),
('609512','DMT1','sclerosis, CHMP2B-related (3)'),
('609512','VPS2B','sclerosis, CHMP2B-related (3)'),
('609520','DYT6','Dystonia 6, torsion, 602629 (3)'),
('609520','THAP1','Dystonia 6, torsion, 602629 (3)'),
('609523','ALDH10','Sjogren-Larsson syndrome, 270200 (3)'),
('609523','ALDH3A2','Sjogren-Larsson syndrome, 270200 (3)'),
('609523','FALDH','Sjogren-Larsson syndrome, 270200 (3)'),
('609523','SLS','Sjogren-Larsson syndrome, 270200 (3)'),
('609541','SPOAN','Spastic paraplegia, optic atrophy, and neuropathy (2)'),
('609558','HPC6','{Prostate cancer, susceptibility to}, 176807 (2)'),
('609562','CPA6','Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures,'),
('609562','CPAH','Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures,'),
('609562','ETL5','Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures,'),
('609562','FEB11','Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures,'),
('609562','CPA6','familial, 11, 614418 (3)'),
('609562','CPAH','familial, 11, 614418 (3)'),
('609562','ETL5','familial, 11, 614418 (3)'),
('609562','FEB11','familial, 11, 614418 (3)'),
('609570','MGR8','{Migraine, susceptibility to, 8} (2)'),
('609572','PPR2','Photoparoxysmal response 2 (2)'),
('609573','PPR3','Photoparoxysmal response 3 (2)'),
('609575','ACADVL','VLCAD deficiency, 201475 (3)'),
('609575','VLCAD','VLCAD deficiency, 201475 (3)'),
('609577','CUL7','3-M syndrome 1, 273750 (3)'),
('609578','RCM2','Cardiomyopathy, familial restrictive, 2 (2)'),
('609584','C14orf160','L-2-hydroxyglutaric aciduria, 236792 (3)'),
('609584','L2HGDH','L-2-hydroxyglutaric aciduria, 236792 (3)'),
('609588','C14orf87','205950 (3)'),
('609588','FLB4739','205950 (3)'),
('609588','GLRX5','205950 (3)'),
('609588','PRO1238','205950 (3)'),
('609588','C14orf87','Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,'),
('609588','FLB4739','Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,'),
('609588','GLRX5','Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,'),
('609588','PRO1238','Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,'),
('609595','FLJ40906','and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)'),
('609595','RSPO1','and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)'),
('609595','FLJ40906','Palmoplantar hyperkeratosis with squamous cell carcinoma of skin'),
('609595','RSPO1','Palmoplantar hyperkeratosis with squamous cell carcinoma of skin'),
('609607','EDSS1','Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)'),
('609607','PRR4','Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)'),
('609607','PVRL4','Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)'),
('609625','C10q26DEL','Chromosome 10q26 deletion syndrome (4)'),
('609625','DEL10q26','Chromosome 10q26 deletion syndrome (4)'),
('609630','CLLS1','{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)'),
('609633','BPEO','{Major affective disorder 3, early onset} (2)'),
('609633','MAFD3','{Major affective disorder 3, early onset} (2)'),
('609636','AD10','Alzheimer disease-10, 104300 (2)'),
('609644','FANCM','Fanconi anemia, complementation group M, 614087 (3)'),
('609644','KIAA1596','Fanconi anemia, complementation group M, 614087 (3)'),
('609647','DFNB46','Deafness, autosomal recessive 46 (2)'),
('609648','FCAS2','Familial cold autoinflammatory syndrome 2, 611762 (3)'),
('609648','NALP12','Familial cold autoinflammatory syndrome 2, 611762 (3)'),
('609648','PYPAF7','Familial cold autoinflammatory syndrome 2, 611762 (3)'),
('609648','RNO','Familial cold autoinflammatory syndrome 2, 611762 (3)'),
('609649','TRICY1','Trichilemmal cyst 1 (2)'),
('609653','B17.2L','256000 (3)'),
('609653','MMTN','256000 (3)'),
('609653','NDUFA12L','256000 (3)'),
('609653','NDUFAF2','256000 (3)'),
('609653','B17.2L','Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome,'),
('609653','MMTN','Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome,'),
('609653','NDUFA12L','Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome,'),
('609653','NDUFAF2','Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome,'),
('609656','BSZQTL','{Bone size QTL} (2)'),
('609657','BSZQTL2','{Bone size QTL} (2)'),
('609661','HYDM','Hydatidiform mole, 231090 (3)'),
('609661','NALP7','Hydatidiform mole, 231090 (3)'),
('609661','NOD12','Hydatidiform mole, 231090 (3)'),
('609661','PYPAF3','Hydatidiform mole, 231090 (3)'),
('609669','GLC1G','Glaucoma 1, open angle, G, 609887 (3)'),
('609669','TAWDRP','Glaucoma 1, open angle, G, 609887 (3)'),
('609669','WDR36','Glaucoma 1, open angle, G, 609887 (3)'),
('609670','MGR9','{Migraine with aura, susceptibility to, 9} (2)'),
('609678','KIAA1910','Tourette syndrome, 137580 (3); Trichotillomania, 613229 (3)'),
('609678','SLITRK1','Tourette syndrome, 137580 (3); Trichotillomania, 613229 (3)'),
('609678','TTM','Tourette syndrome, 137580 (3); Trichotillomania, 613229 (3)'),
('609695','HPD','Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)'),
('609701','MPS3B','Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)'),
('609701','NAGLU','Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)'),
('609708','HDLCQ11','familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11] (3)'),
('609708','LIPD','familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11] (3)'),
('609708','LPL','familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11] (3)'),
('609708','HDLCQ11','Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia,'),
('609708','LIPD','Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia,'),
('609708','LPL','Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia,'),
('609712','PK1','elevated, of erythrocytes, 102900 (3)'),
('609712','PKLR','elevated, of erythrocytes, 102900 (3)'),
('609712','PK1','Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate,'),
('609712','PKLR','Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate,'),
('609727','SPG29','Spastic paraplegia 29, autosomal dominant (2)'),
('609739','DFNB42','Deafness, autosomal recessive 42, 609646 (3)'),
('609739','ILDR1','Deafness, autosomal recessive 42, 609646 (3)'),
('609745','GLC1I','Glaucoma 1, open angle, I (2)'),
('609750','EIG4','Epilepsy, idiopathic generalized, susceptibility to 4 (2)'),
('609751','ACOX','Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)'),
('609751','ACOX1','Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)'),
('609751','SCOX','Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)'),
('609754','CELIAC2','{Celiac disease, susceptibility to, 2} (2)'),
('609757','C7DUPq11.23','Chromosome 7q11.23 duplication syndrome (4)'),
('609757','DUP7q11.23','Chromosome 7q11.23 duplication syndrome (4)'),
('609761','KIAA1662','Deafness, autosomal recessive 28, 609823 (3)'),
('609761','TRIOBP','Deafness, autosomal recessive 28, 609823 (3)'),
('609762','BLOC1S3','Hermansky-Pudlak syndrome 8, 614077 (3)'),
('609762','BLOS3','Hermansky-Pudlak syndrome 8, 614077 (3)'),
('609762','HPS8','Hermansky-Pudlak syndrome 8, 614077 (3)'),
('609782','AAA2','Aortic aneurysm, familial abdominal 2 (2)'),
('609790','AD11','Alzheimer disease-11 (2)'),
('609799','JCK','Nephronophthisis 9, 613824 (3)'),
('609799','NEK8','Nephronophthisis 9, 613824 (3)'),
('609799','NPHP9','Nephronophthisis 9, 613824 (3)'),
('609800','GEFSP4','Epilepsy, generalized, with febrile seizures plus, type 4 (2)'),
('609802','NCKX5','[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)'),
('609802','SHEP4','[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)'),
('609802','SLC24A5','[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)'),
('609806','HMBS','intermittent, nonerythroid variant, 176000 (3)'),
('609806','PBGD','intermittent, nonerythroid variant, 176000 (3)'),
('609806','UPS','intermittent, nonerythroid variant, 176000 (3)'),
('609806','HMBS','Porphyria, acute intermittent, 176000 (3); Porphyria, acute'),
('609806','PBGD','Porphyria, acute intermittent, 176000 (3); Porphyria, acute'),
('609806','UPS','Porphyria, acute intermittent, 176000 (3); Porphyria, acute'),
('609815','ZD1','Zygodactyly 1 (2)'),
('609822','STQTL7','{Stature QTL 7} (2)'),
('609825','COQ2','Coenzyme Q10 deficiency, 607426 (3)'),
('609826','HHRH','Hypophosphatemic rickets with hypercalciuria, 241530 (3)'),
('609826','NPTIIC','Hypophosphatemic rickets with hypercalciuria, 241530 (3)'),
('609826','SLC34A3','Hypophosphatemic rickets with hypercalciuria, 241530 (3)'),
('609831','MMACHC','Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)'),
('609840','NCKX4','[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3);'),
('609840','SHEP6','[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3);'),
('609840','SLC24A4','[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3);'),
('609840','NCKX4','[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)'),
('609840','SHEP6','[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)'),
('609840','SLC24A4','[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)'),
('609845','SI','Sucrase-isomaltase deficiency, congenital, 222900 (3)'),
('609856','SPATA16','Spermatogenic failure 6, 102530 (3)'),
('609856','SPGF6','Spermatogenic failure 6, 102530 (3)'),
('609862','IRIDA','Iron-refractory iron deficiency anemia, 206200 (3)'),
('609862','TMPRSS6','Iron-refractory iron deficiency anemia, 206200 (3)'),
('609863','JBTS13','Joubert syndrome 13, 614173 (3)'),
('609863','TECT1','Joubert syndrome 13, 614173 (3)'),
('609868','HSD3','juvenile, autosomal recessive, 268000 (3)'),
('609868','LCA3','juvenile, autosomal recessive, 268000 (3)'),
('609868','SPATA7','juvenile, autosomal recessive, 268000 (3)'),
('609868','HSD3','Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa,'),
('609868','LCA3','Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa,'),
('609868','SPATA7','Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa,'),
('609876','BMND6','[Bone mineral density QTL 6] (2)'),
('609883','BBS13','209900 (3)'),
('609883','MKS','209900 (3)'),
('609883','MKS1','209900 (3)'),
('609883','BBS13','Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13,'),
('609883','MKS','Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13,'),
('609883','MKS1','Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13,'),
('609884','JBTS6','Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3);'),
('609884','MKS3','Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3);'),
('609884','NPHP11','Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3);'),
('609884','TMEM67','Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3);'),
('609884','JBTS6','{Bardet-Biedl syndrome 14, modifier of}, 209900 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)'),
('609884','MKS3','{Bardet-Biedl syndrome 14, modifier of}, 209900 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)'),
('609884','NPHP11','{Bardet-Biedl syndrome 14, modifier of}, 209900 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)'),
('609884','TMEM67','{Bardet-Biedl syndrome 14, modifier of}, 209900 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)'),
('609888','LPRS','{Leprosy, paucibacillary type, susceptibility to} (2)'),
('609893','CHNG3','Hypothyroidism, congenital, nongoitrous, 3 (2)'),
('609893','RTSH','Hypothyroidism, congenital, nongoitrous, 3 (2)'),
('609903','SLEB5','{Systemic lupus erythematosus, susceptibility to, 5} (2)'),
('609913','RP32','Retinitis pigmentosa 32 (2)'),
('609915','CMD1Q','Cardiomyopathy, dilated, 1Q (2)'),
('609918','GDB2','Gallbladder disease 2 (2)'),
('609919','GDB2','Gallbladder disease 3 (2)'),
('609922','EHBP1','{Prostate cancer, hereditary, 12}, 611868 (3)'),
('609922','HPC12','{Prostate cancer, hereditary, 12}, 611868 (3)'),
('609922','KIAA0903','{Prostate cancer, hereditary, 12}, 611868 (3)'),
('609941','DFNB51','Deafness, autosomal recessive 51 (2)'),
('609946','DFNB47','Deafness, neurosensory, autosomal recessive 47 (2)'),
('609952','DFNB55','Deafness, autosomal recessive 55 (2)'),
('609954','ASPG4','{Asperger syndrome susceptibility 4} (2)'),
('609955','GGF3','Fibromatosis, gingival, 3 (2)'),
('609955','GINGF3','Fibromatosis, gingival, 3 (2)'),
('609955','HGF3','Fibromatosis, gingival, 3 (2)'),
('609958','ASRT3','{Asthma-related traits, susceptibility to, 3} (2)'),
('609965','DFNA53','Deafness, autosomal dominant 53 (2)'),
('609981','NKCD','Natural killer cell deficiency, familial isolated (2)'),
('609985','PAND3','Panic disorder 3 (2)'),
('609994','MYP11','Myopia 11 (2)'),
('609995','MYP12','Myopia 12 (2)'),
('610036','CLDN19','Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)'),
('610036','HOMG5','Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)'),
('610045','ALDH5A1','Succinic semialdehyde dehydrogenase deficiency, 271980 (3)'),
('610045','SSADH','Succinic semialdehyde dehydrogenase deficiency, 271980 (3)'),
('610053','GCP6','Microcephaly and chorioretinopathy with or without mental'),
('610053','KIAA1669','Microcephaly and chorioretinopathy with or without mental'),
('610053','MCCRP','Microcephaly and chorioretinopathy with or without mental'),
('610053','TUBGCP6','Microcephaly and chorioretinopathy with or without mental'),
('610053','GCP6','retardation, 251270 (3)'),
('610053','KIAA1669','retardation, 251270 (3)'),
('610053','MCCRP','retardation, 251270 (3)'),
('610053','TUBGCP6','retardation, 251270 (3)'),
('610055','CC2D1A','Mental retardation, autosomal recessive 3, 608443 (3)'),
('610055','MRT3','Mental retardation, autosomal recessive 3, 608443 (3)'),
('610057','GPSN2','Mental retardation, autosomal recessive 14, 614020 (3)'),
('610057','MRT14','Mental retardation, autosomal recessive 14, 614020 (3)'),
('610057','SC2','Mental retardation, autosomal recessive 14, 614020 (3)'),
('610057','TECR','Mental retardation, autosomal recessive 14, 614020 (3)'),
('610057','TER','Mental retardation, autosomal recessive 14, 614020 (3)'),
('610060','POLR1C','Treacher Collins syndrome 3, 248390 (3)'),
('610060','RPA39','Treacher Collins syndrome 3, 248390 (3)'),
('610060','RPA40','Treacher Collins syndrome 3, 248390 (3)'),
('610060','RPA5','Treacher Collins syndrome 3, 248390 (3)'),
('610060','RPAC1','Treacher Collins syndrome 3, 248390 (3)'),
('610060','TCS3','Treacher Collins syndrome 3, 248390 (3)'),
('610062','C14orf168','Ciliary dyskinesia, primary, 16, 614017 (3)'),
('610062','CILD16','Ciliary dyskinesia, primary, 16, 614017 (3)'),
('610062','DNAL1','Ciliary dyskinesia, primary, 16, 614017 (3)'),
('610064','ODS1','{Opioid dependence, susceptibility to, 1} (2)'),
('610065','SLEB7','{Systemic lupus erythematosus, susceptibility to, 7} (2)'),
('610066','SLEB8','{Systemic lupus erythematosus, susceptibility to, 8} (2)'),
('610071','HRPT3','Hyperparathyroidism 3 (2)'),
('610079','AIS6','{Autoimmune disease, susceptibility to, 6}, 613551 (3)'),
('610079','SIAE','{Autoimmune disease, susceptibility to, 6}, 613551 (3)'),
('610099','MPD3','Myopathy, distal 3 (2)');
INSERT INTO omim VALUES
('610113','ADAMTSL4','Ectopia lentis, isolated, autosomal recessive, 225100 (3)'),
('610113','TSRC1','Ectopia lentis, isolated, autosomal recessive, 225100 (3)'),
('610114','STQTL8','{Stature QTL 8} (2)'),
('610132','STBM2','(3)'),
('610132','VANGL1','(3)'),
('610132','STBM2','Caudal regression syndrome, 600145 (3); Neural tube defects, 182940'),
('610132','VANGL1','Caudal regression syndrome, 600145 (3); Neural tube defects, 182940'),
('610141','QTV','[QT interval, variation in] (2)'),
('610142','3H11AG','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','BBS14','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','CEP290','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','JBTS5','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','KIAA0373','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','LCA10','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','SLSN6','Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);'),
('610142','3H11AG','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','BBS14','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','CEP290','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','JBTS5','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','KIAA0373','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','LCA10','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610142','SLSN6','Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)'),
('610143','DFNB62','Deafness, autosomal recessive 62 (2)'),
('610148','BBS10','Bardet-Biedl syndrome 10, 209900 (3)'),
('610148','C12orf58','Bardet-Biedl syndrome 10, 209900 (3)'),
('610148','FLJ23560','Bardet-Biedl syndrome 10, 209900 (3)'),
('610150','CCT5','Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)'),
('610150','CCTE','Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)'),
('610150','KIAA0098','Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)'),
('610154','DFNB44','Deafness, autosomal recessive 44 (2)'),
('610155','IDDM19','{Diabetes mellitus, insulin-dependent, 19} (2)'),
('610158','FCD1','Corneal dystrophy, Fuchs endothelial, 2 (2)'),
('610158','FECD2','Corneal dystrophy, Fuchs endothelial, 2 (2)'),
('610162','CCDC28B','{Bardet-Biedl syndrome, modifier of}, 209900 (3)'),
('610162','MGC1203','{Bardet-Biedl syndrome, modifier of}, 209900 (3)'),
('610170','KYPSC1','Kyphoscoliosis 1 (2)'),
('610185','CAMRQ2','Cerebellar hypoplasia, mental retardation, and quadrupedal'),
('610185','CAMRQ2','locomotion 2 (2)'),
('610192','GLIS3','(3)'),
('610192','ZNF515','(3)'),
('610192','GLIS3','Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199'),
('610192','ZNF515','Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199'),
('610197','ARC92','Charcot-Marie-Tooth disease, type 2B2, 605589 (3)'),
('610197','CMT2B2','Charcot-Marie-Tooth disease, type 2B2, 605589 (3)'),
('610197','MED25','Charcot-Marie-Tooth disease, type 2B2, 605589 (3)'),
('610197','PTOV2','Charcot-Marie-Tooth disease, type 2B2, 605589 (3)'),
('610206','BTR1','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','CDPD','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','CHED2','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','FECD4','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','NABC1','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','SLC4A11','Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3);'),
('610206','BTR1','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610206','CDPD','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610206','CHED2','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610206','FECD4','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610206','NABC1','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610206','SLC4A11','Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)'),
('610212','DFNB66','Deafness, autosomal recessive 66 (2)'),
('610213','ANIB4','Aneurysm, intracranial berry, 4 (2)'),
('610219','DFNB59','Deafness, autosomal recessive 59, 610220 (3)'),
('610219','PJVK','Deafness, autosomal recessive 59, 610220 (3)'),
('610222','MACS','Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)'),
('610222','RIN2','Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)'),
('610226','FLJ13841','Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)'),
('610226','ZNF750','Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)'),
('610230','MTO2','transient infantile, 613070 (3)'),
('610230','TRMU','transient infantile, 613070 (3)'),
('610230','TRNT1','transient infantile, 613070 (3)'),
('610230','MTO2','{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure,'),
('610230','TRMU','{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure,'),
('610230','TRNT1','{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure,'),
('610234','SPD3','Synpolydactyly 3 (2)'),
('610239','HDLCQ4','[High density lipoprotein cholesterol level QTL 4] (2)'),
('610243','SPG33','Spastic paraplegia 33, autosomal dominant, 610244 (3)'),
('610243','ZFYVE27','Spastic paraplegia 33, autosomal dominant, 610244 (3)'),
('610247','EE','{Esophagitis, eosinophilic, 1} (2)'),
('610247','EOE1','{Esophagitis, eosinophilic, 1} (2)'),
('610248','DFNB65','Deafness, autosomal recessive 65 (2)'),
('610260','IHPS2','Pyloric stenosis, infantile hypertrophic, 2 (2)'),
('610261','HYT5','{Hypertension, essential, susceptibility to, 5}, 145500 (2)'),
('610262','HYT6','{Hypertension, essential, susceptibility to, 6}, 145500 (2)'),
('610273','PIGM','Glycosylphosphatidylinositol deficiency, 610293 (3)'),
('610274','PIGV','Mabry syndrome, 239300 (3)'),
('610277','CRACM1','defect 1, 612782 (3)'),
('610277','ORAI1','defect 1, 612782 (3)'),
('610277','TMEM142A','defect 1, 612782 (3)'),
('610277','CRACM1','Immune dysfunction with T-cell inactivation due to calcium entry'),
('610277','ORAI1','Immune dysfunction with T-cell inactivation due to calcium entry'),
('610277','TMEM142A','Immune dysfunction with T-cell inactivation due to calcium entry'),
('610285','C4orf25','deformation sequence, 208150 (3)'),
('610285','CMS1B','deformation sequence, 208150 (3)'),
('610285','DOK7','deformation sequence, 208150 (3)'),
('610285','C4orf25','Myasthenia, limb-girdle, familial, 254300 (3); Fetal akinesia'),
('610285','CMS1B','Myasthenia, limb-girdle, familial, 254300 (3); Fetal akinesia'),
('610285','DOK7','Myasthenia, limb-girdle, familial, 254300 (3); Fetal akinesia'),
('610290','CRCS1','{Colorectal cancer, susceptibility to, 1}, 608812 (3)'),
('610290','GALNT12','{Colorectal cancer, susceptibility to, 1}, 608812 (3)'),
('610292','BANK','{Systemic lupus erythematosus, association with}, 152700 (3)'),
('610292','BANK1','{Systemic lupus erythematosus, association with}, 152700 (3)'),
('610292','FLJ20706','{Systemic lupus erythematosus, association with}, 152700 (3)'),
('610294','INTLQ3','{Intelligence QTL3} (2)'),
('610295','INTLQ2','{Intelligence QTL3} (2)'),
('610308','B3GALTL; B3GTL','Peters-plus syndrome, 261540 (3)'),
('610308','B3GLCT','Peters-plus syndrome, 261540 (3)'),
('610320','MYP14','Myopia 14 (2)'),
('610321','HPC7','{Prostate cancer, hereditary, 7} (2)'),
('610326','AGS2','Aicardi-Goutieres syndrome 2, 610181 (3)'),
('610326','DLEU8','Aicardi-Goutieres syndrome 2, 610181 (3)'),
('610326','FLJ11712','Aicardi-Goutieres syndrome 2, 610181 (3)'),
('610326','RNASEH2B','Aicardi-Goutieres syndrome 2, 610181 (3)'),
('610330','AGS3','Aicardi-Goutieres syndrome 3, 610329 (3)'),
('610330','AYP1','Aicardi-Goutieres syndrome 3, 610329 (3)'),
('610330','FLJ20974','Aicardi-Goutieres syndrome 3, 610329 (3)'),
('610330','RNASEH2C','Aicardi-Goutieres syndrome 3, 610329 (3)'),
('610339','GROS1','Osteogenesis imperfecta, type VIII, 610915 (3)'),
('610339','LEPRE1','Osteogenesis imperfecta, type VIII, 610915 (3)'),
('610339','OI8','Osteogenesis imperfecta, type VIII, 610915 (3)'),
('610339','P3H1','Osteogenesis imperfecta, type VIII, 610915 (3)'),
('610341','LEPREL1','(3)'),
('610341','MCVD','(3)'),
('610341','P3H2','(3)'),
('610341','LEPREL1','Myopia, high, with cataract and vitreoretinal degeneration, 614292'),
('610341','MCVD','Myopia, high, with cataract and vitreoretinal degeneration, 614292'),
('610341','P3H2','Myopia, high, with cataract and vitreoretinal degeneration, 614292'),
('610345','AGK','Sengers syndrome, 212350 (3)'),
('610345','MTDPS10','Sengers syndrome, 212350 (3)'),
('610345','MULK','Sengers syndrome, 212350 (3)'),
('610355','FANCN','Fanconi anemia, complementation group N, 610832 (3); {Breast cancer,'),
('610355','PALB2','Fanconi anemia, complementation group N, 610832 (3); {Breast cancer,'),
('610355','PNCA3','Fanconi anemia, complementation group N, 610832 (3); {Breast cancer,'),
('610355','FANCN','susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)'),
('610355','PALB2','susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)'),
('610355','PNCA3','susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)'),
('610361','OFC9','Orofacial cleft 9 (2)'),
('610362','ARMD6','11, 610381 (3)'),
('610362','CORD11','11, 610381 (3)'),
('610362','QRX','11, 610381 (3)'),
('610362','RAXL1','11, 610381 (3)'),
('610362','ARMD6','Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy'),
('610362','CORD11','Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy'),
('610362','QRX','Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy'),
('610362','RAXL1','Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy'),
('610389','MAPBPIP','(3)'),
('610389','p14','(3)'),
('610389','MAPBPIP','Immunodeficiency due to defect in MAPBP-interacting protein, 610798'),
('610389','p14','Immunodeficiency due to defect in MAPBP-interacting protein, 610798'),
('610402','ANIB5','Aneurysm, intracranial berry, 5 (2)'),
('610422','APMR2','Alopecia with mental retardation syndrome 2 (2)'),
('610430','WM2','{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)'),
('610438','RLS3','{Restless legs syndrome 3} (2)'),
('610439','RLS4','{Restless legs syndrome 4} (2)'),
('610443','C17DELq21.31','Chromosome 17q21.31 microdeletion syndrome (4)'),
('610443','DEL17q21.31','Chromosome 17q21.31 microdeletion syndrome (4)'),
('610453','HGSNAT','Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)'),
('610453','MPS3C','Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)'),
('610453','TMEM76','Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)'),
('610456','NFTC','Tumoral calcinosis, familial, normophosphatemic, 610455 (3)'),
('610456','SAMD9','Tumoral calcinosis, familial, normophosphatemic, 610455 (3)'),
('610511','CLSD','Craniolenticulosutural dysplasia, 607812 (3)'),
('610511','SEC23A','Craniolenticulosutural dysplasia, 607812 (3)'),
('610512','CDAN2','Anemia, dyserythropoietic congenital, type II, 224100 (3)'),
('610512','HEMPAS','Anemia, dyserythropoietic congenital, type II, 224100 (3)'),
('610512','SEC23B','Anemia, dyserythropoietic congenital, type II, 224100 (3)'),
('610513','ATP13A2','Parkinson disease 9, 606693 (3)'),
('610513','KRPPD','Parkinson disease 9, 606693 (3)'),
('610513','PARK9','Parkinson disease 9, 606693 (3)'),
('610516','GLYCTK','D-glyceric aciduria, 220120 (3)'),
('610516','GLYCTK1','D-glyceric aciduria, 220120 (3)'),
('610523','CEP41','Joubert syndrome 15, 614464 (3)'),
('610523','JBTS15','Joubert syndrome 15, 614464 (3)'),
('610523','TSGA14','Joubert syndrome 15, 614464 (3)'),
('610531','DRCTNNB1A','Leukodystrophy, hypomyelinating, 5, 610532 (3)'),
('610531','FAM126A','Leukodystrophy, hypomyelinating, 5, 610532 (3)'),
('610531','HLD5','Leukodystrophy, hypomyelinating, 5, 610532 (3)'),
('610533','KIAA0869','[Memory, enhanced, association with] (3)'),
('610533','KIBRA','[Memory, enhanced, association with] (3)'),
('610533','WWC1','[Memory, enhanced, association with] (3)'),
('610535','GLC1M','Glaucoma 1, open angle, M (2)'),
('610540','GNASAS','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('610540','GNASAS1','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('610540','NESPAS','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('610540','SANG','Pseudohypoparathyroidism, type IB, 603233 (3)'),
('610543','DEL16p13.3','Chromosome 16p13.3 deletion syndrome (4)'),
('610543','RSTSS','Chromosome 16p13.3 deletion syndrome (4)'),
('610550','MAT1A','Hypermethioninemia, persistent, autosomal dominant, due to'),
('610550','MATA1','Hypermethioninemia, persistent, autosomal dominant, due to'),
('610550','SAMS1','Hypermethioninemia, persistent, autosomal dominant, due to'),
('610550','MAT1A','methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)'),
('610550','MATA1','methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)'),
('610550','SAMS1','methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)'),
('610564','C6orf210','Coenzyme Q10 deficiency, 607426 (3)'),
('610564','DLP1','Coenzyme Q10 deficiency, 607426 (3)'),
('610564','PDSS2','Coenzyme Q10 deficiency, 607426 (3)'),
('610572','DFNB49','Deafness, autosomal recessive 49, 610153 (3)'),
('610572','MARVD2','Deafness, autosomal recessive 49, 610153 (3)'),
('610572','MARVELD2','Deafness, autosomal recessive 49, 610153 (3)'),
('610572','TRIC','Deafness, autosomal recessive 49, 610153 (3)'),
('610573','CRISTIN4','Anonychia congenita, 206800 (3)'),
('610573','RSPO4','Anonychia congenita, 206800 (3)'),
('610576','ARHGAP9','{Coronary artery spasm 3, susceptibility to} (3)'),
('610598','PRCD','Retinitis pigmentosa 36, 610599 (3)'),
('610598','RP36','Retinitis pigmentosa 36, 610599 (3)'),
('610613','CYP11B1','Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase'),
('610613','FHI','Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase'),
('610613','P450C11','Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase'),
('610613','CYP11B1','deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)'),
('610613','FHI','deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)'),
('610613','P450C11','deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)'),
('610619','F12','610618 (3)'),
('610619','HAE3','610618 (3)'),
('610619','HAF','610618 (3)'),
('610619','F12','Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III,'),
('610619','HAE3','Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III,'),
('610619','HAF','Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III,'),
('610634','CTPP5','Cataract, posterior polar, 5 (2)'),
('610635','CTHRC1','Barrett esophagus/esophageal adenocarcinoma, 614266 (3)'),
('610647','CML3','N-acetylaspartate deficiency, 614063 (3)'),
('610647','NACED','N-acetylaspartate deficiency, 614063 (3)'),
('610647','NAT8L','N-acetylaspartate deficiency, 614063 (3)'),
('610649','BSZQTL3','[Bone size quantitative trait locus 3] (2)'),
('610655','HHT4','Telangiectasia, hereditary hemorrhagic, type 4 (2)'),
('610657','KIAA0196','Spastic paraplegia 8, autosomal dominant, 603563 (3)'),
('610657','SPG8','Spastic paraplegia 8, autosomal dominant, 603563 (3)'),
('610676','AUTS7','{Autism susceptibility 7} (2)'),
('610681','GSD7','Glycogen storage disease VII, 232800 (3)'),
('610681','PFKM','Glycogen storage disease VII, 232800 (3)'),
('610683','BBS12','Bardet-Biedl syndrome 12, 209900 (3)'),
('610683','C4orf24','Bardet-Biedl syndrome 12, 209900 (3)'),
('610683','FLJ35630','Bardet-Biedl syndrome 12, 209900 (3)'),
('610685','SHFLD2','Split-hand/foot malformation with long deficiency 2 (2)'),
('610690','HIBCH','3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)'),
('610693','FLJ32915','Hydrolethalus syndrome, 236680 (3)'),
('610693','HYLS1','Hydrolethalus syndrome, 236680 (3)'),
('610707','PSORS8','{Psoriasis susceptibility 8} (2)'),
('610708','OPA5','Optic atrophy 5 (2)'),
('610745','MCOPS9','Microphthalmia, syndromic 9, 601186 (3)'),
('610745','STRA6','Microphthalmia, syndromic 9, 601186 (3)'),
('610746','CDG1M','Congenital disorder of glycosylation, type Im, 610768 (3)'),
('610746','DK1','Congenital disorder of glycosylation, type Im, 610768 (3)'),
('610746','KIAA1094','Congenital disorder of glycosylation, type Im, 610768 (3)'),
('610746','SEC59','Congenital disorder of glycosylation, type Im, 610768 (3)'),
('610746','TMEM15','Congenital disorder of glycosylation, type Im, 610768 (3)'),
('610753','AA2','Alopecia areata 2 (2)'),
('610760','CLQTL2','[Cholesterol level QTL 2] (2)'),
('610761','HDLCQ5','[High density lipoprotein cholesterol level QTL 5] (2)'),
('610767','APG16L','{Inflammatory bowel disease 10}, 611081 (3)'),
('610767','ATG16L1','{Inflammatory bowel disease 10}, 611081 (3)'),
('610767','IBD10','{Inflammatory bowel disease 10}, 611081 (3)'),
('610804','KIAA0260','Schneckenbecken dysplasia, 269250 (3)'),
('610804','SLC35D1','Schneckenbecken dysplasia, 269250 (3)'),
('610804','UGTREL7','Schneckenbecken dysplasia, 269250 (3)'),
('610805','RHDNS1','Renal hypodysplasia, nonsyndromic, 1 (2)'),
('610819','SLC25A38','205950 (3)'),
('610819','SLC25A38','Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,'),
('610836','AUTS11','{Autism susceptibility 11} (2)'),
('610838','AUTS12','{Autism susceptibility 12} (2)'),
('610839','GOA1','{Osteoarthritis susceptibility 4} (2)'),
('610839','OS4','{Osteoarthritis susceptibility 4} (2)'),
('610840','MMVP3','Mitral valve prolapse, myxomatous 3 (2)'),
('610844','FLJ21439','Spastic paraplegia 11, autosomal recessive, 604360 (3)'),
('610844','KIAA1840','Spastic paraplegia 11, autosomal recessive, 604360 (3)'),
('610844','SPG11','Spastic paraplegia 11, autosomal recessive, 604360 (3)'),
('610855','ANKRD26','Thrombocytopenia 2, 188000 (3)'),
('610855','KIAA1074','Thrombocytopenia 2, 188000 (3)'),
('610855','THC2','Thrombocytopenia 2, 188000 (3)'),
('610860','AGL','Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease'),
('610860','GDE','Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease'),
('610860','AGL','IIIb, 232400 (3)'),
('610860','GDE','IIIb, 232400 (3)'),
('610865','C14orf58','Proliferative vasculopathy and hydraencephaly-hydrocephaly'),
('610865','CCT','Proliferative vasculopathy and hydraencephaly-hydrocephaly'),
('610865','EPV','Proliferative vasculopathy and hydraencephaly-hydrocephaly'),
('610865','FLVCR2','Proliferative vasculopathy and hydraencephaly-hydrocephaly'),
('610865','PVHH','Proliferative vasculopathy and hydraencephaly-hydrocephaly'),
('610865','C14orf58','syndrome, 225790 (3)'),
('610865','CCT','syndrome, 225790 (3)'),
('610865','EPV','syndrome, 225790 (3)'),
('610865','FLVCR2','syndrome, 225790 (3)'),
('610865','PVHH','syndrome, 225790 (3)'),
('610873','MENAQ1','{Menarche, age at, QTL} (2)'),
('610883','PTLS','Potocki-Lupski syndrome (4)'),
('610897','CHMP4B','Cataract, posterior polar, 3, 605387 (3)'),
('610897','CTPP3','Cataract, posterior polar, 3, 605387 (3)'),
('610897','SNF7','Cataract, posterior polar, 3, 605387 (3)'),
('610898','PSNP3','Supranuclear palsy, progressive, 3 (2)'),
('610906','ASRT4','{Asthma-related traits, susceptibility to, 4} (2)'),
('610908','AUTS13','{Autism susceptibility 13} (2)'),
('610911','AOS1','Adams-Oliver syndrome 1, 100300 (3)'),
('610911','ARHGAP31','Adams-Oliver syndrome 1, 100300 (3)'),
('610911','CDGAP','Adams-Oliver syndrome 1, 100300 (3)'),
('610911','KIAA1204','Adams-Oliver syndrome 1, 100300 (3)'),
('610926','STHAG5','Tooth agenesis, selective, 5 (2)'),
('610928','SOX17','Vesicoureteral reflux 3, 613674 (3)'),
('610928','VUR3','Vesicoureteral reflux 3, 613674 (3)'),
('610931','AITD3','{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)'),
('610931','ZFAT1','{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)'),
('610931','ZNF406','{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)'),
('610933','CMT2P','Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)'),
('610933','LRSAM1','Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)'),
('610933','RIFLE','Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)'),
('610933','TAL','Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)'),
('610934','NOBOX','Premature ovarian failure 5, 611548 (3)'),
('610934','POF5','Premature ovarian failure 5, 611548 (3)'),
('610936','EPIP','Phosphoserine aminotransferase deficiency, 610992 (3)'),
('610936','PSAT','Phosphoserine aminotransferase deficiency, 610992 (3)'),
('610936','PSAT1','Phosphoserine aminotransferase deficiency, 610992 (3)'),
('610937','JBTS7','COACH syndrome, 216360 (3)'),
('610937','KIAA1005','COACH syndrome, 216360 (3)'),
('610937','MKS5','COACH syndrome, 216360 (3)'),
('610937','RPGRIP1L','COACH syndrome, 216360 (3)'),
('610937','JBTS7','Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3);'),
('610937','KIAA1005','Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3);'),
('610937','MKS5','Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3);'),
('610937','RPGRIP1L','Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3);'),
('610948','HYT7','{Hypertension, essential, susceptibility to, 7} (2)'),
('610949','SCAR11','Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)'),
('610949','SYT14','Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)'),
('610956','ASPRS. LBSL','lactate elevation, 611105 (3)'),
('610956','DARS2','lactate elevation, 611105 (3)'),
('610956','ASPRS. LBSL','Leukoencephalopathy with brain stem and spinal cord involvement and'),
('610956','DARS2','Leukoencephalopathy with brain stem and spinal cord involvement and'),
('610957','MLASA2','Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)'),
('610957','TYRRS','Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)'),
('610957','YARS2','Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)'),
('610966','FTO','death, 612938 (3)'),
('610966','FTO','Growth retardation, developmental delay, coarse facies, and early'),
('610982','C14orf173','Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)'),
('610982','CMTDIE','Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)'),
('610982','FSGS5','Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)'),
('610982','INF2','Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)'),
('610982','C14orf173','Glomerulosclerosis, focal segmental, 5, 613237 (3);'),
('610982','CMTDIE','Glomerulosclerosis, focal segmental, 5, 613237 (3);'),
('610982','FSGS5','Glomerulosclerosis, focal segmental, 5, 613237 (3);'),
('610982','INF2','Glomerulosclerosis, focal segmental, 5, 613237 (3);'),
('610991','3M2','3-M syndrome 2, 612921 (3)'),
('610991','KIAA0657','3-M syndrome 2, 612921 (3)'),
('610991','OBSL1','3-M syndrome 2, 612921 (3)'),
('610997','HPC9','{Prostate cancer, hereditary, 9} (2)'),
('611003','SQTL1','{Smoking as a quantitative trait locus 1} (2)'),
('611004','SQTL2','{Smoking as a quantitative trait locus 2} (2)'),
('611010','GGF4','Fibromatosis, gingival, 4 (2)'),
('611010','GINGF4','Fibromatosis, gingival, 4 (2)'),
('611010','HGF4','Fibromatosis, gingival, 4 (2)'),
('611014','HYT8','{Hypertension, essential, susceptibility to, 8} (2)'),
('611026','FA2H','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611026','FAAH','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611026','FAH1','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611026','FAXDC1','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611026','SCS7','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611026','SPG35','Spastic paraplegia 35, autosomal recessive, 612319 (3)'),
('611031','EKD2','Episodic kinesigenic dyskinesia 2 (2)'),
('611034','NPT4','?Glycogen storage disease Ic, 232240 (3)'),
('611034','SLC17A3','?Glycogen storage disease Ic, 232240 (3)'),
('611045','G6PC3','Darsun syndrome, 612541 (3)'),
('611045','SCN4','Darsun syndrome, 612541 (3)'),
('611045','UGRP','Darsun syndrome, 612541 (3)'),
('611045','G6PC3','Neutropenia, severe congenital 4, autosomal recessive, 612541 (3);'),
('611045','SCN4','Neutropenia, severe congenital 4, autosomal recessive, 612541 (3);'),
('611045','UGRP','Neutropenia, severe congenital 4, autosomal recessive, 612541 (3);'),
('611046','MTBS2','{Mycobacterium tuberculosis, susceptibility to, 2} (2)'),
('611051','C3orf6','Deafness, autosomal dominant 44, 607453 (3)'),
('611051','CCDC50','Deafness, autosomal dominant 44, 607453 (3)'),
('611051','DFNA44','Deafness, autosomal dominant 44, 607453 (3)'),
('611060','KIAA0437','Schinzel-Giedion midface retraction syndrome, 269150 (3)'),
('611060','SEB','Schinzel-Giedion midface retraction syndrome, 269150 (3)'),
('611060','SETBP1','Schinzel-Giedion midface retraction syndrome, 269150 (3)'),
('611061','DMP4','Raine syndrome, 259775 (3)'),
('611061','FAM20C','Raine syndrome, 259775 (3)'),
('611062','AIGFS','614253 (3)'),
('611062','FAM20A','614253 (3)'),
('611062','AIGFS','Amelogenesis imperfecta and gingival fibromatosis syndrome,'),
('611062','FAM20A','Amelogenesis imperfecta and gingival fibromatosis syndrome,'),
('611073','AD12','{Alzheimer disease 12} (2)'),
('611082','C22orf35','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('611082','MIAT','{Myocardial infarction, susceptibility to}, 608446 (3)'),
('611089','C3orf29','{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)'),
('611089','HJUMPY','{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)'),
('611089','MTMR14','{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)'),
('611091','MRT5','Mental retardation, autosomal recessive, 5 (2)'),
('611094','MRT8','Mental retardation, autosomal recessive, 8 (2)'),
('611095','MRT26','Mental retardation, autosomal recessive, 9/26 (3)'),
('611095','MRT9','Mental retardation, autosomal recessive, 9/26 (3)'),
('611096','MRT10','Mental retardation, autosomal recessive 10/20 (2)'),
('611096','MRT20','Mental retardation, autosomal recessive 10/20 (2)'),
('611097','MRT11','Mental retardation, autosomal recessive, 11 (2)'),
('611100','HPC10','{Prostate cancer, hereditary, 10} (2)'),
('611101','DSMA4','Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)'),
('611101','KIAA0720','Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)'),
('611101','PLEKHG5','Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)'),
('611102','C15DELq15.3','Deafness and male infertility (4)'),
('611102','DEL15q15.3','Deafness and male infertility (4)'),
('611103','ACAD9','ACAD9 deficiency, 611126 (3)'),
('611104','CMT4H','Charcot-Marie-Tooth disease, type 4H, 609311 (3)'),
('611104','FGD4','Charcot-Marie-Tooth disease, type 4H, 609311 (3)'),
('611104','FRABIN','Charcot-Marie-Tooth disease, type 4H, 609311 (3)'),
('611107','MRT4','Mental retardation, autosomal recessive, 4 (2)'),
('611109','CINN','[Cinnamon odor, pleasantness of] (2)'),
('611119','KLHL7','Retinitis pigmentosa 42, 612943 (3)'),
('611119','RP42','Retinitis pigmentosa 42, 612943 (3)'),
('611124','CLN7','Ceroid lipofuscinosis, neuronal, 7, 610951 (3)'),
('611124','MFSD8','Ceroid lipofuscinosis, neuronal, 7, 610951 (3)'),
('611124','MGC33302','Ceroid lipofuscinosis, neuronal, 7, 610951 (3)'),
('611139','CHDS8','{Coronary heart disease, susceptibility to, 8} (2)'),
('611145','SLC30A8','(3)'),
('611145','ZNT8','(3)'),
('611145','SLC30A8','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('611145','ZNT8','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('611146','HMDPC','613280 (3)'),
('611146','SLC30A10','613280 (3)'),
('611146','ZNT10','613280 (3)'),
('611146','HMDPC','Hypermanganesemia with dystonia, polycythemia, and cirrhosis,'),
('611146','SLC30A10','Hypermanganesemia with dystonia, polycythemia, and cirrhosis,'),
('611146','ZNT10','Hypermanganesemia with dystonia, polycythemia, and cirrhosis,'),
('611147','PNKD2','Paroxysmal nonkinesigenic dyskinesia 2 (2)'),
('611150','ATXN10','Spinocerebellar ataxia 10, 603516 (3)'),
('611150','SCA10','Spinocerebellar ataxia 10, 603516 (3)'),
('611152','AD13','{Alzheimer disease-13} (2)'),
('611153','XPA','Xeroderma pigmentosum, group A, 278700 (3)'),
('611153','XPAC','Xeroderma pigmentosum, group A, 278700 (3)'),
('611154','AD14','{Alzheimer disease-14} (2)'),
('611155','AD15','{Alzheimer disease-15} (2)'),
('611177','ATD2','Asphyxiating thoracic dystrophy 2, 611263 (3)'),
('611177','IFT80','Asphyxiating thoracic dystrophy 2, 611263 (3)'),
('611177','KIAA1374','Asphyxiating thoracic dystrophy 2, 611263 (3)'),
('611177','WDR56','Asphyxiating thoracic dystrophy 2, 611263 (3)'),
('611185','RLS6','{Restless legs syndrome 6} (2)'),
('611192','ANCO1','KBG syndrome, 148050 (3)'),
('611192','ANKRD11','KBG syndrome, 148050 (3)'),
('611192','KBGS','KBG syndrome, 148050 (3)'),
('611203','CLN4B','Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)'),
('611203','CSP','Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)'),
('611203','DNAJC5','Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)'),
('611203','DNAJC5A','Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)'),
('611224','MTDPS9','Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type'),
('611224','SUCLA1','Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type'),
('611224','SUCLG1','Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type'),
('611224','MTDPS9','with methylmalonic aciduria), 245400 (3)'),
('611224','SUCLA1','with methylmalonic aciduria), 245400 (3)'),
('611224','SUCLG1','with methylmalonic aciduria), 245400 (3)'),
('611242','RLS5','{Restless legs syndrome 5} (2)'),
('611247','BPAD','Major affective disorder 4 (2)'),
('611247','MAFD4','Major affective disorder 4 (2)'),
('611252','SPG32','Spastic paraplegia 32, autosomal recessive (2)'),
('611254','ACLS','200990 (3); Joubert syndrome 12, 200990 (3)'),
('611254','HLS2','200990 (3); Joubert syndrome 12, 200990 (3)'),
('611254','JBTS12','200990 (3); Joubert syndrome 12, 200990 (3)'),
('611254','KIF7','200990 (3); Joubert syndrome 12, 200990 (3)'),
('611254','ACLS','Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome,'),
('611254','HLS2','Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome,'),
('611254','JBTS12','Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome,'),
('611254','KIF7','Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome,'),
('611258','CATC4','Cataract, autosomal recessive congenital 4, 613887 (3)'),
('611258','KIAA1529','Cataract, autosomal recessive congenital 4, 613887 (3)'),
('611258','TDRD7','Cataract, autosomal recessive congenital 4, 613887 (3)'),
('611258','TRAP','Cataract, autosomal recessive congenital 4, 613887 (3)'),
('611259','CDKAL1','(3)'),
('611259','CDKAL1','{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853'),
('611276','GLC1H','Glaucoma 1, open angle, H (2)'),
('611290','NHEJ1','retardation, and sensitivity to ionizing radiation, 611291 (3)'),
('611290','XLF','retardation, and sensitivity to ionizing radiation, 611291 (3)'),
('611290','NHEJ1','Severe combined immunodeficiency with microcephaly, growth'),
('611290','XLF','Severe combined immunodeficiency with microcephaly, growth'),
('611302','SPAX2','Ataxia, spastic 2, autosomal recessive (2)'),
('611313','ARMD8','{Macular degeneration, age-related, 8}, 613778 (3)'),
('611313','LOC387715','{Macular degeneration, age-related, 8}, 613778 (3)'),
('611332','DJ4','Muscular dystrophy, limb-girdle, type 1E, 603511 (3)'),
('611332','DNAJB6','Muscular dystrophy, limb-girdle, type 1E, 603511 (3)'),
('611332','LGMD1E','Muscular dystrophy, limb-girdle, type 1E, 603511 (3)'),
('611332','MRJ','Muscular dystrophy, limb-girdle, type 1E, 603511 (3)'),
('611358','MMFD','Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)'),
('611358','RNF135','Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)'),
('611360','FANCI','Fanconi anemia, complementation group I, 609053 (3)'),
('611360','KIAA1794','Fanconi anemia, complementation group I, 609053 (3)'),
('611364','EJM4','Myoclonic epilepsy, juvenile, 4 (2)'),
('611376','MGS','Mungen syndrome (2)'),
('611379','DIP2B','Mental retardation, FRA12A type, 136630 (3)'),
('611379','KIAA1463','Mental retardation, FRA12A type, 136630 (3)'),
('611390','ARSAL','Ataxia, spastic, 3, autosomal recessive (2)'),
('611390','SPAX3','Ataxia, spastic, 3, autosomal recessive (2)'),
('611403','ASRT6','{Asthma-related traits, susceptibility to, 6} (2)'),
('611408','C6orf152','Leber congenital amaurosis 5, 604537 (3)'),
('611408','LCA5','Leber congenital amaurosis 5, 604537 (3)'),
('611409','BOCA','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','D15S12','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','EYCL3','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','HCL3','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','OCA2','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','P','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','PED','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','SHEP1','Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown'),
('611409','BOCA','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','D15S12','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','EYCL3','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','HCL3','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','OCA2','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','P','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','PED','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611409','SHEP1','oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)'),
('611414','CALR3','Cardiomyopathy, familial hypertrophic, 19, 613875 (3)'),
('611414','CMH19','Cardiomyopathy, familial hypertrophic, 19, 613875 (3)'),
('611414','CRT2','Cardiomyopathy, familial hypertrophic, 19, 613875 (3)'),
('611421','FLHS','Floating-Harbor syndrome, 136140 (3)'),
('611421','KIAA0309','Floating-Harbor syndrome, 136140 (3)'),
('611421','SRCAP','Floating-Harbor syndrome, 136140 (3)'),
('611421','SWR1','Floating-Harbor syndrome, 136140 (3)'),
('611432','DOCK8','Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)'),
('611432','MRD2','Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)'),
('611432','DOCK8','Mental retardation, autosomal dominant 2, 614113 (3);'),
('611432','MRD2','Mental retardation, autosomal dominant 2, 614113 (3);'),
('611458','GLB1','230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)'),
('611458','MPS4B','230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)'),
('611458','GLB1','GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,'),
('611458','MPS4B','GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,'),
('611466','AP162','Osteopetrosis, autosomal recessive 6, 611497 (3)'),
('611466','KIAA0356','Osteopetrosis, autosomal recessive 6, 611497 (3)'),
('611466','OPTB6','Osteopetrosis, autosomal recessive 6, 611497 (3)'),
('611466','PLEKHM1','Osteopetrosis, autosomal recessive 6, 611497 (3)'),
('611469','CRCS2','{Colorectal cancer, susceptibility to, 2} (2)'),
('611472','KIAA1461','Mental retardation, autosomal dominant 1, 156200 (3)'),
('611472','MBD5','Mental retardation, autosomal dominant 1, 156200 (3)'),
('611472','MRD1','Mental retardation, autosomal dominant 1, 156200 (3)'),
('611492','CA2','259730 (3)'),
('611492','CA2','Osteopetrosis, autosomal recessive 3, with renal tubular acidosis,'),
('611494','ATFB5','{Atrial fibrillation, familial, 5} (2)'),
('611495','CYP4F22','Ichthyosis, lamellar, 3, 604777 (3)'),
('611495','LI3','Ichthyosis, lamellar, 3, 604777 (3)'),
('611499','GUSB','Mucopolysaccharidosis VII, 253220 (3)'),
('611499','MPS7','Mucopolysaccharidosis VII, 253220 (3)'),
('611507','CISD2','Wolfram syndrome 2, 604928 (3)'),
('611507','ERIS','Wolfram syndrome 2, 604928 (3)'),
('611507','WFS2','Wolfram syndrome 2, 604928 (3)'),
('611507','ZCD2','Wolfram syndrome 2, 604928 (3)'),
('611515','FEB7','Febrile seizures, familial, 7 (2)'),
('611524','PCH6','Pontocerebellar hypoplasia, type 6, 611523 (3)'),
('611524','RARS2','Pontocerebellar hypoplasia, type 6, 611523 (3)'),
('611524','RARSL','Pontocerebellar hypoplasia, type 6, 611523 (3)'),
('611531','BWCNS','Bowen-Conradi syndrome, 211180 (3)'),
('611531','C2F','Bowen-Conradi syndrome, 211180 (3)'),
('611531','EMG1','Bowen-Conradi syndrome, 211180 (3)'),
('611531','NEP1','Bowen-Conradi syndrome, 211180 (3)'),
('611535','MAFD5','{Major affective disorder 5} (2)'),
('611536','BPAD','{Major affective disorder 6} (2)'),
('611536','MAFD6','{Major affective disorder 6} (2)'),
('611539','AIS1','{Autoimmune disease, susceptibility to, 1}, 607836 (3)'),
('611539','FOXD3','{Autoimmune disease, susceptibility to, 1}, 607836 (3)'),
('611539','VAMAS2','{Autoimmune disease, susceptibility to, 1}, 607836 (3)'),
('611542','ARSB','Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)'),
('611542','MPS6','Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)'),
('611543','CODA','Cavitary optic disc anomalies (2)'),
('611547','STQTL9','{Stature QTL 9} (2)'),
('611550','1C7','{Malaria, mild, susceptibility to}, 609148 (3)'),
('611550','CD337','{Malaria, mild, susceptibility to}, 609148 (3)'),
('611550','MALS','{Malaria, mild, susceptibility to}, 609148 (3)'),
('611550','NCR3','{Malaria, mild, susceptibility to}, 609148 (3)'),
('611550','NKP30','{Malaria, mild, susceptibility to}, 609148 (3)'),
('611559','UPIII','Renal adysplasia, 191830 (3); Urogenital adysplasia, 191830 (3)'),
('611559','UPK3','Renal adysplasia, 191830 (3); Urogenital adysplasia, 191830 (3)'),
('611559','UPK3A','Renal adysplasia, 191830 (3); Urogenital adysplasia, 191830 (3)'),
('611570','FBP1','Fructose-1,6-bidphosphatase deficiency, 229700 (3)'),
('611571','OTSC4','{Otosclerosis 4} (2)'),
('611572','OTSC7','Otosclerosis 7 (2)'),
('611598','AIS5','susceptibility to, 5} (2)'),
('611598','CELIAC6','susceptibility to, 5} (2)'),
('611598','AIS5','{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease,'),
('611598','CELIAC6','{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease,'),
('611605','C8orf2','Spastic paraplegia 18, autosomal recessive, 611225 (3)'),
('611605','ERLIN2','Spastic paraplegia 18, autosomal recessive, 611225 (3)'),
('611605','SPFH2','Spastic paraplegia 18, autosomal recessive, 611225 (3)'),
('611605','SPG18','Spastic paraplegia 18, autosomal recessive, 611225 (3)'),
('611606','DFNA50','Deafness, autosomal dominant 50, 613074 (3)'),
('611606','MIR96','Deafness, autosomal dominant 50, 613074 (3)'),
('611606','MIRN96','Deafness, autosomal dominant 50, 613074 (3)'),
('611630','ETL3','Epilepsy, familial mesial temporal lobe (2)'),
('611630','FMTLE','Epilepsy, familial mesial temporal lobe (2)'),
('611631','ETL4','Epilepsy, familial temoral lobe, 4 (2)'),
('611631','ETOLM','Epilepsy, familial temoral lobe, 4 (2)'),
('611632','SCCD','Corneal dystrophy, crystalline, of Schnyder, 121800 (3)'),
('611632','TERE1','Corneal dystrophy, crystalline, of Schnyder, 121800 (3)'),
('611632','UBIAD1','Corneal dystrophy, crystalline, of Schnyder, 121800 (3)'),
('611634','FEB9','Febrile seizures, familial, 9 (2)'),
('611637','PLSA','Primary lateral sclerosis, adult, 1 (2)'),
('611637','PLSA1','Primary lateral sclerosis, adult, 1 (2)'),
('611642','HEPACAM','613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)'),
('611642','MLC2A','613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)'),
('611642','MLC2B','613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)'),
('611642','HEPACAM','Megalencephalic leukoencephalopathy with subcortical cysts 2A,'),
('611642','MLC2A','Megalencephalic leukoencephalopathy with subcortical cysts 2A,'),
('611642','MLC2B','Megalencephalic leukoencephalopathy with subcortical cysts 2A,'),
('611644','HSCR9','{Hirschsprung disease, susceptibility to, 9} (2)'),
('611672','HCP1','Folate malabsorption, hereditary, 229050 (3)'),
('611672','PCFT','Folate malabsorption, hereditary, 229050 (3)'),
('611672','SLC46A1','Folate malabsorption, hereditary, 229050 (3)'),
('611684','DSAP1','Porokeratosis, disseminated superficial actinic, 1, 175900 (3)'),
('611684','KIAA0156','Porokeratosis, disseminated superficial actinic, 1, 175900 (3)'),
('611684','P100','Porokeratosis, disseminated superficial actinic, 1, 175900 (3)'),
('611684','SART3','Porokeratosis, disseminated superficial actinic, 1, 175900 (3)'),
('611684','TIP110','Porokeratosis, disseminated superficial actinic, 1, 175900 (3)'),
('611687','C6orf221','Hydatidiform mole, recurrent, 2, 614293 (3)'),
('611687','ECAT1','Hydatidiform mole, recurrent, 2, 614293 (3)'),
('611687','HYDM2','Hydatidiform mole, recurrent, 2, 614293 (3)'),
('611695','SCA11','Spinocerebellar ataxia 11, 604432 (3)'),
('611695','TTBK2','Spinocerebellar ataxia 11, 604432 (3)'),
('611706','MGR12','{Migraine, with or without aura, susceptibility to, 12} (2)'),
('611715','CDG1Q','Congenital disorder of glycosylation, type Iq, 612379 (3);'),
('611715','KRIZI','Congenital disorder of glycosylation, type Iq, 612379 (3);'),
('611715','SRD5A2L','Congenital disorder of glycosylation, type Iq, 612379 (3);'),
('611715','SRD5A3','Congenital disorder of glycosylation, type Iq, 612379 (3);'),
('611715','CDG1Q','Kahrizi syndrome, 612713 (3)'),
('611715','KRIZI','Kahrizi syndrome, 612713 (3)'),
('611715','SRD5A2L','Kahrizi syndrome, 612713 (3)'),
('611715','SRD5A3','Kahrizi syndrome, 612713 (3)'),
('611716','ARCL2A','Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin'),
('611716','ATP6V0A2','Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin'),
('611716','WSS','Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin'),
('611716','ARCL2A','syndrome, 278250 (3)'),
('611716','ATP6V0A2','syndrome, 278250 (3)'),
('611716','WSS','syndrome, 278250 (3)'),
('611724','SHEP8','[Skin/hair/eye pigmentation 8, freckling] (2)'),
('611725','EPM3','Epilepsy, progressive myoclonic 3, 611726 (3)'),
('611725','KCTD7','Epilepsy, progressive myoclonic 3, 611726 (3)'),
('611731','APC','613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Gardner syndrome (3);'),
('611731','BTPS2','613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Gardner syndrome (3);'),
('611731','FPC','613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Gardner syndrome (3);'),
('611731','GS','613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Gardner syndrome (3);'),
('611731','APC','Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic,'),
('611731','BTPS2','Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic,'),
('611731','FPC','Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic,'),
('611731','GS','Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic,'),
('611731','APC','Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2 (3)'),
('611731','BTPS2','Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2 (3)'),
('611731','FPC','Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2 (3)'),
('611731','GS','Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2 (3)'),
('611738','BMND7','{Osteoporosis}, 166710 (2)'),
('611739','BMND8','{Osteoporosis}, 166710 (2)'),
('611761','LMF1','Lipase deficiency, combined, 246650 (3)'),
('611761','TMEM112','Lipase deficiency, combined, 246650 (3)'),
('611770','CSX2','Persistent truncus arteriosus, 217095 (3)'),
('611770','NKX2-6','Persistent truncus arteriosus, 217095 (3)'),
('611776','C6orf66','Mitochondrial complex I deficiency, 252010 (3)'),
('611776','HRPAP20','Mitochondrial complex I deficiency, 252010 (3)'),
('611776','NDUFAF4','Mitochondrial complex I deficiency, 252010 (3)'),
('611778','GPD1L','Brugada syndrome 2, 611777 (3)'),
('611778','KIAA0089','Brugada syndrome 2, 611777 (3)'),
('611863','MNDEC','Microtia with nasolacrimal duct imperforation and eye coloboma (1)'),
('611867','C22DELq11.2','Chromosome 22q11.2 deletion syndrome, distal (4)'),
('611867','DEL22q11.2','Chromosome 22q11.2 deletion syndrome, distal (4)'),
('611891','AAA3','{Aneurysm, familial abdominal 3} (2)'),
('611892','ANIB6','{Aneurysm, intracranial berry, 6} (2)'),
('611897','NNO3','Nanophthalmos 3 (2)'),
('611907','EA7','Episodic ataxia, type 7 (2)'),
('611908','CDG1N','Congenital disorder of glycosylation, type In, 612015 (3)'),
('611908','RFT1','Congenital disorder of glycosylation, type In, 612015 (3)'),
('611910','CJMG','Cataract, juvenile, with microcornea and glucosuria, 612018 (3)'),
('611910','MCT12','Cataract, juvenile, with microcornea and glucosuria, 612018 (3)'),
('611910','SLC16A12','Cataract, juvenile, with microcornea and glucosuria, 612018 (3)'),
('611911','HML','Myopathy with lactic acidosis, hereditary, 255125 (3)'),
('611911','ISCU','Myopathy with lactic acidosis, hereditary, 255125 (3)'),
('611913','AUTS14','Chromosome 16p11.2 deletion syndrome, 593kb (4);'),
('611913','C16DELp11.2','Chromosome 16p11.2 deletion syndrome, 593kb (4);'),
('611913','C16DUPp11.2','Chromosome 16p11.2 deletion syndrome, 593kb (4);'),
('611913','DEL16p11.2','Chromosome 16p11.2 deletion syndrome, 593kb (4);'),
('611913','DUP16p11.2','Chromosome 16p11.2 deletion syndrome, 593kb (4);'),
('611913','AUTS14','{Autism susceptibility 14} (2); Chromosome 16p11.2 duplication syndrome (4)'),
('611913','C16DELp11.2','{Autism susceptibility 14} (2); Chromosome 16p11.2 duplication syndrome (4)'),
('611913','C16DUPp11.2','{Autism susceptibility 14} (2); Chromosome 16p11.2 duplication syndrome (4)'),
('611913','DEL16p11.2','{Autism susceptibility 14} (2); Chromosome 16p11.2 duplication syndrome (4)'),
('611913','DUP16p11.2','{Autism susceptibility 14} (2); Chromosome 16p11.2 duplication syndrome (4)'),
('611920','CPROTQ','[C-reactive protein QTL] (2)'),
('611927','AI3','Amelogenesis imperfecta, type 3, 130900 (3)'),
('611927','FAM83H','Amelogenesis imperfecta, type 3, 130900 (3)'),
('611934','EIG5','Epilepsy, idiopathic generalized, susceptibility to, 5 (2)'),
('611935','C2orf25','aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)'),
('611935','MMADHC','aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)'),
('611935','C2orf25','Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic'),
('611935','MMADHC','Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic'),
('611936','DUP3q29','Chromosome 3q29 microduplication syndrome (4)'),
('611936','MICRODUP3q29','Chromosome 3q29 microduplication syndrome (4)'),
('611944','LMPH1B','Lymphedema, hereditary, IB (2)'),
('611945','SPG37','Spastic paraplegia 37, autosomal dominant (2)'),
('611951','B9D2','Meckel syndrome 10, 614175 (3)'),
('611951','MKS10','Meckel syndrome 10, 614175 (3)'),
('611955','HPC11','{Prostate cancer, hereditary, 11} (2)'),
('611958','HPC14','{Prostate cancer, hereditary, 14} (2)'),
('611959','HPC15','{Prostate cancer, hereditary, 15} (2)'),
('611966','KIAA1882','Mental retardation, autosomal recessive 13, 613192 (3)'),
('611966','MRT13','Mental retardation, autosomal recessive 13, 613192 (3)'),
('611966','NIBP','Mental retardation, autosomal recessive 13, 613192 (3)'),
('611966','TRAPPC9','Mental retardation, autosomal recessive 13, 613192 (3)'),
('612001','DEL15q13.3','Chromosome 15q13.3 microdeletion syndrome (4)'),
('612001','MICRODEL15q13.3','Chromosome 15q13.3 microdeletion syndrome (4)'),
('612003','GIGYF2','Parkinson disease 11, 607688 (3)'),
('612003','KIAA0642','Parkinson disease 11, 607688 (3)'),
('612003','PARK11','Parkinson disease 11, 607688 (3)'),
('612005','CELIAC7','{Celiac disease, susceptibility to, 7} (2)'),
('612006','CELIAC8','{Celiac disease, susceptibility to, 8} (2)'),
('612007','CELIAC9','{Celiac disease, susceptibility to, 9} (2)'),
('612008','CELIAC10','{Celiac disease, susceptibility to, 10} (2)'),
('612009','CELIAC11','{Celiac disease, susceptibility to, 11} (2)'),
('612010','CELIAC12','{Celiac disease, susceptibility to, 12} (2)'),
('612011','CELIAC13','{Celiac disease, susceptibility to, 13} (2)'),
('612012','KIAA0321','Spastic paraplegia 15, autosomal recessive, 270700 (3)'),
('612012','SPG15','Spastic paraplegia 15, autosomal recessive, 270700 (3)'),
('612012','ZFYVE26','Spastic paraplegia 15, autosomal recessive, 270700 (3)'),
('612013','CC2D2A','COACH syndrome, 216360 (3)'),
('612013','KIAA1345','COACH syndrome, 216360 (3)'),
('612013','MKS6','COACH syndrome, 216360 (3)'),
('612013','CC2D2A','Joubert syndrome 9, 612285 (3); Meckel syndrome, type 6, 612284 (3);'),
('612013','KIAA1345','Joubert syndrome 9, 612285 (3); Meckel syndrome, type 6, 612284 (3);'),
('612013','MKS6','Joubert syndrome 9, 612285 (3); Meckel syndrome, type 6, 612284 (3);'),
('612014','ATD4','4, 613819 (3)'),
('612014','NPHP12','4, 613819 (3)'),
('612014','THM1','4, 613819 (3)'),
('612014','TTC21B','4, 613819 (3)'),
('612014','ATD4','Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy'),
('612014','NPHP12','Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy'),
('612014','THM1','Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy'),
('612014','TTC21B','Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy'),
('612017','IHPS3','Pyloric stenosis, infantile hypertrophic, 3 (2)'),
('612025','DEHAL1','Thyroid dyshormonogenesis 4, 274800 (3)'),
('612025','IYD','Thyroid dyshormonogenesis 4, 274800 (3)'),
('612025','TDH4','Thyroid dyshormonogenesis 4, 274800 (3)'),
('612030','CHDS9','{Coronary heart disease, susceptibility to, 9} (2)'),
('612035','AARS2','Combined oxidative phosphorylation deficiency 8, 614096 (3)'),
('612035','COXPD8','Combined oxidative phosphorylation deficiency 8, 614096 (3)'),
('612035','KIAA1270','Combined oxidative phosphorylation deficiency 8, 614096 (3)'),
('612035','MTALARS','Combined oxidative phosphorylation deficiency 8, 614096 (3)'),
('612041','RNF212','Recombination rate QTL 1, 612042 (3)'),
('612041','ZHP3','Recombination rate QTL 1, 612042 (3)'),
('612048','ARVC5','Arrhythmogenic right ventricular dysplasia 5, 604400 (3)'),
('612048','ARVD5','Arrhythmogenic right ventricular dysplasia 5, 604400 (3)'),
('612048','TMEM43','Arrhythmogenic right ventricular dysplasia 5, 604400 (3)'),
('612051','BEAN','Spinocerebellar ataxia 31, 117210 (3)'),
('612051','SCA31','Spinocerebellar ataxia 31, 117210 (3)'),
('612074','RBM28','Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)'),
('612078','BCS','Brittle cornea syndrome, 229200 (3)'),
('612078','KIAA1858','Brittle cornea syndrome, 229200 (3)'),
('612078','ZNF469','Brittle cornea syndrome, 229200 (3)'),
('612080','QPC','Mitochondrial complex III deficiency, 124000 (3)'),
('612080','UQCRQ','Mitochondrial complex III deficiency, 124000 (3)'),
('612083','MUSTQTL1','Muscle strength quantitative trait locus 1 (2)'),
('612089','HPRHP','Hypophosphatemic rickets and hyperparathyroidism (2)'),
('612096','OTSC8','Otosclerosis 8 (2)'),
('612099','MFT2','Trichoepithelioma, multiple familial, 2 (2)'),
('612099','TEM','Trichoepithelioma, multiple familial, 2 (2)'),
('612108','FGQTL1','[Fasting plasma glucose level QTL 1] (2)'),
('612110','BMND9','[Bone mineral density QTL 9] (2)'),
('612113','BMND10','[Bone mineral density QTL 10] (2)'),
('612114','BMND11','[Bone mineral density QTL 11] (2)'),
('612161','ANIB7','Aneurysm, intracranial berry, 7 (2)'),
('612162','ANIB8','Aneurysm, intracranial berry, 8 (2)'),
('612163','SHEP10','[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)'),
('612163','TPC2','[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)'),
('612163','TPCN2','[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)'),
('612165','RP29','Retinitis pigmentosa 29 (2)'),
('612169','CD32C','Thrombocytopenic purpura, autoimmune, 188030 (1)'),
('612169','FCGR2C','Thrombocytopenic purpura, autoimmune, 188030 (1)'),
('612182','AAC2','[Acetylation, slow], 243400 (3)'),
('612182','NAT2','[Acetylation, slow], 243400 (3)'),
('612192','TNDM1','Diabetes mellitus, transient neonatal, 1, 601410 (3)'),
('612192','ZFP57','Diabetes mellitus, transient neonatal, 1, 601410 (3)'),
('612221','STQTL10','{Stature QTL 10} (2)'),
('612222','GALNS','Mucopolysaccharidosis IVA, 253000 (3)'),
('612222','MPS4A','Mucopolysaccharidosis IVA, 253000 (3)'),
('612223','STQTL11','{Stature QTL 11} (2)'),
('612224','STQTL12','{Stature QTL 12} (2)'),
('612226','STQTL13','{Stature QTL 13} (2)'),
('612228','STQTL14','{Stature QTL 14} (2)'),
('612230','CRCS5','{Colorectal cancer, susceptibility to, 5} (2)'),
('612231','CRCS6','{Colorectal cancer, susceptibility to, 6} (2)'),
('612232','CRCS7','{Colorectal cancer, susceptibility to, 7} (2)'),
('612238','IS4','{Scoliosis, idiopathic, susceptibility to, 4} (2)'),
('612241','IBD12','{Inflammatory bowel disease 12} (2)'),
('612242','C10DELq23','Chromosome 10q23 deletion syndrome (4)'),
('612242','DEL10q23','Chromosome 10q23 deletion syndrome (4)'),
('612253','SLEB11','{Systemic lupus erythematosus, susceptibility to, 11} (2)'),
('612254','SLEB12','{Systemic lupus erythematosus, susceptibility to, 12} (2)'),
('612255','IBD15','{Inflammatory bowel disease 15} (2)'),
('612259','IBD16','{Inflammatory bowel disease 16} (2)'),
('612262','IBD18','{Inflammatory bowel disease 18} (2)'),
('612263','CMM7','{Melanoma, cutaneous malignant, 7} (2)'),
('612271','SHEP11','[Skin/hair/eye pigmentation 11, blue/nonblue eyes] (2)'),
('612274','CILD8','Ciliary dyskinesia, primary, 8 (2)'),
('612277','ADAMTSL2','Geleophysic dysplasia 1, 231050 (3)'),
('612277','GPHYSD1','Geleophysic dysplasia 1, 231050 (3)'),
('612277','KIAA0605','Geleophysic dysplasia 1, 231050 (3)'),
('612279','GEFSP6','Generalized epilepsy with febrile seizures plus, type 6 (2)'),
('612280','FUCA1','Fucosidosis, 230000 (3)'),
('612283','PC','176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)'),
('612283','PROC','176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)'),
('612283','THPH3','176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)'),
('612283','THPH4','176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)'),
('612283','PC','Thrombophilia due to protein C deficiency, autosomal dominant,'),
('612283','PROC','Thrombophilia due to protein C deficiency, autosomal dominant,'),
('612283','THPH3','Thrombophilia due to protein C deficiency, autosomal dominant,'),
('612283','THPH4','Thrombophilia due to protein C deficiency, autosomal dominant,'),
('612288','IBD20','{Inflammatory bowel disease 20} (2)'),
('612293','DSAP3','Porokeratosis, disseminated superficial actinic, 3 (2)'),
('612306','TSHQTL1','[Thyroid-stimulating hormone level QTL 1] (2)'),
('612309','F5','due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated'),
('612309','RPRGL1','due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated'),
('612309','THPH2','due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated'),
('612309','F5','Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to,'),
('612309','RPRGL1','Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to,'),
('612309','THPH2','Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to,'),
('612309','F5','protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)'),
('612309','RPRGL1','protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)'),
('612309','THPH2','protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)'),
('612311','ADHD5','{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)'),
('612312','ADHD6','{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)'),
('612313','C2DELq32q33','Chromosome 2q32-q33 deletion syndrome (4)'),
('612313','DEL2q32q33','Chromosome 2q32-q33 deletion syndrome (4)'),
('612322','FASTKD2','Mitochondrial complex IV deficiency, 220110 (3)'),
('612322','KIAA0971','Mitochondrial complex IV deficiency, 220110 (3)'),
('612325','ECO','Endocrine-cerebroosteodysplasia, 612651 (3)'),
('612325','ICK','Endocrine-cerebroosteodysplasia, 612651 (3)'),
('612325','KIAA0936','Endocrine-cerebroosteodysplasia, 612651 (3)'),
('612325','MRK','Endocrine-cerebroosteodysplasia, 612651 (3)'),
('612335','SPG38','Spastic paraplegia 38, autosomal dominant (2)'),
('612337','C1DELq42q44','Chromosome 1q42-q44 deletion syndrome (4)'),
('612337','DEL1q42q44','Chromosome 1q42-q44 deletion syndrome (4)'),
('612343','MUSQTL1','[Musical aptitude QTL 1] (2)'),
('612345','DEL2q31','Chromosome 2q31.2 deletion syndrome (4)'),
('612348','THPH9','?Thrombophilia due to decreased release of tissue plasminogen (1)'),
('612349','PAH','261600 (3)'),
('612349','PKU1','261600 (3)'),
('612349','PAH','Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild],'),
('612349','PKU1','Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild],'),
('612353','DSAP4','Porokeratosis, disseminated superficial actinic, 4 (2)'),
('612354','IBD21','{Inflammatory bowel disease 21} (2)'),
('612357','MAFD8','{Major affective disorder-8, susceptibility to} (2)'),
('612358','KNG','deficiency], 228960 (3)'),
('612358','KNG1','deficiency], 228960 (3)'),
('612358','KNG','[Kininogen deficiency], 228960 (3); [High molecular weight kininogen'),
('612358','KNG1','[Kininogen deficiency], 228960 (3); [High molecular weight kininogen'),
('612360','C20orf7','Mitochondrial complex 1 deficiency, 252010 (3)'),
('612361','SCZD14','{Schizophrenia, susceptibility to, 14} (2)'),
('612367','ALPQTL2','{Alkaline phosphatase, plasma level of, QTL 2} (2)'),
('612368','ALPQTL3','{Alkaline phosphatase, plasma level of, QTL3} (2)'),
('612369','ALPQTL4','{Alkaline phosphatase, plasma level of, QTL4} (2)'),
('612372','MAFD9','{Major affective disorder-9, susceptibility to} (2)'),
('612373','ENT3','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('612373','HCLAP','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('612373','PHID','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('612373','SLC29A3','Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)'),
('612378','SLEB13','{Systemic lupus erythematosus, susceptibility to, 13} (2)'),
('612380','IBD22','{Inflammatory bowel disease 22} (2)'),
('612381','IBD23','{Inflammatory bowel disease 23} (2)'),
('612386','FCE','Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)'),
('612386','FECH','Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)'),
('612388','SS3','{Sarcoidosis, susceptibility to, 3} (2)'),
('612392','C8orf38','Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)'),
('612395','CHKB','Muscular dystrophy, congenital, megaconial type, 602541 (3)'),
('612395','CHKL','Muscular dystrophy, congenital, megaconial type, 602541 (3)'),
('612395','CKEKB','Muscular dystrophy, congenital, megaconial type, 602541 (3)'),
('612395','EKB','Muscular dystrophy, congenital, megaconial type, 602541 (3)'),
('612395','MDCMC','Muscular dystrophy, congenital, megaconial type, 602541 (3)'),
('612401','OS6','{Osteoarthritis susceptibility 6} (2)'),
('612406','DYT17','Dystonia-17, primary torsion (2)'),
('612410','PSORS10','{Psoriasis susceptibility 10} (3)'),
('612414','DFNB63','Deafness, autosomal recessive 63, 611451 (3)'),
('612414','LRTOMT','Deafness, autosomal recessive 63, 611451 (3)'),
('612414','LRTOMT1','Deafness, autosomal recessive 63, 611451 (3)'),
('612414','LRTOMT2','Deafness, autosomal recessive 63, 611451 (3)'),
('612417','NRCLP4','{Narcolepsy 4} (2)'),
('612418','MC5DN2','614052 (3)'),
('612418','TMEM70','614052 (3)'),
('612418','MC5DN2','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2,'),
('612418','TMEM70','Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2,'),
('612421','AGA3','Alopecia, androgenetic, 3 (2)'),
('612424','EYS','Retinitis pigmentosa 25, 602772 (3)'),
('612424','RP25','Retinitis pigmentosa 25, 602772 (3)'),
('612431','DFNA27','Deafness, autosomal dominant 27 (2)'),
('612433','DFNB45','Deafness, autosomal recessive 45 (2)'),
('612448','ARHI1','{Age-related hearing impairment 1} (2)'),
('612453','EMARDD','early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)'),
('612453','KIAA1780','early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)'),
('612453','MEGF10','early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)'),
('612453','EMARDD','Myopathy, areflexia, respiratory distress, and dysphagia,'),
('612453','KIAA1780','Myopathy, areflexia, respiratory distress, and dysphagia,'),
('612453','MEGF10','Myopathy, areflexia, respiratory distress, and dysphagia,'),
('612459','BMIQ13','[Body mass index QTL13] (2)'),
('612460','BMIQ14','[Body mass index QTL14] (2)'),
('612469','DEL11p14p12','WAGRO syndrome (4)'),
('612469','WAGRO','WAGRO syndrome (4)'),
('612474','C1DELq21','Chromosome 1q21.1 deletion syndrome (4)'),
('612474','DEL1q21','Chromosome 1q21.1 deletion syndrome (4)'),
('612475','C1DUPq21','Chromosome 1q21.1 duplication syndrome (4)'),
('612475','DUP1q21','Chromosome 1q21.1 duplication syndrome (4)'),
('612502','3MC2','3MC syndrome 2, 265050 (3)'),
('612502','CLK1','3MC syndrome 2, 265050 (3)'),
('612502','COLEC11','3MC syndrome 2, 265050 (3)'),
('612513','C2DELp161-p15','Chromosome 2p16.1-p15 deletion syndrome (4)'),
('612513','DEL2p16.1-p15','Chromosome 2p16.1-p15 deletion syndrome (4)'),
('612514','SLI4','{Specific language impairment 4} (2)'),
('612515','C20orf37','Woodhouse-Sakati syndrome, 241080 (3)'),
('612515','DCAF17','Woodhouse-Sakati syndrome, 241080 (3)'),
('612517','C14orf104','Ciliary dyskinesia, primary, 10, 612518 (3)'),
('612517','CILD10','Ciliary dyskinesia, primary, 10, 612518 (3)'),
('612517','KTU','Ciliary dyskinesia, primary, 10, 612518 (3)'),
('612521','IDDM21','{Diabetes mellitus, insulin-dependent, 21} (2)'),
('612525','IHPS5','Pyloric stenosis, infantile hypertrophic, 5 (2)'),
('612530','C1DELq41q42','Chromosome 1q41-q42 deletion syndrome (4)'),
('612530','DEL1q41q42','Chromosome 1q41-q42 deletion syndrome (4)'),
('612554','MYP16','Myopia 16 (2)'),
('612557','CLLS3','{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)'),
('612558','CLLS4','{Leukemia, chronic lymphocytic susceptibility to, 4} (2)'),
('612559','CLLS5','{Leukemia, chronic lymphocytic susceptibility to, 5} (2)'),
('612566','IBD24','{Inflammatory bowel disease 24} (2)'),
('612570','CCA','Contractural arachnodactyly, congenital, 121050 (3)'),
('612570','FBN2','Contractural arachnodactyly, congenital, 121050 (3)'),
('612571','LNCR3','{Lung cancer susceptibility 3} (2)'),
('612573','MPVQTL1','[Mean platelet volume QTL1] (2)'),
('612574','MPVQTL2','[Mean platelet volume QTL2] (2)'),
('612575','MPVQTL3','[Mean platelet volume QTL3] (2)'),
('612576','SHFLD3','Split-hand/foot malformation with long bone deficiency 3 (2)'),
('612578','STQTL15','{Stature QTL 15} (2)'),
('612579','STQTL16','{Stature QTL 16} (2)'),
('612582','C6DELpter','Chromosome 6pter-p24 deletion syndrome (4)'),
('612582','DEL6pter','Chromosome 6pter-p24 deletion syndrome (4)'),
('612586','ANIB9','{Aneurysm, intracranial berry, 9} (2)'),
('612587','ANIB10','{Aneurysm, intracranial berry, 10} (2)'),
('612589','CRCS8','{Colorectal cancer, susceptibility to, 8} (2)'),
('612590','CRCS9','{Colorectal cancer, susceptibility to, 9} (2)'),
('612591','CRCS10','{Colorectal cancer, susceptibility to, 10} (2)'),
('612592','CRCS11','{Colorectal cancer, susceptibility to, 11} (2)'),
('612593','LNCR4','{Lung cancer susceptibility 4} (2)'),
('612594','MS2','{Multiple sclerosis, susceptibility to, 2} (2)'),
('612595','MS3','{Multiple sclerosis, susceptibility to, 3} (2)'),
('612596','MS4','{Multiple sclerosis, susceptibility to, 4} (2)'),
('612599','PSORS11','{Psoriasis susceptibility 11} (2)'),
('612622','IDDM23','{Diabetes mellitus, insulin-dependent, 23} (2)'),
('612625','LMBD1','Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)'),
('612625','LMBRD1','Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)'),
('612625','NESI','Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)'),
('612626','C15DELq26qter','Chromosome 15q26-qter deletion syndrome (4)'),
('612626','DEL15q26qter','Chromosome 15q26-qter deletion syndrome (4)'),
('612627','BFIC4','Seizures, benign familial infantile, 4 (2)'),
('612627','BFIS4','Seizures, benign familial infantile, 4 (2)'),
('612629','ADIPQTL4','{Adiponectin, serum level of, QTL4} (2)'),
('612632','USH1H','Usher syndrome, type 1H (2)'),
('612637','FEB10','Febrile seizures, familial, 10 (2)'),
('612638','NDUFA11','Mitochondrial complex I deficiency, 252010 (3)'),
('612639','IBD26','{Inflammatory bowel disease 26} (2)'),
('612641','ANK1','Spherocytosis, type 1, 182900 (3)'),
('612641','SPH2','Spherocytosis, type 1, 182900 (3)'),
('612642','DFNA59','Deafness, autosomal dominant 59 (2)'),
('612647','CILD11','Ciliary dyskinesia, primary, 11, 612649 (3)'),
('612647','RSPH4A','Ciliary dyskinesia, primary, 11, 612649 (3)'),
('612648','CILD12','Ciliary dyskinesia, primary, 12, 612650 (3)'),
('612648','RSPH9','Ciliary dyskinesia, primary, 12, 612650 (3)'),
('612659','MTFS','Martinez-Frias syndrome, 601346 (3)'),
('612659','RFX6','Martinez-Frias syndrome, 601346 (3)'),
('612659','RFXDC1','Martinez-Frias syndrome, 601346 (3)'),
('612661','DKCB3','Dyskeratosis congenita, autosomal recessive 3, 613988 (3)'),
('612661','TCAB1','Dyskeratosis congenita, autosomal recessive 3, 613988 (3)'),
('612661','WDR79','Dyskeratosis congenita, autosomal recessive 3, 613988 (3)'),
('612661','WRAP53','Dyskeratosis congenita, autosomal recessive 3, 613988 (3)'),
('612671','GOUT4','[Uric acid concentration, serum, QTL4] (2)'),
('612671','UAQTL4','[Uric acid concentration, serum, QTL4] (2)'),
('612676','DHPR','Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)'),
('612676','QDPR','Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)'),
('612688','RNF168','RIDDLE syndrome, 611943 (3)'),
('612691','BOP','Polymicrogyria, bilateral occipital (2)'),
('612715','DUH2','Dyschromatosis universalis hereditaria 2 (2)'),
('612717','MYP15','Myopia 15 (2)'),
('612719','PTS','Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)'),
('612724','ALDOB','Fructose intolerance, 229600 (3)'),
('612727','BMND13','[Bone mineral density QTL 13] (2)'),
('612728','BMND14','[Bone mineral density QTL 14] (2)'),
('612729','LBMQTL1','[Lean body mass QTL 1] (2)'),
('612732','CPOX','Coproporphyria, 121300 (3); Harderoporphyria, 121300 (3)'),
('612737','STQTL17','{Stature QTL 17} (2)'),
('612753','CCBE1','Hennekam lymphangiectasia-lymphedema syndrome, 235510 (3)'),
('612753','KIAA1983','Hennekam lymphangiectasia-lymphedema syndrome, 235510 (3)'),
('612759','SYNSTH','Synesthesia (2)'),
('612761','ADERM','Adermatoglyphia, 136000 (3)'),
('612761','ETL1','Adermatoglyphia, 136000 (3)'),
('612761','HEL1','Adermatoglyphia, 136000 (3)'),
('612761','KIAA1122','Adermatoglyphia, 136000 (3)'),
('612761','SMARCAD1','Adermatoglyphia, 136000 (3)'),
('612772','DUOXA2','Thyroid dyshormonogenesis 5, 274900 (3)'),
('612772','TDH5','Thyroid dyshormonogenesis 5, 274900 (3)'),
('612773','AU','system], 111200 (3); [Blood group, Lutheran null], 247420 (3)'),
('612773','BCAM','system], 111200 (3); [Blood group, Lutheran null], 247420 (3)'),
('612773','LU','system], 111200 (3); [Blood group, Lutheran null], 247420 (3)'),
('612773','AU','[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger'),
('612773','BCAM','[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger'),
('612773','LU','[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger'),
('612779','DPD','5-fluorouracil toxicity, 274270 (3)'),
('612779','DPYD','5-fluorouracil toxicity, 274270 (3)'),
('612779','DPD','Dihydropyrimidine dehydrogenase deficiency, 274270 (3);'),
('612779','DPYD','Dihydropyrimidine dehydrogenase deficiency, 274270 (3);'),
('612789','DFNB71','Deafness, autosomal recessive 71 (2)'),
('612795','PURAQTL1','[Polyunsaturated fatty acids plasma level QTL1] (2)'),
('612796','IBD27','{Inflammatory bowel disease 27} (2)'),
('612804','SARS2','613845 (3)'),
('612804','SARS2','Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis,'),
('612837','C16orf49','Coenzyme Q10 deficiency, 607426 (3)'),
('612837','COQ9','Coenzyme Q10 deficiency, 607426 (3)'),
('612839','KIAA1546','Myelodysplastic syndrome, somatic, 614286 (3)'),
('612839','MDS','Myelodysplastic syndrome, somatic, 614286 (3)'),
('612839','TET2','Myelodysplastic syndrome, somatic, 614286 (3)'),
('612841','MUHH2','Hypotrichosis, hereditary, Marie Unna type, 2 (2)'),
('612848','SDHAF1','Mitochondrial complex II deficiency, 252011 (3)'),
('612850','TUBB2B','Polymicrogyria, asymmetric, 610031 (3)'),
('612851','NRCLP5','{Narcolepsy 5} (2)'),
('612853','RLS7','{Restless legs syndrome 7} (2)'),
('612858','OFC12','Orofacial cleft 12 (2)'),
('612862','CTEPH1','thrombosis, susceptibility to} (2)'),
('612862','CTEPH1','{Pulmonary hypertension, chronic thromboembolic, without deep vein'),
('612863','C6DELq25q25','Chromosome 6q25-q25 deletion syndrome (4)'),
('612863','DEL6q24q25','Chromosome 6q25-q25 deletion syndrome (4)'),
('612881','PVNH5','Periventricular nodular heterotopia 5 (2)'),
('612882','MENAQ2','{Menarche, age at, QTL2} (2)'),
('612883','MENAQ3','{Menarche, age at, QTL3} (2)'),
('612884','MENOQ2','{Menopause, natural, age at, QTL2} (2)'),
('612885','MENOQ3','{Menopause, natural, age at, QTL3} (2)'),
('612886','MENOQ4','{Menopause, natural, age at, QTL4} (2)'),
('612892','STQTL18','{Stature QTL 18} (2)'),
('612893','STQTL19','{Stature QTL 19} (2)'),
('612894','STQTL20','{Stature QTL 20} (2)'),
('612901','TUBB1','Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)'),
('612911','NDUFAF3','Mitochondrial complex I deficiency, 252010 (3)'),
('612929','MTBS3','{Mycobacterium tuberculosis, susceptibility to, 3} (2)'),
('612931','GSD10','Glycogen storage disease X, 261670 (3)'),
('612931','PGAM2','Glycogen storage disease X, 261670 (3)'),
('612931','PGAMM','Glycogen storage disease X, 261670 (3)'),
('612944','RNASE6PL','Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)'),
('612944','RNASET2','Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)'),
('612950','PSORS12','{Psoriasis susceptibility 12} (2)'),
('612957','B6QTL1','{Vitamin B6 plasma level QTL 1} (2)');
INSERT INTO omim VALUES
('612967','BMIQ15','[Body mass index QTL 15] (2)'),
('612968','CATC3','Cataract, autosomal recessive congenital 3 (2)'),
('612971','PDZD7','(3); Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)'),
('612971','PDZD7','{Retinal disease in Usher syndrome type IIA, modifier of}, 276901'),
('612976','ARHI2','{Age-related hearing impairment 2} (2)'),
('612988','OPA7','Optic atrophy-7, 612989 (3)'),
('612988','TMEM126A','Optic atrophy-7, 612989 (3)'),
('612990','ASXL1','Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome,'),
('612990','BOPS','Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome,'),
('612990','KIAA0978','Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome,'),
('612990','MDS','Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome,'),
('612990','ASXL1','somatic, 614286 (3)'),
('612990','BOPS','somatic, 614286 (3)'),
('612990','KIAA0978','somatic, 614286 (3)'),
('612990','MDS','somatic, 614286 (3)'),
('613004','HD','Huntington disease, 143100 (3)'),
('613004','HTT','Huntington disease, 143100 (3)'),
('613004','IT15','Huntington disease, 143100 (3)'),
('613006','IDDM24','{Diabetes mellitus, insulin-dependent, 24} (2)'),
('613007','PBC2','{Biliary cirrhosis, primary, 2} (2)'),
('613008','PBC3','{Biliary cirrhosis, primary, 3} (2)'),
('613009','LP','Pontocerebellar hypoplasia type 2D, 613811 (3)'),
('613009','PCH2D','Pontocerebellar hypoplasia type 2D, 613811 (3)'),
('613009','SEPSECS','Pontocerebellar hypoplasia type 2D, 613811 (3)'),
('613009','SLA','Pontocerebellar hypoplasia type 2D, 613811 (3)'),
('613012','UROC1','Urocanase deficiency, 276880 (3)'),
('613015','NBLST4','{Neuroblastoma, susceptibility to, 4} (2)'),
('613016','NBLST5','{Neuroblastoma, susceptibility to, 5} (2)'),
('613017','NBLST6','{Neuroblastoma, susceptibility to, 6} (2)'),
('613018','TAT','Tyrosinemia, type II, 276600 (3)'),
('613019','PGL2','Paragangliomas 2, 601650 (3)'),
('613019','SDH5','Paragangliomas 2, 601650 (3)'),
('613019','SDHAF2','Paragangliomas 2, 601650 (3)'),
('613022','OGDH','Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)'),
('613024','FL1','{Follicular lymphoma, susceptibility to, 1} (2)'),
('613025','SCZD13','{Schizophrenia, susceptibility to, 13} (2)'),
('613026','C19DELq13.11','Chromosome 19q13.11 deletion syndrome (4)'),
('613026','DEL19q13.11','Chromosome 19q13.11 deletion syndrome (4)'),
('613030','GLM5','{Glioma susceptibility 5} (2)'),
('613031','GLM6','{Glioma susceptibility 6} (2)'),
('613033','GLM8','{Glioma susceptibility 8} (2)'),
('613037','CORS1','Mental retardation, truncal obesity, retinal dystrophy, and'),
('613037','INPP5E','Mental retardation, truncal obesity, retinal dystrophy, and'),
('613037','JBTS1','Mental retardation, truncal obesity, retinal dystrophy, and'),
('613037','MORMS','Mental retardation, truncal obesity, retinal dystrophy, and'),
('613037','CORS1','micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)'),
('613037','INPP5E','micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)'),
('613037','JBTS1','micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)'),
('613037','MORMS','micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)'),
('613055','ATFB8','Atrial fibrillation, familial, 8 (2)'),
('613058','BCC2','{Basal cell carcinoma, susceptibility to, 2} (2)'),
('613059','BCC3','{Basal cell carcinoma, susceptibility to, 3} (2)'),
('613061','BCC4','{Basal cell carcinoma, susceptibility to, 4} (2)'),
('613062','BCC5','{Basal cell carcinoma, susceptibility to, 5} (2)'),
('613063','BCC6','{Basal cell carcinoma, susceptibility to, 6} (2)'),
('613064','ATOD7','{Dermatitis, atopic, susceptibility to, 7} (2)'),
('613065','ALL1','{Leukemia, acute lymphocytic, susceptibility to, 1} (2)'),
('613067','ALL2','{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)'),
('613072','DFNB77','Deafness, autosomal recessive 77, 613079 (3)'),
('613072','LOXHD1','Deafness, autosomal recessive 77, 613079 (3)'),
('613085','GLC3C','Glaucoma 3, primary congenital, C (2)'),
('613088','PVOP2','{Pelvic organ prolapse, susceptibility to, 2} (2)'),
('613096','SPG36','Spastic paraplegia 36, autosomal dominant (2)'),
('613106','BRV2','Vertigo, benign recurrent, 2 (2)'),
('613109','GM2A','GM2-gangliosidosis, AB variant, 272750 (3)'),
('613111','CTSA','Galactosialidosis, 256540 (3)'),
('613111','GLB2','Galactosialidosis, 256540 (3)'),
('613111','GSL','Galactosialidosis, 256540 (3)'),
('613111','NGBE','Galactosialidosis, 256540 (3)'),
('613111','PPGB','Galactosialidosis, 256540 (3)'),
('613113','NF1','myelomonocytic, 607785 (3); Melanoma, desmoplastic neurotrophic (2); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan'),
('613113','NFNS','myelomonocytic, 607785 (3); Melanoma, desmoplastic neurotrophic (2); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan'),
('613113','VRNF','myelomonocytic, 607785 (3); Melanoma, desmoplastic neurotrophic (2); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan'),
('613113','WSS','myelomonocytic, 607785 (3); Melanoma, desmoplastic neurotrophic (2); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan'),
('613113','NF1','Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile'),
('613113','NFNS','Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile'),
('613113','VRNF','Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile'),
('613113','WSS','Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile'),
('613113','NF1','syndrome, 601321 (3); Watson syndrome, 193520 (3)'),
('613113','NFNS','syndrome, 601321 (3); Watson syndrome, 193520 (3)'),
('613113','VRNF','syndrome, 601321 (3); Watson syndrome, 193520 (3)'),
('613113','WSS','syndrome, 601321 (3); Watson syndrome, 193520 (3)'),
('613114','FAM134B','Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)'),
('613114','HSAN2B','Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)'),
('613121','CMD1CC','Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial'),
('613121','CMH20','Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial'),
('613121','NELIN','Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial'),
('613121','NEXN','Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial'),
('613121','CMD1CC','hypertrophic, 20, 613876 (3)'),
('613121','CMH20','hypertrophic, 20, 613876 (3)'),
('613121','NELIN','hypertrophic, 20, 613876 (3)'),
('613121','NEXN','hypertrophic, 20, 613876 (3)'),
('613129','AAF132','612199 (3)'),
('613129','C17orf68','612199 (3)'),
('613129','CRMCC','612199 (3)'),
('613129','CTC1','612199 (3)'),
('613129','AAF132','Cerebroretinal microangiopathy with calcifications and cysts,'),
('613129','C17orf68','Cerebroretinal microangiopathy with calcifications and cysts,'),
('613129','CRMCC','Cerebroretinal microangiopathy with calcifications and cysts,'),
('613129','CTC1','Cerebroretinal microangiopathy with calcifications and cysts,'),
('613138','EVR5','Exudative vitreoretinopathy 5, 613310 (3)'),
('613138','NET2','Exudative vitreoretinopathy 5, 613310 (3)'),
('613138','TSPAN12','Exudative vitreoretinopathy 5, 613310 (3)'),
('613145','SLEB14','{Systemic lupus erythematosus, susceptibility to, 14} (2)'),
('613146','EDICT','EDICT syndrome, 614303 (3)'),
('613146','KTCNCT','EDICT syndrome, 614303 (3)'),
('613146','MIR184','EDICT syndrome, 614303 (3)'),
('613146','MIRN184','EDICT syndrome, 614303 (3)'),
('613160','F8VWF','von Willebrand disease, type 2A, 2B, 2M, and 2N, 613554 (3); von'),
('613160','VWF','von Willebrand disease, type 2A, 2B, 2M, and 2N, 613554 (3); von'),
('613160','F8VWF','Willebrand disease, type 1, 193400 (3); von Willibrand disease, type 3, 277480 (3)'),
('613160','VWF','Willebrand disease, type 1, 193400 (3); von Willibrand disease, type 3, 277480 (3)'),
('613162','SPG45','Spastic paraplegia 45, autosomal recessive (2)'),
('613164','PARK16','{Parkinson disease-16} (2)'),
('613165','CANT1','Desbuquois dysplasia, 251450 (3)'),
('613165','DBQD','Desbuquois dysplasia, 251450 (3)'),
('613165','SCAN1','Desbuquois dysplasia, 251450 (3)'),
('613168','PLI','Alpha-2-plasmin inhibitor deficiency, 262850 (3)'),
('613168','SERPINF2','Alpha-2-plasmin inhibitor deficiency, 262850 (3)'),
('613169','KLHDC8B','Hodgkin lymphoma, 236000 (3)'),
('613171','RBM20','Cardiomyopathy, dilated, 1DD, 613172 (3)'),
('613174','C5DUPp13','Chromosome 5p13 duplication syndrome (4)'),
('613174','DUP5p13','Chromosome 5p13 duplication syndrome (4)'),
('613183','BOLA3','Multiple mitochondrial dysfunctions syndrome 2, 614299 (3)'),
('613183','MMDS2','Multiple mitochondrial dysfunctions syndrome 2, 614299 (3)'),
('613190','CILD13','Ciliary dyskinesia, primary, 13, 613193 (3)'),
('613190','LRRC50','Ciliary dyskinesia, primary, 13, 613193 (3)'),
('613190','ODA7','Ciliary dyskinesia, primary, 13, 613193 (3)'),
('613207','ASRT8','{Asthma-related traits, susceptibility to, 8} (2)'),
('613208','XPC','Xeroderma pigmentosum, group C, 278720 (3)'),
('613208','XPCC','Xeroderma pigmentosum, group C, 278720 (3)'),
('613213','B5R','250800 (3)'),
('613213','CYB5R3','250800 (3)'),
('613213','DIA1','250800 (3)'),
('613213','B5R','Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II,'),
('613213','CYB5R3','Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II,'),
('613213','DIA1','Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II,'),
('613214','AI2A3','Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)'),
('613214','WDR72','Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)'),
('613215','C17DUPp13.3','Chromosome 17p13.3 duplication syndrome (4)'),
('613215','DUP17p13.3','Chromosome 17p13.3 duplication syndrome (4)'),
('613218','CYB5A','Methemoglobinemia, type IV, 250790 (3)'),
('613218','MCB5','Methemoglobinemia, type IV, 250790 (3)'),
('613219','BWQTL1','[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)'),
('613219','FGQTL2','[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)'),
('613228','AGA','Aspartylglucosaminuria, 208400 (3)'),
('613230','PEPD','Prolidase deficiency, 170100 (3)'),
('613233','FGQTL3','[Fasting plasma glucose level QTL 3] (2)'),
('613236','KCNJ18','{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)'),
('613236','KIR2.6','{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)'),
('613236','TTPP2','{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)'),
('613238','SPDA3','{Spondylarthropathy, susceptibility to, 3} (2)'),
('613267','FCD2','Corneal dystrophy, Fuchs endothelial, 3 (2)'),
('613267','FECD3','Corneal dystrophy, Fuchs endothelial, 3 (2)'),
('613269','FCD3','Corneal dystrophy, Fuchs endothelial, 5 (2)'),
('613269','FECD5','Corneal dystrophy, Fuchs endothelial, 5 (2)'),
('613271','FCD4','Corneal dystrophy, Fuchs endothelial, 7 (2)'),
('613271','FECD7','Corneal dystrophy, Fuchs endothelial, 7 (2)'),
('613276','C16orf57','Poikiloderma with neutropenia, 604173 (3)'),
('613276','PN','Poikiloderma with neutropenia, 604173 (3)'),
('613277','CORS2','Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)'),
('613277','JBTS2','Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)'),
('613277','MKS2','Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)'),
('613277','TMEM216','Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)'),
('613278','BTBD12','Fanconi anemia, complementation group P, 613951 (3)'),
('613278','FANCP','Fanconi anemia, complementation group P, 613951 (3)'),
('613278','KIAA1784','Fanconi anemia, complementation group P, 613951 (3)'),
('613278','KIAA1987','Fanconi anemia, complementation group P, 613951 (3)'),
('613278','MUS312','Fanconi anemia, complementation group P, 613951 (3)'),
('613278','SLX4','Fanconi anemia, complementation group P, 613951 (3)'),
('613282','NAFLD1','{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)'),
('613283','GRXCR1','Deafness, autosomal recessive 25, 613285 (3)'),
('613284','HCHGQ3','[Hematocrit/hemoglobin quantitative trait locus 3] (2)'),
('613289','ATXN8','Spinocerebellar ataxia 8, 608768 (3)'),
('613290','CIHL','{?Hearing loss, cisplatin-induced, susceptibility to} (2)'),
('613293','FTHS','Frank-ter Haar syndrome, 249420 (3)'),
('613293','KIAA1295','Frank-ter Haar syndrome, 249420 (3)'),
('613293','SH3PXD2B','Frank-ter Haar syndrome, 249420 (3)'),
('613293','TKS4','Frank-ter Haar syndrome, 249420 (3)'),
('613318','MMD2','Miyoshi muscular dystrophy 2 (2)'),
('613326','DHP','Dihydropyrimidinuria, 222748 (3)'),
('613326','DPYS','Dihydropyrimidinuria, 222748 (3)'),
('613328','RCHTS','?Roifman-Chitayat syndrome (2)'),
('613339','HWE1','Epilepsy, hot water, 1 (2)'),
('613340','HWE2','Epilepsy, hot water, 2 (2)'),
('613349','GACR','Gyrate atrophy of choroid and retina with or without'),
('613349','OAT','Gyrate atrophy of choroid and retina with or without'),
('613349','GACR','ornithinemia, 258870 (3)'),
('613349','OAT','ornithinemia, 258870 (3)'),
('613350','BVVLS','211500 (3)'),
('613350','C20orf54','211500 (3)'),
('613350','RFT2','211500 (3)'),
('613350','BVVLS','Brown-Vialetto-Van Laere syndrome, 211530 (3); Fazio-Londe disease,'),
('613350','C20orf54','Brown-Vialetto-Van Laere syndrome, 211530 (3); Fazio-Londe disease,'),
('613350','RFT2','Brown-Vialetto-Van Laere syndrome, 211530 (3); Fazio-Londe disease,'),
('613354','C9orf75','Deafness, autosomal recessive 79, 613307 (3)'),
('613354','DFNB79','Deafness, autosomal recessive 79, 613307 (3)'),
('613354','TPRN','Deafness, autosomal recessive 79, 613307 (3)'),
('613355','C17DELq23.1q23.2','Chromosome 17q23.1-q23.2 deletion syndrome (4)'),
('613355','DEL17q23.1q23.2','Chromosome 17q23.1-q23.2 deletion syndrome (4)'),
('613364','SPG41','?Spastic paraplegia 41, autosomal dominant (2)'),
('613371','SCA30','?Spinocerebellar ataxia 30 (2)'),
('613381','CBS','Homocystinuria, B6-responsive and nonresponsive types, 236200 (3);'),
('613381','CBS','Thrombosis, hyperhomocysteinemic, 236200 (3)'),
('613386','POMP','keratoderma, 601952 (3)'),
('613386','UMP1','keratoderma, 601952 (3)'),
('613386','POMP','Keratosis linearis with ichthyosis congenita and sclerosing'),
('613386','UMP1','Keratosis linearis with ichthyosis congenita and sclerosing'),
('613387','NAFLD2','{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)'),
('613392','DFNB85','Deafness, autosomal recessive 85 (2)'),
('613401','C14orf133','Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)'),
('613401','SPE39','Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)'),
('613401','VIPAR','Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)'),
('613403','TMEM127','{Pheochromocytoma, susceptibility to}, 171300 (3)'),
('613405','BMND15','[Bone mineral density QTL 15], 613418 (3)'),
('613405','MIR2861','[Bone mineral density QTL 15], 613418 (3)'),
('613405','MIRN2861','[Bone mineral density QTL 15], 613418 (3)'),
('613406','CHR15DELq24','Chromosome 15q24 deletion syndrome (4)'),
('613406','DEL15q24','Chromosome 15q24 deletion syndrome (4)'),
('613407','LPRS6','{Leprosy, susceptiblity to, 6} (2)'),
('613412','EOE2','{Esophagitis, eosinophilic, 2} (2)'),
('613425','C2orf71','Retinitis pigmentosa 54, 613428 (3)'),
('613440','STQTL21','{Stature QTL 21} (2)'),
('613441','TC2','Transcobalamin II deficiency, 275350 (3)'),
('613441','TCN2','Transcobalamin II deficiency, 275350 (3)'),
('613444','BMIQ16','Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass'),
('613444','C16DELp11.2','Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass'),
('613444','DEL16p.11.2','Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass'),
('613444','BMIQ16','index QTL16] (4)'),
('613444','C16DELp11.2','index QTL16] (4)'),
('613444','DEL16p.11.2','index QTL16] (4)'),
('613457','C14DELq11q22','Chromosome 14q11-q22 deletion syndrome (4)'),
('613457','DEL14q11q22','Chromosome 14q11-q22 deletion syndrome (4)'),
('613458','C16DUPq13.3','Chromosome 16p13.3 duplication syndrome (4)'),
('613458','DUP16p13.3','Chromosome 16p13.3 duplication syndrome (4)'),
('613459','BWQTL2','[Birth weight QTL 2] (2)'),
('613460','BWQTL3','[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2);'),
('613460','FGQTL6','[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2);'),
('613460','PGQTL1','[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2);'),
('613460','BWQTL3','[Plasma glucose, 2-hour, QTL 1] (2)'),
('613460','FGQTL6','[Plasma glucose, 2-hour, QTL 1] (2)'),
('613460','PGQTL1','[Plasma glucose, 2-hour, QTL 1] (2)'),
('613462','FGQTL4','[Fasting plasma glucose level QTL 4] (2)'),
('613468','AC','Farber lipogranulomatosis, 228000 (3)'),
('613468','ASAH1','Farber lipogranulomatosis, 228000 (3)'),
('613469','HPA2','Urofacial syndrome, 236730 (3)'),
('613469','HPSE2','Urofacial syndrome, 236730 (3)'),
('613469','UFS','Urofacial syndrome, 236730 (3)'),
('613497','CESD','(3)'),
('613497','LIPA','(3)'),
('613497','CESD','Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000'),
('613497','LIPA','Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000'),
('613498','SXGQTL1','[Sex hormone-binding blobulin circulating level QTL 1] (2)'),
('613509','C4DELq21','Chromosome 4q21 deletion syndrome (4)'),
('613509','DEL4q21','Chromosome 4q21 deletion syndrome (4)'),
('613521','UROD','176100 (3)'),
('613521','UROD','Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic,'),
('613522','BCP','Colorblindness, tritan, 190900 (3)'),
('613522','CBT','Colorblindness, tritan, 190900 (3)'),
('613522','OPN1SW','Colorblindness, tritan, 190900 (3)'),
('613523','SCLL','Chromosome 8p11 myeloproliferative syndrome (4)'),
('613524','CCCAP SLSN7','Senior-Loken syndrome 7, 613615 (3)'),
('613524','SDCCAG8','Senior-Loken syndrome 7, 613615 (3)'),
('613529','CEP152','Microcephaly, primary autosomal recessive, 4, 604321 (3);'),
('613529','KIAA0912','Microcephaly, primary autosomal recessive, 4, 604321 (3);'),
('613529','MCPH4','Microcephaly, primary autosomal recessive, 4, 604321 (3);'),
('613529','SCKL5','Microcephaly, primary autosomal recessive, 4, 604321 (3);'),
('613529','CEP152','Seckel syndrome 5, 613823 (3)'),
('613529','KIAA0912','Seckel syndrome 5, 613823 (3)'),
('613529','MCPH4','Seckel syndrome 5, 613823 (3)'),
('613529','SCKL5','Seckel syndrome 5, 613823 (3)'),
('613530','LGMD1H','Muscular dystrophy, limb-girdle, type 1H (2)'),
('613533','C17DUPq21.31','Chromosome 17q21.31 duplication syndrome (4)'),
('613533','DUP17q21.31','Chromosome 17q21.31 duplication syndrome (4)'),
('613541','C12orf65','Combined oxidative phosphorylation deficiency 7, 613559 (3)'),
('613541','COXPD7','Combined oxidative phosphorylation deficiency 7, 613559 (3)'),
('613544','C6DELq11q14','Chromosome 6q11-q14 deletion syndrome (4)'),
('613544','DEL6q11q14','Chromosome 6q11-q14 deletion syndrome (4)'),
('613545','MACST','Macrostomia (2)'),
('613547','STQTL22','{Stature QTL 22} (2)'),
('613548','STQTL23','{Stature QTL 23} (2)'),
('613549','STQTL24','{Stature QTL 24} (2)'),
('613553','APP3','Nephronophthisis-like nephropathy 1, 613159 (3)'),
('613553','NPHPL1','Nephronophthisis-like nephropathy 1, 613159 (3)'),
('613553','XPNPEP3','Nephronophthisis-like nephropathy 1, 613159 (3)'),
('613558','C9DUPq21.11','Deafness, autosomal dominant 51 (4)'),
('613558','DFNA51','Deafness, autosomal dominant 51 (4)'),
('613558','DUP9q21.11','Deafness, autosomal dominant 51 (4)'),
('613564','C2DELp12p11.2','Chromosome 2p12-p11.2 deletion syndrome (4)'),
('613564','DEL2p12p11.2','Chromosome 2p12-p11.2 deletion syndrome (4)'),
('613576','EDSS2','Ectodermal dysplasia-syndactyly syndrome 2 (2)'),
('613577','FIME','Myoclonic epilepsy, infantile, familial, 605021 (3)'),
('613577','KIAA1171','Myoclonic epilepsy, infantile, familial, 605021 (3)'),
('613577','TBC1D24','Myoclonic epilepsy, infantile, familial, 605021 (3)'),
('613580','BBS15','Bardet-Biedl syndrome 15, 209900 (3)'),
('613580','C2orf86','Bardet-Biedl syndrome 15, 209900 (3)'),
('613583','C19orf14','cortical malformations, 604317 (3)'),
('613583','MCPH2','cortical malformations, 604317 (3)'),
('613583','WDR62','cortical malformations, 604317 (3)'),
('613583','C19orf14','Microcephaly 2, primary, autosomal recessive, with or without'),
('613583','MCPH2','Microcephaly 2, primary, autosomal recessive, with or without'),
('613583','WDR62','Microcephaly 2, primary, autosomal recessive, with or without'),
('613596','FAM161A','Retinitis pigmentosa 28, 606068 (3)'),
('613596','RP28','Retinitis pigmentosa 28, 606068 (3)'),
('613597','DHDPSL','Hyperoxaluria, primary, type III, 613616 (3)'),
('613597','HP3','Hyperoxaluria, primary, type III, 613616 (3)'),
('613598','RP58','Retinitis pigmentosa 58, 613617 (3)'),
('613598','ZNF513','Retinitis pigmentosa 58, 613617 (3)'),
('613599','ABHD12','cataract, 612674 (3)'),
('613599','PHARC','cataract, 612674 (3)'),
('613599','ABHD12','Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and'),
('613599','PHARC','Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and'),
('613602','CED2','Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly'),
('613602','KIAA1336','Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly'),
('613602','NAOFEN','Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly'),
('613602','WDR35','Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly'),
('613602','CED2','syndrome, type V, 614091 (3)'),
('613602','KIAA1336','syndrome, type V, 614091 (3)'),
('613602','NAOFEN','syndrome, type V, 614091 (3)'),
('613602','WDR35','syndrome, type V, 614091 (3)'),
('613603','C4TRIPq32.1q32.2','Chromosome 4q32.1-q32.2 triplication syndrome (4)'),
('613603','TRIP4q32.1q32.2','Chromosome 4q32.1-q32.2 triplication syndrome (4)'),
('613604','C16DELp12.1p11.2','Chromosome 16p12.2-p11.2 deletion syndrome (4)'),
('613604','DEL16p12.1p11.2','Chromosome 16p12.2-p11.2 deletion syndrome (4)'),
('613606','FWS','Forsythe-Wakeling syndrome (2)'),
('613608','FAME3','Epilepsy, myoclonic, familial adult, 3 (2)'),
('613608','FCMTE3','Epilepsy, myoclonic, familial adult, 3 (2)'),
('613609','HFE','7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease,'),
('613609','HFE1','7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease,'),
('613609','HLA-H','7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease,'),
('613609','MVCD7','7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease,'),
('613609','TFQTL2','7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease,'),
('613609','HFE','Hemochromatosis, 235200 (3); {Microvascular complications of diabetes'),
('613609','HFE1','Hemochromatosis, 235200 (3); {Microvascular complications of diabetes'),
('613609','HLA-H','Hemochromatosis, 235200 (3); {Microvascular complications of diabetes'),
('613609','MVCD7','Hemochromatosis, 235200 (3); {Microvascular complications of diabetes'),
('613609','TFQTL2','Hemochromatosis, 235200 (3); {Microvascular complications of diabetes'),
('613609','HFE','susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)'),
('613609','HFE1','susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)'),
('613609','HLA-H','susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)'),
('613609','MVCD7','susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)'),
('613609','TFQTL2','susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)'),
('613618','C17DUPq23.1q23.2','Chromosome 17q23.1-q23.2 duplication syndrome (4)'),
('613618','DUP17q23.1q23.2','Chromosome 17q23.1-q23.2 duplication syndrome (4)'),
('613619','SCARF2','Van den Ende-Gupta syndrome, 600920 (3)'),
('613619','SREC2','Van den Ende-Gupta syndrome, 600920 (3)'),
('613619','VDEGS','Van den Ende-Gupta syndrome, 600920 (3)'),
('613621','IND1','Mitochondrial complex I deficiency, 252010 (3)'),
('613621','NUBPL','Mitochondrial complex I deficiency, 252010 (3)'),
('613622','FOXRED1','Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3);'),
('613622','FOXRED1','Mitochondrial complex I deficiency, 252010 (3)'),
('613624','CAMOS','Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)'),
('613624','KIAA0211','Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)'),
('613624','SCAR5','Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)'),
('613624','ZNF592','Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)'),
('613636','TST1','[Tuberculin skin test reactivity, absence of] (2)'),
('613637','TST2','[Tuberculin skin test reactivity QTL] (2)'),
('613638','C19DELp13.13','Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13'),
('613638','C19DUPp13.13','Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13'),
('613638','DEL19p13.13','Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13'),
('613638','DUP19p13.13','Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13'),
('613638','C19DELp13.13','duplication syndrome (4)'),
('613638','C19DUPp13.13','duplication syndrome (4)'),
('613638','DEL19p13.13','duplication syndrome (4)'),
('613638','DUP19p13.13','duplication syndrome (4)'),
('613653','KIAA0415','Spastic paraplegia 48, autosomal recessive, 613647 (3)'),
('613653','SPG48','Spastic paraplegia 48, autosomal recessive, 613647 (3)'),
('613655','KCNK18','{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)'),
('613655','MGR13','{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)'),
('613655','TRESK','{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)'),
('613655','TRIK','{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)'),
('613658','RJBS','Rajab syndrome (2)'),
('613665','DARC','against}, 611162 (3); [White blood cell count QTL], 611862 (3)'),
('613665','FY','against}, 611162 (3); [White blood cell count QTL], 611862 (3)'),
('613665','GPD','against}, 611162 (3); [White blood cell count QTL], 611862 (3)'),
('613665','WBCQ1','against}, 611162 (3); [White blood cell count QTL], 611862 (3)'),
('613665','DARC','[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection'),
('613665','FY','[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection'),
('613665','GPD','[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection'),
('613665','WBCQ1','[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection'),
('613666','ALG11','Congenital disorder of glycosylation, type Ip, 613661 (3)'),
('613666','CDG1P','Congenital disorder of glycosylation, type Ip, 613661 (3)'),
('613666','KIAA1266','Congenital disorder of glycosylation, type Ip, 613661 (3)'),
('613667','JXC1','613671 (3)'),
('613667','MRAMS','613671 (3)'),
('613667','SOBP','613671 (3)'),
('613667','JXC1','Mental retardation, anterior maxillary protrusion, and strabismus,'),
('613667','MRAMS','Mental retardation, anterior maxillary protrusion, and strabismus,'),
('613667','SOBP','Mental retardation, anterior maxillary protrusion, and strabismus,'),
('613669','MTPAP','Ataxia, spastic, 4, 613672 (3)'),
('613669','PAPD1','Ataxia, spastic, 4, 613672 (3)'),
('613669','SPAX4','Ataxia, spastic, 4, 613672 (3)'),
('613675','DEL17q11.2; C17DELq1','Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)'),
('613680','MMRFCGU','cardiac and genitourinary malformations (2)'),
('613680','MMRFCGU','Microcephaly, mental retardation, and distinctive facies, with'),
('613681','C2DUPq31.1','Chromosome 2q31.1 duplication syndrome (4)'),
('613681','DUP2q31.1','Chromosome 2q31.1 duplication syndrome (4)'),
('613685','DFNB83','Deafness, autosomal recessive 83 (2)'),
('613689','MDNS','Mammary-digital-nail syndrome (2)'),
('613698','CAC','Carnitine-acylcarnitine translocase deficiency, 212138 (3)'),
('613698','CACT','Carnitine-acylcarnitine translocase deficiency, 212138 (3)'),
('613698','SLC25A20','Carnitine-acylcarnitine translocase deficiency, 212138 (3)'),
('613700','DER22t8-22','Supernumerary der(22)t(8-22) syndrome (4)'),
('613715','POLR1D','Treacher Collins syndrome 2, 613717 (3)'),
('613715','RPA16','Treacher Collins syndrome 2, 613717 (3)'),
('613715','RPAC2','Treacher Collins syndrome 2, 613717 (3)'),
('613715','TCS2','Treacher Collins syndrome 2, 613717 (3)'),
('613719','DFNB74','Deafness, autosomal recessive 74, 613718 (3)'),
('613719','MSRB3','Deafness, autosomal recessive 74, 613718 (3)'),
('613726','ANO10','Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)'),
('613726','SCAR10','Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)'),
('613726','TMEM16K','Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)'),
('613727','KBTBD13','Nemaline myopathy 6, 609273 (3)'),
('613727','NEM6','Nemaline myopathy 6, 609273 (3)'),
('613729','C7DELq11.23','Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)'),
('613729','DEL7q11.23','Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)'),
('613733','MEN1','(3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Angiofibroma, somatic (3); Adrenal adenoma, somatic (3)'),
('613733','MEN1','Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung'),
('613735','C1DELp32p31','Chromosome 1p32-p31 deletion syndrome (4)'),
('613735','DEL1p32p31','Chromosome 1p32-p31 deletion syndrome (4)'),
('613741','PYGL','Glycogen storage disease VI, 232700 (3)'),
('613742','G6PC','Glycogen storage disease Ia, 232200 (3)'),
('613742','G6PT','Glycogen storage disease Ia, 232200 (3)'),
('613768','ALO17','{Moyamoya disease 2, susceptibility to}, 607151 (3)'),
('613768','KIAA1618','{Moyamoya disease 2, susceptibility to}, 607151 (3)'),
('613768','MYMY2','{Moyamoya disease 2, susceptibility to}, 607151 (3)'),
('613768','RNF213','{Moyamoya disease 2, susceptibility to}, 607151 (3)'),
('613776','C17DELp13.1','Chromosome 17p13.1 deletion syndrome (4)'),
('613776','DEL17p13.1','Chromosome 17p13.1 deletion syndrome (4)'),
('613785','C1R','C1r/C1s deficiency, combined, 216950 (1)'),
('613792','C3DELpterp25','3p- syndrome (4)'),
('613792','DEL3pterp25','3p- syndrome (4)'),
('613798','CCDC39','Ciliary dyskinesia, primary, 14, 613807 (3)'),
('613799','CCDC40','Ciliary dyskinesia, primary, 15, 613808 (3)'),
('613799','KIAA1640','Ciliary dyskinesia, primary, 15, 613808 (3)'),
('613806','PSC','Cholangitis, primary sclerosing (2)'),
('613814','TTC19','Mitochondrial complex III deficiency, 124000 (3)'),
('613815','CA21H','201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)'),
('613815','CYP21','201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)'),
('613815','CYP21A2','201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)'),
('613815','CA21H','Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency,'),
('613815','CYP21','Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency,'),
('613815','CYP21A2','Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency,'),
('613828','GEFSP8','Generalized epilepsy with febrile seizures plus, type 8 (2)'),
('613836','ADIPQTL5','{Adiponectin, serum level of, QTL5] (2)'),
('613846','MKS8','Meckel syndrome, type 8, 613885 (3)'),
('613846','TCTN2','Meckel syndrome, type 8, 613885 (3)'),
('613846','TECT2','Meckel syndrome, type 8, 613885 (3)'),
('613857','OFC13','Orofacial cleft 13 (2)'),
('613858','MCOP6','Microphthalmia, isolated 6, 613517 (3)'),
('613858','PRSS56','Microphthalmia, isolated 6, 613517 (3)'),
('613868','JK','[Blood group, Kidd], 111000 (3)'),
('613868','SLC14A1','[Blood group, Kidd], 111000 (3)'),
('613868','UT1','[Blood group, Kidd], 111000 (3)'),
('613868','UTE','[Blood group, Kidd], 111000 (3)'),
('613871','FAH','Tyrosinemia, type I, 276700 (3)'),
('613872','F10','Factor X deficiency, 227600 (3)'),
('613878','F7','decreased susceptibility to}, 608446 (3)'),
('613878','F7','Factor VII deficiency, 227500 (3); {Myocardial infarction,'),
('613879','TRH','Thyrotropin-releasing hormone deficiency, 275120 (1)'),
('613883','KEL','[Blood group, Kell], 110900 (3)'),
('613884','C13DELq14','Chromosome 13q14 deletion syndrome (4)'),
('613884','DEL13q14','Chromosome 13q14 deletion syndrome (4)'),
('613890','HSD3B2','3-beta-hydroxysteroid dehydrogenase, type II, deficiency, 201810 (3)'),
('613891','OPRT','Orotic aciduria, 258900 (3)'),
('613891','UMPS','Orotic aciduria, 258900 (3)'),
('613893','DPY19L2','Spermatogenic failure 9, 613958 (3)'),
('613893','SPGF9','Spermatogenic failure 9, 613958 (3)'),
('613896','BPGM','222800 (3)'),
('613896','BPGM','Erythrocytosis due to bisphosphoglycerate mutase deficiency,'),
('613897','FANCF','Fanconi anemia, complementation group F, 603467 (3)'),
('613898','HMGCL','HMG-CoA lyase deficiency, 246450 (3)'),
('613899','FACC','Fanconi anemia, complementation group C, 227645 (3)'),
('613899','FANCC','Fanconi anemia, complementation group C, 227645 (3)'),
('613900','SCA35','Spinocerebellar ataxia 35, 613908 (3)'),
('613900','TG6','Spinocerebellar ataxia 35, 613908 (3)'),
('613900','TGM6','Spinocerebellar ataxia 35, 613908 (3)'),
('613900','TGY','Spinocerebellar ataxia 35, 613908 (3)'),
('613909','SCA32','Spinocerebellar ataxia 32 (2)'),
('613916','DFNB89','Deafness, autosomal recessive 89 (2)'),
('613920','C2orf64','Mitochondrial complex IV deficiency, 220110 (3)'),
('613920','PET191','Mitochondrial complex IV deficiency, 220110 (3)'),
('613924','LI4','Ichthyosis, lamellar, 4, 613943 (3)'),
('613924','LIPL4','Ichthyosis, lamellar, 4, 613943 (3)'),
('613924','LIPN','Ichthyosis, lamellar, 4, 613943 (3)'),
('613927','C2','C2 deficiency, 217000 (3); {Macular degeneration, age-related,'),
('613927','C2','reduced risk of}, 603075 (3)'),
('613930','APMR3','Alopecia-mental retardation syndrome 3 (2)'),
('613938','PSMNSW','Parasomnia, sleepwalking type (2)'),
('613944','IGAN2','{IgA nephropathy, susceptibility to, 2} (2)'),
('613959','C16DUPq36.3','Schizophrenia 16 (4)'),
('613959','DUP7q36.3','Schizophrenia 16 (4)'),
('613959','SCZD16','Schizophrenia 16 (4)'),
('613969','MYP19','Myopia 19 (2)'),
('613976','FACE','Fanconi anemia, complementation group E, 600901 (3)'),
('613976','FANCE','Fanconi anemia, complementation group E, 600901 (3)'),
('613979','ANT1','Retinitis pigmentosa 60, 613983 (3)'),
('613979','C20orf14','Retinitis pigmentosa 60, 613983 (3)'),
('613979','PRP6','Retinitis pigmentosa 60, 613983 (3)'),
('613979','PRPF6','Retinitis pigmentosa 60, 613983 (3)'),
('613979','TOM','Retinitis pigmentosa 60, 613983 (3)'),
('613984','FACD','Fanconi anemia, complementation group D2, 227646 (3)'),
('613984','FAD','Fanconi anemia, complementation group D2, 227646 (3)'),
('613984','FANCD','Fanconi anemia, complementation group D2, 227646 (3)'),
('613984','FANCD2','Fanconi anemia, complementation group D2, 227646 (3)'),
('614010','GPAPP','Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)'),
('614010','IMPA3','Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)'),
('614010','IMPAD1','Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)'),
('614021','CPVT3','Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)'),
('614041','RB1','Bladder cancer, somatic, 109800 (3); Small cell cancer of the lung, somatic, 182280 (3); Retinoblastoma, trilateral, 180200 (3)'),
('614041','RB1','Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3);'),
('614058','KHK','[Fructosuria], 229800 (3)'),
('614064','ICF2','614069 (3)'),
('614064','KIAA0441','614069 (3)'),
('614064','PATZ2','614069 (3)'),
('614064','ZBTB24','614069 (3)'),
('614064','ZNF450','614069 (3)'),
('614064','ICF2','Immunodeficiency-centromeric instability-facial anomalies syndrome-2,'),
('614064','KIAA0441','Immunodeficiency-centromeric instability-facial anomalies syndrome-2,'),
('614064','PATZ2','Immunodeficiency-centromeric instability-facial anomalies syndrome-2,'),
('614064','ZBTB24','Immunodeficiency-centromeric instability-facial anomalies syndrome-2,'),
('614064','ZNF450','Immunodeficiency-centromeric instability-facial anomalies syndrome-2,'),
('614068','C14orf179','Cranioectodermal dysplasia 3, 614099 (3)'),
('614068','CED3','Cranioectodermal dysplasia 3, 614099 (3)'),
('614068','IFT43','Cranioectodermal dysplasia 3, 614099 (3)'),
('614088','CD242','[Blood group, Landsteiner-Wiener], 111250 (3)'),
('614088','ICAM4','[Blood group, Landsteiner-Wiener], 111250 (3)'),
('614088','LW','[Blood group, Landsteiner-Wiener], 111250 (3)'),
('614095','PCK2','PEPCK deficiency, mitochondrial, 261650 (1)'),
('614095','PEPCK2','PEPCK deficiency, mitochondrial, 261650 (1)'),
('614123','CFSMR','Craniofacial dysmorphism, skeletal anomalies, and mental retardation'),
('614123','TMCO1','Craniofacial dysmorphism, skeletal anomalies, and mental retardation'),
('614123','CFSMR','syndrome, 614132 (3)'),
('614123','TMCO1','syndrome, 614132 (3)'),
('614129','DFNB81','Deafness, autosomal recessive 81 (2)'),
('614140','KIAA0376','Facial clefting, oblique, 1, 600251 (3)'),
('614140','OBLFC1','Facial clefting, oblique, 1, 600251 (3)'),
('614140','SPECC1L','Facial clefting, oblique, 1, 600251 (3)'),
('614144','B9D1','Meckel syndrome 9, 614209 (3)'),
('614144','MKS9','Meckel syndrome 9, 614209 (3)'),
('614144','MKSR1','Meckel syndrome 9, 614209 (3)'),
('614145','3M3','Three M syndrome 3, 614205 (3)'),
('614145','CCDC8','Three M syndrome 3, 614205 (3)'),
('614149','NDNC9','Nail disorder, nonsyndromic congenital, 9 (2)'),
('614154','NOP56','Spinocerebellar ataxia 36, 614153 (3)'),
('614154','SCA36','Spinocerebellar ataxia 36, 614153 (3)'),
('614159','MYP21','Myopia 21, autosomal dominant, 614167 (3)'),
('614159','ZNF644','Myopia 21, autosomal dominant, 614167 (3)'),
('614161','BCS2','Brittle cornea syndrome 2, 614170 (3)'),
('614161','PRDM5','Brittle cornea syndrome 2, 614170 (3)'),
('614166','MYP20','Myopia 20, autosomal dominant (2)'),
('614168','PCK1','(1)'),
('614168','PCK1','?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680'),
('614169','BDPLT4','Gray platelet syndrome, 139090 (3)'),
('614169','GPS','Gray platelet syndrome, 139090 (3)'),
('614169','KIAA0540','Gray platelet syndrome, 139090 (3)'),
('614169','NBEAL2','Gray platelet syndrome, 139090 (3)'),
('614184','DIS3L2','Perlman syndrome, 267000 (3)'),
('614184','PRLMNS','Perlman syndrome, 267000 (3)'),
('614187','HPPD','Hypertelorism, preauricular sinus, punctal pits, and deafness (2)'),
('614194','AOS2','Adams-Oliver syndrome 2, 614219 (3)'),
('614194','DOCK6','Adams-Oliver syndrome 2, 614219 (3)'),
('614194','KIAA1395','Adams-Oliver syndrome 2, 614219 (3)'),
('614207','MRT17','Mental retardation, autosomal recessive 17/21 (2)'),
('614207','MRT21','Mental retardation, autosomal recessive 17/21 (2)'),
('614208','MRT16','Mental retardation, autosomal recessive 16 (2)'),
('614210','LNCR5','{Lung cancer susceptibility 5} (2)'),
('614211','DFNA33','Deafness, autosomal dominant 33 (2)'),
('614215','ASCC1','Barrett esophagus/esophageal adenocarcinoma, 614266 (3)'),
('614215','p50','Barrett esophagus/esophageal adenocarcinoma, 614266 (3)'),
('614220','PBC4','Biliary cirrhosis, primary, 4 (2)'),
('614221','PBC5','Biliary cirrhosis, primary, 5 (2)'),
('614223','NRCLP6','Narcolepsy 6 (2)'),
('614227','HNFJ3','Hyperuricemic nephropathy, familial juvenile, 3 (2)'),
('614230','C8DELq21.11','Chromosome 8q21.11 deletion syndrome (4)'),
('614230','DEL8q21.11','Chromosome 8q21.11 deletion syndrome (4)'),
('614232','AME','Apparent mineralocorticoid excess, 218030 (3)'),
('614232','HSD11B2','Apparent mineralocorticoid excess, 218030 (3)'),
('614232','HSD11K','Apparent mineralocorticoid excess, 218030 (3)'),
('614233','FPH1','Hyperpigmentation, familial progressive, 1 (2)'),
('614233','HPP','Hyperpigmentation, familial progressive, 1 (2)'),
('614233','MUH','Hyperpigmentation, familial progressive, 1 (2)'),
('614237','HYPT9','Hypotrichosis 9 (2)'),
('614238','HYP10','Hypotrichosis 10 (2)'),
('614243','OPLAH','5-oxoprolinase deficiency, 260005 (3)'),
('614243','OPLAHD','5-oxoprolinase deficiency, 260005 (3)'),
('614245','ACSF3','Combined malonic and methylmalonic aciduria, 614265 (3)'),
('614252','ANIB11','Aneurysm, intracranial berry, 11 (2)'),
('614258','ADDH','and/or hypogonadotropic hypogonadism, 607694 (3)'),
('614258','HLD7','and/or hypogonadotropic hypogonadism, 607694 (3)'),
('614258','POLR3A','and/or hypogonadotropic hypogonadism, 607694 (3)'),
('614258','RPC1','and/or hypogonadotropic hypogonadism, 607694 (3)'),
('614258','RPC155','and/or hypogonadotropic hypogonadism, 607694 (3)'),
('614258','ADDH','Leukodystrophy, hypomyelinating, 7, with or without oligodontia'),
('614258','HLD7','Leukodystrophy, hypomyelinating, 7, with or without oligodontia'),
('614258','POLR3A','Leukodystrophy, hypomyelinating, 7, with or without oligodontia'),
('614258','RPC1','Leukodystrophy, hypomyelinating, 7, with or without oligodontia'),
('614258','RPC155','Leukodystrophy, hypomyelinating, 7, with or without oligodontia'),
('614259','VWS2','van der Woude syndrome 2, 606713 (3)'),
('614259','WDR65','van der Woude syndrome 2, 606713 (3)'),
('614260','ALSFTD','(3)'),
('614260','C9orf72','(3)'),
('614260','FTDALS','(3)'),
('614260','ALSFTD','Amyotrophic lateral sclerosis with frontotemporal dementia, 105550'),
('614260','C9orf72','Amyotrophic lateral sclerosis with frontotemporal dementia, 105550'),
('614260','FTDALS','Amyotrophic lateral sclerosis with frontotemporal dementia, 105550'),
('614280','EJM9','{Epilepsy, juvenile myoclonic, susceptiblity to, 9} (2)'),
('614283','GCTR','{Glucocorticoid therapy, response to}, 614400 (3)'),
('614283','GLCCI1','{Glucocorticoid therapy, response to}, 614400 (3)'),
('614283','TSSN1','{Glucocorticoid therapy, response to}, 614400 (3)'),
('614290','TET18P','Tetrasomy 18p (4)'),
('614294','C15DELq25','Chromosome 15q25 deletion syndrome (4)'),
('614294','DEL15q25','Chromosome 15q25 deletion syndrome (4)'),
('614295','BICC','{Renal dysplasia, cystic, susceptibility to}, 601331 (3)'),
('614295','BICC1','{Renal dysplasia, cystic, susceptibility to}, 601331 (3)'),
('614295','CYSRD','{Renal dysplasia, cystic, susceptibility to}, 601331 (3)'),
('614297','C19orf12','Neurodegeneration with brain iron accumulation 4, 614298 (3)'),
('614317','VUR4','Vesicoureteral reflux 4 (2)'),
('614318','VUR5','Vesicoureteral reflux 5 (2)'),
('614319','VUR6','Vesicoureteral reflux 6 (2)'),
('614322','SCAR12','Spinocerebellar ataxia, autosomal recessive 12 (2)'),
('614329','MRT31','Mental retardation, autosomal recessive 31 (2)'),
('614333','MRT29','Mental retardation, autosomal recessive 29 (2)'),
('614339','MRT32','Mental retardation, autosomal recessive 32 (2)'),
('614340','MRT27','Mental retardation, autosomal recessive 27 (2)'),
('614341','MRT33','Mental retardation, autosomal recessive 33 (2)'),
('614342','MRT30','Mental retardation, autosomal recessive 30 (2)'),
('614343','MRT19','Mental retardation, autosomal recessive 19 (2)'),
('614344','MRT23','Mental retardation, autosomal recessive 23 (2)'),
('614345','MRT24','Mental retardation, autosomal recessive 24 (2)'),
('614346','MRT25','Mental retardation, autosomal recessive 25 (2)'),
('614347','MRT28','Mental retardation, autosomal recessive 28 (2)'),
('614366','C128','and/or hypogonadotropic hypogonadism, 614381 (3)'),
('614366','HLD8','and/or hypogonadotropic hypogonadism, 614381 (3)'),
('614366','POLR3B','and/or hypogonadotropic hypogonadism, 614381 (3)'),
('614366','RPC2','and/or hypogonadotropic hypogonadism, 614381 (3)'),
('614366','C128','Leukodystrophy, hypomyelinating, 8, with or without oligodontia'),
('614366','HLD8','Leukodystrophy, hypomyelinating, 8, with or without oligodontia'),
('614366','POLR3B','Leukodystrophy, hypomyelinating, 8, with or without oligodontia'),
('614366','RPC2','Leukodystrophy, hypomyelinating, 8, with or without oligodontia'),
('614375','AAA4','Aortic aneurysm, familial abdominal, 4 (2)'),
('614386','DYT10','Episodic kinesigenic dyskinesia 1, 128200 (3)'),
('614386','EKD1','Episodic kinesigenic dyskinesia 1, 128200 (3)'),
('614386','PKC','Episodic kinesigenic dyskinesia 1, 128200 (3)'),
('614386','PRRT2','Episodic kinesigenic dyskinesia 1, 128200 (3)'),
('614404','IRHOM2','Tylosis with esophageal cancer, 148500 (3)'),
('614404','RHBDF2','Tylosis with esophageal cancer, 148500 (3)'),
('614404','TOC','Tylosis with esophageal cancer, 148500 (3)'),
('614409','SPG46','Spastic paraplegia 46, autosomal recessive (2)'),
('614414','DFNB96','Deafness, autosomal recessive 96 (2)'),
('614422','CCA5','Cataract, congenital cerulean type, 5 (2)'),
('614423','ALS2CR4','Joubert syndrome 14, 614424 (3)'),
('614423','JBTS14','Joubert syndrome 14, 614424 (3)'),
('614423','TMEM237','Joubert syndrome 14, 614424 (3)'),
('614427','CAA','Aural atresia, congenital, 607842 (3)'),
('614427','TSH1','Aural atresia, congenital, 607842 (3)'),
('614427','TSHZ1','Aural atresia, congenital, 607842 (3)'),
('614459','JBTS16','Joubert syndrome 16, 614465 (3)'),
('614459','TMEM138','Joubert syndrome 16, 614465 (3)'),
('614477','C8orf37','(3)'),
('614477','CORD16','(3)'),
('614477','RP64','(3)'),
('614477','C8orf37','Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500'),
('614477','CORD16','Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500'),
('614477','RP64','Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500'),
('614478','C12orf62','Mitochondrial complex IV deficiency, 220110 (3)'),
('614494','RP63','Retinitis pigmentosa 63 (2)'),
('614505','EDSKMH','and hearing loss, 614557 (3)'),
('614505','FKBP14','and hearing loss, 614557 (3)'),
('614505','EDSKMH','Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy,'),
('614505','FKBP14','Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy,'),
('614506','BAAT1','614498 (3)'),
('614506','BRAT1','614498 (3)'),
('614506','C7orf27','614498 (3)'),
('614506','RMFSL','614498 (3)'),
('614506','BAAT1','Rigidity and multifocal seizure syndrome, lethal neonatal,'),
('614506','BRAT1','Rigidity and multifocal seizure syndrome, lethal neonatal,'),
('614506','C7orf27','Rigidity and multifocal seizure syndrome, lethal neonatal,'),
('614506','RMFSL','Rigidity and multifocal seizure syndrome, lethal neonatal,'),
('614515','CSNB1E','Night blindness, congenital stationary, type 1E, 614565 (3)'),
('614515','GPR158L','Night blindness, congenital stationary, type 1E, 614565 (3)'),
('614515','GPR158L1','Night blindness, congenital stationary, type 1E, 614565 (3)'),
('614515','GPR179','Night blindness, congenital stationary, type 1E, 614565 (3)'),
('614526','C17DUPq12','Chromosome 17q12 duplication syndrome (4)'),
('614526','DUP17q12','Chromosome 17q12 duplication syndrome (4)'),
('614527','C17DELq12','Chromosome 17q12 deletion syndrome (4)'),
('614527','DEL17q12','Chromosome 17q12 deletion syndrome (4)'),
('614530','NDUFA12','256000 (3)'),
('614530','NDUFA12','Leigh syndrome due to mitochondrial complex 1 deficiency,'),
('614541','C16DELq22','Chromosome 16q22 deletion syndrome (4)'),
('614541','DEL16q22','Chromosome 16q22 deletion syndrome (4)'),
('614556','ARID1B','Mental retardation, autosomal dominant 12, 614562 (3)'),
('614556','BAF250B','Mental retardation, autosomal dominant 12, 614562 (3)'),
('614556','KIAA1235','Mental retardation, autosomal dominant 12, 614562 (3)'),
('614556','MRD12','Mental retardation, autosomal dominant 12, 614562 (3)'),
('614566','CILD2','Ciliary dyskinesia, primary, 2, 606763 (3)'),
('614566','DAB1','Ciliary dyskinesia, primary, 2, 606763 (3)'),
('614566','DNAAF3','Ciliary dyskinesia, primary, 2, 606763 (3)'),
('614566','PF22','Ciliary dyskinesia, primary, 2, 606763 (3)'),
('614567','AUNA1','Auditory neuropathy, autosomal dominant, 1, 609129 (3)'),
('614567','DIA2','Auditory neuropathy, autosomal dominant, 1, 609129 (3)');
